Citrus Sinensis ID: 019844
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 335 | 2.2.26 [Sep-21-2011] | |||||||
| Q39019 | 421 | Shaggy-related protein ki | yes | no | 0.597 | 0.475 | 0.805 | 5e-92 | |
| Q9FVS6 | 420 | Shaggy-related protein ki | no | no | 0.591 | 0.471 | 0.783 | 5e-89 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.573 | 0.467 | 0.638 | 8e-71 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.573 | 0.467 | 0.653 | 2e-70 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.576 | 0.469 | 0.655 | 2e-69 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.519 | 0.429 | 0.694 | 2e-69 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.540 | 0.442 | 0.668 | 7e-68 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.564 | 0.460 | 0.625 | 8e-68 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.573 | 0.469 | 0.616 | 3e-67 | |
| Q96287 | 472 | Shaggy-related protein ki | no | no | 0.525 | 0.372 | 0.661 | 2e-65 |
| >sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 337 bits (865), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 162/201 (80%), Positives = 181/201 (90%), Gaps = 1/201 (0%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MAS+ LGNG VG+SRS G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1 MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 181 PLIYVKLYTYQICRALAYIHN 201
PLIYVKLYTYQICRALAYIHN
Sbjct: 180 PLIYVKLYTYQICRALAYIHN 200
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 156/199 (78%), Positives = 178/199 (89%), Gaps = 1/199 (0%)
Query: 4 ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
+ LGNG VGSSRS K++SSSVDWL R+MLEM++RD+ + DE+RDSEPDIIDGVGAE
Sbjct: 3 SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61
Query: 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62 GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181
Query: 184 YVKLYTYQICRALAYIHNC 202
YVKLYTYQICR LAY+HNC
Sbjct: 182 YVKLYTYQICRGLAYLHNC 200
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 127/199 (63%), Positives = 158/199 (79%), Gaps = 7/199 (3%)
Query: 6 LGNGGVGSSRSVNGFKSSSS-SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETG 64
+ GV + + +SS+ +VD L E+L MR++D D++ E ++DG E G
Sbjct: 1 MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKD------DKEMEAHVVDGNSTEAG 54
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
HVI TTIGG+NG KQ +SY+AE VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55 HVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
ELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+YS+++QRMPLIY
Sbjct: 115 ELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIY 174
Query: 185 VKLYTYQICRALAYIHNCI 203
VKLY+YQICR+LAYIHNC+
Sbjct: 175 VKLYSYQICRSLAYIHNCV 193
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 130/199 (65%), Positives = 160/199 (80%), Gaps = 7/199 (3%)
Query: 6 LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEP-DIIDGVGAETG 64
+ +GGV + +SS V+ L EM +M++RD D++ E I+DG G ETG
Sbjct: 1 MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRD------DKEMEAATIVDGNGTETG 54
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
H+I TTIGG+NG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55 HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
ELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y++++QRMP+IY
Sbjct: 115 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIY 174
Query: 185 VKLYTYQICRALAYIHNCI 203
VKLY+YQICRALAYIHN I
Sbjct: 175 VKLYSYQICRALAYIHNSI 193
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 131/200 (65%), Positives = 156/200 (78%), Gaps = 7/200 (3%)
Query: 4 ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
AS+G R V G D L EM +M++RD DR+ E ++DG G ET
Sbjct: 2 ASVGVAPTSGFREVLG-DGEIGVDDILPEEMSDMKIRD------DREMEATVVDGNGTET 54
Query: 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
GH+I TTIGGRNG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKN
Sbjct: 55 GHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKN 114
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
RELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++YS+++QRMP+I
Sbjct: 115 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMI 174
Query: 184 YVKLYTYQICRALAYIHNCI 203
YVKLYTYQI RAL+YIH CI
Sbjct: 175 YVKLYTYQIFRALSYIHRCI 194
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 125/180 (69%), Positives = 152/180 (84%), Gaps = 6/180 (3%)
Query: 24 SSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS 83
S+ VD L EM +M++RD D++ E ++DG G ETGH+I TTIGGRNG KQ +S
Sbjct: 15 STGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS 68
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 143
Y+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHC
Sbjct: 69 YMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHC 128
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
FFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH CI
Sbjct: 129 FFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCI 188
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 127/190 (66%), Positives = 155/190 (81%), Gaps = 9/190 (4%)
Query: 17 VNGFKSSSS---SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGG 73
V+G + SSS VD L EM +MR+RD D++ E I+DG G ETGH+I TTIGG
Sbjct: 9 VSGLRESSSHSVGVDRLPEEMNDMRIRD------DKEIEAAIVDGNGTETGHIIVTTIGG 62
Query: 74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLD 133
R+G KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LD
Sbjct: 63 RHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y++++QRMPLI VKLYTYQI
Sbjct: 123 HPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIF 182
Query: 194 RALAYIHNCI 203
RAL+YIH+ I
Sbjct: 183 RALSYIHHTI 192
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 122/195 (62%), Positives = 154/195 (78%), Gaps = 6/195 (3%)
Query: 9 GGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIR 68
G + +S ++S + L + EM+++D D++ E ++DG G ETGH+I
Sbjct: 5 GTLPASSMATKQSNASICAEKLPEGINEMKIKD------DKEMEAAVVDGNGTETGHIIV 58
Query: 69 TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI 128
TTIGG+NG KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ
Sbjct: 59 TTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YSR +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178
Query: 189 TYQICRALAYIHNCI 203
TYQICRALAYIH +
Sbjct: 179 TYQICRALAYIHGGV 193
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 122/198 (61%), Positives = 157/198 (79%), Gaps = 6/198 (3%)
Query: 6 LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGH 65
+ + G+ S +V + + D L EM +M+++D D++ E I++G ETGH
Sbjct: 1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQD------DKEMEATIVNGNVTETGH 54
Query: 66 VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
+I TTIGGRNG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRE
Sbjct: 55 IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 114
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV 185
LQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPL+YV
Sbjct: 115 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYV 174
Query: 186 KLYTYQICRALAYIHNCI 203
KLYTYQI R+L+YIH CI
Sbjct: 175 KLYTYQIFRSLSYIHRCI 192
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 117/177 (66%), Positives = 148/177 (83%), Gaps = 1/177 (0%)
Query: 28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
D L M+EM++RD+ + N ED+D E +++G G ETG VI TT+GGR+G KQ +SY+A
Sbjct: 81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
+ VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
TTDK+ELYLNLVLEYVPETV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H +
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVV 257
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 335 | ||||||
| 449522383 | 690 | PREDICTED: uncharacterized protein LOC10 | 0.605 | 0.294 | 0.935 | 1e-109 | |
| 449460309 | 428 | PREDICTED: shaggy-related protein kinase | 0.605 | 0.474 | 0.935 | 1e-108 | |
| 224119932 | 422 | predicted protein [Populus trichocarpa] | 0.605 | 0.481 | 0.940 | 1e-107 | |
| 147833249 | 435 | hypothetical protein VITISV_015513 [Viti | 0.826 | 0.636 | 0.584 | 1e-106 | |
| 224129720 | 422 | predicted protein [Populus trichocarpa] | 0.605 | 0.481 | 0.935 | 1e-106 | |
| 225465185 | 422 | PREDICTED: shaggy-related protein kinase | 0.605 | 0.481 | 0.935 | 5e-99 | |
| 218184901 | 525 | hypothetical protein OsI_34360 [Oryza sa | 0.683 | 0.436 | 0.608 | 2e-95 | |
| 359806970 | 420 | uncharacterized protein LOC100799387 [Gl | 0.543 | 0.433 | 0.924 | 4e-94 | |
| 116787454 | 424 | unknown [Picea sitchensis] | 0.605 | 0.478 | 0.819 | 5e-94 | |
| 359806021 | 420 | uncharacterized protein LOC100820098 [Gl | 0.543 | 0.433 | 0.891 | 5e-91 |
| >gi|449522383|ref|XP_004168206.1| PREDICTED: uncharacterized protein LOC101227928 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-109, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 196/203 (96%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7 MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67 AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186
Query: 181 PLIYVKLYTYQICRALAYIHNCI 203
PLIYVKLYTYQICRALAYIHNCI
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCI 209
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 196/203 (96%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7 MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67 AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186
Query: 181 PLIYVKLYTYQICRALAYIHNCI 203
PLIYVKLYTYQICRALAYIHNCI
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCI 209
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1008), Expect = e-107, Method: Compositional matrix adjust.
Identities = 191/203 (94%), Positives = 197/203 (97%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
M+SASLGNGGVGSSRSVNGFKSSSSS+DWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1 MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCI 203
PLIYVKLYTYQICRALAYIHNCI
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCI 203
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147833249|emb|CAN73053.1| hypothetical protein VITISV_015513 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1008), Expect = e-106, Method: Compositional matrix adjust.
Identities = 190/325 (58%), Positives = 234/325 (72%), Gaps = 48/325 (14%)
Query: 49 RDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 108
R+ +I+G TGH+I TTIGG+NG KQ +SY+AE +VGTGSFG+VFQAKC ETGE
Sbjct: 52 REMSAAVIEGNDPVTGHIISTTIGGKNGEPKQTISYMAERIVGTGSFGIVFQAKCLETGE 111
Query: 109 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 168
VAIKKVLQD+RYKNRELQ+++++DHPN+V LKHCFFSTT ++EL+LNLV+EYVPET+ R
Sbjct: 112 TVAIKKVLQDRRYKNRELQLLRLMDHPNVVTLKHCFFSTTSRDELFLNLVMEYVPETMYR 171
Query: 169 IARNYSRIHQRMPLIYVKLYTYQI---------C------------RALAYI-------- 199
+ ++YS +QRMPLIYVKLYTYQ+ C ++YI
Sbjct: 172 VLKHYSNANQRMPLIYVKLYTYQVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 231
Query: 200 -----------------HNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 242
C+ +L+ + +VLGTPTREEI+CMNPNYT+F+FPQIK HPW
Sbjct: 232 ELIFGATEYTTSIDIWSAGCVFAELL-LGQVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 290
Query: 243 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN 302
HKVF KR+PPEA+DL R QYSP+LRCTALEAC H FFDELR+PN RLPNGRPLPPLFN
Sbjct: 291 HKVFHKRMPPEALDLASRLLQYSPSLRCTALEACAHSFFDELREPNARLPNGRPLPPLFN 350
Query: 303 FKPPELSGIPPETINRLIPEHARKQ 327
FK EL+ PE ++RLIPEH R+Q
Sbjct: 351 FK-QELAAASPELLHRLIPEHVRRQ 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1005), Expect = e-106, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 196/203 (96%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
M+SASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1 MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCI 203
PLIYVKLYTYQICRALAYIHNCI
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCI 203
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 367 bits (942), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 196/203 (96%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MASASLG+GGVGSSR+ NGFK SSSSVDWLGREMLEMRLRD+VD D+DRDSEPDIIDGVG
Sbjct: 1 MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCI 203
PLIYVKLYTYQICRALAYIHNCI
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCI 203
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218184901|gb|EEC67328.1| hypothetical protein OsI_34360 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 355 bits (910), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 171/281 (60%), Positives = 199/281 (70%), Gaps = 52/281 (18%)
Query: 98 VFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157
+QAKC ETGE VAIKKVLQDKRYKNRELQ MQ+LDHPN+V LKH FFSTT++ E+YLNL
Sbjct: 245 AYQAKCLETGETVAIKKVLQDKRYKNRELQTMQLLDHPNVVQLKHHFFSTTERGEVYLNL 304
Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------- 203
VLEYV ETV R+A+ Y+R++QR+P+++VKLY YQICRALAYIH +
Sbjct: 305 VLEYVSETVYRVAKYYNRMNQRVPILHVKLYAYQICRALAYIHRVVGVWHRDIKPQNLRA 364
Query: 204 --------------------------------------VDQLVEIIKVLGTPTREEIKCM 225
VDQLVEIIK+LGTPTREEI+CM
Sbjct: 365 PELIFGATEYTTAIDIWSVGCVLAELLIGQPLFPGESGVDQLVEIIKILGTPTREEIRCM 424
Query: 226 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285
NPNY+EFKFPQIK HPWHK+F KR+PPEAVDLV R QYSPNLRCTA++AC HPFFDELR
Sbjct: 425 NPNYSEFKFPQIKAHPWHKLFGKRMPPEAVDLVSRLLQYSPNLRCTAVDACAHPFFDELR 484
Query: 286 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 326
DP T L NGR LPPLF+F EL G+P E ++R+IPEH RK
Sbjct: 485 DPKTCLSNGRSLPPLFDFSAAELEGLPVELVHRIIPEHMRK 525
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 350 bits (899), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 171/185 (92%), Positives = 177/185 (95%), Gaps = 3/185 (1%)
Query: 19 GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
GF+ SSSSVDWLGREMLEMRLRD D DRDSEPDIIDGVGAETGHVIRT+IGGRNG S
Sbjct: 20 GFRGSSSSVDWLGREMLEMRLRDHED---DRDSEPDIIDGVGAETGHVIRTSIGGRNGQS 76
Query: 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
KQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77 KQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196
Query: 199 IHNCI 203
IHNCI
Sbjct: 197 IHNCI 201
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 350 bits (898), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 168/205 (81%), Positives = 190/205 (92%), Gaps = 2/205 (0%)
Query: 1 MASASLG-NGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD-QVDNDEDRDSEPDIIDG 58
MASASLG +GGVGSSR++N K +SVDWLGREMLEMR+RD ++D D+++D EP I+DG
Sbjct: 1 MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60
Query: 59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
+GAE+GH+I TTIGGRNG KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61 MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120
Query: 119 KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 178
KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180
Query: 179 RMPLIYVKLYTYQICRALAYIHNCI 203
RMPLIYVKLY+YQICR+LAYIHNC+
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCV 205
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 340 bits (873), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 165/185 (89%), Positives = 175/185 (94%), Gaps = 3/185 (1%)
Query: 19 GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
GF+ SSSSVDWLGREMLEM LRD D RDSEPDIIDG+GAETGHVIRT++GGRNG S
Sbjct: 20 GFRGSSSSVDWLGREMLEMSLRDHEDV---RDSEPDIIDGLGAETGHVIRTSVGGRNGQS 76
Query: 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
KQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77 KQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196
Query: 199 IHNCI 203
IHNCI
Sbjct: 197 IHNCI 201
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 335 | ||||||
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.394 | 0.313 | 0.946 | 8.1e-140 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.510 | 0.422 | 0.627 | 8.9e-113 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.388 | 0.317 | 0.815 | 1.8e-112 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.388 | 0.317 | 0.792 | 1.3e-111 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.367 | 0.298 | 0.814 | 7.2e-107 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.525 | 0.372 | 0.587 | 1.5e-106 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.367 | 0.302 | 0.798 | 4.5e-105 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.367 | 0.323 | 0.741 | 1.7e-103 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.367 | 0.280 | 0.707 | 2.6e-94 | |
| UNIPROTKB|E2R4Y4 | 420 | GSK3B "Uncharacterized protein | 0.364 | 0.290 | 0.696 | 2.2e-76 |
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 702 (252.2 bits), Expect = 8.1e-140, Sum P(2) = 8.1e-140
Identities = 125/132 (94%), Positives = 129/132 (97%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQ
Sbjct: 290 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQ 349
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEH
Sbjct: 350 YSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEH 409
Query: 324 ARKQNLFMALHS 335
ARKQNLFMALHS
Sbjct: 410 ARKQNLFMALHS 421
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 111/177 (62%), Positives = 136/177 (76%)
Query: 27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
VD L EM +M++RD D++ E ++DG G ETGH+I TTIGGRNG KQ +SY+A
Sbjct: 18 VDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 71
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
E VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFS
Sbjct: 72 ERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFS 131
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
TT+K TV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH CI
Sbjct: 132 TTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCI 188
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 1.8e-112, Sum P(2) = 1.8e-112
Identities = 106/130 (81%), Positives = 113/130 (86%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R Q
Sbjct: 281 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQ 340
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G E +++LIP+H
Sbjct: 341 YSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDH 400
Query: 324 ARKQNLFMAL 333
ARKQ F+AL
Sbjct: 401 ARKQCSFLAL 410
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.3e-111, Sum P(2) = 1.3e-111
Identities = 103/130 (79%), Positives = 114/130 (87%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R Q
Sbjct: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 339
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEH
Sbjct: 340 YSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEH 399
Query: 324 ARKQNLFMAL 333
ARKQ +++L
Sbjct: 400 ARKQCPWLSL 409
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 7.2e-107, Sum P(2) = 7.2e-107
Identities = 101/124 (81%), Positives = 110/124 (88%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL R Q
Sbjct: 279 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 338
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK ELSG PE INRLIPEH
Sbjct: 339 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELSGASPELINRLIPEH 397
Query: 324 ARKQ 327
R+Q
Sbjct: 398 VRRQ 401
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 104/177 (58%), Positives = 134/177 (75%)
Query: 28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
D L M+EM++RD+ + N ED+D E +++G G ETG VI TT+GGR+G KQ +SY+A
Sbjct: 81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
+ VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
TTDK TV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H +
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVV 257
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 4.5e-105, Sum P(2) = 4.5e-105
Identities = 99/124 (79%), Positives = 108/124 (87%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL R Q
Sbjct: 277 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 336
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK EL G E INRLIPEH
Sbjct: 337 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGASMELINRLIPEH 395
Query: 324 ARKQ 327
R+Q
Sbjct: 396 VRRQ 399
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.7e-103, Sum P(2) = 1.7e-103
Identities = 92/124 (74%), Positives = 108/124 (87%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D R Q
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSP+LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK E++G PE +N+LIP+H
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ-EVAGSSPELVNKLIPDH 365
Query: 324 ARKQ 327
++Q
Sbjct: 366 IKRQ 369
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 2.6e-94, Sum P(2) = 2.6e-94
Identities = 87/123 (70%), Positives = 99/123 (80%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIK PWHK+F++++ PEA+DL R Q
Sbjct: 316 VDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQ 375
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
YSPNLRCTALEAC HPFFD+LRDP LPNGR LPPLF+F EL+G E +RLIPEH
Sbjct: 376 YSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEH 435
Query: 324 ARK 326
ARK
Sbjct: 436 ARK 438
|
|
| UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
Identities = 87/125 (69%), Positives = 94/125 (75%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +
Sbjct: 263 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 322
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPE 322
Y+P R T LEAC H FFDELRDPN +LPNGR P LFNF ELS PP TI LIP
Sbjct: 323 YTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPP 380
Query: 323 HARKQ 327
HAR Q
Sbjct: 381 HARIQ 385
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8059 | 0.5970 | 0.4750 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 335 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-38 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-15 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-05 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.002 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.002 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.003 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.003 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.004 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.004 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 62/128 (48%), Positives = 95/128 (74%), Gaps = 3/128 (2%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
N SY +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120
Query: 137 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
I+ LK +++ +++ ++LN+V+E++P+TV++ ++Y+R + +PL VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 194 RALAYIHN 201
RALAYIH+
Sbjct: 181 RALAYIHS 188
|
Length = 440 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 55/120 (45%), Positives = 75/120 (62%), Gaps = 1/120 (0%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLV II+VLGTPT +++K MNPNY + KFP +KP KVF K P +A++ + +F +
Sbjct: 277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLK 336
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNG-RPLPPLFNFKPPELSGIPPETINRLIPE 322
Y P R +EA PFFD+LRDP +LP LP LFNF E+ + ++IP+
Sbjct: 337 YEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396
|
Length = 440 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 18/129 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
Y +G GSFG V+ A+ ++TG++VAIK + +D+ RE++I++ L HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L F D+++LY LV+EY + + + + R+ + Y QI AL
Sbjct: 61 RLYDVF---EDEDKLY--LVMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110
Query: 197 AYIH-NCIV 204
Y+H IV
Sbjct: 111 EYLHSKGIV 119
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 64/270 (23%), Positives = 99/270 (36%), Gaps = 82/270 (30%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G+GSFG V++AK + TG+IVA+K + + RE++I++ L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L F DK+ LY LV+EY +Y + K QI R L
Sbjct: 61 VRLIDAF---EDKDHLY--LVMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLE 112
Query: 198 YIH------------NCIVDQLVEIIKV-------------------LGTPTR---EEIK 223
Y+H N ++D+ ++K+ +GTP E +
Sbjct: 113 YLHSNGIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 224 CMNPNYT------------------EFKFPQIKPHPWHKVFQKRLPPE------------ 253
Y + F ++ ++ L P
Sbjct: 172 -GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 254 --AVDLVCRFFQYSPNLRCTALEACVHPFF 281
A DL+ + P+ R TA E HP+F
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 7e-24
Identities = 43/125 (34%), Positives = 72/125 (57%), Gaps = 15/125 (12%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
++G GSFG V+ A ++TGE++A+K V L + RE++I+ L HPNIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ S D+E+ LN+ LEYV +++ + + + ++ + + ++ YT QI LAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 201 -NCIV 204
N IV
Sbjct: 119 SNGIV 123
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 45/119 (37%), Positives = 65/119 (54%), Gaps = 14/119 (11%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 141
VVG G++GVV + + + TGEIVAIKK + D+ K RE+++++ L H NIV LK
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F K LY LV EYV T+ + +P V+ Y +Q+ +A+AY H
Sbjct: 67 EAFRR---KGRLY--LVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCH 117
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 21/132 (15%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 133
QK+ I G G++GVV++A+ + TGEIVAIKK+ RE+++++ L+
Sbjct: 2 QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPNI+ L F K +LY LV E++ + ++ ++ R +P +K Y YQ+
Sbjct: 57 HPNIIKLLDVFR---HKGDLY--LVFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108
Query: 194 RALAYIH--NCI 203
+ LA+ H +
Sbjct: 109 QGLAFCHSHGIL 120
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 4e-20
Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 14/119 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
+G G FG V+ A+ ++TG+ VAIK + ++ RE++I++ L+HPNIV L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
++E +L LV+EY ++ + + ++ + QI L Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN 111
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 8e-20
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 21/131 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
Y +G G++GVV++A+ ++TGEIVA+KK+ D + RE+ +++ L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 194
NIV L + + +LY LV EY + + Y + + +K YQ+ R
Sbjct: 59 NIVKLLDVIHT---ERKLY--LVFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 195 ALAYIH-NCIV 204
LAY H + I+
Sbjct: 110 GLAYCHSHRIL 120
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 18/127 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G+G++GVV A + TG VAIKK+ L D + RE+++++ L H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 138 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 193
+ L S D ++Y +V E + ++++ I PL +++ + YQI
Sbjct: 62 IGLLDILRPPSPEDFNDVY--IVTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113
Query: 194 RALAYIH 200
R L Y+H
Sbjct: 114 RGLKYLH 120
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
Y +G G++ VV++A+ +ETG IVAIKK+ +R + RE++++Q L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
PNI+ L F +NLV E++ + ++ ++ S + +K Y R
Sbjct: 62 PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113
Query: 195 ALAYIHNC 202
L Y+H+
Sbjct: 114 GLEYLHSN 121
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 7e-18
Identities = 29/124 (23%), Positives = 61/124 (49%), Gaps = 12/124 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G GSFG V+ + + G++ +K++ +++ E++I++ L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ F +E+ L +V+EY +++ + + + P + + Q+C AL
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 197 AYIH 200
Y+H
Sbjct: 117 KYLH 120
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G+ G+VF+AK RETGE VA+KKV + RE++ +Q HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F LV+EY+P ++ + R+ R +P VK Y + + +AY+H
Sbjct: 68 F---PHGSGFV--LVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-17
Identities = 39/119 (32%), Positives = 68/119 (57%), Gaps = 17/119 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 141
+G G+FG V+ A+ +ETGE+VAIKK+ + ++ + RE++ + ++ +HPNIV LK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F + +ELY V EY+ + ++ + R + ++ YQI + LA+IH
Sbjct: 65 EVF---RENDELY--FVFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIH 116
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I++VLGTP+ E++K + + + P+ P K+F PEA+DL+ +
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEK 271
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 309
+ P R TA EA HP+ +L DP P +P F EL+
Sbjct: 272 MLVFDPKKRITADEALAHPYLAQLHDPE-DEPVAKPPFDFDFFDDDELT 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 72/295 (24%), Positives = 110/295 (37%), Gaps = 106/295 (35%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
QKV I E G++GVV++A+ + TGE+VA+KK+ D + RE+ +++ L+
Sbjct: 3 QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57
Query: 134 HPNIVALKHC--------------------FFSTTDKEELYLNLVLEYVPETVNRIARNY 173
HPNIV L F + + L L+ Y+ + + +A +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 174 SR--IHQRMP----LI----YVKLYTYQICRAL-----AYIHN----------------- 201
S +H+ + LI +KL + + RA Y H
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 202 -----------CI----------------VDQLVEIIKVLGTPTREEIKCMNPNYTEFK- 233
CI +DQL I + LGTP + P T
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLPD 233
Query: 234 ----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFF 281
FP+ F K +PP + DL+ + Y PN R +A A HPFF
Sbjct: 234 YKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G G++G V++A+ ++TGE+VA+KK+ + K RE++++Q L HPNIV LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
S K +Y +V EY+ + + + + +K Y Q+ L Y+H+
Sbjct: 66 IVTS-KGKGSIY--MVFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 32/119 (26%), Positives = 62/119 (52%), Gaps = 13/119 (10%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G FG V++A+ + TG+ VAIK + L+ K K E+QI++ HPNIV
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ K+EL+ +V+E+ ++ + ++ +Q + + ++ + L Y+H+
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS 116
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 34/120 (28%), Positives = 64/120 (53%), Gaps = 16/120 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 142
++G G+FGVV++ ETG+ VAIK++ L+ + + +E+ +++ L HPNIV
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ L ++LEY ++ +I + + + + V +Y YQ+ + LAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 6e-16
Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 21/130 (16%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V++ + VA+K + +D + RE +IM+ LDHPNI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
V L T++E L +V+EY+P +Y R ++ L L + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 196 LAYIH--NCI 203
+ Y+ N I
Sbjct: 116 MEYLESKNFI 125
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 7e-16
Identities = 36/123 (29%), Positives = 63/123 (51%), Gaps = 19/123 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
+GTGSFG V + + +G+ A+K K+++ K+ + E +I+Q + HP +V L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F +++ L LV+EYVP E + + ++ R P + Y Q+ AL Y+
Sbjct: 68 GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117
Query: 200 HNC 202
H+
Sbjct: 118 HSL 120
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 35/131 (26%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 89 VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
+G G+FG V++ K + VA+K + +D + R E ++M+ L HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
T++E LY LVLEY+ R +R ++ L L + QI +
Sbjct: 62 LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 195 ALAYIH--NCI 203
+ Y+ +
Sbjct: 117 GMEYLASKKFV 127
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 20/129 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V++ K + VA+K + +D + RE +IM+ LDHPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L T++E LY +V+EY+ +Y R ++ ++ L + + QI R +
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 197 AYIH--NCI 203
Y+ N I
Sbjct: 116 EYLESKNFI 124
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 44/123 (35%), Positives = 70/123 (56%), Gaps = 18/123 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
+G GS+GVVF+ + RETG+IVAIKK ++ K+ RE+++++ L HPN+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 144 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
F + + L+LV EY TV N + +N + +P +K +Q +A+ + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 201 NCI 203
NCI
Sbjct: 120 NCI 122
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 1e-14
Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 10/86 (11%)
Query: 201 NCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAV 255
+ +DQL +I ++LGTPT E P T+ FP+ P KV RL PE +
Sbjct: 202 DSEIDQLFKIFQILGTPTEESW----PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGI 256
Query: 256 DLVCRFFQYSPNLRCTALEACVHPFF 281
DL+ + QY+P R +A EA HP+F
Sbjct: 257 DLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 39/128 (30%), Positives = 64/128 (50%), Gaps = 16/128 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y VG+G++G V A +TG VAIKK+ + KR Y REL++++ +DH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 136 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
N++ L F + E+ + LV + +N I + Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129
Query: 195 ALAYIHNC 202
L YIH+
Sbjct: 130 GLKYIHSA 137
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 16/127 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 135
+ ++G GSF V AK +ET + AIK +++++K+ Y E +++ L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
I+ L + F D+E LY VLEY P N Y R + + + Y +I A
Sbjct: 63 GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 196 LAYIHNC 202
L Y+H+
Sbjct: 115 LEYLHSK 121
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-14
Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 19/121 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 142
+G GSFG V + ++TG++ A+K K+++ K + E I+ ++HP IV L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F T +K L LVLEY P E + +++ R + Y +I AL Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110
Query: 201 N 201
+
Sbjct: 111 S 111
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-14
Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 20/127 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
+G G+FG V++ + GE VA+K + + + E IM+ L HPNIV
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
L T E LY +V EY+P ++ R H +++ L + QI + + Y
Sbjct: 66 LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 199 IH--NCI 203
+ N +
Sbjct: 118 LESKNFV 124
|
Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 24/135 (17%)
Query: 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 127
++ ++G G++G V+ A TGE++A+K+V D R K E++
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVK 186
++ LDH NIV + E YL++ LEYVP ++ R Y R +++ V+
Sbjct: 61 TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111
Query: 187 LYTYQICRALAYIHN 201
+T Q+ LAY+H+
Sbjct: 112 FFTEQVLEGLAYLHS 126
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 15/126 (11%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 136
Y +G+G++GVV A +G+ VAIKK V + REL+I++ H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 194
I+A++ + + +V++ + ++ I IH PL +++ + YQ+ R
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118
Query: 195 ALAYIH 200
L YIH
Sbjct: 119 GLKYIH 124
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 29/81 (35%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
++QL + + LGTP E + + P+Y + FP+ KP P ++F PEA+DL+
Sbjct: 207 IEQLAIVFRTLGTPNEETWPGLTSL-PDYNKITFPESKPIPLEEIFPD-ASPEALDLLKG 264
Query: 261 FFQYSPNLRCTALEACVHPFF 281
Y P+ R +A EA HP+F
Sbjct: 265 LLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 13/124 (10%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
+ +G G++G+V++A+ +GEIVA+KKV D RE+ ++ L HPNIV LK
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
K + LV+EY + + + N VK Q+ R L Y+H
Sbjct: 73 EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 201 NCIV 204
N I+
Sbjct: 127 NFII 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 13/125 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 136
+ E +G G F VV++A C G +VA+KKV + D + + E+ +++ LDHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
++ F E LN+VLE ++R+ +++ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 196 LAYIH 200
L ++H
Sbjct: 119 LEHMH 123
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 34/122 (27%), Positives = 68/122 (55%), Gaps = 16/122 (13%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
+ +G G+FG V+ A +TGE++A+K++ +QD K E++++++L HPN+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ +E++Y+ +EY T+ + + RI + +++YT Q+ LAY+H
Sbjct: 64 -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116
Query: 201 NC 202
+
Sbjct: 117 SH 118
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 65/260 (25%), Positives = 99/260 (38%), Gaps = 79/260 (30%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 140
+G+GSFG V++ + G+ A+K+V + + +E+ ++ L HPNIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ T++EE L + LE VP +A+ + + P ++LYT QI L Y+H
Sbjct: 67 ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119
Query: 201 ------------NCIVD-----------------QLVEIIKVLGTP---TREEIKCMNPN 228
N +VD + G+P E I
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG- 178
Query: 229 Y-----------TEFKFPQIKPHPWHKVFQ----------KRLPP-------EAVDLVCR 260
Y T + KP PW ++ K LPP EA D + +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKP-PWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 261 FFQYSPNLRCTALEACVHPF 280
Q P+LR TA E HPF
Sbjct: 238 CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 67.5 bits (163), Expect = 1e-12
Identities = 39/130 (30%), Positives = 58/130 (44%), Gaps = 16/130 (12%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 135
SY +G GSFG V+ A+ R+ +VA+K + + K+ RE+QI+ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 136 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L F ++E L LV+EYV + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 195 ALAYIHNCIV 204
AL Y+H+ +
Sbjct: 113 ALEYLHSKGI 122
|
Length = 384 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 41/128 (32%), Positives = 68/128 (53%), Gaps = 19/128 (14%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
+K++ I E G++GVV++A+ ++TGEIVA+KK+ +K + RE+ I+ L
Sbjct: 8 EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62
Query: 134 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
HPNIV +K S DK +Y +V+EYV + + + Q VK Q+
Sbjct: 63 HPNIVTVKEVVVGSNLDK--IY--MVMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115
Query: 193 CRALAYIH 200
+A++H
Sbjct: 116 LSGVAHLH 123
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 43/120 (35%), Positives = 69/120 (57%), Gaps = 16/120 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 142
+VG GS+G+V + K +ETG+IVAIKK L+ DK K RE+++++ L H N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 143 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F K+ LY LV E+V TV + + + + + + V+ Y +QI R + + H+
Sbjct: 68 VF---RRKKRLY--LVFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 7/82 (8%)
Query: 204 VDQLVEIIKVLGTPTREE----IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
+DQL +I VLGTPT+++ K + F+FPQ P H++ PEA+DL+
Sbjct: 205 IDQLYKICSVLGTPTKQDWPEGYKLASK--LGFRFPQFAPTSLHQLIP-NASPEAIDLIK 261
Query: 260 RFFQYSPNLRCTALEACVHPFF 281
++ P R TA +A HP+F
Sbjct: 262 DMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 16/122 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 142
+G G+FG VF+A+ ++T +IVA+KKVL + + RE++I+Q+L H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 143 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C T K Y LV E+ + +A S + + L +K + L Y
Sbjct: 80 CRTKATPYNRYKGSFY--LVFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 199 IH 200
IH
Sbjct: 135 IH 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I + LGTP + + + P+Y FP+ KV L + +DL+ +
Sbjct: 206 IDQLFRIFRTLGTPDEDVWPGVTSL-PDYKP-TFPKWARQDLSKVVP-NLDEDGLDLLSK 262
Query: 261 FFQYSPNLRCTALEACVHPFF 281
Y P R +A A HP+F
Sbjct: 263 MLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 62/259 (23%), Positives = 99/259 (38%), Gaps = 78/259 (30%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 146
+G GS+G V++A +ETG++VAIK V ++ + +E+ I++ D P IV +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 147 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIH--- 200
TD L +V+EY +V+ I N + + + I YQ + L Y+H
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHSNK 119
Query: 201 ---------NCIVD--------------QLVEIIK----VLGTP---TREEIKCMNPNY- 229
N +++ QL + + V+GTP E I Y
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYN 177
Query: 230 ---------------TEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFF 262
E K P HP +F ++ PE D V +
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237
Query: 263 QYSPNLRCTALEACVHPFF 281
P R +A++ HPF
Sbjct: 238 VKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 23/122 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 140
+G G++G+V++A R T E+VA+KK+ D + RE IM ++ DHPNIV L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 198
+ + DK ++Y LV EY+ ++ + R +H+R Y+ YQ+ +AL Y
Sbjct: 73 LNVIKAENDK-DIY--LVFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122
Query: 199 IH 200
IH
Sbjct: 123 IH 124
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 261
+DQL +I + LGTP E +F FP+ P K+F P+A+DL+ +
Sbjct: 205 IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQM 263
Query: 262 FQYSPNLRCTALEACVHPFF 281
Y P+ R TA +A HP+F
Sbjct: 264 LHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 142
G G+F V +A+ R+TG+ AIK + K +K+ RE+Q ++ L HPNI+ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F D++ L LV E + + + + + +P VK Y YQ+ ++L ++H
Sbjct: 66 VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 9e-12
Identities = 31/80 (38%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 261
+DQL +I + LGTPT E + P+Y EFK P P ++F +A+DL+ R
Sbjct: 209 IDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRL 265
Query: 262 FQYSPNLRCTALEACVHPFF 281
+PN R TA +A HP+F
Sbjct: 266 LTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 24/87 (27%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
++QL +II+V+G P+ E+I+ + + P P ++ + +A+DL+ +
Sbjct: 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKK 277
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDP 287
++PN R TA EA HP+ + +P
Sbjct: 278 LLVFNPNKRLTAEEALEHPYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 31/120 (25%), Positives = 61/120 (50%), Gaps = 15/120 (12%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 142
V+G GS GVV++ + + TG+I A+KK+ ++ R + REL+ ++ + P +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F+ E +++VLEY+ ++ + + ++P + QI + L Y+H
Sbjct: 67 AFYK-----EGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHT 117
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 38/119 (31%), Positives = 64/119 (53%), Gaps = 17/119 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ + TGEIVA+KK+ + + RE+ +++ L+HPNIV L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIH 200
S +LY LV E+ ++ + Y S + +K Y YQ+ + +AY H
Sbjct: 67 VHSEN---KLY--LVFEF----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 30/85 (35%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 200 HNCIVDQLVEIIKVLGTPTREEIK--CMNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVD 256
+ DQL +I +VLGTPT E NP + + FP P P + P +
Sbjct: 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEE 266
Query: 257 LVCRFFQYSPNLRCTALEACVHPFF 281
L +F QY P R +A EA HP+F
Sbjct: 267 LALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 16/126 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y + V+G GS+GVV A TGE VAIKK+ + D RE++++++L HP+I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 194
V +KH + +E + +V E + ++++ + + + H + + YQ+ R
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114
Query: 195 ALAYIH 200
AL YIH
Sbjct: 115 ALKYIH 120
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 20/121 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 139
+G G++GVV++ + ++TG+IVA+KK+ R ++ RE+ +++ L HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L+ +E L L+ E++ + + + Q M VK Y YQI + + +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 200 H 200
H
Sbjct: 118 H 118
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
G G+FG V++A+ +TG +VA+KK+L K+ RE++I++ L HPN+V L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 144 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
DK +Y +V Y+ ++ + N + I K Y Q+ + Y
Sbjct: 76 AVERPDKSKRKRGSVY--MVTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130
Query: 199 IH 200
+H
Sbjct: 131 LH 132
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 23/132 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 130
+I ++G+GSFG V+ +GE++A+K+V R ++ RE+ +++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYT 189
L H NIV +LN+ LEYVP +V + NY + + V+ +
Sbjct: 62 ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 190 YQICRALAYIHN 201
QI + L Y+HN
Sbjct: 113 RQILKGLNYLHN 124
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 18/128 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 145
+G GS G+VF A + + VA+KK VL D + + RE++I++ LDH NIV +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 146 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
T D L + +V EY+ + + + + +L+ YQ+ R L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127
Query: 197 AYIHNCIV 204
YIH+ V
Sbjct: 128 KYIHSANV 135
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 17/118 (14%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 145
G++G VF AK + TG+I AIK + D KN+ E I+ P +V L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
S K+ LY LV+EY+P + + N + + + ++Y +I AL Y+H+
Sbjct: 61 SFQGKKNLY--LVMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN 112
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
V QL I+ VLG+P+ E + + Y + P+ +P PW K+F K PEA+DL+
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLS 275
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDP 287
+ Q+ P R T +A HPF + DP
Sbjct: 276 QMLQFDPEERITVEQALQHPFLAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 28/120 (23%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G GSFG V + + + G+I+ K++ ++K+ E+ I++ L HPNIV
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
D+ L +V+EY + ++ + + + + ++ Q+ AL HN
Sbjct: 67 RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 39/117 (33%), Positives = 62/117 (52%), Gaps = 14/117 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NIV L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
S DK+ L LV EY + + + + + + VK + +Q+ + LA+ H
Sbjct: 68 LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 20/144 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 142
+G G++G V++A+ + TG++VA+KK + + RE+ ++QML IV L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
+ L LV EY+ + + + N + +P +K + YQ+ + +A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 201 -----------NCIVDQLVEIIKV 213
N +VD+ ++K+
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKI 152
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 9/89 (10%)
Query: 198 YIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKPHPWHKVFQKRLPPE 253
+ + + QL+ I K+LGTPT + P ++ + FPQ KP + L PE
Sbjct: 212 FPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLRDWHEFPQWKPQDLSRAVPD-LSPE 266
Query: 254 AVDLVCRFFQYSPNLRCTALEACVHPFFD 282
+DL+ + +Y P R +A A HP+FD
Sbjct: 267 GLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 17/119 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
+G G++ V++ + R TGEIVA+K++ D RE+ +M+ L H NIV L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIH 200
T +K L LV EY+ + + + Y H + VK +TYQ+ + +A+ H
Sbjct: 67 IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 20/124 (16%)
Query: 90 VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
+G G FG V CR TGE VA+K Q + RE++I++ LDH NIV
Sbjct: 12 LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
K L L++EY+P R Y + H+ ++ L + L++ QIC+ +
Sbjct: 70 KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 198 YIHN 201
Y+ +
Sbjct: 124 YLGS 127
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 26/128 (20%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G+ G V++A R TG+ VAIKK+ L+ + + E+ IM+ HPNIV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 145 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+EL++ V+EY+ T N + N +I YV ++ + L
Sbjct: 85 L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130
Query: 198 YIH--NCI 203
Y+H N I
Sbjct: 131 YLHSQNVI 138
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 21/122 (17%)
Query: 90 VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
+G G+FG V CR TGE+VA+KK+ R RE++I++ L H NIV
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 197
K +S + L LV+EY+P R + ++ R+ R L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122
Query: 198 YI 199
Y+
Sbjct: 123 YL 124
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 205 DQLVEIIKVLGTPTREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
QL I+ VLGTP++E++ C+ + NY + P PW+K+F P+A+DL+ +
Sbjct: 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDK 274
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 305
++P+ R T EA HP+ ++ DP+ P P F
Sbjct: 275 MLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFD 319
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 15/120 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 142
+GTGSFG V AK + TGE AIK ++L+ K+ + +E I+ L HP IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F D+ +Y +LE+V V + R R P K Y ++ A Y+H+
Sbjct: 86 SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
|
Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 36/121 (29%), Positives = 67/121 (55%), Gaps = 19/121 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ R T E +A+KK+ ++ + RE+ +++ + H NIV L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 144 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
S E L LV EY+ + + + ++++ + R+ +K Y YQI R +AY H
Sbjct: 70 VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119
Query: 201 N 201
+
Sbjct: 120 S 120
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
+Y +G GS+ V++ + + TG++VA+K++ L+ + RE +++ L H NI
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T L LV EY+ + + + + + V+L+ +Q+ R LA
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117
Query: 198 YIH 200
Y H
Sbjct: 118 YCH 120
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
+G G++G+V AK ET E VAIKK+ D + RE+++++ LDH N++A+K
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 144 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ ++Y +V E + +++I R+ Q + + + + YQ+ R L YIH
Sbjct: 73 MPPPHREAFNDVY--IVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH 125
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 24/78 (30%), Positives = 42/78 (53%), Gaps = 9/78 (11%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 143
+G+G++G V++A+ TGE+VAIK + L+ +E+ +++ HPNIVA
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 144 FFSTTDKEELYLNLVLEY 161
+ L +V+EY
Sbjct: 69 YLRRD-----KLWIVMEY 81
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 4/79 (5%)
Query: 205 DQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
DQL++I +++GTPT ++ P Y + FP+ P ++F P +DL+ R
Sbjct: 208 DQLLKIFRIMGTPTESTWPGISQLPEY-KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLL 265
Query: 263 QYSPNLRCTALEACVHPFF 281
Q +P LR +A +A HP+F
Sbjct: 266 QLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 15/118 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
VG G+FG+V A+ + TG+ VAIKK+++ + REL++++ L H NI++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F S E++Y V E + ++R+ + + + +++ + YQI R L Y+H+
Sbjct: 78 FISP--LEDIY--FVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS 126
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 20/129 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 136
+G G++G V++A+ TG VA+KKV R RE+ +++ L+ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV L EL L LV E+V + + + +P +K Q+ R +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120
Query: 197 AYIH-NCIV 204
++H + IV
Sbjct: 121 DFLHSHRIV 129
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 20/81 (24%), Positives = 39/81 (48%), Gaps = 4/81 (4%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
++QL +I ++ G+PT E + + P + K + + F+ + P A+DL+ +
Sbjct: 208 LEQLEKIFELCGSPTDENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 261 FFQYSPNLRCTALEACVHPFF 281
P R +A +A H +F
Sbjct: 267 LLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
+DQL I+ ++GTP E ++ ++ NY + PQ+ + +VF P A+DL+
Sbjct: 222 IDQLKRIMNLVGTPDEELLQKISSESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLE 279
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPN 288
+ P+ R TA EA HP+ E DP
Sbjct: 280 KMLVLDPDKRITAAEALAHPYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 33/129 (25%), Positives = 62/129 (48%), Gaps = 16/129 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G G++G+V A + TG VAIKK+ +R RE++I++ H NI
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65
Query: 138 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ + + + ++Y +V E + + ++ + Q + +++ + YQI R
Sbjct: 66 IGILDIIRPPSFESFNDVY--IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118
Query: 196 LAYIHNCIV 204
L YIH+ V
Sbjct: 119 LKYIHSANV 127
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 10/78 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 143
V+G G+ VV+ A C E VAIK++ +K + +E+Q M +HPN+V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 144 FFSTTDKEELYLNLVLEY 161
F +EL+ LV+ Y
Sbjct: 67 SF--VVGDELW--LVMPY 80
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 42/123 (34%), Positives = 56/123 (45%), Gaps = 22/123 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 139
V+G GSFG V AK + G+ A+ KVLQ K K + IM + + HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F T DK L VL+YV E + R + P + Y +I AL
Sbjct: 61 L-HYSFQTADK----LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110
Query: 198 YIH 200
Y+H
Sbjct: 111 YLH 113
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 36/123 (29%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
E +G G F V++A C G VA+KKV L D + + +E+ +++ L+HPN++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F E+ LN+VLE ++R+ +++ + + +P V Y Q+C AL +
Sbjct: 67 YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 199 IHN 201
+H+
Sbjct: 122 MHS 124
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 142
V+G G++G V++A+ ++TG++VAIK + D E I++ +HPNI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 143 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F + ++L+ LV+E +V + + + +R+ ++ + R LAY
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 199 IHN 201
+H
Sbjct: 129 LHE 131
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 136
+ V+G G+FG V + R+T ++ A+K K ++ +N E +I+Q L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
+V L ++S D+E +Y LV++ + R Y + + VK + +I A
Sbjct: 62 LVNL---WYSFQDEENMY--LVVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112
Query: 196 LAYIHN 201
L Y+H+
Sbjct: 113 LEYLHS 118
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 9/120 (7%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
V QL I ++LG+P+ E++ + N + P + ++F P A+DL+ +
Sbjct: 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEK 273
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 320
+ P+ R T EA HP+ L DP+ P F+F+ L+ E I LI
Sbjct: 274 MLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFS--FDFEEDALT---EEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 43/122 (35%), Positives = 62/122 (50%), Gaps = 22/122 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
VVG G++GVV + + +ET EIVAIKK K REL++++ L NIV LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 198
F + +LY LV EYV +N + + MP V+ Y YQ+ +A+ +
Sbjct: 68 AF---RRRGKLY--LVFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 199 IH 200
H
Sbjct: 116 CH 117
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 19/123 (15%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
+G GSFG V+ A+ T E+VAIKK+ + N +E++ +Q L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
K C+ E LV+EY + A + +H++ PL V++ + + LAY
Sbjct: 81 KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130
Query: 199 IHN 201
+H+
Sbjct: 131 LHS 133
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 30/145 (20%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 123
+ ++ H+ G G++G V +A TG+IVAIKKV + N
Sbjct: 5 SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62
Query: 124 ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
REL+IM + H NI+ L + E ++NLV++ + + ++ +I
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114
Query: 178 QRMPLIYVKLYTYQICRALAYIHNC 202
R+ VK QI L +H
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKW 138
|
Length = 335 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 32/124 (25%), Positives = 66/124 (53%), Gaps = 20/124 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 138
+GTG+F +QA+ +TG ++A+K+V Q++ + +E+++M L+HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+T E+ + NL +E++ +V+ + Y + + + YT Q+ R L+
Sbjct: 67 ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117
Query: 198 YIHN 201
Y+H
Sbjct: 118 YLHE 121
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 16/121 (13%)
Query: 89 VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
V+G G FG V + TGE+VA+K + ++ +N E+ I++ L H NIV
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
K C +++ L L++EYVP R+Y H ++ L + L+ QIC +AY+
Sbjct: 71 YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123
Query: 200 H 200
H
Sbjct: 124 H 124
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP-NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
+DQ+ +I VLGTP E +K + + FP K K+ E +DL+ +
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLL 263
Query: 263 QYSPNLRCTALEACVHPFF 281
Y P+ R TA +A HP+F
Sbjct: 264 AYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 30/96 (31%), Positives = 42/96 (43%), Gaps = 20/96 (20%)
Query: 204 VDQLVEIIKVLGTPTRE------EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPP 252
VDQL +I++VLGTP E K N PN + F I P+ P
Sbjct: 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA---------NP 266
Query: 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288
A+DL+ + + P R + EA HP+ DP+
Sbjct: 267 LALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCR 260
+DQL +I+KV G P E ++ + + + + P K F P P+AVDL+ +
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAK-SYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
+ + R TA EA HP+FD RD +
Sbjct: 280 MLELDVDKRLTATEALEHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 19/127 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
++ H +G GSFG V+ A T E+VA+KK+ + N +E++ +Q L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
+ K C+ +E LV+EY + A + +H++ PL V++ T+ +
Sbjct: 83 TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132
Query: 195 ALAYIHN 201
LAY+H+
Sbjct: 133 GLAYLHS 139
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLP---PEAVD 256
+DQL+EI+KV GTP++E ++ + NY + K P+ + K F+ LP P AV+
Sbjct: 222 LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK-KLPRFR----KKDFRSLLPNANPLAVN 276
Query: 257 LVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288
++ + R TA EA HP+F+E DP
Sbjct: 277 VLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+YI +G G++ VF+ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L TDK L LV EY+ + + + + I M + VK++ YQI R LA
Sbjct: 67 VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118
Query: 198 YIH 200
Y H
Sbjct: 119 YCH 121
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 34/134 (25%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
+G G++G V++A+ ++TGE+VA+KKV D + RE++I++ L+H NIV LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 143 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 190
D K++ LV EY+ H M L+ L +
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120
Query: 191 ---QICRALAYIHN 201
Q+ L Y H
Sbjct: 121 FMKQLLEGLNYCHK 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 29/86 (33%), Positives = 38/86 (44%), Gaps = 10/86 (11%)
Query: 205 DQLVEIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAV 255
DQL I +VLGTPT ++ IK M P Y K +K +
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 256 DLVCRFFQYSPNLRCTALEACVHPFF 281
DL+ + +Y P R TA EA HP+F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 21/125 (16%)
Query: 90 VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
+G G++G V++AK + G+ AIKK DK RE+ +++ L H N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 195
F DK + L+ +Y + +I + + + I M VK +QI
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120
Query: 196 LAYIH 200
+ Y+H
Sbjct: 121 VHYLH 125
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 37/141 (26%), Positives = 70/141 (49%), Gaps = 20/141 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 138
V+G G++G V+ G+++A+K+V D K Y+ E+ +++ L H NIV
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ T ++ +++ +E+VP I+ +R ++ K YT QI +AY
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117
Query: 199 IH-NCIVDQLVEIIKVLGTPT 218
+H NC+V + ++ V+ P
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPN 138
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 205 DQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
+QL I ++LGTPT E + N + + +P+ + H RL + +L+ +
Sbjct: 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLL 270
Query: 263 QYSPNLRCTALEACVHPFFDELRDPNTRLPN 293
Q+ R +A EA HP+F L + +LP+
Sbjct: 271 QFEGRKRISAEEAMKHPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 14/119 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
VG+G++G V A R TG VAIKK+ L KR REL++++ + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81
Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F + + LV+ ++ + ++ + H+++ ++ YQ+ + L YIH
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIH 135
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 15/119 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
C+ E LV+EY + + + + + Q + + V T+ + LAY+H+
Sbjct: 83 CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHS 133
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 205 DQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
D+L I ++LGTPT E ++ N + + FP+ KP P RL E ++L+ +F
Sbjct: 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFL 270
Query: 263 QYSPNLRCTALEACVHPFFDEL 284
QY R +A EA H +F L
Sbjct: 271 QYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 7e-07
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 11/85 (12%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVD 256
+DQL +I K+LGTPT + P ++E + K + Q K+ P D
Sbjct: 213 IDQLNKIFKLLGTPTEKIW----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFD 268
Query: 257 LVCRFFQYSPNLRCTALEACVHPFF 281
L+ R Y P R +A +A HP+F
Sbjct: 269 LLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+Y+ +G G++ VF+ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T E L LV EY+ + + N + M + VK++ +Q+ R L+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117
Query: 198 YIH 200
Y H
Sbjct: 118 YCH 120
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 261
+D+L +I ++LGTP E + P+Y FP+ P V L P VDL+ +
Sbjct: 210 IDELFKIFRILGTPNEETWPGVTSLPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKM 267
Query: 262 FQYSPNLRCTALEACVHPFFDELRD 286
+ P+ R TA A H +F +L D
Sbjct: 268 LRLDPSKRITARAALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 13/124 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPNI 137
Y + VG+G++G V A + TGE VAIKK+ Q + + REL +++ + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L F S +E LV+ Y+ + +I + + V+ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130
Query: 197 AYIH 200
YIH
Sbjct: 131 KYIH 134
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 27/118 (22%), Positives = 54/118 (45%), Gaps = 12/118 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G+ GVV + R TG+I+A+K + ++ + REL I+ + P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F++ D +++ +EY+ + + + R+P + + + L Y+H
Sbjct: 68 FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 30/81 (37%), Positives = 39/81 (48%), Gaps = 12/81 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 142
VG G +G VF AK ++TGEIVA+ K +L L I+ +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 143 CFFSTTDKEELYLNLVLEYVP 163
F D E LY L +EYVP
Sbjct: 69 AF---QDDEYLY--LAMEYVP 84
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 14/123 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
+ +G GSFG V++A + T ++VAIK + + +E+Q + P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F + L +++EY + + ++ Y+ ++ L Y
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 199 IHN 201
+H
Sbjct: 114 LHE 116
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 16/125 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 137
YI V+G G+FG + E +V K+V L K R E+ I+ +L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+A + F ++ L + +EY ++I R + Q V Y +QI A
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113
Query: 196 LAYIH 200
++YIH
Sbjct: 114 VSYIH 118
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 26/132 (19%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
+G G++G V++A+ +G VA+K V R + E L+ ++ DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 137 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 193
IV L C S TD+ E + LV E+V + + R Y ++ +P +K Q
Sbjct: 64 IVRLMDVCATSRTDR-ETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 194 RALAYIH-NCIV 204
R L ++H NCIV
Sbjct: 119 RGLDFLHANCIV 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 203 IVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLV 258
+ +QL +I VLG PT + ++ PNY F KP V+ KRL PP+A DL
Sbjct: 210 VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLA 268
Query: 259 CRFFQYSPNLRCTALEACVHPFF 281
+ P R +A +A +HP+F
Sbjct: 269 SQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 4/87 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
V+Q I +LGTP + I + + N F P+ +P P+ + F+ P A+DL+ +
Sbjct: 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEK 270
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDP 287
+ P R +A EA HP+ DP
Sbjct: 271 MLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 19/122 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
V+G G+FG V+ + ++TG++ A+K + + K ++ I+ D P IV L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
++S D+E LY LV+EY+P + +N + R P + Y ++ AL +
Sbjct: 67 --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117
Query: 200 HN 201
H
Sbjct: 118 HK 119
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 19/121 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G GSFG V+ A+ T E+VAIKK+ + N +E++ +Q + HPN + K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
C+ E LV+EY + A + +H++ PL + + T+ + LAY+H
Sbjct: 93 CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142
Query: 201 N 201
+
Sbjct: 143 S 143
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 12/119 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
VG+G++G V A + VA+KK+ L R REL++++ + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F T E + LV + +N I + Q++ +V+ YQ+ R L YIH+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS 136
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 31/127 (24%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 135
++ E +G G F V++A C + VA+KKV + D + + +E+ +++ L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
N++ F + LN+VLE ++++ + + + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 195 ALAYIHN 201
A+ ++H+
Sbjct: 118 AVEHMHS 124
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/124 (33%), Positives = 60/124 (48%), Gaps = 22/124 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
V+G GSFG V AK + G+ A+ KVLQ K NR+ Q +++ + HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F TT+K L VL++V E + R S P + Y +I AL
Sbjct: 61 L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110
Query: 198 YIHN 201
Y+H+
Sbjct: 111 YLHS 114
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 19/120 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
VGTG+FG V + R + A+K + L+ +++ + E ++++ + HP I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F++ D+ LY +++EYVP E + + RN R L Y +I AL Y+H
Sbjct: 67 -FWTEHDQRFLY--MLMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH---KVFQKRLPPEAVDLVCR 260
+DQL I++V+GTP+ E +K ++ + + P K+F + P A+DL+ +
Sbjct: 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEK 280
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 296
+ R +A EA HP+F + DP P P
Sbjct: 281 MLVLDSDKRISASEALAHPYFSQYHDPEDE-PEAEP 315
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 14/120 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
VG+G++G V A +TG VA+KK ++ KR REL++++ + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F EE + LV + +N I + Q++ +V+ YQI R L YIH+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 28/84 (33%), Positives = 37/84 (44%), Gaps = 14/84 (16%)
Query: 205 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP-------WHKVFQKRLPPEAVDL 257
DQL I ++LGTPT E P + K P KP+P V +L DL
Sbjct: 208 DQLKRIFRLLGTPTEESW----PGVS--KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDL 260
Query: 258 VCRFFQYSPNLRCTALEACVHPFF 281
+ +P R +A EA HP+F
Sbjct: 261 LQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 39/124 (31%), Positives = 63/124 (50%), Gaps = 15/124 (12%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
SY +G GS+ V++ K + G++VA+K + LQ++ RE +++ L H NI
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V L H T + L LV EYV + + ++ +H VKL+ +Q+ R L
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116
Query: 197 AYIH 200
+YIH
Sbjct: 117 SYIH 120
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 29/124 (23%), Positives = 59/124 (47%), Gaps = 14/124 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 137
+ + +G GSFGVVF+ + + A+K++ L ++R + E +++ LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ F ++ LN+V+EY ++++ + + +P V + QI L
Sbjct: 62 IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114
Query: 197 AYIH 200
A++H
Sbjct: 115 AHLH 118
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 4/80 (5%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 261
+DQL I ++LGTPT + + P+Y FP+ K + K L + +DL+ +
Sbjct: 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKM 265
Query: 262 FQYSPNLRCTALEACVHPFF 281
Y P R +A +A HP+F
Sbjct: 266 LIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 33/123 (26%), Positives = 60/123 (48%), Gaps = 13/123 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+YI +G G++ V++ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T E L LV EY+ + + + + + + VKL+ +Q+ R L
Sbjct: 67 VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118
Query: 198 YIH 200
Y H
Sbjct: 119 YCH 121
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 8/81 (9%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCR 260
DQL +I V+G P+ EE N + FP P F+ +P E +DL+ +
Sbjct: 212 ADQLDKIFDVIGLPSEEEWP-RNVSLPRSSFPSYTPRS----FKSFVPEICEEGLDLLKK 266
Query: 261 FFQYSPNLRCTALEACVHPFF 281
++P+ R +A EA HP+F
Sbjct: 267 MLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
+DQL I++++GTP E +K ++ NY + Q+ + VF P AVDL+
Sbjct: 224 IDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGA-NPLAVDLLE 281
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPN 288
+ + R TA +A H +F + DP+
Sbjct: 282 KMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 19/122 (15%)
Query: 90 VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 141
+G G+FG V + E+ VA+K + K+ RE +M LDHP IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
E L LV+E P + + Y + + +P+ +K +Q+ +AY+
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112
Query: 201 NC 202
+
Sbjct: 113 SK 114
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 141
++G G G VF + + TG++ A+K K KR K + E +I+ LDHP + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F + T YL LV++Y P + R+ + + + + + Y ++ AL Y+H
Sbjct: 68 ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 201 N 201
Sbjct: 121 L 121
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 204 VDQLVEIIKVLGT--PTREEIKCMNPNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCR 260
+DQL IIK LG P +EI NP + + P++K P K F K L +DL +
Sbjct: 207 IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQ 265
Query: 261 FFQYSPNLRCTALEACVHPFF 281
+ P+ R ++ + H FF
Sbjct: 266 CLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 37/122 (30%), Positives = 57/122 (46%), Gaps = 18/122 (14%)
Query: 90 VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 139
+G G++G+V A+ ET E VAIKK+ + KR REL++++ H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66
Query: 140 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L ELYL E + +++I R+ Q + + + + YQI L Y
Sbjct: 67 LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120
Query: 199 IH 200
IH
Sbjct: 121 IH 122
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 17/125 (13%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
SY+ +G GS+ V++ R G++VA+K V+ K + RE +++ L H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
IV L H T + L V EY+ + + ++ +H V+L+ +Q+ R
Sbjct: 65 IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115
Query: 196 LAYIH 200
LAYIH
Sbjct: 116 LAYIH 120
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
+G GS G+V A + TG VA+KK+ D R + R E+ IM+ HPNIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ S +EL+ +V+E++ + I H RM + + +AL+++H
Sbjct: 82 YSSYLVGDELW--VVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA 133
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 18/121 (14%)
Query: 89 VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 140
+G G FG V+Q E +I VA+K RE IM+ DHP+IV L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 199
E + +V+E P R+Y ++++ + L + LY+YQ+ ALAY+
Sbjct: 73 IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 200 H 200
Sbjct: 124 E 124
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I ++LGTP + + K + P YTEF KP +F +A+DL+
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SDDAIDLLQS 295
Query: 261 FFQYSPNLRCTALEACVHPFF 281
+ +P R +A EA H +F
Sbjct: 296 LLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 1e-04
Identities = 18/45 (40%), Positives = 22/45 (48%)
Query: 237 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281
KP P + + PEA DL+ + P R TA EA HPFF
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 23/81 (28%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 204 VDQLVEIIKVLG--TPTREEIKCMNPNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCR 260
+DQL I K LG P+ +E+ NP + FP+ P + + ++ A+D +
Sbjct: 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA 267
Query: 261 FFQYSPNLRCTALEACVHPFF 281
+ P R T E HP+F
Sbjct: 268 CLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
V+G G+FG V + + + ++ A+K + + + K E IM + IV L
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
H F +++ YL +V+EY+P + VN ++ NY +P + + YT ++ AL I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158
Query: 200 HN 201
H+
Sbjct: 159 HS 160
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 24/99 (24%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 89 VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 137
+G G+FG VF +C E+VA+ K L++ ++ RE +++ H NI
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR 175
V T+ + +V EY+ +N+ R++
Sbjct: 71 VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGP 104
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/120 (23%), Positives = 51/120 (42%), Gaps = 17/120 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 140
++G G++G V++ K TG +VA+K + D + RE+ ++ L PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ L +++EY R I ++ Y+ + ++ AL YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 15/118 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
+G G+FG V++AK +ETG +A KV++ K + E++I+ +HP IV L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ + L +++E+ P V+ I R P I ++ Q+ AL Y+H+
Sbjct: 79 Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS 128
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 30/127 (23%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 138
+G G+FGVV+ G+ VA+KK V Q+ KR REL+++ H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 139 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 193
F EE+Y+ V E + +++ I Q + +VK++ YQI
Sbjct: 67 ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113
Query: 194 RALAYIH 200
R L Y+H
Sbjct: 114 RGLKYLH 120
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 23/79 (29%), Positives = 35/79 (44%), Gaps = 3/79 (3%)
Query: 205 DQLVEIIKVLGTPTREEIK--CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
++L I ++LGTPT E N + + FPQ + P RL + +DL+
Sbjct: 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLL 269
Query: 263 QYSPNLRCTALEACVHPFF 281
Y R +A A H +F
Sbjct: 270 LYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 16/121 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G GSFG ++ AK + E IK++ +++K +E+ ++ + HPNIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
FF++ +E L +V+EY + + RI R + ++ + QI L +IH
Sbjct: 64 -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118
Query: 201 N 201
+
Sbjct: 119 D 119
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
VG G++G V++AK R+ G+ A+K++ RE+ +++ L HPN++AL+ F
Sbjct: 9 VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
S +D++ + L+ +Y + I A ++ ++P VK YQI + Y+
Sbjct: 68 LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 200 HNCIV---DQLVEIIKVLGT-PTREEIKCMNPNYTEFKFPQIKP 239
H V D I V+G P R +K + + +KP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 8/112 (7%)
Query: 203 IVDQLVEIIKVLGTPTREEI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLV 258
+V QL I +LGTP+ E I + N + K P F ++ P P A+ L+
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLL 270
Query: 259 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELS 309
R + P R TA EA P+F L R P+ +P+ L F F+ L+
Sbjct: 271 ERLLAFDPKDRPTAEEALADPYFKGLAKVE-REPSAQPITKLEFEFERRRLT 321
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 142
VVG G+FG+V + + ++V IK++ ++ K+ E Q++++L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 143 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F E+ L +V+EY P T+ + R + + + + QI AL ++H
Sbjct: 67 NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 11/79 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
+G G+FG V++ + E VA+K KR +E +I++ DHPNIV L
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58
Query: 145 FSTTDKEELYLNLVLEYVP 163
K+ +Y +V+E VP
Sbjct: 59 GVCVQKQPIY--IVMELVP 75
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 31/128 (24%), Positives = 60/128 (46%), Gaps = 20/128 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 137
Y+ +G GSFG K +E G+ IK++ + K + +E+ ++ + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 193
V + F +E L +V++Y Y +I+ + +++ + + QIC
Sbjct: 62 VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 194 RALAYIHN 201
AL ++H+
Sbjct: 112 LALKHVHD 119
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 19/90 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 135
Y +G+G+ G+V A TG+ VAIKK V KR Y REL +M++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 136 NIVALKHCFFSTTDK-----EELYLNLVLE 160
NI+ L + F T K +++Y LV+E
Sbjct: 76 NIIGLLNVF--TPQKSLEEFQDVY--LVME 101
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 29/123 (23%), Positives = 46/123 (37%), Gaps = 34/123 (27%)
Query: 96 GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 149
+V AK + T +VA+KK+ D K E+ + L HPNI+ F
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70
Query: 150 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
ELY+ +L+ + PE +P + + + AL Y
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116
Query: 199 IHN 201
IH+
Sbjct: 117 IHS 119
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G G FG V K + A+K V + + E +I++ +HP IV L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 143 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F K++ Y+ +++EY T+ R + R Y + A Y
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108
Query: 199 IHN 201
+HN
Sbjct: 109 LHN 111
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCR 260
+ QL I +LGTP+ E ++ P V EAV L+CR
Sbjct: 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR 270
Query: 261 FFQYSPNLRCTALEACVHPFFDELR 285
+ P+ R +A +A HP+ DE R
Sbjct: 271 MLVFDPDKRISAADALAHPYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 18/125 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 140
+G G+FG V+ +TG +A+K+V K E+Q+++ L H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
C D E L + +EY+P ++ + + + + YT QI + Y+H
Sbjct: 70 YGCL---RDDETLS--IFMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 201 -NCIV 204
N IV
Sbjct: 122 SNMIV 126
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 40/124 (32%), Positives = 56/124 (45%), Gaps = 22/124 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
V+G GSFG V A+ + + A+ KVLQ K K E IM + + HP +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F T DK L VL+Y+ E + R + R + Y +I AL
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 198 YIHN 201
Y+H+
Sbjct: 111 YLHS 114
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 31/128 (24%), Positives = 50/128 (39%), Gaps = 25/128 (19%)
Query: 90 VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 141
+G GSFGVV + + G++ VA+K + DK +E IM LDH N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 197
+ L +V E P + R+ + + + Y QI +
Sbjct: 63 GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 198 YIH--NCI 203
Y+ I
Sbjct: 112 YLESKRFI 119
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 18/127 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A+K+V D + E+Q+++ L H IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D EE L++ +EY+P ++ + Y + + + + YT QI + ++Y
Sbjct: 69 YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121
Query: 199 IH-NCIV 204
+H N IV
Sbjct: 122 LHSNMIV 128
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 132
Q+ +AE +G G++G VF+A+ + G VA+K+V + RE+ +++ L
Sbjct: 1 QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 133 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
+ HPN+V L C S TD+E L LV E+V + + +P +K
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115
Query: 189 TYQICRALAYIHN 201
+Q+ R L ++H+
Sbjct: 116 MFQLLRGLDFLHS 128
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
+Y VVG GS+G V + R G+ IKK+ ++++ +E Q++ L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IVA + + + E+ L +V+ + E + + + + +P V + QI AL
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 197 AYIH 200
Y+H
Sbjct: 116 QYLH 119
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 6/61 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
+G G+FG V++A+ +ETG ++A KV+ K + E+ I+ DHPNIV L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 145 F 145
+
Sbjct: 72 Y 72
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 12/82 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 141
V+G G+FG V + ++TG I A+KK+ + + K + E I+ D+P +V L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP 163
+ F ++E YL L++EY+P
Sbjct: 68 YSF-----QDENYLYLIMEYLP 84
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 20/127 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
Y V+G G+FG V + + + ++ A+K + + D + E IM + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V L C F +++ YL +V+EY+P + VN ++ NY +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153
Query: 195 ALAYIHN 201
AL IH+
Sbjct: 154 ALDAIHS 160
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 23/124 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
+G G FG V + + TG++ A KK L KR K R E +I++ + IV+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 142 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ F T D L + L+ L+Y V +R Y QI L
Sbjct: 60 YA-FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109
Query: 198 YIHN 201
++H
Sbjct: 110 HLHQ 113
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 28/122 (22%), Positives = 58/122 (47%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
V+G GS+ V + ++T I A+K + ++ + ++ +Q +HP +V L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF + E L V+E+V + + + R +++P + + Y+ +I AL +
Sbjct: 62 HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111
Query: 199 IH 200
+H
Sbjct: 112 LH 113
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
VG G++G V++AK R+ G+ A+K++ RE+ +++ L HPN+++L+ F
Sbjct: 9 VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
S D++ + L+ +Y + I A ++ ++P VK YQI + Y+
Sbjct: 68 LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 200 HNCIV---DQLVEIIKVLGT-PTREEIKCMNPNYTEFKFPQIKP 239
H V D I V+G P R +K + + +KP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V + + T ++ A+K + + D + E IM + P +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F +++ YL +V+EY+P + VN ++ NY +P + + YT ++ AL I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158
Query: 200 HN 201
H+
Sbjct: 159 HS 160
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 31/122 (25%), Positives = 60/122 (49%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 140
V+G GS+ V + ++ +I A+K V ++ + + ++ +Q H P +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF +T+ L LV+EYV + + + R +++P + + Y +IC AL +
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111
Query: 199 IH 200
+H
Sbjct: 112 LH 113
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 34/118 (28%), Positives = 52/118 (44%), Gaps = 15/118 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
+G GSFG V Q + R+T I A+K + + E+ ++ ++ P IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
FS E+LYL L E + + R R L + YT ++ AL +H
Sbjct: 60 --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLH 110
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 19/125 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
++G G+FG V + + TG+ A+K + ++ E+ +++Q HP + ALK
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D L V+EY E ++R R + Y +I AL Y+
Sbjct: 62 YS-FQTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111
Query: 200 HNCIV 204
H+C V
Sbjct: 112 HSCDV 116
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 18/121 (14%)
Query: 90 VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
+G G FG V + + TGE VA+K + + + +E++I++ L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 198
K T+ + L++E++P + + RN ++I+ + L Y QIC+ + Y
Sbjct: 72 KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124
Query: 199 I 199
+
Sbjct: 125 L 125
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 28/84 (33%), Positives = 39/84 (46%), Gaps = 15/84 (17%)
Query: 89 VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 138
+G G FG VF AK E GE + + K LQ + +N REL + + L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 139 ALKHCFFSTTDKEELYLNLVLEYV 162
L + E Y ++LEY
Sbjct: 72 RL---LGLCREAEPHY--MILEYT 90
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 13/82 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
V+G GSFG V A+ + T E+ A+K +LQD + E +++ + HP + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYV 162
H F T D+ L V+EYV
Sbjct: 62 -HSCFQTKDR----LFFVMEYV 78
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 24/82 (29%), Positives = 47/82 (57%), Gaps = 12/82 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
V+G G+FG V + ++TG+I A+K +L+ + +K +L ++ D P +V+L
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP 163
+ F ++ YL L++E++P
Sbjct: 68 YSF-----QDAQYLYLIMEFLP 84
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 22/124 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
V+G GSFG V AK + G A+ KVLQ K ++ Q +++ L HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L + F + E+LY VL+YV E + R + R + Y ++ A+
Sbjct: 61 LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110
Query: 198 YIHN 201
Y+H+
Sbjct: 111 YLHS 114
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 32/82 (39%), Positives = 43/82 (52%), Gaps = 13/82 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 140
V+G GSFG V A+ + T E+ AIK +LQD E +I+ + HP + AL
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYV 162
HC F T D+ L V+EYV
Sbjct: 62 -HCCFQTKDR----LFFVMEYV 78
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 18/120 (15%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
G GS+G V++ K + A+K+V L K R E++I+ ++HPNI++ K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 200
D +L +V+EY P + I++ R +R + +++ Q+ R L +H
Sbjct: 69 L---DGNKLC--IVMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 25/132 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+GTG FGVV K R + VAIK + + ++ E ++M L H +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY------I 199
T + +Y +V EY+ N NY R H + L +C +AY I
Sbjct: 68 CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 200 H------NCIVD 205
H NC+VD
Sbjct: 123 HRDLAARNCLVD 134
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 23/121 (19%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
G G+FG V++A+ +ETG A K + L+D E+ I+ HPNIV L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 200
+F L +++E+ ++ I R L ++ Q+ AL ++H
Sbjct: 71 YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120
Query: 201 N 201
+
Sbjct: 121 S 121
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 22/76 (28%), Positives = 37/76 (48%), Gaps = 13/76 (17%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 139
+G G+FG V+Q + ++T I A+K + + + +E L + + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 140 LKHCFFSTTDKEELYL 155
LK F + +D LYL
Sbjct: 61 LKFSFQTDSD---LYL 73
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 22/72 (30%), Positives = 42/72 (58%), Gaps = 7/72 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
+G+G++G V++A+ TGE+ AIK + +D +E+ +M+ H NIVA F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 146 STTDKEELYLNL 157
S +++L++ +
Sbjct: 74 SYLRRDKLWICM 85
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163
HPNIV + +EL+ +V+EY+
Sbjct: 73 NKHPNIVNYLDSYLVG---DELW--VVMEYLA 99
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 18/137 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A K+V D E+Q+++ L H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D+ E L + +EY+P +V + Y + + + + YT QI ++Y
Sbjct: 69 YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121
Query: 199 IH-NCIVDQLVEIIKVL 214
+H N IV + ++ +L
Sbjct: 122 LHSNMIVHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 16/99 (16%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNP---NYTEFKFPQIKPHPWHKVF------------QK 248
+DQ +II+ LGTP+ E + + P NY E + P+ + + ++F K
Sbjct: 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNK 281
Query: 249 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287
+A DL+ + P R + +A HP+ + DP
Sbjct: 282 LKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 10/78 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A KK L+ KR K R E QI++ ++ +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 141 KHCFFSTTDKEELYLNLV 158
+ + T D L L L+
Sbjct: 66 AYA-YETKDALCLVLTLM 82
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 24/81 (29%), Positives = 41/81 (50%), Gaps = 11/81 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
V+G GSFG V A+ + T E+ AIK + +D ++ +++ ++ + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 142 HCFFSTTDKEELYLNLVLEYV 162
H F T D+ L V+EYV
Sbjct: 67 HSCFQTMDR----LYFVMEYV 83
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 140
V+G GS+ V + ++T I A+K V +D + E + Q +HP +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF + E L V+EYV + + + R +++P + + Y+ +I AL Y
Sbjct: 62 HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111
Query: 199 IH 200
+H
Sbjct: 112 LH 113
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 18/137 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A+K+V D E+Q+++ L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D E L++ +E++P ++ ++Y + + + + YT QI ++Y
Sbjct: 69 YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121
Query: 199 IH-NCIVDQLVEIIKVL 214
+H N IV + ++ +L
Sbjct: 122 LHSNMIVHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 335 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.93 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.92 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.92 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.92 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.91 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.91 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.91 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.89 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.88 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.88 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.88 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.88 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.87 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.87 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.87 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.87 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.87 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.87 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.86 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.86 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.86 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.86 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.86 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.86 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.85 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.85 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.85 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.85 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.85 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.84 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.84 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.84 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.84 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.84 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.84 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.83 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.83 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.83 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.82 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.82 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.82 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.82 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.81 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.81 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.81 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.81 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.81 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.8 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.78 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.77 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.77 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.75 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.75 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.74 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.73 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.73 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.7 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.68 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.62 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.6 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.58 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.51 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.51 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.48 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.46 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.45 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.45 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.45 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.35 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.34 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.31 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.29 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.22 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.21 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.12 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.11 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.02 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 98.93 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.16 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.97 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.89 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.71 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.85 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 96.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.46 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 96.43 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 96.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 95.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 95.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 95.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 95.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 94.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 93.39 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 92.83 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 92.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 90.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 90.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 89.65 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 88.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 88.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 86.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 85.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 85.45 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 85.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 84.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 82.84 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=304.78 Aligned_cols=268 Identities=69% Similarity=1.088 Sum_probs=244.8
Q ss_pred CceEEeeccCCCCCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeecee
Q 019844 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 143 (335)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 143 (335)
+........+..........|...+++|.|+||.||+|....+++.||||.+..+.+...+|+++|+.++|||||++..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~ 85 (364)
T KOG0658|consen 6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF 85 (364)
T ss_pred eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence 34445555566666677788999999999999999999999999999999999988899999999999999999999999
Q ss_pred eeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------
Q 019844 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------- 203 (335)
Q Consensus 144 ~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------- 203 (335)
|....+.++.++.+|||||+.+|.+.++.+...+..++.-.++-|.+||++||.|||+.|
T Consensus 86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeE
Confidence 987665557789999999999999999988777889999999999999999999999988
Q ss_pred ------------------------------------------------------------------cChHHhHhhhcCCC
Q 019844 204 ------------------------------------------------------------------VDQLVEIIKVLGTP 217 (335)
Q Consensus 204 ------------------------------------------------------------------~~~~~~~~~~~g~~ 217 (335)
.+++..++..+|+|
T Consensus 166 KicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred EeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 78899999999999
Q ss_pred CHHHhhhhCCCCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCC
Q 019844 218 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 297 (335)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~ 297 (335)
+.+++.+++++|..+.++++...+|...+....++++.+|+.++|+++|.+|.++.|+|.||||.+++.|...+++++++
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~l 325 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPL 325 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcC
Confidence 99999999999999999999999999877789999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCCCHHHHhhcChHHHhhcccccc
Q 019844 298 PPLFNFKPPELSGIPPETINRLIPEHARKQNLFMA 332 (335)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (335)
|++++|+.. .....++.+..++++++++......
T Consensus 326 p~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~~~~~ 359 (364)
T KOG0658|consen 326 PPLFNFKRA-ELGISPELVNVLIPEHLREQEKDKI 359 (364)
T ss_pred CCccCchHH-HhccchHHHHhhccHhhhhhccccc
Confidence 999999955 7778889999999999888765443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.45 Aligned_cols=233 Identities=31% Similarity=0.506 Sum_probs=197.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.+|..++.||+|+||.|+.+.++.+|+.||||+|.. ..++..||+.+|+.++|+||+.+++++.........-+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 357778999999999999999999999999999962 34677899999999999999999999977444556669
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------------- 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------- 203 (335)
|+|+|+|+.||.++++. .+.+++..++.+++||++||+|+|+.+
T Consensus 102 YiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999999999997 566999999999999999999999988
Q ss_pred --------------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCC
Q 019844 204 --------------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNP 227 (335)
Q Consensus 204 --------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~ 227 (335)
++++..+...+|+|..+.+.....
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 678888888999998888776542
Q ss_pred CCC-C--CCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCC
Q 019844 228 NYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304 (335)
Q Consensus 228 ~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 304 (335)
... . ..++.....+|...| +..++.+.||+.+||.+||.+|+|++|+|+||||..+.+|.+++..... .+.+
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~---~~~~- 332 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI---FDSF- 332 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC---Cccc-
Confidence 211 1 156777888999999 5999999999999999999999999999999999999999988654221 1123
Q ss_pred cccCCCCCHHHHhhcChHHHhh
Q 019844 305 PPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+.. ++.+.|++++|+|+..
T Consensus 333 --~~~-~~~~~~r~~i~~e~~~ 351 (359)
T KOG0660|consen 333 --EHE-LTEEELRELIYKEILD 351 (359)
T ss_pred --ccc-ccHHHHHHHHHHHHHh
Confidence 233 8899999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=266.52 Aligned_cols=200 Identities=29% Similarity=0.378 Sum_probs=156.2
Q ss_pred CccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----------hhHHHHHHHHHhCCCCceeeeceeee
Q 019844 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFF 145 (335)
Q Consensus 77 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----------~~~~~Ei~~l~~l~hpnIv~~~~~~~ 145 (335)
.....+.|.+.+.||+|+||.|.+|..+.||+.||||+|.+.. ..+.+|+++|++|+|||||+++++|
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f- 245 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF- 245 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-
Confidence 3346678999999999999999999999999999999996421 2356999999999999999999999
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------- 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------- 203 (335)
....+.||||||++| +|.+.+-. ++.+.|...+.+++||+.||.|||++|
T Consensus 246 ----~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 246 ----EVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ----ecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceE
Confidence 666678999999996 99998887 778999999999999999999999999
Q ss_pred -----------cChHHhHhhhcCCCCHHHhhhh---CCC---------------------CCCCC----CC----CC--C
Q 019844 204 -----------VDQLVEIIKVLGTPTREEIKCM---NPN---------------------YTEFK----FP----QI--K 238 (335)
Q Consensus 204 -----------~~~~~~~~~~~g~~~~~~~~~~---~~~---------------------~~~~~----~~----~~--~ 238 (335)
......+.++||||.|...... ... |.+|. -+ ++ .
T Consensus 318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G 397 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG 397 (475)
T ss_pred EEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence 1112223467888874332211 111 11110 00 00 1
Q ss_pred CCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 239 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
...+.+..|..+++++.+||.+||..||++|||++++|+||||+...
T Consensus 398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 11233456678999999999999999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.37 Aligned_cols=198 Identities=25% Similarity=0.393 Sum_probs=152.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+|..++.||+|+|+.||.+++..+|+.||+|+|.+. ...+.+||+|++.|+|||||++|++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 5799999999999999999999999999999999752 35678999999999999999999999 88888
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------cChH-------------
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------VDQL------------- 207 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------~~~~------------- 207 (335)
+|||+|+|. |+|..+++. ++.++|.+|++|++||+.||.|||+++ .+.+
T Consensus 93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee
Confidence 999999999 699999886 788999999999999999999999998 1111
Q ss_pred ----HhHhhhcCCCCHHHhhhhCC---------------CCCC-CCCCCCCCCccc----------cccccCCChHHHHH
Q 019844 208 ----VEIIKVLGTPTREEIKCMNP---------------NYTE-FKFPQIKPHPWH----------KVFQKRLPPEAVDL 257 (335)
Q Consensus 208 ----~~~~~~~g~~~~~~~~~~~~---------------~~~~-~~~~~~~~~~~~----------~~~~~~~s~~~~~l 257 (335)
....++||||.|...+...- -|.. ...|......+. ..+|..+|.++++|
T Consensus 169 e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 169 EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDL 248 (592)
T ss_pred cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHH
Confidence 22234455555322111110 0000 011111111111 23567899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
|++||..||.+|||++++|.|+||..-.-|.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 9999999999999999999999995544443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=271.16 Aligned_cols=199 Identities=33% Similarity=0.529 Sum_probs=171.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccch-----hHHHHHHHHHhCC-CCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 153 (335)
.-+||.++++||.|+||.||+|+.+.+|..||||.+++... .-.||+..|++|+ |||||++.+++.+. +.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cc
Confidence 34679999999999999999999999999999999975431 2349999999998 99999999999532 22
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
.+|+|||||+.+|+++++.. +..|+|..++.|++||+.||+|+|.+|
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 79999999999999999973 577999999999999999999999999
Q ss_pred -------------------------------------------------------cChHHhHhhhcCCCCHHHhhhh--C
Q 019844 204 -------------------------------------------------------VDQLVEIIKVLGTPTREEIKCM--N 226 (335)
Q Consensus 204 -------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~--~ 226 (335)
+|++.++..++|+|....|..+ .
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 7889999999999997776543 1
Q ss_pred CCCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 227 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
.....+.++.....++...++. +++++.+||.+||.+||.+||||.++|+||||+....
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 2234567888888888888855 9999999999999999999999999999999986543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.39 Aligned_cols=196 Identities=34% Similarity=0.588 Sum_probs=168.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|...++||+|+||.||+|++..||+.||||+|+... ....|||.+|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 46999999999999999999999999999999997432 3467999999999999999999999 666669
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------------- 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------- 203 (335)
.||+|||+.||...++.. ...++..+++.|+.+++.||+|||.+.
T Consensus 77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999999999999999863 567999999999999999999999876
Q ss_pred ------------------------------------------------------cChHHhHhhhcCCCCHHHhhhh--CC
Q 019844 204 ------------------------------------------------------VDQLVEIIKVLGTPTREEIKCM--NP 227 (335)
Q Consensus 204 ------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~--~~ 227 (335)
++|+..++..+|||.+..|..+ -|
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 7889999999999999999876 36
Q ss_pred CCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 228 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
.|..+. .....+....| +..++++.||+.+||.+||.+|+|+.|+|+|+||+....|.
T Consensus 234 dY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 234 DYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred cHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 666544 23333444456 67888999999999999999999999999999999865543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=265.47 Aligned_cols=246 Identities=41% Similarity=0.767 Sum_probs=184.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCC---CCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~---~~~~~~~~i 157 (335)
..+|++++.||+|+||.||+|.+..+++.||||++........+|+.+|+.++|||||+++++|+... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34699999999999999999999999999999999776667779999999999999999999886432 123456889
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--hHHhHhhh----------
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD--QLVEIIKV---------- 213 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~--~~~~~~~~---------- 213 (335)
||||++++|.+++.........+++..++.|+.||+.||.|||+++ ++ .....+..
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 9999999998888766555678999999999999999999999988 10 00000111
Q ss_pred ------cCCCC---HHHhh----------------------hhCC-------------------------------CCCC
Q 019844 214 ------LGTPT---REEIK----------------------CMNP-------------------------------NYTE 231 (335)
Q Consensus 214 ------~g~~~---~~~~~----------------------~~~~-------------------------------~~~~ 231 (335)
.|++. ++.+. .+.+ .|..
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 12211 11110 0011 1111
Q ss_pred CCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCC-CCCCCCCCCCCcccCCC
Q 019844 232 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFKPPELSG 310 (335)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 310 (335)
..++......+...++...++++.+||.+||++||.+|||+.|+|+||||..+..+....+. ...+|.+++|...++..
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKE 384 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhh
Confidence 12222223334445566788999999999999999999999999999999998876655554 35678889999888888
Q ss_pred CCHHHHhhcChHHHhh
Q 019844 311 IPPETINRLIPEHARK 326 (335)
Q Consensus 311 ~~~~~~~~~~~~~~~~ 326 (335)
+..+..+.+++....+
T Consensus 385 ~~~~~~~~~~~~~~~~ 400 (440)
T PTZ00036 385 MSDACRRKIIPKCTYE 400 (440)
T ss_pred CCHHHHHHHhhHHHHH
Confidence 8988888888775554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.65 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=164.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+.|+.+++||+|+||.||+|++..||+.||+|+|+.+. ....|||.||++|+|||||++.+..+.. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~ 190 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS 190 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence 34567999999999999999999999999999999997443 4467999999999999999999998653 34
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
..+|+|+|||+.||..++..- .-.|++.++++|++||+.||+|||++|
T Consensus 191 ~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred ceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence 569999999999999988752 346999999999999999999999988
Q ss_pred ----------------------------------------------------------cChHHhHhhhcCCCCHHHhhhh
Q 019844 204 ----------------------------------------------------------VDQLVEIIKVLGTPTREEIKCM 225 (335)
Q Consensus 204 ----------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~ 225 (335)
++|+..|+.+||+|....|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 7889999999999998887633
Q ss_pred -CCCCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 226 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.|.+..+.-...-...+.+.+ ..+++.+.+|+..||+.||.+|.||.++|+|+||..-
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 233333322222223334444 6789999999999999999999999999999999544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.27 Aligned_cols=204 Identities=28% Similarity=0.434 Sum_probs=168.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccch------hHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+..+.|+.+..|++|+||+||+|+++.|++.||+|+++-+.. ...|||.+|.+++|||||.+..+..- .+-
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~ 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNM 149 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---ccc
Confidence 344579999999999999999999999999999999974332 24699999999999999999998753 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
..+|||||||+.||..++... .++|...+++.++.|++.||+|||.+.
T Consensus 150 d~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 448999999999999999974 368999999999999999999999876
Q ss_pred ---------------------------------------------------------cChHHhHhhhcCCCCHHHhhhhC
Q 019844 204 ---------------------------------------------------------VDQLVEIIKVLGTPTREEIKCMN 226 (335)
Q Consensus 204 ---------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~ 226 (335)
++++..|+..+|+|....|....
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 78889999999999977775442
Q ss_pred --CCCCCCCCCCCCCCccccccccC-CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 227 --PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
|......++......+...|+.. +++...+|++.+|.+||.+|.||.|+|+|+||.+.+.|.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 22223345555555566666544 789999999999999999999999999999999976543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=234.79 Aligned_cols=201 Identities=24% Similarity=0.411 Sum_probs=149.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..+.+.++.||+|+.|+||+|+|+.|++.+|+|+|..+ .+++.+|+++++.++||+||.+|++|+.... .+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 34678899999999999999999999999999999422 3667899999999999999999999965431 48
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC-cC-------------------------hH
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI-VD-------------------------QL 207 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~-~~-------------------------~~ 207 (335)
+|+||||+| +|.+++.. .++++|.....|+.+|++||.|||+ .+ ++ .+
T Consensus 154 sI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 899999995 99999987 5789999999999999999999996 44 00 00
Q ss_pred H--hHhhhcCCCCHHHhhhhCC-CCC------------------CCCCCCCC--CCcc-----------ccccccC-CCh
Q 019844 208 V--EIIKVLGTPTREEIKCMNP-NYT------------------EFKFPQIK--PHPW-----------HKVFQKR-LPP 252 (335)
Q Consensus 208 ~--~~~~~~g~~~~~~~~~~~~-~~~------------------~~~~~~~~--~~~~-----------~~~~~~~-~s~ 252 (335)
. ...+..||..|...+...- .|. .|.++... ...| ...+|.. +|+
T Consensus 230 vnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 230 VNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred hhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 0 1123456655333221110 111 11222110 0111 1223444 899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
++++||..||++||.+|+++.|+|+|||++....+..
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 9999999999999999999999999999998765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=229.52 Aligned_cols=194 Identities=31% Similarity=0.549 Sum_probs=147.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|+.+.++|+|+||+||+|+++.||+.||||++..+. +...|||++|++|+|||+|.++++| ..+..+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 35899999999999999999999999999999985322 4467999999999999999999999 777779
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------------- 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------- 203 (335)
++|+|||+.++.+-+..+ ...++...++.|++|++.|+.|+|+++
T Consensus 77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999999998776666654 466999999999999999999999998
Q ss_pred ------------------------------------------------------cChHHhHhhhcCCCCHHHhh--hhCC
Q 019844 204 ------------------------------------------------------VDQLVEIIKVLGTPTREEIK--CMNP 227 (335)
Q Consensus 204 ------------------------------------------------------~~~~~~~~~~~g~~~~~~~~--~~~~ 227 (335)
+|++..|...+|...+.... ..+|
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22222222222222222111 1122
Q ss_pred CCCCCCCCCCC-CCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 228 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
-|....+|... ..+.+..+ +.++.-+.||+++||+.||++|++.+++|.|+||..+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 22222333221 12333444 5678899999999999999999999999999999664
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=241.56 Aligned_cols=196 Identities=28% Similarity=0.410 Sum_probs=155.2
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
|++++.||.|+-|.|.+|++..||+..|||+|.+. ...+.+||-||+.+.||||+++|++| .++.++|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ly 88 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHLY 88 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceEE
Confidence 99999999999999999999999999999999865 34578999999999999999999999 7778899
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChHH-hHhhhcCCCCH---
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQLV-EIIKVLGTPTR--- 219 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~~-~~~~~~g~~~~--- 219 (335)
+|+||++| .|++++.. +++++|.++..+++||+.|+.|||..+ ++.-. ..+..+|...-
T Consensus 89 lvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999995 99999887 889999999999999999999999988 11000 11122333221
Q ss_pred ---HHhhhhCCCCCCCC------CCCCCCCccc-------------------------------cccccCCChHHHHHHH
Q 019844 220 ---EEIKCMNPNYTEFK------FPQIKPHPWH-------------------------------KVFQKRLPPEAVDLVC 259 (335)
Q Consensus 220 ---~~~~~~~~~~~~~~------~~~~~~~~~~-------------------------------~~~~~~~s~~~~~li~ 259 (335)
....|+.|.|...+ +...+.+.|. ...|..+|+++.+||+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 12235555554321 1122233332 1245789999999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 260 RFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 260 ~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
+||..||.+|+|.+||++|||+..+..+.
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCCCC
Confidence 99999999999999999999999886643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=234.60 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=155.7
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-------cchhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.+...+|.+++.||.|+|++|++|+++.+++.||||++.+ ..+++.+|-.+|..| +||.||+||..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----- 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----- 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence 3455679999999999999999999999999999999854 346788999999999 899999999999
Q ss_pred CCccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-------------ChHHhH-----
Q 019844 150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-------------DQLVEI----- 210 (335)
Q Consensus 150 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-------------~~~~~~----- 210 (335)
+++..+|+|+||++ |+|.++|+. .+.|+|..+++|+.||+.||+|||++|+ ......
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecc
Confidence 77777999999999 599999998 5789999999999999999999999990 001111
Q ss_pred -------------------------hhhcCCCCHHHhhhhCCCCCCC----------------CCCCCC-CC--------
Q 019844 211 -------------------------IKVLGTPTREEIKCMNPNYTEF----------------KFPQIK-PH-------- 240 (335)
Q Consensus 211 -------------------------~~~~g~~~~~~~~~~~~~~~~~----------------~~~~~~-~~-------- 240 (335)
..++||..|...+.++..+..+ ..|... ..
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 2234444432222111111110 000000 00
Q ss_pred -ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 241 -PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 241 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
.....|++.+++.++|||+++|..||++|+|+.+|.+||||..+.|..
T Consensus 300 ~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 300 QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 111246788999999999999999999999999999999999998743
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=224.27 Aligned_cols=196 Identities=29% Similarity=0.320 Sum_probs=148.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+.|.+.++||+|+|+.||+|.++.||+.+|+|+|.. +.+.+.+|+.|.+.|+|||||++.+.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 455679999999999999999999999999999999853 336678999999999999999999999 888
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------- 203 (335)
.+.|||+|+|.| +|..-+-. +..++|..+..+++||+.||.|+|.++
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred ceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence 889999999997 76544433 345899999999999999999999998
Q ss_pred ----cChHHhHhhhcCCCCHHH---------------hhhhC------CCCCCCC-------CCCC--CCCccccccccC
Q 019844 204 ----VDQLVEIIKVLGTPTREE---------------IKCMN------PNYTEFK-------FPQI--KPHPWHKVFQKR 249 (335)
Q Consensus 204 ----~~~~~~~~~~~g~~~~~~---------------~~~~~------~~~~~~~-------~~~~--~~~~~~~~~~~~ 249 (335)
+..........|+|.+.. |.|+. .+|.+|- +..+ ....+....|..
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 111112223455555221 11110 0111110 0011 112333446688
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999999999999976
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=222.98 Aligned_cols=117 Identities=24% Similarity=0.411 Sum_probs=106.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
....|++++.||+|.-|+||+|+.+.++..+|+|++.+. ..++..|.+||+.++||.++.+|..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 345699999999999999999999999999999999753 24567899999999999999999999 888
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+.|++||||+| ||..+.+... .+.|++..+++|+.+|+.||+|||.+|
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG 199 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG 199 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc
Confidence 889999999996 9999988755 778999999999999999999999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=237.48 Aligned_cols=192 Identities=25% Similarity=0.377 Sum_probs=147.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|.+.+.||+|+||.||+|+.+.|.+.||+|.|.|.. +.+.+|++|++.|+|||||.++++| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 35999999999999999999999999999999996532 4478999999999999999999999 777789
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC----------------------hH------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD----------------------QL------ 207 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~----------------------~~------ 207 (335)
|+|+|||.|+|..++.. .+.++|+.++.|+.+++.||.|||++++- .+
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 99999999999999998 78899999999999999999999999810 00
Q ss_pred --HhHhhhcCCCCHHHhhhh------------------------CCCCCCCCCCC----CCCCccccccccCCChHHHHH
Q 019844 208 --VEIIKVLGTPTREEIKCM------------------------NPNYTEFKFPQ----IKPHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 208 --~~~~~~~g~~~~~~~~~~------------------------~~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~~l 257 (335)
.....+-|||.|...... .|.|..-.+.. +...+ ...|...+..+++|
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSFVNF 230 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHHHHH
Confidence 011123456553221111 11111000000 00000 11235789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|+++|.+||.+|+|+.++|.|||++.-
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=224.12 Aligned_cols=199 Identities=27% Similarity=0.343 Sum_probs=153.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|+++++||+|+||+|++++.+.|++.||+|+++|. .+....|..||..++||+||+++..| ++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence 3456799999999999999999999999999999999653 35577899999999999999999999 77
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------- 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------- 203 (335)
...+|+|+||+.| +|...|.+ .+.|+|..++.|+.+|+.||.|||++|
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 7889999999996 99999987 788999999999999999999999999
Q ss_pred ---cChHHhHhhhcCCCCHHHhhh------------------------hCCCCCCCCCC----CCCCCccccccccCCCh
Q 019844 204 ---VDQLVEIIKVLGTPTREEIKC------------------------MNPNYTEFKFP----QIKPHPWHKVFQKRLPP 252 (335)
Q Consensus 204 ---~~~~~~~~~~~g~~~~~~~~~------------------------~~~~~~~~~~~----~~~~~~~~~~~~~~~s~ 252 (335)
...-....++|||+.|..... +.|.|...... .+.... ....+..++.
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~ 251 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSE 251 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCH
Confidence 111112234577776432211 11111110000 000000 0123345899
Q ss_pred HHHHHHHHhccCCCCCCC----CHHHHhcCcccccCCCC
Q 019844 253 EAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDP 287 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~----t~~~~L~hp~f~~~~~~ 287 (335)
++++||+++|+.||++|. .+.++-+||||..+.|.
T Consensus 252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 999999999999999996 68999999999998873
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=215.96 Aligned_cols=197 Identities=23% Similarity=0.344 Sum_probs=154.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++++.||.|+||.|.+++++.+|..||+|++.+. .+....|..+|+.+.||+++++++.| .+.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~ 116 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN 116 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence 345699999999999999999999999999999999753 24567899999999999999999999 778
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-------------- 205 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-------------- 205 (335)
.++||||||++| .|..+++. .++|++..+++|+.||+.||+|||+++ ++
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred CeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 889999999996 99999987 788999999999999999999999998 11
Q ss_pred -hHHhHhhhcCCCCHHHhhhh---------------------CCCCCCCCCCCCCCCcc------ccccccCCChHHHHH
Q 019844 206 -QLVEIIKVLGTPTREEIKCM---------------------NPNYTEFKFPQIKPHPW------HKVFQKRLPPEAVDL 257 (335)
Q Consensus 206 -~~~~~~~~~g~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~l 257 (335)
--..+.++||||.+...... ..+|.+|...+ ....+ .-.||..++++++||
T Consensus 193 ~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-~~~iY~KI~~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 193 RVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-PIQIYEKILEGKVKFPSYFSSDAKDL 271 (355)
T ss_pred EecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-hHHHHHHHHhCcccCCcccCHHHHHH
Confidence 11124567888874322111 11111111000 01111 124678899999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|.++|+.|-.+|. ...+|.+||||+.+.|
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 9999999999995 4789999999998876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=227.19 Aligned_cols=116 Identities=26% Similarity=0.404 Sum_probs=107.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|+++++||+|+||.||+|+.+.||..||+|++++. ...+..|..+|...++|+||++|..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 3556899999999999999999999999999999999764 25577899999999999999999999 88
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++||||||++| |+..+|.. .+.|+|..+++|+.+++.|++-||..|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g 261 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG 261 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC
Confidence 8999999999996 99999987 789999999999999999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=228.73 Aligned_cols=190 Identities=29% Similarity=0.403 Sum_probs=148.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCC-CCceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~ 149 (335)
...+|.+++.||+|+||+|+.|.+..++..||+|++.+. .+.+.+|+.+++.+. ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 345699999999999999999999999999999977543 234568999999998 99999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------cC---------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------VD--------- 205 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------~~--------- 205 (335)
.....+|+|||||.| +|++.+.. .+++.|.+++.+|+||+.||+|||++| .+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 555559999999996 99999987 688999999999999999999999998 01
Q ss_pred --------hHHhHhhhcCCCCHHHhhhhC--CCCCCCCCCCCCCCccc-------------------------------c
Q 019844 206 --------QLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWH-------------------------------K 244 (335)
Q Consensus 206 --------~~~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-------------------------------~ 244 (335)
......+.||+|.|....... +.|.. ...+.|. .
T Consensus 166 G~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g-----~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 166 GLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSG-----KAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF 240 (370)
T ss_pred ccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCC-----chhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence 011122345555533322221 11221 1111121 2
Q ss_pred ccccCC-ChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 245 VFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 245 ~~~~~~-s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
.+|..+ |+++++||++||..||.+|+|+.++++||||+.
T Consensus 241 ~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 345667 999999999999999999999999999999997
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=200.52 Aligned_cols=192 Identities=30% Similarity=0.547 Sum_probs=163.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|...++||+|+||+|++++.+.+++.||+|.++.+. ....|||.+|+.++|.|||+++++. ..+..+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4777899999999999999999999999999997432 4567999999999999999999998 4555588
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------------- 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------- 203 (335)
+|+|||+.+|..+.... ++.++...++.++.|+++||.|+|+++
T Consensus 78 lvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred EeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99999999999888763 678999999999999999999999987
Q ss_pred ------------------------------------------------------cChHHhHhhhcCCCCHHHhhhhC--C
Q 019844 204 ------------------------------------------------------VDQLVEIIKVLGTPTREEIKCMN--P 227 (335)
Q Consensus 204 ------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~--~ 227 (335)
.+++..++..+|+|..+.|..+. |
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 56788889999999988887763 6
Q ss_pred CCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 228 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.|..|.... ....|.... +.++..-+||++++|.-+|.+|++++++|+||||.+.
T Consensus 235 dyk~yp~yp-attswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 235 DYKPYPIYP-ATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCcccCCcc-ccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 666543221 223565555 6788889999999999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=223.17 Aligned_cols=197 Identities=23% Similarity=0.397 Sum_probs=149.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
....+|.+.+.||.|+||+||+|+++.++..||||.|.+. .+.+..||.+|+.++|||||++++++ ...
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence 3445699999999999999999999999999999999643 24467899999999999999999999 666
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------- 203 (335)
.++|+|||||+| ||..+|.. +++++|..++.++.||+.||++||+++
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 679999999995 99999998 778999999999999999999999998
Q ss_pred -------cChHHhHhhhcCCCCHHHhhhh-CCCCCCC---------------CCCCCC-------------CCccccccc
Q 019844 204 -------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF---------------KFPQIK-------------PHPWHKVFQ 247 (335)
Q Consensus 204 -------~~~~~~~~~~~g~~~~~~~~~~-~~~~~~~---------------~~~~~~-------------~~~~~~~~~ 247 (335)
........++||+|.|...+.+ ...|.+- ..+.+. .......++
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 0111112244555553222111 1111110 000000 111112334
Q ss_pred cCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 248 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
..+++...+|+...|+.||.+|.+..+-+.|+++..-
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 5678888899999999999999999999999998754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=216.48 Aligned_cols=207 Identities=29% Similarity=0.583 Sum_probs=167.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCc-eeeeceeeeeCCC-CCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~-~~~~ 153 (335)
..|..+++||+|+||+||+|+.+.+|+.||+|+|+-+. ....||+.+|+.|+|+| ||.+++++.+.+. ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34888899999999999999999999999999997432 34579999999999999 9999999965432 2334
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
.+++|+||++-||..++....+....++...++.+++||+.||+|||+++
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 68999999999999999986533246888999999999999999999998
Q ss_pred --------------------------------------------------------cChHHhHhhhcCCCCHHHhhhh--
Q 019844 204 --------------------------------------------------------VDQLVEIIKVLGTPTREEIKCM-- 225 (335)
Q Consensus 204 --------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~-- 225 (335)
.+++..++..+|||....|...
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 5677778888899887777654
Q ss_pred CCCCCCCCCCCCC-CCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCC
Q 019844 226 NPNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 290 (335)
Q Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~ 290 (335)
.|.|.. .++... ...+.... +..+++..+++.+||++||.+|.||..+|.||||.....+...
T Consensus 251 ~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 251 LPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred cccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 344543 233333 33444444 4566899999999999999999999999999999998665443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-28 Score=217.77 Aligned_cols=114 Identities=28% Similarity=0.512 Sum_probs=100.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
++|.+.+.||.|+||.||+|.++.++..||+|++... ...+.+|+.+++.++||||+++++++ ....++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 4699999999999999999999999999999998632 23466899999999999999999999 5566799
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++|+|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ 123 (288)
T cd07871 80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK 123 (288)
T ss_pred EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999998888652 345899999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=218.56 Aligned_cols=204 Identities=23% Similarity=0.373 Sum_probs=151.0
Q ss_pred CccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 77 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.....+.|++..+||.|.-++||+|+++.+++.||||++.-+ ...+.+|+..|+.++||||++++..|. .
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v 95 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----V 95 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----e
Confidence 335556799999999999999999999999999999999632 356789999999999999999999994 4
Q ss_pred ccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------cChHH--------
Q 019844 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------VDQLV-------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------~~~~~-------- 208 (335)
+..+|+||.||. |++.++++.+. ...|.|..+..|+++++.||.|||.+| .+...
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 455999999999 59999999876 456999999999999999999999999 00000
Q ss_pred ------------hHhhhcCCCCHHHhhh--------------------------hCCCCCCCC-----CCCCCCCc----
Q 019844 209 ------------EIIKVLGTPTREEIKC--------------------------MNPNYTEFK-----FPQIKPHP---- 241 (335)
Q Consensus 209 ------------~~~~~~g~~~~~~~~~--------------------------~~~~~~~~~-----~~~~~~~~---- 241 (335)
....+.|+|.+..... +...|..|. +..+...+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 0023456666322111 111111110 00000000
Q ss_pred ---cccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 242 ---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
....-...++..++.+|..||+.||.+||||+++|+|+||+.....
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 0001113467789999999999999999999999999999887553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=217.63 Aligned_cols=193 Identities=31% Similarity=0.489 Sum_probs=145.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.+|..++.||+|+||.||++.+..+|..+|||.+... .+.+.+|+.+|++|+|||||++++....... ..++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 4589999999999999999999999999999998755 4557899999999999999999997532221 36889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHhHhhhc--------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVEIIKVL-------- 214 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~~~~~~-------- 214 (335)
+|||++| +|.+++..+. +.++|..++.+.+||+.||.|||++| ++. ....+..+
T Consensus 94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999995 9999999743 27999999999999999999999998 111 01111122
Q ss_pred ------------CCCCHHHhhhhCCCCCCC------------------CCCCCCCCccc------------------ccc
Q 019844 215 ------------GTPTREEIKCMNPNYTEF------------------KFPQIKPHPWH------------------KVF 246 (335)
Q Consensus 215 ------------g~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~------------------~~~ 246 (335)
||+. ++.|+.... .+.. ...+|. +.+
T Consensus 171 ~~~~~~~~~~~~Gtp~-----~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPN-----YMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccCCcc-----ccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHHhccCCCCCC
Confidence 3322 222221110 0000 012222 245
Q ss_pred ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 247 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|..+|+++++||.+||..||++||||.++|+|||.+....
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 6789999999999999999999999999999999987543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=224.04 Aligned_cols=198 Identities=25% Similarity=0.351 Sum_probs=150.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCC-CCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~ 150 (335)
.....|.+.+.||+|.||.||+|+++.||+.+|+|.|.+.. ..+.+|+.+|+++. |||||+++++| +
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 44557999999999999999999999999999999997532 36789999999998 99999999999 6
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------- 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------- 203 (335)
...++++|||+|.| .|++.+... .++|..+..++.||+.|+.|||+.|
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEe
Confidence 66679999999996 999888763 3999999999999999999999998
Q ss_pred -------cChHHhHhhhcCCCCHHHhhhhC-CCCC--------------------CCCCCC-------CC--CCcccccc
Q 019844 204 -------VDQLVEIIKVLGTPTREEIKCMN-PNYT--------------------EFKFPQ-------IK--PHPWHKVF 246 (335)
Q Consensus 204 -------~~~~~~~~~~~g~~~~~~~~~~~-~~~~--------------------~~~~~~-------~~--~~~~~~~~ 246 (335)
..........+|+|.+....... ..|. +|.-.. +. ...+....
T Consensus 182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred eCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 00011122345665533222111 1111 110000 00 11223344
Q ss_pred ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 247 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|..++..+++||++||..||.+|+|+.++|+|||++....
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 5788999999999999999999999999999999987633
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=220.05 Aligned_cols=117 Identities=32% Similarity=0.538 Sum_probs=102.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.++||+|+||.||+|+++.+++.||||++... ...+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999998632 23467899999999999999999998655444445689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||+++|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ 123 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN 123 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999988876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=220.05 Aligned_cols=193 Identities=23% Similarity=0.327 Sum_probs=148.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
....+|++.+.||+|+||+|.+|++...|+.||||.|+++. -.+.|||+||..|+||||+++|++| ++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence 34458999999999999999999999999999999997643 3467999999999999999999999 77
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------- 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------- 203 (335)
...+.|||||..| .|++++.+ .+.++|.+++.+|+||+.|+.|+|.++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchh
Confidence 7779999999995 99999998 788999999999999999999999988
Q ss_pred --cChHHhHhhhcCCCCHHHhhhhC-CCCCCC-------------------CCC---------CCCCCccccccccCCCh
Q 019844 204 --VDQLVEIIKVLGTPTREEIKCMN-PNYTEF-------------------KFP---------QIKPHPWHKVFQKRLPP 252 (335)
Q Consensus 204 --~~~~~~~~~~~g~~~~~~~~~~~-~~~~~~-------------------~~~---------~~~~~~~~~~~~~~~s~ 252 (335)
..+.....++||.|.|......+ ..|... .|. ++... ..+.+.-+.
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G---aYrEP~~PS 277 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG---AYREPETPS 277 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc---cccCCCCCc
Confidence 01111223556666543222110 111110 000 00111 112245677
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
++.-||+.||..||++|.|+.++-.|=|+.-
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 8999999999999999999999999988753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=216.57 Aligned_cols=201 Identities=26% Similarity=0.364 Sum_probs=146.5
Q ss_pred CCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------------hhHHHHHHHHHhCCCCce
Q 019844 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHPNI 137 (335)
Q Consensus 76 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------~~~~~Ei~~l~~l~hpnI 137 (335)
......+.|++++.||+|.||+|.+|++..+++.||||++.+.. +.+.+||.||++|+||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34456678999999999999999999999999999999996421 357799999999999999
Q ss_pred eeeceeeeeCCCCCccEEEEEeecch-hhHHHHHHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCC------------
Q 019844 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCI------------ 203 (335)
Q Consensus 138 v~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~------------ 203 (335)
|+|+++. ++....++|||+|||. |.+... . ..+. +++.+++.|++.++.||+|||.+|
T Consensus 171 V~LiEvL---DDP~s~~~YlVley~s~G~v~w~-p----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 171 VKLIEVL---DDPESDKLYLVLEYCSKGEVKWC-P----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred eEEEEee---cCcccCceEEEEEeccCCccccC-C----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 9999998 4456677999999999 444211 1 1344 999999999999999999999998
Q ss_pred -----------------------cChHHhHhhhcCCCCH---HHhhhhC-CCCCCC-----------------CCC----
Q 019844 204 -----------------------VDQLVEIIKVLGTPTR---EEIKCMN-PNYTEF-----------------KFP---- 235 (335)
Q Consensus 204 -----------------------~~~~~~~~~~~g~~~~---~~~~~~~-~~~~~~-----------------~~~---- 235 (335)
.+.........|||.. +....+. ..|..+ ..|
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 0112222335677762 2222111 011100 011
Q ss_pred -------CCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 236 -------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 236 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.+...++.....+.+.++++|||.+||++||.+|++..++..|||....
T Consensus 323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1111222222224578999999999999999999999999999999776
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=214.18 Aligned_cols=115 Identities=30% Similarity=0.442 Sum_probs=101.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ....+|+.+++.++||||+++++++ ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 356999999999999999999999999999999986422 3467899999999999999999999 555679
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.++|.+++... .+.+++..++.++.||+.||+|||+++
T Consensus 79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ 123 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY 123 (303)
T ss_pred EEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999988887652 356899999999999999999999988
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=204.89 Aligned_cols=198 Identities=23% Similarity=0.311 Sum_probs=149.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.+++.||+|-||.||+|+.+.++-.||+|++.++ ..++.||++|...|+||||.++|++| .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 345799999999999999999999999999999999654 25678999999999999999999999 555
Q ss_pred cEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc---------------------------
Q 019844 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV--------------------------- 204 (335)
Q Consensus 153 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------------------- 204 (335)
..+|+++||.. |.|+..|.... ..++++..++.|++|++.||.|+|.+++
T Consensus 95 ~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 55999999999 69999988533 6779999999999999999999999980
Q ss_pred -ChHHhHhhhcCCCCHHHhhhhCCC-CCC---------------CCCCCCCCC----------ccccccccCCChHHHHH
Q 019844 205 -DQLVEIIKVLGTPTREEIKCMNPN-YTE---------------FKFPQIKPH----------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 205 -~~~~~~~~~~g~~~~~~~~~~~~~-~~~---------------~~~~~~~~~----------~~~~~~~~~~s~~~~~l 257 (335)
.....-.++|||..+....-..+. +.. ...+.+... .....+|..++..+.||
T Consensus 173 ~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 173 HAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred ecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 001122234555442222111000 000 001111100 11123568899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|.+||..+|.+|++..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=227.36 Aligned_cols=198 Identities=24% Similarity=0.334 Sum_probs=152.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
...++|.++++||+|+||+|+++..+.+++.||||+++|+. ...+.|..|+... +||.+++++.+| +
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence 44568999999999999999999999999999999998643 5567898988888 599999999999 8
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------- 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------- 203 (335)
...++|+||||+.| |+..+.. .+.|+|..++.|+.+|+.||+|||++|
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 88889999999997 7443333 477999999999999999999999999
Q ss_pred ----cChHHhHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCC-CCC------ccccccccCCChH
Q 019844 204 ----VDQLVEIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQI-KPH------PWHKVFQKRLPPE 253 (335)
Q Consensus 204 ----~~~~~~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~-~~~------~~~~~~~~~~s~~ 253 (335)
........++||||.+....... ..|.. ..|+.- ... .-...+|..+|.+
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~e 594 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKE 594 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHH
Confidence 11223445678887743222111 11110 011100 000 0123467789999
Q ss_pred HHHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 254 AVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+.++|+++|..||++|.. +.+|..||||+.+.|
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 999999999999999996 589999999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=214.79 Aligned_cols=192 Identities=28% Similarity=0.426 Sum_probs=150.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
-|.++.+||+|+||.||+|.++.+|..+|||.++.+ .+.+.+||.||.+++.|+||+||+.|+...+ +|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 388999999999999999999999999999999754 4778899999999999999999999976555 999999
Q ss_pred cch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------cChHHh
Q 019844 161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------VDQLVE 209 (335)
Q Consensus 161 ~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------~~~~~~ 209 (335)
||+ |++.++++.. +++++|.++..+++..+.||+|||... .+...+
T Consensus 109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999 7999999863 678999999999999999999999765 233344
Q ss_pred HhhhcCCCCH---HHhh---------------------hhCCCCCC-------CCCCCCCCCccccccccCCChHHHHHH
Q 019844 210 IIKVLGTPTR---EEIK---------------------CMNPNYTE-------FKFPQIKPHPWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 210 ~~~~~g~~~~---~~~~---------------------~~~~~~~~-------~~~~~~~~~~~~~~~~~~~s~~~~~li 258 (335)
-.++.|||.+ +.+. .+.|.|.. |-.|...+..|. -|..+|.++.|||
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~--KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK--KPEEWSSEFNDFI 263 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC--ChHhhhhHHHHHH
Confidence 4456777762 2221 12233321 111111111111 1345789999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccC
Q 019844 259 CRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
++||..+|++|-||.++++|||++..
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=225.91 Aligned_cols=194 Identities=24% Similarity=0.336 Sum_probs=146.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...|....+||+|+-|.||.|+...+++.||||.+... .+.+..|+.+|+..+|+|||.+++.|+.. ..+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeE
Confidence 34688899999999999999999999999999999643 34577999999999999999999999654 4499
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------------------------C
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------------------------D 205 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------------------------~ 205 (335)
+|||||+| +|.+++.. -.++|.++..|+++++.||+|||.+++ .
T Consensus 347 VVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999996 99999985 449999999999999999999999980 0
Q ss_pred hHHhHhhhcCCCCHHHhhhhCC-CCCC----------------CCCCCCCCCccc------------cccccCCChHHHH
Q 019844 206 QLVEIIKVLGTPTREEIKCMNP-NYTE----------------FKFPQIKPHPWH------------KVFQKRLPPEAVD 256 (335)
Q Consensus 206 ~~~~~~~~~g~~~~~~~~~~~~-~~~~----------------~~~~~~~~~~~~------------~~~~~~~s~~~~~ 256 (335)
...+-.+.+|||++...+.... .|.. -+-|.+...++. ...+..+|+.++|
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 0112234567777332221110 0100 000111111111 1234679999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
||.+||+.|+.+|++|.+||+||||+..
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999644
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=221.31 Aligned_cols=195 Identities=31% Similarity=0.460 Sum_probs=157.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchh---HHHHHHHHHhCC-C-----CceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~---~~~Ei~~l~~l~-h-----pnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||+|+||.|-+|.+..|++.||||+|++...+ ...|+.+|..|+ | -|||+++++| .-.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 899999999999999999999999999999999876644 457999999996 4 4899999999 7777
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
|+|||+|+++-+|+++++.+. ..+|+...++.|+.||+.||.+||..+
T Consensus 262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 899999999999999999866 566999999999999999999999988
Q ss_pred ------------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCCCC
Q 019844 204 ------------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNPNY 229 (335)
Q Consensus 204 ------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~~~ 229 (335)
.+++..|+.++|.|+...+..+.-.+
T Consensus 340 ~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 340 FESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred ccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 67888889999988877665332111
Q ss_pred CCC----CCCC-----------------------------C-CCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHH
Q 019844 230 TEF----KFPQ-----------------------------I-KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 275 (335)
Q Consensus 230 ~~~----~~~~-----------------------------~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 275 (335)
.-+ .++. . ....+...+.......+.|||.+||.+||.+|+|+.++
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 000 0000 0 11122222322345678999999999999999999999
Q ss_pred hcCcccccC
Q 019844 276 CVHPFFDEL 284 (335)
Q Consensus 276 L~hp~f~~~ 284 (335)
|+||||...
T Consensus 500 l~Hpfl~~~ 508 (586)
T KOG0667|consen 500 LNHPFLTGT 508 (586)
T ss_pred hcCcccccc
Confidence 999999854
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=215.14 Aligned_cols=235 Identities=26% Similarity=0.382 Sum_probs=165.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..+|.+.+.||+|+||+||+|.+..+++.||||.+... ...+.+|+.+++.++||||+++++++.........+
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34699999999999999999999999999999998642 234568999999999999999999885443333356
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--hHHhHh---------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--QLVEII--------- 211 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--~~~~~~--------- 211 (335)
+|+||||+.++|.+++.. .+.+++..++.++.||+.||.|||++++ + ....+.
T Consensus 84 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999999999888875 5679999999999999999999999880 0 000000
Q ss_pred -------hhcCCCC---HHHhhhhC-C------------------CCCCCCCCC--------------------------
Q 019844 212 -------KVLGTPT---REEIKCMN-P------------------NYTEFKFPQ-------------------------- 236 (335)
Q Consensus 212 -------~~~g~~~---~~~~~~~~-~------------------~~~~~~~~~-------------------------- 236 (335)
...|+.. ++.+.... . ....+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 0011111 11111000 0 000000000
Q ss_pred -----------CCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCc
Q 019844 237 -----------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 305 (335)
Q Consensus 237 -----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.....+.. ..+.+++++.+||++||+.||++|||+.++|+||||..+..+...... .. .++|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~--~~~~~- 313 (337)
T cd07858 240 KARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QT--PFSFD- 313 (337)
T ss_pred hhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CC--ccchh-
Confidence 00000011 124688999999999999999999999999999999998887764432 22 33444
Q ss_pred ccCCCCCHHHHhhcChHHHh
Q 019844 306 PELSGIPPETINRLIPEHAR 325 (335)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~ 325 (335)
.+...+..+.++++|..|+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~ 333 (337)
T cd07858 314 FEEDALTEEDIKELIYNEML 333 (337)
T ss_pred hhhhhcCHHHHHHHHHHHHh
Confidence 44666889999999988875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-27 Score=211.76 Aligned_cols=114 Identities=30% Similarity=0.518 Sum_probs=99.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
++|.+.+.||+|+||.||+|+++.+++.||+|++.... ..+.+|+.+++.++||||+++++++ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 46999999999999999999999999999999986322 3466899999999999999999999 4555689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ 124 (309)
T cd07872 81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK 124 (309)
T ss_pred EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999888877652 345899999999999999999999988
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=216.31 Aligned_cols=197 Identities=27% Similarity=0.343 Sum_probs=143.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|.+.+.||+|+||.||+|+++.+++.||||++.+. ...+.+|+.+++.++||||+++++++ ....
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 45699999999999999999999999999999998642 23467899999999999999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh--------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII-------- 211 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~-------- 211 (335)
++|+||||+.| +|.+++.. .+.+++..++.++.||+.||+|||++++ +. ....+
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 79999999986 99988876 5679999999999999999999999980 00 00000
Q ss_pred ------hhcCCCC---HHHhhhhCCCC--CCC------------CCCCCCCCcc---------ccccccCCChHHHHHHH
Q 019844 212 ------KVLGTPT---REEIKCMNPNY--TEF------------KFPQIKPHPW---------HKVFQKRLPPEAVDLVC 259 (335)
Q Consensus 212 ------~~~g~~~---~~~~~~~~~~~--~~~------------~~~~~~~~~~---------~~~~~~~~s~~~~~li~ 259 (335)
..+|++. ++.+....... .-| ..+.....+. ...++..+++.+++||.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 168 VPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred cCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 1123332 22111110000 000 0000000000 11234568899999999
Q ss_pred HhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 260 RFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 260 ~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+||+.||.+|++ +.++++||||....+
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 999999999997 799999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=207.39 Aligned_cols=195 Identities=23% Similarity=0.398 Sum_probs=154.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.|.-.+.||+|..++|..|.++.+|+.+|+|+|.... +...+|+.||+++ .||+|+.+.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 4888899999999999999999999999999995211 2345899999999 799999999999
Q ss_pred CCccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------
Q 019844 150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------- 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------- 203 (335)
+...++++|+|+|+ |.|++++.+ .-.++|..++.|++|++.|++|||.++
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 77888999999999 799999997 678999999999999999999999888
Q ss_pred ----cChHHhHhhhcCCCCHH---Hhhh----hCCCCCC-----------CC------------------CCCCCCCccc
Q 019844 204 ----VDQLVEIIKVLGTPTRE---EIKC----MNPNYTE-----------FK------------------FPQIKPHPWH 243 (335)
Q Consensus 204 ----~~~~~~~~~~~g~~~~~---~~~~----~~~~~~~-----------~~------------------~~~~~~~~~~ 243 (335)
+....+...+||||.+. .+.| ..|+|.. |. +.......+.
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 23334555678888743 3332 2344431 00 0000111233
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
..-|.++|.+++|||.+||+.||.+|+|++++|.||||.++-.
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 4456789999999999999999999999999999999976543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=211.75 Aligned_cols=234 Identities=26% Similarity=0.435 Sum_probs=164.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++.........++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 45799999999999999999999999999999998532 2346689999999999999999998754433444568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-Ch-------------HHhH-----------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-DQ-------------LVEI----------- 210 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~-------------~~~~----------- 210 (335)
|+||||++++|.+++. ...+++..++.++.||+.||.|||++++ +. ...+
T Consensus 84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9999999998888775 3569999999999999999999999980 00 0000
Q ss_pred --------hhhcCCCC---HHHhhh----------------------hCCCCCCCCC-------------C---------
Q 019844 211 --------IKVLGTPT---REEIKC----------------------MNPNYTEFKF-------------P--------- 235 (335)
Q Consensus 211 --------~~~~g~~~---~~~~~~----------------------~~~~~~~~~~-------------~--------- 235 (335)
....|++. ++.+.. +.+.|..... +
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 00011111 111100 0011100000 0
Q ss_pred ------------CCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCC
Q 019844 236 ------------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 303 (335)
Q Consensus 236 ------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~ 303 (335)
.....++.... +..++++.+||.+||+.||++|||+.++++||||..+..+...... +-+..++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~--~~~~~~~~ 315 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVA--EEPFPFDF 315 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccC--CCCCChhh
Confidence 00000011111 3568889999999999999999999999999999999876543322 22345666
Q ss_pred CcccCCCCCHHHHhhcChHHH
Q 019844 304 KPPELSGIPPETINRLIPEHA 324 (335)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~ 324 (335)
+ .++.++.+.+++.|.+++
T Consensus 316 ~--~~~~~~~~~~~~~~~~~~ 334 (336)
T cd07849 316 E--LFDDLPKEKLKELIFEEI 334 (336)
T ss_pred c--cccccCHHHHHHHHHHHh
Confidence 6 668888888888888775
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-30 Score=211.95 Aligned_cols=196 Identities=22% Similarity=0.401 Sum_probs=145.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEec------ccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~------~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..+|+++++||+|+||.||++.+..+|+.+|.|.|. +..+.+..|+.+|++|+|||||++|++-+. ++..-
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 345999999999999999999999999999999985 234567899999999999999999994432 33334
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--C----------------------------
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--I---------------------------- 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~---------------------------- 203 (335)
++||||||+ |||.++++.+.+.++.++|..+|.++.|+|.||..+|++ +
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 889999999 699999999988889999999999999999999999982 2
Q ss_pred ----cChHHhHhhhcCCCCHHHhhhh-CCCCCC-----------------------CCCC----CCCCCccccccc-cCC
Q 019844 204 ----VDQLVEIIKVLGTPTREEIKCM-NPNYTE-----------------------FKFP----QIKPHPWHKVFQ-KRL 250 (335)
Q Consensus 204 ----~~~~~~~~~~~g~~~~~~~~~~-~~~~~~-----------------------~~~~----~~~~~~~~~~~~-~~~ 250 (335)
........+.+|||.+...... ...|.. -.+. ++....+.. +| ..+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~-~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP-LPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC-CcHHHh
Confidence 1111122356788885433221 111211 0000 011112211 22 567
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
|.++..||..|+..||+.||+. +|++.++.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 8999999999999999999987 56665543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=220.64 Aligned_cols=195 Identities=22% Similarity=0.347 Sum_probs=147.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...|..++.||+|+||.||+|.+..+++.||+|+|..+ ...+++|+.+|.+++++||.++|+.|+... .+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cH
Confidence 34588899999999999999999999999999999743 355789999999999999999999995544 49
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------c
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------V 204 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------~ 204 (335)
||+||||.| ++.++++. ...+.|.++..++++++.||.|||..+ .
T Consensus 87 wiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 999999996 99999986 555699999999999999999999988 1
Q ss_pred ChHHhHhhhcCCCCHHHhhhhC-CCCCCC----------------CCCCCCCCc----------cccccccCCChHHHHH
Q 019844 205 DQLVEIIKVLGTPTREEIKCMN-PNYTEF----------------KFPQIKPHP----------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 205 ~~~~~~~~~~g~~~~~~~~~~~-~~~~~~----------------~~~~~~~~~----------~~~~~~~~~s~~~~~l 257 (335)
.......+++|||.+....... ..|..- .-|.....+ ..+.+...+|+.+++|
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence 1112225667888732222111 112110 000001111 1122334789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|..||.+||+.||+|.++|+|+|++..
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 999999999999999999999998763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=214.21 Aligned_cols=195 Identities=24% Similarity=0.303 Sum_probs=142.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 599999999999999999999999999999998632 23467899999999999999999998 566779
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh----------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII---------- 211 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~---------- 211 (335)
|+||||++| +|.+++.. .+.+++..++.++.||+.||+|||++++ +. ....+
T Consensus 77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999995 99999876 5679999999999999999999999980 00 00000
Q ss_pred ----hhcCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHHHHHHHHh
Q 019844 212 ----KVLGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEAVDLVCRF 261 (335)
Q Consensus 212 ----~~~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~~~li~~~ 261 (335)
..+|++. ++.+........ ...+...... .....++..+++.+++||++|
T Consensus 153 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHH
Confidence 1123322 111110000000 0000000000 001124456789999999999
Q ss_pred ccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 262 FQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 262 L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
|+.||.+|++ +.++++||||....+
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999995 999999999987655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=207.60 Aligned_cols=115 Identities=27% Similarity=0.490 Sum_probs=101.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|.+.+.||.|+||.||+|.++.+++.||+|.+.... ..+.+|+.+++.++||||+++++++ ....++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 356999999999999999999999999999999986322 3466899999999999999999999 555679
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ 124 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK 124 (301)
T ss_pred EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999998887652 346899999999999999999999988
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=206.38 Aligned_cols=113 Identities=35% Similarity=0.551 Sum_probs=97.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++++++ ....++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 599999999999999999999999999999998642 23467899999999999999999999 5566799
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++++.+.+... ...+++..++.++.||+.||.|||+.+
T Consensus 77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~ 120 (287)
T cd07848 77 LVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND 120 (287)
T ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999998554444331 456999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=212.35 Aligned_cols=190 Identities=26% Similarity=0.367 Sum_probs=137.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|+++.+|+.||||++.+.. ..+.+|+.+++.++||||+++++++ ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999996431 3456899999999999999999999 56667999999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh--------------
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK-------------- 212 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~-------------- 212 (335)
|+.| +|.+++.. .+.+++..++.++.||+.||+|||++|+ +. ....+.
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9996 99888875 5679999999999999999999999980 00 000011
Q ss_pred ---hcCCCC---HHHhhhhCCCC--CCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhcc
Q 019844 213 ---VLGTPT---REEIKCMNPNY--TEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFFQ 263 (335)
Q Consensus 213 ---~~g~~~---~~~~~~~~~~~--~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L~ 263 (335)
.+|++. ++.+....... .-|.+.- ....+| ...++..+++++.+||.+||+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 122322 11111000000 0000000 000011 112456789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccCCC
Q 019844 264 YSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 264 ~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.||++|| ++.++++||||....+
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999 8999999999988644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=214.88 Aligned_cols=117 Identities=25% Similarity=0.359 Sum_probs=100.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+++.||+|+||.||+|.+..+++.||||.+... .+.+.+|+.+++.++||||+++++++.........++|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 378899999999999999999999999999998642 24567899999999999999999998543322223689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ 123 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG 123 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999988887765 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=202.80 Aligned_cols=202 Identities=31% Similarity=0.492 Sum_probs=156.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..|++++.||+|+||.||+|..+.++. .||||.++.+. ....||+.+++.|+|||||.+..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 459999999999999999997665533 79999997542 3467999999999999999999999742
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCI--------------------------- 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------- 203 (335)
+..+++++||.+.||..+++..... ...++...++.|++||+.|+.|||++-
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 4559999999999999999865432 346899999999999999999999864
Q ss_pred ---------------------------------------------------------------------------cChHH
Q 019844 204 ---------------------------------------------------------------------------VDQLV 208 (335)
Q Consensus 204 ---------------------------------------------------------------------------~~~~~ 208 (335)
.+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 67788
Q ss_pred hHhhhcCCCCHHHhhhh--CCCCCC----CCCCCCCCCcccccc--ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019844 209 EIIKVLGTPTREEIKCM--NPNYTE----FKFPQIKPHPWHKVF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 280 (335)
Q Consensus 209 ~~~~~~g~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~ 280 (335)
.|+.++|+|....|..+ -|.|.. +.........+...+ ...-++.+.+|+.+||++||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 88899999987777655 233311 000001111111111 1234566999999999999999999999999999
Q ss_pred cccCCCC
Q 019844 281 FDELRDP 287 (335)
Q Consensus 281 f~~~~~~ 287 (335)
|.....|
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987655
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-26 Score=208.37 Aligned_cols=119 Identities=22% Similarity=0.292 Sum_probs=100.1
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~ 151 (335)
...++|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3456799999999999999999999999999999998642 2356789999999999999999998854321 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||+++
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ 146 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG 146 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 345899999999988777642 3889999999999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=210.37 Aligned_cols=112 Identities=20% Similarity=0.250 Sum_probs=98.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeec
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
.+|.+++.||+|+||.||+|.+..+++.||+|+..+. ....|+.+++.++||||+++++++ ....+.|+|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheE-----EeCCeeEEEEEc
Confidence 4699999999999999999999999999999976432 346799999999999999999999 445568899999
Q ss_pred chhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.|+|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 139 ~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 177 (357)
T PHA03209 139 YSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR 177 (357)
T ss_pred cCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999998888652 456999999999999999999999998
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=202.95 Aligned_cols=119 Identities=27% Similarity=0.423 Sum_probs=100.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhC---CCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|++.+.||+|+||.||+|.++.+++.||+|.+.... ....+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999986421 2456788887766 799999999998654444556
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++||||+.++|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ 128 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC 128 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 789999999999988887532 345899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=204.07 Aligned_cols=119 Identities=27% Similarity=0.435 Sum_probs=97.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcC-CCcEEEEEEecccc------hhHHHHHHHHHhC---CCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~------~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~~ 152 (335)
+|++.+.||+|+||.||+|++.. +++.||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 59999999999999999999864 46889999886321 2456788887776 69999999999854333345
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++||||++++|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ 130 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR 130 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5689999999999999887533 345899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=214.11 Aligned_cols=112 Identities=21% Similarity=0.290 Sum_probs=100.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
..+|.+++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.|+|||||+++++| ....+.|+|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEe
Confidence 3569999999999999999999999999999997643 4567999999999999999999999 45556899999
Q ss_pred cchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++.++|..++.. ...+++..++.|+.||+.||.|||+++
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~ 202 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR 202 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999888875 567999999999999999999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=204.41 Aligned_cols=196 Identities=20% Similarity=0.269 Sum_probs=139.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
|++.+.||+|+||.||+|.++.+++.||+|.+.+.. ..+.+|+.+++.++|+||+++++++ ....++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 888999999999999999999999999999986421 2356899999999999999999999 5556799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh---------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV--------- 213 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~--------- 213 (335)
+|||||+| +|..++.... ...+++..+..++.||+.||.|||++++ + .....+..
T Consensus 77 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999995 9987776422 3468999999999999999999999980 0 00000111
Q ss_pred -------cCCCC---HHHhhhhCCCCC--C--------------CCCCCCCC-----------CccccccccCCChHHHH
Q 019844 214 -------LGTPT---REEIKCMNPNYT--E--------------FKFPQIKP-----------HPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 214 -------~g~~~---~~~~~~~~~~~~--~--------------~~~~~~~~-----------~~~~~~~~~~~s~~~~~ 256 (335)
.|++. ++.+........ - ..+..... ......++..+++++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 22222 111110000000 0 00000000 00011234568899999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
||++||+.||.+||+ ++++++||||....+
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=208.56 Aligned_cols=117 Identities=26% Similarity=0.457 Sum_probs=101.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.+|.+.+.||.|+||.||+|.++.+++.||+|++... ...+.+|+.+|+.++||||+++++++.... ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 5699999999999999999999999999999998643 234668999999999999999999875433 345678
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.|+|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ 127 (334)
T cd07855 84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN 127 (334)
T ss_pred EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999888865 556999999999999999999999988
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-26 Score=208.43 Aligned_cols=118 Identities=22% Similarity=0.306 Sum_probs=99.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 456799999999999999999999999999999998642 2446689999999999999999999854321 122
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||++++|.+.+. ..+++..++.++.||+.||.|||+++
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ 143 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG 143 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578999999998777664 24889999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=210.98 Aligned_cols=112 Identities=27% Similarity=0.416 Sum_probs=101.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|+++.+++.||||++.+. ...+.+|+.+|+.++||||++++++| ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 599999999999999999999999999999999642 13456899999999999999999999 666779
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||.| +|.+++.. .+.+++..++.|+.||+.||+|||+++
T Consensus 77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~ 121 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG 121 (364)
T ss_pred EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999985 99999876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=222.31 Aligned_cols=194 Identities=21% Similarity=0.313 Sum_probs=147.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc----cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.+-|.|+..||.|+||+||+|..+.++-..|.|+|.- ....+.-||+||..++||+||++++.|+-. +.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceE
Confidence 3458999999999999999999999999999999852 234567899999999999999999999543 3499
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------cC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------VD 205 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------~~ 205 (335)
|+.|||+| -+..++-.. ...|++.+++.+++|+|.||.|||+++ ..
T Consensus 106 iliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999997 777777664 567999999999999999999999998 11
Q ss_pred hHHhHhhhcCCCCHHH---hhhhCCCCCCCCCCCCCCCcc----------------------------------cccccc
Q 019844 206 QLVEIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----------------------------------HKVFQK 248 (335)
Q Consensus 206 ~~~~~~~~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~ 248 (335)
....--.+.|||++.. ..|-...-.+|.+ ..+.| ...-|.
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDy---kaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDY---KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchh---hhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcc
Confidence 1122234578887322 2222111111110 11111 112346
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 249 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
.++..+.||+.+||..||..||+++++|+||||+...
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 7889999999999999999999999999999998653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=201.32 Aligned_cols=113 Identities=33% Similarity=0.510 Sum_probs=99.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|.++.+|+.||+|.+... ...+.+|+.+++.++||||+++++++ .+..++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 489999999999999999999999999999998632 13466899999999999999999999 5556699
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||++++|.+++... .+.+++..++.++.||+.||.|||+++
T Consensus 76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~ 119 (284)
T cd07839 76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN 119 (284)
T ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999888877642 456999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=206.23 Aligned_cols=231 Identities=27% Similarity=0.423 Sum_probs=163.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||.|+||.||+|++..+++.||||.+... .+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999989999999998642 24577899999999999999999998554323334689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChH-Hh--------------
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQL-VE-------------- 209 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~-~~-------------- 209 (335)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||++|+ +.. ..
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999999999888875 4579999999999999999999999980 000 00
Q ss_pred ------HhhhcCCCC---HHHhh----------------------hhCCCCCCCC-------------------------
Q 019844 210 ------IIKVLGTPT---REEIK----------------------CMNPNYTEFK------------------------- 233 (335)
Q Consensus 210 ------~~~~~g~~~---~~~~~----------------------~~~~~~~~~~------------------------- 233 (335)
.....+++. ++.+. .+.+.+....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 000011111 11000 0011110000
Q ss_pred ---------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCC
Q 019844 234 ---------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304 (335)
Q Consensus 234 ---------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 304 (335)
........+...+ +.+++++.+||.+||+.||.+|||+.++|+||||+....+..+.+.. ..++|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~----~~~~~~ 311 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAK----PPFDFD 311 (330)
T ss_pred cchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCC----Cccccc
Confidence 0000000111111 45789999999999999999999999999999999998877665542 334665
Q ss_pred cccCCCCCHHHHhhcChH
Q 019844 305 PPELSGIPPETINRLIPE 322 (335)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~ 322 (335)
+.+.+.+..++.++.|.+
T Consensus 312 ~~~~~~~~~~~~~~~~~~ 329 (330)
T cd07834 312 FFDDDELTEEELKELIYE 329 (330)
T ss_pred ccchhhcCHHHHhHHhhc
Confidence 566777888888777654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=205.63 Aligned_cols=187 Identities=27% Similarity=0.367 Sum_probs=133.8
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ....++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 79999999999999999999999998642 13456899999999999999999999 5566799999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-H-Hh----------------Hh
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-L-VE----------------II 211 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~-~~----------------~~ 211 (335)
+| +|.+++.. .+.+++..++.++.||+.||.|||++++ +. . .. ..
T Consensus 76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 96 99998876 5679999999999999999999999881 00 0 00 00
Q ss_pred hhcCCCC---HHHhhhhCCC--CCCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhccCC
Q 019844 212 KVLGTPT---REEIKCMNPN--YTEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFFQYS 265 (335)
Q Consensus 212 ~~~g~~~---~~~~~~~~~~--~~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~d 265 (335)
..+|++. ++.+...... ..-|.+.- ....+| ...++..+++++.+||.+||..|
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 1123322 1111100000 00000000 000000 11244678899999999999999
Q ss_pred CCCCC---CHHHHhcCcccccCC
Q 019844 266 PNLRC---TALEACVHPFFDELR 285 (335)
Q Consensus 266 P~~R~---t~~~~L~hp~f~~~~ 285 (335)
|.+|| ++.++|+||||.+..
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCC
Confidence 99997 589999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=207.84 Aligned_cols=190 Identities=25% Similarity=0.350 Sum_probs=135.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||+||+|.++.+++.||||++.+. .....+|+.+++.+ +||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999999999999999999999753 23456788999888 799999999999 5566799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV------------ 213 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~------------ 213 (335)
||++| +|...+.. .+.+++..++.++.||+.||.|||++++ + .....+..
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99986 99888875 5679999999999999999999999981 0 00000111
Q ss_pred -----cCCCC---HHHhhhhCCCC--C--------------CCCCCCCCCC-------ccccccccCCChHHHHHHHHhc
Q 019844 214 -----LGTPT---REEIKCMNPNY--T--------------EFKFPQIKPH-------PWHKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 214 -----~g~~~---~~~~~~~~~~~--~--------------~~~~~~~~~~-------~~~~~~~~~~s~~~~~li~~~L 262 (335)
+|++. ++.+....... . ...+...... .....++..+++++.+||++||
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL 231 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 12222 11111100000 0 0000000000 0011234568999999999999
Q ss_pred cCCCCCCCCH-----HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA-----LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~-----~~~L~hp~f~~~~~ 286 (335)
+.||++||++ .++++||||....+
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999 99999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=209.72 Aligned_cols=198 Identities=26% Similarity=0.315 Sum_probs=142.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCC-cEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..++|.+.+.||+|+||.||+|.++.++ ..||+|++.+. ...+.+|+.+++.++||||+++++++ ..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 3456999999999999999999976655 68999998532 23466899999999999999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HHh--------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LVE-------- 209 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~~-------- 209 (335)
..++|+||||+.| +|.+++.. .+.+++..++.++.||+.||.|||+++ ++. ...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 6679999999985 99999876 567999999999999999999999998 000 000
Q ss_pred ------HhhhcCCCC---HHHhhhhCCCC--CCCC------------CCCCCCCc---------cccccccCCChHHHHH
Q 019844 210 ------IIKVLGTPT---REEIKCMNPNY--TEFK------------FPQIKPHP---------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 210 ------~~~~~g~~~---~~~~~~~~~~~--~~~~------------~~~~~~~~---------~~~~~~~~~s~~~~~l 257 (335)
.....|++. ++.+....... .-|. .|.....+ -...++..+++.+.++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 179 KVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred eecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 011223332 22211110000 0000 00000000 0012356688999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|++||+.||.+|+ ++.++++||||....+
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999996 8999999999998754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=202.38 Aligned_cols=197 Identities=22% Similarity=0.288 Sum_probs=139.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.|++.++||+|+||.||++.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3889999999999999999999999999999986421 2356899999999999999999999 555679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh---------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK--------- 212 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~--------- 212 (335)
|+||||++| +|.+++.... ...+++..+..++.||+.||.|||++++ +. ....+.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999985 9988776422 3569999999999999999999999880 00 000000
Q ss_pred -------hcCCCC---HHHhhhhCCCC--C--------------CCCCCCCCCC-----------ccccccccCCChHHH
Q 019844 213 -------VLGTPT---REEIKCMNPNY--T--------------EFKFPQIKPH-----------PWHKVFQKRLPPEAV 255 (335)
Q Consensus 213 -------~~g~~~---~~~~~~~~~~~--~--------------~~~~~~~~~~-----------~~~~~~~~~~s~~~~ 255 (335)
..|++. ++.+....... . ...+...... .....++..+++.+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 112221 11110000000 0 0000000000 001123346789999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
+||.+||..||.+|| ++.++++||||....+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 999999999999999 8999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=206.67 Aligned_cols=190 Identities=23% Similarity=0.328 Sum_probs=135.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4699999999999999999999999999643 13456899999999999999999999 56667999999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh---------------
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII--------------- 211 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~--------------- 211 (335)
|++| +|...+.. ...+++..++.++.||+.||.|||++++ + .....+
T Consensus 76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9996 89888765 5679999999999999999999999981 0 000001
Q ss_pred --hhcCCCC---HHHhhhhCCC--CCCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhcc
Q 019844 212 --KVLGTPT---REEIKCMNPN--YTEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFFQ 263 (335)
Q Consensus 212 --~~~g~~~---~~~~~~~~~~--~~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L~ 263 (335)
..+|++. ++.+...... ..-|.+.- ....+| ...++..+++++.+||++||+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcC
Confidence 1123322 1111100000 00000000 000011 112456788999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccCCC
Q 019844 264 YSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 264 ~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.||++|+ ++.++++||||....+
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999997 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=209.28 Aligned_cols=197 Identities=22% Similarity=0.312 Sum_probs=148.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|.+++++|+|+||.+++++++..++.|++|.|... .+...+|+.+++++.|||||.+++.|. .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4699999999999999999999999999999999632 346789999999999999999999994 444559
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------c
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------V 204 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------~ 204 (335)
||||+||+| +|.+.+.... +..|+|..+..|+.||+.||.|||+++ .
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999996 9999998755 567999999999999999999999776 0
Q ss_pred ChHHhHhhhcCCCCHH---HhhhhCCCCCC---------CC----CCCCCCCcc-----------ccccccCCChHHHHH
Q 019844 205 DQLVEIIKVLGTPTRE---EIKCMNPNYTE---------FK----FPQIKPHPW-----------HKVFQKRLPPEAVDL 257 (335)
Q Consensus 205 ~~~~~~~~~~g~~~~~---~~~~~~~~~~~---------~~----~~~~~~~~~-----------~~~~~~~~s~~~~~l 257 (335)
.......+.+|||.+. .+.....++.. |. -+.+....+ -...+..++.+++.+
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 0001223456666632 22221111100 00 000111111 123456789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|..||..+|..||++.++|.+|....+
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999999987744
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=206.31 Aligned_cols=195 Identities=26% Similarity=0.407 Sum_probs=140.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|++..+++.||||++.+. ...+.+|+.+++.++||||+++++++ ....++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 599999999999999999999999999999999643 23466899999999999999999999 566679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--HHhH----------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ--LVEI---------- 210 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~--~~~~---------- 210 (335)
||||||++| +|.+++.. .+.+++..++.++.||+.||.|||++++ +. ..++
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999986 99999976 5679999999999999999999999881 00 0000
Q ss_pred ---hhhcCCCC---HHHhhhhCCCC--CCC--------------CCCCCCCC-------ccccc--cc------cCCChH
Q 019844 211 ---IKVLGTPT---REEIKCMNPNY--TEF--------------KFPQIKPH-------PWHKV--FQ------KRLPPE 253 (335)
Q Consensus 211 ---~~~~g~~~---~~~~~~~~~~~--~~~--------------~~~~~~~~-------~~~~~--~~------~~~s~~ 253 (335)
...+|++. ++.+....... .-| .+...... .|... .+ ..++++
T Consensus 153 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 11223332 22111100000 000 00000000 00000 00 145899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+.+||.+||..+|.+|+++.++++||||....+
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=205.49 Aligned_cols=188 Identities=24% Similarity=0.360 Sum_probs=134.8
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHH---HhCCCCceeeeceeeeeCCCCCcc
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l---~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
|++.+.||+|+||.||+|.++.+++.||||++++. ...+.+|+.++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 67899999999999999999999999999999642 13455666655 566899999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhhc-----
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKVL----- 214 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~~----- 214 (335)
++|+||||++| +|..++. .+.+++..++.++.||+.||.|||++++ + .....+..+
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 79999999996 8887765 3569999999999999999999999981 0 000001111
Q ss_pred ------------CCCCHHHhhhhCCCCCCCCCCCCCCCcc-------------------------------ccccccCCC
Q 019844 215 ------------GTPTREEIKCMNPNYTEFKFPQIKPHPW-------------------------------HKVFQKRLP 251 (335)
Q Consensus 215 ------------g~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~s 251 (335)
|++.+ +.|+...........+.| ...++..++
T Consensus 151 ~~~~~~~~~~~~g~~~y-----~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 225 (324)
T cd05589 151 GMGFGDRTSTFCGTPEF-----LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 225 (324)
T ss_pred CCCCCCcccccccCccc-----cCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 22211 111100000000000111 012445689
Q ss_pred hHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||.+|| ++.++++||||....+
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999999999999999 6999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=206.40 Aligned_cols=185 Identities=26% Similarity=0.355 Sum_probs=135.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|+++.+|+.||+|++.+. ...+.+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4699999999999999999999999998643 13356899999999999999999999 55567999999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh--------------
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK-------------- 212 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~-------------- 212 (335)
|++| +|..++.. .+.+++..++.++.||+.||.|||++++ +. ....+.
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9996 99888765 5679999999999999999999999980 00 000001
Q ss_pred ---hcCCCCHHHhhhhCCCCCCCCCCCCCCCcc-------------------------------ccccccCCChHHHHHH
Q 019844 213 ---VLGTPTREEIKCMNPNYTEFKFPQIKPHPW-------------------------------HKVFQKRLPPEAVDLV 258 (335)
Q Consensus 213 ---~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~s~~~~~li 258 (335)
..|++. ++.|+...........+.| ...++..+++++.+||
T Consensus 152 ~~~~~gt~~-----y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05595 152 MKTFCGTPE-----YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred cccccCCcC-----cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 112221 1111111000000000111 0123467899999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.+||+.||.+|+ ++.++++||||....+
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 227 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred HHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999998 8999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=203.97 Aligned_cols=118 Identities=23% Similarity=0.304 Sum_probs=99.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456799999999999999999999999999999998642 2456689999999999999999999854322 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++|
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g 139 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG 139 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999988776642 4889999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-26 Score=202.81 Aligned_cols=113 Identities=24% Similarity=0.411 Sum_probs=100.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.+.+.||+|+||.||+|.++.+++.||+|++++.. ..+.+|+.+++.++||||+++++++ ....++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999997432 3467899999999999999999998 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~ 122 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG 122 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999985 999998763 357999999999999999999999988
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=205.37 Aligned_cols=190 Identities=22% Similarity=0.342 Sum_probs=136.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+|++++.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.++|+||+++++++ .....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 345699999999999999999999999999999998543 24567999999999999999999999 55667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-C------------hHHhHhhhc------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-D------------QLVEIIKVL------ 214 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~------------~~~~~~~~~------ 214 (335)
+|+|||||.| +|.+ .....+..+..++.||+.||.|||++++ + .....+..+
T Consensus 147 ~~lv~e~~~~~~L~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 147 IQVLLEFMDGGSLEG--------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEEEEecCCCCcccc--------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9999999996 7643 2346788889999999999999999880 0 000001111
Q ss_pred -----------CCCCHHHhhhhCCCCCC-----------------------------CCCCCCCCCccc-----------
Q 019844 215 -----------GTPTREEIKCMNPNYTE-----------------------------FKFPQIKPHPWH----------- 243 (335)
Q Consensus 215 -----------g~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~----------- 243 (335)
|+.. ++.|++.. ..+.......|.
T Consensus 219 ~~~~~~~~~~~gt~~-----y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 293 (353)
T PLN00034 219 AQTMDPCNSSVGTIA-----YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293 (353)
T ss_pred ccccccccccccCcc-----ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC
Confidence 2221 11111100 000000001110
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
...+..+++++++||.+||+.||++|||+.|+|+||||.....+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 11234678899999999999999999999999999999886543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=207.52 Aligned_cols=119 Identities=28% Similarity=0.403 Sum_probs=100.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|++++.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++|..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 346799999999999999999999999999999998643 2345689999999999999999998853221 223
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|++|+++.++|.+++. ...+++..++.++.||+.||.|||+++
T Consensus 93 ~~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ 138 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG 138 (343)
T ss_pred CcEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578999999889988775 356999999999999999999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=199.68 Aligned_cols=113 Identities=31% Similarity=0.541 Sum_probs=99.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||.|+||.||+|.+..+++.||||.+.... ..+..|+.+++.++|+||+++++++ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 4889999999999999999999999999999996432 2356799999999999999999999 5566
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|+||||+.|+|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ 122 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW 122 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 79999999966999998752 126999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=206.06 Aligned_cols=114 Identities=22% Similarity=0.296 Sum_probs=99.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc--CCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
...+|.+++.||+|+||.||+|... .+++.||+|.+... ....+|+.+|+.++|||||+++++| .....+|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEE
Confidence 3457999999999999999999764 35678999988653 4567899999999999999999999 55667999
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||++.++|.+++.. ...+++..++.|+.||+.||.|||+++
T Consensus 164 v~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g 205 (392)
T PHA03207 164 VMPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG 205 (392)
T ss_pred EehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999888854 567999999999999999999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=204.73 Aligned_cols=114 Identities=21% Similarity=0.331 Sum_probs=100.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|++.+.||+|+||.||+|+++.++..||+|.+.... ..+.+|+.+|+.++||||+++++++ .....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 457999999999999999999999999999999986432 4577999999999999999999999 445568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||++| +|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ 123 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123 (331)
T ss_pred EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 999999996 99999876 567999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=208.40 Aligned_cols=198 Identities=23% Similarity=0.271 Sum_probs=149.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...-|.+.+.||+|-|++|.+|++.-||..||||+|.+.. ..+.+|++.|+.++|||||++|++. ..+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 3445999999999999999999999999999999997643 4577999999999999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
.+|+|+|+-+| ||+++|..+ ...+.|..++.||.||+.|+.|+|...
T Consensus 91 KlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 69999999995 999999864 467999999999999999999999876
Q ss_pred -cChHHhHhhhcCCCCHHHhh-------------------------hhCCCCCCCC----CCCCCCCccccccccCCChH
Q 019844 204 -VDQLVEIIKVLGTPTREEIK-------------------------CMNPNYTEFK----FPQIKPHPWHKVFQKRLPPE 253 (335)
Q Consensus 204 -~~~~~~~~~~~g~~~~~~~~-------------------------~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~ 253 (335)
.....+..+.||...|.... |+.+.|.+.. +-.+. .-....|..++.+
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS~e 245 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVSKE 245 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchhhhHH
Confidence 01111222334433321111 1111111100 00000 1112346778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
++|||..||+.||.+|.+.++|..|+|++....+
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999999999987654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=201.22 Aligned_cols=192 Identities=22% Similarity=0.270 Sum_probs=135.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||+|+||+||+|.++.+++.||+|.+.+.. ..+..|+.+++.++||||+++++++ ....++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 799999999999999999999999986421 3356799999999999999999998 5566699999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh---------------
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV--------------- 213 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~--------------- 213 (335)
+| +|..++.........+++..++.++.||+.||.|||++++ +. ....+..
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 95 9988876543335679999999999999999999999981 00 0000011
Q ss_pred --cCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-----------ccccccccCCChHHHHHHHHh
Q 019844 214 --LGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-----------PWHKVFQKRLPPEAVDLVCRF 261 (335)
Q Consensus 214 --~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-----------~~~~~~~~~~s~~~~~li~~~ 261 (335)
.|++. ++.+........ ...+...... .-...++..+++++.+|+.+|
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence 12221 111110000000 0000000000 000123356789999999999
Q ss_pred ccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 262 FQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 262 L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|+.||++|| +++++++||||++..+
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 999999999 8899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=195.78 Aligned_cols=204 Identities=21% Similarity=0.271 Sum_probs=147.6
Q ss_pred cceeeeEEe-eeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|.+- ++||-|-.|+|..|.++.|++.+|+|++.. ....++|++++... .|||||.++++|...- .+..++.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLL 135 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLL 135 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeE
Confidence 345567774 689999999999999999999999997754 56688999998777 6999999999995433 4567788
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcCh-----------------------------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVDQ----------------------------- 206 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~----------------------------- 206 (335)
||||+|+| .|+.-+...+ .+.|+|.++..|++||+.|+.|||+.++-.
T Consensus 136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 99999996 9998888744 667999999999999999999999998100
Q ss_pred ---HHhHhhhcCCCCHHHh------------------------hhhCCCC-CCCCCC-------CC--CCCccccccccC
Q 019844 207 ---LVEIIKVLGTPTREEI------------------------KCMNPNY-TEFKFP-------QI--KPHPWHKVFQKR 249 (335)
Q Consensus 207 ---~~~~~~~~g~~~~~~~------------------------~~~~~~~-~~~~~~-------~~--~~~~~~~~~~~~ 249 (335)
-....+-|-||.|... .|+-|.| ...... .+ ....|...-|..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 0011111222221111 1121111 110000 00 011222334567
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+|++++|+|+++|..+|.+|.|+.+++.|||+.+...
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 8999999999999999999999999999999988754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=203.64 Aligned_cols=190 Identities=27% Similarity=0.421 Sum_probs=134.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|+++.+++.||||++.+.. ....+|+.++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986431 3455788888877 799999999999 5566799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhh-------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIK------------- 212 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~------------- 212 (335)
|||+| +|..++.. ...+++..++.++.||+.||.|||++++ + .....+.
T Consensus 76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99996 99888876 5679999999999999999999999981 0 0000011
Q ss_pred ----hcCCCC---HHHhhhhCCCC--CCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 213 ----VLGTPT---REEIKCMNPNY--TEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 213 ----~~g~~~---~~~~~~~~~~~--~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
..|++. ++.+....... .-|.+.- ....+| ...++..+++++.+||++||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFM 231 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 122222 11111100000 0000000 000011 01234568899999999999
Q ss_pred cCCCCCCCCH------HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA------LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~------~~~L~hp~f~~~~~ 286 (335)
+.||.+|+++ .++++||||..+.+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999998 99999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-25 Score=197.43 Aligned_cols=118 Identities=31% Similarity=0.485 Sum_probs=100.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++.+.||+|+||.||+|.++.+|+.||+|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCC
Confidence 3456999999999999999999999999999999986321 234589999999999999999999843 2234
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++||||+.++|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF 128 (309)
T ss_pred eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 58899999999988888753 356899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=206.18 Aligned_cols=112 Identities=27% Similarity=0.420 Sum_probs=101.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.+.+.||+|+||.||+|++..+++.||||++.+. ...+.+|+.++..++||||+++++++ ....++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 599999999999999999999999999999999642 23467899999999999999999999 566679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||++|
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g 121 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG 121 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999986 99999886 467999999999999999999999988
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=202.73 Aligned_cols=118 Identities=25% Similarity=0.345 Sum_probs=100.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
...+|++.+.||+|+||.||+|.+..+++.||||.+.+. ...+.+|+.+++.++||||++++++|..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 446799999999999999999999999999999998642 2345689999999999999999999854322 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+||||+.++|.+.+.. .+++..++.++.||+.||+|||++|
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g 138 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG 138 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999988887753 2899999999999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=198.29 Aligned_cols=115 Identities=30% Similarity=0.558 Sum_probs=100.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||.|+||.||+|+++.++..||+|++... ...+.+|+.+++.++||||+++++++ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 489999999999999999999999999999998532 13467899999999999999999999 4556699
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 76 ~v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ 121 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR 121 (285)
T ss_pred EEEecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999998888865331 356999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=204.39 Aligned_cols=107 Identities=25% Similarity=0.484 Sum_probs=94.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.++.+++.||||++++.. ..+.+|+.++..+ +||||++++++| ....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997421 3466899999998 799999999999 5566799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+| +|..++.. .+.+++..++.|+.||+.||.|||+++
T Consensus 76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ 116 (329)
T cd05588 76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG 116 (329)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99996 99888765 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=207.26 Aligned_cols=112 Identities=21% Similarity=0.341 Sum_probs=100.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.|.+++.||+|+||+||+|+++.+++.||||++.+. ...+.+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 489999999999999999999999999999999642 13467899999999999999999999 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g 121 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG 121 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999986 99999876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=203.61 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=149.0
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
......|.+.+.||+|.|++|.++++..++..||||.|.+.. ..+.+|+++|+.|+|||||+++.+. ..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t 126 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ET 126 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----ee
Confidence 344556999999999999999999999999999999997642 3367999999999999999999999 45
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-------------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD------------- 205 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~------------- 205 (335)
...+|+||||+.| .+++++.. ++++.+..++.++.|+++|++|||+++ .+
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred cceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccc
Confidence 5559999999985 99999987 788999999999999999999999998 00
Q ss_pred ----hHHhHhhhcCCCCHHHhhhhC-CCCCCC---------------------C---CCCCCCCccc--cccccCCChHH
Q 019844 206 ----QLVEIIKVLGTPTREEIKCMN-PNYTEF---------------------K---FPQIKPHPWH--KVFQKRLPPEA 254 (335)
Q Consensus 206 ----~~~~~~~~~g~~~~~~~~~~~-~~~~~~---------------------~---~~~~~~~~~~--~~~~~~~s~~~ 254 (335)
.....-+.||++.+....... ..|... . +......... ..++..++.++
T Consensus 203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dc 282 (596)
T KOG0586|consen 203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDC 282 (596)
T ss_pred eeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechh
Confidence 011111234444422111100 001100 0 0000111111 12345688999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
.++|+++|..||.+|++.+++..|.|.......
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999998776654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=203.32 Aligned_cols=190 Identities=25% Similarity=0.337 Sum_probs=135.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++ ....++|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999996431 3456799999999999999999998 55667999999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC------------cC-hHHhHhh-------------
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI------------VD-QLVEIIK------------- 212 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~------------~~-~~~~~~~------------- 212 (335)
|++| +|..++.. ...+++..++.++.||+.||.|||+ ++ ++ .....+.
T Consensus 76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9996 89888765 5679999999999999999999997 56 00 0000011
Q ss_pred ----hcCCCC---HHHhhhhCCCC--CCCCCCCC------CCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 213 ----VLGTPT---REEIKCMNPNY--TEFKFPQI------KPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 213 ----~~g~~~---~~~~~~~~~~~--~~~~~~~~------~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
.+|++. ++.+....... .-|.+.-+ ...+| ...++..+++++.+||.+||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 123332 22211110000 00000000 00011 11235568999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 263 QYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
+.||++|+ ++.++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999997 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=207.46 Aligned_cols=112 Identities=19% Similarity=0.306 Sum_probs=101.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++++.||+|+||.||+|+++.+++.||||++.+. ...+.+|+.+|+.++||||+++++.| ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998642 23467899999999999999999999 566679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG 121 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999985 99999876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=207.38 Aligned_cols=112 Identities=23% Similarity=0.402 Sum_probs=100.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.+++.||+|+||.||+|.++.+++.||||++.+. ...+.+|+.+++.++|||||+++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 599999999999999999999999999999998642 13467899999999999999999999 566679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999985 99998876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=205.03 Aligned_cols=112 Identities=21% Similarity=0.320 Sum_probs=101.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|.++.+++.||+|++.+. ...+.+|+.++..++||||+++++++ ....++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 599999999999999999999999999999999642 23466899999999999999999999 666779
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.|+.||+.||.|||++|
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g 121 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG 121 (360)
T ss_pred EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999996 99999876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-25 Score=195.05 Aligned_cols=114 Identities=27% Similarity=0.489 Sum_probs=100.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
++|++.+.||.|+||.||+|.++.+++.||||.+.... ..+.+|+.+++.++||||+++++++ ....+.|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 56999999999999999999999899999999986432 3456899999999999999999999 5566799
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~ 123 (291)
T cd07844 80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR 123 (291)
T ss_pred EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999998888753 346899999999999999999999988
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=201.50 Aligned_cols=234 Identities=26% Similarity=0.402 Sum_probs=163.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|.+.+.||+|+||.||+|++..+++.||+|++... ...+.+|+.+++.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 455799999999999999999999999999999998642 1345689999999999999999998854332 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhh-------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIK------- 212 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~------- 212 (335)
..+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||++++ + .....+.
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 45889999998899988874 569999999999999999999999881 0 0000000
Q ss_pred -------hcCCCC---HHHhhh----------------------hCCCCCCCC---------------------------
Q 019844 213 -------VLGTPT---REEIKC----------------------MNPNYTEFK--------------------------- 233 (335)
Q Consensus 213 -------~~g~~~---~~~~~~----------------------~~~~~~~~~--------------------------- 233 (335)
..+++. ++.+.. +.+.+....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 011111 111100 000000000
Q ss_pred -------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 234 -------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 234 -------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.+......+...+ ..+++++.+||.+||+.||.+|||+.++++||||.+...+... +.+++++-+ .
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~~~-~ 320 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYDQS-F 320 (343)
T ss_pred HHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccCcc-h
Confidence 0000000011111 3468999999999999999999999999999999988766543 234455533 6
Q ss_pred cCCCCCHHHHhhcChHHHh
Q 019844 307 ELSGIPPETINRLIPEHAR 325 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~ 325 (335)
....+...+|++++..++-
T Consensus 321 ~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07851 321 ESRDLTVDEWKELVYKEIM 339 (343)
T ss_pred hhhhcCHHHHHHHhHHHHH
Confidence 6788889999999887654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=202.16 Aligned_cols=189 Identities=25% Similarity=0.343 Sum_probs=133.9
Q ss_pred eeeeccCceEEEEEEE---cCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 88 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~---~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
+.||+|+||.||++++ ..+|+.||+|++.+. .....+|+.+++.++||||+++++++ .....+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 6799999999999986 357899999999642 23456899999999999999999999 555679999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh-------------
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII------------- 211 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~------------- 211 (335)
|||+.| +|.+++.. ...+++..++.++.||+.||.|||++++ + .....+
T Consensus 77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999985 99888865 5679999999999999999999999980 0 000001
Q ss_pred ----hhcCCCC---HHHhhhhCCCC--CCC-------CCCCCCCCccc---------------cccccCCChHHHHHHHH
Q 019844 212 ----KVLGTPT---REEIKCMNPNY--TEF-------KFPQIKPHPWH---------------KVFQKRLPPEAVDLVCR 260 (335)
Q Consensus 212 ----~~~g~~~---~~~~~~~~~~~--~~~-------~~~~~~~~~~~---------------~~~~~~~s~~~~~li~~ 260 (335)
..+|++. ++.+....... .-| .+.. ...+|. ..++..+++++.+||++
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 231 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA 231 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1122222 11111100000 000 0000 000110 12345678999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 261 FFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 261 ~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
||+.||.+||+ +.+++.||||....+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 99999999999 788999999987644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=206.98 Aligned_cols=112 Identities=21% Similarity=0.325 Sum_probs=100.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.++++||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++|||||+++++| .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 499999999999999999999999999999998643 23567899999999999999999999 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999995 99998876 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-25 Score=194.64 Aligned_cols=113 Identities=35% Similarity=0.541 Sum_probs=100.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||.|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999986432 4577899999999999999999999 5566789
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG 119 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999955999988753 356999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=201.05 Aligned_cols=195 Identities=24% Similarity=0.287 Sum_probs=138.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCC-CceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~~~~ 154 (335)
+|++++.||+|+||.||+|+++.+++.||||++.+. ...+..|+.++..++| ++|+++++++ ....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 489999999999999999999999999999998643 2345689999999976 5688899988 55566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh-------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV------- 213 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~------- 213 (335)
+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ + .....+..
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999995 99888876 5679999999999999999999999981 0 00000111
Q ss_pred ----------cCCCC---HHHhhhhCCCC--CCC------------CCCCCCCC---------ccccccccCCChHHHHH
Q 019844 214 ----------LGTPT---REEIKCMNPNY--TEF------------KFPQIKPH---------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 ----------~g~~~---~~~~~~~~~~~--~~~------------~~~~~~~~---------~~~~~~~~~~s~~~~~l 257 (335)
+|++. ++.+....... .-| ..+..... .....++..+++++.+|
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 231 (324)
T cd05587 152 IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI 231 (324)
T ss_pred CCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 12222 11111000000 000 00000000 00112345789999999
Q ss_pred HHHhccCCCCCCCCH-----HHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCTA-----LEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t~-----~~~L~hp~f~~~~~ 286 (335)
|.+||..||.+|+++ .++++||||....+
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999986 89999999988654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-25 Score=196.00 Aligned_cols=121 Identities=26% Similarity=0.414 Sum_probs=102.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.+. ||||+++++++..........+
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5999999999999999999999999999999886422 34678999999995 6999999999865443344558
Q ss_pred EEEeecchhhHHHHHHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++++|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 130 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG 130 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 899999999998888764322 346899999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=196.80 Aligned_cols=196 Identities=23% Similarity=0.313 Sum_probs=139.4
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
|++.+.||+|+||.||+|.++.+++.||+|.+.+.. ..+.+|+.+++.++|+||+.+++.+ ....++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 788999999999999999999999999999986421 2356799999999999999999998 5556799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh----------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK---------- 212 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~---------- 212 (335)
+||||+.| +|.+++.... ...+++..+..++.|++.||.|||+.++ +. ....+.
T Consensus 77 lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999986 9998886532 3469999999999999999999999881 00 000000
Q ss_pred ------hcCCCC---HHHhhhhCCCCC----------------CCCCCCCCC-----------CccccccccCCChHHHH
Q 019844 213 ------VLGTPT---REEIKCMNPNYT----------------EFKFPQIKP-----------HPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 213 ------~~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~-----------~~~~~~~~~~~s~~~~~ 256 (335)
..|++. ++.+........ ...+..... ......++..+++++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS 234 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHH
Confidence 112221 111110000000 000000000 00112234568899999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
||++||+.||.+|+| +.++++||||.+...
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-25 Score=198.58 Aligned_cols=114 Identities=25% Similarity=0.434 Sum_probs=94.7
Q ss_pred eeeeeccCceEEEEEEEc--CCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
+++||+|+||+||+|+++ .+++.||+|.+... .....+|+.+|+.++||||++++++|.. ....++|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence 568999999999999975 46789999998653 2456799999999999999999999854 2345689999999
Q ss_pred hhhHHHHHHHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++|..++..... ....+++..++.++.||+.||.|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 128 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999888764321 1235899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=202.76 Aligned_cols=112 Identities=21% Similarity=0.336 Sum_probs=101.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||+||+|.++.+++.||||++.+.. ..+.+|+.++..++||||+++++++ .+..++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 5999999999999999999999999999999996421 3467899999999999999999999 666679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||++|
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g 121 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG 121 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999996 99999876 577999999999999999999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=196.03 Aligned_cols=114 Identities=32% Similarity=0.574 Sum_probs=100.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||.|+||.||+|+++.+++.||||.+..+. ..+.+|+.++++++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 3899999999999999999999999999999886422 3567899999999999999999998 5556689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|..++.... ...+++..++.++.||+.||+|||+.+
T Consensus 76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (284)
T cd07860 76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR 120 (284)
T ss_pred EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999888888876532 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=203.13 Aligned_cols=115 Identities=21% Similarity=0.237 Sum_probs=96.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCC------CceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDH------PNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~h------pnIv~~~~~~~~~~~~~ 151 (335)
..+|+++++||+|+||+||+|.+..+++.||||+++.. ......|+.+++.+.| .+|++++++|. ..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----NE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----cC
Confidence 36799999999999999999999999999999999642 2345678888887755 45889988884 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
..++|||||++.++|.+++.. .+.+++..++.|+.||+.||+|||++ +
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g 252 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH 252 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 356899999998888888875 56799999999999999999999974 6
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=200.16 Aligned_cols=195 Identities=25% Similarity=0.361 Sum_probs=139.3
Q ss_pred eeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc--------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
+|++++.||+|+||.||+|++. .+++.||+|++.+. ...+.+|+.+++.+ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999874 47899999998642 13456899999999 599999999998 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HH--------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LV-------- 208 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~-------- 208 (335)
...++|+||||+.| +|.+++.. +..+++..++.++.||+.||.|||+++ ++. ..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 66679999999996 99988876 567999999999999999999999998 000 00
Q ss_pred ----------hHhhhcCCCC---HHHhhhhC---CCCCCCCCCC------CCCCcc-------------------ccccc
Q 019844 209 ----------EIIKVLGTPT---REEIKCMN---PNYTEFKFPQ------IKPHPW-------------------HKVFQ 247 (335)
Q Consensus 209 ----------~~~~~~g~~~---~~~~~~~~---~~~~~~~~~~------~~~~~~-------------------~~~~~ 247 (335)
.....+|++. ++.+.... ....-|.+.- ....+| ...++
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd05614 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP 231 (332)
T ss_pred CccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 0011223333 22221100 0000000000 000011 11234
Q ss_pred cCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 248 KRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
..+++.+.+||.+||+.||++|| ++.++++||||+...+
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 56889999999999999999999 8899999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-25 Score=196.44 Aligned_cols=226 Identities=27% Similarity=0.463 Sum_probs=156.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|.+.+.||.|+||.||+|.+..+++.||||++.+. .+.+.+|+.+++.++||||++++++|.. ...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----PLE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----CCC
Confidence 456799999999999999999999999999999987532 2456789999999999999999999843 233
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC------------h-HHhHhhhcC-----
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD------------Q-LVEIIKVLG----- 215 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~------------~-~~~~~~~~g----- 215 (335)
.+|+||||++++|.+++. ...+++..+..++.||+.||.|||++++- . ....+..+|
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 588999999889988876 34689999999999999999999999810 0 000000111
Q ss_pred ---------CCC---HHHhh----------------------hhCCCCCCCC----------------------------
Q 019844 216 ---------TPT---REEIK----------------------CMNPNYTEFK---------------------------- 233 (335)
Q Consensus 216 ---------~~~---~~~~~----------------------~~~~~~~~~~---------------------------- 233 (335)
++. ++.+. .+.+.+....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 100 11000 0001110000
Q ss_pred ------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCccc
Q 019844 234 ------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE 307 (335)
Q Consensus 234 ------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (335)
.+.....++...+ +.+++++.++|++||+.||++|||+.+++.||||.....|...... ...|++. ..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~----~~~~~~~-~~ 312 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA----EEKFDWS-FN 312 (328)
T ss_pred HHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc----hhhcCCc-hh
Confidence 0000000111111 3578899999999999999999999999999999998877655332 2245555 55
Q ss_pred CCCCCHHHHhhcC
Q 019844 308 LSGIPPETINRLI 320 (335)
Q Consensus 308 ~~~~~~~~~~~~~ 320 (335)
..+++.+.|+-.+
T Consensus 313 ~~~~~~~~~~~~~ 325 (328)
T cd07856 313 DADLPVDTWKVMM 325 (328)
T ss_pred cccCCHHHHHHHh
Confidence 7788888887543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=198.82 Aligned_cols=113 Identities=23% Similarity=0.352 Sum_probs=100.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++|+||++++++| ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 599999999999999999999999999999998642 23467899999999999999999999 566679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.| +|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG 122 (331)
T ss_pred EEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999986 999998652 456999999999999999999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=200.84 Aligned_cols=111 Identities=23% Similarity=0.374 Sum_probs=96.0
Q ss_pred Eeeeeecc--CceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 86 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 86 ~~~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
++++||+| +||+||++.++.+|+.||+|++.... ..+.+|+.+++.++||||++++++| .....+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 56789999 78899999999999999999996431 3466899999999999999999999 44556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|.+++.... ...+++..++.++.||+.||+|||+++
T Consensus 77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ 121 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG 121 (327)
T ss_pred EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999995 9999987533 345899999999999999999999988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=201.50 Aligned_cols=113 Identities=20% Similarity=0.349 Sum_probs=100.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|++.+.||.|+||.||+|.+..++..+|+|.+.... ..+.+|+.+++.++||||++++++| ....++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence 356999999999999999999999999999999886432 3477999999999999999999999 445569
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
|+||||+.| +|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~ 122 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK 122 (333)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 999999986 99999876 56789999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=199.93 Aligned_cols=188 Identities=25% Similarity=0.371 Sum_probs=133.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|++..+++.||||++.+.. .....|..++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999996531 3345678888765 899999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV------------ 213 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~------------ 213 (335)
||++| +|.+++.. ...+++..+..++.||+.||.|||++++ +. ....+..
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99985 99988875 5679999999999999999999999981 00 0000111
Q ss_pred -----cCCCC---HHHhhhhCCCCCC------------------CCCCCCCCC-------ccccccccCCChHHHHHHHH
Q 019844 214 -----LGTPT---REEIKCMNPNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEAVDLVCR 260 (335)
Q Consensus 214 -----~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~~~li~~ 260 (335)
.|++. ++.+... .|.. ..+...... .....++..++.++.+||.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVK 229 (316)
T ss_pred ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 12222 1111100 0000 000000000 00112345678999999999
Q ss_pred hccCCCCCCCCHH-HHhcCcccccCCC
Q 019844 261 FFQYSPNLRCTAL-EACVHPFFDELRD 286 (335)
Q Consensus 261 ~L~~dP~~R~t~~-~~L~hp~f~~~~~ 286 (335)
||+.||.+|+++. ++++||||....+
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCCH
Confidence 9999999999996 9999999988754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=201.85 Aligned_cols=114 Identities=25% Similarity=0.424 Sum_probs=100.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 345699999999999999999999999999999999642 13356899999999999999999999 666
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+|||||+| +|.+++.. ..+++..+..++.||+.||.|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ 162 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG 162 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 679999999985 99998864 45899999999999999999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=199.62 Aligned_cols=190 Identities=22% Similarity=0.352 Sum_probs=133.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|+++.+|+.||+|++++.. .....|..++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999996431 3355788888765 899999999999 5666799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhhc-----------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKVL----------- 214 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~~----------- 214 (335)
||+.| +|..++.. ...+++..+..++.||+.||+|||++++ +. ....+..+
T Consensus 76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99996 99888875 5679999999999999999999999980 00 00011112
Q ss_pred ------CCCC---HHHhhhhCCCC--CCC--------------CCCCCCCC-------ccccccccCCChHHHHHHHHhc
Q 019844 215 ------GTPT---REEIKCMNPNY--TEF--------------KFPQIKPH-------PWHKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 215 ------g~~~---~~~~~~~~~~~--~~~--------------~~~~~~~~-------~~~~~~~~~~s~~~~~li~~~L 262 (335)
|++. ++.+....... .-| .+...... .....++..++.++++||++||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF 231 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence 2222 11111000000 000 00000000 0011234567899999999999
Q ss_pred cCCCCCCCCH-HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA-LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~-~~~L~hp~f~~~~~ 286 (335)
+.||++|+++ +++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 9999999997 58999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=198.41 Aligned_cols=191 Identities=26% Similarity=0.332 Sum_probs=134.3
Q ss_pred eeeeeccCceEEEEEEEc---CCCcEEEEEEecccc--------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 87 EHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~--------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++.||+|+||.||+|++. .+++.||+|++.+.. ..+.+|+.+|+.++||||++++++| ....++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 368999999999999874 578899999986421 2356899999999999999999999 555669
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhhcCCCCH--
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKVLGTPTR-- 219 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~~g~~~~-- 219 (335)
|+||||+.| +|.+++.. .+.+++..++.++.||+.||.|||++++ +. ....+..+|....
T Consensus 76 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 76 YLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999996 99988876 5678999999999999999999999981 00 0001111221100
Q ss_pred -----HHhhhhCCCCCCCCC-----CCCCCCcc-------------------------------ccccccCCChHHHHHH
Q 019844 220 -----EEIKCMNPNYTEFKF-----PQIKPHPW-------------------------------HKVFQKRLPPEAVDLV 258 (335)
Q Consensus 220 -----~~~~~~~~~~~~~~~-----~~~~~~~~-------------------------------~~~~~~~~s~~~~~li 258 (335)
.....+.+.|.+.+. .....+.| ...++..+++++.+||
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 231 (323)
T cd05584 152 HEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL 231 (323)
T ss_pred cCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 000011111111100 00001111 0123456789999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.+||+.||++|| ++.++++||||....+
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=195.30 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=141.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||++.+..+++.||+|++.+. ...+.+|+++++.++||||+++++++ ....++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 599999999999999999999999999999998642 24467899999999999999999999 555669
Q ss_pred EEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--HHhH----------
Q 019844 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ--LVEI---------- 210 (335)
Q Consensus 156 ~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~--~~~~---------- 210 (335)
|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||++++ +. ...+
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999997 499999876 5679999999999999999999999881 00 0000
Q ss_pred ---hhhcCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHHHHHHHHh
Q 019844 211 ---IKVLGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEAVDLVCRF 261 (335)
Q Consensus 211 ---~~~~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~~~li~~~ 261 (335)
....|++. ++.+........ ...+...... .....++..+++.++++|.+|
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHH
Confidence 00112211 111110000000 0000000000 001123456789999999999
Q ss_pred ccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 262 FQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 262 L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|..||.+|+ +++++++||||..+.+
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999999 8999999999998765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=199.88 Aligned_cols=190 Identities=27% Similarity=0.391 Sum_probs=134.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|+++.+++.||||++.+.. .....|+.++..+ +||||++++++| ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999986531 2355788888876 799999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh-------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK------------- 212 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~------------- 212 (335)
||++| +|...+.. ...+++..++.++.||+.||.|||++++ +. ....+.
T Consensus 76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99996 99888875 5679999999999999999999999981 00 000011
Q ss_pred ----hcCCCC---HHHhhhhCCC--CCCCCCCC------CCCCccc---------------cccccCCChHHHHHHHHhc
Q 019844 213 ----VLGTPT---REEIKCMNPN--YTEFKFPQ------IKPHPWH---------------KVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 213 ----~~g~~~---~~~~~~~~~~--~~~~~~~~------~~~~~~~---------------~~~~~~~s~~~~~li~~~L 262 (335)
..|++. ++.+...... ..-|.+.- ....+|. ..++..+++++.+||.+||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFM 231 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 112222 1111110000 00000000 0000110 1234457899999999999
Q ss_pred cCCCCCCC-------CHHHHhcCcccccCCC
Q 019844 263 QYSPNLRC-------TALEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~-------t~~~~L~hp~f~~~~~ 286 (335)
+.||++|+ ++.++++||||....+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 99999999 8999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=200.14 Aligned_cols=190 Identities=24% Similarity=0.396 Sum_probs=134.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.++.+++.||+|++.+.. ..+.+|+.++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997431 3456888888777 899999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--hHHh---------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--QLVE--------------- 209 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--~~~~--------------- 209 (335)
||++| +|..++.. .+.+++..++.|+.||+.||.|||++++ + ....
T Consensus 76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99996 99887765 5679999999999999999999999980 0 0000
Q ss_pred -HhhhcCCCC---HHHhhhhCCC------------------CCCCCCCCCCCC--------------ccccccccCCChH
Q 019844 210 -IIKVLGTPT---REEIKCMNPN------------------YTEFKFPQIKPH--------------PWHKVFQKRLPPE 253 (335)
Q Consensus 210 -~~~~~g~~~---~~~~~~~~~~------------------~~~~~~~~~~~~--------------~~~~~~~~~~s~~ 253 (335)
....+|++. ++.+...... ..++........ .-...+|..++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 231 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHH
Confidence 011223332 2221111000 000000000000 0011245678899
Q ss_pred HHHHHHHhccCCCCCCCC------HHHHhcCcccccCCC
Q 019844 254 AVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD 286 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t------~~~~L~hp~f~~~~~ 286 (335)
+.+||.+||+.||++|++ +.++++||||+...+
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999999999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=199.25 Aligned_cols=190 Identities=25% Similarity=0.349 Sum_probs=131.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHH-HHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||+||+|+++.+|+.||||++.+.. ..+.+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999996421 22344544 56788999999999999 5556689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV------------ 213 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~------------ 213 (335)
||+.| +|..++.. .+.+++..++.++.||+.||.|||++++ + .....+..
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99996 99888875 5679999999999999999999999980 0 00000111
Q ss_pred -----cCCCC---HHHhhhhCCC--CCCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 214 -----LGTPT---REEIKCMNPN--YTEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 214 -----~g~~~---~~~~~~~~~~--~~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
+|++. ++.+...... ..-|.+.- ....+| ...+++.+++++.+||++||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLL 231 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 22222 1111100000 00000000 000000 01133567999999999999
Q ss_pred cCCCCCCCCH----HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA----LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~----~~~L~hp~f~~~~~ 286 (335)
+.||.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999987 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=191.61 Aligned_cols=122 Identities=20% Similarity=0.271 Sum_probs=105.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCC-----C---CceeeeceeeeeC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----H---PNIVALKHCFFST 147 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~-----h---pnIv~~~~~~~~~ 147 (335)
-...||.+.++||-|-|++||+|.|..+.+.||+|+++... +....||.+|+++. | ..||+|++.|--.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 34468999999999999999999999999999999987543 44678999999982 3 4799999998543
Q ss_pred CCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 148 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. .+..++|+|+|+++.+|..+|.... .+.++...|+.|++||+.||.|||..-
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 3 6889999999999999999998765 678999999999999999999999765
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=197.90 Aligned_cols=118 Identities=28% Similarity=0.429 Sum_probs=100.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC------
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK------ 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~------ 150 (335)
..+|.+.+.||.|+||.||+|.++.+++.||+|.+... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 35799999999999999999999999999999998542 24467899999999999999999887543211
Q ss_pred ---CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 ---EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ---~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++|+||||++++|.+++. ...+++..++.++.||+.||.|||+.|
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g 134 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN 134 (342)
T ss_pred cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 124688999999999888775 356999999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-25 Score=192.17 Aligned_cols=115 Identities=30% Similarity=0.486 Sum_probs=100.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++.+.||.|++|.||+|++..+|..||||++... ...+.+|+.+++.++||||+++++++ ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 489999999999999999999999999999998643 23566899999999999999999999 44556899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++|+|.+++..... ...+++..+..++.||+.||.|||+++
T Consensus 76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR 120 (284)
T ss_pred EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999888875331 346899999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=198.50 Aligned_cols=190 Identities=26% Similarity=0.386 Sum_probs=131.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.+..+++.||||++++.. .....|..++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999996432 2345677777654 899999999999 5566799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh-------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK------------- 212 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~------------- 212 (335)
||++| +|..++.. .+.+++..++.|+.||+.||.|||++++ +. ....+.
T Consensus 76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99986 99888876 5679999999999999999999999981 00 000011
Q ss_pred ----hcCCCCH---HHhhhhCCC--CCCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 213 ----VLGTPTR---EEIKCMNPN--YTEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 213 ----~~g~~~~---~~~~~~~~~--~~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
.+|++.+ +.+...... ..-|.+.- ....+| ...++..+++++.+||.+||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 1223221 111100000 00000000 000011 11234568899999999999
Q ss_pred cCCCCCCCCH-HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA-LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~-~~~L~hp~f~~~~~ 286 (335)
+.||.+||++ .++++||||....+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCH
Confidence 9999999986 58889999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=195.74 Aligned_cols=233 Identities=24% Similarity=0.315 Sum_probs=157.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 446799999999999999999999999999999998643 2346689999999999999999998854321 123
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--------------ChHHhHh-------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV--------------DQLVEII------- 211 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------~~~~~~~------- 211 (335)
..+|++++++.++|.+++.. ..+++..++.++.||+.||+|||++++ +....+.
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 45789999998899887763 469999999999999999999999981 0000000
Q ss_pred ------hhcCCCC---HHHhhh----------------------hCCCCCCCC----------------------C----
Q 019844 212 ------KVLGTPT---REEIKC----------------------MNPNYTEFK----------------------F---- 234 (335)
Q Consensus 212 ------~~~g~~~---~~~~~~----------------------~~~~~~~~~----------------------~---- 234 (335)
...|++. ++.+.. +.+.+.... +
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 0011111 111100 001110000 0
Q ss_pred --------CCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 235 --------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 235 --------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
+......+.. .....++++.+||.+||+.||.+||++.++|+||||+++..|..... +..+++. .
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~-----~~~~~~~-~ 322 (345)
T cd07877 250 ARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQS-F 322 (345)
T ss_pred HHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcccc-----CCCccCc-c
Confidence 0000000000 01246888999999999999999999999999999999877665432 3334443 4
Q ss_pred cCCCCCHHHHhhcChHHH
Q 019844 307 ELSGIPPETINRLIPEHA 324 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~ 324 (335)
.+..+-.+.+.....+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~ 340 (345)
T cd07877 323 ESRDLLIDEWKSLTYDEV 340 (345)
T ss_pred hhcccCHHHHHHHHHHHH
Confidence 455666677777666654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=194.12 Aligned_cols=116 Identities=30% Similarity=0.456 Sum_probs=99.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++.+.||.|+||.||+|.+..+++.+|+|.++... ..+.+|+.+++.++||||+++++++... +..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 45999999999999999999999999999999996322 2346899999999999999999998532 22568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.++|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999998888752 235899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=189.51 Aligned_cols=124 Identities=24% Similarity=0.403 Sum_probs=106.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCC-CCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~-~~~~~ 154 (335)
..++|++.+.||+|+||.||+|.++.+++.+|+|++... ...+.+|+.+++.+ +|+||+++++++..... ....+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 346799999999999999999999989999999998643 24577899999999 79999999999965443 34566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||||+++ +|.+++.........+++..++.++.||+.||.|||+.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~ 133 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 8999999996 999988765434567999999999999999999999988
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=187.94 Aligned_cols=114 Identities=25% Similarity=0.434 Sum_probs=99.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....+.|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999998532 23577899999999999999999998 5666799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.| +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 76 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK 121 (256)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999986 9988887522 345899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=191.53 Aligned_cols=112 Identities=26% Similarity=0.449 Sum_probs=100.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+|+.++.||+|+||.||++.+..+++.||+|++... ...+.+|+.+++.++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 388899999999999999999999999999998642 24567899999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++||||+.| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~ 123 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ 123 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 668999999996 99999876 567899999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-24 Score=199.70 Aligned_cols=114 Identities=20% Similarity=0.210 Sum_probs=99.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
....|.+.+.||+|+||.||+|.+..+++.||||... .....+|+.+|++|+|+|||++++++ ......|+||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~lv~ 239 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTCLVL 239 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEEEEE
Confidence 3446999999999999999999999999999999643 23467899999999999999999998 4445688999
Q ss_pred ecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|++.++|..++... ...+++..++.|+.||+.||.|||+++
T Consensus 240 e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g 280 (461)
T PHA03211 240 PKYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG 280 (461)
T ss_pred EccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999998887652 346999999999999999999999998
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=195.34 Aligned_cols=115 Identities=31% Similarity=0.417 Sum_probs=99.5
Q ss_pred ceeeeEE-eeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------------hhHHHHHHHHHhCCCCceeee
Q 019844 80 QKVSYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHPNIVAL 140 (335)
Q Consensus 80 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------~~~~~Ei~~l~~l~hpnIv~~ 140 (335)
..++|.. .+.||.|+||+||+|.++.+++.||||++.... ..+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456764 578999999999999999999999999985321 135689999999999999999
Q ss_pred ceeeeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++ ....++|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 86 ~~~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~ 139 (335)
T PTZ00024 86 VDVY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY 139 (335)
T ss_pred eEEE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999 55567999999999999988875 567999999999999999999999988
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=194.10 Aligned_cols=114 Identities=24% Similarity=0.341 Sum_probs=100.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
++|++.+.||.|+||.||+|.+..++..+|+|.+... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEEE
Confidence 4699999999999999999999889999999998643 23567899999999999999999999 44556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++| +|.+++... ...+++..++.++.|++.||.|||+++
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~ 123 (280)
T cd06611 80 LIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK 123 (280)
T ss_pred EeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999996 998888752 356999999999999999999999988
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=195.07 Aligned_cols=111 Identities=21% Similarity=0.330 Sum_probs=98.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++.+.||+|+||.||++.+..++..+|+|.+.... ..+.+|+++++.++||||+++++++ ....++|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEEE
Confidence 5999999999999999999999999999999986432 3467899999999999999999999 45566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
||||++| +|.+++.. .+.+++..+..++.||+.||.|||+.
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK 118 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 9999996 99999876 56799999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-25 Score=195.95 Aligned_cols=195 Identities=24% Similarity=0.312 Sum_probs=138.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+|.+.+.||+|+||.||+|+++.+++.||+|++.+.. .....|..++..+ +|++|+++++++ ....+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4889999999999999999999999999999987532 2345678888777 589999999998 55567
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhh--------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIK-------- 212 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~-------- 212 (335)
+|+||||++| +|.+.+.. .+.+++..+..++.||+.||.|||++++ + .....+.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999985 99888875 5679999999999999999999999880 0 0000011
Q ss_pred ---------hcCCCC---HHHhhhhCCCC--CCCCCCC------CCCCcc---------------ccccccCCChHHHHH
Q 019844 213 ---------VLGTPT---REEIKCMNPNY--TEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDL 257 (335)
Q Consensus 213 ---------~~g~~~---~~~~~~~~~~~--~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~l 257 (335)
.+|++. ++.+....... .-|.+.- ....+| ...++..+++++.+|
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (323)
T cd05616 152 MWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 231 (323)
T ss_pred CCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 122322 11111100000 0000000 000000 012345789999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|++ ..++++||||+...+
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999998 489999999988764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=192.79 Aligned_cols=196 Identities=23% Similarity=0.343 Sum_probs=150.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|..+++||+|.||+|-+|+.+.+++.||+|+++++. .....|-++|+..+||.+..+...| +....
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence 57999999999999999999999999999999998653 2345788999999999999999999 77777
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
+|+||||+.| .|+-.+.. ...|+|..+++|..+|+.||.|||+++
T Consensus 243 lCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999996 88877765 677999999999999999999999988
Q ss_pred cChHHhHhhhcCCCCHHHhhhhCC-CCCC-----------C-----CCCCCCCC--cc-------ccccccCCChHHHHH
Q 019844 204 VDQLVEIIKVLGTPTREEIKCMNP-NYTE-----------F-----KFPQIKPH--PW-------HKVFQKRLPPEAVDL 257 (335)
Q Consensus 204 ~~~~~~~~~~~g~~~~~~~~~~~~-~~~~-----------~-----~~~~~~~~--~~-------~~~~~~~~s~~~~~l 257 (335)
+.......++||||.+........ .|.. | .+|..... .+ ...||..++++++.|
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 111122335677776432221110 0100 0 11111111 11 123678999999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+..+|..||.+|.. |.++.+|+||..+.|
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 99999999999995 789999999999877
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=190.55 Aligned_cols=125 Identities=22% Similarity=0.316 Sum_probs=106.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...++|++.+.||+|+||.||+|.+..+++.+|+|++... ...+.+|+.+++.+ +||||+++++++.........+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 3456799999999999999999999999999999988642 24567899999999 7999999999986544445567
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||++| +|.+++.........+++..++.++.|++.||.|||+++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 8999999996 999988754434567899999999999999999999887
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=201.45 Aligned_cols=187 Identities=23% Similarity=0.247 Sum_probs=137.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc---cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~---~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
..+.+++.||+|.||.||.|.+. ....||+|.++. ....+.+|+++|++|+|+|||++|+++. .+.-+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceEEE
Confidence 34566899999999999999995 334799999864 2366789999999999999999999994 33359999
Q ss_pred eecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------cChHHhHhhhcCCCCH-----
Q 019844 159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------VDQLVEIIKVLGTPTR----- 219 (335)
Q Consensus 159 ~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------~~~~~~~~~~~g~~~~----- 219 (335)
||||. |+|.++|+.. .+..+...+...++.|||+||+||++++ .+.+...+..+|-...
T Consensus 280 tE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999 7999999872 2677999999999999999999999998 1122222333443221
Q ss_pred --------HHhhhhCCCCCCCCCCCCCCCccc---------------------------------cccccCCChHHHHHH
Q 019844 220 --------EEIKCMNPNYTEFKFPQIKPHPWH---------------------------------KVFQKRLPPEAVDLV 258 (335)
Q Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~s~~~~~li 258 (335)
-.+.+.+|+...+....++.+.|+ ...|..+|+++.+++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 112222232222222222223322 234678999999999
Q ss_pred HHhccCCCCCCCCHHHHh
Q 019844 259 CRFFQYSPNLRCTALEAC 276 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L 276 (335)
..||..+|++|||++.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999998654
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=187.24 Aligned_cols=114 Identities=27% Similarity=0.441 Sum_probs=100.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ...+.+|+.+++.++||||+++++.+ .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 489999999999999999999999999999998642 23567899999999999999999998 4556689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.... ...+++..+..++.|++.||.|||+++
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 121 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL 121 (256)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 9999987632 345899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=190.85 Aligned_cols=196 Identities=22% Similarity=0.259 Sum_probs=139.0
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
|+..+.||+|+||+||+|.+..+++.||+|.+.+.. ..+.+|+.+|+.++|+||+.+++++ ..+..+|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 788899999999999999999999999999986421 2356899999999999999999998 5556799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-------------ChHHhHhhhcC-------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-------------DQLVEIIKVLG------- 215 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-------------~~~~~~~~~~g------- 215 (335)
+||||+.| +|.+++.... ...+++..+..++.|++.||.|||++++ ......+..+|
T Consensus 77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999996 8988776532 3469999999999999999999999981 00000011112
Q ss_pred ---------CCC---HHHhhhhCCCC--C--------------CCCCCCCCC-----------CccccccccCCChHHHH
Q 019844 216 ---------TPT---REEIKCMNPNY--T--------------EFKFPQIKP-----------HPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 216 ---------~~~---~~~~~~~~~~~--~--------------~~~~~~~~~-----------~~~~~~~~~~~s~~~~~ 256 (335)
+.. ++.+....... . ...+..... ......++..+++++.+
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 111 11110000000 0 000000000 00011234568899999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
||.+||+.||++||+ +.++++|+||.....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=205.03 Aligned_cols=199 Identities=23% Similarity=0.262 Sum_probs=140.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCC-CcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+|+.+|+.++|||||++++++ ....++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEE
Confidence 34599999999999999999998877 7889999875322 3467899999999999999999999 555669
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--hHHh-----------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--QLVE----------- 209 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--~~~~----------- 209 (335)
||||||++| +|.+++.........+++..+..++.||+.||.|||++++ + ...+
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999985 9999887654445679999999999999999999999880 0 0000
Q ss_pred -------HhhhcCCCCHHHhhhhC-CCCCC----C------------CCCCCCCCc----------cccccccCCChHHH
Q 019844 210 -------IIKVLGTPTREEIKCMN-PNYTE----F------------KFPQIKPHP----------WHKVFQKRLPPEAV 255 (335)
Q Consensus 210 -------~~~~~g~~~~~~~~~~~-~~~~~----~------------~~~~~~~~~----------~~~~~~~~~s~~~~ 255 (335)
....+|++.+....... ..|.. | ..|...... -...++..+++++.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 01112333211110000 00000 0 000000000 00123356789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+||.+||..||++||++.++|.|+|++..
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999998653
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=190.43 Aligned_cols=116 Identities=22% Similarity=0.327 Sum_probs=97.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHH-HHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~-l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|.++.+|+.||+|+++... ..+..|+.+ ++.++||||+++++++. ....+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 5999999999999999999999999999999986432 234456665 56679999999999994 444589
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
++|||++|+|.+++.........+++..++.++.||+.||.|||++ +
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~ 124 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999988876544456799999999999999999999987 5
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=222.56 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=153.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.++++||+|+||.|.+++++.|++.||+|++++. ...+..|..+|..-+.+.||+++.+| ++.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 456799999999999999999999999999999999752 34577899999999999999999999 899
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------- 203 (335)
.|+|+|||||+| ||..+|.. ..+++|..+++|+.+|+.||+-||+.|
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999996 99999987 447999999999999999999999999
Q ss_pred ---cChHHhHhhhcCCCCHH---HhhhhCCC---CC------------------------CC---CCCCCCCCccccccc
Q 019844 204 ---VDQLVEIIKVLGTPTRE---EIKCMNPN---YT------------------------EF---KFPQIKPHPWHKVFQ 247 (335)
Q Consensus 204 ---~~~~~~~~~~~g~~~~~---~~~~~~~~---~~------------------------~~---~~~~~~~~~~~~~~~ 247 (335)
.+..+.....+|||.|. .+..+... |. .- .+..+....-...||
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 12222222346777633 22222111 11 00 011111111111233
Q ss_pred --cCCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccCCCCC
Q 019844 248 --KRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPN 288 (335)
Q Consensus 248 --~~~s~~~~~li~~~L~~dP~~R~t---~~~~L~hp~f~~~~~~~ 288 (335)
..+|+++++||+++++ +|+.|.. ++++-+||||.++.|..
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence 4689999999999997 8999998 99999999999998843
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=190.94 Aligned_cols=115 Identities=30% Similarity=0.473 Sum_probs=99.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++.+.||+|+||.||+|.++.+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 3699999999999999999999999999999988542 13467899999999999999999999 555679
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++++|.+.+.... ...+++..++.++.||+.||+|||+++
T Consensus 77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ 122 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR 122 (294)
T ss_pred EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999988888776522 234688899999999999999999988
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-24 Score=188.82 Aligned_cols=118 Identities=21% Similarity=0.348 Sum_probs=102.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|...+.||.|++|.||+|.+..+++.+|+|.+... ...+.+|+++++.++||||++++++|.. .....+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence 599999999999999999999999999999998643 2357799999999999999999999843 23345889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++| +|.+++.........+++..+..++.||+.||.|||+.+
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999996 999888765444567899999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=196.14 Aligned_cols=196 Identities=27% Similarity=0.409 Sum_probs=148.7
Q ss_pred eEE--eeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 84 YIA--EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 84 y~~--~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
|++ -++||.|.||+||-|+++.+|+.||||+|.+ ....++.|+.||..++||.||.+-..| +....+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence 555 4799999999999999999999999999964 235678999999999999999999999 555569
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------------- 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------- 203 (335)
++|||-+.||+...+-... .+++++...++++.||+.||.|||.+|
T Consensus 639 FVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999998777776544 688999999999999999999999998
Q ss_pred cChHHhHhhhcCCCCHHHhhhh-CCCCCC----C------------CCCCCCCC-----------ccccccccCCChHHH
Q 019844 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTE----F------------KFPQIKPH-----------PWHKVFQKRLPPEAV 255 (335)
Q Consensus 204 ~~~~~~~~~~~g~~~~~~~~~~-~~~~~~----~------------~~~~~~~~-----------~~~~~~~~~~s~~~~ 255 (335)
+....---.++|||.|...... +.+|.. + .||..... .+...-|..+++++.
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHH
Confidence 1111112245788874332211 111210 0 11111111 111222357899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|||..+|+..-.+|.+++..|.|||++++..
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 9999999999999999999999999988643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=192.52 Aligned_cols=107 Identities=24% Similarity=0.357 Sum_probs=92.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||+|+||.||++.++.+|+.||+|.+... ......|+++++.++||||+++++++ ....++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 79999999999999999999999998532 12345799999999999999999999 5666799999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+| +|.+++.... ...+++..+..++.||+.||+|||+.+
T Consensus 76 ~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ 115 (277)
T cd05607 76 NGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD 115 (277)
T ss_pred CCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 86 9988876532 345899999999999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=189.26 Aligned_cols=112 Identities=26% Similarity=0.475 Sum_probs=99.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.|.+.+.||.|+||.||.|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 499999999999999999999999999999998532 13467899999999999999999999 5555
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||+.+
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~ 124 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM 124 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 79999999986 99998876 567899999999999999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-24 Score=187.13 Aligned_cols=114 Identities=28% Similarity=0.450 Sum_probs=98.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.+|.+.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++|+||+++++++ ....+.|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999986432 2456899999999999999999998 4556689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+.+... ...+++..++.++.||+.||.|||+.+
T Consensus 80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 80 FVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred EEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999998877766542 345888999999999999999999988
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=187.49 Aligned_cols=111 Identities=26% Similarity=0.479 Sum_probs=97.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+|++.+.||+|+||.||+|.. .+++.+|+|.+.... ..+.+|+++++.++|+||+++++++ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 488999999999999999987 588999999885321 3467899999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+||||++| +|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC 122 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 679999999986 99999876 567899999999999999999999988
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=192.39 Aligned_cols=116 Identities=29% Similarity=0.375 Sum_probs=98.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCC--CcEEEEEEeccc------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~vAvK~i~~~------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|++.+.||+|+||.||+|.+..+ +..||+|.+... .+.+.+|+.+++.+ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 489999999999999999999888 899999998642 23467899999999 5999999999764322 2334
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|++|||++++|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g 125 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN 125 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5789999999999888865 567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=189.41 Aligned_cols=121 Identities=21% Similarity=0.349 Sum_probs=102.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC-CccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~-~~~~~ 155 (335)
...|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.+ +||||+++++++...... ...++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34599999999999999999999999999999998643 34577899999998 799999999998654322 23568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+++ +|.+++.... ...+++..++.++.|++.||.|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ 131 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK 131 (272)
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 899999996 9999887632 356899999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=189.37 Aligned_cols=113 Identities=35% Similarity=0.614 Sum_probs=97.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++.+.||+|+||.||+|.++.+++.||+|++.... +.+.+|+.+++.++||||+++++++ ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 36999999999999999999999999999999885321 3457899999999999999999999 555668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||+++ .|..++.. ...+++..++.++.||+.||.|||+++
T Consensus 76 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~ 120 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN 120 (286)
T ss_pred EEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999997 66655543 456999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=195.03 Aligned_cols=195 Identities=24% Similarity=0.292 Sum_probs=137.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+|.+.+.||+|+||.||+|+++.+++.||+|++.+.. .....|+.++..+. |++|+++++++ .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3788999999999999999999999999999986431 33567888998885 57888899988 55566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh-------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV------- 213 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~------- 213 (335)
+|+||||++| +|.+++.. .+.+++..++.|+.||+.||.|||++++ +. ....+..
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999985 99888875 5679999999999999999999999880 00 0000111
Q ss_pred ----------cCCCC---HHHhhhhCCCC--CCC------------CCCCCCCCc---------cccccccCCChHHHHH
Q 019844 214 ----------LGTPT---REEIKCMNPNY--TEF------------KFPQIKPHP---------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 ----------~g~~~---~~~~~~~~~~~--~~~------------~~~~~~~~~---------~~~~~~~~~s~~~~~l 257 (335)
.|++. ++.+....... .-| ..+...... ....++..+++++.+|
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 231 (323)
T cd05615 152 MVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI 231 (323)
T ss_pred CCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 12222 12111100000 000 000000000 0012345688999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+.+||+.||.+|++ ..++++||||....+
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 99999999999997 579999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=190.87 Aligned_cols=114 Identities=26% Similarity=0.452 Sum_probs=94.1
Q ss_pred eeeeeccCceEEEEEEEcC--CCcEEEEEEecccc--hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~--~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
+.+||+|+||.||+|+++. ++..||+|.+.... ..+.+|+.+++.++||||+++++++.. ....++|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence 5689999999999999754 56889999986532 356789999999999999999999854 2345688999999
Q ss_pred hhhHHHHHHHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 128 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9998888764321 1235889999999999999999999988
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=195.37 Aligned_cols=190 Identities=23% Similarity=0.405 Sum_probs=135.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.++.+++.||+|++.+.. ..+.+|+.++..+ +||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997431 3466899999888 699999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--hHHhH--------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--QLVEI-------------- 210 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--~~~~~-------------- 210 (335)
||++| +|..++.. .+.+++..++.|+.||+.||+|||++++ + ....+
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99986 99888765 5679999999999999999999999980 0 00000
Q ss_pred --hhhcCCCC---HHHhhhhCCCCC----------------CCCCCCCCCCc--------------cccccccCCChHHH
Q 019844 211 --IKVLGTPT---REEIKCMNPNYT----------------EFKFPQIKPHP--------------WHKVFQKRLPPEAV 255 (335)
Q Consensus 211 --~~~~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~~--------------~~~~~~~~~s~~~~ 255 (335)
...+|++. ++.+........ ...+....... -...++..+++.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 231 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS 231 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 01223332 121111000000 00010000000 00124456789999
Q ss_pred HHHHHhccCCCCCCCC------HHHHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRCT------ALEACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t------~~~~L~hp~f~~~~~ 286 (335)
++|.+||..||.+|++ +.++++||||....+
T Consensus 232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999999999999998 579999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=191.15 Aligned_cols=112 Identities=27% Similarity=0.381 Sum_probs=100.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||.|+||.||+|.+..+++.||+|++.+. .+.+.+|+.++++++||||+++++++ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 489999999999999999999999999999998642 24567899999999999999999999 666679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.| +|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG 120 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999997 99998876 457999999999999999999999988
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=192.75 Aligned_cols=119 Identities=26% Similarity=0.451 Sum_probs=100.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC-Cc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~-~~ 152 (335)
..++|++.+.||+|+||.||+|.+..++..||||++.+. ...+.+|+.+|+.++||||+++++++...... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456799999999999999999999999999999998542 13466899999999999999999998543221 12
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||++++|.+++. ...+++..++.++.||+.||.|||+.+
T Consensus 93 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g 138 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG 138 (343)
T ss_pred ceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3468999999779888876 356999999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=205.35 Aligned_cols=196 Identities=24% Similarity=0.348 Sum_probs=145.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.|.-++.||.|+||-||.|++..+.+.||||.+.-.. ..+.+||..|+++.|||+|.|.+||.- +...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence 4778999999999999999999999999999996432 346799999999999999999999953 3338
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cC-------------------h------HHh
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-VD-------------------Q------LVE 209 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~~-------------------~------~~~ 209 (335)
|+|||||-|+-.+++.-. ++++.|.++..|+.+.+.||.|||+++ ++ . ..-
T Consensus 102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 899999999888888764 467999999999999999999999988 00 0 011
Q ss_pred HhhhcCCCCH---HHhhhhCCC-CCC----CC-------CCCCCC----------------CccccccccCCChHHHHHH
Q 019844 210 IIKVLGTPTR---EEIKCMNPN-YTE----FK-------FPQIKP----------------HPWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 210 ~~~~~g~~~~---~~~~~~~~~-~~~----~~-------~~~~~~----------------~~~~~~~~~~~s~~~~~li 258 (335)
..+++|||.+ +.+..|..+ |.. +. +..-++ ..-...-...+|..+..||
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 1245777773 333222221 110 00 000000 0000111246788999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
..||+.=|.+|||.+++|.|+|+..-+.
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 9999999999999999999999986543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=195.48 Aligned_cols=117 Identities=31% Similarity=0.502 Sum_probs=100.1
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|.+.+.||+|+||.||+|.+..+++.+|+|++.+. ...+.+|+.+++.+ +||||+++++++.. .+
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~ 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---EN 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CC
Confidence 4456799999999999999999999989999999988532 23456899999999 99999999998833 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+||||++++|..++.. ..+++..++.++.||+.||.|||+++
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ 127 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN 127 (337)
T ss_pred CceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445889999999999888764 36889999999999999999999988
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=190.69 Aligned_cols=118 Identities=28% Similarity=0.484 Sum_probs=100.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcC--CCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||+|+||.||+|.++. +++.||+|.+.... ....+|+.+++.++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 48999999999999999999988 89999999997522 456789999999999999999999943 2235
Q ss_pred EEEEEeecchhhHHHHHHHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++++|.+++....... ..+++..++.++.||+.||.|||+++
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 128 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 699999999998888876544322 37899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=195.27 Aligned_cols=113 Identities=27% Similarity=0.452 Sum_probs=100.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++||||+++++++ .+..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence 35699999999999999999999999999999998642 23466899999999999999999999 6667
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|+|||||+| +|.+++.. ..+++..++.++.||+.||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~ 162 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG 162 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 79999999985 99998864 45899999999999999999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=189.47 Aligned_cols=112 Identities=34% Similarity=0.590 Sum_probs=98.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|.++.+++.||+|.+.+. .+.+.+|+.+++.++||||+++++++ ....++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 599999999999999999999989999999987532 13467899999999999999999999 5666799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ +|..+... ...+++..++.++.||+.||.|||+.+
T Consensus 77 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 77 LVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred EEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999997 67665543 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=188.96 Aligned_cols=112 Identities=31% Similarity=0.483 Sum_probs=98.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------------hhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
+|.+...||.|+||.||+|.+..+++.||+|.+.... +.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 4888999999999999999999899999999885321 2466899999999999999999998
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+.++||||++| +|.+++.. .+.+++..++.++.|++.||+|||+++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~ 126 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG 126 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC
Confidence 455568899999986 99999976 567899999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=203.94 Aligned_cols=203 Identities=20% Similarity=0.220 Sum_probs=144.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC---CC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---~~ 151 (335)
..+|.+.+.||+|+||.||+|++..+++.||||++... ...+.+|+.++..++|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 34799999999999999999999999999999998642 2346789999999999999999988753322 12
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII------ 211 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~------ 211 (335)
...+++||||+.+ +|.+++.........+++..++.++.||+.||.|||++++ + .....+
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 2357899999995 9999998655445679999999999999999999999880 0 000001
Q ss_pred -------------hhcCCCCH---HHhhhhCCCCCC------------------CCCCCCCC--------CccccccccC
Q 019844 212 -------------KVLGTPTR---EEIKCMNPNYTE------------------FKFPQIKP--------HPWHKVFQKR 249 (335)
Q Consensus 212 -------------~~~g~~~~---~~~~~~~~~~~~------------------~~~~~~~~--------~~~~~~~~~~ 249 (335)
..+|++.+ +.+.... |.. ..+..... ......++..
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 11233221 1111000 000 00000000 0001124567
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+++++.+||.+||+.||.+||++.++|+|||++.+.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 899999999999999999999999999999987653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=205.12 Aligned_cols=120 Identities=24% Similarity=0.352 Sum_probs=100.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-c---chhHHHHHHHHHhCC-CCceeeece-eeeeCCCCC-ccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-D---KRYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~---~~~~~~Ei~~l~~l~-hpnIv~~~~-~~~~~~~~~-~~~ 154 (335)
.+++|.++|.+|||+.||+|++...|..||+|++-. + .+.+.+||++|+.|. |+|||.|+| ........+ ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 469999999999999999999988889999998742 2 355789999999995 999999999 443332233 344
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.|+||||.| .|-++|.... ..+|+|.+|+.|+.|+|+|+.+||...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~ 164 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLK 164 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCC
Confidence 7799999994 9999998755 456999999999999999999999988
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-24 Score=187.05 Aligned_cols=123 Identities=23% Similarity=0.337 Sum_probs=105.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++... ...+.+|+.+++.+ +||||+++++++..........+|
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 45699999999999999999999999999999998642 24567899999999 899999999998754433445688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.........+++..++.++.|++.||.|||+.+
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 148 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR 148 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999986 999988754434567999999999999999999999988
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=188.15 Aligned_cols=113 Identities=32% Similarity=0.531 Sum_probs=98.9
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.+.||.|++|.||+|.++.+|..||+|++..+. ..+.+|+.+++.++||||+++++++ ....+.|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 678899999999999999999999999999986432 3467899999999999999999999 55567999
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||++++|.+++.... ...+++..++.++.||+.||+|||+++
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~ 119 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR 119 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999889998887632 236899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-24 Score=188.44 Aligned_cols=196 Identities=23% Similarity=0.261 Sum_probs=139.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+|++.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 35699999999999999999999999999999998642 24467899999999999999999999 5556689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhhc--------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKVL-------- 214 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~~-------- 214 (335)
+||||++| +|.+++.. ..+++..+..++.|++.||.|||+.++ + .....+..+
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999996 99888863 458999999999999999999999881 0 000000111
Q ss_pred ---------CCCC---HHHhhh---------------------hCCCCCCCCC-C---CCC-CCccccccccCCChHHHH
Q 019844 215 ---------GTPT---REEIKC---------------------MNPNYTEFKF-P---QIK-PHPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 215 ---------g~~~---~~~~~~---------------------~~~~~~~~~~-~---~~~-~~~~~~~~~~~~s~~~~~ 256 (335)
|++. ++.+.. +.+.|..... . ... ........+..++..+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 1111 111100 0011100000 0 000 000011123457788999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
||.+||..||++||++.++|+||||.....
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-24 Score=190.77 Aligned_cols=114 Identities=25% Similarity=0.352 Sum_probs=100.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|.+.+.||+|+||.||+++++.+++.||+|++.+. ...+.+|+.++..++|+||+++++++ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 3699999999999999999999999999999998642 13356789999999999999999999 66677
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||||+.| +|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~ 122 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH 122 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999985 999998752 356899999999999999999999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-24 Score=190.63 Aligned_cols=113 Identities=21% Similarity=0.341 Sum_probs=99.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.+.+.||+|+||.||+++++.+++.||+|++.+. ...+.+|+.++..++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 599999999999999999999999999999998642 12366899999999999999999999 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.| +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ 122 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH 122 (332)
T ss_pred EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999985 999998752 356899999999999999999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=187.64 Aligned_cols=113 Identities=23% Similarity=0.333 Sum_probs=100.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.+|++.+.||+|+||.||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEEE
Confidence 4699999999999999999999999999999998632 23467899999999999999999999 44556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|.+++.. ...+++..+..++.|++.||+|||+.+
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ 126 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG 126 (267)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999996 99988875 567899999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=183.90 Aligned_cols=114 Identities=24% Similarity=0.359 Sum_probs=100.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ .....+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 388999999999999999999999999999998532 34567899999999999999999999 5556789
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.... ...+++..++.++.||+.||.|||+.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~ 121 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK 121 (256)
T ss_pred EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999986 9999988642 457999999999999999999999988
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=191.53 Aligned_cols=114 Identities=26% Similarity=0.461 Sum_probs=100.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+.. +.+..|+.+++.++||||+++++.+ ....++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 5999999999999999999999999999999986432 3467899999999999999999998 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.| +|.+++.... ...+++..++.++.||+.||+|||+.+
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred EEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999986 9999887532 357999999999999999999999988
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=183.82 Aligned_cols=115 Identities=29% Similarity=0.416 Sum_probs=98.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.|++++.||+|+||.||++.++.+++.||+|.+... .+.+.+|+.+++.++|+||+++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 389999999999999999999999999999998532 234678999999999999999998873 2344688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||++| +|.+++.... ...+++.+++.++.||+.||.|||+++
T Consensus 77 lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ 122 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH 122 (257)
T ss_pred EEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 9998887632 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=186.04 Aligned_cols=112 Identities=29% Similarity=0.514 Sum_probs=99.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|+..+.||+|+||+||+|.+..++..||+|.+.... +.+.+|+.+++.++|+||+++++++ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4888899999999999999998899999999985422 3467899999999999999999998 5556
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|++|||++| +|.+++.. ...+++..++.++.||+.||.|||+.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN 122 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 68999999996 99998875 456899999999999999999999988
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=193.30 Aligned_cols=190 Identities=25% Similarity=0.360 Sum_probs=130.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHH-HHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||+||+|.++.+|+.||+|++.+.. ..+.+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986431 23345554 56778999999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh--------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII-------------- 211 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~-------------- 211 (335)
||+.| +|...+.. .+.+++..++.++.||+.||+|||++|+ + .....+
T Consensus 76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99996 89887765 5679999999999999999999999981 0 000001
Q ss_pred ---hhcCCCC---HHHhhhhCCCC--CCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 212 ---KVLGTPT---REEIKCMNPNY--TEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 212 ---~~~g~~~---~~~~~~~~~~~--~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
..+|++. ++.+....... .-|.+.- ....+| ...+++..+..+.++|++||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELL 231 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHh
Confidence 1122222 11111100000 0000000 000011 01123567899999999999
Q ss_pred cCCCCCCCCH----HHHhcCcccccCCC
Q 019844 263 QYSPNLRCTA----LEACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~----~~~L~hp~f~~~~~ 286 (335)
+.||.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999976 69999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=187.10 Aligned_cols=120 Identities=23% Similarity=0.354 Sum_probs=101.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCC-CCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~-~~~~~~~ 156 (335)
..|++.+.||.|+||.||+|.+..+++.+|+|++... ...+..|+.+++.+ +|+||+++++++..... ....++|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4699999999999999999999999999999998643 23567899999998 79999999999864322 2356789
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||+++ +|.+++.... ...+++..++.++.||+.||.|||+.+
T Consensus 96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ 141 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK 141 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999996 9999887633 356889999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=187.32 Aligned_cols=121 Identities=29% Similarity=0.426 Sum_probs=100.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCC---C
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---K 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---~ 150 (335)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3446999999999999999999999999999999885321 234679999999999999999998854321 2
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....|+||||+.++|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ 139 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK 139 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 33557899999999888877642 346899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=185.27 Aligned_cols=114 Identities=25% Similarity=0.353 Sum_probs=99.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||+|+||.||+|.++.+|..+|+|.+... ...+.+|+.+++.++|+||+++++.+ .....+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 489999999999999999999999999999998532 24567899999999999999999998 5556799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK 121 (257)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999986 9999887532 335899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=188.43 Aligned_cols=115 Identities=26% Similarity=0.393 Sum_probs=99.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.+.|++++.||.|+||.||+|++..+++.+|+|.+.... ..+.+|+.+++.++||||+++++++ ....++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEE
Confidence 356999999999999999999999999999999986432 3466899999999999999999998 4445689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|..++... ...+++..++.++.||+.||.|||+++
T Consensus 86 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ 130 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK 130 (292)
T ss_pred EEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999996 887776542 356899999999999999999999988
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-24 Score=187.71 Aligned_cols=195 Identities=21% Similarity=0.213 Sum_probs=138.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++.+ ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEEE
Confidence 34699999999999999999999999999999998643 24567899999999999999999998 4445689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh---------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV--------- 213 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~--------- 213 (335)
+||||++| +|.+++.. ..+++.++..++.|++.||.|||++++ +. ....+..
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999996 99998863 458999999999999999999999981 00 0000011
Q ss_pred --------cCCCC---HHHhhhhCC------------------CCCCCCCCCC--------CCCccccccccCCChHHHH
Q 019844 214 --------LGTPT---REEIKCMNP------------------NYTEFKFPQI--------KPHPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 214 --------~g~~~---~~~~~~~~~------------------~~~~~~~~~~--------~~~~~~~~~~~~~s~~~~~ 256 (335)
.|++. ++.+..... ...++..... .........+..+++.+.+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 12211 111110000 0000000000 0000011123457889999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
||.+||..||.+|||+.++++||||...+
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=188.65 Aligned_cols=113 Identities=21% Similarity=0.320 Sum_probs=100.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
++|.+.+.||+|+||.||+|.+..+++.||+|.++... ..+.+|+.+++.++||||+++++++ .....+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence 46999999999999999999999999999999986432 3467899999999999999999998 45566899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|.+++.. .+.+++..++.++.|++.||.|||++|
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ 126 (267)
T cd06645 84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG 126 (267)
T ss_pred EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999996 99998876 567999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=208.74 Aligned_cols=121 Identities=26% Similarity=0.363 Sum_probs=104.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
....+|.+++.||.|+||.||+|.++.++..||+|++... ...+.+|+.+|+.|+|||||+++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence 3445799999999999999999999999999999998632 2456789999999999999999999854 233
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
..+|||||||++ +|.++|.........+++..++.|+.||+.||.|||..
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~ 137 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 468999999995 99999986544456799999999999999999999984
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=187.72 Aligned_cols=114 Identities=19% Similarity=0.257 Sum_probs=101.2
Q ss_pred eeeeEE-eeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+-|++ .+.||+|+|+.|--|....+|..||||+|.+. ..++.||++++.++ .|+||++++++| +++..
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTR 150 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccce
Confidence 344655 46899999999999999999999999999764 36688999999999 699999999999 77777
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+|||-|.| .|...|.. +..|+|.++..+.++|+.||+|||.+|
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg 196 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG 196 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC
Confidence 9999999996 88777776 678999999999999999999999998
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-24 Score=183.38 Aligned_cols=115 Identities=23% Similarity=0.364 Sum_probs=99.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||.|+||.||+|.+..++..||+|.+... ...+..|+.+++.++||||+++++++.. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 489999999999999999999999999999998532 2346689999999999999999998753 3345688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 200 (335)
++|||+++ +|.+++.........+++..++.++.||+.||.|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 99999996 999999875544567999999999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=185.65 Aligned_cols=112 Identities=31% Similarity=0.500 Sum_probs=98.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--------------chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
+|.+.+.||.|+||.||+|.+..+++.||+|.+... .+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 589999999999999999999999999999987521 12356899999999999999999998
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+++||||++| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG 128 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 455568999999986 99998876 467999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=190.07 Aligned_cols=111 Identities=32% Similarity=0.581 Sum_probs=99.3
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++++.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ ....++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 889999999999999999999999999999997542 1234599999999999999999999 44666889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~ 118 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG 118 (260)
T ss_dssp EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccc----ccccccccccccccccccccccccccc
Confidence 9999998 99999984 577999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-24 Score=187.08 Aligned_cols=195 Identities=23% Similarity=0.273 Sum_probs=138.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+|++.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ .....+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEE
Confidence 35699999999999999999999999999999998532 24567899999999999999999999 4555699
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhhcCCCCH---
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKVLGTPTR--- 219 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~~g~~~~--- 219 (335)
+||||+.| +|..++.. ..+++.++..++.|++.||.|||++++ + .....+..+|....
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999996 99888763 458999999999999999999999981 0 00000111111000
Q ss_pred ---------HHhhhhCCCCCC------------------------CCCCCCC----------CCccccccccCCChHHHH
Q 019844 220 ---------EEIKCMNPNYTE------------------------FKFPQIK----------PHPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 220 ---------~~~~~~~~~~~~------------------------~~~~~~~----------~~~~~~~~~~~~s~~~~~ 256 (335)
....++.|+... ..+.... ........+..+++.+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 000011111100 0000000 000001123457889999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
||++||..||.+|||+.++++||||....
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=187.70 Aligned_cols=108 Identities=20% Similarity=0.335 Sum_probs=93.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++.++||+|+||.||+|.+..+++.||+|.+..+ ...+.+|+.+++.++||||+++++++ ......++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEEE
Confidence 588999999999999999999999999999998643 23467899999999999999999999 44455889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|..+ ..+++..+..++.|++.||.|||+.+
T Consensus 77 v~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 77 CTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred EEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999996 66432 24789999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=200.88 Aligned_cols=189 Identities=26% Similarity=0.357 Sum_probs=142.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecch
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~ 163 (335)
-+||+|+||+||.|+++.|...+|||.|+.. .+-+..||.+.++|+|.|||+++|.+ ..++++-|.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 4799999999999999999999999999643 24467999999999999999999998 77778999999999
Q ss_pred h-hHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCC------------c--ChHHhHhhhcC-----------
Q 019844 164 E-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCI------------V--DQLVEIIKVLG----------- 215 (335)
Q Consensus 164 g-~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~------------~--~~~~~~~~~~g----------- 215 (335)
| +|.++++. ..+++ .|..+-+|.+||++||.|||.+. + ......+..+|
T Consensus 656 GGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 656 GGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 6 99999986 35777 88999999999999999999987 0 00111112222
Q ss_pred ------CCC---HHHhhhhCCCCCC-----------------------CCCCC-----CCCCccccccccCCChHHHHHH
Q 019844 216 ------TPT---REEIKCMNPNYTE-----------------------FKFPQ-----IKPHPWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 216 ------~~~---~~~~~~~~~~~~~-----------------------~~~~~-----~~~~~~~~~~~~~~s~~~~~li 258 (335)
|.. ++.+..+..+|.. ..-++ ......++.+|..++.++++||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 222 2222222222221 11010 0111223456778899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccC
Q 019844 259 CRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.+|+.+||.+||+|.++|.+||++.-
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=184.12 Aligned_cols=114 Identities=30% Similarity=0.447 Sum_probs=96.1
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.+.||+|+||.||+|.++.+++.||+|++.+.. ....+|+.+++++. |+||+++++++... ...++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 678999999999999999999999999999986432 22347899999885 99999999998532 2256899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+.|+|.+.+... ...+++..++.++.||+.||.|||+.+
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ 120 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG 120 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999888877652 356899999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-23 Score=186.51 Aligned_cols=121 Identities=29% Similarity=0.407 Sum_probs=100.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCC----
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---- 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---- 149 (335)
..++|++.+.||.|+||.||+|.++.+++.||+|.+.... ..+.+|+.+++.++||||+++++++....+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3456999999999999999999999999999999986422 245689999999999999999999854331
Q ss_pred -CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 -KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 -~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++|+||||+++++.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 136 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN 136 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 123378999999999887776642 346899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=189.09 Aligned_cols=117 Identities=30% Similarity=0.454 Sum_probs=97.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~ 153 (335)
..+|.+.+.||+|+||.||+|.++.+|+.||||++.+. ...+.+|+.+++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35799999999999999999999999999999998642 1346789999999999999999999854321 1223
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||+.++|..++ ...+++..++.++.||+.||.|||+++
T Consensus 94 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred eEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46899999988776654 245899999999999999999999988
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-24 Score=186.27 Aligned_cols=113 Identities=27% Similarity=0.381 Sum_probs=97.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
-|++.+.||.|+||.||+|.+..++..+|+|.+... ...+.+|+.+++.++||||+++++++ ....+.|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEE
Confidence 378899999999999999999999999999998643 23467899999999999999999999 445568999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+++ +|..++... ...+++..+..++.||+.||.|||+.+
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ 123 (282)
T cd06643 81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK 123 (282)
T ss_pred EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999996 887776541 456999999999999999999999988
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=185.66 Aligned_cols=105 Identities=27% Similarity=0.403 Sum_probs=93.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||.|+||.||+|.+..+++.||+|++.+.. +.+.+|+.+++.++||||+++++.+ ....++|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 799999999999999999999999986422 4577899999999999999999998 4555689999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+| +|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~ 113 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG 113 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 86 99999976 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=187.53 Aligned_cols=112 Identities=23% Similarity=0.433 Sum_probs=100.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+|.+.+.||+|+||.||++.++.+++.||+|.+.+.. ..+.+|+.+++.++||||+++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5999999999999999999999999999999986432 3456899999999999999999998 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.. .+.+++..+..++.|++.||.|||+++
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG 121 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999996 99999876 567999999999999999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=184.88 Aligned_cols=112 Identities=38% Similarity=0.593 Sum_probs=96.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEEE
Confidence 599999999999999999999999999999988532 24577999999999999999999999 4455689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ .+..+... ...+++..++.++.||+.||.|||.++
T Consensus 77 iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 77 LVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred EEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999997 44444433 456999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=191.98 Aligned_cols=190 Identities=22% Similarity=0.304 Sum_probs=130.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHH-HHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei-~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||+||+|+++.+++.||+|++.+.. ..+.+|. .+++.++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999999999999999986421 2233444 356788999999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhh-------------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIK------------- 212 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~------------- 212 (335)
||+.| +|.+++.. .+.+++..++.++.||+.||.|||++|+ + .....+.
T Consensus 76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99996 99888876 5679999999999999999999999980 0 0000011
Q ss_pred ----hcCCCC---HHHhhhhCCCC--CCCCCCC------CCCCcc---------------ccccccCCChHHHHHHHHhc
Q 019844 213 ----VLGTPT---REEIKCMNPNY--TEFKFPQ------IKPHPW---------------HKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 213 ----~~g~~~---~~~~~~~~~~~--~~~~~~~------~~~~~~---------------~~~~~~~~s~~~~~li~~~L 262 (335)
.+|++. ++.+....... .-|.+.- ....+| ...+++.+++.+.++|.+||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHc
Confidence 123322 12111100000 0000000 000000 01233578999999999999
Q ss_pred cCCCCCCCCHH----HHhcCcccccCCC
Q 019844 263 QYSPNLRCTAL----EACVHPFFDELRD 286 (335)
Q Consensus 263 ~~dP~~R~t~~----~~L~hp~f~~~~~ 286 (335)
+.||.+|+++. ++++|+||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 99999999875 8999999977644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=184.84 Aligned_cols=110 Identities=20% Similarity=0.343 Sum_probs=97.3
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
|++.+.||.|+||.||+|.+..+++.||||.+.... ..+.+|+.+++.++||||+++++++ ....++|+|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 888999999999999999999899999999875322 3467899999999999999999999 555668999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||++| +|.+++.. ..+++..+..++.|++.||.|||+.+
T Consensus 81 ~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06641 81 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK 121 (277)
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 999996 89888763 46899999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=180.80 Aligned_cols=196 Identities=29% Similarity=0.499 Sum_probs=150.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-cchhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++|++.+++|+|.|+.|+.|....+++.++||+++. ..+.+.||+.||..|. ||||++++++..++. .....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchh
Confidence 34579999999999999999999999999999999964 4567889999999995 999999999985433 223568
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------------- 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------- 203 (335)
|+||+.. |...+.. .++..+++.++.|++.||.|+|++|
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999997 6655543 4888899999999999999999999
Q ss_pred ------------------------------------------------------cChHHhHhhhcCCCCHHH-hh----h
Q 019844 204 ------------------------------------------------------VDQLVEIIKVLGTPTREE-IK----C 224 (335)
Q Consensus 204 ------------------------------------------------------~~~~~~~~~~~g~~~~~~-~~----~ 224 (335)
.+++.++..++||..-.. +. .
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 456666666666543111 00 1
Q ss_pred hCCCCCCCCCCCCCCCcccccccc----CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 225 MNPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
..|.|.. .+......+|...++. -.++++.|||.++|.+|..+|+||.|++.||||.....
T Consensus 266 Ldp~~~~-i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 266 LDPQFED-ILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred CChhHhh-HhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 2233322 1223344566654432 25799999999999999999999999999999987654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=192.40 Aligned_cols=114 Identities=27% Similarity=0.454 Sum_probs=100.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 345799999999999999999999999999999998642 23456899999999999999999999 566
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+|||||+| +|.+++.. ..+++..++.++.||+.||.|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ 162 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG 162 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 779999999985 99998864 45899999999999999999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=186.40 Aligned_cols=116 Identities=23% Similarity=0.356 Sum_probs=98.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc---------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~---------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||+|+||.||++.+..++..+++|+++. ....+.+|+.+++.++||||+++++++ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 58999999999999999999988877777776642 112355799999999999999999998 4445
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++||||+++ +|.+++.........+++..++.++.|++.||.|||+++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 58899999996 999988765444567999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=180.32 Aligned_cols=114 Identities=30% Similarity=0.419 Sum_probs=100.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++++.||.|+||.||.+++..+++.+|+|.+... ...+.+|+.++++++|+||+++++++ .....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 599999999999999999999999999999987532 24567899999999999999999999 4556699
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||+| +|.+++.... ...+++..+..++.|++.||.|||+.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG 121 (256)
T ss_pred EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 9999887632 356899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=190.00 Aligned_cols=107 Identities=26% Similarity=0.416 Sum_probs=90.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHH-HHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
++||+|+||.||+|++..+++.||+|++.+.. ..+.+|+. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999986421 22344544 67889999999999998 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+| +|...+.. ...+++..++.++.||+.||.|||+++
T Consensus 76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ 116 (321)
T cd05603 76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN 116 (321)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99996 89877765 567999999999999999999999988
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=185.06 Aligned_cols=112 Identities=35% Similarity=0.541 Sum_probs=98.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++|+||+++++++ ....++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 667889999999999999999999999999987531 3456899999999999999999999 44466999
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++++|.+++... ...+++..++.++.|++.||.|||+++
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~ 118 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR 118 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999998862 146999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=184.36 Aligned_cols=114 Identities=26% Similarity=0.446 Sum_probs=98.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|++.+.||+|+||.||+|.+..++..||+|.+... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 599999999999999999999999999999988532 1346789999999999999999998843 2235
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++++|||+++ +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ 126 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM 126 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68899999986 99998875 556899999999999999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=183.43 Aligned_cols=112 Identities=28% Similarity=0.458 Sum_probs=101.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|.+.+.||.|++|.||+|.+..+++.||+|++... ...+.+|+..+..++|+||+++++++ .....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 589999999999999999999999999999998654 24577899999999999999999999 45566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
||||++| +|.+++.. ...+++..++.++.||+.||.|||+ ++
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~ 120 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH 120 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence 9999995 99999986 4679999999999999999999999 87
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=175.39 Aligned_cols=125 Identities=21% Similarity=0.267 Sum_probs=110.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEec----ccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~----~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
....||++.+.||.|+|+-||+++...+++.||+|+|. .+.+...+|++..++++||||++++++...........
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 44568999999999999999999999999999999984 33466789999999999999999999987655556667
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.||+++|.. |+|.+.+......+..++|.++..|+.+|++||++||+..
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~ 147 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE 147 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC
Confidence 999999998 7999999887766668999999999999999999999887
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=181.43 Aligned_cols=116 Identities=25% Similarity=0.461 Sum_probs=101.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||.|+||.||++.+..++..||+|++... ...+.+|+++++.++|||++++++.+ .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence 489999999999999999999999999999998643 24567899999999999999999998 4446689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.........+++..+..++.|++.||.|||+++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 123 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 999998874333467999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=186.03 Aligned_cols=111 Identities=22% Similarity=0.360 Sum_probs=98.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++|+||+++++++ .+..++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEEE
Confidence 5899999999999999999999999999999986432 3467899999999999999999998 44466999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||+++ +|.+++.. ..+++..++.++.|++.||.|||+++
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~ 118 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG 118 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999996 99988874 37999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=185.01 Aligned_cols=112 Identities=33% Similarity=0.589 Sum_probs=98.0
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ..+.+|+.+++.++|+||+++++++ .....+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 567889999999999999999999999999986432 3467899999999999999999998 44566899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++++|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~ 118 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG 118 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999888887652 357999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=187.28 Aligned_cols=113 Identities=24% Similarity=0.396 Sum_probs=99.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++.+.||.|+||.||+|.++.+++.+|+|.+.... ..+.+|+.+++.++||||+++++++ .....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEEE
Confidence 5888999999999999999999999999999986432 3467899999999999999999999 44566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
+|||++| +|.+++... ...+++..++.++.||+.||.|||+ .+
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 121 (265)
T cd06605 77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK 121 (265)
T ss_pred EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC
Confidence 9999995 999998862 2679999999999999999999999 66
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=181.33 Aligned_cols=114 Identities=25% Similarity=0.394 Sum_probs=101.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
++|++.+.||.|+||.||+|.+..+++.+|+|++... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 5699999999999999999999999999999998643 34578999999999999999999998 45556999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||++| +|.+++... ...+++..++.++.|++.||.|||+++
T Consensus 78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~ 121 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG 121 (262)
T ss_pred EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999996 998888752 257999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=189.86 Aligned_cols=105 Identities=27% Similarity=0.392 Sum_probs=89.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC---CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +||||+++++++ ....++|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999999999999996421 2234566676655 699999999999 5566799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.| +|..++.. .+.+++..++.++.||+.||+|||+++
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~ 116 (330)
T cd05586 76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD 116 (330)
T ss_pred cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99985 99888875 667999999999999999999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=180.95 Aligned_cols=115 Identities=25% Similarity=0.354 Sum_probs=100.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++++.||.|+||.||+|....++..+|+|++... ...+.+|+.+++.++|+||+++++.+ .....+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 599999999999999999999889999999998643 24577899999999999999999998 45556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+++| +|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~ 122 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG 122 (267)
T ss_pred EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999996 99999876321 246899999999999999999999988
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=186.54 Aligned_cols=199 Identities=20% Similarity=0.310 Sum_probs=139.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++++.||+|+||.||+|.+..++..||+|.+... ...+.+|+.+++.++||||+++++++ ....++|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 589999999999999999999999999999988642 13567899999999999999999998 45567999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-Cc------------Ch-HHhHhhhcCC------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IV------------DQ-LVEIIKVLGT------ 216 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~------------~~-~~~~~~~~g~------ 216 (335)
||||++| +|..++.... ....+++..+..++.||+.||.|||+. ++ +. ....+..+|.
T Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999997 9988887521 124799999999999999999999964 50 00 0000111111
Q ss_pred ---------CC---HHHhhhhCC----CCC------------------CCCCCCCCCCc-----------cccccccCCC
Q 019844 217 ---------PT---REEIKCMNP----NYT------------------EFKFPQIKPHP-----------WHKVFQKRLP 251 (335)
Q Consensus 217 ---------~~---~~~~~~~~~----~~~------------------~~~~~~~~~~~-----------~~~~~~~~~s 251 (335)
+. ++.+....+ .+. ...+....... ....++..++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 11 111110000 000 00000000000 0012334578
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
+++.+||.+||+.||++||++.++++||||.....+
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 999999999999999999999999999999877544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=183.43 Aligned_cols=114 Identities=30% Similarity=0.495 Sum_probs=98.5
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ..+.+|+.+++.++||||+++++++... ....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678999999999999999999999999999997542 3467899999999999999999998432 1256899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++++|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~ 120 (287)
T cd07840 78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG 120 (287)
T ss_pred EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988887652 247999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=183.16 Aligned_cols=113 Identities=35% Similarity=0.540 Sum_probs=97.5
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.+.||.|+||.||+|....+++.||||.+.... ....+|+..++.++ ||||+++++++ ......|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 678899999999999999999899999999986432 23457999999998 99999999999 44566899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+.|+|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999889988887632 246899999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=181.15 Aligned_cols=114 Identities=27% Similarity=0.402 Sum_probs=101.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
++|++.+.||.|+||.||+|..+.+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....++|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEEEE
Confidence 4699999999999999999999988999999998654 35678999999999999999999999 4456699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+++ +|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (256)
T cd06612 78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK 119 (256)
T ss_pred ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99996 999988642 356899999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=199.56 Aligned_cols=192 Identities=26% Similarity=0.406 Sum_probs=140.6
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEec------c--cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------Q--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~------~--~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+...+||+|+|-+||+|.|..+|..||.-.++ . ...++..|+++|+.|+|||||++|++|.+.. ..++.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 34678999999999999999999999976553 1 2267889999999999999999999997643 35588
Q ss_pred EEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------cChHHhH--
Q 019844 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------VDQLVEI-- 210 (335)
Q Consensus 157 iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------~~~~~~~-- 210 (335)
+|+|++. |+|..+.+. +++++...++.|++||+.||.|||++. +..+...
T Consensus 120 ~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 9999998 699999887 678999999999999999999999987 1111111
Q ss_pred ------hhhcCCCCHHHhhhhCCCCCC----------------CCCCCC----CCCcccc--------ccccCCChHHHH
Q 019844 211 ------IKVLGTPTREEIKCMNPNYTE----------------FKFPQI----KPHPWHK--------VFQKRLPPEAVD 256 (335)
Q Consensus 211 ------~~~~g~~~~~~~~~~~~~~~~----------------~~~~~~----~~~~~~~--------~~~~~~s~~~~~ 256 (335)
..+.|||..........+|.+ ..+|.. .+..+.. -+..--.+++++
T Consensus 196 ~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 196 LRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred hhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 124677763222221122221 111111 0111111 111234689999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
||.+||.. .++|+|+.|+|+||||+.-
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999998 9999999999999999874
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=188.85 Aligned_cols=193 Identities=21% Similarity=0.295 Sum_probs=136.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.|...+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++ ....++|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4778899999999999999999999999999986432 3467899999999999999999999 45556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcCh-------------HHhHhhhc---------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVDQ-------------LVEIIKVL--------- 214 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-------------~~~~~~~~--------- 214 (335)
||||++| +|.+++. .+.+++..++.++.||+.||.|||++++-. ....+..+
T Consensus 80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999996 9988875 356899999999999999999999988100 00000111
Q ss_pred --------CCC---CHHHhhhhCCCCC--------------CCCCC--CCCC--------CccccccccCCChHHHHHHH
Q 019844 215 --------GTP---TREEIKCMNPNYT--------------EFKFP--QIKP--------HPWHKVFQKRLPPEAVDLVC 259 (335)
Q Consensus 215 --------g~~---~~~~~~~~~~~~~--------------~~~~~--~~~~--------~~~~~~~~~~~s~~~~~li~ 259 (335)
|+. .++.+........ ....+ .... .......+..++.++.++|.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 111 1111110000000 00000 0000 00011122356788999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccCC
Q 019844 260 RFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 260 ~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+||+.+|++||++.++++||||..+.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHHh
Confidence 99999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=183.42 Aligned_cols=193 Identities=24% Similarity=0.284 Sum_probs=134.8
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||+|+||+||+|.+..+|+.||+|.+.+. ...+.+|+.+++.++||||+++++++ ....++|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 69999999999999999999999998642 12346799999999999999999999 5556689999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcCh-------------HHhHhhhcC-------------
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVDQ-------------LVEIIKVLG------------- 215 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-------------~~~~~~~~g------------- 215 (335)
+| +|.+++.... ...+++..++.++.|++.||.|||++++-. ....+..+|
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 96 9998887632 236999999999999999999999998100 000000111
Q ss_pred ---C---CCHHHhhhhCC------------------CCCCCCCCCC--C-------CCccccccccCCChHHHHHHHHhc
Q 019844 216 ---T---PTREEIKCMNP------------------NYTEFKFPQI--K-------PHPWHKVFQKRLPPEAVDLVCRFF 262 (335)
Q Consensus 216 ---~---~~~~~~~~~~~------------------~~~~~~~~~~--~-------~~~~~~~~~~~~s~~~~~li~~~L 262 (335)
+ ..++.+..... +..++..... . .......++..+++.+.++|.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 0 11111110000 0000000000 0 000011233567899999999999
Q ss_pred cCCCCCCC-----CHHHHhcCcccccCCCCCC
Q 019844 263 QYSPNLRC-----TALEACVHPFFDELRDPNT 289 (335)
Q Consensus 263 ~~dP~~R~-----t~~~~L~hp~f~~~~~~~~ 289 (335)
+.||.+|| ++.++++||||..+.+...
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 99999999 8999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-26 Score=185.16 Aligned_cols=203 Identities=28% Similarity=0.393 Sum_probs=149.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc--cc----hhHHHHHHHHHhCCCCceeeeceeeeeCC---CCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DK----RYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~---~~~~ 152 (335)
..|....+||+|.||.||+|+.+.+|+.||+|++-- +. ....+|+.+|..|+|+|++.+++.+-+.. ..+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 358889999999999999999999999999987632 11 34579999999999999999988875432 2345
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
..+|+||++|+.||..++... ..+|+..+++.++.+++.||.|+|.+.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 568999999999999998752 367999999999999999999999876
Q ss_pred -------------------------------------------------------------cChHHhHhhhcCCCCHHHh
Q 019844 204 -------------------------------------------------------------VDQLVEIIKVLGTPTREEI 222 (335)
Q Consensus 204 -------------------------------------------------------------~~~~~~~~~~~g~~~~~~~ 222 (335)
..++..|..+||...++.|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 2334445555666665555
Q ss_pred hhhC--CCCCCCCCCCCCCCcccc---c-cccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 223 KCMN--PNYTEFKFPQIKPHPWHK---V-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 223 ~~~~--~~~~~~~~~~~~~~~~~~---~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
.... |-|.....+......++. . -|-.-++++.||+.+||..||.+|+.++++|+|.||..-..|
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 4331 112111111111111111 0 112236789999999999999999999999999999865444
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=191.02 Aligned_cols=109 Identities=19% Similarity=0.359 Sum_probs=93.6
Q ss_pred eeeecc--CceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
..||+| +||+||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||++++++| ....++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456666 99999999999999999999986322 4567899999999999999999999 5556689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.+ +|.+++.... ...+++..++.++.||+.||+|||+++
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ 121 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG 121 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99996 9999888643 345899999999999999999999988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=187.46 Aligned_cols=112 Identities=29% Similarity=0.476 Sum_probs=96.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcE-EEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc-E
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL-Y 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~-vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~-~ 154 (335)
...+.+.||.|+||+||++.++ |.. ||+|++... .+.+.+|+.+|.+++|||||++++++. +.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~-----~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT-----SPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCc
Confidence 3566777999999999999996 555 999999643 247889999999999999999999994 333 5
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||||++ |+|.+++... ....++...+..|+.||++||+|||+++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999 5999999864 2577999999999999999999999998
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=197.64 Aligned_cols=119 Identities=18% Similarity=0.212 Sum_probs=89.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCc-EEEEE------------------Eecc---cchhHHHHHHHHHhCCCCce
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE-IVAIK------------------KVLQ---DKRYKNRELQIMQMLDHPNI 137 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-~vAvK------------------~i~~---~~~~~~~Ei~~l~~l~hpnI 137 (335)
...+|++++.||+|+||+||+|..+.... ..++| .+.. ....+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34679999999999999999998653322 22222 1111 11346789999999999999
Q ss_pred eeeceeeeeCCCCCccEEEEEeecchhhHHHHHHHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 138 v~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|++++++ ....+.|+||+++.++|..++.... ..........++.|+.||+.||.|||+++
T Consensus 226 v~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g 287 (501)
T PHA03210 226 LKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK 287 (501)
T ss_pred CcEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999 5555689999999988887775421 11223456778899999999999999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-23 Score=182.34 Aligned_cols=120 Identities=27% Similarity=0.443 Sum_probs=101.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC---CC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---~~ 151 (335)
.++|.+.+.||.|+||.||+|.++.+++.+|||++... .....+|+.+++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46799999999999999999999999999999998532 1245789999999999999999998864332 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+||||+.++|...+... ...+++..++.++.||+.||.|||+++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~ 135 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH 135 (311)
T ss_pred CceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4568999999998887766542 356999999999999999999999988
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=202.04 Aligned_cols=189 Identities=23% Similarity=0.316 Sum_probs=136.2
Q ss_pred eeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+....+.||+|+||+||+|+.. .....||||.++... ..++||+++|..|+|||||+++|++ ..+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----REG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----ccC
Confidence 4667899999999999999864 234579999997533 5688999999999999999999999 455
Q ss_pred cEEEEEeecch-hhHHHHHHHHhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCC-------------cChHH
Q 019844 153 LYLNLVLEYVP-ETVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCI-------------VDQLV 208 (335)
Q Consensus 153 ~~~~iv~e~~~-g~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------~~~~~ 208 (335)
.-+|+|+|||. |||.++|...... ...++..+...|+.||+.||.||-++. .+++.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 55999999999 7999999864321 123889999999999999999999887 11111
Q ss_pred hHhhhcCCC--------------CHHHhhhhCCCCCCCCCCCCCCCccc-------------------------------
Q 019844 209 EIIKVLGTP--------------TREEIKCMNPNYTEFKFPQIKPHPWH------------------------------- 243 (335)
Q Consensus 209 ~~~~~~g~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------- 243 (335)
..+..+|-. +...+.+|.|+-..|.-...+.+.|.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 122222211 11123344443322222222222222
Q ss_pred --cccccCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 019844 244 --KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 276 (335)
Q Consensus 244 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L 276 (335)
...|..+|.++++|+..||+.+|.+||++.||=
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 124678999999999999999999999999873
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=184.04 Aligned_cols=112 Identities=30% Similarity=0.465 Sum_probs=100.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+|.+.+.||+|+||.||+|.++.+++.||+|++.+. ...+.+|+.+++.++ ||||+++++++ .....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 599999999999999999999999999999998642 234678999999998 99999999998 55566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||+.+ +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8999999974 99999886 557999999999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=184.20 Aligned_cols=111 Identities=21% Similarity=0.341 Sum_probs=98.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.|+..+.||.|+||.||+|.+..++..||+|++.... ..+.+|+.+++.++||||+++++++ .+..++|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 4888999999999999999999999999999986432 3467899999999999999999999 55566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++| +|.+++.. +.+++..+..++.|++.||+|||+.+
T Consensus 80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK 121 (277)
T ss_pred EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999996 99888863 46899999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-23 Score=177.09 Aligned_cols=114 Identities=32% Similarity=0.521 Sum_probs=99.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ..+.+|+.++++++||||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4889999999999999999999999999999986432 45778999999999999999999984321 26689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999975 99999886 447999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=181.60 Aligned_cols=116 Identities=22% Similarity=0.356 Sum_probs=102.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCC--C----ceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDH--P----NIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~h--p----nIv~~~~~~~~~~~~~ 151 (335)
..+|.+.+.+|+|+||.|-.|.+..++..||||+|+.- .....-|+++|.++.+ | -+|++.+|| ..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 56799999999999999999999999999999998642 3456789999999942 3 388999999 88
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++|||+|.++-+++++|..+. ..+++...++.|++||+.+++|||+++
T Consensus 163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k 212 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK 212 (415)
T ss_pred cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc
Confidence 88899999999999999999755 567999999999999999999999988
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=183.13 Aligned_cols=113 Identities=26% Similarity=0.326 Sum_probs=99.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|.+.+.||.|+||.||++.+..++..||+|.+... ...+.+|+.+++.++||||+++++++ ......|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence 35799999999999999999999889999999998532 24567899999999999999999998 4455689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||++| +|.+++.. ..+++..+..++.|++.||.|||+++
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g 135 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ 135 (293)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 99988864 45889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=180.39 Aligned_cols=112 Identities=25% Similarity=0.384 Sum_probs=95.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.....||+|+||.||+|.+..++..||+|.+... .+.+.+|+.+++.++|+||+++++++ ....++++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEE
Confidence 33456899999999999999999999999988643 24577999999999999999999998 5556799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++| +|.+++... ...+ ++..+..++.||+.||.|||+++
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 128 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 99996 999988752 2345 88889999999999999999988
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-23 Score=178.85 Aligned_cols=114 Identities=25% Similarity=0.400 Sum_probs=98.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|++.+.||+|+||.||.|.+..+++.||||.+... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 599999999999999999999999999999988521 1346689999999999999999998732 2234
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++++|||++| +|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM 126 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68899999986 99998875 556899999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=184.74 Aligned_cols=112 Identities=25% Similarity=0.340 Sum_probs=98.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
++|++.+.||+|+||+||++.+..+++.||+|++... ...+.+|+++++.++||||+++++++ ....++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence 4699999999999999999999999999999987533 24567899999999999999999999 4556799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+||||+++ +|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~ 122 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV 122 (284)
T ss_pred EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 99999996 99888875 56799999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=177.86 Aligned_cols=112 Identities=24% Similarity=0.453 Sum_probs=99.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++|+||+++++++ .....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 589999999999999999999889999999998643 23567899999999999999999988 5556689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||+++ +|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~ 119 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG 119 (264)
T ss_pred EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC
Confidence 99999996 99998875 556899999999999999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=179.18 Aligned_cols=117 Identities=26% Similarity=0.476 Sum_probs=101.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+|++.+.||+|+||.||+|+++.+++.||||.+... ...+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 4699999999999999999999999999999987531 134678999999999999999999984 4456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||+++ +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 126 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 8899999996 999998765544566899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=177.48 Aligned_cols=114 Identities=25% Similarity=0.368 Sum_probs=99.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+|++.+.||.|+||.||++.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++ ....++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 489999999999999999999999999999998532 24567899999999999999999999 55667999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~ 120 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR 120 (255)
T ss_pred EEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9999985 9988886532 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=185.80 Aligned_cols=198 Identities=24% Similarity=0.262 Sum_probs=138.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+.|.....||+|+||.||++.+..++..||||.+... ...+.+|+.+++.++||||+++++.+ ....+.|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEE
Confidence 3466778899999999999999999999999998542 24567899999999999999999998 45556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh----------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV---------- 213 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~---------- 213 (335)
||||++| +|.+++. .+.+++..++.++.||+.||.|||++++ + .....+..
T Consensus 97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9999996 8888775 3568999999999999999999999881 0 00000001
Q ss_pred -------cCCCC---HHHhhhhCCCCCC--------------CCCCCCCCCc------------cccccccCCChHHHHH
Q 019844 214 -------LGTPT---REEIKCMNPNYTE--------------FKFPQIKPHP------------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 -------~g~~~---~~~~~~~~~~~~~--------------~~~~~~~~~~------------~~~~~~~~~s~~~~~l 257 (335)
.|++. ++........... ...+...... .........++.+.++
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 11111 1111000000000 0000000000 0000112468889999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
|.+||..||.+|||+.++++||||.....|..
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 99999999999999999999999998877664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=181.47 Aligned_cols=105 Identities=30% Similarity=0.452 Sum_probs=93.4
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||.|+||.||+|.+..+++.+|+|.+.... ..+.+|+.+++.++||||+++++.+ .....+|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999899999999986432 3467899999999999999999998 5566689999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~ 113 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG 113 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 86 99999876 457999999999999999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-23 Score=175.92 Aligned_cols=112 Identities=32% Similarity=0.585 Sum_probs=100.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|.+.+.||+|++|.||++.+..+++.||+|.+.... ..+.+|+++++.++||||+++++++ .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 4899999999999999999999999999999986443 3467899999999999999999998 4456689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||+++ +|.+++.. ...+++..++.++.|++.||.|||+++
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~ 119 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG 119 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 99999996 99998876 467999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=177.75 Aligned_cols=118 Identities=29% Similarity=0.438 Sum_probs=97.9
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhC---CCCceeeeceeeeeCCCCCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
|++.+.||+|+||.||+|.++.+++.||+|.+.... ..+.+|+.+++.+ +||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999998889999999996321 2355788877766 5999999999996544334445
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++|||+.++|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~ 127 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR 127 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 89999999999988887532 235899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=184.96 Aligned_cols=114 Identities=28% Similarity=0.420 Sum_probs=98.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++. ....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence 45999999999999999999999999999999985321 34678999999999999999999994 4445
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|+||||+.|+|.+++... ...+++..+..++.||+.||.|||+.+
T Consensus 90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~ 135 (307)
T cd06607 90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE 135 (307)
T ss_pred EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999999887777542 356899999999999999999999988
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=192.73 Aligned_cols=203 Identities=22% Similarity=0.315 Sum_probs=152.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+.|++.++||.|.+|.||+++.+.+++..|+|+...+ ...+..|..+|+.+ +|||++.+|++|+-.......-
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3445699999999999999999999999999999987543 35567788899888 7999999999999777677778
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
+|||||||.| +..++++... ..++.|..+.+|++.++.||.+||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 9999999995 9999999866 788999999999999999999999876
Q ss_pred cChHHhHhhhcCCCCHH---HhhhhC---CCCCC----C-----------------------CCCCCCCCcc-ccccccC
Q 019844 204 VDQLVEIIKVLGTPTRE---EIKCMN---PNYTE----F-----------------------KFPQIKPHPW-HKVFQKR 249 (335)
Q Consensus 204 ~~~~~~~~~~~g~~~~~---~~~~~~---~~~~~----~-----------------------~~~~~~~~~~-~~~~~~~ 249 (335)
......-.+..|||.+. .+.|.. +.|.. + .+..+.+.|- ...-|..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 01112223446776632 222221 11110 0 0001111111 1112456
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
.+.++.+||..||..|-.+||+..++|.|||+.+
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 7889999999999999999999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=178.23 Aligned_cols=107 Identities=26% Similarity=0.398 Sum_probs=89.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHH-HhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l-~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||.|+||.||+|.+..+++.||+|++.+.. .....|..++ ..++|+||+++++++ ....++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 57999999999999999999999999986432 1233454444 445899999999999 5556799999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++| +|.+++.. .+.+++..+..++.||+.||.|||+.+
T Consensus 77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ 117 (260)
T cd05611 77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG 117 (260)
T ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99986 99999876 567999999999999999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=179.31 Aligned_cols=114 Identities=20% Similarity=0.232 Sum_probs=97.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|++.+.||+|+||.||+|.++ ..+..||+|.+.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecCC
Confidence 35999999999999999999875 456689999986432 3467899999999999999999998 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|+||||+++ +|.+++... ...+++..++.++.||+.||+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~ 127 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG 127 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 68999999996 999888752 346899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=187.48 Aligned_cols=119 Identities=19% Similarity=0.322 Sum_probs=96.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++.+.||+|+||.||+|.+. .+++.||+|++... ...+.+|+.+++.+ +|||||++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 457999999999999999999852 44578999998642 24577899999999 89999999998842
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh----------------------------------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI---------------------------------------------------- 176 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~---------------------------------------------------- 176 (335)
....+|+|||||+| +|.+++......
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 23348899999995 999998753210
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 177 ------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 177 ------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++..+..++.||+.||.|||+++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 194 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK 194 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 134788899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=178.62 Aligned_cols=111 Identities=25% Similarity=0.436 Sum_probs=97.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.|++.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++ ||||+++++++ ....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 388899999999999999999999999999998642 235678999999996 99999999998 45556
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||||++| +|.+++.. +.+++..++.++.|++.||.|||+.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 8999999986 99888764 46899999999999999999999988
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=183.04 Aligned_cols=197 Identities=22% Similarity=0.270 Sum_probs=137.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
|.....||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++ ....++|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence 55566899999999999999999999999998532 24567899999999999999999998 4455689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--------hHHh---------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--------QLVE--------- 209 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--------~~~~--------- 209 (335)
||+++ +|..++.. ..+++..++.++.||+.||.|||++++ + .+..
T Consensus 98 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 98 EFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred ecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99996 88887653 568999999999999999999999881 0 0000
Q ss_pred -HhhhcCCCC---HHHhhhhCC------------------CCCCCCCCC-------CCCC-ccccccccCCChHHHHHHH
Q 019844 210 -IIKVLGTPT---REEIKCMNP------------------NYTEFKFPQ-------IKPH-PWHKVFQKRLPPEAVDLVC 259 (335)
Q Consensus 210 -~~~~~g~~~---~~~~~~~~~------------------~~~~~~~~~-------~~~~-~~~~~~~~~~s~~~~~li~ 259 (335)
.....|++. ++.+..... ...++.... .... ......+..+++.+.++|.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 000111111 111110000 000000000 0000 0000112357889999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccCCCCCCC
Q 019844 260 RFFQYSPNLRCTALEACVHPFFDELRDPNTR 290 (335)
Q Consensus 260 ~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~ 290 (335)
+||+.||.+||++.++++||||.+...|...
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~ 283 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLPECL 283 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCcccc
Confidence 9999999999999999999999988766553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=178.15 Aligned_cols=196 Identities=24% Similarity=0.299 Sum_probs=136.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.|...+.||+|++|.||++.+..+++.+|+|++... .+.+.+|+.+++.++||||+++++++ ....+.|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 466678999999999999999999999999988532 23467899999999999999999998 445568999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh-----------
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV----------- 213 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~----------- 213 (335)
+||+.| +|.+++.. ..+++..+..++.||+.||.|||++++ +. ....+..
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999986 99888874 458999999999999999999999881 00 0000001
Q ss_pred ------cCCCC---HHHhhhhCCCC--CCC------------CCCCCCCC------------ccccccccCCChHHHHHH
Q 019844 214 ------LGTPT---REEIKCMNPNY--TEF------------KFPQIKPH------------PWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 214 ------~g~~~---~~~~~~~~~~~--~~~------------~~~~~~~~------------~~~~~~~~~~s~~~~~li 258 (335)
.|++. ++......... .-| ..+..... ......+..++..+.+||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 11111 11110000000 000 00000000 000011123778999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 259 CRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
++||+.||++|||+.++++||||.....|.
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=181.59 Aligned_cols=114 Identities=28% Similarity=0.446 Sum_probs=98.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+.|...+.||+|+||+||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++ .....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCE
Confidence 34777889999999999999999999999999986321 3466899999999999999999999 44556
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|+||||+.|+|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 96 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g 141 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN 141 (313)
T ss_pred EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8999999999888777642 456899999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=178.89 Aligned_cols=188 Identities=22% Similarity=0.282 Sum_probs=128.1
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHH---hCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQ---MLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~---~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.||+|+||.||++.+..+++.+|+|.+.+.. ....+|..+++ ..+||||+.+++++ .....+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 4899999999999999999999999885421 12334444333 34799999999999 445568999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC-------------hHHhHhhh-----------
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD-------------QLVEIIKV----------- 213 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-------------~~~~~~~~----------- 213 (335)
|||++| +|..++.. .+.+++..+..|+.||+.||.|||++++- .....+..
T Consensus 76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999996 99888875 56799999999999999999999998810 00000011
Q ss_pred ----cCCCC---HHHhhhhCCCCCC------------------CCCCCCCCC----------ccccccccCCChHHHHHH
Q 019844 214 ----LGTPT---REEIKCMNPNYTE------------------FKFPQIKPH----------PWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 214 ----~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~s~~~~~li 258 (335)
.|++. ++..... ..+.. ..+...... .....++..+++++.++|
T Consensus 152 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL 230 (279)
T ss_pred ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence 12221 1111100 00000 000000000 011123456789999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.+||+.||.+|+ ++.++++||||+.+..
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999999999999 6999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=186.26 Aligned_cols=201 Identities=22% Similarity=0.259 Sum_probs=138.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+..|+++++||+||.+.||++.. .+...||+|.+... ..-+..|+.+|.+| +|.+||++|||- -.+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTD 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccC
Confidence 345799999999999999999997 44566777766421 24467999999999 599999999998 667
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------cChHHhH---------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------VDQLVEI--------- 210 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------~~~~~~~--------- 210 (335)
.++||||||-+.||..+|... ..-++...+++|..||+.|+.++|.+| +....++
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAI 509 (677)
T ss_pred ceEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhccc
Confidence 889999999999999999873 233444689999999999999999999 0100000
Q ss_pred ---------hhhcCCCCH---HHhhhhC--------------------------------CCCCCCC-----CCCCCCCc
Q 019844 211 ---------IKVLGTPTR---EEIKCMN--------------------------------PNYTEFK-----FPQIKPHP 241 (335)
Q Consensus 211 ---------~~~~g~~~~---~~~~~~~--------------------------------~~~~~~~-----~~~~~~~~ 241 (335)
...+||+.| +.+.++. +.|..+. +..+....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 123455542 2222211 1111110 00001111
Q ss_pred cccccccCCCh-HHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 242 WHKVFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 242 ~~~~~~~~~s~-~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
-...||..-+. ++.++++.||.+||++|||+.++|+|||++-..-|..
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~ 638 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVE 638 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccch
Confidence 11123333333 3999999999999999999999999999987544443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=176.96 Aligned_cols=112 Identities=19% Similarity=0.223 Sum_probs=91.3
Q ss_pred eeeEEeeee--eccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~l--G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
++|.+.+.+ |.|+||.||++.++.++..+|+|.+..... ...|+.+...+ +||||++++++| .....+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~-----~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSV-----TTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEE-----ecCCeeEEE
Confidence 346666665 999999999999999999999999865321 11244443333 799999999999 444569999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||++| +|.+++.. ...+++..++.++.||+.||.|||+.+
T Consensus 88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ 129 (267)
T PHA03390 88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN 129 (267)
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999985 99999876 457999999999999999999999998
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=180.53 Aligned_cols=196 Identities=23% Similarity=0.303 Sum_probs=136.4
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
|....+||+|+||.||++....+++.||||.+... ...+.+|+.+++.++|+||+++++++ ....+.|+||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence 55567899999999999999999999999988532 23467899999999999999999999 4556689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhhc-----------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKVL----------- 214 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~~----------- 214 (335)
||+++ +|.+++. ...+++..++.++.|++.||.|||++++ +. ....+..+
T Consensus 97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99996 8888765 3468999999999999999999999881 00 00000011
Q ss_pred ------CCC---CHHHhhhhCCCC--CCC------------CCCCCCCC------------ccccccccCCChHHHHHHH
Q 019844 215 ------GTP---TREEIKCMNPNY--TEF------------KFPQIKPH------------PWHKVFQKRLPPEAVDLVC 259 (335)
Q Consensus 215 ------g~~---~~~~~~~~~~~~--~~~------------~~~~~~~~------------~~~~~~~~~~s~~~~~li~ 259 (335)
|++ .++......... .-+ ..+..... +........+++.+.++|.
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 111 111110000000 000 00000000 0000011346889999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 260 RFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 260 ~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
+||+.||.+||++.++|+||||.....|..
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~ 281 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGPPSC 281 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence 999999999999999999999998876553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=174.98 Aligned_cols=116 Identities=23% Similarity=0.389 Sum_probs=101.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|++.+.||.|+||.||++.++.+++.+|+|.+... ...+.+|+.+++.++|+||+++++++ ......|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 489999999999999999999999999999998642 23456899999999999999999999 4446689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~ 123 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 99999986 999998775544567999999999999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=188.45 Aligned_cols=118 Identities=19% Similarity=0.256 Sum_probs=97.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEE-----cCCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++++.||+|+||.||+|.+ ..++..||||+++.. ...+.+|+.+|+.+ +|||||++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34799999999999999999974 346778999998642 23567899999999 899999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh-----------------------------------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~----------------------------------------------------- 175 (335)
......++|||||+| +|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 555568899999995 99998865211
Q ss_pred ------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 176 ------------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 176 ------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++..+..++.||+.||.|||+++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 234 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN 234 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 0124788899999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=175.03 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=175.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCC-CC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~ 151 (335)
....||.-++.+|.|+- .|..+.|.-+++.||+|.+.. ..++..+|..++..++|+||++++.+|..... ..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 44567999999999998 888999999999999998743 23567799999999999999999999965432 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------- 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------- 203 (335)
...+|+|||||+.+|.+.+.. .++...+++|++|+++|++|||+.|
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 344889999999999888763 3778889999999999999999998
Q ss_pred --------------------------------------------------------cChHHhHhhhcCCCCHHHhhhhC-
Q 019844 204 --------------------------------------------------------VDQLVEIIKVLGTPTREEIKCMN- 226 (335)
Q Consensus 204 --------------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~- 226 (335)
++++.++...+|+|.+.....+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 77888888889999866544332
Q ss_pred ---------CCCCCCCCCCC-CCCcccccc--ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCC
Q 019844 227 ---------PNYTEFKFPQI-KPHPWHKVF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 294 (335)
Q Consensus 227 ---------~~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~ 294 (335)
|.|..+.+... +...|.... +..-+..++||+.+||..||++|.++.++|+||||+-+..+.. ..
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e-v~-- 323 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE-VE-- 323 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc-cc--
Confidence 33333322222 111222111 1234567899999999999999999999999999994433222 11
Q ss_pred CCCCC-CCCCCcccCCCCCHHHHhhcChHHHhhccc
Q 019844 295 RPLPP-LFNFKPPELSGIPPETINRLIPEHARKQNL 329 (335)
Q Consensus 295 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (335)
.+-|+ ...+ .+.+...+++|++.|.+|+..=+.
T Consensus 324 ap~pe~~d~~--~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 324 APPPEIYDKQ--LDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred CCCCchhhhh--cccccCCHHHHHHHHHHHHHhhcc
Confidence 11222 2111 245666799999999999886433
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=177.15 Aligned_cols=116 Identities=28% Similarity=0.357 Sum_probs=101.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+.|.+.+.||.|+||.||+|.+..++..||+|++.... ..+.+|+.+++.++|+||+++++++ .....+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY-----LVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCEEE
Confidence 3445999999999999999999999899999999997543 4567899999999999999999999 4445699
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||++| +|.+++.... ..+++..+..++.|++.||.|||+.|
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g 136 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN 136 (286)
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999995 9999998621 37999999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=185.28 Aligned_cols=113 Identities=24% Similarity=0.387 Sum_probs=95.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCc---E-EEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~---~-vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
+-.+.++||+|+||.||+|..+..+. . ||+|..+.+ ...+.+|.++|+.++|||||++||+....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~---- 233 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE---- 233 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC----
Confidence 45567999999999999999875432 3 899988641 24577999999999999999999998443
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.-++||||+|.| +|.++|+... +.++..+...++.+.+.||+|||+++
T Consensus 234 -~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~ 282 (474)
T KOG0194|consen 234 -EPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN 282 (474)
T ss_pred -CccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC
Confidence 339999999996 9999999732 35999999999999999999999998
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=174.44 Aligned_cols=117 Identities=30% Similarity=0.530 Sum_probs=102.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|.++. ....+.+|+.++++++|+||+++++++ .....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 469999999999999999999999999999998852 134577899999999999999999999 44456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++||||++| +|.+++.........+++..++.++.||+.||.|||+.+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 126 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 8999999996 999998765444566899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=178.10 Aligned_cols=119 Identities=18% Similarity=0.228 Sum_probs=95.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
..++|++.+.||+|+||.||+|.++. .+..||+|.+.... ..+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34679999999999999999997652 34589999886332 2356899999999999999999998
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
......|+||||+++ +|.+++...... ...++...+..++.||+.||.|||+++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 139 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 139 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 444558899999985 999999763211 133567788999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=181.83 Aligned_cols=103 Identities=23% Similarity=0.327 Sum_probs=86.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh-hH
Q 019844 94 SFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TV 166 (335)
Q Consensus 94 ~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L 166 (335)
++|.||.++++.+++.||||++... ...+.+|+.+++.++||||++++++| .....+|++|||+++ +|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence 4456677777779999999998643 14577999999999999999999999 455568999999995 99
Q ss_pred HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 167 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++.... ...+++..+..++.||+.||+|||+++
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~ 121 (314)
T cd08216 87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG 121 (314)
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99988643 346899999999999999999999988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=176.31 Aligned_cols=117 Identities=29% Similarity=0.491 Sum_probs=101.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+|.+.+.||+|+||.||+|.++.+++.+|||.+... ...+.+|+.+++.++||||+++++++ ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 3589999999999999999999999999999987531 23566899999999999999999999 44456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++|||+.| +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 126 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999996 999998865444567899999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-24 Score=197.19 Aligned_cols=196 Identities=21% Similarity=0.327 Sum_probs=148.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...++|.++..+|.|+||.||+++++.+++..|+|+|+.. ..-+++|+-+++..+|||||.|++.|... ..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cC
Confidence 4456799999999999999999999999999999999743 35577999999999999999999999543 33
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
+||.||||+| +|+++..- .+.++|.++.+.+++.+.||+|||+++
T Consensus 87 lwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred cEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence 9999999996 99888765 678999999999999999999999998
Q ss_pred cChHHhHhhhcCCCCHHHhhhh----CCCCCC------CCCCCC-----CC-----Ccc--------------ccccccC
Q 019844 204 VDQLVEIIKVLGTPTREEIKCM----NPNYTE------FKFPQI-----KP-----HPW--------------HKVFQKR 249 (335)
Q Consensus 204 ~~~~~~~~~~~g~~~~~~~~~~----~~~~~~------~~~~~~-----~~-----~~~--------------~~~~~~~ 249 (335)
...+.+-.++.|||.+..+... .-.|.. .....+ .. .+. ...-+..
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k 242 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK 242 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence 1112233456788874433211 111211 000000 00 000 0011235
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
.++.+.+|++.+|..||++||+++.+|.|||..+
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 7889999999999999999999999999999865
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=178.93 Aligned_cols=116 Identities=17% Similarity=0.268 Sum_probs=94.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+|...+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.++.++. ||||+++++++. .....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 477788999999999999999999999999998642 234678999999995 999999999984 344578
Q ss_pred EEeecchhhHHHHHHHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 157 LVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
++|||+.+++.++..... .....+++..+..++.|++.||+|||+. +
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~ 128 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 999999876665544321 1246799999999999999999999975 5
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=175.87 Aligned_cols=112 Identities=24% Similarity=0.425 Sum_probs=97.6
Q ss_pred eeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc--------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
+|++.+.||.|+||.||+|.+. .+|+.||+|++... .+.+.+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3889999999999999999985 47899999998642 24467899999999 699999999998 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+||||++| +|.+++.. ...+++..+..++.||+.||.|||+.+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ 125 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG 125 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 56678999999996 99988876 567899999999999999999999988
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=197.35 Aligned_cols=67 Identities=25% Similarity=0.428 Sum_probs=59.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 145 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 145 (335)
+...+|+.+..||+||||.||+|+.+-+|+.||||+|+-. ...+.+|+.+|++|+|||||+||..|.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 4566799999999999999999999999999999999643 245779999999999999999999884
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-22 Score=171.69 Aligned_cols=114 Identities=26% Similarity=0.450 Sum_probs=98.5
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence 599999999999999999999999999999987421 1346789999999999999999998843 2234
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++++|||++| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~ 126 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM 126 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999986 99888875 456899999999999999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-24 Score=185.35 Aligned_cols=120 Identities=28% Similarity=0.360 Sum_probs=103.3
Q ss_pred CCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEec--cc---------chhHHHHHHHHHhCCCCceeeeceee
Q 019844 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QD---------KRYKNRELQIMQMLDHPNIVALKHCF 144 (335)
Q Consensus 76 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~--~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~ 144 (335)
+.....++|.++.+||+|+|+.||+|.+....++||||+-. ++ .+...||..|.+.|+||-||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 34456678999999999999999999999999999999753 21 13456999999999999999999999
Q ss_pred eeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 145 ~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.... ..+|-|+|||+| ||.-+|+. ++.++|.+++.|+-||+.||.||....
T Consensus 537 slDt----dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik 588 (775)
T KOG1151|consen 537 SLDT----DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK 588 (775)
T ss_pred eecc----ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC
Confidence 6433 348899999998 99888887 778999999999999999999999776
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=174.56 Aligned_cols=115 Identities=21% Similarity=0.346 Sum_probs=100.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.+|.+.+.||+|+||.||+|.++.+++.||+|.+..+. ..+.+|+.+++.++||||+++++++ .....++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence 35999999999999999999999999999999987543 3467899999999999999999998 445568899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+++ +|.+++.... ...+++..++.++.|++.||.|||+++
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~ 124 (263)
T cd05052 81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN 124 (263)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999985 9999887532 346899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=180.52 Aligned_cols=113 Identities=27% Similarity=0.415 Sum_probs=97.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.|...+.||+|+||.||++++..++..+|+|++.... ..+.+|+.+++.++||||+++++++ ......
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence 4888999999999999999999999999999986321 3466899999999999999999999 444558
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.|+|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 899999999887777542 456899999999999999999999988
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=178.66 Aligned_cols=118 Identities=20% Similarity=0.283 Sum_probs=95.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC----------------CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVA 139 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~ 139 (335)
..+|++.++||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3469999999999999999998632 34479999986432 35778999999999999999
Q ss_pred eceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR---------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 140 ~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++++ .....+|+||||+.+ +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 84 LLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred EEEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999 444458999999985 99998865221 0124677889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=173.83 Aligned_cols=188 Identities=24% Similarity=0.319 Sum_probs=128.5
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHH---HHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei---~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.||+|+||.||+|.+..+++.||+|.+.+.. .....|. .+++..+||||+.+++++ ....++|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999999999999999986421 1122333 344556899999999999 555669999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh-----------
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV----------- 213 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~----------- 213 (335)
|||+.| +|..++.. .+.+++..++.|+.|++.||.|||+.++ + .....+..
T Consensus 76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999996 99888765 5679999999999999999999999880 0 00000011
Q ss_pred ----cCCCC---HHHhhhhCCCCCC------------------CCCCCCCC----------CccccccccCCChHHHHHH
Q 019844 214 ----LGTPT---REEIKCMNPNYTE------------------FKFPQIKP----------HPWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 214 ----~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~----------~~~~~~~~~~~s~~~~~li 258 (335)
.|+.. ++.+... ..+.. ..+..... ......++..++.++.++|
T Consensus 152 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 230 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230 (278)
T ss_pred CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHH
Confidence 12211 1111100 00000 00000000 0001123345789999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.+||..||.+|+ ++.++++||||....+
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 231 EGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 999999999999 9999999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=173.40 Aligned_cols=105 Identities=32% Similarity=0.495 Sum_probs=93.5
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
||.|+||.||++.+..+++.||+|++.+.. ..+..|+.+++.++||||+++++.+ ....++|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999998899999999986432 3567899999999999999999998 6667799999999
Q ss_pred h-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+ ++|.+++.. ...+++..++.++.||+.||.|||+.+
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~ 113 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG 113 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6 499999876 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=184.12 Aligned_cols=118 Identities=20% Similarity=0.230 Sum_probs=97.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... ..+.+|+.+++.+ +|+|||++++++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence 457999999999999999999865443 579999996432 3467899999999 899999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh-----------------------------------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~----------------------------------------------------- 175 (335)
.....+|+|||||.+ +|.+++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 555568999999995 99999865321
Q ss_pred -------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 176 -------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 176 -------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++++..++.|+.||+.||.|||+++
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g 232 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN 232 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 0134788999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=170.79 Aligned_cols=101 Identities=20% Similarity=0.151 Sum_probs=87.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHH
Q 019844 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR 171 (335)
Q Consensus 93 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~ 171 (335)
|.||.||+|+++.+++.||+|.+.+.. ...+|...+....||||+++++++ ....++|+||||++| +|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999997643 344566666667899999999998 555668999999996 9999887
Q ss_pred HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 172 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. ...+++..+..++.|++.||+|||+++
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~~~ 105 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHREG 105 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6 456999999999999999999999988
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=175.38 Aligned_cols=112 Identities=24% Similarity=0.398 Sum_probs=95.9
Q ss_pred eeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc--------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
+|.+.+.||+|+||.||+|.+. .+++.||||.+++. ...+.+|+.++..+ +||||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3889999999999999999864 46788999998642 13456899999999 699999999998 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+||||++| +|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~ 125 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG 125 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 55668999999996 99888875 466999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-23 Score=183.45 Aligned_cols=174 Identities=18% Similarity=0.319 Sum_probs=133.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecch-hh
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET 165 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~ 165 (335)
++-||.|+-|.||+|+.+ ++.||||+++. ....+|.-|++|+||||+.|.+++ ....++|||||||. |-
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 678999999999999985 88999998743 234688999999999999999999 77778999999999 79
Q ss_pred HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------cChHHhHhhhcCC
Q 019844 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------------VDQLVEIIKVLGT 216 (335)
Q Consensus 166 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------~~~~~~~~~~~g~ 216 (335)
|+.+|+. +..++......|..+|+.||.|||.+. .......+.++||
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 9999997 778999999999999999999999887 0111112233444
Q ss_pred CCHHHhhhhCCCCCC------------------------CCCCCC---------CCCccccccccCCChHHHHHHHHhcc
Q 019844 217 PTREEIKCMNPNYTE------------------------FKFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQ 263 (335)
Q Consensus 217 ~~~~~~~~~~~~~~~------------------------~~~~~~---------~~~~~~~~~~~~~s~~~~~li~~~L~ 263 (335)
-. +|.|+... ..+..+ ....+....|..+++-++-||+.||+
T Consensus 275 Va-----WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 275 VA-----WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred Hh-----hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 33 22221110 011111 11223345667899999999999999
Q ss_pred CCCCCCCCHHHHhcCc
Q 019844 264 YSPNLRCTALEACVHP 279 (335)
Q Consensus 264 ~dP~~R~t~~~~L~hp 279 (335)
..|..||++.++|.|-
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 9999999999999985
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=172.62 Aligned_cols=108 Identities=23% Similarity=0.329 Sum_probs=93.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
+.||+|+||.||+|.++.+++.||+|.+... ...+.+|+.+++.++||||+++++++ .....+|+||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 4699999999999999999999999987542 24577899999999999999999998 4455689999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.| +|.+++... ...+++..++.++.|++.||.|||+++
T Consensus 76 ~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~ 114 (252)
T cd05084 76 QGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH 114 (252)
T ss_pred cCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 86 999888642 346899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=183.88 Aligned_cols=89 Identities=24% Similarity=0.284 Sum_probs=73.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCC-----CcEEEEEEeccc-----chhHHHHHHHHHhCC-CCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~ 148 (335)
..++|+++++||+|+||.||+|.+... +..||||++... ...+.+|+.+|+.++ |||||++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 345799999999999999999987533 346999999643 235678999999996 99999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHH
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNY 173 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~ 173 (335)
.....+|||||||+| +|.+++...
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~ 135 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKN 135 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHh
Confidence 555669999999995 999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=171.16 Aligned_cols=113 Identities=22% Similarity=0.328 Sum_probs=96.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
++|++.+.||+|+||.||++..+ .+..+|+|.+... ...+.+|+.+++.++||||+++++++ .....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence 35899999999999999999885 4567999988643 24577899999999999999999998 445568999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05114 78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS 120 (256)
T ss_pred EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999985 999888752 245899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=174.65 Aligned_cols=112 Identities=29% Similarity=0.410 Sum_probs=92.6
Q ss_pred EEeeeeeccCceEEEEEEEc----CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 85 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.+.+.||.|+||.||+|... ..+..|+||.++.. ...+.+|+++++.++||||+++++++.. ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----cccc
Confidence 46789999999999999997 45678999999532 3567899999999999999999999962 2228
Q ss_pred EEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||||+ |+|.+++.... ...+++..+..|+.||+.||.|||+++
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~ 123 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN 123 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence 89999999 59999999731 357999999999999999999999988
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=177.83 Aligned_cols=198 Identities=23% Similarity=0.303 Sum_probs=137.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..|...+.||+|+||.||+|+++.++..+|+|.+... ...+.+|+.+++.++|+||+++++++. ....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCe
Confidence 3488899999999999999999999999999998532 134568999999999999999999984 4455
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC------------h-HHhHhhh--------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD------------Q-LVEIIKV-------- 213 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~------------~-~~~~~~~-------- 213 (335)
.++||||+.|+|.+++... ...+++..+..++.|++.||.|||+.++- . ....+..
T Consensus 90 ~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 8899999999887776542 35689999999999999999999998800 0 0000001
Q ss_pred -----cCCC---CHHHhhhhCC-CC----CCC--------------CCCCCCC---------CccccccccCCChHHHHH
Q 019844 214 -----LGTP---TREEIKCMNP-NY----TEF--------------KFPQIKP---------HPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 -----~g~~---~~~~~~~~~~-~~----~~~--------------~~~~~~~---------~~~~~~~~~~~s~~~~~l 257 (335)
.|++ +++.+..... .+ .-| .+..... ..........++..+.+|
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 1111 1221110000 00 000 0000000 000011123578889999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
|.+||+.+|.+||++.++++|||+.....+
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 999999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=180.49 Aligned_cols=198 Identities=25% Similarity=0.328 Sum_probs=146.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+.|..-++||+|+||.||-|+-+.||+.||+|.+.+. ..-...|-.+|..++.+.||.+-.+| +....
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCCc
Confidence 4588899999999999999999999999999988532 13356899999999999999999999 66666
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------cChHH-----
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------VDQLV----- 208 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------~~~~~----- 208 (335)
+|+||..|.| ||.-.|.+.. ...|+|..+.+|+.+|+.||++||..+ +..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999996 9987777644 458999999999999999999999988 11111
Q ss_pred ----hHhhhcCCCC---HHHhhhhCCCCCC---------C-------CCCCCCCC-cc----------ccccccCCChHH
Q 019844 209 ----EIIKVLGTPT---REEIKCMNPNYTE---------F-------KFPQIKPH-PW----------HKVFQKRLPPEA 254 (335)
Q Consensus 209 ----~~~~~~g~~~---~~~~~~~~~~~~~---------~-------~~~~~~~~-~~----------~~~~~~~~s~~~ 254 (335)
.+...+||.. ++.+......|.. | .|...+.. .+ ...++..+|+++
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 1111234443 3333222111110 0 01111110 11 123567899999
Q ss_pred HHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 255 VDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
++|++.+|+.||++|.. +.++.+||||+.+++
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 99999999999999995 679999999999877
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=172.60 Aligned_cols=117 Identities=23% Similarity=0.290 Sum_probs=97.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+|.+.+.||.|+||.||+|+.+. +.+.+|+|.+.... ..+.+|+.+++.++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 469999999999999999999754 34679999885432 3477899999999999999999998 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+.|+||||+++ +|.+++....... ..+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~ 137 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR 137 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC
Confidence 5668999999995 9999997632111 16899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-21 Score=166.32 Aligned_cols=113 Identities=24% Similarity=0.402 Sum_probs=99.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
+|.+.+.||+|++|.||++.+..+++.+++|++.... ..+.+|+.+++.++|+||+++++++ ......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 3889999999999999999999899999999986543 4677999999999999999999998 444558899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||++| +|.+++... ...+++..+..++.|++.||.|||.++
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~ 118 (253)
T cd05122 76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118 (253)
T ss_pred EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 999995 999988762 257999999999999999999999988
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=171.78 Aligned_cols=114 Identities=22% Similarity=0.306 Sum_probs=97.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
++|++.+.||+|+||.||+|..+.+ ...||+|.+.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4599999999999999999998654 4579999886432 3466899999999999999999998 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||+++ +|.+++... .+.+++..+..++.|++.||.|||+++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 126 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN 126 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 58999999986 999998752 346899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=182.15 Aligned_cols=90 Identities=23% Similarity=0.300 Sum_probs=74.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCC-CCceeeeceeeeeC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFST 147 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~ 147 (335)
...++|.+++.||+|+||.||+|+++ .+++.||+|++.... ..+.+|+.+|..+. |||||++++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~--- 110 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC--- 110 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE---
Confidence 44457999999999999999999964 355789999996432 34678999999997 99999999999
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHH
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNY 173 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~ 173 (335)
.....+++|||||.| +|.+++...
T Consensus 111 --~~~~~~~iv~E~~~~g~L~~~l~~~ 135 (401)
T cd05107 111 --TKGGPIYIITEYCRYGDLVDYLHRN 135 (401)
T ss_pred --ccCCCcEEEEeccCCCcHHHHHHhc
Confidence 444558999999995 999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=169.12 Aligned_cols=113 Identities=24% Similarity=0.365 Sum_probs=98.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.+|++.+.||.|+||.||+|... |+.||+|.+.... +.+.+|+.+++.++|+||+++++++ ......|+|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeEEE
Confidence 45999999999999999999874 8899999997553 3677899999999999999999998 444558899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+++ +|.+++.... ...+++..++.++.|++.||.|||+++
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999995 9999987632 236899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=183.17 Aligned_cols=118 Identities=20% Similarity=0.359 Sum_probs=102.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
....+.....+||-|.||.||.|.+++....||||.++.+. ..+..|..+|+.++|||+|+++++| ..+.-+
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPF 338 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPF 338 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCe
Confidence 33445667899999999999999999999999999997653 6788999999999999999999999 444458
Q ss_pred EEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+|||. |+|.++|++.. +..++.-...+++.||..||+||..++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn 385 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN 385 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh
Confidence 99999998 79999999865 455777788899999999999999887
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=169.93 Aligned_cols=116 Identities=31% Similarity=0.502 Sum_probs=97.7
Q ss_pred eeeEEeeeeeccCceEEEEEEE----cCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|++.+.||+|+||.||+|.. ..+++.||+|.+.... +.+.+|+.+++.++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 3599999999999999999984 4578899999986432 3567899999999999999999987532 334
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~ 128 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR 128 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 58899999985 999998752 345899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=169.74 Aligned_cols=115 Identities=21% Similarity=0.286 Sum_probs=98.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++.++||+|+||.||+|.+. ++..||+|.+... .+.+.+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 456999999999999999999974 6678999988643 34677899999999999999999998 45556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||+.| +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 79 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~ 123 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN 123 (261)
T ss_pred EEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999985 9999887532 456889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=180.20 Aligned_cols=185 Identities=26% Similarity=0.435 Sum_probs=132.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCC--C--cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRET--G--EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~--~--~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...+.+.||.|.||.||+|.+... | --||||..+.+ .+.+..|..+|+.++|||||+++|++.. .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence 445578999999999999997543 2 24899988753 3568899999999999999999999832 2
Q ss_pred EEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cChHHhH------------hhhcCCCC-
Q 019844 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-VDQLVEI------------IKVLGTPT- 218 (335)
Q Consensus 154 ~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~~~~~~~------------~~~~g~~~- 218 (335)
-+|||||+++ |.|..++..+ ...++......|++||+.||.|||+.+ ++..... ...+|...
T Consensus 464 P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 2889999999 8999999874 467999999999999999999999998 1111110 01112111
Q ss_pred ------------HHHhhhhCCCCCCCCCCCCCCCcc---------------------------------ccccccCCChH
Q 019844 219 ------------REEIKCMNPNYTEFKFPQIKPHPW---------------------------------HKVFQKRLPPE 253 (335)
Q Consensus 219 ------------~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~s~~ 253 (335)
...+.++.|+-..|.......+.| +.+.|+.|++.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChH
Confidence 122445555433322111111111 13467899999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHh
Q 019844 254 AVDLVCRFFQYSPNLRCTALEAC 276 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L 276 (335)
++.|+.+||.+||.+||++.++.
T Consensus 621 LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHH
Confidence 99999999999999999976543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=173.76 Aligned_cols=117 Identities=25% Similarity=0.410 Sum_probs=97.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcE--EEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
++|.+.+.||+|+||.||+|.++.++.. +|+|.+... ...+.+|+.++.++ +||||+++++++ ....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 4699999999999999999999877764 577776532 23567899999999 899999999998 5556
Q ss_pred EEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|+||||+++ +|.+++..... ....+++..++.++.||+.||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999985 99999875321 1235899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=168.43 Aligned_cols=113 Identities=24% Similarity=0.290 Sum_probs=96.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.+|++++.||+|+||.||++.+. .+..+|+|.+... ...+.+|+.+++.++||||+++++++ .....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 35999999999999999999875 3456999988643 24577899999999999999999998 444558899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05113 78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ 120 (256)
T ss_pred EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999985 999988753 236899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=171.19 Aligned_cols=118 Identities=20% Similarity=0.238 Sum_probs=98.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS-----F 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----c
Confidence 3469999999999999999999987 77889999886332 3467899999999999999999988 3
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....++||||+.| +|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 136 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH 136 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44457899999985 99999976421 1125899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=169.25 Aligned_cols=114 Identities=25% Similarity=0.382 Sum_probs=97.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|++.+.||+|+||.||+|.++.++. .+|+|.+... ...+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 469999999999999999999865543 7999988642 24567899999999999999999998 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|+||||++| +|.+++... ...+++..+..++.|++.||.|||+++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG 126 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 68999999986 999998752 346899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=172.67 Aligned_cols=117 Identities=22% Similarity=0.285 Sum_probs=97.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
..++|.+.+.||+|+||.||+|.+ ..++..+|+|.++... ..+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC---- 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE----
Confidence 345799999999999999999986 3355689999886432 3467899999999 799999999998
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 109 -~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 109 -TIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred -ecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 444558999999995 9999887522 234899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=171.84 Aligned_cols=118 Identities=19% Similarity=0.191 Sum_probs=97.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|.+.+.||+|+||.||+|.++..+ ..||+|.+.... ..+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 457999999999999999999986443 789999986432 3467899999999999999999998 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+.|+||||+++ +|.+++...... ...+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 139 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK 139 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45668999999984 999998753211 234788899999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=170.62 Aligned_cols=118 Identities=19% Similarity=0.239 Sum_probs=96.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|++.+.||+|+||.||+|.++ .++..||+|.+.... ..+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~ 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence 456999999999999999999874 245679999885422 3466899999999999999999998 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....++||||+++ +|.+++...... ...++...+..++.|++.||.|||+.+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 139 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 55568899999995 999998753211 123577889999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=171.69 Aligned_cols=118 Identities=22% Similarity=0.352 Sum_probs=98.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
..+|++.+.||+|+||.||++..+... ..+|+|.+.... ..+.+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence 346999999999999999999986443 789999886432 3467899999999 899999999998
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....++++|||+.+ +|..++.... .....+++..+..++.||+.||.|||+++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 152 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445558999999985 9999987531 12456899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=169.72 Aligned_cols=108 Identities=12% Similarity=0.226 Sum_probs=91.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
..||+|++|.||+|.+ +|+.||||.+.... +.+.+|+.+|++++|||||++++++.... ....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 6799999999999998 68999999986431 34569999999999999999999985421 22346889999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
||+| +|.+++.. .+.+++.....++.|++.||.|||+.
T Consensus 103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 9996 99999976 56789999999999999999999974
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=172.93 Aligned_cols=115 Identities=20% Similarity=0.311 Sum_probs=100.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+|+++++||.|+||.||+|.++. ++.+|+|.+.... ..+.+|+.+++.++||||+++++++ .....++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 3459999999999999999999976 8999999986433 4567899999999999999999998 4555689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~ 124 (261)
T cd05148 79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN 124 (261)
T ss_pred EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999996 9999997532 456899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=175.99 Aligned_cols=198 Identities=23% Similarity=0.324 Sum_probs=148.4
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.....+|..+.+||+|+||+|.+|..+.+.+.||||+++++. +....|-++|... +-|.+++++.+|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF----- 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF----- 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----
Confidence 455567999999999999999999999999999999997653 3345788888777 578999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------- 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------- 203 (335)
+.-..+|+||||+.| ||.-.+.+ .+.+.|..+.+|+.+|+-||-|||++|
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 555559999999996 99888887 677999999999999999999999999
Q ss_pred -----cChHHhHhhhcCCCCHHHhhhhCCCCCCCC------------------CCCCCCCc----------cccccccCC
Q 019844 204 -----VDQLVEIIKVLGTPTREEIKCMNPNYTEFK------------------FPQIKPHP----------WHKVFQKRL 250 (335)
Q Consensus 204 -----~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~------------------~~~~~~~~----------~~~~~~~~~ 250 (335)
+.......++||||.|...... .|.+|. -+...... -...+|..+
T Consensus 496 mcKEni~~~~TTkTFCGTPdYiAPEIi--~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKsl 573 (683)
T KOG0696|consen 496 MCKENIFDGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSL 573 (683)
T ss_pred cccccccCCcceeeecCCCcccccceE--EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccc
Confidence 1111122245676663221111 011110 00000000 012367889
Q ss_pred ChHHHHHHHHhccCCCCCCCCH-----HHHhcCcccccCCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD 286 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~-----~~~L~hp~f~~~~~ 286 (335)
|.++.+++..+|...|.+|..+ .++-.||||+.+.|
T Consensus 574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 9999999999999999999964 68999999999887
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=179.27 Aligned_cols=119 Identities=20% Similarity=0.300 Sum_probs=96.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++.+.||+|+||.||+|.+ ..+++.||||.++... ..+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 35799999999999999999985 3467899999996422 3467899999999 68999999998842
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh-----------------------------------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~----------------------------------------------------- 175 (335)
....+++|||||++ +|.+++.....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 23457899999995 99999865210
Q ss_pred ----------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 176 ----------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 176 ----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++..+..++.||+.||.|||+++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 199 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK 199 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 0124788888999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=168.48 Aligned_cols=112 Identities=24% Similarity=0.331 Sum_probs=96.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+|++.+.||+|+||.||+|.++ ++..+|+|.+.+. ...+.+|+.+++.++||||+++++++ ....+.|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5899999999999999999985 5678999998643 23567899999999999999999998 5555689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 120 (256)
T cd05059 79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG 120 (256)
T ss_pred ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99986 999988752 246899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=176.89 Aligned_cols=111 Identities=16% Similarity=0.254 Sum_probs=96.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.....++..||+|.||+||+|++. -.||||++..+ .+.++.|+.++++-+|.||+-+.|++ .+..+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~ 462 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL 462 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce
Confidence 345778999999999999999984 45999999643 36688999999999999999999999 55554
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.||+.+|+| +|+.+++... ..|.......|++||+.||.|||.++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~ 508 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN 508 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh
Confidence 799999999 9999998643 45899999999999999999999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=171.79 Aligned_cols=117 Identities=21% Similarity=0.313 Sum_probs=97.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCC-----cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ..+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 35999999999999999999986555 679999986432 3467899999999999999999998 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....|++|||+++ +|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~ 144 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4558899999995 99999976321 0145889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=172.11 Aligned_cols=116 Identities=18% Similarity=0.302 Sum_probs=96.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++.+.||+|+||.||+|.+..+++.||||.+.+.. ..+.+|+.++..+ +||||+++++++ ....
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCC
Confidence 3456999999999999999999999889999999986432 2345677767666 599999999999 5555
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
.+|++|||+.++|.+++... ...+++..+..++.||+.||.|||+. +
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 69999999998887777653 34789999999999999999999974 5
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-21 Score=169.12 Aligned_cols=114 Identities=25% Similarity=0.388 Sum_probs=96.3
Q ss_pred eEEeeeeeccCceEEEEEEE----cCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
|++++.||+|+||.||+|.+ +.+++.||+|.+... ...+.+|+.+++.++||||+++++++.. .+...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGNG 82 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCCc
Confidence 78999999999999999984 457889999998633 2457789999999999999999998843 22355
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||++| +|.+++... ...+++..+..++.||+.||+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g 129 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ 129 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999986 999988652 235899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=170.97 Aligned_cols=118 Identities=23% Similarity=0.354 Sum_probs=98.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ..+.+|+.+++.++||||+++++++ ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 456999999999999999999863 345679999986432 3577899999999999999999998 45
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+||||+++ +|.+++..... ....+++..++.++.||+.||+|||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5568999999995 99999875321 1235899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=189.83 Aligned_cols=119 Identities=19% Similarity=0.325 Sum_probs=99.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCc-----EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
.....++...||+|+||.||.|....... .||+|.+++. ...+.+|..+|+.++|||||+++|++++...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34568889999999999999999864333 3999998753 3557899999999999999999999975333
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|++|||.| ||..+|++.+.. ...++..+...++.||+.|++||++++
T Consensus 770 -----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~ 822 (1025)
T KOG1095|consen 770 -----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH 822 (1025)
T ss_pred -----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC
Confidence 7799999995 999999974211 345899999999999999999999988
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=171.48 Aligned_cols=117 Identities=20% Similarity=0.293 Sum_probs=97.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCC----------------cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeee
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~----------------~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~ 140 (335)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 46999999999999999999876544 46899998643 2456789999999999999999
Q ss_pred ceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++ ....+++++|||+.+ +|.+++..... ....+++..++.++.|++.||.|||+++
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~ 150 (296)
T cd05051 85 LGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN 150 (296)
T ss_pred EEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 9998 444568999999985 99999876321 1126899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=167.64 Aligned_cols=115 Identities=20% Similarity=0.267 Sum_probs=97.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|+++++||+|+||.||+|..+ +++.||+|.+.... ..+.+|+.+++.++||||+++++++. . ..+|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcE
Confidence 3456999999999999999999874 67889999986533 45778999999999999999999862 2 2378
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~ 122 (260)
T cd05067 77 IITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN 122 (260)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999985 9999886532 356899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=195.69 Aligned_cols=200 Identities=22% Similarity=0.373 Sum_probs=147.7
Q ss_pred CccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 77 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
......+|..+..||.|.||.||-|.+..+|+..|+|.|.- ..+.+.+|..++..|+|||+|++|++-...+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 33566689999999999999999999999999999999852 2355679999999999999999999985433
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-------------------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------------------- 204 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------------------- 204 (335)
.++|.||||.| +|.+++.. .+-.+|...+.|..|++.|+.|||++|+
T Consensus 1308 ---kv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1308 ---KVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred ---HHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccc
Confidence 38899999995 99999986 5567888889999999999999999990
Q ss_pred ---------ChHHhHhhhcCCCCHHHhhhhCCCC--C---C---CCCC------CCCCCccc-----------------c
Q 019844 205 ---------DQLVEIIKVLGTPTREEIKCMNPNY--T---E---FKFP------QIKPHPWH-----------------K 244 (335)
Q Consensus 205 ---------~~~~~~~~~~g~~~~~~~~~~~~~~--~---~---~~~~------~~~~~~~~-----------------~ 244 (335)
+--......+|||.|.......-.- . + +.+. .....||. +
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 0001122334554422211110000 0 0 0000 00122333 3
Q ss_pred ccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 245 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
.+|..+|.+.+|||.+||+.||++|.++.|+|.|.|-+...
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 46678999999999999999999999999999999977653
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=166.94 Aligned_cols=111 Identities=28% Similarity=0.441 Sum_probs=95.2
Q ss_pred eeeeccCceEEEEEEEcCC---CcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.+... +..||+|.+... ...+.+|+.+++.++|+||+++++++ .....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence 4699999999999999866 889999999643 24577899999999999999999999 4456689999
Q ss_pred ecchh-hHHHHHHHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++| +|.+++...... ...+++..++.++.||+.||+|||+++
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~ 125 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 99975 999998873211 267999999999999999999999988
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=172.56 Aligned_cols=117 Identities=21% Similarity=0.288 Sum_probs=95.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCC--------------cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeece
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKH 142 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~--------------~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~ 142 (335)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+|+++++.++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 46999999999999999999875432 359999986432 34678999999999999999999
Q ss_pred eeeeCCCCCccEEEEEeecchh-hHHHHHHHHhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 143 ~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++ .....+|+||||+++ +|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 99 445568999999996 99998864210 0124688899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=170.96 Aligned_cols=117 Identities=23% Similarity=0.376 Sum_probs=98.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+|.+.+.||+|+||.||+|.+.. +++.||+|.+... ...+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----TE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----ec
Confidence 459999999999999999998753 4678999998643 24577899999999999999999999 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhh----------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSR----------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....|+||||++| +|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 142 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 4568999999996 99999976321 1245889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=166.91 Aligned_cols=113 Identities=24% Similarity=0.394 Sum_probs=97.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+|++.+.||+|+||.||+|.++.+++ .||||.+... ...+..|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 48999999999999999999987665 5999998642 23577899999999999999999998 55556
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||+++ +|.+++... .+.+++..++.++.|++.||.|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g 126 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN 126 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999996 999888752 356899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=170.18 Aligned_cols=117 Identities=20% Similarity=0.289 Sum_probs=96.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEc----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
++|++.+.||+|+||.||+|... .++..||+|.+.... ..+.+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 45899999999999999999853 456789999986422 3567899999999999999999998 444
Q ss_pred cEEEEEeecchh-hHHHHHHHHhh-------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSR-------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...|+||||+++ +|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 144 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF 144 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC
Confidence 558999999995 99998863210 1234788999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=176.06 Aligned_cols=112 Identities=19% Similarity=0.307 Sum_probs=102.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
-|..++.||-|+||+|.+++...|...||.|.+++.. ..++.|..||...+++.||+||..| +++.++
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 5889999999999999999999999999999986532 3456899999999999999999999 888889
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| |+..+|-. .+-|.|..+++|+.+|.+|+++.|..|
T Consensus 705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG 749 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG 749 (1034)
T ss_pred EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 999999996 99999887 678999999999999999999999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=175.51 Aligned_cols=119 Identities=21% Similarity=0.299 Sum_probs=96.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++.+.||+|+||.||+|.+. .+++.||+|++... .+.+.+|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 457999999999999999999754 34578999998632 13466899999999 89999999998852
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh-----------------------------------------------------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~----------------------------------------------------- 175 (335)
....++++|||++| +|.+++.....
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 33458899999996 99998864221
Q ss_pred ----hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 176 ----IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 176 ----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++..+..++.||+.||.|||+++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ 193 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK 193 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 0236899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=173.16 Aligned_cols=117 Identities=22% Similarity=0.261 Sum_probs=96.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
....+..+.++||+|.||.|.+|.-. .+..||+|.++.+. ..+.+||.+|.+|+|||||++++++..++.
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP---- 609 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP---- 609 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc----
Confidence 34456889999999999999999973 46899999997532 568899999999999999999999954433
Q ss_pred EEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+|||||+ |||.+++..+.. ..+.-.....|+.||+.||+||.+.+
T Consensus 610 -icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n 657 (807)
T KOG1094|consen 610 -LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN 657 (807)
T ss_pred -hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc
Confidence 889999999 799999987421 22344455679999999999999887
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=167.50 Aligned_cols=120 Identities=19% Similarity=0.307 Sum_probs=96.8
Q ss_pred eEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCcc
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL 153 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~ 153 (335)
|.+++.||+|+||.||+|....+ +..||+|.+.... ..+.+|+.+++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56889999999999999997653 4789999986432 356789999999999999999998854332 2334
Q ss_pred EEEEEeecchh-hHHHHHHHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.+++|||+.+ +|..++..... ....+++..+..++.|++.||.|||+++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~ 133 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999995 99988865321 1246899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-23 Score=168.84 Aligned_cols=199 Identities=26% Similarity=0.420 Sum_probs=153.2
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.+--+.||-|+||+||.+.+.++|+.||+|++.. ..+++.+|+.+|.-++|.||...++............+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3345679999999999999999999999999863 3467789999999999999999998874433333334789
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------------- 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------- 203 (335)
++|+|..||..++-. .+.++...++.+++||++||+|||+.+
T Consensus 135 ~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999999999999886 788999999999999999999999987
Q ss_pred -----------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCCCCC
Q 019844 204 -----------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNPNYT 230 (335)
Q Consensus 204 -----------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~~~~ 230 (335)
+.++..+++++|||.-+.+.....+..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 667888889999999887764322211
Q ss_pred CCCCC-CCCCCcccccc----ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 231 EFKFP-QIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 231 ~~~~~-~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
..-+. ..+...+...+ +..-..+..+++.+||.+||++|++..+++.|++..+.+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 11000 00111111111 1234567889999999999999999999999999877654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=168.27 Aligned_cols=113 Identities=32% Similarity=0.521 Sum_probs=95.0
Q ss_pred ee-EEeeeeeccCceEEEEEEE----cCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SY-IAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y-~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+| ++.+.||+|+||+||++.. ..++..||+|.+... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 45 8999999999999988653 357889999998643 2346789999999999999999998743 234
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||+.+ +|.+++.. ..+++.+++.++.|++.||.|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~ 127 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH 127 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 468899999996 99988864 45999999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=170.01 Aligned_cols=119 Identities=21% Similarity=0.339 Sum_probs=97.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcC-------CCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeee
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS 146 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 146 (335)
..++|.+++.||+|+||.||+|.+.. +...+|+|.+..+. ..+.+|+.+++.+ +||||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 34579999999999999999998743 23569999987432 3466899999999 799999999999
Q ss_pred CCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||+++ +|.+++..... ....+++..+..++.||+.||+|||+++
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g 160 (307)
T cd05098 94 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160 (307)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445568999999995 99999976321 1135888999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=164.62 Aligned_cols=114 Identities=24% Similarity=0.348 Sum_probs=96.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
.+|++.+.||+|+||.||++... +..+|+|.+.... +.+.+|+.+++.++|+||++++++++ .....+|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEEE
Confidence 46999999999999999999874 7889999986543 45779999999999999999999764 2334588999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+++ +|.+++.... ...+++..+..++.||+.||+|||+++
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (256)
T cd05082 80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN 122 (256)
T ss_pred ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99995 9999987532 335889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-21 Score=164.53 Aligned_cols=116 Identities=24% Similarity=0.306 Sum_probs=99.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|.+.+.||.|+||.||+|.+. .++.+|||.+... ...+.+|+.+++.++|+||+++++++ .....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 3457999999999999999999985 5578999998643 34678999999999999999999998 4445589
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 78 ~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~ 123 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN 123 (261)
T ss_pred EEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999986 9999987532 346899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-22 Score=181.28 Aligned_cols=192 Identities=25% Similarity=0.362 Sum_probs=136.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
..+.|.+...+|.|+|+.|..|.+..+++.+|+|+|.+......+|+.++... +||||+++++++ .+..++|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 46679999999999999999999999999999999988777788899777666 799999999999 777889999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-Ch-------HH------hHhhhcCCCCHHHhh
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-DQ-------LV------EIIKVLGTPTREEIK 223 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~-------~~------~~~~~~g~~~~~~~~ 223 (335)
||++.| -|.+-+.. ...+. .++..|++||+.|+.|||++|+ .. +. ..+..+|......-.
T Consensus 395 ~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999996 44333332 22233 7888999999999999999991 00 00 011112221111111
Q ss_pred hhC----CCCCCCCCCCC----CCCccc-------------------------------cccccCCChHHHHHHHHhccC
Q 019844 224 CMN----PNYTEFKFPQI----KPHPWH-------------------------------KVFQKRLPPEAVDLVCRFFQY 264 (335)
Q Consensus 224 ~~~----~~~~~~~~~~~----~~~~~~-------------------------------~~~~~~~s~~~~~li~~~L~~ 264 (335)
+.. -.|.+...... ...+|. ..+...+|++++|||++||+.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~ 549 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQV 549 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccC
Confidence 111 12221111100 011111 112357899999999999999
Q ss_pred CCCCCCCHHHHhcCccc
Q 019844 265 SPNLRCTALEACVHPFF 281 (335)
Q Consensus 265 dP~~R~t~~~~L~hp~f 281 (335)
||.+|+++.+++.||||
T Consensus 550 dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 550 DPALRLGADEIGAHPWF 566 (612)
T ss_pred ChhhCcChhhhccCcch
Confidence 99999999999999999
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=169.31 Aligned_cols=107 Identities=16% Similarity=0.201 Sum_probs=87.5
Q ss_pred eeeccCceEEEEEEEcCC------------------------CcEEEEEEecccc----hhHHHHHHHHHhCCCCceeee
Q 019844 89 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL 140 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~~~------------------------~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~ 140 (335)
.||+|+||.||+|....+ ...||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975322 2358899886432 346688999999999999999
Q ss_pred ceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++. ...+.++||||+++ +|..++... .+.+++..+..++.||+.||+|||+++
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 99984 44458899999996 888887642 456899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=165.54 Aligned_cols=115 Identities=21% Similarity=0.243 Sum_probs=98.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..+|++.+.||+|+||.||+|.+. +++.||+|.+... .+.+.+|+.++++++||||+++++++ .....+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence 346999999999999999999974 5578999998653 24577899999999999999999998 44555899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++| +|.+++.... ...+++..+..++.|++.||.|||+++
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 123 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN 123 (261)
T ss_pred eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999974 9999987532 346899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=169.80 Aligned_cols=118 Identities=25% Similarity=0.321 Sum_probs=97.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 3469999999999999999999753 6788999998643 24577899999999999999999998 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+||||+++ +|.+++..... ....+++..++.++.||+.||.|||.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~ 150 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK 150 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 44558899999995 99999875211 1124788899999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=171.34 Aligned_cols=113 Identities=21% Similarity=0.383 Sum_probs=94.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcE----EEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|++.+.||+|+||.||+|++..++.. ||+|.+... ...+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 4699999999999999999998766654 899998632 2456789999999999999999999842 2
Q ss_pred cEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+||+. |+|.+++... ...+++..+..++.||+.||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ 129 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR 129 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 2568999998 5999988752 345889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=165.16 Aligned_cols=114 Identities=23% Similarity=0.284 Sum_probs=96.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+... ...+.+|+.+++.++|+||+++++++ .. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-----SE-EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-----CC-CCcEE
Confidence 356999999999999999999875 6677999998642 24577999999999999999999987 22 23679
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||+++ +|.+++.... ...+++..++.++.|++.||.|||+++
T Consensus 78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN 122 (260)
T ss_pred EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999986 9999887532 345899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=168.66 Aligned_cols=117 Identities=24% Similarity=0.362 Sum_probs=96.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc--EEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
++|++.+.||+|+||.||+|.++.++. .+|+|.++.. .+.+.+|+.+++++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 469999999999999999999877765 4688887631 23567899999999 799999999998 5555
Q ss_pred EEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||+++ +|.+++..... ....+++..++.++.||+.||+|||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 68999999985 99999875321 1135889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=162.63 Aligned_cols=112 Identities=22% Similarity=0.347 Sum_probs=96.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+|++.+.||.|+||.||++.+. .+..+|+|.+... ...+.+|+.+++.++||||+++++++ .....+|+||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 5999999999999999999885 4778999988643 24577899999999999999999998 4555689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.| +|.+++... ...+++..++.++.|++.||+|||+.+
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~ 120 (256)
T cd05112 79 EFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN 120 (256)
T ss_pred EcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99996 998888652 345899999999999999999999888
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=166.38 Aligned_cols=119 Identities=17% Similarity=0.197 Sum_probs=98.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC----CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4579999999999999999999875 3578999988643 23467899999999999999999987532
Q ss_pred ccEEEEEeecch-hhHHHHHHHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVP-ETVNRIARNYSRIH----QRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~-g~L~~~l~~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++++||++ |+|.+++....... ..+++..++.++.||+.||.|||+++
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 137 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG 137 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 334779999998 49999987643211 46899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=162.34 Aligned_cols=200 Identities=21% Similarity=0.353 Sum_probs=148.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
....+|.++.+||+|+|++|.+++++.|.+.||+|+++++. ..++.|-.+..+. +||.+|.++.+| +
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----q 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----Q 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----c
Confidence 34457999999999999999999999999999999997532 4467788888777 799999999999 6
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------------------- 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------- 203 (335)
.+..+++|.||++| +|.-.+.. ...++|+.+++|..+|+.||.|||+.|
T Consensus 322 tesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred ccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 77779999999996 98777776 567999999999999999999999999
Q ss_pred ----cChHHhHhhhcCCCCHHHhhhh-CCCCC--------------------CCC---CCCCC--CCc--c------ccc
Q 019844 204 ----VDQLVEIIKVLGTPTREEIKCM-NPNYT--------------------EFK---FPQIK--PHP--W------HKV 245 (335)
Q Consensus 204 ----~~~~~~~~~~~g~~~~~~~~~~-~~~~~--------------------~~~---~~~~~--~~~--~------~~~ 245 (335)
+.......++||||.+...... ...|. +|. ..+.. ... + ...
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 1111122345677663221111 00010 110 00000 000 0 112
Q ss_pred cccCCChHHHHHHHHhccCCCCCCCC------HHHHhcCcccccCCCC
Q 019844 246 FQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRDP 287 (335)
Q Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t------~~~~L~hp~f~~~~~~ 287 (335)
+|..+|-.+..+++..|.+||.+|.. +.++..|+||+.+.|.
T Consensus 478 iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 46778889999999999999999985 6899999999988763
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=164.77 Aligned_cols=106 Identities=28% Similarity=0.384 Sum_probs=90.5
Q ss_pred eeeeccCceEEEEEEEcCCC---cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
++||+|+||.||+|.+..++ ..+|+|.+.... +.+.+|+.+++.++||||+++++++ .. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----cC-CceEEEE
Confidence 47999999999999876655 789999986433 3567899999999999999999987 22 2368999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.+ +|.+++.. ...+++..+..++.|++.||.|||..+
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~ 115 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH 115 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 99985 99999876 457999999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=164.71 Aligned_cols=114 Identities=21% Similarity=0.314 Sum_probs=97.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|+..+.||+|+||.||+|.++.++. .+|+|.+... ...+..|+.+++.++||||+++++++ ....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 368999999999999999999876665 7999998643 23467899999999999999999999 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.|+||||+++ +|.+++... .+.+++..+..++.|++.||+|||+.+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~ 127 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN 127 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 68899999996 998888652 356899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=164.88 Aligned_cols=114 Identities=25% Similarity=0.290 Sum_probs=95.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..+|++.++||+|+||.||+|.+..+ ..||+|.+.+. ...+.+|+.+++.++||||+++++++ .. .+.|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CCcEE
Confidence 34699999999999999999998655 45999998753 24577899999999999999999876 22 23679
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+++ +|.+++.... ...+++..+..++.|++.||.|||+++
T Consensus 78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN 122 (262)
T ss_pred EEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999995 9999987532 345889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=165.96 Aligned_cols=116 Identities=28% Similarity=0.431 Sum_probs=97.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEc----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..|++.+.||+|+||.||+|... .+++.||||.+.... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 35888999999999999999864 348899999997443 357899999999999999999998733 224
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+.++||||+++ +|.+++... ...+++..+..++.||+.||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~ 129 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR 129 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568899999985 999998753 235899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=168.32 Aligned_cols=117 Identities=21% Similarity=0.282 Sum_probs=95.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcC----------------CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeee
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL 140 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~ 140 (335)
.+|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ..+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986532 34579999986432 356789999999999999999
Q ss_pred ceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++ .....+|+||||+++ +|.+++...... ...+++..+..++.||+.||+|||+++
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 150 (296)
T cd05095 85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN 150 (296)
T ss_pred EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9998 444558999999985 999998763211 124778899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=163.56 Aligned_cols=113 Identities=29% Similarity=0.418 Sum_probs=96.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCC----cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+++.+.||.|+||.||+|.+...+ ..||+|.+.... ..+..|+.+++.++|+||+++++++ .....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence 356789999999999999998766 899999996432 3577899999999999999999999 44456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|++|||++| +|.+++.... ...+++..+..++.||+.||.|||+.+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 8999999986 9999987632 122899999999999999999999998
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=162.87 Aligned_cols=115 Identities=21% Similarity=0.312 Sum_probs=96.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ..+.+|+.+++.++|+||+++++++. . ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence 3467999999999999999999864 55679999886532 45678999999999999999999983 3 3478
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN 122 (260)
T ss_pred EEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999985 9999987532 345788899999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=170.39 Aligned_cols=119 Identities=21% Similarity=0.336 Sum_probs=96.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCC-------CcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeee
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFS 146 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 146 (335)
...+|++++.||+|+||.||+|++... +..||+|.+... ...+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE--
Confidence 334699999999999999999987432 236899988642 24567899999999 799999999999
Q ss_pred CCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....++++|||+++ +|.+++..... ....++...+..++.||+.||.|||+++
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 154 (334)
T cd05100 88 ---TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154 (334)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445568999999985 99999876321 1234788889999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-20 Score=161.99 Aligned_cols=114 Identities=25% Similarity=0.287 Sum_probs=95.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|.+...||+|+||.||+|.+..+ ..+|+|.+.... ..+.+|+.+++.++||||+++++++ .. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CCcEE
Confidence 35699999999999999999998654 469999886432 4567899999999999999999887 22 23679
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.+
T Consensus 78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN 122 (260)
T ss_pred EEEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999996 9999987532 345889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=165.33 Aligned_cols=120 Identities=18% Similarity=0.260 Sum_probs=94.8
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCc--EEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~ 154 (335)
|.+++.||+|+||.||+|.+..++. .+|+|.++.. ...+.+|+.+++.++||||++++++++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999977765 6999987532 2446789999999999999999998754322 12235
Q ss_pred EEEEeecchh-hHHHHHHHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++|||+.+ +|.+++.... .....+++..+..++.||+.||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 132 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS 132 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 7899999995 9988875322 11245899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=165.61 Aligned_cols=117 Identities=23% Similarity=0.362 Sum_probs=97.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|.+.+.||+|+||.||+|.+. .++..+|+|.+.... +.+.+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 35999999999999999999864 345679999886432 4577999999999999999999998 455
Q ss_pred cEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++||||+++ +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 143 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999985 99999976321 1234899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=166.16 Aligned_cols=116 Identities=20% Similarity=0.366 Sum_probs=95.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ..+.+|+.+++.++||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 48889999999999999998753 23579999886432 3467899999999999999999998 445
Q ss_pred cEEEEEeecchh-hHHHHHHHHhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++|||+.+ +|.+++..... ....+++..++.++.|++.||.|||+++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 147 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 558899999995 99998875321 1235889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=167.70 Aligned_cols=119 Identities=20% Similarity=0.353 Sum_probs=97.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcC-------CCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeee
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS 146 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 146 (335)
..++|.+++.||+|+||.||+|++.. ....+|+|.+.... ..+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC-- 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence 34579999999999999999998642 34579999886432 3466899999999 699999999998
Q ss_pred CCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++|++|||+++ +|.+++..... ....+++..+..++.||+.||.|||++|
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g 154 (314)
T cd05099 88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154 (314)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445568999999995 99999976321 1245889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=163.37 Aligned_cols=105 Identities=24% Similarity=0.361 Sum_probs=89.3
Q ss_pred eeeccCceEEEEEEE--cCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 89 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~--~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
.||+|+||.||+|.+ ..++..+|+|++.... ..+.+|+.+++.++||||+++++++ ... ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999965 4678899999986432 3467899999999999999999987 322 3679999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+++ +|.+++.. ...+++..+..++.||+.||+|||+++
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ 115 (257)
T cd05116 76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN 115 (257)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9995 89998875 567999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=167.22 Aligned_cols=120 Identities=23% Similarity=0.343 Sum_probs=97.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-------CCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFF 145 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 145 (335)
...++|.+.+.||+|+||.||+|++. ..+..||+|.+... ...+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~- 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence 34567999999999999999999853 23457999988642 24567899999999 899999999998
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||+.+ +|.+++..... ....++...+..++.||+.||.|||+++
T Consensus 91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g 157 (304)
T cd05101 91 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157 (304)
T ss_pred ----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 445568999999985 99999986321 1235788889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=164.86 Aligned_cols=117 Identities=25% Similarity=0.395 Sum_probs=96.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|.+.++||+|+||.||+|... .++..+|+|.+... ...+.+|+.+++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 45889999999999999999753 35678999988643 24577899999999999999999998 444
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRI-----------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...|++|||+++ +|.+++...... ...+++..+..++.||+.||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 142 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH 142 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 558999999995 999998753210 135889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=182.25 Aligned_cols=117 Identities=22% Similarity=0.311 Sum_probs=99.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+|++.++||+|+||.||+|++..+++.||+|++..+ .+.+.+|+.+++.++||||+++++++ .....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 4699999999999999999999999999999998642 23567899999999999999999998 55566
Q ss_pred EEEEeecchh-hHHHHHHHHhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|+||||++| +|.+++..... ....++...+..++.||+.||+|||+++
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G 133 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG 133 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8999999996 99999875321 1234566778899999999999999998
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=162.22 Aligned_cols=115 Identities=23% Similarity=0.357 Sum_probs=96.2
Q ss_pred eEEeeeeeccCceEEEEEEEcC-CCcEEEEEEecccc--------------hhHHHHHHHHHh-CCCCceeeeceeeeeC
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFST 147 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~--------------~~~~~Ei~~l~~-l~hpnIv~~~~~~~~~ 147 (335)
|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ..+.+|+.++.. ++||||+++++++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--- 78 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--- 78 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence 8889999999999999999987 68899999885211 235578888765 6999999999999
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
....++|+||||++| +|.+++.........+++..++.++.|++.||.|||+ .+
T Consensus 79 --~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 134 (269)
T cd08528 79 --LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR 134 (269)
T ss_pred --ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 555679999999996 9999887654445679999999999999999999996 44
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=161.59 Aligned_cols=113 Identities=27% Similarity=0.366 Sum_probs=94.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|.+.+.||+|+||.||+|.+... ...||||.+.... +.+.+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-
Confidence 4599999999999999999997544 4569999886432 35678999999999999999999883 22
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..|+||||+++ +|.+++... ...+++..++.++.||+.||+|||+.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~ 127 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR 127 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 26799999985 999998752 335899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=168.75 Aligned_cols=108 Identities=19% Similarity=0.221 Sum_probs=89.5
Q ss_pred eeeeccCceEEEEEEEcCCCc-------EEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 88 HVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~-------~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+.||+|+||.||+|.++.++. .+|+|.+.... ..+..|+.+++.++||||+++++++. ...+.+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 469999999999999866544 38888875432 34678999999999999999999994 334478
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+++ +|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG 120 (258)
T ss_pred EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999995 999998752 235899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-22 Score=178.96 Aligned_cols=196 Identities=19% Similarity=0.235 Sum_probs=152.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++.++..||-|+||.|-++........+|+|++++. ...+..|-.||..++.|.||++|..| .+..|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 4577889999999999999998766667999998752 24567899999999999999999999 88899
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------c
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------------V 204 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------~ 204 (335)
+|++||-|=| .|+.+|+. ++.|.+..+++|+..+++|++|||++| +
T Consensus 495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999875 99999987 889999999999999999999999999 2
Q ss_pred ChHHhHhhhcCCCCHHHhh------------------------hhCCCCCCCC----CCCCCCCccccccccCCChHHHH
Q 019844 205 DQLVEIIKVLGTPTREEIK------------------------CMNPNYTEFK----FPQIKPHPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 205 ~~~~~~~~~~g~~~~~~~~------------------------~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~ 256 (335)
....+.+++||||.|.... .+.|+|.... +..+....-...+|..++..+.+
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 2233455678887643221 1222222110 00000111112356788999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
||+++...+|.+|.. +.+|-+|.||..++|
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 999999999999996 899999999999877
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=160.86 Aligned_cols=112 Identities=22% Similarity=0.393 Sum_probs=95.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
.+|++.+.||+|+||.||++.. +++.||+|.+... ...+.+|+.+++.++||||+++++++. .. ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-----HN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc-----CC-CcEEEE
Confidence 4699999999999999999874 6889999998643 345778999999999999999999883 22 267999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.| +|.+++.... ...+++..+..++.|++.||.|||+++
T Consensus 78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (254)
T cd05083 78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK 120 (254)
T ss_pred ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99995 9999987632 345899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=161.99 Aligned_cols=114 Identities=25% Similarity=0.389 Sum_probs=97.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3569999999999999999999877665 58999886432 346689999999999999999999843
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++||||+.+ +|.+++... ...+++..+..++.||+.||+|||+.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ 129 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR 129 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 347899999985 999988753 345899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=161.79 Aligned_cols=108 Identities=15% Similarity=0.134 Sum_probs=86.8
Q ss_pred eeeeccCceEEEEEEEcC------------CCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 88 HVVGTGSFGVVFQAKCRE------------TGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~------------~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
+.||+|+||.||+|.... ....+|+|.+.... ..+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 368999999999998532 23358999875432 34567899999999999999999983 4
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++||||+++ +|..++... ...+++..++.++.||+.||+|||+++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD 125 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 4447899999996 887776541 356899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=160.05 Aligned_cols=107 Identities=24% Similarity=0.389 Sum_probs=92.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
++||.|+||.||+|.+.. ++.||+|.+... ...+.+|+.+++.++||||+++++++ ....+.++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 469999999999999977 999999988643 23567899999999999999999998 4455689999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+| +|.+++... ...+++..+..++.|++.||.|||+++
T Consensus 75 ~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~ 113 (251)
T cd05041 75 PGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN 113 (251)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 86 898888652 346889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=160.53 Aligned_cols=108 Identities=28% Similarity=0.333 Sum_probs=91.2
Q ss_pred eeeeccCceEEEEEEEcC-CC--cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~-~~--~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.+.. .+ ..||||.+.... +.+.+|+.++++++||||+++++.+. . ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999865 33 369999997543 35678999999999999999999983 3 5689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+++ +|.+.+.... ...+++..++.++.|++.||.|||+++
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ 117 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESKR 117 (257)
T ss_pred EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhCC
Confidence 99985 9999988632 146899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=165.03 Aligned_cols=116 Identities=20% Similarity=0.264 Sum_probs=95.4
Q ss_pred eeEEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
+|.+.+.||+|+||.||+|.+..+ ++.||+|++.... ..+.+|+.++..++||||+++++++ ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TKE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cCC
Confidence 588899999999999999987543 5789999996432 3467899999999999999999998 444
Q ss_pred cEEEEEeecchh-hHHHHHHHHh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++++||+.+ +|.+++.... .....+++..++.++.|++.||.|||+++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g 144 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 558899999995 9998885311 11235888899999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-20 Score=159.58 Aligned_cols=106 Identities=25% Similarity=0.324 Sum_probs=88.6
Q ss_pred eeeccCceEEEEEEEc--CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeec
Q 019844 89 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
.||+|+||.||+|.++ .++..||+|++.... ..+.+|+.+++.++||||+++++++ .. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence 4899999999999875 445679999986432 3467899999999999999999987 22 247899999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 115 (257)
T cd05115 76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN 115 (257)
T ss_pred CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 985 999888642 456899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=160.94 Aligned_cols=114 Identities=21% Similarity=0.326 Sum_probs=95.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|++.+.||+|+||.||+|.+..++. .||+|.+... ...+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4569999999999999999999877776 4899988532 2356789999999999999999998842
Q ss_pred ccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++|||++ |+|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~ 129 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR 129 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 12668999998 4998888752 346899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=160.58 Aligned_cols=111 Identities=26% Similarity=0.443 Sum_probs=91.2
Q ss_pred eeeeccCceEEEEEEEcCCCc--EEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|++..++. .+|+|.+... ...+.+|+.++.++ +||||+++++++ .....+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence 368999999999999988776 4688887632 23566899999999 899999999999 4455689999
Q ss_pred ecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+++ +|.+++..... ....+++..++.++.|++.||+|||+++
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ 132 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99985 99999875321 1135889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-20 Score=157.99 Aligned_cols=107 Identities=24% Similarity=0.369 Sum_probs=90.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
++||+|+||.||+|.. .++..+|+|.+.... ..+.+|+.+++.++||||+++++++ ......++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECC
Confidence 4699999999999986 468899999886432 3467899999999999999999998 4445588999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+| +|.+++... ...+++..+..++.|++.||.|||+++
T Consensus 75 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 113 (250)
T cd05085 75 PGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113 (250)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 85 998887642 345889999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=159.01 Aligned_cols=107 Identities=20% Similarity=0.210 Sum_probs=90.0
Q ss_pred eeeeccCceEEEEEEEcCCC----------cEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 88 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~----------~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+.||+|+||.||+|.+..++ ..+++|.+... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 46999999999999998776 35888877543 3467789999999999999999998843 33
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++||||+++ +|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 6799999995 999988762 226899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-20 Score=160.20 Aligned_cols=113 Identities=22% Similarity=0.286 Sum_probs=92.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|++.+.||+|+||+||+|.+..++. .+|+|.+.... ..+..|+.+++.++||||+++++++ ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-----~~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-----PG- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-----CC-
Confidence 469999999999999999999987776 47777774321 3455677888999999999999987 22
Q ss_pred cEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++|||++ |+|.+++... .+.+++..+..++.||+.||.|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR 129 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 23668999998 5999998752 356899999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=157.36 Aligned_cols=111 Identities=18% Similarity=0.239 Sum_probs=88.9
Q ss_pred eeeeccCceEEEEEEEcCC--CcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~--~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||++..... ...+++|.+... ...+.+|+.+++.++||||+++++.+ .....+|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEe
Confidence 3699999999999976433 235677766532 24577899999999999999999999 44556899999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+++ +|.+++.........+++..++.++.||+.||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 119 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9995 999999764322345777888999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-19 Score=156.15 Aligned_cols=111 Identities=21% Similarity=0.299 Sum_probs=88.9
Q ss_pred eeeeccCceEEEEEEEcC--CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|.... ....+|+|.+.... ..+.+|+.+++.++||||+++++.+ .....+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 369999999999997533 34578889875321 3467899999999999999999998 44556899999
Q ss_pred cchh-hHHHHHHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+++ +|.+++...... ...+++..++.++.||+.||+|||+++
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 9995 999999764321 233567888999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=160.74 Aligned_cols=111 Identities=19% Similarity=0.267 Sum_probs=91.3
Q ss_pred eeeeccCceEEEEEEEcCCC------cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 88 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~------~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+.||+|+||.||+|.++... +.+|+|.+.+. ...+.+|+.+++.++||||+++++++ ......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence 36899999999999986544 68999988542 23567899999999999999999998 4444589
Q ss_pred EEeecchh-hHHHHHHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++...... ...+++..+..++.||+.||.|||+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH 126 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999995 999998753221 245788999999999999999999988
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-19 Score=156.12 Aligned_cols=111 Identities=20% Similarity=0.191 Sum_probs=89.9
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+.||+|+||.||+|... .++..+|+|.+.... ..+.+|+.+++.++||||+++++++ .....+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 36899999999999864 355679999886432 3567899999999999999999998 44555889999
Q ss_pred cchh-hHHHHHHHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+++ +|.+++...... ....++..++.++.|++.||.|||+.+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9995 999999753321 234667788899999999999999988
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=171.53 Aligned_cols=121 Identities=20% Similarity=0.188 Sum_probs=82.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCC----CcEEEEEEecccchhHHHHHHH---HHhCCCCceeeeceeeeeCCC-CC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQI---MQMLDHPNIVALKHCFFSTTD-KE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~vAvK~i~~~~~~~~~Ei~~---l~~l~hpnIv~~~~~~~~~~~-~~ 151 (335)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++..... .|+.+ ++...+.+++.+...|..... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 456899999999999999999999988 89999998864321 22222 222233444444433322111 34
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhh----------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++||||+++ +|.+++..... ......+..++.|+.||+.||.|||+++
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568899999996 99998864210 0011224457789999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.9e-20 Score=186.57 Aligned_cols=108 Identities=25% Similarity=0.349 Sum_probs=94.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
.|.....||+|+||.||+|+++.++..||||.+.........|+.++++++|||||++++++. .....|+|||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCC
Confidence 466778999999999999999999999999999765555567899999999999999999994 344588999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+| +|.+++.. +++..+..|+.||+.||+|||..
T Consensus 766 ~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred CCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccC
Confidence 95 99999863 78899999999999999999943
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=156.41 Aligned_cols=109 Identities=20% Similarity=0.293 Sum_probs=87.6
Q ss_pred eeeeccCceEEEEEEEcC---CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+.||+|+||.||+|.+.. .+..+|+|.+... ...+.+|+.+++.++||||+++++++.. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998753 3457999988532 2356689999999999999999997642 233477999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+.+ +|.+++... ...+++..+..++.||+.||.|||+.+
T Consensus 77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 118 (262)
T cd05058 77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK 118 (262)
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99995 999998752 234677888899999999999999988
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=159.26 Aligned_cols=114 Identities=24% Similarity=0.342 Sum_probs=94.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 4568999999999999999999987776 47888876432 246789999999999999999998842
Q ss_pred ccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. ..++++||++ |+|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ 129 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR 129 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 1 2568999999 5998888752 335899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=148.55 Aligned_cols=195 Identities=18% Similarity=0.288 Sum_probs=138.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++.+.+..||.|+.|+|++++++.+|..+|||.+.+. .+++...+.++... +.|+||+.+++|....+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d----- 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD----- 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----
Confidence 34577789999999999999999999999999999653 25566777776655 58999999999976554
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cChHHh-----------------------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--VDQLVE----------------------- 209 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~~~~----------------------- 209 (335)
++|.||.|...+..+++.. .++++|..+-.+...++.||.||..+. ++...+
T Consensus 166 V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 8899999998778877764 567999999999999999999998776 000000
Q ss_pred -----HhhhcCCCCHHHhhhhCCCCCCCCCCCCCCCccc---------------------------------cccc--cC
Q 019844 210 -----IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH---------------------------------KVFQ--KR 249 (335)
Q Consensus 210 -----~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~--~~ 249 (335)
.....|.+.|.......|+-. .-..+..+.|. ..++ ..
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~--~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDK--PKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred ecccccccccCCccccCccccCCCCC--CccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 011123333322222222100 00011111221 1111 24
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+|+.+.+|+..||+.|+.+||...++|+|||+..+.
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 899999999999999999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=170.66 Aligned_cols=187 Identities=21% Similarity=0.299 Sum_probs=137.9
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEecc-----cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~-----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+.++||.|.||.|++|+.+..|+ .||||.++. ....+..|..||-+++||||++|.++. ....-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 46788999999999999999987775 599999973 345688999999999999999999998 44455
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------cChHHhHhhhcCCCC--
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-------------VDQLVEIIKVLGTPT-- 218 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------~~~~~~~~~~~g~~~-- 218 (335)
+.||+|||+ |+|..+|+.+ .+.|+..+...+++.|+.||+||-+++ ...+......+|...
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 899999999 6999999975 466999999999999999999999988 111122222233211
Q ss_pred -------------HHHhhhhCCCCCCCCCCCCCCCccc---------------------------------cccccCCCh
Q 019844 219 -------------REEIKCMNPNYTEFKFPQIKPHPWH---------------------------------KVFQKRLPP 252 (335)
Q Consensus 219 -------------~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~s~ 252 (335)
...+.+..|+...|.......+.|. .+-|-++|.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 0112222333222221111122221 223457899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhc
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACV 277 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~ 277 (335)
.+..|+..||++|-.+||++.||+.
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999999999886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=168.20 Aligned_cols=113 Identities=24% Similarity=0.371 Sum_probs=92.0
Q ss_pred eEEeeeeeccCceE-EEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEEee
Q 019844 84 YIAEHVVGTGSFGV-VFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 84 y~~~~~lG~G~fg~-V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
|.-.+++|.|+-|+ ||+|... |+.||||.+..+. ..+.|||.+|+.- +|||||++|+.- .+..++||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 55567899999995 8999984 8899999986554 4788999999999 599999999887 78889999999
Q ss_pred cchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|..+|.+++...............+..+.|++.||++||+.+
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~ 626 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK 626 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc
Confidence 9999999999873111111111456788999999999999987
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-20 Score=167.97 Aligned_cols=114 Identities=24% Similarity=0.286 Sum_probs=95.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCC---cEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+.++.++||+|.||+|+.|.+...+ ..||||+++.+. ..+.+|+.+|.+|+|||+|++|++..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------ 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------ 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------
Confidence 34677899999999999999986533 359999997543 5688999999999999999999998531
Q ss_pred EEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
-+.+|||+++ |+|.+-|+.. ....|.......|+.||+.||.||.+++
T Consensus 184 p~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 2669999999 6998888762 2567888899999999999999999988
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-19 Score=158.20 Aligned_cols=117 Identities=24% Similarity=0.405 Sum_probs=98.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..++|.-...||+|+||.||+|... +|..||||++... .+.+.+|+.++.+++|||+|+++|||..... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 4457888899999999999999984 4589999988642 3569999999999999999999999943221 47
Q ss_pred EEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||+|||+ |+|.+.+..... ..+++.....|+.+++.||+|||...
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~--~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKG--EPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCC--CCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 79999999 699999986221 17899999999999999999999865
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=155.06 Aligned_cols=120 Identities=20% Similarity=0.294 Sum_probs=94.0
Q ss_pred eEEeeeeeccCceEEEEEEEcC---CCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc-c
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE-L 153 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~-~ 153 (335)
|.+.+.||+|+||.||+|.++. +++.||||++..+ ...+.+|+.+++.++||||+++++++........ .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998653 5789999998643 2346789999999999999999998854332221 2
Q ss_pred EEEEEeecch-hhHHHHHHHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~-g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++++||+. |+|.+++.... .....+++..++.++.||+.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578899998 49988775321 11235789999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=158.11 Aligned_cols=116 Identities=26% Similarity=0.395 Sum_probs=103.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCC------CceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDH------PNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~h------pnIv~~~~~~~~~~~~~~ 152 (335)
.+|.+....|+|-|++|..|.+...|..||||+|..+. +.-.+|++||++|+. -|+++|+..| ...
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence 48999999999999999999999999999999998654 445689999999943 4899999999 778
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++|||+|-+.-+|..+|+.++++ -.|....|+.|+.||..||..|-..|
T Consensus 507 nHLClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~ 556 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG 556 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC
Confidence 889999999999999999998764 45999999999999999999999887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-18 Score=160.76 Aligned_cols=124 Identities=17% Similarity=0.166 Sum_probs=88.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc----------------CCCcEEEEEEecccc------------------hhHHHH
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDK------------------RYKNRE 125 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~----------------~~~~~vAvK~i~~~~------------------~~~~~E 125 (335)
..++|.+.++||+|+||+||+|... ..++.||||.+.... .....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999999752 345679999985321 112347
Q ss_pred HHHHHhCCCCce-----eeeceeeeeCCC---CCccEEEEEeecchh-hHHHHHHHHhh--------------------h
Q 019844 126 LQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYSR--------------------I 176 (335)
Q Consensus 126 i~~l~~l~hpnI-----v~~~~~~~~~~~---~~~~~~~iv~e~~~g-~L~~~l~~~~~--------------------~ 176 (335)
+.++.+++|.++ ++++++|..... ..+...|+||||+++ +|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876554 667777643211 123457899999995 99998864210 0
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 177 HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 177 ~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++..++.++.||+.||.|||+++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ 329 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG 329 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 123466788999999999999999988
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-19 Score=154.38 Aligned_cols=111 Identities=26% Similarity=0.435 Sum_probs=98.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC---CCcEEEEEEecc--cchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~--~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...|.+.++||.|+|++||++.+.. ..+.||+|.|.. ...++..|+++|..+ .+.||+++.+++ .++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence 3459999999999999999999987 788999999853 346788999999999 699999999999 77777
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++||||++. +..++... ++..+++.|++.++.||.++|.+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G 152 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG 152 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC
Confidence 9999999996 66666654 788999999999999999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-19 Score=164.61 Aligned_cols=111 Identities=27% Similarity=0.404 Sum_probs=94.9
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCc----EEEEEEecc-----cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~-----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+..++||.|+||+||+|.+...|+ +||+|++.. ....+..|+-+|..|+|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 5567899999999999999876655 589998853 2356789999999999999999999984322
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.||++|++ |+|.++++.. +..+.......|..||+.||.|||.++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr 818 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR 818 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc
Confidence 669999999 6999999974 567899999999999999999999887
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-18 Score=145.92 Aligned_cols=101 Identities=36% Similarity=0.540 Sum_probs=88.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh-hHH
Q 019844 94 SFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN 167 (335)
Q Consensus 94 ~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~ 167 (335)
+||.||+|.+..+++.+|+|++... .+.+.+|+..++.++|+||+++++++. .....+++|||+++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998643 356789999999999999999999984 44568899999997 999
Q ss_pred HHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 168 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++.. ...+++..++.++.+++.||.|||..+
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ 107 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHSNG 107 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 98876 334899999999999999999999988
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-19 Score=144.89 Aligned_cols=202 Identities=18% Similarity=0.273 Sum_probs=139.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-----cchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++.+-+..||.|+||+|++..++.+|+..|||.|+. +.+++..|.+...+- +.||||++|++.+...+ +
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence 345667899999999999999999999999999963 346677888865555 78999999999965544 8
Q ss_pred EEEeecchhhHHHHHHH-HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 019844 156 NLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------- 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------- 203 (335)
||-||+|+-+|..+.+. +.....+++|.-+-.|....+.||+||-..-
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99999999776665543 2334667999999999999999999997543
Q ss_pred cChHHhHhhhcCCCCHHHhhhhCCCCCCCC----------------CCCCCCCcccccc----------------c---c
Q 019844 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFK----------------FPQIKPHPWHKVF----------------Q---K 248 (335)
Q Consensus 204 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~----------------~---~ 248 (335)
++.... ....|..++.......|.-..|. -...+-..|...| + -
T Consensus 219 v~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 219 VDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 111111 11122222222222222111110 0011111222111 1 2
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 249 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
.++..+..+|.-||.+|-+.||...+++.+||++.+-....
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 47889999999999999999999999999999988755433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-19 Score=161.78 Aligned_cols=119 Identities=24% Similarity=0.319 Sum_probs=99.6
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-----cchhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~i 157 (335)
|...+.||+|+||.||+++++.+|+.||||.+++ ......+|+++|++|+|||||+++++-.+... --...-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 7788999999999999999999999999999964 34567799999999999999999887622110 00223469
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||.| ||...|..- ++..+|+|.++..++..++.||.|||.+|
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~ 140 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG 140 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 9999996 999999853 34567999999999999999999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=162.21 Aligned_cols=113 Identities=19% Similarity=0.293 Sum_probs=101.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|.++++||+|+||.||+|.+..+++.||||++.+.. ..+.+|+.+++.++||||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 46999999999999999999999999999999996432 4577899999999999999999988 55667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||||+.| +|.+++.. .+.+++..++.|+.||+.||.|||.++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g 124 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG 124 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999986 99999876 456899999999999999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-18 Score=154.90 Aligned_cols=116 Identities=25% Similarity=0.311 Sum_probs=104.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCC---CCceeeecee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---HPNIVALKHC 143 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~---hpnIv~~~~~ 143 (335)
....+|..++.+|.|+||.|++|.++.....|+||.|.|++ -.+..||+||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34446999999999999999999999999999999997653 12457999999997 9999999999
Q ss_pred eeeCCCCCccEEEEEeecch-h-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 144 FFSTTDKEELYLNLVLEYVP-E-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 144 ~~~~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
| +++.++||+||--. | ||++++.. +.+++|.+++.|++||+.|+++||+++
T Consensus 638 F-----Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~ 690 (772)
T KOG1152|consen 638 F-----EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG 690 (772)
T ss_pred e-----ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC
Confidence 9 88889999999877 7 99999997 788999999999999999999999999
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-16 Score=141.05 Aligned_cols=117 Identities=18% Similarity=0.240 Sum_probs=87.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccchhHH---------------HHHHHHHhCCCCceeeecee
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHC 143 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~~~~~---------------~Ei~~l~~l~hpnIv~~~~~ 143 (335)
.+|.+.+.||+|+||.||+|.+..+ +..+|+|+......... .+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4699999999999999999999877 66788886532221111 22334556689999999997
Q ss_pred eeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 144 ~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..... ....+.+++|+++..++.+++.. ....++..++.|+.||+.||+|||+++
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ 146 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG 146 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 64332 22335678999988777777664 334688899999999999999999988
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=8e-17 Score=134.23 Aligned_cols=106 Identities=32% Similarity=0.516 Sum_probs=93.5
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE 164 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g 164 (335)
||.|++|.||++.+..+++.+++|++.... ..+.+|+.+++.+.|++|+++++++ ......+++||+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 689999999999998889999999997653 4588999999999999999999999 444568899999995
Q ss_pred -hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 165 -TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 165 -~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|.+++... ...+++..++.++.+++.+|.|||+.+
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~ 112 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999988752 146899999999999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-17 Score=156.04 Aligned_cols=117 Identities=24% Similarity=0.348 Sum_probs=94.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcC-------CCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
.+..+.+.||.|+||.|++|.... ....||||.++.. .+.+..|+.+|+.+ .|+||+.+.+++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~---- 371 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC---- 371 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee----
Confidence 345677799999999999997531 1457999988642 35678999999999 599999999999
Q ss_pred CCCccEEEEEeecch-hhHHHHHHHHh---hh-------c--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVP-ETVNRIARNYS---RI-------H--QRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~-g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+++|+|||. |+|..+++..+ .. . ..++..+...+++||+.|++||++..
T Consensus 372 -t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~ 438 (609)
T KOG0200|consen 372 -TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP 438 (609)
T ss_pred -ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence 44566899999999 79999998743 00 0 13899999999999999999999887
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=137.73 Aligned_cols=115 Identities=24% Similarity=0.293 Sum_probs=95.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-cchhHHHHHHHHHhC--CCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~Ei~~l~~l--~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
....+..+.+.||+|.||.||+|.++ |+.||||++.. +.....||.+|.... +|+||..|+..=.... ..-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEE
Confidence 34457889999999999999999996 99999999964 455677888877654 9999999887654333 234558
Q ss_pred EEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 156 ~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
|||++|-+ |+|+++|.. ..++...+..++..++.||++||.
T Consensus 285 wLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~ 326 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHM 326 (513)
T ss_pred EEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHH
Confidence 99999999 799999995 569999999999999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-16 Score=130.93 Aligned_cols=116 Identities=19% Similarity=0.260 Sum_probs=99.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+.|.+.+.||+|-||.+.+|+++.++..+|+|.+++. .+.+.+|...--.| .|.||+.-|++-+ +...+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF----qt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF----QTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh----hcCce
Confidence 4456799999999999999999999999999999999764 35677898877777 5899999888766 44457
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++|||++ |||..-+.. .++.|...+.++.|+++|+.|||+++
T Consensus 97 YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn 141 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN 141 (378)
T ss_pred EEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc
Confidence 889999999 799877663 55899999999999999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.2e-15 Score=133.54 Aligned_cols=114 Identities=21% Similarity=0.308 Sum_probs=92.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-cchhHHHHHHHHHh--CCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~Ei~~l~~--l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
+..++.++||+|.||.||+|+.. ++.||||+++. +...++.|-.|.+. ++|+||++|+++---.. ....-++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 34778899999999999999974 79999999974 34556777666655 58999999988752221 123358899
Q ss_pred eecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|.+ |+|.++|+. ..+++.....|+..|++||+|||.-.
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~ 327 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEEL 327 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccC
Confidence 99999 799999996 45999999999999999999999654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=130.82 Aligned_cols=105 Identities=16% Similarity=0.194 Sum_probs=81.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcC-CCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceee-eceeeeeC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVA-LKHCFFST 147 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~-~~~~~~~~ 147 (335)
...++|.+.+.||+|+||+||+|+++. +++.+|||++... ...+.+|+.+|+.++|+||+. ++++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~--- 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATG--- 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcC---
Confidence 344569999999999999999999876 6788899986422 234789999999999999985 44321
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..|+|||||+| +|.. +. ... ...++.|++.||.|||++|
T Consensus 92 ------~~~LVmE~~~G~~L~~-~~-------~~~---~~~~~~~i~~aL~~lH~~g 131 (365)
T PRK09188 92 ------KDGLVRGWTEGVPLHL-AR-------PHG---DPAWFRSAHRALRDLHRAG 131 (365)
T ss_pred ------CcEEEEEccCCCCHHH-hC-------ccc---hHHHHHHHHHHHHHHHHCC
Confidence 26899999997 7752 11 011 1467899999999999988
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-14 Score=124.43 Aligned_cols=121 Identities=17% Similarity=0.200 Sum_probs=91.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCc-----EEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
...+|++...++-+|+||.||.|.++.... .+-+|.++... ..+..|-.++..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-- 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-- 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee--
Confidence 345678999999999999999997764332 34556554433 335578888999999999999998864
Q ss_pred CCCccEEEEEeecch-hhHHHHHHHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+....++++.++. |+|..++...+. ..+.++-.+...++.|++.|++|||+.+
T Consensus 359 --~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ 416 (563)
T KOG1024|consen 359 --DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG 416 (563)
T ss_pred --ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC
Confidence 3333567888888 799999984331 1245777788899999999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=5e-14 Score=116.06 Aligned_cols=105 Identities=16% Similarity=0.194 Sum_probs=79.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------------hh-----------------HHHHHHHHHhCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RY-----------------KNRELQIMQMLDHPN 136 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~-----------------~~~Ei~~l~~l~hpn 136 (335)
...||+|+||.||+|.+. +|+.||||+++... .. ..+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999996431 11 124999999998877
Q ss_pred eeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCC
Q 019844 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCI 203 (335)
Q Consensus 137 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ 203 (335)
|...+.+. ... .+|||||++| ++...+.. ...+++..+..++.||+.+|.|| |+.|
T Consensus 81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g 138 (190)
T cd05147 81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR 138 (190)
T ss_pred CCCCcEEE-----ecC--CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 74433332 111 2699999997 55443322 45799999999999999999999 6877
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-13 Score=114.47 Aligned_cols=111 Identities=33% Similarity=0.509 Sum_probs=97.6
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
|.+.+.||.|++|.||++.+..+++.+|+|.+... ...+.+|+..++.++|+||+++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56789999999999999999988999999999653 45677899999999999999999998 444558899
Q ss_pred eecchh-hHHHHHHHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|++++ +|.+++.. ... +++..+..++.+++.+|.|||..+
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 118 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSLG 118 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999997 99999886 333 899999999999999999999988
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-14 Score=137.48 Aligned_cols=191 Identities=19% Similarity=0.287 Sum_probs=127.1
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEec----ccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~----~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
....++|.|++|.|+.+......+.++.|... ... ..+..|..+-..|.|||++.....+.... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~----~- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID----G- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc----c-
Confidence 35789999999999999888777777777553 111 11456777788889999988777774322 1
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--------------C---------------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV--------------D--------------- 205 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------~--------------- 205 (335)
.+-+||||++||+.++.. ...++..++..++.||+.||+|||+.|+ .
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 333499999999999986 4579999999999999999999999990 0
Q ss_pred -----hHHhHhhhcCCCCHHHhhhhCC-CCCCC------------CCCCCCCCccc------------------------
Q 019844 206 -----QLVEIIKVLGTPTREEIKCMNP-NYTEF------------KFPQIKPHPWH------------------------ 243 (335)
Q Consensus 206 -----~~~~~~~~~g~~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~------------------------ 243 (335)
.......++|..+|...+...+ .|.+. .+. ....+|.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~-~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI-LGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe-cCCCccccccccccchhhhccccccccccCh
Confidence 0011122233322111100000 01100 000 0011111
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
..+...++.+.+.+|.+||+.||.+|.|+++|++.+||+.+.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 011245788999999999999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.8e-13 Score=110.92 Aligned_cols=107 Identities=19% Similarity=0.202 Sum_probs=82.3
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhC-----CCCceeeeceeeeeCCCCCccE-
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELY- 154 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l-----~hpnIv~~~~~~~~~~~~~~~~- 154 (335)
.-.+.||+|+||.||. +..++.. +||++... .+.+.+|+.+++.+ +||||+++|+++.+.. ...+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 3467899999999995 7666665 69988643 35688999999999 6799999999995432 1234
Q ss_pred EEEEeecch---hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 019844 155 LNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~---g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~ 203 (335)
+.+||||++ |+|.+++.. ..+++. ..++.|++.++ +|||+++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~ 125 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR 125 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC
Confidence 347899954 499999964 346666 46688888888 9999999
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.2e-13 Score=107.33 Aligned_cols=120 Identities=18% Similarity=0.322 Sum_probs=102.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-----cchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+....+..||+|+||.|-+.++..+|...|+|.|.. ..++..+|+.+..+. ..|.+|++|+.++. .
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----e 117 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----E 117 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----c
Confidence 444556778899999999999999999999999999963 235567888876665 79999999999954 4
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+||.||.|+.+|..+.+...+.++.++|..+-.|+..++.||.|||++-
T Consensus 118 gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL 168 (282)
T KOG0984|consen 118 GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL 168 (282)
T ss_pred ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh
Confidence 449999999999999888887777889999999999999999999999875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.1e-13 Score=110.33 Aligned_cols=104 Identities=13% Similarity=0.184 Sum_probs=80.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------------------------hhHHHHHHHHHhCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHPN 136 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------------------~~~~~Ei~~l~~l~hpn 136 (335)
...||+|+||.||+|.+. +|+.||||+++... ....+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999986431 01247889999999998
Q ss_pred eeeeceeeeeCCCCCccEEEEEeecchh-hHHH-HHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 137 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
|.....+.. .. .||||||++| ++.. .+. ...+++..+..++.|++.+|.|||+ .|
T Consensus 81 i~~p~~~~~-----~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g 138 (190)
T cd05145 81 VPVPEPILL-----KK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG 138 (190)
T ss_pred CCCceEEEe-----cC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 855444432 11 3699999997 3432 233 3468889999999999999999999 77
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.6e-13 Score=113.77 Aligned_cols=121 Identities=22% Similarity=0.261 Sum_probs=104.5
Q ss_pred CCCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEec--ccchhHHHHHHHHHhCC-CCceeeeceeeeeCCCCC
Q 019844 75 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 75 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~--~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~ 151 (335)
++....+..|+++++||+|+||+++.|...-+++.||||.-+ .+..++..|....+.|. .++|..+|.+- +.
T Consensus 21 s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qe 95 (449)
T KOG1165|consen 21 SGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QE 95 (449)
T ss_pred CCceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cc
Confidence 344466778999999999999999999999999999999754 34567889999999994 69999988877 66
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..|-.+|||+++.+|.+++.-+ ..+|+...+..++.|++.-++|+|++.
T Consensus 96 G~~NiLVidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 6677799999998888888764 567999999999999999999999998
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.8e-13 Score=108.19 Aligned_cols=117 Identities=21% Similarity=0.267 Sum_probs=100.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--hhHHHHHHHHHhCCC-CceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~ 155 (335)
....+|.++++||.|+||.+|+|....+|+.||||+-+... ..+..|..+.+.|++ ..|..++.++ .+..|-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence 45567999999999999999999999999999999876544 457789999999965 6777777777 666777
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|||+++.+|.+++.-. ..+|+...+..++-|++.-++|+|.++
T Consensus 87 vlVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~ 131 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN 131 (341)
T ss_pred eeeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc
Confidence 899999998888888764 356999999999999999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-12 Score=110.18 Aligned_cols=110 Identities=14% Similarity=0.023 Sum_probs=82.0
Q ss_pred eeEEeeeeeccCceEEEEEE-EcCCCcEEEEEEecccc----------------------------hhHHHHHHHHHhCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD 133 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~vAvK~i~~~~----------------------------~~~~~Ei~~l~~l~ 133 (335)
-|.+.+.||+|+||.||+|. +..+|+.||||++.... ..+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 66799999999986321 12457999999997
Q ss_pred CCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 134 hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+. ++.+..++.. . . .++||||++| +|...+.. ...+.+..+..++.||+.+|.|||..|
T Consensus 109 ~~-~i~~p~~~~~---~--~-~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 109 EA-GVPVPKPIAW---R--R-NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred hc-CCCCCeeeEe---c--C-ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 53 2332333311 1 1 4699999998 66554322 345677778899999999999999988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=110.88 Aligned_cols=115 Identities=17% Similarity=0.183 Sum_probs=97.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCC-cEEEEEEecccc----hhHHHHHHHHHhCCC----CceeeeceeeeeCCCCCcc
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~~----~~~~~Ei~~l~~l~h----pnIv~~~~~~~~~~~~~~~ 153 (335)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... ..+..|+.++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 6999999999999999999997774 679999875431 257899999999963 58888888772 2555
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+-||||++++.+|.++..... .+.++...+..|+.|++.+|++||+.|
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G 142 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG 142 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC
Confidence 678999999999999887654 578999999999999999999999999
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.4e-12 Score=110.84 Aligned_cols=66 Identities=21% Similarity=0.284 Sum_probs=55.5
Q ss_pred CCCceeeeceeeeeCCC----------------------CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHH
Q 019844 133 DHPNIVALKHCFFSTTD----------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190 (335)
Q Consensus 133 ~hpnIv~~~~~~~~~~~----------------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ 190 (335)
.|||||++..+|.+.-. .....+|+||..++.+|..++.. ...+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 69999999999864321 23456899999999999999985 4578888899999
Q ss_pred HHHHHHHHHHhCC
Q 019844 191 QICRALAYIHNCI 203 (335)
Q Consensus 191 qi~~aL~yLH~~~ 203 (335)
|+++|+.|||.+|
T Consensus 349 QlLEav~hL~~hg 361 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG 361 (598)
T ss_pred HHHHHHHHHHHcc
Confidence 9999999999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.6e-13 Score=109.77 Aligned_cols=111 Identities=15% Similarity=0.275 Sum_probs=92.5
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++.+|.....|..|+|++. |..+++|++.. ..+.+..|.--|+-+.||||+.+++.+ +...++.+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCceE
Confidence 556778899999999999985 55677787642 235678899999999999999999999 55566899
Q ss_pred Eeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+..||+ |+|+.++.... .-..+..++..++.+|++|+.|||+..
T Consensus 265 isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle 309 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE 309 (448)
T ss_pred eeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc
Confidence 999999 79999998744 345788899999999999999999876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.2e-11 Score=99.98 Aligned_cols=101 Identities=15% Similarity=0.226 Sum_probs=80.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+.||+|++|.||+|.+ .|..+++|+..... ..+.+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999987 67889999764211 2356899999999999887766666332 236
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||++| +|.+++.. . .. ....++.+++.+|.+||..+
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~~ 115 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSAG 115 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhCC
Confidence 799999997 99888864 1 12 78899999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=97.38 Aligned_cols=109 Identities=11% Similarity=0.075 Sum_probs=83.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----h---------hHHHHHHHHHhCCCCceeeeceeeeeC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----R---------YKNRELQIMQMLDHPNIVALKHCFFST 147 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~---------~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 147 (335)
..+|++.++||.|+||.||++.+ ++..+|+|++.... . .+.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45799999999999999999765 47789999985321 1 156899999999999999999987643
Q ss_pred CCC---CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 148 TDK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 148 ~~~---~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
... .....+|||||++| +|.++.. +++ ....+|+.+|..||..|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g 155 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG 155 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC
Confidence 211 12347899999998 8876632 333 24569999999999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-11 Score=119.71 Aligned_cols=71 Identities=13% Similarity=-0.004 Sum_probs=54.3
Q ss_pred HhCCC-CceeeeceeeeeCCC--CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 130 QMLDH-PNIVALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 130 ~~l~h-pnIv~~~~~~~~~~~--~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.+.| +||++++++|-.... .....++++|||++++|.+++... ...+++.+++.|++||+.||.|||++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 34556 688888888722211 122347789999988999999741 356999999999999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-10 Score=95.24 Aligned_cols=97 Identities=11% Similarity=0.180 Sum_probs=72.4
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeccc------------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.||+|+||.||++.. ++..+++|..... ...+.+|+.++..+.|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 489999999999985 5788999985421 13456899999999887655444444221 2257
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++... . . .++.|++.+|.+||+.+
T Consensus 74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~~g 110 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHKAG 110 (199)
T ss_pred EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHHCC
Confidence 99999997 898877541 1 1 78999999999999988
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-09 Score=103.79 Aligned_cols=102 Identities=13% Similarity=0.158 Sum_probs=77.2
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEe-ccc-----------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i-~~~-----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.|...+.||+|+||.||++.+. +..+++|+. .+. ...+.+|+.+++.++|++|+..+.++...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence 4567899999999999999874 334444432 111 13466899999999999998876666332
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++||||++| +|.+++. ....++.|++.+|.|||+.+
T Consensus 409 --~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 409 --EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred --CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC
Confidence 226799999997 9988775 24678999999999999988
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.4e-10 Score=95.73 Aligned_cols=107 Identities=21% Similarity=0.306 Sum_probs=81.3
Q ss_pred EEEEEEEcCCCcEEEEEEec----ccc--hhHHHH--HHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecch-hhHH
Q 019844 97 VVFQAKCRETGEIVAIKKVL----QDK--RYKNRE--LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVN 167 (335)
Q Consensus 97 ~V~~~~~~~~~~~vAvK~i~----~~~--~~~~~E--i~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~ 167 (335)
.||++.++..|.+|+.-.+. ++. +.-.++ ..-|-.+.|-|||+++.+|.+....+.....+++|||. |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 47888887777776654442 111 111122 33455668999999999996655446666889999999 6999
Q ss_pred HHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 168 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|++..+....+....-+.|+-||+.||.|||+..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 999998888888999999999999999999999876
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.7e-09 Score=89.95 Aligned_cols=100 Identities=16% Similarity=0.095 Sum_probs=75.1
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--------------------------hhHHHHHHHHHhCCCCc-
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPN- 136 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------------------------~~~~~Ei~~l~~l~hpn- 136 (335)
|.+.+.||+|+||.||+|... +|+.||||+++... ....+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999874 89999999875321 12457888999997774
Q ss_pred -eeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 137 -IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 137 -Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+...++. ...++||||++| +|..+.. ......++.+++.++.++|..+
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~g 145 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHG 145 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCC
Confidence 3333321 114799999998 7755432 1345678899999999999987
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-08 Score=89.08 Aligned_cols=111 Identities=34% Similarity=0.477 Sum_probs=91.9
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCC-ceeeeceeeeeCCCCCccEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hp-nIv~~~~~~~~~~~~~~~~~ 155 (335)
|.+.+.||.|+||.||++.+. ..+|+|.+... ...+.+|+.++..+.|+ +|+++++.+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 788999999999999999996 88999998632 34477899999999988 799999999 334447
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++++++.| ++.+++...... ..+.+..+..++.|++.++.|+|..+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~ 121 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG 121 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899999996 887666642100 26999999999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=83.91 Aligned_cols=98 Identities=16% Similarity=0.169 Sum_probs=74.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--------hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+.+...|++|+||+||.+.. .+..++.+.+.... ..+.+|+++|++|+ |++|++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~---- 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G---- 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence 34578899999999997765 67788877665332 24679999999995 58899988853 2
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|++|||+.| +|.+.+.. . ...++.|++.+|.+||.+|
T Consensus 73 ~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~G 111 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCG 111 (218)
T ss_pred EEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCc
Confidence 6799999998 77543211 1 1357889999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-09 Score=87.84 Aligned_cols=37 Identities=16% Similarity=0.034 Sum_probs=32.1
Q ss_pred hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 164 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|.+++... +..+++.+++.|+.||+.||.|||+++
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~ 37 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA 37 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 6788888752 356999999999999999999999976
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.1e-10 Score=102.52 Aligned_cols=190 Identities=22% Similarity=0.342 Sum_probs=128.5
Q ss_pred eeeccCceEEEEEEE---cCCCcEEEEEEeccc------chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEEE
Q 019844 89 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~---~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
++|+|+||.|++++. ...|..||+|+.++. ......|..++..++ ||.+|+++.+| +....++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 479999999987653 456778999988642 224457888999986 99999999999 555558999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChHH-hHhhhcCCCC---HHH
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQLV-EIIKVLGTPT---REE 221 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~~-~~~~~~g~~~---~~~ 221 (335)
++|..| +|...+.. ...+.+..++.+...++.|++++|..++ +... ...+.+|... ...
T Consensus 76 ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred hhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999996 88776665 5678999999999999999999998870 0000 0000000000 011
Q ss_pred hhhhCCCCCCCCCCC--CCCCcc----------------------------ccccccCCChHHHHHHHHhccCCCCCCCC
Q 019844 222 IKCMNPNYTEFKFPQ--IKPHPW----------------------------HKVFQKRLPPEAVDLVCRFFQYSPNLRCT 271 (335)
Q Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t 271 (335)
..|++..|.+....+ .....| ...+|..++..+.+++..++..+|..|..
T Consensus 152 ~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 152 IACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred hcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhc
Confidence 112222222111100 111111 12345678889999999999999999996
Q ss_pred -----HHHHhcCcccccCCCC
Q 019844 272 -----ALEACVHPFFDELRDP 287 (335)
Q Consensus 272 -----~~~~L~hp~f~~~~~~ 287 (335)
+.++++|+||+.+.+.
T Consensus 232 ~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 232 AGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred cCcchhHHHhccchheeeeHh
Confidence 4799999999988764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.1e-08 Score=91.21 Aligned_cols=107 Identities=22% Similarity=0.300 Sum_probs=85.0
Q ss_pred eEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh--hHHHH
Q 019844 96 GVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRI 169 (335)
Q Consensus 96 g~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~ 169 (335)
.+.|+|....+|..|++|++..+. .....=++.++++.|+|||.+.++|.+.. .....+++|++|+++ +|+++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHH
Confidence 368999999999999999994322 12335688999999999999999997433 456779999999994 88876
Q ss_pred HHHHhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 170 ARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 170 l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.-.... .+...+|..+|.|+.||..||.++|+.|
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG 413 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG 413 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence 543211 1345789999999999999999999999
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-09 Score=106.24 Aligned_cols=109 Identities=21% Similarity=0.301 Sum_probs=87.0
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+|...+.||.+.|=+|.+|++. .| .|+||++-+.. .+-.+|++ ...++|||++.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 5888999999999999999984 34 49999985432 22234555 5566999999988876 45555
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|||=+|...+|++-+.. +.-+.+.+-+.|+.||+.||.-+|..|
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 778999999999988875 555788889999999999999999998
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.6e-07 Score=81.40 Aligned_cols=121 Identities=17% Similarity=0.195 Sum_probs=71.3
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCC----------Cceeeeceeee
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH----------PNIVALKHCFF 145 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~h----------pnIv~~~~~~~ 145 (335)
.+..+..||.|+|+.||.+++..||+.+|+|+..-.. +.+++|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4788999999999999999999999999999874211 233344332222211 11111112111
Q ss_pred eC---------CCCCcc---EEEEEeecchhhHHHHHHHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 ST---------TDKEEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~---------~~~~~~---~~~iv~e~~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
-. .+.... +.+++|+-+.+||.+++......... +....-..+..|++..+++||+.|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 10 001111 24789999989998887653322222 112222355699999999999999
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-08 Score=100.49 Aligned_cols=115 Identities=23% Similarity=0.311 Sum_probs=87.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..+..|.|.+.||+|+||.||+|.+.. |+.||||+-+... -.+--=.+++.+|+ -+.|..+..++.- .+-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~-----~~~ 768 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF-----QNA 768 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc-----CCc
Confidence 345689999999999999999999976 9999999775432 11222234455555 2456666665532 222
Q ss_pred EEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
-++|+||.+ |+|.+++.. .+.+++..+..+..|||.-|+.||..+
T Consensus 769 S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~ 814 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG 814 (974)
T ss_pred ceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc
Confidence 569999999 799999984 678999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.8e-08 Score=78.19 Aligned_cols=100 Identities=16% Similarity=0.181 Sum_probs=79.0
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecccc--hhHHHHHHHHHhCCC--CceeeeceeeeeCCCCCccEEEEEeec
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
+.+.||.|.++.||++... +..+++|.+.... ..+.+|+.+++.+.| .++++++.++ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 3578999999999999984 3789999987654 367899999999976 5888888877 333558899999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.| .+..+ +......++.+++.+|.+||...
T Consensus 75 ~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~ 106 (155)
T cd05120 75 IEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLP 106 (155)
T ss_pred cCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCC
Confidence 997 45322 44556778999999999999754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.6e-08 Score=90.38 Aligned_cols=120 Identities=22% Similarity=0.201 Sum_probs=98.8
Q ss_pred CCccceeeeEEeeeeec--cCceEEEEEEE--cCCCcEEEEEEe--c----ccchhHHHHHHHHHhC-CCCceeeeceee
Q 019844 76 GNSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKV--L----QDKRYKNRELQIMQML-DHPNIVALKHCF 144 (335)
Q Consensus 76 ~~~~~~~~y~~~~~lG~--G~fg~V~~~~~--~~~~~~vAvK~i--~----~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 144 (335)
........+.+.+.+|. |.+|.||.+.. ..++..+|+|.- + .....-.+|+...+.+ .|+|.++.+..|
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 33445556888899999 99999999998 899999999973 2 2234456888888888 499999999988
Q ss_pred eeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHH----HHHHHHhCC
Q 019844 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCI 203 (335)
Q Consensus 145 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~ 203 (335)
.....+|+-+|+|+.+|..+.... ..-+++..++.++.+... ||.++|+.+
T Consensus 188 -----e~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 188 -----EGSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN 242 (524)
T ss_pred -----ccCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc
Confidence 667779999999999888887752 344899999999999999 999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.4e-08 Score=80.53 Aligned_cols=101 Identities=18% Similarity=0.149 Sum_probs=67.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccch------h----------------------HHHHHHHHHhCCCCc--
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------Y----------------------KNRELQIMQMLDHPN-- 136 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~----------------------~~~Ei~~l~~l~hpn-- 136 (335)
.+.||+|+||.||+|.+. +++.||||++..... . ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999986 899999999864321 0 024555555554332
Q ss_pred eeeeceeeeeCCCCCccEEEEEeecchh-hHH-HHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 137 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
+.+.+++. . .++||||++| ++. ..+.... . ...++.++.+++.++.++|. .+
T Consensus 81 ~~~~~~~~-----~----~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 81 VPKPIDLN-----R----HVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred CCceEecC-----C----CEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccC
Confidence 33333322 1 5799999997 321 2232211 1 16688999999999999998 76
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-08 Score=99.56 Aligned_cols=57 Identities=32% Similarity=0.378 Sum_probs=42.2
Q ss_pred cCCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccCCCCCCCCCCCCCCCCCCCCC
Q 019844 248 KRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304 (335)
Q Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t---~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 304 (335)
..++++++++|.++|+.+|..|.. +.++.+|+||+.+++...-......+|.+.+++
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~ed 341 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESED 341 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccc
Confidence 457899999999999999999984 678889999999988633222223344444443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=75.22 Aligned_cols=105 Identities=10% Similarity=0.096 Sum_probs=74.2
Q ss_pred eeeee-ccCceEEEEEEEcCCCcEEEEEEeccc-----------------chhHHHHHHHHHhCCCCce--eeeceeeee
Q 019844 87 EHVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFS 146 (335)
Q Consensus 87 ~~~lG-~G~fg~V~~~~~~~~~~~vAvK~i~~~-----------------~~~~~~Ei~~l~~l~hpnI--v~~~~~~~~ 146 (335)
...|| .|+.|+||.+... +..+|||.+... ...+.+|+.++..|.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34677 8888889988773 778999987421 1345689999999988775 666665432
Q ss_pred CCCCCccEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||.+|
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~G 162 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDAG 162 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHCC
Confidence 11 111123599999995 88888753 3455543 678999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-07 Score=88.70 Aligned_cols=112 Identities=17% Similarity=0.214 Sum_probs=68.7
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccch--------------------------------------hH--
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------YK-- 122 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--------------------------------------~~-- 122 (335)
.|.. +.||.|++|.||+|+.+.+|+.||||++.+... .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999988899999999964310 01
Q ss_pred ----HHHHHHHHhC----CCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHH--HHHhhhcCCCCHHHHHHHHHH
Q 019844 123 ----NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIA--RNYSRIHQRMPLIYVKLYTYQ 191 (335)
Q Consensus 123 ----~~Ei~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l--~~~~~~~~~l~~~~~~~i~~q 191 (335)
.+|+..+.++ .+.+.+.+-.+|.+-. ..-+|||||++| .+.++- .........+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1333333333 2334444444443211 124599999998 887642 221111124667778888888
Q ss_pred HHHHHHHHH
Q 019844 192 ICRALAYIH 200 (335)
Q Consensus 192 i~~aL~yLH 200 (335)
++. -.+.|
T Consensus 276 if~-~GffH 283 (537)
T PRK04750 276 VFR-DGFFH 283 (537)
T ss_pred HHh-CCeee
Confidence 875 33444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=73.12 Aligned_cols=109 Identities=10% Similarity=0.061 Sum_probs=79.9
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCC--CceeeeceeeeeCCCCCccEEEEEe
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
.+.||.|..+.||++... .|+.+++|..... ...+.+|+.+++.+.+ .++.+++.+.... ......++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 367899999999999874 3688999987643 3467899999999965 3456666654211 1112467999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++| ++...+. ...+++.+...++.+++.+|.+||+..
T Consensus 80 e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ 119 (223)
T cd05154 80 ERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVD 119 (223)
T ss_pred EEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 99998 6654432 134788888899999999999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-07 Score=90.27 Aligned_cols=192 Identities=19% Similarity=0.207 Sum_probs=129.0
Q ss_pred eeEEeeeeeccCceEEEEEEEc-CCCcEEEEEEeccc---c---hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQD---K---RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~---~---~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.|.+.+.||+|+|+.|-.+... .+...+|.|.+... . .....|..+-+.+. |+|++++++.. ....+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 3888899999999999988774 34456777877432 1 33456888888886 99999999998 66777
Q ss_pred EEEEeecchh-hHHHHH-HHHhhhcC-CCCHHHHHHHHHHHHHHHHHHH-hCC------------cCh-H-HhHhhhcCC
Q 019844 155 LNLVLEYVPE-TVNRIA-RNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCI------------VDQ-L-VEIIKVLGT 216 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l-~~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH-~~~------------~~~-~-~~~~~~~g~ 216 (335)
.+++++|..| ++...+ .. .. .++...+..++.|+..|+.|+| ..+ .+. . ......+|.
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccccCcccccccccccccC----CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchh
Confidence 8899999886 887777 32 33 6788889999999999999999 554 000 0 000001111
Q ss_pred CC----------HHHhhhh-CCCCCCCCCCC--------------------------------CCC----------Cccc
Q 019844 217 PT----------REEIKCM-NPNYTEFKFPQ--------------------------------IKP----------HPWH 243 (335)
Q Consensus 217 ~~----------~~~~~~~-~~~~~~~~~~~--------------------------------~~~----------~~~~ 243 (335)
.. .....++ .+.|....... ... ..+.
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 00 0001122 22222111000 000 0011
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
...+..++....+++.++|..+|..|.+..++-.++|+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 2234678899999999999999999999999999999988
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.4e-06 Score=77.53 Aligned_cols=106 Identities=22% Similarity=0.238 Sum_probs=78.6
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
|.+ ...+-++.+.+-.|..+.++.+|.|...+... ....+.++-|+.++||||++|++.+ .....+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 665 44444444433357777889999999886433 3466888999999999999999999 6666799999
Q ss_pred ecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|-+.. |...+++ ++...+..-++||+.||.|||+.+
T Consensus 89 ErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~ 124 (690)
T KOG1243|consen 89 ERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDC 124 (690)
T ss_pred ecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccC
Confidence 99874 2223443 346678888999999999998655
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.6e-05 Score=73.60 Aligned_cols=67 Identities=21% Similarity=0.371 Sum_probs=56.2
Q ss_pred HHhCCCCceeeeceeeeeCCCCCccEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 129 l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+.+.|.|+.++++..+.. ..+++|.+||. |+|.+++.. ....++......++++|+.||.|||+.-
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~ 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP 68 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc
Confidence 4678999999999999654 44889999999 799999986 2455777788899999999999999754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.8e-05 Score=63.64 Aligned_cols=97 Identities=10% Similarity=0.026 Sum_probs=68.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCcee-eeceeeeeCCCCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv-~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
.+.|+.|.++.||++... +..|++|...... ....+|+.+++.+.+.+++ +++.+. ... -++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 467899999999999874 7889999876543 3457899999998655543 444433 222 35899999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV 204 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~ 204 (335)
+| ++... ......++.+++.+|..||..+.
T Consensus 74 ~G~~l~~~------------~~~~~~~~~~l~~~l~~LH~~~~ 104 (170)
T cd05151 74 EGSELLTE------------DFSDPENLEKIAKLLKKLHSSPL 104 (170)
T ss_pred CCCccccc------------cccCHHHHHHHHHHHHHHhCCCC
Confidence 98 65322 01123457899999999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.1e-05 Score=69.75 Aligned_cols=106 Identities=19% Similarity=0.164 Sum_probs=64.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc-h-------------------------------------------hH
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-R-------------------------------------------YK 122 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~-------------------------------------------~~ 122 (335)
.+.||.|++|.||+|+. .+|+.||||+..... + .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 46799999999999997 479999999985421 0 11
Q ss_pred HHHHHHHHhC----CCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHH-HH
Q 019844 123 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL 196 (335)
Q Consensus 123 ~~Ei~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-aL 196 (335)
.+|...+.++ .|.+-+.+-.+|.... ..-+|||||++| +|.++..... .... ...++.+++. .+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence 2344444444 2333344444442211 114699999998 8877765311 1122 2345555555 36
Q ss_pred HHHHhCC
Q 019844 197 AYIHNCI 203 (335)
Q Consensus 197 ~yLH~~~ 203 (335)
..+|..|
T Consensus 271 ~ql~~~g 277 (437)
T TIGR01982 271 NQVLRDG 277 (437)
T ss_pred HHHHhCC
Confidence 6778776
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00015 Score=59.59 Aligned_cols=103 Identities=17% Similarity=0.203 Sum_probs=70.5
Q ss_pred eeeeeccCceEEEEEEEcC------CCcEEEEEEeccc-------------c-------------hh----HHHHHHHHH
Q 019844 87 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQD-------------K-------------RY----KNRELQIMQ 130 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~------~~~~vAvK~i~~~-------------~-------------~~----~~~Ei~~l~ 130 (335)
...||.|--+.||.|.... .+..+|||+.+-. . +. ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 3578999987410 0 01 127999999
Q ss_pred hCCC--CceeeeceeeeeCCCCCccEEEEEeecchh-hHH-HHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCC
Q 019844 131 MLDH--PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCI 203 (335)
Q Consensus 131 ~l~h--pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ 203 (335)
++.. -++...+++. . -+|||||++| .+. ..++ ...+++.++..+..|++.+|.+| |..|
T Consensus 82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g 145 (197)
T cd05146 82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN 145 (197)
T ss_pred HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 9843 4555555542 2 4599999986 332 1222 23456667788899999999999 7777
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=5.7e-05 Score=70.30 Aligned_cols=118 Identities=21% Similarity=0.172 Sum_probs=91.3
Q ss_pred CccceeeeEEeeeeeccCceEEEEEEEc-CCCcEEEEEEecccc------hhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 77 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
......+|..+..||.|.|+.|+.+..+ .++..||+|.+.+.. .+-..|+.+...+ .|.+++.++..|.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--- 336 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--- 336 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---
Confidence 3455567999999999999999998866 678899999886432 3345788888888 5999999998884
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....||-.|||+| ++...+.. ...+.+...+.+..|++.|+.++|++.
T Consensus 337 --~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 337 --QLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred --ccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh
Confidence 33336699999985 44333321 345888899999999999999999887
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.71 E-value=3.3e-05 Score=70.78 Aligned_cols=114 Identities=19% Similarity=0.218 Sum_probs=67.6
Q ss_pred eEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeece-------eeeeCCC
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKH-------CFFSTTD 149 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~-------~~~~~~~ 149 (335)
+.+.+..+.+++|.+...+-... .+.++-+....+. ....+++..+....|-+..-+.+ .+.....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 55556667777776665544322 3334444333221 33446666665555444433333 1111111
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y 198 (335)
....|+||.|++|.- +|.++|.... .....+...++.++.|+..|++|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y 374 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY 374 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh
Confidence 234579999999994 9999997422 23456777889999999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0057 Score=49.26 Aligned_cols=109 Identities=15% Similarity=0.166 Sum_probs=75.3
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEec-c-----------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-Q-----------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~-~-----------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+..|-+|+-+.|+.+.+ .|+.+.||.=. + ..++..+|+.+|.++.--.|.--.=+|.+. ..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~---~~- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT---YG- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec---CC-
Confidence 578899999999999997 48888888542 2 124567899999888544443322233221 11
Q ss_pred EEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
-+|+|||++| ++.+++.... .......-...++..|-..+.-||.++
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd 133 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND 133 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC
Confidence 3489999998 8888887643 222223333688899999999999988
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00056 Score=54.56 Aligned_cols=77 Identities=21% Similarity=0.337 Sum_probs=57.4
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceee-eceeeeeCCCCCccEEEEEee
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVA-LKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~-~~~~~~~~~~~~~~~~~iv~e 160 (335)
-.+.+.||+|.+|.||+|..+ |..+|+|+-+.+ ...+..|+++|..++-.++.. +|.+- . .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----E----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----h----hhhhhh
Confidence 345788999999999999985 779999987654 356889999999997766643 33332 2 236699
Q ss_pred cchh-hHHHHHH
Q 019844 161 YVPE-TVNRIAR 171 (335)
Q Consensus 161 ~~~g-~L~~~l~ 171 (335)
|+.| .|..+-.
T Consensus 93 ~i~G~~L~~~~~ 104 (201)
T COG2112 93 YIDGRPLGKLEI 104 (201)
T ss_pred hhcCcchhhhhh
Confidence 9999 8766544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.013 Score=49.44 Aligned_cols=102 Identities=17% Similarity=0.169 Sum_probs=74.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCC--ceeeeceeeeeCCCCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHP--NIVALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hp--nIv~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
++.|+.|..+.||++.... ..+++|..... ...+.+|..+++.+... .+.+++...... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEEEEEe
Confidence 5789999999999999853 58999988654 35677899998888433 344555433211 2333478999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+| .+.. ..+......++.++...|.-||..
T Consensus 78 ~g~~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~ 108 (239)
T PF01636_consen 78 PGRPLDD----------ELSPEQRPELLRQLGRALAQLHQV 108 (239)
T ss_dssp SSEEHHH----------TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred ccccccc----------cccccccccccccchhhhhhcccc
Confidence 98 6654 366777888999999999999987
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00074 Score=67.14 Aligned_cols=114 Identities=16% Similarity=0.086 Sum_probs=84.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc-------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
-.+.+.+.+-+-+|++|.++.+.-..+|...++|+..+ +.+...++-.++-.-.+|.++.....+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 44568888899999999999999888887777775532 122333444444444567777765554 333
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
...+++|+|+.| +|...+.. -+..++.-++.+...+..+++|||..
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~ 923 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS 923 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc
Confidence 348899999986 99888886 45678888899999999999999987
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0042 Score=62.89 Aligned_cols=109 Identities=14% Similarity=0.118 Sum_probs=75.1
Q ss_pred eeeeeccCceEEEEEEEcCCC--cEEEEEEecc-----cchhHHHHHHHHHhCC-CCce--eeeceeeeeCCCCCccEEE
Q 019844 87 EHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQ-----DKRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~--~~vAvK~i~~-----~~~~~~~Ei~~l~~l~-hpnI--v~~~~~~~~~~~~~~~~~~ 156 (335)
.+.|+.|.++.+|+......+ ..+++|+.+. ....+.+|+.+|+.+. |++| .+++.++.+. ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 577899999999998764332 4678887643 2245789999999995 6665 5666555221 1123467
Q ss_pred EEeecchhh-HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++|. +.+. .-..++..+...++.+++.+|..||...
T Consensus 121 lVME~v~G~~~~~~------~~~~~~~~~r~~l~~~l~~~La~LH~vd 162 (822)
T PLN02876 121 YIMEYLEGRIFVDP------KLPGVAPERRRAIYRATAKVLAALHSAD 162 (822)
T ss_pred EEEEecCCcccCCc------cCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 999999993 3210 0123567778889999999999999865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0027 Score=64.07 Aligned_cols=76 Identities=16% Similarity=0.275 Sum_probs=58.7
Q ss_pred HHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 123 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 123 ~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
..|+..+..+.|+|++.++.|-....... --+.+..++|.+ ++..++.. .+..+...++.+..+++.||.|+|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 35677788889999999988875433221 123355677886 88888876 6779999999999999999999998
Q ss_pred CC
Q 019844 202 CI 203 (335)
Q Consensus 202 ~~ 203 (335)
..
T Consensus 305 ~~ 306 (1351)
T KOG1035|consen 305 LS 306 (1351)
T ss_pred hc
Confidence 86
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00094 Score=65.99 Aligned_cols=41 Identities=22% Similarity=0.290 Sum_probs=36.4
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 249 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
.++..+.+++.+||..||.+||++.++|+||||....+...
T Consensus 605 ~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~~~~~~ 645 (669)
T cd05610 605 KLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENL 645 (669)
T ss_pred cCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCCCHHHh
Confidence 56888999999999999999999999999999988765433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0036 Score=59.24 Aligned_cols=109 Identities=18% Similarity=0.264 Sum_probs=66.9
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccch--------------------------------------------hH
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------------YK 122 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--------------------------------------------~~ 122 (335)
.+.|+.++-|.||+|+.+ +|+.||||+...+.+ .+
T Consensus 130 ~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 130 PEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 367999999999999985 599999999864210 01
Q ss_pred HHHHHHHHhC----CCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHH--HHHHhhhcCCCCHHHHHHHHHHHHHH
Q 019844 123 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRI--ARNYSRIHQRMPLIYVKLYTYQICRA 195 (335)
Q Consensus 123 ~~Ei~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~--l~~~~~~~~~l~~~~~~~i~~qi~~a 195 (335)
.+|..-+.++ .+..=+.+-.+|+..... -.|+|||++| -+.++ ++..+.....+.+.-+..++.|++.
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~- 283 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-
Confidence 2455555444 223333444444321111 3499999999 77776 3432222223555566677777777
Q ss_pred HHHHHh
Q 019844 196 LAYIHN 201 (335)
Q Consensus 196 L~yLH~ 201 (335)
-.|.|.
T Consensus 284 dgffHa 289 (517)
T COG0661 284 DGFFHA 289 (517)
T ss_pred cCcccc
Confidence 667773
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.11 Score=45.10 Aligned_cols=79 Identities=9% Similarity=0.077 Sum_probs=53.6
Q ss_pred hHHHHHHHHHhCCC-----CceeeeceeeeeCCCCCccEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHH
Q 019844 121 YKNRELQIMQMLDH-----PNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQIC 193 (335)
Q Consensus 121 ~~~~Ei~~l~~l~h-----pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 193 (335)
.+.+|...+..|.. |.+|-+ ...........-+||||+++| +|.+++.... ....++.....++.+++
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~---~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la 148 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAF---GERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVA 148 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEE---EEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHH
Confidence 36789888877733 433433 321111112235699999997 7988886432 23456777889999999
Q ss_pred HHHHHHHhCCc
Q 019844 194 RALAYIHNCIV 204 (335)
Q Consensus 194 ~aL~yLH~~~~ 204 (335)
..+.-||.+|+
T Consensus 149 ~~i~~LH~~Gi 159 (268)
T PRK15123 149 TMVRDMHAAGI 159 (268)
T ss_pred HHHHHHHHCcC
Confidence 99999999993
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.035 Score=49.12 Aligned_cols=106 Identities=11% Similarity=-0.008 Sum_probs=71.7
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEecc--cchhHHHHHHHHHhCCC---CceeeeceeeeeCCCCCccEEEEEe
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~Ei~~l~~l~h---pnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
.-.+.||.|..+.||..... .+ .+.+|..+. ....+..|...|+.|.. -.|.++++++... .....-+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEE
Confidence 34678999999999999752 33 467777543 23578899999998843 3566777665221 1123367999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+++| ++.+. ..+......+..+++.+|.-||...
T Consensus 93 E~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La~LH~~~ 128 (297)
T PRK10593 93 ERLRGVSVEAP---------ARTPERWEQLKDQIVEGLLAWHRID 128 (297)
T ss_pred eccCCEecCCC---------CCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 99998 55431 1233445567788899999999753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.031 Score=45.21 Aligned_cols=96 Identities=11% Similarity=0.199 Sum_probs=65.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEE-eccc-----------chhHHHHHHHHHhCCCCc--eeeeceeeeeCCCCCcc
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKK-VLQD-----------KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEEL 153 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~-i~~~-----------~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~~~~~ 153 (335)
..+++|+-+.+|.+.+. |..+.+|. ++|. ..+..+|..++..+.--. +..+|++. .+.
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~- 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN- 73 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC-
Confidence 46789999999999764 55566664 3331 134568999999885433 34444443 222
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..|+|||++| .|.+++... ...++..+-.-+.-||..|
T Consensus 74 -~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g 112 (204)
T COG3642 74 -GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG 112 (204)
T ss_pred -CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC
Confidence 4499999999 777777752 1445667777788899998
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.026 Score=47.82 Aligned_cols=99 Identities=13% Similarity=0.056 Sum_probs=66.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCc--eeeeceeeeeCCCCCccEEEEEeecch
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVP 163 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~iv~e~~~ 163 (335)
..||.|..+.||++ .+..+++|..... ...+.+|.++++.+..-+ +.+.+++. .......+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 57899999999984 2556788987542 245789999998885332 34555554 23333678999999
Q ss_pred h-h-HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 164 E-T-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 164 g-~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
| + +...+. .+......++.+++..+.-||+..
T Consensus 78 G~~~~~~~~~--------~~~~~~~~l~~~la~~l~~lH~~~ 111 (226)
T TIGR02172 78 GKRSFSRIIS--------DNPSRLEEIAKIFAEMAKKLHSTK 111 (226)
T ss_pred Cccchhhhhc--------CCHHHHHHHHHHHHHHHHHHhCCC
Confidence 9 3 322221 334455577888999999999754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.21 Score=41.52 Aligned_cols=111 Identities=11% Similarity=0.040 Sum_probs=72.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEec----------ccchhHHHHHHHHHhCCCCc--eeeeceeeeeCCCCCccEEEE
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~----------~~~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~i 157 (335)
-|+||-+-|+..... |+.|=+|.-. .....+.+|+..+..|..-+ +.+.. ++-.........-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 356777778877653 4456677653 12345779999999884322 33333 221111122333679
Q ss_pred Eeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC
Q 019844 158 VLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD 205 (335)
Q Consensus 158 v~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~ 205 (335)
|+|-++| +|.+++.... -.+.++..-..++.+++..+.-||..|+.
T Consensus 103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~Gv~ 150 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVNRQ 150 (216)
T ss_pred EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCCCc
Confidence 9999986 9998886522 23456777789999999999999999943
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.067 Score=44.11 Aligned_cols=104 Identities=22% Similarity=0.250 Sum_probs=70.9
Q ss_pred eeeEEeeeeeccCc-eEEEEEEEcCCCcEEEEEEecc-----------c----c----------hhHHHHHHHHHhC---
Q 019844 82 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ-----------D----K----------RYKNRELQIMQML--- 132 (335)
Q Consensus 82 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~vAvK~i~~-----------~----~----------~~~~~Ei~~l~~l--- 132 (335)
.+++.++.||.|.- |.||+++. .|+.||+|.+.. . . .-+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46999999999999 99999997 588999999421 0 0 1234677766555
Q ss_pred CCCce--eeeceeeeeCCC-------------CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHH
Q 019844 133 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197 (335)
Q Consensus 133 ~hpnI--v~~~~~~~~~~~-------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 197 (335)
++.++ |++++|.....+ .......||.||++..- .+.... +.+|++-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 55677 999999865421 11223468888877521 122222 567778888
Q ss_pred HHHhCC
Q 019844 198 YIHNCI 203 (335)
Q Consensus 198 yLH~~~ 203 (335)
.+|..|
T Consensus 179 ~~~k~g 184 (207)
T PF13095_consen 179 ILHKLG 184 (207)
T ss_pred HHHHCC
Confidence 899888
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.031 Score=45.73 Aligned_cols=91 Identities=18% Similarity=0.197 Sum_probs=56.6
Q ss_pred EEEEEEEcCCCcEEEEEEecccc------------------------------hhHHHHHHHHHhCCCC--ceeeeceee
Q 019844 97 VVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHP--NIVALKHCF 144 (335)
Q Consensus 97 ~V~~~~~~~~~~~vAvK~i~~~~------------------------------~~~~~Ei~~l~~l~hp--nIv~~~~~~ 144 (335)
.||.|.. ..|..+|||+.+... ....+|...|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 578899999874210 1235899999999765 456666543
Q ss_pred eeCCCCCccEEEEEeecch--h-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCC
Q 019844 145 FSTTDKEELYLNLVLEYVP--E-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCI 203 (335)
Q Consensus 145 ~~~~~~~~~~~~iv~e~~~--g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~ 203 (335)
. -+|||||++ | .+..+... .++......++.+++..+.. +|..|
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred -----C----CEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC
Confidence 2 249999999 7 55443332 12244567788888886665 46777
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.0021 Score=59.26 Aligned_cols=72 Identities=24% Similarity=0.474 Sum_probs=59.6
Q ss_pred CccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 77 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
..+..+.|..+..+|.|+||+|+.+..+.++-.+|||.|... .....+|+.-+..+.|++|+++...|....
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 345566799999999999999999999888889999998532 244668888999999999999999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.0011 Score=62.77 Aligned_cols=125 Identities=11% Similarity=0.018 Sum_probs=86.3
Q ss_pred EeeccCCCCCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCc-eeeeceeeee
Q 019844 68 RTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFS 146 (335)
Q Consensus 68 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~ 146 (335)
..+.............|....-+++|+++++++.+...+.... .+.+... ....-++++|.+++||| .+.+++-+
T Consensus 228 TkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-- 303 (829)
T KOG0576|consen 228 TKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-- 303 (829)
T ss_pred hccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC--
Confidence 3344444444445556777888999999999999986655544 6666543 34456899999999999 66666655
Q ss_pred CCCCCccEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+.+.+.+|+|+++.+ +....+.. ....+.+-+...+.+.-+++|+|||+.
T Consensus 304 ---~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 304 ---DGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred ---CcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc
Confidence 778889999999984 22211111 123355556667778888999999987
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.12 Score=44.36 Aligned_cols=101 Identities=18% Similarity=0.125 Sum_probs=65.4
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc----------c----------------chhHHHHHHHHHhCCCC--
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------D----------------KRYKNRELQIMQMLDHP-- 135 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----------~----------------~~~~~~Ei~~l~~l~hp-- 135 (335)
+.++..||-|--+.||.|.+ ..|..+|||.=+. . ...+++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 55789999999999999998 4789999994320 0 02346899999999644
Q ss_pred ceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 136 nIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|.+.+++- .-.+||||++| -|..+ +++...+..++..|++-+.-+-..|
T Consensus 172 ~VP~P~~~n---------RHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 172 KVPKPIAWN---------RHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred CCCCccccc---------cceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcC
Confidence 566554432 24599999998 54322 1234445555555555444333333
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.12 Score=44.12 Aligned_cols=98 Identities=13% Similarity=0.078 Sum_probs=63.6
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEEEeecchh-
Q 019844 89 VVGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVPE- 164 (335)
Q Consensus 89 ~lG~G~f-g~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g- 164 (335)
.|-.|.. ..||++... +..+.+|+.... .....+|+++++.+. +--+.+++++. .....-++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCCc
Confidence 3455555 679999753 467888876532 235678999998884 43355666655 222336699999999
Q ss_pred hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 165 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|..... ......++.++...|.-||+..
T Consensus 78 ~l~~~~~----------~~~~~~~~~~l~~~l~~lH~i~ 106 (244)
T cd05150 78 PAAALWE----------ELEPERLVDALAEALRRLHALP 106 (244)
T ss_pred cHhHhhc----------ccCHHHHHHHHHHHHHHHhcCC
Confidence 6643221 1122457888999999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.52 Score=43.41 Aligned_cols=78 Identities=18% Similarity=0.250 Sum_probs=53.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecc-----------cchhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~ 152 (335)
.+.||.|.++.||++.+...++.+.||.-.. ...+...|.+.|+.+. -.++.+++.+- ..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EE- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CC-
Confidence 4679999999999999854336899997431 2244567888888872 24566776653 21
Q ss_pred cEEEEEeecchh--hHHHHHH
Q 019844 153 LYLNLVLEYVPE--TVNRIAR 171 (335)
Q Consensus 153 ~~~~iv~e~~~g--~L~~~l~ 171 (335)
..++|||++++ .+.+.+.
T Consensus 105 -~~~lVME~L~~~~~lr~~Ll 124 (401)
T PRK09550 105 -LAVTVMEDLSDHKILRKGLI 124 (401)
T ss_pred -CCEEEEecCCCccHHHHHHh
Confidence 14599999996 4555544
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.36 Score=40.83 Aligned_cols=96 Identities=20% Similarity=0.270 Sum_probs=61.4
Q ss_pred eeeeeccCceEEEEEEEcC-CCcEEEEEEecccch---hHHHHHHHHHhCCCCc-eeeeceeeeeCCCCCccEEEEEeec
Q 019844 87 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~---~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
.+.|..|-...||++.... .++.|++|+...... ...+|+.+++.+...+ +.+++..+ .. .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 4667888888999997643 356888997654322 2247999999885333 34444433 21 279999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++| ++.... +. -..++.+++..|.-||...
T Consensus 74 i~G~~l~~~~---------~~---~~~~~~~la~~l~~lH~~~ 104 (235)
T cd05157 74 IPGRTLEPED---------LR---NPKIYRLIARELAKLHSIK 104 (235)
T ss_pred eCCCcCCHHH---------cc---ChHHHHHHHHHHHHHhccc
Confidence 998 442110 10 1235778899999999766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.81 Score=38.04 Aligned_cols=80 Identities=13% Similarity=0.101 Sum_probs=53.9
Q ss_pred hhHHHHHHHHHhCCCCc--eeeeceeeeeCCCCCccEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHH
Q 019844 120 RYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195 (335)
Q Consensus 120 ~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 195 (335)
....+|...+..|..-+ +...+.+....... ....++|||+++| +|.+++.. ...++......++.++...
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHH
Confidence 35668888877774322 22333333221111 1345799999997 79888886 2336777788999999999
Q ss_pred HHHHHhCCc
Q 019844 196 LAYIHNCIV 204 (335)
Q Consensus 196 L~yLH~~~~ 204 (335)
+.-||.+|+
T Consensus 131 i~~lH~~gi 139 (206)
T PF06293_consen 131 IAKLHDAGI 139 (206)
T ss_pred HHHHHHCcC
Confidence 999999993
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.19 Score=47.76 Aligned_cols=30 Identities=30% Similarity=0.393 Sum_probs=26.3
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~ 117 (335)
.+.||.-+.|.||+|+.+. |+.||||+-.+
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P 195 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHP 195 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCc
Confidence 4789999999999999965 99999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.52 Score=40.16 Aligned_cols=99 Identities=13% Similarity=0.126 Sum_probs=62.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEecccc----------------------------hhHHHHHHHHHhCC--CCce
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD--HPNI 137 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------------------------~~~~~Ei~~l~~l~--hpnI 137 (335)
..|..|--+.||+|.. .++..+|+|+..... ....+|+.-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666777778999986 578899999885221 01236777777773 3444
Q ss_pred eeeceeeeeCCCCCccEEEEEeecchhh--HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 138 VALKHCFFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 138 v~~~~~~~~~~~~~~~~~~iv~e~~~g~--L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
.+-+.++ . -.|||||++.. -.-.|+ .-.+...++..+..+++..+.-|-.
T Consensus 133 P~Pi~~~-----~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 133 PEPIAFR-----N----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred CCceeec-----C----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH
Confidence 5555554 2 34999999843 111122 1223344677888888888876655
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.96 Score=37.38 Aligned_cols=100 Identities=18% Similarity=0.223 Sum_probs=65.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc--------------------hhHHHHHHHHHhCC------CCceeee
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVAL 140 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------------------~~~~~Ei~~l~~l~------hpnIv~~ 140 (335)
...||+|+.=.||.-- .....+||++.... +...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4578999988888753 45567889886544 44567887766665 7899999
Q ss_pred ceeeeeCCCCCccEEEEEeecch---h----hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~---g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||+..+. .-+-+|+|.+. | +|.+++. .+.+++ .+...+.++. +||-.++
T Consensus 83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f~---~~l~~~~ 138 (199)
T PF10707_consen 83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEFK---RYLLDHH 138 (199)
T ss_pred eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHHH---HHHHHcC
Confidence 9998443 33678888863 2 6777775 345666 4444444443 3444444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.045 Score=41.22 Aligned_cols=44 Identities=23% Similarity=0.300 Sum_probs=34.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHh
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM 131 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~ 131 (335)
...||.|+.|.||+|+.+ +|+.||||+..... ..+...+.+|+.
T Consensus 16 ~~PlasASiaQVh~a~l~-~g~~VaVKV~rP~i~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLK-DGEEVAVKVQRPGIEEQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeec-ccchhhhhhcchHHHHHHHHHHHHHHH
Confidence 467999999999999985 49999999987654 345556666654
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=92.34 E-value=2.3 Score=35.76 Aligned_cols=108 Identities=14% Similarity=0.160 Sum_probs=61.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccch-------------hHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------------YKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------------~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
.+|.+.+++-.....-|.+..- .|+.+.+|..+...+ ...+.+..+..+...++..+-+.++...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3578888888777766666654 578899997753321 1224444444443322222222111111
Q ss_pred C---CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 D---KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~---~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. .-....+++|||++| .|.++.. +++ .+...|..++.-||..|
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G 155 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG 155 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC
Confidence 1 122335689999999 6654432 333 24456777889999988
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=90.96 E-value=0.93 Score=38.45 Aligned_cols=98 Identities=10% Similarity=0.045 Sum_probs=58.7
Q ss_pred eeeeccCce-EEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCC---ceeeeceeeeeCCCCCccEEEEEeec
Q 019844 88 HVVGTGSFG-VVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 88 ~~lG~G~fg-~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hp---nIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
+.|+.|+.. .||++. ..+++|..... ...+.+|..++..|... -+..+++.. .........|++|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~--~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKG--EPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecC--CCccCCCcceEEEEe
Confidence 457767666 488762 35777865542 23578899999888532 223333222 010112235789999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++| ++.... +. ....++.++...|.-||+..
T Consensus 76 i~G~~l~~~~---------~~--~~~~l~~~la~~l~~LH~i~ 107 (235)
T cd05155 76 LEGETATAAA---------LS--DPSEFAEDLADFLAALRQID 107 (235)
T ss_pred ecCCCCCccc---------cC--CHHHHHHHHHHHHHHHhCCC
Confidence 998 664321 11 12367788889899999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=90.56 E-value=3 Score=37.88 Aligned_cols=76 Identities=18% Similarity=0.208 Sum_probs=50.5
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEecc-----------cchhHHHHHHHHHhCC--CC-ceeeeceeeeeCCCCCccE
Q 019844 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 89 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~Ei~~l~~l~--hp-nIv~~~~~~~~~~~~~~~~ 154 (335)
.||.|...-||++.+...++.++||.-.. ...+...|...|+... -| .+.++|.+ ....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~- 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEM- 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------cccc-
Confidence 57999999999999854446899996421 1245567888887773 24 45555543 2222
Q ss_pred EEEEeecchh--hHHHHHH
Q 019844 155 LNLVLEYVPE--TVNRIAR 171 (335)
Q Consensus 155 ~~iv~e~~~g--~L~~~l~ 171 (335)
..+|||+++. .|.+.|-
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 3499999984 6655554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.65 E-value=1.4 Score=40.01 Aligned_cols=104 Identities=17% Similarity=0.205 Sum_probs=63.6
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cc------------------------hhHHHHHHHHHhCCC
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DK------------------------RYKNRELQIMQMLDH 134 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~------------------------~~~~~Ei~~l~~l~h 134 (335)
.+-..|..|--+.||.|.. .+|..+|||+.+- +. .....|++-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3456677888889999987 6888899998752 11 012367888888866
Q ss_pred CceeeeceeeeeCCCCCccEEEEEeecchhh-H-HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPET-V-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 135 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~-L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
..|.-- .-.. -.. -.|||+|++++ . .-.|+ .-.++...+..+-.|++.-|.-|..
T Consensus 226 aGIP~P-ePIl-----Lk~-hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~ 282 (520)
T KOG2270|consen 226 AGIPCP-EPIL-----LKN-HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQ 282 (520)
T ss_pred cCCCCC-Ccee-----eec-ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHH
Confidence 553321 1111 112 24999999842 1 11222 3447777777777777776665543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=88.74 E-value=5.6 Score=36.82 Aligned_cols=98 Identities=12% Similarity=0.126 Sum_probs=62.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecc-----------cchhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~ 152 (335)
.+.||.|....||+..+. +..++||.-.. ...+...|...|+.+. ..+|.++|.+. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 678899999999999873 45688997541 2334456777777663 24677777766 322
Q ss_pred cEEEEEeecchhh---HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q 019844 153 LYLNLVLEYVPET---VNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198 (335)
Q Consensus 153 ~~~~iv~e~~~g~---L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~y 198 (335)
-+++||++++. +.+-+- .+......+..+...++..|-|
T Consensus 110 --~vlvME~L~~~~~ilr~~Ll-----~G~~~p~~a~~ig~~la~tLf~ 151 (418)
T PLN02756 110 --ALIGMRYLEPPHIILRKGLI-----AGIEYPLLAEHMSDYMAKTLFF 151 (418)
T ss_pred --CEEEEeecCCcceehhhhhc-----cCCCCHHHHHHHHHHHHHHHhh
Confidence 44899999863 333332 2223345566666666666544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=88.58 E-value=2.8 Score=38.61 Aligned_cols=78 Identities=14% Similarity=0.158 Sum_probs=53.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEec----------ccchhHHHHHHHHHhCC--CC-ceeeeceeeeeCCCCCcc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~----------~~~~~~~~Ei~~l~~l~--hp-nIv~~~~~~~~~~~~~~~ 153 (335)
.+.||-|.-.-||++.+...++.++||.-. ....+...|..+|+.+. -| .+.++|.+ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence 678999999999999984446779999642 12355677888888773 34 45555553 2233
Q ss_pred EEEEEeecchh--hHHHHHH
Q 019844 154 YLNLVLEYVPE--TVNRIAR 171 (335)
Q Consensus 154 ~~~iv~e~~~g--~L~~~l~ 171 (335)
..+|||+++. .|.+.|-
T Consensus 108 -~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 108 -NCCVMEDLSDHTILRTALI 126 (409)
T ss_pred -hhHHHHhCcccHHHHHHHH
Confidence 3499999974 5555554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=86.41 E-value=2.4 Score=36.38 Aligned_cols=91 Identities=13% Similarity=0.107 Sum_probs=57.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEecccch----hHHHHHHHHHhCCCCce-eeeceeeeeCCCCCccEEEEEeecchh
Q 019844 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLNLVLEYVPE 164 (335)
Q Consensus 90 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~----~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~iv~e~~~g 164 (335)
+..|-.+.+|+.. .+++.+++|....... ...+|..+++.+...++ .+++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 4567777899887 3567888887654322 24679999999854333 2333322 2 1489999998
Q ss_pred -hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 165 -TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 165 -~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+... .+. ....+.+++..|.-||+..
T Consensus 73 ~~~~~~---------~~~---~~~~~~~la~~l~~lH~~~ 100 (256)
T TIGR02721 73 EVITLD---------QFV---ALDLLLELAALLHQLHSQP 100 (256)
T ss_pred cccccc---------ccc---CchhHHHHHHHHHHHhCCC
Confidence 43210 010 1134678899999999876
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=85.92 E-value=1.7 Score=35.61 Aligned_cols=68 Identities=19% Similarity=0.161 Sum_probs=50.5
Q ss_pred HHHHHHHHhCCC-CceeeeceeeeeCCCCCccEEEEEeecchh-hHHHH---HHHHhhhcCCCCHHHHHHHHHHHHHHHH
Q 019844 123 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRI---ARNYSRIHQRMPLIYVKLYTYQICRALA 197 (335)
Q Consensus 123 ~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~---l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 197 (335)
..|.-+|+.+.+ +++.+++|++ . -++|+||.+. ++... +.. -...++.....|+.+++..+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHH
Confidence 468888999965 6999999998 3 2378999984 55321 111 123678888999999999999
Q ss_pred HHHhCC
Q 019844 198 YIHNCI 203 (335)
Q Consensus 198 yLH~~~ 203 (335)
+|+..-
T Consensus 74 ~l~~~~ 79 (188)
T PF12260_consen 74 ELDHGP 79 (188)
T ss_pred HHhcCC
Confidence 998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.56 E-value=4.2 Score=36.09 Aligned_cols=89 Identities=17% Similarity=0.206 Sum_probs=54.3
Q ss_pred ceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCC---CceeeeceeeeeCCC----CCccEEEEEeecchhhHH
Q 019844 95 FGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH---PNIVALKHCFFSTTD----KEELYLNLVLEYVPETVN 167 (335)
Q Consensus 95 fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~h---pnIv~~~~~~~~~~~----~~~~~~~iv~e~~~g~L~ 167 (335)
-|.||++.. ++..+++|.+......+...+.++..|.. +.++.++..- +. ..+...|++|++++|.-
T Consensus 19 ~~~v~~v~T--~~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~---~G~~~~~~~~~~~~L~~wi~G~~- 92 (309)
T TIGR02904 19 TGKLFKVYT--DQGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTK---DGSYYLFHGHFLYYLMPWLDIER- 92 (309)
T ss_pred cCcEEEEEe--CCCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecC---CCCeeeEECCEEEEEeCCccccc-
Confidence 568899875 34469999997665555566666766643 4445542211 11 11233579999999810
Q ss_pred HHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 168 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. +... .-+.+++..|+-||..+
T Consensus 93 ----~-------~~~~---~~~~~~~~~LA~lH~~~ 114 (309)
T TIGR02904 93 ----N-------EERN---YQHESMFQELALLHRKT 114 (309)
T ss_pred ----c-------cCCH---HHHHHHHHHHHHHHHhh
Confidence 0 1111 33678888899999877
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=85.45 E-value=2.9 Score=36.89 Aligned_cols=96 Identities=19% Similarity=0.264 Sum_probs=60.7
Q ss_pred eeeeeccCceEEEEEEEcC------CCcEEEEEEecccc---hhHHHHHHHHHhCCCCce-eeeceeeeeCCCCCccEEE
Q 019844 87 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~------~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~ 156 (335)
++.|..|--..||++.... +++.|++|+..... ....+|..++..+...++ .+++.++ .+ .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----C
Confidence 3456666677888887533 25789999875432 335689889988853333 3444444 21 2
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||++| .+.... +. -..++.+++..|.-||+..
T Consensus 74 ~v~e~i~G~~l~~~~---------~~---~~~~~~~ia~~L~~lH~~~ 109 (302)
T cd05156 74 RIEEFIPSRTLTTEE---------LR---DPDISAEIARRMAKLHSIV 109 (302)
T ss_pred chhheeCCCcCCHhH---------cC---CcHHHHHHHHHHHHhhCCC
Confidence 68999998 443210 10 1235778999999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=85.07 E-value=2.3 Score=36.55 Aligned_cols=75 Identities=16% Similarity=0.153 Sum_probs=52.5
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHH---HHHHhCCCCceeeeceeeeeCCCCCccEEEEEeecch
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei---~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~ 163 (335)
...+..|..+.|+.|+. .+|...++|+..... ....|. ..|+..+-...|++++.- ... -.|++|.+.
T Consensus 7 ~~~~~~g~~s~V~pv~~-~dG~~avLKl~~p~~-~~~~E~~g~~~L~~w~G~GaVrll~~d-----~~~--~AlLLErl~ 77 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRR-ADGTPAVLKLAPPHA-EAEHEARGEAALRWWNGRGAVRLLAAD-----PER--GALLLERLD 77 (253)
T ss_pred CCCCCCCcceEEEEEEc-CCCCeEEEEecCCcc-cchhhhhHHhHhheeCCCCceeeeccc-----ccc--chhhhhhcc
Confidence 34466788899999985 679999999775432 233444 668888888899998864 222 338999994
Q ss_pred -h-hHHHHH
Q 019844 164 -E-TVNRIA 170 (335)
Q Consensus 164 -g-~L~~~l 170 (335)
| +|.++.
T Consensus 78 ~g~~L~~~~ 86 (253)
T PF04655_consen 78 PGRSLASLP 86 (253)
T ss_pred CCCchhhcc
Confidence 5 776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=84.62 E-value=6.8 Score=34.46 Aligned_cols=93 Identities=15% Similarity=0.108 Sum_probs=54.7
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCccEEEEEee
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
+-.+.|+-|....+|... .+++.+.||+-... ...+..|..-|+.|. --.|.+++.+..... .-++|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEEEE
Confidence 346788989999999987 57888999977633 355778988888883 334556666653222 2379999
Q ss_pred cchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
|++... .. .. -..++..+|+-||.
T Consensus 93 ~l~~~~----------~~-~~------~~~~lg~~LA~LH~ 116 (288)
T PF03881_consen 93 FLEMGS----------PS-PP------DWEELGRQLAALHQ 116 (288)
T ss_dssp -------------------CC------HHHHHHHHHHHHHH
T ss_pred eecCCC----------CC-ch------hHHHHHHHHHHHhh
Confidence 988420 00 11 13467778888997
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=82.84 E-value=7.1 Score=34.57 Aligned_cols=101 Identities=8% Similarity=-0.028 Sum_probs=60.2
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCc--eeeeceeeeeC-CCCCccEEEEEee
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFST-TDKEELYLNLVLE 160 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~-~~~~~~~~~iv~e 160 (335)
.++.++.|.-..+|++.. . +..+++|+.... ...+..|+.++..|...+ |.+++...... .....+..+++|+
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 366778887788999875 3 345778977542 345667888888874322 33433321000 0012344679999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|++| .+. . .+. ..+.++...|.-||...
T Consensus 104 ~i~G~~~~----------~-~~~----~~~~~~G~~LA~lH~~~ 132 (307)
T TIGR00938 104 FLQGLSVG----------R-PTA----MHCRPVGEVLAWMHLAG 132 (307)
T ss_pred eCCCCCCC----------C-CCH----HHHHHHHHHHHHHHhhh
Confidence 9998 331 1 111 23578888899999654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 335 | ||||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-44 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-44 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-44 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-44 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-44 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-44 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-44 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-44 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-43 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-43 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-43 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-43 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-43 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-43 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-43 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-43 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-43 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-43 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-43 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-43 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-42 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-42 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-25 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-04 |
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 335 | |||
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-67 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-65 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-66 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-66 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-64 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 8e-60 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-61 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-55 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-24 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-24 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-24 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-23 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 6e-23 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-22 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-22 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-22 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-22 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-22 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-16 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-22 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-22 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-22 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 7e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-22 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-16 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-22 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-21 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-18 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-21 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-21 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-21 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-19 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-21 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-21 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-18 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-21 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-21 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-18 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-20 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-20 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-15 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-19 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 8e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-20 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-20 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-20 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-18 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-19 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-04 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-19 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-17 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-19 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-04 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-19 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-19 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-18 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-16 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-18 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-04 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-18 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-04 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 6e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-17 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-18 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-18 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-17 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-16 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-17 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-17 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-17 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-17 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-17 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-17 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-17 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-17 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-16 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-16 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-15 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-15 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-14 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-14 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-14 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-14 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-14 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-14 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-14 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-14 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-14 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-14 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-13 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-13 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-13 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-13 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-13 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-13 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-13 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-12 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-12 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-12 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-12 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-12 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-12 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-12 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-12 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-12 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-12 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-12 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-12 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 6e-12 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-12 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-12 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 9e-12 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-11 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-11 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-11 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-11 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-11 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-11 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-11 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-11 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-11 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-11 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-11 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-05 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-10 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-10 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-10 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-06 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-10 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-10 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-04 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-10 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-10 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-10 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-10 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 8e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 9e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-09 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-09 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-09 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 9e-09 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-08 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-08 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-06 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-06 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-08 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-05 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-08 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-08 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 9e-08 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-07 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-07 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 9e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-05 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-05 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-04 |
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-67
Identities = 86/145 (59%), Positives = 113/145 (77%), Gaps = 3/145 (2%)
Query: 57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
D G++ V+ T G+ + Q+VSY V+G GSFGVV+QAK ++GE+VAIKKVL
Sbjct: 31 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 175
QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIH 200
Q +P+IYVKLY YQ+ R+LAYIH
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH 173
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-65
Identities = 84/124 (67%), Positives = 91/124 (73%), Gaps = 1/124 (0%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +
Sbjct: 263 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 322
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
Y+P R T LEAC H FFDELRDPN +LPNGR P LFNF ELS P LIP H
Sbjct: 323 YTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPH 381
Query: 324 ARKQ 327
AR Q
Sbjct: 382 ARIQ 385
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 78/126 (61%), Positives = 99/126 (78%), Gaps = 1/126 (0%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
Y+P+ R TA+EA HPFFDELR R+PNGR LPPLFN+ ELS + P+ I+RL+P+H
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQH 366
Query: 324 ARKQNL 329
A + L
Sbjct: 367 AEAELL 372
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 9e-66
Identities = 76/150 (50%), Positives = 106/150 (70%), Gaps = 3/150 (2%)
Query: 52 EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 111
++ + + G+ G ++ ++Y V+G GSFGVVFQAK E+ E VA
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68
Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 170
IKKVLQDKR+KNRELQIM+++ HPN+V LK F+S DK+ E++LNLVLEYVPETV R +
Sbjct: 69 IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
R+Y+++ Q MP++ +KLY YQ+ R+LAYIH
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 5e-64
Identities = 57/145 (39%), Positives = 87/145 (60%), Gaps = 7/145 (4%)
Query: 64 GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
G ++ + K+ + E + G G+FG V K + TG VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 122 KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 176
+NRELQIMQ L HPNIV L+ F++ D+ ++YLN+V+EYVP+T++R RNY R
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 177 HQRMPLIYVKLYTYQICRALAYIHN 201
P I +K++ +Q+ R++ +H
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHL 147
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-60
Identities = 48/123 (39%), Positives = 67/123 (54%), Gaps = 4/123 (3%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCR 260
QL EI++VLG P+RE ++ +NP++T+ K PW VF + EA DL+
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRL 319
QY P R EA HP+FDEL DP T+LPN + LP LF F P E+ + +L
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357
Query: 320 IPE 322
+ +
Sbjct: 358 VRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-61
Identities = 56/134 (41%), Positives = 83/134 (61%), Gaps = 9/134 (6%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
+DQLV II+++GTPT+E++ MNP+YTE +FP +K W K+ + P A+DL+ + +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 264 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPPELSGIPPE 314
Y P+LR EA HPFFD LR+ N+ P+G + +P LFNF P ELS IP
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 315 TINRLIPEHARKQN 328
+NR++P++
Sbjct: 368 VLNRILPKNFSPNY 381
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-55
Identities = 53/158 (33%), Positives = 85/158 (53%), Gaps = 33/158 (20%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 135
G Y +GTGSFG+V + E+G+ A+KKVLQD RYKNREL IM++LDH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 136 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 162
NI+ L F++T D+ + YLN+++EYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
P+T++++ +++ R + +P+ + +Y YQ+ RA+ +IH
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 42/117 (35%), Positives = 63/117 (53%), Gaps = 14/117 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G GS+GVVF+ + R+TG+IVAIKK L+ + RE+++++ L HPN+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F K L+ LV EY TV Y + +P VK T+Q +A+ + H
Sbjct: 71 F---RRKRRLH--LVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCH 119
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 24/104 (23%), Positives = 37/104 (35%), Gaps = 5/104 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCR 260
VDQL I K LG + N ++ K P + P F + A+ L+
Sbjct: 209 VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF-PNISYPALGLLKG 267
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304
P R T + HP+F+ +R+ L P +
Sbjct: 268 CLHMDPTERLTCEQLLHHPYFENIREI-EDLAKEHDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
VG GS+G+V + + ++TG IVAIKK L+ K RE+++++ L H N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
K+ Y LV E+V T+ + + V+ Y +QI + + H
Sbjct: 93 C---KKKKRWY--LVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCH 141
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 4/87 (4%)
Query: 204 VDQLVEIIKVLGTPTRE--EIKCMNPNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCR 260
+DQL I+ LG E+ NP + + P+IK P + + +L +DL +
Sbjct: 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY-PKLSEVVIDLAKK 289
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDP 287
P+ R E H FF
Sbjct: 290 CLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 49/253 (19%), Positives = 84/253 (33%), Gaps = 68/253 (26%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 141
+G GS+G VF+ + +E G + A+K+ + +D+ K E+ ++ HP V L+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
+ + LY L E + + ++ +P V Y ALA++H
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 201 -----------NCIVDQLVEI-------IKVLGTPTREEIKC-----MNP-----NYTE- 231
N + + LGT E++ M P +Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTA 235
Query: 232 ----------FKFPQIKPHP-----WHKVFQKRLPP--------EAVDLVCRFFQYSPNL 268
+ P W ++ Q LPP E ++ + P L
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295
Query: 269 RCTALEACVHPFF 281
R TA P
Sbjct: 296 RATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 27/129 (20%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
++ ++G G+ VF+ + ++TG++ AIK L+ + RE ++++ L+H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L TT + L++E+ P + + +P + + +
Sbjct: 71 KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 197 AYIH-NCIV 204
++ N IV
Sbjct: 126 NHLRENGIV 134
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
+G G F V++A+ + T +IVAIKK+ R + RE++++Q L HPNI+ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F ++LV +++ + I ++ S + ++K Y + L Y+H
Sbjct: 78 -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 201 N 201
Sbjct: 130 Q 130
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 30/99 (30%), Positives = 41/99 (41%), Gaps = 9/99 (9%)
Query: 204 VDQLVEIIKVLGTPTREEI---KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I + LGTPT EE C P+Y F P H +F + +DL+
Sbjct: 219 LDQLTRIFETLGTPT-EEQWPDMCSLPDYVTF--KSFPGIPLHHIF-SAAGDDLLDLIQG 274
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 299
F ++P R TA +A +F P P P
Sbjct: 275 LFLFNPCARITATQALKMKYFSNR--PGPTPGCQLPRPN 311
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 35/124 (28%), Positives = 66/124 (53%), Gaps = 13/124 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
++ +G G++GVV++A+ + TGE+VA+KK+ D + RE+ +++ L+HPN
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV L + L LV E++ + + + + +PL +K Y +Q+ + L
Sbjct: 64 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGL 116
Query: 197 AYIH 200
A+ H
Sbjct: 117 AFCH 120
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I + LGTP + M P+Y + FP+ + KV L + L+ +
Sbjct: 210 IDQLFRIFRTLGTPDEVVWPGVTSM-PDY-KPSFPKWARQDFSKVV-PPLDEDGRSLLSQ 266
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 300
Y PN R +A A HPFF ++ +P+P L
Sbjct: 267 MLHYDPNKRISAKAALAHPFFQDV---------TKPVPHL 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 28/124 (22%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y + +GTGS+G + + + G+I+ K++ +K+ E+ +++ L HPNI
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V D+ L +V+EY + + ++ Q + +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 197 AYIH 200
H
Sbjct: 125 KECH 128
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 30/137 (21%), Positives = 50/137 (36%), Gaps = 16/137 (11%)
Query: 70 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 125
I ++ Y+ +G G F V + G A+K++L QD+ RE
Sbjct: 25 IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 126 LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
+ ++ +HPNI+ L K E + L+L + T+ +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 184 YVKLYTYQICRALAYIH 200
+ ICR L IH
Sbjct: 135 QILWLLLGICRGLEAIH 151
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 27/129 (20%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
++ ++G G+ VF+ + ++TG++ AIK L+ + RE ++++ L+H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L TT + L++E+ P + + +P + + +
Sbjct: 71 KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125
Query: 197 AYIH-NCIV 204
++ N IV
Sbjct: 126 NHLRENGIV 134
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
+ E +G G F V++A C G VA+KKV + + +E+ +++ L+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
++ F E+ LN+VLE ++R+ +++ + + +P V Y Q+C A
Sbjct: 94 VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 196 LAYIHN 201
L ++H+
Sbjct: 149 LEHMHS 154
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 3e-22
Identities = 34/117 (29%), Positives = 59/117 (50%), Gaps = 14/117 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
++L LV E+ + + + + + + VK + +Q+ + L + H
Sbjct: 70 L---HSDKKLT--LVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH 118
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
DQL I ++LGTPT E + + P+Y + V +L DL+
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPYPMYP-ATTSLVNVV-PKLNATGRDLLQN 265
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDP 287
+ +P R +A EA HP+F + P
Sbjct: 266 LLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 49/263 (18%), Positives = 90/263 (34%), Gaps = 75/263 (28%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
+G GSF V++ ET VA ++ K K+ E ++++ L HPNIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
+ ST ++ + LV E + T+ + Y + + M + ++ + QI + L ++H
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 201 -------------NCIVDQLVEIIK-----------------VLGTP------------- 217
N + +K V+GTP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYD 207
Query: 218 ----------TREEIKCMNPNYTE-------FKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
E+ Y+E ++ P F K PE +++
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEIIEG 265
Query: 261 FFQYSPNLRCTALEACVHPFFDE 283
+ + + R + + H FF E
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 31/138 (22%), Positives = 61/138 (44%), Gaps = 16/138 (11%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
+ + + + ++G+G FG VF+AK R G+ IK+V + RE++ + LDH N
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65
Query: 137 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
IV C+ +++ + L + +E+ I + R +++ +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122
Query: 184 YVKLYTYQICRALAYIHN 201
QI + + YIH+
Sbjct: 123 LALELFEQITKGVDYIHS 140
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-22
Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 13/120 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 140
Y +G G + VF+A E V +K + ++ K+ K RE++I++ L PNI+ L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ V E+V T ++ +++Q + ++ Y Y+I +AL Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 27/92 (29%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 204 VDQLVEIIKVLGTPTREEI--KCMNPNYTEFK--FPQIKPHPWHKVF----QKRLPPEAV 255
DQLV I KVLGT + K F + W + Q + PEA+
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 297
Query: 256 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287
D + + +Y R TA EA HP+F +
Sbjct: 298 DFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-22
Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 15/128 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 137
+G G++G V++A+ +G VA+K V RE+ +++ L +HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L ++ E+ + LV E+V + + +P +K Q R L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134
Query: 198 YIH-NCIV 204
++H NCIV
Sbjct: 135 FLHANCIV 142
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 19/88 (21%), Positives = 33/88 (37%), Gaps = 9/88 (10%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
DQL +I ++G P ++ P FP P P V + L+
Sbjct: 225 ADQLGKIFDLIGLPPEDDW----PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLE 279
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
++P+ R +A A H + + + N
Sbjct: 280 MLTFNPHKRISAFRALQHSYLHKD-EGN 306
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-22
Identities = 30/138 (21%), Positives = 51/138 (36%), Gaps = 13/138 (9%)
Query: 72 GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 127
G S+ + +G+G FG VF+ R G I AIK+ L + L+
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 128 ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
+ H ++V + E+ ++ + EY ++ RI
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 184 YVKLYTYQICRALAYIHN 201
+K Q+ R L YIH+
Sbjct: 116 ELKDLLLQVGRGLRYIHS 133
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 27/117 (23%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G V++A T E VAIK++ + + RE+ +++ L H NI+ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
L+ L+ EY + + + + + +K + YQ+ + + H
Sbjct: 102 I---HHNHRLH--LIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH 149
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 16/99 (16%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL +I +VLG P + + P++ + FP+ + +V L E +DL+
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTAL-PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTA 301
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 299
+ P R +A A HP+F P
Sbjct: 302 MLEMDPVKRISAKNALEHPYFSHN-----------DFDP 329
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 51/275 (18%), Positives = 91/275 (33%), Gaps = 81/275 (29%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 144
V+G G++G+V+ + +AIK++ +D RY E+ + + L H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
+ + E ++ + +E VP +++ + R+ + + I YT QI L Y+H
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141
Query: 201 ----------NCIVDQLVEIIK-------------------VLGTP---TREEIKCMNPN 228
N +++ ++K GT E I
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 229 YTE-------------------------------FKFPQIKPHPWHKVFQKRLPPEAVDL 257
Y + FK K HP + + EA
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP---EIPESMSAEAKAF 258
Query: 258 VCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 292
+ + F+ P+ R A + V F P
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 21/127 (16%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 133
+YI +G G++ V++ K + T +VA+K++ R ++ RE+ +++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
H NIV L ++ L LV EY+ + + + + + + VKL+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLT--LVFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110
Query: 194 RALAYIH 200
R LAY H
Sbjct: 111 RGLAYCH 117
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+QL I ++LGTPT E I + + +P+ + RL + DL+ +
Sbjct: 207 EEQLHFIFRILGTPTEETWPGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTK 264
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304
Q+ R +A +A HPFF L + +LP+ + L +
Sbjct: 265 LLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 30/122 (24%), Positives = 57/122 (46%), Gaps = 20/122 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
+G G++ V++ + TG VA+K+V + + RE+ +M+ L H NIV L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ +L LV E++ + + +R + + L VK + +Q+ + LA+
Sbjct: 69 YDVI---HTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 199 IH 200
H
Sbjct: 124 CH 125
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 10/103 (9%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVD 256
+QL I ++GTP + + P Y Q P +V Q L +D
Sbjct: 215 EEQLKLIFDIMGTPNESLWPSVTKL-PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272
Query: 257 LVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 299
+ Q +P++R +A +A HP+F E + R
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHHPWFAEYYHH-ASMGGSRSHHH 314
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 34/129 (26%), Positives = 59/129 (45%), Gaps = 22/129 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y H++GTGS+G V +A + +VAIKK+L+ KR RE+ I+ L+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
++V + +ELY +VLE ++ + L +++K Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164
Query: 192 ICRALAYIH 200
+ + Y+H
Sbjct: 165 LLVGVKYVH 173
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 34/133 (25%), Positives = 55/133 (41%), Gaps = 9/133 (6%)
Query: 164 ETVNRIARNYSRIHQRMPL-----IYVKLYTYQICRALAYIHNCIVDQLVEIIKVLGTPT 218
E +N I N + R PL + + + DQL I +LGTP+
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335
Query: 219 REEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 275
E+I+ + + + FP+ + + F +A+ L+ R ++PN R T E
Sbjct: 336 EEDIEALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINEC 394
Query: 276 CVHPFFDELRDPN 288
HPFF E+R
Sbjct: 395 LAHPFFKEVRIAE 407
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-21
Identities = 26/127 (20%), Positives = 46/127 (36%), Gaps = 19/127 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
Y+ +G G F F+ +T E+ A K +L + E+ I + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V F D + ++ +VLE + R + + + Y QI
Sbjct: 77 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126
Query: 195 ALAYIHN 201
Y+H
Sbjct: 127 GCQYLHR 133
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 22/129 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 135
YI +H++G GS+G V+ A + T + VAIKKV L D KR RE+ I+ L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
I+ L +ELY +VLE + ++ + L ++K Y
Sbjct: 86 YIIRLYDLIIPDDLLKFDELY--IVLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137
Query: 192 ICRALAYIH 200
+ +IH
Sbjct: 138 LLLGENFIH 146
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
DQL I ++GTPT +++K + P ++ FP KP + + + + ++L+
Sbjct: 286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDGINLLES 344
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
+++PN R T +A HP+ ++R
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVRKKK 372
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 19/119 (15%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 143
G G FG V+ A+ +++ I+A+K ++ + RE++I L HPNI+ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F D +Y L+LEY P + + + Y ++ AL+Y H
Sbjct: 78 FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCH 126
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 13/144 (9%)
Query: 72 GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 124
GGR+ + + + + +GTG FG V + ++TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 181
E+QIM+ L+HPN+V+ + L L +EY + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119
Query: 182 LIYVKLYTYQICRALAYIH-NCIV 204
++ I AL Y+H N I+
Sbjct: 120 EGPIRTLLSDISSALRYLHENRII 143
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 26/127 (20%), Positives = 46/127 (36%), Gaps = 19/127 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
Y+ +G G F F+ +T E+ A K +L + E+ I + L H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V F D + ++ +VLE + R + + + Y QI
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152
Query: 195 ALAYIHN 201
Y+H
Sbjct: 153 GCQYLHR 159
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 15/143 (10%)
Query: 74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 125
++G + Y +G G++G VF+A+ + G VA+K+V + RE
Sbjct: 3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61
Query: 126 LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 182
+ +++ L +HPN+V L + E L LV E+V + + +P
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 183 IYVKLYTYQICRALAYIH-NCIV 204
+K +Q+ R L ++H + +V
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVV 142
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
VDQL +I+ V+G P E+ P F P K + DL+ +
Sbjct: 225 VDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLK 279
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 299
++P R +A A HP+F +L L + LPP
Sbjct: 280 CLTFNPAKRISAYSALSHPYFQDLERCKENLDS--HLPP 316
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 28/138 (20%), Positives = 53/138 (38%), Gaps = 17/138 (12%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 133
+ + + V+G G+FG V +A+ AIKK+ + + E+ ++ L+
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 134 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
H +V + T K++ L + +EY + I +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 184 YVKLYTYQICRALAYIHN 201
+ QI AL+YIH+
Sbjct: 121 LFR----QILEALSYIHS 134
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 31/122 (25%), Positives = 57/122 (46%), Gaps = 19/122 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
+G G FG V+ A+ ++ I+A+K ++ ++ RE++I L HPNI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D++ +Y L+LE+ P E + + H R + ++ AL Y
Sbjct: 81 NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130
Query: 200 HN 201
H
Sbjct: 131 HE 132
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-20
Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 15/117 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ GE A+KK+ +K + RE+ I++ L H NIV L
Sbjct: 10 IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
K+ L LV E++ + + ++ + + K + Q+ +AY H
Sbjct: 69 I---HTKKRLV--LVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH 117
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-17
Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
DQL+ I ++LGTP + + + P Y + F +P PW K L +DL+ +
Sbjct: 207 ADQLMRIFRILGTPNSKNWPNVTEL-PKY-DPNFTVYEPLPWESFL-KGLDESGIDLLSK 263
Query: 261 FFQYSPNLRCTALEACVHPFFDEL 284
+ PN R TA +A H +F E
Sbjct: 264 MLKLDPNQRITAKQALEHAYFKEN 287
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 12/121 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G+FG VF+A+ R+TG+ VA+KKVL + + RE++I+Q+L H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 144 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ LV ++ + + N + + L +K + L YIH
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 201 N 201
Sbjct: 142 R 142
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 20/100 (20%), Positives = 34/100 (34%), Gaps = 7/100 (7%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVC 259
QL I ++ G+ T E + Y + + + + + P A+DL+
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 299
+ P R + +A H FF DP G
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWS--DPMPSDLKGMLSTH 331
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 16/126 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y+ +G GSFG K E G IK++ +++ RE+ ++ + HPNI
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V + F +E L +V++Y + RI + + + QIC A
Sbjct: 86 VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137
Query: 196 LAYIHN 201
L ++H+
Sbjct: 138 LKHVHD 143
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-20
Identities = 34/117 (29%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
VG G++GVV++AK G IVA+K++ D + RE+ +++ L HPNIV+L
Sbjct: 29 VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ L LV E++ + + ++ + +K+Y YQ+ R +A+ H
Sbjct: 88 I---HSERCLT--LVFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCH 136
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 204 VDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
DQL +I +LGTP +++ + P + + F + PW + E +DL+
Sbjct: 226 DDQLPKIFSILGTPNPREWPQVQEL-PLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSN 283
Query: 261 FFQYSPNLRCTALEACVHPFFDEL 284
+ PN R +A +A HP+F +L
Sbjct: 284 MLCFDPNKRISARDAMNHPYFKDL 307
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 32/126 (25%), Positives = 63/126 (50%), Gaps = 18/126 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 136
+ + ++G G++GVV A + TGEIVAIKK+ R RE++I++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 137 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ + + + + E+Y ++ E + ++R+ Q + +++ + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVY--IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123
Query: 195 ALAYIH 200
A+ +H
Sbjct: 124 AVKVLH 129
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 36/122 (29%), Positives = 55/122 (45%), Gaps = 8/122 (6%)
Query: 204 VDQLVEIIKVLGTPTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVC 259
QL+ I ++GTP + +P E+ P P K+F + + P+ +DL+
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQ 287
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELSGIPPETINR 318
R + P R TA EA HP+ DPN P G P+PP F F + + + +
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKK 345
Query: 319 LI 320
LI
Sbjct: 346 LI 347
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 31/120 (25%), Positives = 52/120 (43%), Gaps = 13/120 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 142
+ VG GSFG V + K ++TG A+KKV L+ ++ EL L P IV L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+E ++N+ +E + ++ ++ + +P Y Q L Y+H
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT 168
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 15/146 (10%)
Query: 65 HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 117
H + G N + + +I + +G+G+FG V + R +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 175
E+++++ LDHPNI+ + F D +Y +V+E E + RI +R
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHN 201
+ + YV Q+ ALAY H+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHS 142
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 28/131 (21%), Positives = 52/131 (39%), Gaps = 14/131 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 138
+ +G G FGVVF+AK + AIK++ + RE++ + L+HP IV
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 139 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 190
+ + ++YL + ++ E + I +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 191 QICRALAYIHN 201
QI A+ ++H+
Sbjct: 126 QIAEAVEFLHS 136
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 42/167 (25%), Positives = 64/167 (38%), Gaps = 19/167 (11%)
Query: 41 DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
+V D D + + + G+ Y +G+G+FGVV +
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHR 69
Query: 101 AKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
+ TG + K DK E+ IM L HP ++ L F DK E+
Sbjct: 70 CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV-- 124
Query: 157 LVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
L+LE++ E +RI A +Y M V Y Q C L ++H
Sbjct: 125 LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMH 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 26/134 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 137
Y+ +G G G+VF A + + VAIKK+ L D K RE++I++ LDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 138 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 186
V + S T+ +Y +V EY+ + + + + +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVY--IVQEYMETDLANVLE-----QGPLLEEHAR 123
Query: 187 LYTYQICRALAYIH 200
L+ YQ+ R L YIH
Sbjct: 124 LFMYQLLRGLKYIH 137
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRF 261
++Q+ I++ + E+ + + + P ++ + EAVD + +
Sbjct: 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQI 289
Query: 262 FQYSPNLRCTALEACVHPFFDELRDPN 288
+SP R TA EA HP+ P
Sbjct: 290 LTFSPMDRLTAEEALSHPYMSIYSFPM 316
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 29/151 (19%), Positives = 53/151 (35%), Gaps = 26/151 (17%)
Query: 59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 115
+G E + ++ GR Y +G+G VFQ E +I AIK V
Sbjct: 13 LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63
Query: 116 -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 170
++ + E+ + L + I+ L + +Y+ V+E +N
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ + + K Y + A+ IH
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQ 145
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 13/70 (18%)
Query: 225 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284
++PN+ E +FP I + D++ + P R + E HP+
Sbjct: 253 IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
Query: 285 RDPNTRLPNG 294
P ++ G
Sbjct: 300 THPVNQMAKG 309
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 17/141 (12%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 126
+ + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 183
+M LDH N++ L F K ++ LV+EYV E +RI +Y+ + +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187
Query: 184 YVKLYTYQICRALAYIHNCIV 204
L+ QIC + ++H +
Sbjct: 188 DTILFMKQICEGIRHMHQMYI 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 25/132 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 131
YI +G+G+ G V A R+T + VAI+ + + K E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
L+HP I+ +K+ F D E+ Y +VLE + E +++ ++R+ KLY
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245
Query: 190 YQICRALAYIHN 201
YQ+ A+ Y+H
Sbjct: 246 YQMLLAVQYLHE 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 22/136 (16%)
Query: 76 GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 129
G++K ++ Y E+ +G GS+G V A + T A K ++D +E++IM
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
+ LDHPNI+ L F D ++Y LV+E E R+ +
Sbjct: 61 KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108
Query: 186 KLYTYQICRALAYIHN 201
+ A+AY H
Sbjct: 109 ARIMKDVLSAVAYCHK 124
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 31/126 (24%), Positives = 59/126 (46%), Gaps = 17/126 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y++ VG+G++G V A + +GE VAIKK+ + REL +++ + H N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 138 VALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+ L F + + Y LV+ ++ + +I + + ++ YQ+ +
Sbjct: 86 IGLLDVFTPASSLRNFYDFY--LVMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLK 137
Query: 195 ALAYIH 200
L YIH
Sbjct: 138 GLKYIH 143
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL +I+KV G P E ++ + + + PQ + ++F R P+A DL+ +
Sbjct: 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEK 288
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
+ + R TA +A HPFF+ RDP
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEPFRDPE 316
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 26/132 (19%), Positives = 46/132 (34%), Gaps = 18/132 (13%)
Query: 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 131
S + Y +G+G VFQ E +I AIK V ++ E+ +
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 132 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
L + I+ L + +Y+ V+E +N + + + K Y
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161
Query: 190 YQICRALAYIHN 201
+ A+ IH
Sbjct: 162 KNMLEAVHTIHQ 173
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 13/70 (18%)
Query: 225 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284
++PN+ E +FP I + D++ + P R + E HP+
Sbjct: 281 IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
Query: 285 RDPNTRLPNG 294
P ++ G
Sbjct: 328 THPVNQMAKG 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 18/119 (15%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
G GSF V++A+ TG VAIK + + YK E++I L HP+I+ L +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F D +Y LVLE E + + + + +QI + Y+H
Sbjct: 80 F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLH 129
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-19
Identities = 34/130 (26%), Positives = 65/130 (50%), Gaps = 21/130 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 139
+I V+G+G+F VF K R TG++ A+K + + +++ E+ +++ + H NIV
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 195
L+ + Y LV++ V E +RI Y+ ++ + ++ Q+ A
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118
Query: 196 LAYIH-NCIV 204
+ Y+H N IV
Sbjct: 119 VKYLHENGIV 128
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 15/125 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
Y +GTG+FGVV + R TG A K V DK +E+Q M +L HP +V
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L F D E+ ++ E++ E ++A ++++ + + Y++ Q+C+ L
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 198 YIHNC 202
++H
Sbjct: 270 HMHEN 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 25/126 (19%), Positives = 44/126 (34%), Gaps = 18/126 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 136
Y +G+G VFQ E +I AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
I+ L + +Y+ V+E +N + + + K Y + A
Sbjct: 70 KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120
Query: 196 LAYIHN 201
+ IH
Sbjct: 121 VHTIHQ 126
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 13/72 (18%)
Query: 223 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 282
++PN+ E +FP I + D++ + P R + E HP+
Sbjct: 232 AIIDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 283 ELRDPNTRLPNG 294
P ++ G
Sbjct: 279 IQTHPVNQMAKG 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 48/279 (17%), Positives = 84/279 (30%), Gaps = 65/279 (23%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ P+IV +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ L +V+E + E +RI R Q I A+ Y+H
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 201 NC-IV----------------DQLVEII------KVLGTPTREEIKC------------- 224
+ I + ++++ + G +
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCG 194
Query: 225 ------MNPNYTEFK-FPQIK-------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 270
+ +I+ W +V E L+ + P R
Sbjct: 195 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-----SEEVKMLIRNLLKTEPTQRM 249
Query: 271 TALEACVHPFFDELRD-PNTRLPNGRPLPPLFNFKPPEL 308
T E HP+ + P T L R L + ++
Sbjct: 250 TITEFMNHPWIMQSTKVPQTPLHTSRVL-KEDKERWEDV 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 27/128 (21%), Positives = 52/128 (40%), Gaps = 24/128 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 140
Y+ +G G FG+V + + + +K D+ +E+ I+ + H NI+ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 193
F EEL ++ E++ + RI + + Y +Q+C
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112
Query: 194 RALAYIHN 201
AL ++H+
Sbjct: 113 EALQFLHS 120
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 33/126 (26%), Positives = 67/126 (53%), Gaps = 19/126 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 134
Y +G G++G+V+++ R TGE+VA+KK+ Q+ +R + RE+ I+ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L + + D+ ++Y LV +Y+ ++ + R + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDR-DVY--LVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120
Query: 195 ALAYIH 200
+ Y+H
Sbjct: 121 VIKYLH 126
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 24/135 (17%), Positives = 46/135 (34%), Gaps = 22/135 (16%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP--------- 251
++QL II V+ P+ E+++ + +P +
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 252 ------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 305
EA+DL+ + Q++PN R +A +A HPF +PN +
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPI 352
Query: 306 PELSGIPPETINRLI 320
+ + L+
Sbjct: 353 NDNVKHSIDDYRNLV 367
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 31/126 (24%), Positives = 60/126 (47%), Gaps = 16/126 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y VG+G++G V A TG VAIKK+ + REL++++ + H N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 138 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+ L F + D + Y LV+ ++ + ++ ++ +++ ++ YQ+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFY--LVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139
Query: 195 ALAYIH 200
L YIH
Sbjct: 140 GLRYIH 145
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL EI+KV GTP E ++ + + + P+++ + + P AV+L+ +
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEK 290
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
R TA EA HP+F+ L D
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTE 318
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 26/128 (20%), Positives = 57/128 (44%), Gaps = 14/128 (10%)
Query: 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 138
K+S+ + V+G G+ G + + VA+K++L + + +RE+Q+++ D HPN++
Sbjct: 23 KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
K+ + + +E + + P+ ++ Q LA
Sbjct: 82 RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132
Query: 198 YIHNC-IV 204
++H+ IV
Sbjct: 133 HLHSLNIV 140
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 11/67 (16%), Positives = 19/67 (28%), Gaps = 10/67 (14%)
Query: 215 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 274
G + + + + H A +L+ + P R +A
Sbjct: 231 GKSLQRQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKH 280
Query: 275 ACVHPFF 281
HPFF
Sbjct: 281 VLKHPFF 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 29/136 (21%), Positives = 53/136 (38%), Gaps = 12/136 (8%)
Query: 75 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 133
N K ++E ++G GS G V + G VA+K++L D E++++ D
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 134 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 189
HPN++ +C + LY + LE + + +
Sbjct: 67 DHPNVIRY-YCSET--TDRFLY--IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 190 YQICRALAYIH-NCIV 204
QI +A++H I+
Sbjct: 122 RQIASGVAHLHSLKII 137
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 13/51 (25%), Positives = 21/51 (41%), Gaps = 5/51 (9%)
Query: 231 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281
F ++K + EA DL+ + + P R TA++ HP F
Sbjct: 254 IFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 28/126 (22%), Positives = 54/126 (42%), Gaps = 17/126 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G+G+ G+V A VAIKK+ + REL +M+ ++H NI
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 138 VALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+ L + F E ++Y +V+E + + ++ I + + YQ+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVY--IVMELMDANLCQV------IQMELDHERMSYLLYQMLC 138
Query: 195 ALAYIH 200
+ ++H
Sbjct: 139 GIKHLH 144
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 14/119 (11%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQ-----------KRL 250
+DQ ++I+ LGTP E +K + P + P+ + + K+F K
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK 291
Query: 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 309
+A DL+ + + R + EA HP+ + DP+ P P E +
Sbjct: 292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 31/136 (22%), Positives = 54/136 (39%), Gaps = 27/136 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 128
Y + + +GS+G V G VAIK+V RE+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 184
+ HPNI+ L+ F F +LY LV E + + ++ QR+ + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLY--LVTELMRTDLAQVIH-----DQRIVISPQH 135
Query: 185 VKLYTYQICRALAYIH 200
++ + Y I L +H
Sbjct: 136 IQYFMYHILLGLHVLH 151
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
+QL +I++V+GTP E++ +P +Y + W V P A+DL+
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIA 298
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 309
+ +++P R + +A HP+F+ L DP L G F+F
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDPL-DLTEGLSER--FHFDESVTD 345
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 26/136 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 131
YI +G+G+ G V A R+T + VAIK + + E++I++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
L+HP I+ +K+ F D E+ Y +VLE + E +++ ++R+ KLY
Sbjct: 72 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120
Query: 190 YQICRALAYIH-NCIV 204
YQ+ A+ Y+H N I+
Sbjct: 121 YQMLLAVQYLHENGII 136
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 22/128 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y ++G GSFG V + K R T + A+K + + RE+++++ LDHPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L D Y +V E E + I + +S Q+
Sbjct: 84 MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131
Query: 194 RALAYIHN 201
+ Y+H
Sbjct: 132 SGITYMHK 139
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 29/126 (23%), Positives = 56/126 (44%), Gaps = 18/126 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 136
Y +G G++G+V A VAIKK+ + +R RE++I+ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 137 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ + + +++Y +V + + + ++ + Q + ++ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139
Query: 195 ALAYIH 200
L YIH
Sbjct: 140 GLKYIH 145
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 24/88 (27%), Positives = 49/88 (55%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I+ +LG+P++E++ C+ N + P PW+++F +A+DL+ +
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDK 296
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
++P+ R +A HP+ ++ DP+
Sbjct: 297 MLTFNPHKRIEVEQALAHPYLEQYYDPS 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 31/121 (25%), Positives = 62/121 (51%), Gaps = 12/121 (9%)
Query: 90 VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
VG G++G V++AK ++ + A+K++ + RE+ +++ L HPN+++L+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 146 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
S D++ + L+ +Y + I A ++ ++P VK YQI + Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 201 N 201
Sbjct: 146 A 146
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 21/134 (15%), Positives = 44/134 (32%), Gaps = 11/134 (8%)
Query: 204 VDQLVEIIKVLGTPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 254
DQL I V+G P + E + ++ + + + + + +A
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 314
L+ + P R T+ +A P+F E DP + + P +
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPDD 368
Query: 315 TINRLIPEHARKQN 328
++ + + N
Sbjct: 369 KGDKKNQQQQQGNN 382
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 21/128 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y +G+G+ G+V A VAIKK+ + KR Y REL +M+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
NI++L + F E ++Y LV+E + + ++ I + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVY--LVMELMDANLCQV------IQMELDHERMSYLLYQM 173
Query: 193 CRALAYIH 200
+ ++H
Sbjct: 174 LCGIKHLH 181
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 13/98 (13%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKPHPWHKVF-----------QKRL 250
+DQ ++I+ LGTP E +K + P + P+ + K+F K
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288
+A DL+ + P R + +A HP+ + DP
Sbjct: 329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 22/128 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y ++G GSFG V + K R T + A+K + +D RE+++++ LDHPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L D Y +V E E + I + +S Q+
Sbjct: 84 MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131
Query: 194 RALAYIHN 201
+ Y+H
Sbjct: 132 SGITYMHK 139
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 36/127 (28%), Positives = 58/127 (45%), Gaps = 19/127 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 136
Y + V+G GSFG V K + TG+ A+K + ++ K K RE+Q+++ LDHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ L F +++ Y LV E E + I +R + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137
Query: 195 ALAYIHN 201
+ Y+H
Sbjct: 138 GITYMHK 144
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 30/134 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG+ A K + + RE+ I++ +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
HPNI+ L F +K ++ L+LE V E + +A S
Sbjct: 67 HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112
Query: 188 YTYQICRALAYIHN 201
+ QI + Y+H+
Sbjct: 113 FLKQILDGVHYLHS 126
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 29/133 (21%), Positives = 52/133 (39%), Gaps = 30/133 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F VV + + + TG A K + + RE+ I++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
HPN++ L + +K ++ L+LE V E + +A S
Sbjct: 73 HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118
Query: 188 YTYQICRALAYIH 200
+ QI + Y+H
Sbjct: 119 FLKQILNGVYYLH 131
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 31/132 (23%), Positives = 47/132 (35%), Gaps = 23/132 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G+F VV + G+ A + K RE +I ++L HPNI
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L +++ Y L+ + V E I YS QI
Sbjct: 73 VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYSE-------ADASHCIQQIL 120
Query: 194 RALAYIH-NCIV 204
A+ + H +V
Sbjct: 121 EAVLHCHQMGVV 132
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 20/128 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y VG+G++G V A +TG VA+KK+ + KR Y REL++++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
N++ L F E ++Y LV + +N I + Q++ +V+ YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141
Query: 193 CRALAYIH 200
R L YIH
Sbjct: 142 LRGLKYIH 149
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 204 VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
+DQL I++++GTP E +K + + + + Q+ + VF P AVDL+ +
Sbjct: 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEK 294
Query: 261 FFQYSPNLRCTALEACVHPFFDELRDPN 288
+ R TA +A H +F + DP+
Sbjct: 295 MLVLDSDKRITAAQALAHAYFAQYHDPD 322
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 38/133 (28%), Positives = 53/133 (39%), Gaps = 25/133 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
Y V+G G F VV + RETG+ A+K V K + RE I ML H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 188
P+IV L + + LY +V E++ + I + +Y Y
Sbjct: 86 PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135
Query: 189 TYQICRALAYIHN 201
QI AL Y H+
Sbjct: 136 MRQILEALRYCHD 148
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 22/128 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y +G+G++G V + + T AIK + E+ ++++LDHPNI
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L F +++ LV+E E + I ++ + + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146
Query: 194 RALAYIHN 201
+ Y+H
Sbjct: 147 SGVTYLHK 154
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 26/132 (19%), Positives = 53/132 (40%), Gaps = 26/132 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG A K + + RE+ I++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 189
H N++ L + ++ ++ L+LE V E + +A+ + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121
Query: 190 YQICRALAYIHN 201
QI + Y+H
Sbjct: 122 KQILDGVNYLHT 133
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 36/122 (29%), Positives = 50/122 (40%), Gaps = 19/122 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
++G GSF V A+ T AIK ++++ Y RE +M LDHP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D E+LY L Y E + I + + YT +I AL Y+
Sbjct: 97 FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146
Query: 200 HN 201
H
Sbjct: 147 HG 148
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 27/126 (21%), Positives = 47/126 (37%), Gaps = 7/126 (5%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 138
V+ G F V++A+ +G A+K++L + R +E+ M+ L HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 139 ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L+L + + + V YQ CRA+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 197 AYIHNC 202
++H
Sbjct: 150 QHMHRQ 155
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 19/128 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
+ E +G G+ +V++ K + T + A+K + + K E+ ++ L HPNI+ LK
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
F E+ LVLE V E +RI YS +R VK QI A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162
Query: 198 YIH-NCIV 204
Y+H N IV
Sbjct: 163 YLHENGIV 170
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 31/125 (24%), Positives = 52/125 (41%), Gaps = 19/125 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
Y +G+G+FGV + + T E+VA+K + + RE+ + L HPNIV
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
K + T L +++EY E RI R + + Q+ +
Sbjct: 80 RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129
Query: 197 AYIHN 201
+Y H+
Sbjct: 130 SYCHS 134
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 37/132 (28%), Positives = 50/132 (37%), Gaps = 23/132 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y + +G G+F VV + + TG A K + K RE +I + L HPNI
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L ++ Y LV + V E I YS QI
Sbjct: 91 VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138
Query: 194 RALAYIH-NCIV 204
++AY H N IV
Sbjct: 139 ESIAYCHSNGIV 150
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 34/128 (26%), Positives = 48/128 (37%), Gaps = 22/128 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y + +G G+F VV + + TG A K + K RE +I + L HPNI
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L ++ Y LV + V E I YS QI
Sbjct: 68 VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 194 RALAYIHN 201
++AY H+
Sbjct: 116 ESIAYCHS 123
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 26/135 (19%), Positives = 51/135 (37%), Gaps = 32/135 (23%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG A K + + RE+ I++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 186
HPNI+ L + ++ ++ L+LE V E + + +
Sbjct: 74 HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118
Query: 187 LYTYQICRALAYIHN 201
+ QI + Y+H
Sbjct: 119 SFIKQILDGVNYLHT 133
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 17/131 (12%), Positives = 42/131 (32%), Gaps = 16/131 (12%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 133
H++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
+ + LV E +N I + + MP V + +
Sbjct: 126 QHMFMKFYSAHL---FQNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 192 ICRALAYIHNC 202
+ + +H+C
Sbjct: 181 MLYMIEQVHDC 191
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 32/125 (25%), Positives = 50/125 (40%), Gaps = 17/125 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K V + +E+ I +ML+H N+V
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
Y L LEY E +RI MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118
Query: 197 AYIHN 201
Y+H
Sbjct: 119 VYLHG 123
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 30/130 (23%), Positives = 61/130 (46%), Gaps = 21/130 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 135
Y+ ++G GS+G V + ET A+K K+ + + +E+Q+++ L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
N++ L ++ K+++Y +V+EY E ++ + +R P+ Y Q
Sbjct: 67 NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117
Query: 192 ICRALAYIHN 201
+ L Y+H+
Sbjct: 118 LIDGLEYLHS 127
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ P+IV +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 196
+ L +V+E + E +SRI R + I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 197 AYIHN 201
Y+H+
Sbjct: 175 QYLHS 179
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 32/137 (23%), Positives = 52/137 (37%), Gaps = 29/137 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 126
Y +G+G++G V K + AIK + + + K E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 184
+++ LDHPNI+ L F DK+ Y LV E+ E +I N + +
Sbjct: 98 SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147
Query: 185 VKLYTYQICRALAYIHN 201
QI + Y+H
Sbjct: 148 AANIMKQILSGICYLHK 164
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 25/125 (20%), Positives = 51/125 (40%), Gaps = 17/125 (13%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNI 137
+ +G G F VV Q + TG+ A K + + +R ++ E+ ++++ P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ L + + E+ L+LEY E + + + + V QI
Sbjct: 92 INLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEG 143
Query: 196 LAYIH 200
+ Y+H
Sbjct: 144 VYYLH 148
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 20/139 (14%)
Query: 73 GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 124
G + + K+ Y+ +G G+FG V + + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
E+Q +++ HP+I+ L + TD + +V+EYV E + I + H R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110
Query: 183 IYVKLYTYQICRALAYIHN 201
+ + QI A+ Y H
Sbjct: 111 MEARRLFQQILSAVDYCHR 129
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 26/125 (20%), Positives = 51/125 (40%), Gaps = 16/125 (12%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 143
+++ V+G G G V + R TG+ A+K +L D +E+ P+IV +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
+ + L +++E + E +SRI +R + I A+
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 198 YIHNC 202
++H+
Sbjct: 143 FLHSH 147
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 41/132 (31%), Positives = 57/132 (43%), Gaps = 23/132 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
Y +G G+F V A+ TG VAIK + DK N RE++IM++L+HP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
NIV L + L L++EY E + + H RM + QI
Sbjct: 75 NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124
Query: 194 RALAYIH-NCIV 204
A+ Y H IV
Sbjct: 125 SAVQYCHQKRIV 136
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 19/122 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+G GSFG V + +T ++ A+K K ++ R +ELQIMQ L+HP +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D+E+++ +V++ + + + +N VKL+ ++ AL Y+
Sbjct: 82 YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131
Query: 200 HN 201
N
Sbjct: 132 QN 133
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 32/125 (25%), Positives = 50/125 (40%), Gaps = 17/125 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K V + +E+ I +ML+H N+V
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
Y L LEY E +RI MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118
Query: 197 AYIHN 201
Y+H
Sbjct: 119 VYLHG 123
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 19/137 (13%), Positives = 45/137 (32%), Gaps = 33/137 (24%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 129
G F + + + A+K + + + + ELQI+
Sbjct: 40 NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 184
+ + + + T+ +E+Y ++ EY+ + +P+
Sbjct: 98 TDIKNEYCLTCEGII---TNYDEVY--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 185 VKLYTYQICRALAYIHN 201
+K + + +YIHN
Sbjct: 153 IKCIIKSVLNSFSYIHN 169
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 30/151 (19%)
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
H I + + Y + +G GS+ V + + T A+K + + KR
Sbjct: 7 HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64
Query: 125 ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 174
E++I+ HPNI+ LK + D + +Y +V E + E +++I R +S
Sbjct: 65 EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNC-IV 204
+ + I + + Y+H +V
Sbjct: 120 AV------------LFTITKTVEYLHAQGVV 138
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 27/122 (22%), Positives = 51/122 (41%), Gaps = 18/122 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V K + ++ A+K ++L+ E ++ D I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D LY LV++Y + + + S+ R+P + Y ++ A+ +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 200 HN 201
H
Sbjct: 192 HQ 193
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-15
Identities = 32/123 (26%), Positives = 61/123 (49%), Gaps = 19/123 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+GTGSFG V + R G A+K V++ K + N E ++ ++ HP I+ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D ++++ ++++Y+ E + + ++ QR P K Y ++C AL Y+
Sbjct: 73 GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122
Query: 200 HNC 202
H+
Sbjct: 123 HSK 125
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 18/122 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 141
V+G G+F V K ++TG++ A+K +L+ E ++ D I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D+ LY LV+EY + + + S+ +R+P + Y +I A+ +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 200 HN 201
H
Sbjct: 179 HR 180
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 34/139 (24%), Positives = 60/139 (43%), Gaps = 20/139 (14%)
Query: 73 GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 124
+ + + K+ YI +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
E+Q +++ HP+I+ L + +D ++ +V+EYV E + I + + R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115
Query: 183 IYVKLYTYQICRALAYIHN 201
+ QI + Y H
Sbjct: 116 KESRRLFQQILSGVDYCHR 134
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 23/124 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
E VVG G+FGVV +AK R + VAIK++ + K EL+ + ++HPNIV L
Sbjct: 13 EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 198
+ + LV+EY ++ Y+ +H PL Y Q + +AY
Sbjct: 70 --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 199 IHNC 202
+H+
Sbjct: 118 LHSM 121
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 32/122 (26%), Positives = 59/122 (48%), Gaps = 20/122 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V + + T ++ A+K ++++ + E IM + P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D LY +V+EY+P + VN ++ +P + + YT ++ AL I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184
Query: 200 HN 201
H+
Sbjct: 185 HS 186
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 19/133 (14%)
Query: 78 SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 129
SK+ + YI +G GSFG V A +T + VA+K + + + RE+ +
Sbjct: 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 188
++L HP+I+ L + TD + +V+EY E + I +RM + +
Sbjct: 64 KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113
Query: 189 TYQICRALAYIHN 201
QI A+ Y H
Sbjct: 114 FQQIICAIEYCHR 126
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 15/128 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
Y + V+G+G+ VV A C E VAIK++ +K + +E+Q M HPNIV
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 139 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+ F K+EL+ LV++ V + + I + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 194 RALAYIHN 201
L Y+H
Sbjct: 132 EGLEYLHK 139
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 23/126 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 138
E ++G G FG V++A G+ VA+K D +E ++ ML HPNI+
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 139 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
AL+ C + L LV+E+ +NR+ +R+P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118
Query: 197 AYIHNC 202
Y+H+
Sbjct: 119 NYLHDE 124
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 22/128 (17%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 135
E +G G FG+V + + + +VAIK ++ RE+ IM L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L + +V+E+VP + + + + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133
Query: 195 ALAYIHNC 202
+ Y+ N
Sbjct: 134 GIEYMQNQ 141
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 24/136 (17%), Positives = 49/136 (36%), Gaps = 30/136 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 130
Y + ++G G VV + + T + A+K + +Q+ R +E+ I++
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 131 MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
+ HPNI+ LK + + LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 186 KLYTYQICRALAYIHN 201
+ + +H
Sbjct: 128 -KIMRALLEVICALHK 142
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 31/137 (22%), Positives = 56/137 (40%), Gaps = 26/137 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 131
Y +G+G+FG V+ A +E + V +K KVL+D ++ E+ I+
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
++H NI+ + F ++ LV+E + I R H R+
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135
Query: 189 TYQICRALAYIH-NCIV 204
Q+ A+ Y+ I+
Sbjct: 136 FRQLVSAVGYLRLKDII 152
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 26/132 (19%), Positives = 49/132 (37%), Gaps = 33/132 (25%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 139
+ E V+G G+ V T + A+K + + RE++++ H N++
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 189
L F +++ Y LV E + S IH+R + +
Sbjct: 76 LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117
Query: 190 YQICRALAYIHN 201
+ AL ++HN
Sbjct: 118 QDVASALDFLHN 129
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 19/123 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+GTGSFG V K +E+G A+K KV++ K + E +I+Q ++ P +V L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D LY +V+EYV E + + R R + + Y QI Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 200 HNC 202
H+
Sbjct: 158 HSL 160
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 24/124 (19%), Positives = 57/124 (45%), Gaps = 18/124 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 141
+ + +G GSF + + +++ + A+K + + +E+ +++ + HPNIV L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
F D+ + LV+E + E RI + ++S + ++ A++
Sbjct: 73 EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120
Query: 198 YIHN 201
++H+
Sbjct: 121 HMHD 124
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 26/88 (29%), Positives = 41/88 (46%), Gaps = 14/88 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 134
Y + +G GS+GVV A +T I AIK + +D E+++M+ L H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYV 162
PNI L + D++ + LV+E
Sbjct: 88 PNIARLYEVY---EDEQYIC--LVMELC 110
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 30/137 (21%), Positives = 62/137 (45%), Gaps = 25/137 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 142
V+G G FG + RETGE++ +K++++ ++ + +E+++M+ L+HPN++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
+ L + EY+ T+ I ++ + P + I +AY+H
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126
Query: 201 -----------NCIVDQ 206
NC+V +
Sbjct: 127 MNIIHRDLNSHNCLVRE 143
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 23/118 (19%), Positives = 49/118 (41%), Gaps = 14/118 (11%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
G V A+ + TGE V ++++ ++ EL + ++ +HPNIV + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ + L +V ++ + + + M + + + +AL YIH+
Sbjct: 96 IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH 146
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 26/136 (19%), Positives = 52/136 (38%), Gaps = 31/136 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 131
Y + V+G G VV + R TG A+K + L++ R RE I++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 185
+ HP+I+ L + ++ LV + + E + + S +
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202
Query: 186 KLYTYQICRALAYIHN 201
+ + A++++H
Sbjct: 203 RSIMRSLLEAVSFLHA 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 15/125 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ + C+ LV+EY + + + + + + + + T+ + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167
Query: 197 AYIHN 201
AY+H+
Sbjct: 168 AYLHS 172
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 17/123 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG VF + + TG++ A K L KR K R E +I+ + IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ F T L LV+ + + I + YT QI L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304
Query: 199 IHN 201
+H
Sbjct: 305 LHQ 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 15/123 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+ +G GSFG V +A+ G VA+K +++ + RE+ IM+ L HPNIV
Sbjct: 42 KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ T L +V EY+ ++ R+ S +++ Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 200 HNC 202
HN
Sbjct: 154 HNR 156
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 19/122 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
++G G+FG V + + TG A+K ++ + E +++Q HP + ALK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D+ L V+EY E ++R + + Y +I AL Y+
Sbjct: 72 YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121
Query: 200 HN 201
H+
Sbjct: 122 HS 123
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 19/83 (22%), Positives = 36/83 (43%), Gaps = 10/83 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G GSFG VF+ T ++VAIK + ++ +E+ ++ D P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 139 ALKHCFFSTTDKEELYLNLVLEY 161
+ T L +++EY
Sbjct: 84 KYYGSYLKDTK-----LWIIMEY 101
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 21/130 (16%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V + TGE+VA+KK LQ ++ RE++I++ L H NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 138 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
V K + L L++EY+P R+Y + H+ R+ I + YT QIC+
Sbjct: 74 VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 196 LAYI--HNCI 203
+ Y+ I
Sbjct: 127 MEYLGTKRYI 136
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 6e-13
Identities = 25/210 (11%), Positives = 49/210 (23%), Gaps = 31/210 (14%)
Query: 22 SSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQK 81
S + D R++L+ E+ EP + T + S+ +
Sbjct: 2 SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61
Query: 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDH 134
+ G VVF + E E A+K + L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 135 PNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETVNRIA 170
+ + D L++ E +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
++ + + T Q+ R A +
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 1/80 (1%)
Query: 217 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 276
P + ++ LP L+ RF + R LEA
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
Query: 277 VHPFFDELRD-PNTRLPNGR 295
P F +L++ ++ L G+
Sbjct: 352 ETPEFLQLQNEISSSLSTGQ 371
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 27/126 (21%), Positives = 55/126 (43%), Gaps = 24/126 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
++G G FG V+ + +TG++ A+ K L KR K ++ L ++ D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V + + F ++L +L+ + + +++ H ++ Y +I
Sbjct: 255 VCMSYAF---HTPDKLS--FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304
Query: 196 LAYIHN 201
L ++HN
Sbjct: 305 LEHMHN 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 7e-13
Identities = 25/122 (20%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 143
++G G +G V++ VA+K +++ E I ++ ++H NI
Sbjct: 18 LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 144 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
T + LV+EY P ++ + S L + + R LAY+H
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA------HSVTRGLAYLHT 129
Query: 202 CI 203
+
Sbjct: 130 EL 131
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 138
+G G+FG V + TGE+VA+K + ++ ++ RE++I++ L H NIV
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 139 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
K + L L++EY+P R+Y + H+ R+ I + YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 197 AYI--HNCI 203
Y+ I
Sbjct: 159 EYLGTKRYI 167
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 26/123 (21%), Positives = 51/123 (41%), Gaps = 15/123 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
Y +G G+ G V+ A TG+ VAI+++ K E+ +M+ +PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + L +V+EY+ ++ + M + + +AL +
Sbjct: 82 YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131
Query: 199 IHN 201
+H+
Sbjct: 132 LHS 134
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 28/127 (22%), Positives = 57/127 (44%), Gaps = 21/127 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
+ +G G+FG V++AK +ETG + A K + ++ E++I+ DHP IV
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 140 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
L ++ L +++E+ V + + R + +++ Q+
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128
Query: 195 ALAYIHN 201
AL ++H+
Sbjct: 129 ALNFLHS 135
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 14/123 (11%), Positives = 43/123 (34%), Gaps = 14/123 (11%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
+ G +++ + + G + +K + R N E +++ HPN++ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ L+ ++P ++ + + + + + R +A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127
Query: 200 HNC 202
H
Sbjct: 128 HTL 130
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 26/175 (14%)
Query: 41 DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS-----YIAEHVVGTGSF 95
V + + + ++ G+ + + + K +V+ Y+ ++G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK--LLGKGTF 161
Query: 96 GVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFSTT 148
G V K + TG A+K ++ + E +++Q HP + ALK+ F T
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-FQTH 220
Query: 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
D+ L V+EY E ++R + + Y +I AL Y+H+
Sbjct: 221 DR--LC--FVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS 266
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 18/128 (14%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G FG V TGE+VA+K + D ++ +E+ I++ L H +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ K C D L LV+EYVP R+Y H + L + L+ QIC +A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 198 YIH--NCI 203
Y+H + I
Sbjct: 149 YLHAQHYI 156
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 25/136 (18%), Positives = 49/136 (36%), Gaps = 25/136 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
Y ++G+G FG V+ VAIK ++ N E+ +++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 134 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
++ L +F D L+LE + + I + + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FV--LILERPEPVQDLFDFITE-----RGALQEELARSF 154
Query: 189 TYQICRALAYIHNCIV 204
+Q+ A+ + HNC V
Sbjct: 155 FWQVLEAVRHCHNCGV 170
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 35/129 (27%), Positives = 60/129 (46%), Gaps = 19/129 (14%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V + TG +VA+K LQ RE+QI++ L I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V + ++ L LV+EY+P + R++ + H+ R+ + LY+ QIC+ +
Sbjct: 87 VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 197 AYI--HNCI 203
Y+ C+
Sbjct: 141 EYLGSRRCV 149
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 15/123 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G FG V R G VA+K + D + E +M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
+K LY +V EY+ +Y R R L L ++ +C A+ Y+ +
Sbjct: 83 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 201 NCI 203
N +
Sbjct: 137 NFV 139
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 11/121 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
+ +G GS+G V++A +ETG+IVAIK+V + + +E+ IMQ D P++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+F TD L +V+EY +V+ I ++ + + + L Y+H
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 201 N 201
Sbjct: 143 F 143
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 25/120 (20%), Positives = 49/120 (40%), Gaps = 16/120 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
VG G +G V++ + GE VA+K +D++ RE ++ L H NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
S +L+ L+ Y ++ + + + ++ I LA++H
Sbjct: 71 DMTSRHSSTQLW--LITHYHEMGSLYDYLQLTTLDTVSCLRIV------LSIASGLAHLH 122
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 30/124 (24%), Positives = 54/124 (43%), Gaps = 15/124 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
T + Y ++ E++ +Y R R + V L QI A+ Y+
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 200 HNCI 203
N I
Sbjct: 130 KNFI 133
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 28/117 (23%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
+G GS G+V A+ + +G VA+K + Q + E+ IM+ H N+V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
EEL+ +++E++ + I R+ + + +ALAY+H
Sbjct: 113 V---GEELW--VLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA 159
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 25/124 (20%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 139
+ +VG G++G V++ + +TG++ AIK + ++ +E+ +++ H NI
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 140 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
F + L LV+E+ +V + +N + ++ +I R L+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143
Query: 198 YIHN 201
++H
Sbjct: 144 HLHQ 147
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 15/123 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G FG V R G VA+K + D + E +M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
+K LY +V EY+ +Y R R L L ++ +C A+ Y+ +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 201 NCI 203
N +
Sbjct: 309 NFV 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 30/129 (23%), Positives = 56/129 (43%), Gaps = 18/129 (13%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G FG V + TGE VA+K + + + +E++I++ L H NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 196
V K T+ + L++E++P + + Y + ++ L Y QIC+ +
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 197 AYI--HNCI 203
Y+ +
Sbjct: 140 DYLGSRQYV 148
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 35/123 (28%), Positives = 52/123 (42%), Gaps = 19/123 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A K L+ KR K R E QI++ ++ +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + T D L LVL + + I Y P Y +IC L
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 199 IHN 201
+H
Sbjct: 302 LHR 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 27/142 (19%), Positives = 50/142 (35%), Gaps = 41/142 (28%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 123
G GS+GVV A A+K K+++ +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 124 ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 178
+E+ I++ LDHPN+V L +++ LY +V E V + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLY--MVFELVNQGPVMEVPT------LK 132
Query: 179 RMPLIYVKLYTYQICRALAYIH 200
+ + Y + + + Y+H
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH 154
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-12
Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 21/124 (16%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 139
V+G GSFG VF K + ++ A+K + R + + E I+ ++HP IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L + F T K LY L+L+++ + R+++ VK Y ++ AL
Sbjct: 91 LHYA-FQTEGK--LY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140
Query: 198 YIHN 201
++H+
Sbjct: 141 HLHS 144
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 25/119 (21%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G G++GVV + + +G+I+A+K++ + + K +L I M+ +D P V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F D + + +E + ++++ + Q +P + I +AL ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 27/138 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
Y ++G G FG VF VAIK +VL + E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 134 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 186
HP ++ L +F T + LVLE + + I + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG--FM--LVLERPLPAQDLFDYITE-----KGPLGEGPSR 142
Query: 187 LYTYQICRALAYIHNCIV 204
+ Q+ A+ + H+ V
Sbjct: 143 CFFGQVVAAIQHCHSRGV 160
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 30/124 (24%), Positives = 54/124 (43%), Gaps = 15/124 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
T + Y ++ E++ +Y R R + V L QI A+ Y+
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 200 HNCI 203
N I
Sbjct: 337 KNFI 340
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 28/124 (22%), Positives = 49/124 (39%), Gaps = 16/124 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
+G G +G V+ K R GE VA+K ++ RE +I Q + H NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
T +LY L+ +Y ++ ++ + + L Y L ++H
Sbjct: 100 DIKGTGSWTQLY--LITDYHENGSLYDYLKSTTLDAKSMLKLA------YSSVSGLCHLH 151
Query: 201 NCIV 204
I
Sbjct: 152 TEIF 155
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 28/130 (21%), Positives = 54/130 (41%), Gaps = 23/130 (17%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
L C + L+ + +P +Y R H+ + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 196 LAYI--HNCI 203
+ Y+ +
Sbjct: 130 MNYLEDRRLV 139
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 35/173 (20%), Positives = 68/173 (39%), Gaps = 27/173 (15%)
Query: 44 DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVV 98
D D +G+ +G + + + V+G GS+ V
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKV 68
Query: 99 FQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDK 150
+ ++T I A++ V D+ + E + + +HP +V L C F T +
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR 127
Query: 151 EELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
L+ V+EYV + + + R +++P + + Y+ +I AL Y+H
Sbjct: 128 --LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE 171
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 23/126 (18%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 137
V+G G +G VFQ + TG+I A+K ++++ + E I++ + HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V L + F T K LY L+LEY+ E ++ R Y +I A
Sbjct: 84 VDLIYA-FQTGGK--LY--LILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133
Query: 196 LAYIHN 201
L ++H
Sbjct: 134 LGHLHQ 139
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 140
V+G GSFG V A+ + A+K +L+ K ++ E ++ + + HP +V L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F T DK LY VL+Y+ E + R + + Y +I AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154
Query: 199 IHN 201
+H+
Sbjct: 155 LHS 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 32/123 (26%), Positives = 58/123 (47%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 140
V+G GS+ V + ++T I A+K V D+ + E + + +HP +V L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T + L+ V+EYV + + + R +++P + + Y+ +I AL Y
Sbjct: 76 HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125
Query: 199 IHN 201
+H
Sbjct: 126 LHE 128
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 26/119 (21%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G+G+ G V++ + R+TG ++A+K++ + K +L + ++ D P IV
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F + TD + + +E + ++ R+ +P + T I +AL Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKE 142
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 14/124 (11%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
+ +G G FG V++ K R GE VA+K +++R RE +I Q L H NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+L+ LV +Y ++ Y+ + M +KL LA++H
Sbjct: 105 DNKDNGTWTQLW--LVSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157
Query: 202 CIVD 205
IV
Sbjct: 158 EIVG 161
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 26/129 (20%), Positives = 52/129 (40%), Gaps = 19/129 (14%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
+ + +G+G+FG V + + + VA+K + D K+ E +MQ LD+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV + + E LV+E Y + ++ + + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 197 AYI--HNCI 203
Y+ N +
Sbjct: 131 KYLEESNFV 139
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 32/123 (26%), Positives = 55/123 (44%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 140
V+G GSFG V ++ + T E+ A+K V+QD + E +++ + P + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ LY V+EYV + + I + R + Y +I L +
Sbjct: 87 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136
Query: 199 IHN 201
+ +
Sbjct: 137 LQS 139
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 25/120 (20%), Positives = 54/120 (45%), Gaps = 12/120 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G G++G V + + +G+I+A+K++ + +K K +L + M+ D P IV
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F D + +E + + ++ + YS + +P + T +AL ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 26/122 (21%), Positives = 49/122 (40%), Gaps = 12/122 (9%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
V G FG V++A+ E VA+K QDK+ E ++ + + H NI+ +
Sbjct: 29 LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
T+ +L+ L+ + ++ + + + + R LAY+H
Sbjct: 87 EKRGTSVDVDLW--LITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140
Query: 203 IV 204
I
Sbjct: 141 IP 142
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 36/123 (29%), Positives = 62/123 (50%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
V+G GSFG V A+ +ETG++ A+K +LQD + E +I+ + +HP + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ L+ V+E+V + + I + +R + Y +I AL +
Sbjct: 90 FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139
Query: 199 IHN 201
+H+
Sbjct: 140 LHD 142
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 20/157 (12%), Positives = 50/157 (31%), Gaps = 32/157 (20%)
Query: 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
++ + + V+G +A +ETGE + +R + E+ ++
Sbjct: 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 131 ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 165
+L ++ ++ +L ++ +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ ++S H+ + T Q+ R LA +H+
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 12/46 (26%), Positives = 21/46 (45%), Gaps = 2/46 (4%)
Query: 243 HKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286
+F+ K +P L+ F +Y R L+A P +++LR
Sbjct: 323 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
++G GSFG VF A+ ++T + AIK VL D + E +++ + +HP + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F T + L+ V+EY+ + + I + L Y +I L +
Sbjct: 84 FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133
Query: 199 IHN 201
+H+
Sbjct: 134 LHS 136
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 27/175 (15%), Positives = 51/175 (29%), Gaps = 57/175 (32%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G FGVVF+AK + AIK++ R RE++ + L+HP IV
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 139 ALKHCF----------------------------------------------------FS 146
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
++YL + ++ + + N + QI A+ ++H+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 24/124 (19%), Positives = 57/124 (45%), Gaps = 15/124 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
+ +G G+ GVVF+ + +G ++A K + ++ RELQ++ + P IV
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
F+S + +++ +E++ +++++ + RI P + + + + L
Sbjct: 95 GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145
Query: 198 YIHN 201
Y+
Sbjct: 146 YLRE 149
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 20/124 (16%), Positives = 45/124 (36%), Gaps = 20/124 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
++G G FG V+ + VAI+ + ++ ++ RE+ + H N+V
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C L ++ T+ + R+ + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145
Query: 199 IHNC 202
+H
Sbjct: 146 LHAK 149
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 37/138 (26%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
++ +G G+FG V + + + A+K V K+Y E I++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 136 NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 184
NIV F F E L +L ++ NY +
Sbjct: 97 NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138
Query: 185 VKLYTYQICRALAYIHNC 202
+KLY +I +AL Y+
Sbjct: 139 IKLYCIEILKALNYLRKM 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 14/96 (14%), Positives = 30/96 (31%), Gaps = 17/96 (17%)
Query: 204 VDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 254
++ L + ++ + + K +N + + +P+ K+ P
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 255 --------VDLVCRFFQYSPNLRCTALEACVHPFFD 282
D + Q P LR + E H F +
Sbjct: 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 34/130 (26%), Positives = 58/130 (44%), Gaps = 15/130 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
YI +G G F V+ AK VA+K V DK Y E++++Q +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 136 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
+ + H F+ +++ +V E + E + + + Y H+ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 191 QICRALAYIH 200
Q+ L Y+H
Sbjct: 139 QLLLGLDYMH 148
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 18/108 (16%), Positives = 29/108 (26%), Gaps = 15/108 (13%)
Query: 205 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP------------ 252
D + +II++LG ++ F + K+ L
Sbjct: 248 DHIAQIIELLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 253 --EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 298
E D + Q P R A HP+ + R L
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 28/124 (22%), Positives = 50/124 (40%), Gaps = 17/124 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ A + + VA+K + E +M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
KE +Y ++ E++ ++ + + KL ++ QI +A+I
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 200 HNCI 203
N I
Sbjct: 303 RNYI 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 29/148 (19%), Positives = 53/148 (35%), Gaps = 33/148 (22%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
++G G FG V +A+ ++ VA+K + D + RE M+ DHP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 189
L S ++L ++ +RI N + + L+ +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143
Query: 190 YQICRALAY------IH------NCIVD 205
I + Y IH NC++
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLA 171
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 17/124 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y +V EY+ ++ + L +L QI +AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 200 HNCI 203
N +
Sbjct: 299 MNYV 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 32/139 (23%), Positives = 57/139 (41%), Gaps = 38/139 (27%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
Y V+G GSFG V +A + + VA+K V +KR+ E++I++ L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 135 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 183
N++ + F F E L +NL +++ N+ Q L
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200
Query: 184 YVKLYTYQICRALAYIHNC 202
V+ + + I + L +H
Sbjct: 201 LVRKFAHSILQCLDALHKN 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 18/110 (16%), Positives = 38/110 (34%), Gaps = 30/110 (27%)
Query: 204 VDQLVEIIKVLGTPTREEIK-----------CMNPNYTEFKF---------------PQI 237
DQL +I++LG P+++ + P Y ++
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 238 KPHPWHKVFQKRLPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 283
+ P + + L +D + + ++ P +R T +A HP+
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 20/127 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
+G G+FG VF + R +VA+K + + E +I++ HPNIV L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 142 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 198
C T K+ +Y +V+E V + R + L + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 199 IH--NCI 203
+ CI
Sbjct: 229 LESKCCI 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 29/124 (23%), Positives = 51/124 (41%), Gaps = 17/124 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G FG V+ + VA+K + Q + E +M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y ++ EY+ N ++ + + L KL QI +A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 200 HNCI 203
N I
Sbjct: 128 RNYI 131
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 32/127 (25%), Positives = 62/127 (48%), Gaps = 24/127 (18%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 136
V+GTG++G VF + +TG++ A+K ++Q + E Q+++ + P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V L + F T K L+ L+L+Y+ E +++ +R V++Y +I
Sbjct: 121 LVTLHYA-FQTETK--LH--LILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170
Query: 195 ALAYIHN 201
AL ++H
Sbjct: 171 ALEHLHK 177
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 28/130 (21%), Positives = 54/130 (41%), Gaps = 23/130 (17%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
L C + L+ + +P +Y R H+ + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 196 LAYI--HNCI 203
+ Y+ +
Sbjct: 130 MNYLEDRRLV 139
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 17/124 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y +V EY+ ++ + L +L QI +AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 200 HNCI 203
N +
Sbjct: 382 MNYV 385
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 34/170 (20%), Positives = 59/170 (34%), Gaps = 36/170 (21%)
Query: 49 RDSEPDIIDGVGAETGH--------VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
+G G + G+ Y + + G G ++
Sbjct: 48 DSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQ---------YEVKGCIAHGGLGWIYL 98
Query: 101 AKCRE-TGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
A R G V +K L E Q + + HP+IV + F TD+
Sbjct: 99 ALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQI-FNFVEHTDRHG 155
Query: 153 LYLN-LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ +V+EYV +++ R Q++P+ Y +I AL+Y+H
Sbjct: 156 DPVGYIVMEYVGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLH 199
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 19/123 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+G+GSFG V++ K VA+K + E+ +++ H NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F + +L +V ++ ++ + + + Q R + Y+
Sbjct: 85 ---FMGYSTAPQLA--IVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136
Query: 200 HNC 202
H
Sbjct: 137 HAK 139
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 34/129 (26%), Positives = 51/129 (39%), Gaps = 19/129 (14%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
IA+ +G G+FG V Q R + VAIK + Q + E QIM LD+P I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L E L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 197 AYI--HNCI 203
Y+ N +
Sbjct: 124 KYLEEKNFV 132
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 24/147 (16%), Positives = 50/147 (34%), Gaps = 32/147 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
++G G FG V + ++ VA+K + D + E M+ HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
+ L + + ++L ++ +R+ I + L+ +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154
Query: 191 QICRALAY------IH------NCIVD 205
I + Y +H NC++
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLR 181
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 34/147 (23%), Positives = 55/147 (37%), Gaps = 30/147 (20%)
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 118
H+I I R Y +G G V+ A+ VAI K +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAI-KAIFIPPREKE 52
Query: 119 ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 174
KR++ RE+ L H NIV++ + + Y LV+EY+ T+ Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYY--LVMEYIEGPTL----SEYI 102
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHN 201
H + + +T QI + + H+
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD 129
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 32/123 (26%), Positives = 54/123 (43%), Gaps = 20/123 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 140
V+G GSFG V ++ + T E+ A+K V+QD E +++ + P + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ LY V+EYV + + I + R + Y +I L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457
Query: 199 IHN 201
+ +
Sbjct: 458 LQS 460
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 21/129 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G FG V + GE V IK + ++ + + LDH +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L L LV +Y+P ++ R H+ + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 197 AYI--HNCI 203
Y+ H +
Sbjct: 129 YYLEEHGMV 137
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 35/129 (27%), Positives = 52/129 (40%), Gaps = 19/129 (14%)
Query: 85 IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
IA+ +G G+FG V Q R +I VAIK + Q + E QIM LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L E L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 197 AYI--HNCI 203
Y+ N +
Sbjct: 450 KYLEEKNFV 458
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 29/145 (20%), Positives = 52/145 (35%), Gaps = 34/145 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 135
+G G+F +F+ RE G+ V +K + + R + +M L H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 136 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 193
++V C +E LV E+V Y + ++ I KL Q+
Sbjct: 73 HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 194 RALAY------IH------NCIVDQ 206
A+ + IH N ++ +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIR 148
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 31/136 (22%), Positives = 53/136 (38%), Gaps = 27/136 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+G+G FG+V + VAIK + + + E ++M L HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAY--- 198
C ++ + LV E++ + +Y R + + L +C +AY
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 199 ---IH------NCIVD 205
IH NC+V
Sbjct: 123 ACVIHRDLAARNCLVG 138
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 37/137 (27%), Positives = 59/137 (43%), Gaps = 27/137 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+G+G FGVV K + + VA+K + + ++ +E Q M L HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAY--- 198
C + + +Y +V EY+ N NY R H + L Y +C +A+
Sbjct: 72 C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 199 ---IH------NCIVDQ 206
IH NC+VD+
Sbjct: 123 HQFIHRDLAARNCLVDR 139
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 35/140 (25%), Positives = 62/140 (44%), Gaps = 30/140 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
++G G FG V++ VA+K +D N+ E IM+ LDHP+IV
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L ++E + +++E P +Y ++ + ++ + LY+ QIC+A+A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 198 Y------IH------NCIVD 205
Y +H N +V
Sbjct: 128 YLESINCVHRDIAVRNILVA 147
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 35/137 (25%), Positives = 56/137 (40%), Gaps = 27/137 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+GTG FGVV K R + VAIK + + ++ E ++M L H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAY--- 198
C T + ++ ++ EY+ N NY R + L +C A+ Y
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 199 ---IH------NCIVDQ 206
+H NC+V+
Sbjct: 139 KQFLHRDLAARNCLVND 155
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 29/140 (20%), Positives = 53/140 (37%), Gaps = 28/140 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + D + E IM+ HPN++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALA 197
+L + +VL Y+ + RN+ R P + + + Q+ + +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 198 Y------IH------NCIVD 205
Y +H NC++D
Sbjct: 143 YLASKKFVHRDLAARNCMLD 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 34/142 (23%), Positives = 51/142 (35%), Gaps = 31/142 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
E ++G+G G V + R G+ VAIK + + R E IM DHPNI+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 196
L+ T +V EY+ N + R H I + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 197 AY------IH------NCIVDQ 206
Y +H N +VD
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDS 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 30/144 (20%), Positives = 54/144 (37%), Gaps = 34/144 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + D + E IM+ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
+L + +VL Y+ + RN+ R P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 195 ALAY------IH------NCIVDQ 206
+ + +H NC++D+
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDE 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 8e-09
Identities = 32/147 (21%), Positives = 49/147 (33%), Gaps = 30/147 (20%)
Query: 67 IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 121
+ + R Y ++G G V A+ VA+ KVL +D +
Sbjct: 6 TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAV-KVLRADLARDPSF 55
Query: 122 KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 174
R E Q L+HP IVA+ + +V+EYV T+ R+
Sbjct: 56 YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHN 201
M C+AL + H
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ 134
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 33/138 (23%), Positives = 53/138 (38%), Gaps = 38/138 (27%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
Y + ++G GSFG V +A R E VAIK + K + N E+++++++
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 135 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 183
IV LK F F E L NL + R + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157
Query: 184 YVKLYTYQICRALAYIHN 201
+ + Q+C AL ++
Sbjct: 158 LTRKFAQQMCTALLFLAT 175
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 34/144 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
+ V+G G FGVV+ + + + AIK + + + RE +M+ L+HPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
AL E L ++L Y+ + + R QR P LI + Q+ R
Sbjct: 86 ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135
Query: 195 ALAY------IH------NCIVDQ 206
+ Y +H NC++D+
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDE 159
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 27/224 (12%), Positives = 66/224 (29%), Gaps = 41/224 (18%)
Query: 13 SSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPD--IIDGVGAETGHV-IRT 69
+ GF+ + + + + E S D + + + +
Sbjct: 12 ENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES 71
Query: 70 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------ 123
+G R + + V+G +A +ETGE + +R +
Sbjct: 72 ELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125
Query: 124 -RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEELYLNL 157
E+ +++L ++ ++ +L
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185
Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
++ +T + ++S H+ + T Q+ R LA +H+
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 18/78 (23%), Positives = 28/78 (35%), Gaps = 5/78 (6%)
Query: 243 HKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPNGRPL 297
+F+ K +P L+ F +Y R L+A P +++LR L
Sbjct: 327 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
Query: 298 PPLFNFKPPELSGIPPET 315
P PP + P E
Sbjct: 387 PTREGGAPPSGTSQPDEA 404
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 26/162 (16%), Positives = 50/162 (30%), Gaps = 48/162 (29%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G FG V +A VA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
++ L + L L++EY + +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 178 QRMPLIYVKL--YTYQICRALAY------IH------NCIVD 205
L L + +QI + + Y +H N +V
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 39/140 (27%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
V + F F E L N L+ N+ Q PL
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122
Query: 183 IYVKLYTYQICRALAYIHNC 202
+V+ YQ+C AL ++H
Sbjct: 123 PHVRHMAYQLCHALRFLHEN 142
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 22/107 (20%), Positives = 34/107 (31%), Gaps = 15/107 (14%)
Query: 205 DQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQKRLPPEA- 254
+ LV + K+LG I + E K + + ++
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 255 -----VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 296
DL+ R ++ P R T EA +HPFF L R
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 22/130 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+G GSFGVV + + VA+K + D + RE+ M LDH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
++ L + + +V E P + R HQ L + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 196 LAYI--HNCI 203
+ Y+ I
Sbjct: 134 MGYLESKRFI 143
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 29/141 (20%), Positives = 50/141 (35%), Gaps = 33/141 (23%)
Query: 91 GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 139
G G+FG V +A + VA+K + L ++ EL+++ L +H NIV
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 140 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 186
L T ++ EY + + L
Sbjct: 92 LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 187 LYT--YQICRALAYI--HNCI 203
L + YQ+ + +A++ NCI
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI 167
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 31/142 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+ VVG G FG V + + + VAIK + K R E IM DHPNI+
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
L+ T + + +V EY+ N ++ R H + +I + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 197 AY------IH------NCIVDQ 206
Y +H N +++
Sbjct: 161 KYLSDMGYVHRDLAARNILINS 182
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 34/158 (21%), Positives = 58/158 (36%), Gaps = 42/158 (26%)
Query: 91 GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 141
G G+FG VF A+C +VA+K + L ++ RE +++ L H +IV
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 142 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 188
D + L +V EY+ I + + L ++
Sbjct: 84 GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 189 TYQICRALAY------IH------NCIV-DQLVEIIKV 213
QI + Y +H NC+V L+ +K+
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKI 174
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 28/140 (20%), Positives = 51/140 (36%), Gaps = 39/140 (27%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
Y +G G+FG V + + G VA+K V RY E+Q+++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
V + F F E L L+ ++ + L
Sbjct: 76 TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117
Query: 183 IYVKLYTYQICRALAYIHNC 202
+++ YQIC+++ ++H+
Sbjct: 118 DHIRKMAYQICKSVNFLHSN 137
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 15/98 (15%)
Query: 205 DQLVEIIKVLGTPTREEIK---------CMNPNYTEFKFPQIKPHPWHKVFQKRLPPE-- 253
+ L + ++LG + I+ ++ E K ++ + +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 254 ----AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287
DL+ + +Y P R T EA HPFFD L+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 26/155 (16%), Positives = 52/155 (33%), Gaps = 33/155 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG V++ + + VA+K + QD+ E I+ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
IV + + +++E + + R R + ++ + I
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 193 CRALAY------IH------NCIVDQLVE--IIKV 213
Y IH NC++ + K+
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 20/128 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+G G FG V Q VAIK R E M+ DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L + ++ +++E R++ ++ + + L + LY YQ+ ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 198 YI--HNCI 203
Y+ +
Sbjct: 506 YLESKRFV 513
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 27/155 (17%), Positives = 52/155 (33%), Gaps = 33/155 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG V++ + + VA+K + QD+ E I+ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
IV + + ++LE + + R R + ++ + I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 193 CRALAY------IH------NCIVDQLVE--IIKV 213
Y IH NC++ + K+
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 28/142 (19%), Positives = 52/142 (36%), Gaps = 30/142 (21%)
Query: 88 HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 136
+G G+FG V +A T VA+K + + R EL+I+ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 183
+V L T L +++E+ E V + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 184 YVKLYTYQICRALAYI--HNCI 203
++ Y++Q+ + + ++ CI
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI 170
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 20/128 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+G G FG V Q VAIK R E M+ DHP+IV
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L + ++ +++E R++ ++ + + L + LY YQ+ ALA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 198 YI--HNCI 203
Y+ +
Sbjct: 131 YLESKRFV 138
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 28/143 (19%), Positives = 51/143 (35%), Gaps = 32/143 (22%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
+ V+G G FG V++ + + VAIK + K R E IM H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
+ L+ + + + ++ EY+ N + R ++ + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 196 LAY------IH------NCIVDQ 206
+ Y +H N +V+
Sbjct: 160 MKYLANMNYVHRDLAARNILVNS 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 27/166 (16%), Positives = 47/166 (28%), Gaps = 29/166 (17%)
Query: 44 DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKC 103
+ + T G Y +VG G G V++A+
Sbjct: 6 HHHHHSSGLVPRGSHMDGTAESREGTQFGP----------YRLRRLVGRGGMGDVYEAED 55
Query: 104 RETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155
IVA+ K++ D ++ RE + L P++V + +LY
Sbjct: 56 TVRERIVAL-KLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLY- 110
Query: 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + + R + QI AL H
Sbjct: 111 -VDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 13/85 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
+ V+G G+FG V +A+ ++ G AIK++ D R EL+++ L HPNI+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP 163
L + LY L +EY P
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAP 109
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 26/148 (17%), Positives = 55/148 (37%), Gaps = 34/148 (22%)
Query: 88 HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 137
+G GSFG+V++ + + VAIK V ++++ E +M+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
V L + + +++E + R A + + L +
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 191 QICRALAY------IH------NCIVDQ 206
+I +AY +H NC+V +
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAE 173
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 36/171 (21%), Positives = 59/171 (34%), Gaps = 51/171 (29%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG VFQA+ E +VA+K + + RE +M D+PN
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
IV L + + L+ EY+ + R
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 178 QRMPLIYVKL--YTYQICRALAY------IH------NCIV-DQLVEIIKV 213
PL + Q+ +AY +H NC+V + +V +K+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKI 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 41/161 (25%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 137
+ +G G+FG VF A+C +VA+K + ++ RE +++ ML H +I
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 187
V T+ L +V EY+ + PL +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 188 --YTYQICRALAY------IH------NCIV-DQLVEIIKV 213
Q+ + Y +H NC+V LV +K+
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKI 199
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 30/150 (20%), Positives = 51/150 (34%), Gaps = 38/150 (25%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 135
V+G+G+FG V A VA+K + ++ EL++M L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 177
NIV L T +Y L+ EY E +
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCI 203
L + L + YQ+ + + ++ +C+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 30/141 (21%), Positives = 51/141 (36%), Gaps = 29/141 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
+G G+FG V +A G+ VA+K + +K EL+IM L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 186
NIV L T + ++ EY + + +
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 187 L--YTYQICRALAYI--HNCI 203
L ++ Q+ + +A++ NCI
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI 186
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 30/145 (20%), Positives = 49/145 (33%), Gaps = 33/145 (22%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G+FG V A+ VA+K + +D E+++M+M+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 183 IYVKL--YTYQICRALAYI--HNCI 203
L YQ+ R + Y+ CI
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 30/145 (20%), Positives = 51/145 (35%), Gaps = 33/145 (22%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G FG V A+ + VA+K + +D E+++M+M+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 183 IYVKL--YTYQICRALAYI--HNCI 203
+ L TYQ+ R + Y+ CI
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 9e-07
Identities = 29/163 (17%), Positives = 49/163 (30%), Gaps = 43/163 (26%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G FG V++ E + VAIK + + E + L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 185
+V L T + L ++ Y + + + L
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 186 KL--YTYQICRALAY------IH------NCIV-DQLVEIIKV 213
QI + Y +H N +V D+L +K+
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKI 169
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 36/203 (17%), Positives = 65/203 (32%), Gaps = 24/203 (11%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
+G G+FG V +A T VA+K + + R EL+I+ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
N+V L T L +++E+ Y R R + K + +
Sbjct: 87 NVVNLLGA--CTKPGGPLM--VIVEFCK---FGNLSTYLRSK-RNEFVPYKTKGARFRQG 138
Query: 196 LAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 255
Y+ VD + + + + + + P +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-----DLYKDFLTLE 193
Query: 256 DLVCRFFQYSPNLRCTALEACVH 278
L+C FQ + + A C+H
Sbjct: 194 HLICYSFQVAKGMEFLASRKCIH 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 24/121 (19%), Positives = 47/121 (38%), Gaps = 11/121 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
Y +G GSFGV+F+ + VAIK + E + ++L I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ +E L+ LV++ + ++ + R + + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123
Query: 201 N 201
Sbjct: 124 E 124
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 32/157 (20%), Positives = 54/157 (34%), Gaps = 43/157 (27%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G+FG V A+ + VA+K + +D E+++M+M+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 183 IYVKL--YTYQICRALAY------IH------NCIVD 205
+ L TYQ+ R + Y IH N +V
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 11/121 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 140
+ +G G+FG + K T E VAIK + + E + + L I +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ Y +VLE + ++ + R L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122
Query: 201 N 201
+
Sbjct: 123 S 123
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 30/121 (24%), Positives = 51/121 (42%), Gaps = 11/121 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
Y +G+GSFG ++ GE VAIK ++ E +I +M+ I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ C E Y +V+E + ++ + SR + L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122
Query: 201 N 201
+
Sbjct: 123 S 123
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 27/128 (21%), Positives = 55/128 (42%), Gaps = 14/128 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 135
Y +G G F V+ + + + VA+K V + Y E+++++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 136 N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
N +V L F + ++ +V E + + + + +Q +PL VK Q+
Sbjct: 99 NREMVVQLLDD-FKISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 193 CRALAYIH 200
+ L Y+H
Sbjct: 156 LQGLDYLH 163
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 23/121 (19%), Positives = 53/121 (43%), Gaps = 11/121 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 140
+ +G+GSFG ++ +T E VAIK ++ E +I ++L I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ E Y LV++ + ++ + ++ +++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 201 N 201
+
Sbjct: 121 S 121
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 4e-05
Identities = 29/130 (22%), Positives = 55/130 (42%), Gaps = 24/130 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 141
+ ++G G FG V++ R+ G VA+K+ + E++ + HP++V+L
Sbjct: 44 KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 195
C E + L+ +Y+ N + Y M + + + +IC R
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151
Query: 196 LAYIHN-CIV 204
L Y+H I+
Sbjct: 152 LHYLHTRAII 161
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 20/159 (12%), Positives = 35/159 (22%), Gaps = 31/159 (19%)
Query: 50 DSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 109
D V G I GR Y G +QA
Sbjct: 11 RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58
Query: 110 VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162
VA+ V + +D P + + + +V E++
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGL--VVAEWI 113
Query: 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
++ +A + + A H
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAH 146
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 3e-04
Identities = 24/154 (15%), Positives = 39/154 (25%), Gaps = 44/154 (28%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 132
+G G FG VF + VAIK + ++ N E+ I + L
Sbjct: 28 IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 133 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 184
+ L L L Y + N + + L +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 185 -----------------VKLYTYQICRALAYIHN 201
K +Q+ +LA
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA 179
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 335 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.93 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.91 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.91 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.91 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.91 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.91 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.91 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.91 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.9 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.9 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.9 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.9 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.9 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.9 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.89 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.89 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.88 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.88 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.86 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.52 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.5 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.44 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.53 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 92.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 91.69 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 91.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.18 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 88.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 88.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 85.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 84.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 80.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 80.05 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.94 Aligned_cols=236 Identities=29% Similarity=0.485 Sum_probs=175.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~ 153 (335)
.++|++++.||+|+||+||+|+++.+|+.||||+|++. .+.+.+|+.+|+.|+|||||++++++..... .+..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 45799999999999999999999999999999999643 2456789999999999999999999854321 2446
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c---------C-hH----
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V---------D-QL---- 207 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~---------~-~~---- 207 (335)
++|||||||+|+|.+++.. .+.+++.+++.|++||+.||+|||++| + | .+
T Consensus 133 ~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 6999999999999998875 678999999999999999999999998 0 0 00
Q ss_pred --------HhHhhhcCCCCHHHhhhh--CCCCCC--------------------C-------------------------
Q 019844 208 --------VEIIKVLGTPTREEIKCM--NPNYTE--------------------F------------------------- 232 (335)
Q Consensus 208 --------~~~~~~~g~~~~~~~~~~--~~~~~~--------------------~------------------------- 232 (335)
......+||+.|...... ...|.. |
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 011234666653222211 111110 0
Q ss_pred ------------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCC
Q 019844 233 ------------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 300 (335)
Q Consensus 233 ------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~ 300 (335)
.++.....+|...+ +.++++++|||.+||++||++|||+.|+|+||||++.+.|...+.. .+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~----~~~ 363 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDC----APP 363 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCC----SSC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCC----CCC
Confidence 01111122233333 5689999999999999999999999999999999999887665332 334
Q ss_pred CCCCcccCCCCCHHHHhhcChHHHhh
Q 019844 301 FNFKPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+++. .+...++.+.+++.|++++..
T Consensus 364 ~~~~-~~~~~~~~~~~k~~i~~ei~~ 388 (398)
T 4b99_A 364 FDFA-FDREALTRERIKEAIVAEIED 388 (398)
T ss_dssp CCCH-HHHSCCCHHHHHHHHHHHHHH
T ss_pred CCCc-cchhhcCHHHHHHHHHHHHHH
Confidence 5554 456678889999988887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.42 Aligned_cols=246 Identities=44% Similarity=0.838 Sum_probs=194.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCC-----------
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD----------- 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~----------- 149 (335)
..+|++++.||+|+||.||+|.+..+|+.||||++..+.....+|+.+|+.++|||||+++++|.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 346999999999999999999999999999999998777777899999999999999999999976432
Q ss_pred ----------------------CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----
Q 019844 150 ----------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---- 203 (335)
Q Consensus 150 ----------------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---- 203 (335)
....++++|||||+|+|.+.+.........+++..++.|+.||+.||.|||++|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~ 165 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 345678999999999999999876666788999999999999999999999988
Q ss_pred --------------------------------------------------------------------------------
Q 019844 204 -------------------------------------------------------------------------------- 203 (335)
Q Consensus 204 -------------------------------------------------------------------------------- 203 (335)
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence
Q ss_pred --cChHHhHhhhcCCCCHHHhhhhCCCCCCCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019844 204 --VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281 (335)
Q Consensus 204 --~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f 281 (335)
.+.+..++..+|++..+.+..+.+.|....++......|...++..+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus 246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325 (383)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence 122223334445555555555566666667777777888888888899999999999999999999999999999999
Q ss_pred ccCCC-------CCCCCCCC--CCCCCCCCCCcccCCCCCHHHHhhcChHHHhh
Q 019844 282 DELRD-------PNTRLPNG--RPLPPLFNFKPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 282 ~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
++++. +....|.. .++|.+++|.+.+++.++++.+..+++++...
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 379 (383)
T 3eb0_A 326 DHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP 379 (383)
T ss_dssp HHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred HHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence 88654 33344444 67899999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.62 Aligned_cols=198 Identities=25% Similarity=0.321 Sum_probs=151.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||+||+|+++.+|+.||||+|.+. .+.+.+|+.+|+.|+|||||+++++| .+..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 35699999999999999999999999999999999642 24578999999999999999999999 6667
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
++|||||||+| +|.+++.. .+.++|.+++.|+.||+.||+|||+++
T Consensus 106 ~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 79999999996 99999986 678999999999999999999999998
Q ss_pred cC---hHHhHhhhcCCCCH---HHhhhhCCCCCC------------------CCCCCCCCC-------ccccccccCCCh
Q 019844 204 VD---QLVEIIKVLGTPTR---EEIKCMNPNYTE------------------FKFPQIKPH-------PWHKVFQKRLPP 252 (335)
Q Consensus 204 ~~---~~~~~~~~~g~~~~---~~~~~~~~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~ 252 (335)
.. ......+.+||+.| |.+... .|.. ..|...... .....+|..+|+
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 259 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP 259 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCH
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCH
Confidence 00 00011234566653 222110 1110 011100000 001235678999
Q ss_pred HHHHHHHHhccCCCCCCCCHHH------HhcCcccccCCCCCC
Q 019844 253 EAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPNT 289 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~------~L~hp~f~~~~~~~~ 289 (335)
++++||.+||+.||++|||+.| +++||||+.+.+...
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 9999999999999999999887 589999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.35 Aligned_cols=194 Identities=23% Similarity=0.292 Sum_probs=140.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++| .+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 35799999999999999999999999999999999643 24578999999999999999999999 5566
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------c
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------------V 204 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------~ 204 (335)
++|||||||+|+|.+++.. ++.+++.+++.|+.||+.||+|||++| .
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 7999999998899999886 678999999999999999999999998 0
Q ss_pred ChHHhHhhhcCCCCHHHhhhhC-CCCCC-------------------CCCCCCCCC-------ccccccccCCChHHHHH
Q 019844 205 DQLVEIIKVLGTPTREEIKCMN-PNYTE-------------------FKFPQIKPH-------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 205 ~~~~~~~~~~g~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~-------~~~~~~~~~~s~~~~~l 257 (335)
.........+||+.+...+... ..|.. ..|...... .-...+|..+|+++++|
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 1111122345666532222111 11110 011100000 00123456789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
|.+||+.||++|||+.|+|+||||+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.78 Aligned_cols=196 Identities=22% Similarity=0.280 Sum_probs=147.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..|+++++||+|+||+||+|+++.+|+.||||++... .+.+.+|+.+|+.++|||||+++++| .+..++||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 4599999999999999999999999999999999632 35578999999999999999999999 55566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c------------------Ch
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V------------------DQ 206 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~------------------~~ 206 (335)
|||||+| +|.+++.. +.+++.+++.|+.||+.||+|||++| + ..
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999996 99998874 56999999999999999999999998 0 00
Q ss_pred HHhHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCC----------CCccccccccCCChHHHHH
Q 019844 207 LVEIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIK----------PHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 207 ~~~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~----------~~~~~~~~~~~~s~~~~~l 257 (335)
.......+||+.|...+... ..|.. ..|.... ..+.....+..+|+++++|
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 01112345666532221110 11110 0010000 0001112235689999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
|.+||+.||++|||+.|+|+||||++...|
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 999999999999999999999999986544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=281.62 Aligned_cols=195 Identities=21% Similarity=0.295 Sum_probs=143.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
-++|++++.||+|+||+||+|+++.+|+.||||+|.+. ...+.+|+.+|+.|+|||||+++++| .+..+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 35799999999999999999999999999999999643 24578999999999999999999999 55667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------c
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------------V 204 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------~ 204 (335)
+|||||||+| +|.++|.... ...++|.+++.|+.||+.||+|||++| .
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 9999999996 9999997632 456899999999999999999999998 1
Q ss_pred Ch-HHhHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCC---------CCCccccccccCCChHHH
Q 019844 205 DQ-LVEIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQI---------KPHPWHKVFQKRLPPEAV 255 (335)
Q Consensus 205 ~~-~~~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~---------~~~~~~~~~~~~~s~~~~ 255 (335)
.. .......+||+.|...+... ..|.. ..|... ....+ ..++..+|++++
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~ 254 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLR 254 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCCHHHH
Confidence 11 11223456777633222110 11210 011100 00001 123467899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 9999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=285.03 Aligned_cols=196 Identities=22% Similarity=0.280 Sum_probs=147.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..|+++++||+|+||+||+|+++.+|+.||||+|... .+.+.+|+.+|+.|+|||||+++++| ....++||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence 4699999999999999999999999999999999632 35578999999999999999999999 45566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c------------------Ch
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V------------------DQ 206 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~------------------~~ 206 (335)
|||||+| +|.+++.. +.+++.+++.|+.||+.||+|||++| + ..
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999996 99999864 56999999999999999999999998 0 00
Q ss_pred HHhHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCC----------CCccccccccCCChHHHHH
Q 019844 207 LVEIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIK----------PHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 207 ~~~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~----------~~~~~~~~~~~~s~~~~~l 257 (335)
.......+||+.|...+... ..|.. ..|.... ..+.....+..+|+++++|
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 01112335665532211110 11110 0010000 0000112235789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
|.+||+.||++|||+.|+|+||||++...|
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=278.06 Aligned_cols=244 Identities=66% Similarity=1.081 Sum_probs=199.4
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccEEE
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLN 156 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~ 156 (335)
.....+|.+++.||+|+||.||+|+++.+|+.||||++........+|+.+|+.++|||||+++++|+.... .+..+++
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 345668999999999999999999999999999999998777777799999999999999999999875432 4566788
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------------- 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------- 203 (335)
+||||++++|.+++.........+++..++.|+.||+.||.|||+++
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999999888888876656778999999999999999999999988
Q ss_pred -----------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCCCCC
Q 019844 204 -----------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNPNYT 230 (335)
Q Consensus 204 -----------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~~~~ 230 (335)
.+++..++..+|++..+.+..+.+.|.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 112233334445555555555666666
Q ss_pred CCCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcccCCC
Q 019844 231 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 310 (335)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (335)
.+.++.+...+|...++..+++++.+||.+||++||.+|||+.|+|+||||+.++++....+.....+.+++|...++..
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS 369 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence 77777777788888888889999999999999999999999999999999999999888878778888899998655543
Q ss_pred CCHHHHhhcChH
Q 019844 311 IPPETINRLIPE 322 (335)
Q Consensus 311 ~~~~~~~~~~~~ 322 (335)
.++....+++.
T Consensus 370 -~~~~~~~~~~~ 380 (420)
T 1j1b_A 370 -NPPLATILIPP 380 (420)
T ss_dssp -CGGGHHHHSCT
T ss_pred -ChhHHHhhCCH
Confidence 33333334433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=276.84 Aligned_cols=249 Identities=61% Similarity=1.051 Sum_probs=201.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccEEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL 157 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~i 157 (335)
....+|++.+.||+|+||.||+|++..+++ +|+|++........+|+.+|+.++||||++++++|..... .+..++|+
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 456789999999999999999999977665 8999887766677799999999999999999999976544 55667899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------------- 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------- 203 (335)
|||||++++...+.........+++..++.|+.||+.||.|||+++
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999999877777765555778999999999999999999999988
Q ss_pred ----------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCCCCCC
Q 019844 204 ----------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNPNYTE 231 (335)
Q Consensus 204 ----------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~~~~~ 231 (335)
.+.+..+...+|++..+.+..+.+.|..
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 1112222333444444444445555555
Q ss_pred CCCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcccCCCC
Q 019844 232 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGI 311 (335)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (335)
..++.....+|...++..+++++.+||.+||++||.+|||+.++|+||||++++++....+....++++++|...++..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 354 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV- 354 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT-
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc-
Confidence 6666677777777887889999999999999999999999999999999999999888888888899999999655444
Q ss_pred CHHHHhhcChHHHhhccc
Q 019844 312 PPETINRLIPEHARKQNL 329 (335)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~ 329 (335)
.++.+.++++.+...+.+
T Consensus 355 ~~~~~~~~~~~~~~~~~~ 372 (394)
T 4e7w_A 355 RPDLISRLVPQHAEAELL 372 (394)
T ss_dssp CGGGHHHHSCGGGCSSSS
T ss_pred CHHHHHhhccHhhhhhhh
Confidence 557888888877655443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.03 Aligned_cols=195 Identities=23% Similarity=0.333 Sum_probs=144.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.++||+|+||+||+|.++.+++.||+|++.+. ...+.+|+.+|+.|+|||||+++++|.... ....++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 47788999999999999999999999999999642 245789999999999999999999985432 24567899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------cCh---HHh----------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------VDQ---LVE---------- 209 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------~~~---~~~---------- 209 (335)
|||||+| +|.+++.. .+.+++..++.|+.||+.||+|||+++ ++. ..+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999995 99999986 577999999999999999999999886 100 000
Q ss_pred ----HhhhcCCCCHHHhhhhCCCCCC------------------CCCCCC----------CCCccccccccCCChHHHHH
Q 019844 210 ----IIKVLGTPTREEIKCMNPNYTE------------------FKFPQI----------KPHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 210 ----~~~~~g~~~~~~~~~~~~~~~~------------------~~~~~~----------~~~~~~~~~~~~~s~~~~~l 257 (335)
....+|||.+.........|.. ..|... ........++..+++++++|
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 1123455553222211111221 011100 11111223456788999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
|.+||+.||++|||+.|+|+||||++
T Consensus 263 i~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=272.42 Aligned_cols=197 Identities=22% Similarity=0.288 Sum_probs=148.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEeec
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
..|.+.++||+|+||+||+|+++.+|+.||||+++.+. ...+|+.+|+.|+|||||+++++| .+..++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEec
Confidence 46999999999999999999999999999999997643 345899999999999999999999 556679999999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH---HhH---------------
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL---VEI--------------- 210 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~---~~~--------------- 210 (335)
|+| +|.+++.. .+.+++.+++.|+.||+.||+|||+++ ++.. .++
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 996 99999986 577999999999999999999999998 1000 000
Q ss_pred ------hhhcCCCCHHHhhhh-CCCCCC------------------CCCCCCCC----------CccccccccCCChHHH
Q 019844 211 ------IKVLGTPTREEIKCM-NPNYTE------------------FKFPQIKP----------HPWHKVFQKRLPPEAV 255 (335)
Q Consensus 211 ------~~~~g~~~~~~~~~~-~~~~~~------------------~~~~~~~~----------~~~~~~~~~~~s~~~~ 255 (335)
...+||+.|...+.. ...|.. ..|..... .+....+++.+|+++.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 112466553221111 011110 01111000 0111234578999999
Q ss_pred HHHHHhccCCCCCCCCHHHH-------------hcCcccccCCCCC
Q 019844 256 DLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPN 288 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~-------------L~hp~f~~~~~~~ 288 (335)
+||.+||+.||++|||+.|+ |+|||+.++..|.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 99999999999999999997 6799999887653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=273.80 Aligned_cols=196 Identities=23% Similarity=0.287 Sum_probs=142.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
++|++++.||+|+||+||+|++. .+++.||||++.+. ...+.+|+.+|+.++|||||+++++| .+.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 46999999999999999999984 46889999999642 24577899999999999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------- 203 (335)
.++|||||||+| +|.+++.. .+.+++.+++.|+.||+.||+|||++|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 679999999996 99999986 678999999999999999999999998
Q ss_pred --cChHHhHhhhcCCCCHHHhhhh-CCCCCC------------------CCCCCCCCC-------ccccccccCCChHHH
Q 019844 204 --VDQLVEIIKVLGTPTREEIKCM-NPNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEAV 255 (335)
Q Consensus 204 --~~~~~~~~~~~g~~~~~~~~~~-~~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~~ 255 (335)
.+........+||+.+...+.. ...|.. ..|...... .-...+|..+|++++
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 0001111234566653222111 111211 011100000 001234577999999
Q ss_pred HHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+||.+||+.||++||| ++|+|+||||+.+++
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 9999999999999998 589999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=265.33 Aligned_cols=206 Identities=19% Similarity=0.291 Sum_probs=138.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCC-------
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD------- 149 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~------- 149 (335)
.+|++++.||+|+||+||+|+++.+|+.||||+|... .+.+.+|+.+|+.|+|||||+++++|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999999642 2457799999999999999999999965432
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c--ChH-------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V--DQL------- 207 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~--~~~------- 207 (335)
....++|||||||+| +|.+++..... .....+..++.|+.||+.||+|||++| + +..
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 234568999999996 99999975221 122455678999999999999999998 0 000
Q ss_pred ---------------------HhHhhhcCCCCHHHhhhhC-CCCCC---------------CCCCCC----------CCC
Q 019844 208 ---------------------VEIIKVLGTPTREEIKCMN-PNYTE---------------FKFPQI----------KPH 240 (335)
Q Consensus 208 ---------------------~~~~~~~g~~~~~~~~~~~-~~~~~---------------~~~~~~----------~~~ 240 (335)
......+||+.|...+... ..|.. +.+... ...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~Pf~~~~~~~~~~~~~~~~ 243 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNL 243 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHccCCCCccHHHHHHHHHhcC
Confidence 0111234665532221110 11111 000000 000
Q ss_pred ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 241 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
.+.. .+...++.+.+||.+||+.||.+|||+.|+|+||||+++.+|..
T Consensus 244 ~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 244 KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 0111 11345677899999999999999999999999999999876654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=268.81 Aligned_cols=197 Identities=21% Similarity=0.296 Sum_probs=148.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHH---HHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~---Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|+++++||+|+||+||+|+++.+|+.||||+|.+.. ..+.+ ++.+++.++|||||+++++| .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 457999999999999999999999999999999996431 22333 45677778999999999999 6
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD------------ 205 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~------------ 205 (335)
+..++|||||||+| +|.++|.. .+.++|..++.|+.||+.||+|||++| ++
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence 66779999999996 99999986 678999999999999999999999999 00
Q ss_pred ----hHHhHhhhcCCCCHHHhhhh--CCCCCC------------------CCCCCCCCC----------ccccccccCCC
Q 019844 206 ----QLVEIIKVLGTPTREEIKCM--NPNYTE------------------FKFPQIKPH----------PWHKVFQKRLP 251 (335)
Q Consensus 206 ----~~~~~~~~~g~~~~~~~~~~--~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~s 251 (335)
......+.+|||.|...... ...|.. ..|...... .....+|..+|
T Consensus 339 A~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S 418 (689)
T 3v5w_A 339 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 418 (689)
T ss_dssp CEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred eeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence 00111234677764333322 112221 011110000 01123567899
Q ss_pred hHHHHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+++++||.+||+.||.+|++ ++||++||||+.++|
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999999999998 799999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=258.81 Aligned_cols=121 Identities=25% Similarity=0.359 Sum_probs=97.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|++++.||+|+||+||+|+++.+++.||||++.+. .+.+.+|+.+|+.++|||||++++++........
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3446799999999999999999999999999999999642 2457799999999999999999999976544455
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||++|+|.+++.. ...+++..++.|+.||+.||+|||+++
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ 176 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG 176 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 67999999999999998875 567999999999999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=270.76 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=150.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|++++.||+|+||+||+|+++.+|+.||||+|.+. ...+.+|+.+|+.|+|||||+++++| .+..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 46799999999999999999999999999999999643 34577999999999999999999999 6667799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC------------------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD------------------ 205 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~------------------ 205 (335)
||||||+| +|.+++.. ..+.+++.+++.|+.||+.||+|||+++ ++
T Consensus 231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999996 99988853 1467999999999999999999999998 00
Q ss_pred -hHHhHhhhcCCCCH---HHhhh---------------------hCCCCCCCCC----CCCCC--CccccccccCCChHH
Q 019844 206 -QLVEIIKVLGTPTR---EEIKC---------------------MNPNYTEFKF----PQIKP--HPWHKVFQKRLPPEA 254 (335)
Q Consensus 206 -~~~~~~~~~g~~~~---~~~~~---------------------~~~~~~~~~~----~~~~~--~~~~~~~~~~~s~~~ 254 (335)
........+||+.+ |.+.. +.+.|..... ..+.. ..+....+..+|+++
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 00001122455442 21111 1111111000 00001 111223346789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
++||.+||+.||.+|||+.|+|+||||+...+|..
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 99999999999999999999999999998776643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=252.52 Aligned_cols=112 Identities=21% Similarity=0.383 Sum_probs=98.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEecccc--hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~--~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|+++++||+|+||+||+|+++ .+++.||||++.+.. ..+.+|+.+|+.+ +|||||+++++| .+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EECC
Confidence 4567999999999999999999985 467899999986533 4577999999998 699999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||||||+| +|.+++. .+++.+++.|++||+.||+|||++|
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g 137 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG 137 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 79999999995 9988873 3999999999999999999999999
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=254.05 Aligned_cols=239 Identities=20% Similarity=0.314 Sum_probs=171.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|.+++.||+|+||.||+|.++.+++.||||++.+. .+.+.+|+.+|+.++||||+++++++........
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3456799999999999999999999999999999999642 2457799999999999999999999965433333
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
..+|+||||++|+|.+++.. ...+++..++.|+.||+.||+|||++|
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 56899999999999999875 567999999999999999999999998
Q ss_pred cChH-----------------------HhHhhhcCCCCHHHhhhh--CCCCCC--------------------C------
Q 019844 204 VDQL-----------------------VEIIKVLGTPTREEIKCM--NPNYTE--------------------F------ 232 (335)
Q Consensus 204 ~~~~-----------------------~~~~~~~g~~~~~~~~~~--~~~~~~--------------------~------ 232 (335)
.... ......+||+.+...... ...|.. +
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 0000 011223444432111100 000100 0
Q ss_pred CCCCC-----------------------------------------------------------CCCccccccccCCChH
Q 019844 233 KFPQI-----------------------------------------------------------KPHPWHKVFQKRLPPE 253 (335)
Q Consensus 233 ~~~~~-----------------------------------------------------------~~~~~~~~~~~~~s~~ 253 (335)
..+.. ....+...+ +.++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~ 337 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD 337 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence 00000 000111112 468999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcccCCCCCHHHHhhcChHHHhh
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+.+||.+||++||++|||+.|+|+||||+.++++..+.....+ ....|+ +...++.+.+++.+++|+..
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~e~~~ 406 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKK--IILPFD--DWMVLSETQLRYIFLKEVQS 406 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCC--CCCSSC--TTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCC--CCCChh--hcccCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999887665433222 223444 34678999999999998865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-31 Score=242.16 Aligned_cols=235 Identities=23% Similarity=0.403 Sum_probs=166.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++..........+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 346999999999999999999999999999999996422 456799999999999999999999965443444568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHh------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVE------------ 209 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~------------ 209 (335)
|+||||++|+|.+++.. +.+++..++.|+.||+.||.|||++| ++. ...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999999999998874 56999999999999999999999998 000 000
Q ss_pred -------HhhhcCCCC---HHHhhh----------------------hCCCCCCCC------------------------
Q 019844 210 -------IIKVLGTPT---REEIKC----------------------MNPNYTEFK------------------------ 233 (335)
Q Consensus 210 -------~~~~~g~~~---~~~~~~----------------------~~~~~~~~~------------------------ 233 (335)
....+|++. ++.+.. +.+.|....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 001123322 221110 111111000
Q ss_pred ----------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCC
Q 019844 234 ----------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 303 (335)
Q Consensus 234 ----------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~ 303 (335)
.+.....+|...+ ..+++++.+||.+||+.||.+|||+.++|+||||++...+...... ...+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~----~~~~~~ 335 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF 335 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCCCC
T ss_pred hhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCC----CCcCCc
Confidence 0000111122222 5688999999999999999999999999999999998766554322 223445
Q ss_pred CcccCCCCCHHHHhhcChHHHhh
Q 019844 304 KPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+ .++..++.+.+++++.+++.+
T Consensus 336 ~-~~~~~~~~~~~~~~~~~e~~~ 357 (364)
T 3qyz_A 336 D-MELDDLPKEKLKELIFEETAR 357 (364)
T ss_dssp C------CCHHHHHHHHHHHTGG
T ss_pred c-cccccCCHHHHHHHHHHHHHH
Confidence 4 567889999999999988765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-32 Score=253.61 Aligned_cols=238 Identities=20% Similarity=0.270 Sum_probs=158.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~ 151 (335)
...++|++++.||+|+||+||+|.++.+++.||||++.+. .+.+.+|+.+|+.++|||||+++++|..... ..
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3456799999999999999999999999999999999643 2456799999999999999999999954332 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--HH---------
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ--LV--------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~--~~--------- 208 (335)
...+|||||||+|+|.+.+. ..+++..++.++.||+.||+|||++|+ +. ..
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CCeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 45689999999998777663 359999999999999999999999980 00 00
Q ss_pred ------hHhhhcCCCC---HHHhhh---------------------hCCCCCCC--------------------------
Q 019844 209 ------EIIKVLGTPT---REEIKC---------------------MNPNYTEF-------------------------- 232 (335)
Q Consensus 209 ------~~~~~~g~~~---~~~~~~---------------------~~~~~~~~-------------------------- 232 (335)
.....+|++. ++.+.. +.+.|...
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 0011233332 221111 01111000
Q ss_pred -------CCCCCCCCccccccccC-----------CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCC
Q 019844 233 -------KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 294 (335)
Q Consensus 233 -------~~~~~~~~~~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~ 294 (335)
..+......+...++.. .++++.+||.+||++||++|||+.|+|+||||+.+..+....+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~-- 370 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA-- 370 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC--
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC--
Confidence 00000111111222111 1567999999999999999999999999999998876543211
Q ss_pred CCCCCCCCCCcccCCCCCHHHHhhcChHHHhh
Q 019844 295 RPLPPLFNFKPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+.+..+++. .+......+.|++.+++++..
T Consensus 371 -~~~~~~~~~-~~~~~~~~~~~~~~~~~e~~~ 400 (464)
T 3ttj_A 371 -PPPQIYDKQ-LDEREHTIEEWKELIYKEVMN 400 (464)
T ss_dssp -CC------------CCCHHHHHHHHHHHHHC
T ss_pred -CCCccCCcc-hhhccCCHHHHHHHHHHHHHH
Confidence 112223333 344567788899988887754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=242.19 Aligned_cols=199 Identities=19% Similarity=0.276 Sum_probs=138.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
..++|.+.+.||+|+||+||+|+++ .++..||||+++.. .+.+.+|+.+|++|+|||||++++++ .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~ 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----V 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----e
Confidence 3457999999999999999999875 36788999999643 24578999999999999999999999 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-- 206 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-- 206 (335)
+...+|||||||+| +|.++|..... ....+++.++..|+.||+.||.|||+++ ++.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 44558999999995 99999986321 1346999999999999999999999998 000
Q ss_pred --------HHhH----------hhhcCCCC---HHHhhh----------------------hCCCCCCCCCCCCCC---C
Q 019844 207 --------LVEI----------IKVLGTPT---REEIKC----------------------MNPNYTEFKFPQIKP---H 240 (335)
Q Consensus 207 --------~~~~----------~~~~g~~~---~~~~~~----------------------~~~~~~~~~~~~~~~---~ 240 (335)
+... ....||+. +|.+.. +.+.|.......+.. .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 0000 01123332 222111 111111100000000 0
Q ss_pred ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 241 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
......|..+|+++.+||.+||+.||++|||+.++ |+|++.+.
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 00123456799999999999999999999999999 56877653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=243.00 Aligned_cols=235 Identities=21% Similarity=0.344 Sum_probs=154.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
...+|++++.||+|+||.||+|.++.+|+.||||++... .+.+.+|+.+|+.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 345699999999999999999999999999999998532 2456799999999999999999999954321 122
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHhH--------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVEI-------- 210 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~~-------- 210 (335)
..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++| ++. ..++
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 44689999997799999874 56999999999999999999999998 000 0000
Q ss_pred -----hhhcCCCC---HHHhhh----------------------hCCCCCCC----------------------------
Q 019844 211 -----IKVLGTPT---REEIKC----------------------MNPNYTEF---------------------------- 232 (335)
Q Consensus 211 -----~~~~g~~~---~~~~~~----------------------~~~~~~~~---------------------------- 232 (335)
....|++. ++.+.. +.+.|...
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 00112211 111110 11111100
Q ss_pred ------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 233 ------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 233 ------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.++......+...+ ..+++++.+||.+||+.||.+|||+.++|+||||+.+..+..+... ..+++. .
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-----~~~~~~-~ 330 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-----QKYDDS-F 330 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-----CCCCCC--
T ss_pred HHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC-----CCCCCC-h
Confidence 01111122233333 5679999999999999999999999999999999999877654322 123333 3
Q ss_pred cCCCCCHHHHhhcChHHHhh
Q 019844 307 ELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (335)
+......+.|++.+++++..
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~ 350 (367)
T 1cm8_A 331 DDVDRTLDEWKRVTYKEVLS 350 (367)
T ss_dssp ----CCHHHHHHHHHHHHHT
T ss_pred hhhcCCHHHHHHHHHHHHHH
Confidence 34467889999999988764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-31 Score=233.61 Aligned_cols=114 Identities=31% Similarity=0.495 Sum_probs=101.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++++.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.++||||+++++++ .....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 46999999999999999999999999999999996432 4567899999999999999999999 555669
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+|+|.+.+... .+.+++..++.++.||+.||.|||++|
T Consensus 77 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ 121 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999877776542 467999999999999999999999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=243.68 Aligned_cols=236 Identities=24% Similarity=0.327 Sum_probs=160.1
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~ 151 (335)
....+|++++.||+|+||.||+|.+..+|+.||||++... .+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3446799999999999999999999999999999998642 2456799999999999999999999854321 12
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--------hH----
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--------QL---- 207 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--------~~---- 207 (335)
...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++|+ + .+
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 345789999998899988864 569999999999999999999999980 0 00
Q ss_pred ---HhHhhhcCCCC---HHHhhh----------------------hCCCCCCC---------------------------
Q 019844 208 ---VEIIKVLGTPT---REEIKC----------------------MNPNYTEF--------------------------- 232 (335)
Q Consensus 208 ---~~~~~~~g~~~---~~~~~~----------------------~~~~~~~~--------------------------- 232 (335)
.......|++. ++.+.. +.+.|...
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 181 HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 00111233332 221111 01111100
Q ss_pred -------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCc
Q 019844 233 -------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 305 (335)
Q Consensus 233 -------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.++......+...+ ...++++.+||.+||+.||++|||+.++|+||||+.+..|..+... +.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~-----~~~~~~- 333 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-----DPYDQS- 333 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCC-----CCCCGG-
T ss_pred HHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCC-----CCCCcc-
Confidence 00011111222222 4678999999999999999999999999999999998887654322 224443
Q ss_pred ccCCCCCHHHHhhcChHHHhh
Q 019844 306 PELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~ 326 (335)
.+...+..+.|++++++++..
T Consensus 334 ~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 334 LESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp GSSCCCCHHHHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHHHH
Confidence 445678899999999998765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=234.26 Aligned_cols=116 Identities=31% Similarity=0.515 Sum_probs=100.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|++++.||+|+||.||+|++. +++.||+|++.... ..+.+|+.+++.++||||+++++++ ...
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence 45568999999999999999999995 69999999986422 4567999999999999999999999 555
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+|||||+|+|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ 139 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR 139 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 669999999999988887652 356999999999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=236.98 Aligned_cols=198 Identities=25% Similarity=0.293 Sum_probs=146.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|++++.||+|+||.||+|.+..+|+.||||++.+. ...+.+|+.+|+.++||||+++++++ ...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 4455799999999999999999999999999999999643 23467999999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-H-----------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-L----------- 207 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~----------- 207 (335)
..+|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||++++ +. .
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 669999999985 99999876 5679999999999999999999999980 00 0
Q ss_pred -----HhHhhhcCCCC---HHHhhhhCCCCCC-------------------CCCCCCCCCc-------cccccccCCChH
Q 019844 208 -----VEIIKVLGTPT---REEIKCMNPNYTE-------------------FKFPQIKPHP-------WHKVFQKRLPPE 253 (335)
Q Consensus 208 -----~~~~~~~g~~~---~~~~~~~~~~~~~-------------------~~~~~~~~~~-------~~~~~~~~~s~~ 253 (335)
......+|++. ++.+... .|.. ..+....... ....+|..++++
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTC--CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ecCCCCccccccCCcceeCcccccCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 00111223322 1111100 0000 0010000000 001234568999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
+.+||++||+.||.+|||+.++|+||||+....+
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 9999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=241.97 Aligned_cols=116 Identities=26% Similarity=0.471 Sum_probs=94.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~ 152 (335)
...+|++++.||+|+||.||+|.++.+|+.||||++.+. .....+|+.+++.+. ||||+++++++.. .+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 445799999999999999999999999999999998532 245678999999997 9999999999854 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|+|||||+|+|.+++.. +.+++..++.++.||+.||+|||++|
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ 129 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG 129 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45899999999999998874 46999999999999999999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=237.85 Aligned_cols=117 Identities=25% Similarity=0.391 Sum_probs=99.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|.+.++||+|+||+||+|+++ .+++.||||+++.. .+.+.+|+.+|++|+|||||++++++ .+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 45999999999999999999875 36889999999643 24578999999999999999999999 445
Q ss_pred cEEEEEeecchh-hHHHHHHHHhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|||||||+| +|.+++..... ...++++.++..|+.||+.||.|||+++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 178 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 558999999995 99999975321 1346999999999999999999999988
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=237.24 Aligned_cols=114 Identities=29% Similarity=0.503 Sum_probs=100.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
++|++++.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.++||||+++++++ .....+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 46999999999999999999999999999999996432 2456899999999999999999999 4455589
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++|+|.+++... ...+++..++.++.||+.||.|||++|
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ 120 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK 120 (324)
T ss_dssp EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999888763 356999999999999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=234.14 Aligned_cols=115 Identities=24% Similarity=0.431 Sum_probs=102.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecCC
Confidence 3456999999999999999999999999999999996432 3466899999999999999999999 5556
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+|||||+|+|.+++.. ...+++..++.|+.||+.||.|||+++
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~ 152 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR 152 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6999999999999999986 567999999999999999999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=237.33 Aligned_cols=225 Identities=36% Similarity=0.616 Sum_probs=145.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCC--CCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--KEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~--~~~~~ 154 (335)
..++|++.+.||+|+||.||+|+++.+++.||||++..+. ....+|+..++.++||||++++++|..... ....+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3457999999999999999999999999999999986543 345677777888899999999999975432 34556
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--hCC------------cC--hHHhHhhhc----
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCI------------VD--QLVEIIKVL---- 214 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~------------~~--~~~~~~~~~---- 214 (335)
+++||||++|+|...+.........+++..++.++.||+.||.||| +++ ++ .....+..+
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 8899999999888777765555778999999999999999999999 776 10 000001111
Q ss_pred ------------CCCC---HHHhh----------------------hhCCCCCC--------------------------
Q 019844 215 ------------GTPT---REEIK----------------------CMNPNYTE-------------------------- 231 (335)
Q Consensus 215 ------------g~~~---~~~~~----------------------~~~~~~~~-------------------------- 231 (335)
|++. ++.+. .+.+.|..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 1111 11110 00011100
Q ss_pred -----CCCCCCCCCccccccc---cCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCC-CCCC
Q 019844 232 -----FKFPQIKPHPWHKVFQ---KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP-PLFN 302 (335)
Q Consensus 232 -----~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~-~~~~ 302 (335)
..+......+|...++ ...++++.+||.+||+.||.+|||+.|+|+||||++...+....+....++ .++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 340 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFR 340 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGGC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHHH
Confidence 0000011111222221 235789999999999999999999999999999999988877666554444 3334
Q ss_pred CC
Q 019844 303 FK 304 (335)
Q Consensus 303 ~~ 304 (335)
|.
T Consensus 341 ~~ 342 (360)
T 3e3p_A 341 FL 342 (360)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=232.16 Aligned_cols=238 Identities=24% Similarity=0.403 Sum_probs=169.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++.++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3456999999999999999999999999999999996422 34568999999999999999999885433233466
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HHh------------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LVE------------ 209 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~~------------ 209 (335)
+|+||||+.|+|.+++.. +.+++..++.++.||+.||.|||++| ++. ...
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999999999998874 56999999999999999999999998 000 000
Q ss_pred ---------------HhhhcCCCC---HHHhh----------------------hhCCCCCCCC----------------
Q 019844 210 ---------------IIKVLGTPT---REEIK----------------------CMNPNYTEFK---------------- 233 (335)
Q Consensus 210 ---------------~~~~~g~~~---~~~~~----------------------~~~~~~~~~~---------------- 233 (335)
....+|++. ++.+. .+.+.|....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 000122222 22111 0111111000
Q ss_pred -------------------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCC
Q 019844 234 -------------------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 294 (335)
Q Consensus 234 -------------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~ 294 (335)
.+......+.. ..+.+++++.+||.+||+.||++|||+.++|+||||+....+......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~- 321 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG- 321 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC-
T ss_pred hhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc-
Confidence 00000001111 124789999999999999999999999999999999999887765433
Q ss_pred CCCC-CCCCCCcccCCCCCHHHHhhcChHHHh
Q 019844 295 RPLP-PLFNFKPPELSGIPPETINRLIPEHAR 325 (335)
Q Consensus 295 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (335)
.++| ..+.|+ .....+..+.+++++++++.
T Consensus 322 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 322 EPIPPSFFEFD-HYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCCGGGGGGG-CCSSCCCHHHHHHHHHHHHT
T ss_pred CCCCcceeeec-chhhcCCHHHHHHHHHHHhh
Confidence 4444 445555 45667889999999988763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=232.79 Aligned_cols=117 Identities=19% Similarity=0.268 Sum_probs=97.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+++++++||+|+||+||+|+.. .+++.||||+++.. .+.+.+|+.+|++|+|||||++++++ ..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-----TK 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----EE
Confidence 35888999999999999999864 46789999999642 25688999999999999999999999 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|||||||++ +|.++|.... .....+++.++..|+.||+.||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 165 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 165 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4458899999995 9999997422 11346999999999999999999999988
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=232.48 Aligned_cols=196 Identities=24% Similarity=0.328 Sum_probs=143.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++++.||+|+||.||+|+++.+|+.||+|++.+. ...+.+|+.+|+.++||||++++++| ....+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence 4699999999999999999999999999999999643 24567899999999999999999999 55567
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh---------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII--------- 211 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~--------- 211 (335)
+|+||||++| +|..++.. .+.+++..++.++.||+.||+|||++|+ +. ....+
T Consensus 80 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999996 99998876 5679999999999999999999999981 00 00001
Q ss_pred --------hhcCCCCHHHhhhhC-CCCCC----------------CCCCCCCCCc---------cccccccCCChHHHHH
Q 019844 212 --------KVLGTPTREEIKCMN-PNYTE----------------FKFPQIKPHP---------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 212 --------~~~g~~~~~~~~~~~-~~~~~----------------~~~~~~~~~~---------~~~~~~~~~s~~~~~l 257 (335)
..+|++.+....... ..|.. ...+...... -...++..+++++.+|
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 112222211100000 00000 0000000000 0012456789999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|| ++.++++||||..+.+
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999999 8999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.20 Aligned_cols=196 Identities=20% Similarity=0.257 Sum_probs=145.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----------hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
...++|.+++.||+|+||.||+|.++.+|+.||+|++.+.. ..+.+|+.+|+.++||||++++++|
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---- 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---- 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence 44567999999999999999999999999999999996432 3577999999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hH----HhH
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QL----VEI 210 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~----~~~ 210 (335)
.....+|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++| +. .. ...
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 -ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred -EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 556679999999985 99999875 667999999999999999999999998 10 00 001
Q ss_pred hhh----------------cCCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCcc
Q 019844 211 IKV----------------LGTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPW 242 (335)
Q Consensus 211 ~~~----------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~ 242 (335)
+.. +|++. ++.+... .|.. ..+... ....+
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 111 22222 1111100 0100 000000 00112
Q ss_pred ccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 243 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
...++..+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 2233467899999999999999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=235.18 Aligned_cols=242 Identities=20% Similarity=0.237 Sum_probs=162.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|++++.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 345799999999999999999999999999999999642 2456789999999999999999999854321 223
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C---------------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--------------- 205 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--------------- 205 (335)
..+|+|||||+|+|.+++. ..+++..++.++.||+.||.|||++++ +
T Consensus 103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 4689999999998888774 359999999999999999999999980 0
Q ss_pred --hHHhHhhhcCCCC---HHHhhh---------------------hCCCCCCCC--------------------------
Q 019844 206 --QLVEIIKVLGTPT---REEIKC---------------------MNPNYTEFK-------------------------- 233 (335)
Q Consensus 206 --~~~~~~~~~g~~~---~~~~~~---------------------~~~~~~~~~-------------------------- 233 (335)
.........|++. ++.+.. +.+.|....
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 0000011123322 222111 011110000
Q ss_pred -------CCCCCCCccccccc-----------cCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCC
Q 019844 234 -------FPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 295 (335)
Q Consensus 234 -------~~~~~~~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~ 295 (335)
.+......+...++ ...++++++||.+||+.||++|||+.++|+||||+....+.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~--- 333 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA--- 333 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC---
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC---
Confidence 00000000000110 012568999999999999999999999999999998766433211
Q ss_pred CCCCCCCCCcccCCCCCHHHHhhcChHHHhhccccc
Q 019844 296 PLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFM 331 (335)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (335)
+.|.+.... .+......+.|+++++.++......|
T Consensus 334 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (371)
T 2xrw_A 334 PPPKIPDKQ-LDEREHTIEEWKELIYKEVMDLEHHH 368 (371)
T ss_dssp CCCCCCTTT-TCCCCCCHHHHHHHHHHHHHHHCC--
T ss_pred CCCCCCChh-hccccCcHHHHHHHHHHHHHHHhhhc
Confidence 112222222 34556788999999999998866554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-29 Score=227.92 Aligned_cols=235 Identities=20% Similarity=0.355 Sum_probs=165.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---------------hhHHHHHHHHHhCCCCceeeeceeee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFF 145 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------~~~~~Ei~~l~~l~hpnIv~~~~~~~ 145 (335)
.++|.+++.||+|+||.||+|.+. +|+.||||++.... +.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 456999999999999999999985 49999999985321 45779999999999999999999997
Q ss_pred eCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-h------
Q 019844 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-Q------ 206 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~------ 206 (335)
........++|+||||++|+|.+++.. ....+++..++.++.||+.||.|||++++ + .
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 766556677999999999998888774 24579999999999999999999999980 0 0
Q ss_pred ----------HHhHhhhcCCCC---HHHhhh----------------------hCCCCCCC-------------------
Q 019844 207 ----------LVEIIKVLGTPT---REEIKC----------------------MNPNYTEF------------------- 232 (335)
Q Consensus 207 ----------~~~~~~~~g~~~---~~~~~~----------------------~~~~~~~~------------------- 232 (335)
........|++. ++.+.. +.+.|...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 000001112211 121110 01111000
Q ss_pred ----------------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCC
Q 019844 233 ----------------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 296 (335)
Q Consensus 233 ----------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~ 296 (335)
.........|.. ....+++.+.+||.+||+.||.+|||+.++|+||||+.+..|.... ..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~---~~ 332 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT---EG 332 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT---TT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc---cc
Confidence 000001111111 2256789999999999999999999999999999999987665432 23
Q ss_pred CCCCCCCCcccCCCCCHHHHhhcChHHHhh
Q 019844 297 LPPLFNFKPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+...+.|. ....+...+.+.+.+|+.+
T Consensus 333 ~~~~~~~~---~~~~~~~~~~~~~~~e~~~ 359 (362)
T 3pg1_A 333 LSERFHFD---ESVTDVYDMHKIFTAEVER 359 (362)
T ss_dssp CCCCCCCC---TTCCCHHHHHHHHHHHHHH
T ss_pred cccccChh---hhhhhHHHHHHHHHHHHHH
Confidence 44455555 3666778888888887654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=234.74 Aligned_cols=197 Identities=25% Similarity=0.379 Sum_probs=143.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
...++|++++.||+|+||.||+|+++.+++.||||++.+. ...+.+|+.+++.+ +||||++++++| .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 3445799999999999999999999999999999999753 24467899999998 799999999999 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C------------
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D------------ 205 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~------------ 205 (335)
...++|+|||||+| +|..++.. .+.+++..++.|+.||+.||+|||++++ +
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccc
Confidence 56679999999996 99999886 5679999999999999999999999980 0
Q ss_pred ------hHHhHhhhcCCCC---HHHhhhhCC------------------CCCCCCCCCCCCC-------ccccccccCCC
Q 019844 206 ------QLVEIIKVLGTPT---REEIKCMNP------------------NYTEFKFPQIKPH-------PWHKVFQKRLP 251 (335)
Q Consensus 206 ------~~~~~~~~~g~~~---~~~~~~~~~------------------~~~~~~~~~~~~~-------~~~~~~~~~~s 251 (335)
........+|++. ++.+..... ...+ +...... .....++..++
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P--f~~~~~~~~~~~i~~~~~~~p~~~~ 248 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENEDDLFEAILNDEVVYPTWLH 248 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred eeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC--CCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 0011112334433 121110000 0000 1000000 00122456789
Q ss_pred hHHHHHHHHhccCCCCCCCCH------HHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~------~~~L~hp~f~~~~~ 286 (335)
+++.+||++||+.||.+||++ .++++||||+.+.+
T Consensus 249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 999999999999999999998 99999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=222.32 Aligned_cols=113 Identities=27% Similarity=0.434 Sum_probs=99.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++++.||+|+||.||+|++ .+++.||+|++... ...+.+|+.+++.++||||+++++++ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 4699999999999999999999 68999999998532 24567999999999999999999999 444568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++++|.+++... .+.+++..++.++.||+.||.|||+++
T Consensus 76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR 120 (288)
T ss_dssp EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999998888752 367999999999999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=231.41 Aligned_cols=114 Identities=25% Similarity=0.347 Sum_probs=103.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++++.||+|+||.||+|+++.+++.||||++... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEEE
Confidence 45699999999999999999999999999999999643 35678999999999999999999999 45556999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++|
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~ 136 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ 136 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999985 99999876 567999999999999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=231.02 Aligned_cols=235 Identities=24% Similarity=0.390 Sum_probs=163.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC-Cc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~-~~ 152 (335)
...+|.+.+.||+|+||.||+|.++.+|+.||||++... ...+.+|+.+++.++||||+++++++...... ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 445799999999999999999999999999999999643 24567999999999999999999999543321 11
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-h-HH----------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-Q-LV---------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~-~~---------- 208 (335)
..+|+||||+.|+|.+++. ..+++..++.++.||+.||.|||++++ + . ..
T Consensus 120 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 2248999999999877763 459999999999999999999999980 0 0 00
Q ss_pred ---hHhhhcCCCC---HHHhhh----------------------hCCCCCCCC---------------------------
Q 019844 209 ---EIIKVLGTPT---REEIKC----------------------MNPNYTEFK--------------------------- 233 (335)
Q Consensus 209 ---~~~~~~g~~~---~~~~~~----------------------~~~~~~~~~--------------------------- 233 (335)
......|++. ++.+.. +.+.|....
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 0011123332 121110 001110000
Q ss_pred -------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 234 -------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 234 -------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.+......+.. ++..+++++.+||.+||+.||.+|||+.++|+||||+.+..+........++.. ..
T Consensus 274 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~-----~~ 347 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD-----SL 347 (371)
T ss_dssp HHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC-----TT
T ss_pred hhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc-----ch
Confidence 00000011111 124679999999999999999999999999999999998876655433222221 13
Q ss_pred cCCCCCHHHHhhcChHHHhh
Q 019844 307 ELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (335)
+...+..+.|++.+++++..
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~ 367 (371)
T 4exu_A 348 EHEKLTVDEWKQHIYKEIVN 367 (371)
T ss_dssp SSCCCCHHHHHHHHHHHHHH
T ss_pred hhcccchHHHHHHHHHHHHh
Confidence 45667888999999987765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=225.94 Aligned_cols=117 Identities=26% Similarity=0.436 Sum_probs=90.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.+|++++.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++ .....+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 4699999999999999999999999999999999642 24577999999999999999999999 5566799
Q ss_pred EEeecchhhHHHHHHHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||+|+|.+++..... ....+++..++.++.||+.||.|||++|
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 128 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999876431 1245999999999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=230.03 Aligned_cols=196 Identities=24% Similarity=0.316 Sum_probs=144.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.+.+.||+|+||.||+|.+..+++.||||++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 445799999999999999999999999999999998642 24578999999999999999999999 455
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh--------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII-------- 211 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~-------- 211 (335)
..+|+||||++|+|.+++.. .+.+++..++.++.||+.||.|||++|+ +. ....+
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 56999999998899888876 5679999999999999999999999880 00 00001
Q ss_pred --------hhcCCCCHHHhh-------------------------hhCCCCCCCCCCCCCCC--ccccccccCCChHHHH
Q 019844 212 --------KVLGTPTREEIK-------------------------CMNPNYTEFKFPQIKPH--PWHKVFQKRLPPEAVD 256 (335)
Q Consensus 212 --------~~~g~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~ 256 (335)
..+|++.+.... .+.+.|........... .....++..+++++.+
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp TTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHH
T ss_pred ccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 112332211100 01111111000000000 0011244568999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
||++||+.||.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=232.50 Aligned_cols=118 Identities=22% Similarity=0.355 Sum_probs=104.2
Q ss_pred cceeeeEEeeeeecc--CceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...++|++++.||+| +||.||+|+++.+++.||||++.... ..+.+|+.+++.++|||||+++++| .
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~ 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----I 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----E
Confidence 455679999999999 99999999999999999999996432 4567899999999999999999999 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+|||||+| +|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ 148 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG 148 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 55569999999995 9999998632 366999999999999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=224.55 Aligned_cols=122 Identities=25% Similarity=0.402 Sum_probs=102.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCC---CCceeeeceeeeeC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD---HPNIVALKHCFFST 147 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~ 147 (335)
...+|++++.||+|+||.||+|+++.+++.||||++... .....+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 345799999999999999999999999999999998632 135678888887774 99999999999765
Q ss_pred CCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 148 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
......++++||||++|+|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ 140 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC 140 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 545556789999999999999988632 234999999999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=230.63 Aligned_cols=195 Identities=18% Similarity=0.179 Sum_probs=136.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCC-----CcEEEEEEeccc-----chhHHHHHHHHHhCCC-CceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLDH-PNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~ 148 (335)
..++|++++.||+|+||+||+|.++.+ ++.||||.+... .+.+.+|+.+|++++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-- 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence 346799999999999999999998654 368999999643 2457899999999965 999999999843
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC------------
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCI------------ 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~------------ 203 (335)
....+|||||||+| +|.++|+..... ...+++.++..|+.||+.||+|||+++
T Consensus 140 --~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 140 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 23348899999995 999999864321 245899999999999999999999998
Q ss_pred cC-h---------HH----------hHhhhcCCCC---HHHhhh----------------------hCCCCCCCCCCCC-
Q 019844 204 VD-Q---------LV----------EIIKVLGTPT---REEIKC----------------------MNPNYTEFKFPQI- 237 (335)
Q Consensus 204 ~~-~---------~~----------~~~~~~g~~~---~~~~~~----------------------~~~~~~~~~~~~~- 237 (335)
++ . +. .....+||+. ||.+.. +.+.|........
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 00 0 00 0011223332 222111 1111211100000
Q ss_pred ---CCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019844 238 ---KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 278 (335)
Q Consensus 238 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~h 278 (335)
-........|..+++++.+||.+||+.||++|||+.++++|
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 00011223456789999999999999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=226.40 Aligned_cols=111 Identities=17% Similarity=0.251 Sum_probs=94.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.+++.++++||+|+||+||+|+++ ..||||+++.. .+.+.+|+.+|++++|||||++++++. . ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----K-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----C-Ce
Confidence 346889999999999999999874 35999998632 245789999999999999999999872 2 23
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||||+| +|.+++... ...+++.++..|+.||+.||+|||+++
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~ 152 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN 152 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 7899999995 999998742 457999999999999999999999988
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-29 Score=226.81 Aligned_cols=116 Identities=28% Similarity=0.488 Sum_probs=97.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...+|++++.||+|+||.||+|.++.+|+.||||++... ...+.+|+.+++.++||||+++++++ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence 345799999999999999999999999999999998632 13567999999999999999999999 4
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++||||++|+|..++.. ....+++..++.++.||+.||.|||+++
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5556889999999998888764 2356999999999999999999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=228.77 Aligned_cols=198 Identities=19% Similarity=0.229 Sum_probs=146.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
...++|++++.||+|+||.||+|.++.+++.||||++.+......+|++++.++ +||||+++++++ .+..++|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence 345679999999999999999999999999999999987777778999999888 799999999999 56667999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c-Ch----HHhHhhh------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V-DQ----LVEIIKV------ 213 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~-~~----~~~~~~~------ 213 (335)
|||||.| +|.+.+.. .+.+++..++.++.||+.||.|||++| + +. ....+..
T Consensus 94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999986 99998875 567999999999999999999999998 0 00 0011111
Q ss_pred -----------cCCCC---HHHhh---------------------hhCCCCCCCCCCCC---------CCCccccccccC
Q 019844 214 -----------LGTPT---REEIK---------------------CMNPNYTEFKFPQI---------KPHPWHKVFQKR 249 (335)
Q Consensus 214 -----------~g~~~---~~~~~---------------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 249 (335)
+|++. ++.+. .+.+.|........ ....+...++..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 12221 11110 01111110000000 000111123357
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+++++++||++||+.||++|||+.++|+||||....
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 899999999999999999999999999999997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-29 Score=220.20 Aligned_cols=113 Identities=35% Similarity=0.614 Sum_probs=100.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++++.||+|+||.||+|.+..+|+.||||++.... +.+.+|+.+++.++||||+++++++ .....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCeE
Confidence 46999999999999999999999999999999985432 3466899999999999999999999 555668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||||+| +|..++.. ...+++..++.++.||+.||.|||++|
T Consensus 78 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~ 122 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN 122 (311)
T ss_dssp EEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999997 77777664 567999999999999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=230.87 Aligned_cols=199 Identities=28% Similarity=0.317 Sum_probs=144.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc---------cchhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~---------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
...++|++.+.||+|+||.||+|.++.+++.||||++.. ....+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----- 95 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY----- 95 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 345679999999999999999999999999999999853 134578999999999999999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--hHH--hHhh
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD--QLV--EIIK 212 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~--~~~--~~~~ 212 (335)
.....+|+|||||+| +|.+.+.........+++..++.++.||+.||.|||+++ ++ ... ..+.
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 455669999999995 998888765544556999999999999999999999998 10 000 0011
Q ss_pred h-----------------cCCCC---HHHhhhhCCCCCC------------------CCCCCCC----------CCcccc
Q 019844 213 V-----------------LGTPT---REEIKCMNPNYTE------------------FKFPQIK----------PHPWHK 244 (335)
Q Consensus 213 ~-----------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~~----------~~~~~~ 244 (335)
. +|++. ++.+... .|.. ..+.... ...+..
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCc
Confidence 1 12222 1111100 0000 0000000 000111
Q ss_pred ccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 245 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
..+..+++++++||.+||+.||++|||+.++|+||||+..
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1225689999999999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-29 Score=229.71 Aligned_cols=198 Identities=22% Similarity=0.363 Sum_probs=145.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
..++|+++++||+|+||+||+|+++.+++.||+|++++. ...+.+|+.++..+ +|||||+++++| ..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 345699999999999999999999999999999999753 23467899999887 899999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--HH--------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ--LV-------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~--~~-------- 208 (335)
...+|+|||||+| +|..++.. .+.+++..++.|+.||+.||.|||++++ +. ..
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 6679999999996 99998886 5679999999999999999999999980 00 00
Q ss_pred --------hHhhhcCCCC---HHHhhh---------------------hCCCCCCCCCCCC-CCC----------ccccc
Q 019844 209 --------EIIKVLGTPT---REEIKC---------------------MNPNYTEFKFPQI-KPH----------PWHKV 245 (335)
Q Consensus 209 --------~~~~~~g~~~---~~~~~~---------------------~~~~~~~~~~~~~-~~~----------~~~~~ 245 (335)
.....+||+. ++.+.. +.+.|........ ... .....
T Consensus 201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 201 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp BCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred eecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence 0111233332 111110 1111110000000 000 00123
Q ss_pred cccCCChHHHHHHHHhccCCCCCCCCH------HHHhcCcccccCCC
Q 019844 246 FQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 286 (335)
Q Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~------~~~L~hp~f~~~~~ 286 (335)
+|..+++++++||++||+.||.+||++ .++++||||+.+.+
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 556789999999999999999999985 89999999998765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=229.59 Aligned_cols=197 Identities=21% Similarity=0.305 Sum_probs=145.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||.||+|.++.+++.||+|++.+. ...+.+|+.+|+.++|||||+++++| ....
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 45799999999999999999999999999999999643 24567999999999999999999999 5556
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--------------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-------------- 206 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-------------- 206 (335)
.+|+|||||.| +|..++.. ...+++..++.|+.||+.||.|||++|+ +.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 69999999986 99999875 5679999999999999999999999980 00
Q ss_pred ---HHhHhhhcCCCCHHHhhhhC----CCCCC------------------CCCCCCCCCc----------cccccccCCC
Q 019844 207 ---LVEIIKVLGTPTREEIKCMN----PNYTE------------------FKFPQIKPHP----------WHKVFQKRLP 251 (335)
Q Consensus 207 ---~~~~~~~~g~~~~~~~~~~~----~~~~~------------------~~~~~~~~~~----------~~~~~~~~~s 251 (335)
.......+|++.+....... ..|.. ..+....... ....++..++
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 00001122333211111110 00100 0000000000 0012456789
Q ss_pred hHHHHHHHHhccCCCCCCCC-HHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t-~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||.+||+ +.++++||||..+.+
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 99999999999999999998 899999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=229.71 Aligned_cols=196 Identities=20% Similarity=0.269 Sum_probs=144.1
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
...++|.+.+.||+|+||.||+|.++.+++.||+|++.+. ...+.+|+.+|+.++||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---- 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence 4456799999999999999999999999999999999642 24577999999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-H----HhH
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-L----VEI 210 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~----~~~ 210 (335)
.....+|+|||||+| +|.+++.. ...+++..++.++.||+.||.|||+++ +.. . ...
T Consensus 84 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 84 -ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred -EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence 555669999999985 99999875 567999999999999999999999998 000 0 001
Q ss_pred hhh----------------cCCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCcc
Q 019844 211 IKV----------------LGTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPW 242 (335)
Q Consensus 211 ~~~----------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~ 242 (335)
+.. +|++. ++.+... .|.. ..+... ....+
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 111 12222 1111100 0000 000000 00011
Q ss_pred ccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 243 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
....+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 1122356899999999999999999999999999999998653
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=218.49 Aligned_cols=115 Identities=31% Similarity=0.563 Sum_probs=100.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++.+.||+|+||.||+|+++.+++.||||++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEE-----ecCCce
Confidence 4599999999999999999999999999999998642 24577999999999999999999999 445568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||+.|+|.+++.... ...+++..++.++.||+.||.|||++|
T Consensus 78 ~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 123 (299)
T 2r3i_A 78 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR 123 (299)
T ss_dssp EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEcccCCHHHHHHhhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999988633 356899999999999999999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=228.22 Aligned_cols=195 Identities=25% Similarity=0.345 Sum_probs=144.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||.||+|+++.+|+.||||++.+. ...+.+|+.+|+.++||||+++++++ .+..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence 34699999999999999999999999999999999643 24567899999999999999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHhH--------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVEI-------- 210 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~~-------- 210 (335)
++|+||||++| +|.+++.. .+.+++..++.|+.||+.||.|||++| ++. ..++
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence 79999999985 99999986 567999999999999999999999998 000 0000
Q ss_pred -----hhhcCCCC---HHHhhhhCCCCCC------------------CCCCCCCCC-------ccccccccCCChHHHHH
Q 019844 211 -----IKVLGTPT---REEIKCMNPNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 211 -----~~~~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~~~l 257 (335)
...+|++. ++.+... .|.. ..+...... .....++..+++++.+|
T Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 191 VKGRTWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp CSSCBCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ccCCcccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 01123332 1111100 0100 000000000 00112456789999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+||+ +.++++||||+...+
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 99999999999998 999999999988654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=217.48 Aligned_cols=120 Identities=24% Similarity=0.349 Sum_probs=107.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...++|.+.+.||+|+||.||+|.++.++..+|+|++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCC
Confidence 45568999999999999999999999999999999986432 5578999999999999999999999 5556
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++| +|.+++.........+++..++.|+.||+.||.|||+++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 144 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999996 999998876555678999999999999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=227.47 Aligned_cols=195 Identities=23% Similarity=0.393 Sum_probs=145.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+. ...+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 35699999999999999999999999999999999643 24567899999999999999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHh---------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVE--------- 209 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~--------- 209 (335)
.+|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++| ++. ..+
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 79999999996 99999986 567999999999999999999999998 000 000
Q ss_pred ----HhhhcCCCCH---HHhhhhCCCCCC----------------CCCCCCCCCc---------cccccccCCChHHHHH
Q 019844 210 ----IIKVLGTPTR---EEIKCMNPNYTE----------------FKFPQIKPHP---------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 210 ----~~~~~g~~~~---~~~~~~~~~~~~----------------~~~~~~~~~~---------~~~~~~~~~s~~~~~l 257 (335)
....+|++.+ +.+... .|.. ...+...... ....++..+++++.+|
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 156 VPDVTYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 233 (318)
T ss_dssp CSSCBCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCccccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 0112344332 211110 0100 0000000000 0112456789999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|+ +++++++||||+.+.+
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 9999999999999 8999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=232.71 Aligned_cols=197 Identities=23% Similarity=0.368 Sum_probs=144.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
.++|.+++.||+|+||.||+|+++.+|+.||||++.+. ...+.+|..+++.+ +||||+++++++ .+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~~ 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTK 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----EeC
Confidence 35699999999999999999999999999999999653 23467899999877 999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-H-H---------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-L-V--------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~-~--------- 208 (335)
.++|+|||||+| +|.+++.. .+.+++..++.|+.||+.||+|||++|+ +. . .
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 679999999986 99999986 5679999999999999999999999980 00 0 0
Q ss_pred -------hHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCCCC-------ccccccccCCChHHH
Q 019844 209 -------EIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEAV 255 (335)
Q Consensus 209 -------~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~~ 255 (335)
.....+|++.+....... ..|.. ..+...... .....++..+++++.
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence 001122333211111000 00100 000000000 001224567899999
Q ss_pred HHHHHhccCCCCCCCCHH-HHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRCTAL-EACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~-~~L~hp~f~~~~~ 286 (335)
+||.+||+.||++||++. ++++||||+.+.+
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 999999999999999998 9999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=223.35 Aligned_cols=217 Identities=22% Similarity=0.312 Sum_probs=155.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----cc
Confidence 3456799999999999999999999999999999998643 24567899999999999999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh----
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV---- 213 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~---- 213 (335)
...+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ +. ....+..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 5668999999996 99998876 5679999999999999999999999980 00 0000011
Q ss_pred -------------cCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHH
Q 019844 214 -------------LGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEA 254 (335)
Q Consensus 214 -------------~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~ 254 (335)
.|++. ++.+........ ...+...... .....++..+++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHH
Confidence 12211 111110000000 0000000000 00012345688999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 304 (335)
.+||.+||+.||++|||+.++|+||||.....|.........+|+.+.+.
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred HHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcccC
Confidence 99999999999999999999999999998877766555555666666654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=224.95 Aligned_cols=235 Identities=24% Similarity=0.401 Sum_probs=162.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC-Cc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~-~~ 152 (335)
...+|.+.+.||+|+||.||+|.++.+|+.||||++... ...+.+|+.+++.++||||+++++++...... ..
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 345799999999999999999999999999999999642 24567899999999999999999999543211 11
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-H-H----------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-L-V---------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~-~---------- 208 (335)
..+|+||||+.|+|.+++. ..+++..++.++.||+.||.|||++|+ +. . .
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 2358999999998877653 359999999999999999999999980 00 0 0
Q ss_pred ---hHhhhcCCCC---HHHhhh----------------------hCCCCCCCC---------------------------
Q 019844 209 ---EIIKVLGTPT---REEIKC----------------------MNPNYTEFK--------------------------- 233 (335)
Q Consensus 209 ---~~~~~~g~~~---~~~~~~----------------------~~~~~~~~~--------------------------- 233 (335)
......|++. ++.+.. +.+.|....
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 0001122222 221110 011111000
Q ss_pred -------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 234 -------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 234 -------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.+......+.. ....+++++.+||.+||+.||++|||+.++|+||||+....+........+ ++.. .
T Consensus 256 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~----~~~~-~ 329 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP----FDDS-L 329 (353)
T ss_dssp HHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC----CCCT-T
T ss_pred HHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC----Cccc-h
Confidence 00000111111 124679999999999999999999999999999999988776554332221 2222 3
Q ss_pred cCCCCCHHHHhhcChHHHhh
Q 019844 307 ELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (335)
+...++.+.|++.|.+++..
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~ 349 (353)
T 3coi_A 330 EHEKLTVDEWKQHIYKEIVN 349 (353)
T ss_dssp TTCCCCHHHHHHHHHHHHHT
T ss_pred hhccCCHHHHHHHHHHHHHh
Confidence 45678889999999887764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=238.91 Aligned_cols=198 Identities=24% Similarity=0.307 Sum_probs=143.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----------------chhHHHHHHHHHhCCCCceeeece
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNIVALKH 142 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----------------~~~~~~Ei~~l~~l~hpnIv~~~~ 142 (335)
..++|.++++||+|+||.||+|.++.+++.||||++.+. ...+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 445799999999999999999999999999999998642 134678999999999999999999
Q ss_pred eeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH--
Q 019844 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL-- 207 (335)
Q Consensus 143 ~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~-- 207 (335)
++ .+..++|+|||||+| +|.+.+.. ...+++..++.|+.||+.||.|||+++ ++..
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence 99 566679999999986 99998876 567999999999999999999999998 1000
Q ss_pred --HhHhh----------------hcCCCCHHHhhhhCCCCCC------------------CCCCCCC-----------CC
Q 019844 208 --VEIIK----------------VLGTPTREEIKCMNPNYTE------------------FKFPQIK-----------PH 240 (335)
Q Consensus 208 --~~~~~----------------~~g~~~~~~~~~~~~~~~~------------------~~~~~~~-----------~~ 240 (335)
...+. .+|++.+.........|.. ..+.... ..
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 00111 1233221111111111110 0000000 00
Q ss_pred ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 241 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
.+....+..+++++++||++||+.||.+|||+.++|+||||+....
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 0111123578999999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=234.46 Aligned_cols=195 Identities=24% Similarity=0.243 Sum_probs=143.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|++++.||+|+||.||+|.++.+|+.||+|++.... ..+.+|+.+++.++|||||++++++ ...
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 45568999999999999999999999999999999996432 4577999999999999999999999 566
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC----hHHhHhhh--
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD----QLVEIIKV-- 213 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~----~~~~~~~~-- 213 (335)
.++|+|||||.| +|.+.+.. .+.+++..++.++.||+.||.|||++| ++ .....+..
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred CEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 679999999996 99998886 677999999999999999999999998 11 00001111
Q ss_pred ---------------cCCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCcccccc
Q 019844 214 ---------------LGTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPWHKVF 246 (335)
Q Consensus 214 ---------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~ 246 (335)
+|++. ++.+... .|.. ..+... ....+....
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 22222 1111100 0100 000000 000111122
Q ss_pred ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 247 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 24689999999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=224.52 Aligned_cols=198 Identities=21% Similarity=0.194 Sum_probs=142.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|++++.||+|+||.||+|+++.+++.||||++... ...+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence 345799999999999999999999999999999998532 25578999999999999999999999 55667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh---------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII--------- 211 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~--------- 211 (335)
+|+|||||+| +|.+++.. ...+++..++.++.||+.||+|||++|+ +. ....+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 8999999986 99888764 5579999999999999999999999980 00 00000
Q ss_pred ----------hhcCCCC---HHHhhh----------------------hCCCCCCCCCCCC-----CCCccccccccCCC
Q 019844 212 ----------KVLGTPT---REEIKC----------------------MNPNYTEFKFPQI-----KPHPWHKVFQKRLP 251 (335)
Q Consensus 212 ----------~~~g~~~---~~~~~~----------------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~s 251 (335)
..+|++. ++.+.. +.+.|........ .........+..++
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCC
Confidence 1122222 111110 1111110000000 00000011124689
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999999987544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=221.91 Aligned_cols=194 Identities=22% Similarity=0.251 Sum_probs=141.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...+|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++| .....+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEE
Confidence 345699999999999999999999999999999998532 34577999999999999999999999 445568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh--------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV-------- 213 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~-------- 213 (335)
|+|||||+| +|.+++.. ..+++..++.++.||+.||.|||++++ + .....+..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999985 99999874 469999999999999999999999980 0 00000111
Q ss_pred ---------cCCCC---HHHhhhhCCCCCC----------------CCCCCCCCC------------ccccccccCCChH
Q 019844 214 ---------LGTPT---REEIKCMNPNYTE----------------FKFPQIKPH------------PWHKVFQKRLPPE 253 (335)
Q Consensus 214 ---------~g~~~---~~~~~~~~~~~~~----------------~~~~~~~~~------------~~~~~~~~~~s~~ 253 (335)
.|++. ++.+... .|.. ...+..... ......+..+++.
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred CcccccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 22221 1211100 0000 000000000 0011224568899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+.+||.+||+.||++|||+.++|+||||+...
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=233.03 Aligned_cols=199 Identities=22% Similarity=0.294 Sum_probs=145.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc------cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|++++.||+|+||.||+|.++.+++.||||++.+ ....+.+|+.+|+.++|||||++++++ ...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence 456789999999999999999999999999999999853 234578999999999999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-Ch---------------HHhHhhhc-
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-DQ---------------LVEIIKVL- 214 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~---------------~~~~~~~~- 214 (335)
..+|+|||||.| +|.+.+.. .+.+++..++.|+.||+.||.|||++|+ +. ....+..+
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 679999999996 99888876 5679999999999999999999999981 00 00001111
Q ss_pred ---------------CCCCHHHhhhhCCCCCC------------------CCCCCC-----------CCCccccccccCC
Q 019844 215 ---------------GTPTREEIKCMNPNYTE------------------FKFPQI-----------KPHPWHKVFQKRL 250 (335)
Q Consensus 215 ---------------g~~~~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~~~ 250 (335)
|++.+.........|.. ..+... ....+....+..+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 22211000000000100 000000 0001111223568
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|+++++||.+||+.||.+|||+.++|+||||+....
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=222.56 Aligned_cols=119 Identities=28% Similarity=0.456 Sum_probs=102.6
Q ss_pred CCccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 76 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
......++|++++.||+|+||.||+|++..+++.||||++.... +.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 93 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC----- 93 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----
Confidence 34455668999999999999999999999999999999985322 3456899999999999999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|..++.. ...+++..++.++.||+.||.|||+++
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ 144 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN 144 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 555668999999997 67666553 567999999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=222.40 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=138.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.++||+|+||+||+|+++.+++.||||++.... .....|+..+..+ +||||+++++++ ...
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~ 129 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEG 129 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeC
Confidence 4467999999999999999999999999999999985421 2234555555555 899999999999 556
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hHHhHhhhc-----
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QLVEIIKVL----- 214 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~~~~~~~~----- 214 (335)
..+|+|||||+|+|.+++... ...+++..++.|+.||+.||.|||+++ ++ .....+..+
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 130 GILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp TEEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred CEEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 669999999998998888763 456999999999999999999999998 00 000001111
Q ss_pred -----------CCCCHHHhhhhCCCCCC-----------------CCCC-------CCCCCccccccccCCChHHHHHHH
Q 019844 215 -----------GTPTREEIKCMNPNYTE-----------------FKFP-------QIKPHPWHKVFQKRLPPEAVDLVC 259 (335)
Q Consensus 215 -----------g~~~~~~~~~~~~~~~~-----------------~~~~-------~~~~~~~~~~~~~~~s~~~~~li~ 259 (335)
|++.+.........|.. ...+ ..........++..+++++.+||.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 22211100000000100 0000 001111122334578999999999
Q ss_pred HhccCCCCCCCCHHHHhcCccccc
Q 019844 260 RFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 260 ~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
+||+.||++|||+.++|+||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=225.34 Aligned_cols=197 Identities=21% Similarity=0.271 Sum_probs=142.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|.+++.||+|+||.||+|.++.+++.||+|.+... ...+.+|+.+++.++||||+++++++ .+...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEEE
Confidence 35699999999999999999999999999999998643 24567999999999999999999999 55566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC---hHHhHhhhc-------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD---QLVEIIKVL------- 214 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~---~~~~~~~~~------- 214 (335)
|||||+| +|.+++.. ....+++..++.++.||+.||.|||+++ ++ .....+..+
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999996 99988864 1346999999999999999999999998 10 000011111
Q ss_pred ---------CCCC---HHHhh---------------------hhCCCCCCCCCCC----C--CCCccccccccCCChHHH
Q 019844 215 ---------GTPT---REEIK---------------------CMNPNYTEFKFPQ----I--KPHPWHKVFQKRLPPEAV 255 (335)
Q Consensus 215 ---------g~~~---~~~~~---------------------~~~~~~~~~~~~~----~--~~~~~~~~~~~~~s~~~~ 255 (335)
|++. ++.+. .+.+.|....... + ....+....+..+++++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 2221 11110 0011110000000 0 000111112257899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+||.+||+.||.+|||+.|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=217.94 Aligned_cols=120 Identities=24% Similarity=0.324 Sum_probs=106.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.++..+ +||||+++++++ ..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~ 82 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AE 82 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ec
Confidence 4567899999999999999999999999999999998642 24567899999999 999999999999 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+||||++| +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 135 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5568999999986 999999876555578999999999999999999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=221.98 Aligned_cols=197 Identities=22% Similarity=0.364 Sum_probs=144.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
..+|++++.||+|+||.||+|+++.+++.||+|++.+.. ..+.+|+.+++.+ +|||||+++++| ...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 456999999999999999999999999999999997532 3467899999988 899999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C--------hHH---
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D--------QLV--- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~--------~~~--- 208 (335)
..+|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++++ + .+.
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence 679999999986 99999876 5679999999999999999999999980 0 000
Q ss_pred -------hHhhhcCCCC---HHHhh---------------------hhCCCCCCCCCCCCCC-Cc----------ccccc
Q 019844 209 -------EIIKVLGTPT---REEIK---------------------CMNPNYTEFKFPQIKP-HP----------WHKVF 246 (335)
Q Consensus 209 -------~~~~~~g~~~---~~~~~---------------------~~~~~~~~~~~~~~~~-~~----------~~~~~ 246 (335)
.....+|++. ++.+. .+.+.|.......... .. ....+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 238 (345)
T 3a8x_A 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238 (345)
T ss_dssp CSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC
T ss_pred cccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC
Confidence 0011233332 11111 0111111000000000 00 01124
Q ss_pred ccCCChHHHHHHHHhccCCCCCCCCH------HHHhcCcccccCCC
Q 019844 247 QKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 286 (335)
Q Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~------~~~L~hp~f~~~~~ 286 (335)
+..+++++.+||.+||+.||.+||++ .++++||||+.+.+
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 56789999999999999999999995 89999999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=215.44 Aligned_cols=202 Identities=23% Similarity=0.230 Sum_probs=145.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 3457999999999999999999999999999999986432 4567899999999999999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--hH--HhHhhhcC-
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD--QL--VEIIKVLG- 215 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~--~~--~~~~~~~g- 215 (335)
..|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+++ ++ .. ...+..+|
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 68999999996 99888876 567999999999999999999999998 10 00 00111111
Q ss_pred ---------------CCC---HHHhhhhCCCCC----------------CCCCCCCC-----------CCccccccccCC
Q 019844 216 ---------------TPT---REEIKCMNPNYT----------------EFKFPQIK-----------PHPWHKVFQKRL 250 (335)
Q Consensus 216 ---------------~~~---~~~~~~~~~~~~----------------~~~~~~~~-----------~~~~~~~~~~~~ 250 (335)
++. ++.+........ ...+.... ...+....+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc
Confidence 111 111110000000 00000000 000111112467
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 290 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~ 290 (335)
++++.+||.+||+.||++|||+.++|+||||+........
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 8999999999999999999999999999999987654433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=217.26 Aligned_cols=198 Identities=24% Similarity=0.328 Sum_probs=143.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.+.||+|+||.||+|.+..++..||+|++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence 345799999999999999999999999999999998542 24577899999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-H-H---------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-L-V--------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~-~--------- 208 (335)
..+++||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ +. . .
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 668999999995 99999876 4679999999999999999999999980 00 0 0
Q ss_pred -----hHhhhcCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHHHHH
Q 019844 209 -----EIIKVLGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 209 -----~~~~~~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~~~l 257 (335)
......|++. ++.+........ ...+...... .....++..+++++.+|
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 158 HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp CC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred cCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 0011122222 111110000000 0000000000 00112345688999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|||+.++|+||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=236.56 Aligned_cols=196 Identities=22% Similarity=0.322 Sum_probs=141.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++++.||+|+||.||+|+++.++..||||++.+. ...+.+|+.+++.++|||||+++++| ....
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 445799999999999999999999999999999998642 34577999999999999999999999 5566
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-----HHhH-----
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-----LVEI----- 210 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-----~~~~----- 210 (335)
.+|+|||||.| +|.+.+.. ...+++..++.|+.||+.||.|||+++ ++. ..++
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 69999999996 99888876 567999999999999999999999998 100 0000
Q ss_pred ----------hhhcCCCCHHHhhhhCCCCCC------------------CCCCCC-----------CCCccccccccCCC
Q 019844 211 ----------IKVLGTPTREEIKCMNPNYTE------------------FKFPQI-----------KPHPWHKVFQKRLP 251 (335)
Q Consensus 211 ----------~~~~g~~~~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~~~s 251 (335)
...+|++.+.........|.. ..+... ....+....+..++
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred CeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 011233321111111111110 000000 00011112235789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+++++||++||+.||.+|||+.++|+||||+..
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=226.85 Aligned_cols=122 Identities=24% Similarity=0.403 Sum_probs=95.7
Q ss_pred cceeeeEE-eeeeeccCceEEEEEEEc--CCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 79 KQKVSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 79 ~~~~~y~~-~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...+.|.+ +++||+|+||.||+|+++ .+++.||||++... ...+.+|+.+|+.++|||||+++++|.. ....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 93 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADR 93 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCC
Confidence 34456887 568999999999999976 57889999999753 3467899999999999999999999964 2345
Q ss_pred EEEEEeecchhhHHHHHHHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++|+|.+++...... ...+++..++.|+.||+.||.|||+++
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 148 (405)
T 3rgf_A 94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148 (405)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999999999888754321 124999999999999999999999988
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=227.33 Aligned_cols=195 Identities=25% Similarity=0.262 Sum_probs=143.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|.+.+.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++|||||++++++ ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 3456799999999999999999999999999999999643 24567999999999999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChH----HhHhhh--
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQL----VEIIKV-- 213 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~----~~~~~~-- 213 (335)
.++|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||++++ +.. ...+..
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 678999999996 99888865 5679999999999999999999999981 000 001111
Q ss_pred --------------cCCCC---HHHhhhhCCCCCC------------------CCCCCCC-----------CCccccccc
Q 019844 214 --------------LGTPT---REEIKCMNPNYTE------------------FKFPQIK-----------PHPWHKVFQ 247 (335)
Q Consensus 214 --------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~~-----------~~~~~~~~~ 247 (335)
+|++. ++.+... .|.. ..+.... ...+....+
T Consensus 177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp TCBCCTTCCSCCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG
T ss_pred cceEecCCcccccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 22222 1111100 0100 0000000 001111122
Q ss_pred cCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 248 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
..+++++++||.+||+.||++|||+.++|+||||...
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 4679999999999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=224.50 Aligned_cols=216 Identities=22% Similarity=0.309 Sum_probs=152.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+|.+++.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence 345799999999999999999999999999999998643 24567899999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhh-----
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKV----- 213 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~----- 213 (335)
.++|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ +. ....+..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 679999999996 99998876 5679999999999999999999999980 00 0000111
Q ss_pred ------------cCCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHHH
Q 019844 214 ------------LGTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEAV 255 (335)
Q Consensus 214 ------------~g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~~ 255 (335)
.|++. ++.+........ ...+...... .....++..+++++.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHH
Confidence 12211 111110000000 0000000000 000123456889999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 304 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 304 (335)
+||.+||+.||++|||+.++|+||||.....|.........+++.+...
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence 9999999999999999999999999998776654443334444444433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=214.99 Aligned_cols=196 Identities=24% Similarity=0.325 Sum_probs=138.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCCe
Confidence 46999999999999999999999999999999996431 4577999999999999999999999 55567
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh---------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--------------- 206 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--------------- 206 (335)
+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+++ ++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999986 999988752 357999999999999999999999998 000
Q ss_pred ---HHhHhhhcCCCCH---HHhh---------------------hhCCCCCCCCCCCCCCC--ccccccccCCChHHHHH
Q 019844 207 ---LVEIIKVLGTPTR---EEIK---------------------CMNPNYTEFKFPQIKPH--PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 207 ---~~~~~~~~g~~~~---~~~~---------------------~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~l 257 (335)
........|++.+ +.+. .+.+.|........... ......+..+++++.+|
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 0000011222211 1000 01111110000000000 00112345688999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
|.+||+.||++|||+.++|+||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=226.19 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=144.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|.++++||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++|||||+++++| .+..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 45699999999999999999999999999999999642 24577999999999999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HH-----------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LV----------- 208 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~----------- 208 (335)
++|+|||||+| +|.+++.. ..+++..++.|+.||+.||.|||+++ ++. ..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 79999999985 99998864 46999999999999999999999998 000 00
Q ss_pred -------hHhhhcCCCC---HHHhhhhCC-C-CCC----------------CCCCCCCCC-----------ccccccc--
Q 019844 209 -------EIIKVLGTPT---REEIKCMNP-N-YTE----------------FKFPQIKPH-----------PWHKVFQ-- 247 (335)
Q Consensus 209 -------~~~~~~g~~~---~~~~~~~~~-~-~~~----------------~~~~~~~~~-----------~~~~~~~-- 247 (335)
.....+|++. ++.+..... . |.. ...|..... .....++
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 0012234433 222211100 0 100 000000000 0001122
Q ss_pred cCCChHHHHHHHHhccCCCCC--CCCHHHHhcCcccccCCCC
Q 019844 248 KRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDP 287 (335)
Q Consensus 248 ~~~s~~~~~li~~~L~~dP~~--R~t~~~~L~hp~f~~~~~~ 287 (335)
..+++++++||++||+.+|.+ |+++.|+++||||+.+.+.
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 368999999999999999988 9999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=222.37 Aligned_cols=198 Identities=23% Similarity=0.252 Sum_probs=139.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc--------chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
..++|++.+.||+|+||.||+|++. .+++.||+|++.+. ...+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF---- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence 3457999999999999999999985 68999999998643 23466899999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHh-----
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVE----- 209 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~----- 209 (335)
....++|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++|+ +. ...
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 91 -QTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp -ECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred -EcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeC
Confidence 445569999999985 99999876 5679999999999999999999999980 00 000
Q ss_pred ------------HhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCCCC-c------cccccccCCC
Q 019844 210 ------------IIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIKPH-P------WHKVFQKRLP 251 (335)
Q Consensus 210 ------------~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~~~-~------~~~~~~~~~s 251 (335)
....+|++.+....... ..+.. ..+...... . ....++..++
T Consensus 166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp SCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred CcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 01122333211111000 00000 000000000 0 0112446789
Q ss_pred hHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||.+|| ++.++|+||||+.+.+
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 9999999999999999999 8999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=233.14 Aligned_cols=199 Identities=24% Similarity=0.356 Sum_probs=146.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|++.+.||+|+||.||+|.++.+++.||||++.+. ...+.+|+.+++.++|||||++++++ ..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 4556899999999999999999999999999999998532 24578999999999999999999999 56
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC---h---------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD---Q--------- 206 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~---~--------- 206 (335)
..++|+|||||.| +|.+.+.. .+.+++..++.|+.||+.||.|||+++ ++ .
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 6679999999986 99888875 677999999999999999999999998 10 0
Q ss_pred -HH-------hHhhhcCCCC---HHHhhh--------------------hCCCCCCCCCC----CC--CCCccccccccC
Q 019844 207 -LV-------EIIKVLGTPT---REEIKC--------------------MNPNYTEFKFP----QI--KPHPWHKVFQKR 249 (335)
Q Consensus 207 -~~-------~~~~~~g~~~---~~~~~~--------------------~~~~~~~~~~~----~~--~~~~~~~~~~~~ 249 (335)
+. .....+|++. |+.+.. +.+.|...... .+ ....+....+..
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 253 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGG
T ss_pred eeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccccc
Confidence 00 0011123222 221110 01111100000 00 000111122356
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+++++++||++||+.||.+|||+.++|+||||+....
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 8999999999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=233.74 Aligned_cols=196 Identities=24% Similarity=0.313 Sum_probs=138.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++++.||+|+||.||+|.++.+|+.||||++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeC
Confidence 345799999999999999999999999999999999642 23456899999999999999999999 555
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCc-Ch-----------------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIV-DQ----------------------- 206 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~-~~----------------------- 206 (335)
..+|||||||+| +|.+++.. .+.+++..++.|+.||+.||+|||+ +++ +.
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 569999999996 99988876 5679999999999999999999998 760 00
Q ss_pred ------HHhHhhhcCCCC---HHHhhhhCCCCCC------------------CCCCCCCCC-------ccccccccCCCh
Q 019844 207 ------LVEIIKVLGTPT---REEIKCMNPNYTE------------------FKFPQIKPH-------PWHKVFQKRLPP 252 (335)
Q Consensus 207 ------~~~~~~~~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~ 252 (335)
.......+|++. ++.+.. ..|.. ..+...... .....++..+++
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 374 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred eeccCCCcccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 000111223322 111111 01110 000000000 001124567899
Q ss_pred HHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 253 EAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
++.+||.+||+.||.+|| ++.++|+||||+.+.+
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 999999999999999999 9999999999998755
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=222.78 Aligned_cols=117 Identities=26% Similarity=0.372 Sum_probs=98.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------------------------hhHHHHHHH
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQI 128 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------------------~~~~~Ei~~ 128 (335)
...++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34567999999999999999999999999999999986431 346789999
Q ss_pred HHhCCCCceeeeceeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 129 l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+.++||||+++++++.. ....++|+||||+++ +|.+++. ...+++..++.++.||+.||.|||+++
T Consensus 90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999843 235568999999996 8876543 467999999999999999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=213.68 Aligned_cols=202 Identities=18% Similarity=0.197 Sum_probs=143.9
Q ss_pred cceeeeEEe-eeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHH-HhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l-~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|.+. +.||+|+||.||+|.++.+++.||+|++.. .....+|+.++ +.++||||+++++++.... ....++|
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence 344568877 789999999999999999999999999965 45677899988 6669999999999984311 2366789
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC----hHHhHhhhcCCCC-
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD----QLVEIIKVLGTPT- 218 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~----~~~~~~~~~g~~~- 218 (335)
+||||++| +|.+++.... ...+++..++.++.||+.||.|||+++ ++ .....+..+|...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 99999986 9999998732 346999999999999999999999998 11 0001111122211
Q ss_pred -------------------HHHhhhhCCCCCCCC--------CCCCC--CCccccccccCCChHHHHHHHHhccCCCCCC
Q 019844 219 -------------------REEIKCMNPNYTEFK--------FPQIK--PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 269 (335)
Q Consensus 219 -------------------~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 269 (335)
++.+ .+.+.|.... ..... ...+....+..+++++.+||.+||+.||.+|
T Consensus 170 ~~~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 170 TTGEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp CTTCGGGGHHHHHHHHHHHHHHH-HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred cccccCCchhhHHHHHHHHHHHH-HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhC
Confidence 1111 1222221110 00000 1111112225689999999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 019844 270 CTALEACVHPFFDELR 285 (335)
Q Consensus 270 ~t~~~~L~hp~f~~~~ 285 (335)
||+.++|+||||.+..
T Consensus 249 ps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 249 MTITEFMNHPWIMQST 264 (299)
T ss_dssp CCHHHHHTSHHHHTGG
T ss_pred CCHHHHhcChhhcccc
Confidence 9999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=221.06 Aligned_cols=195 Identities=24% Similarity=0.286 Sum_probs=137.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++|.+.+.||+|+||.||+|+++.+++.||||++... .+.+.+|+.+++.++||||+++++++ .....+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEEE
Confidence 445699999999999999999999999999999999753 35577899999999999999999999 45556899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC----hHHhHhh--------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD----QLVEIIK-------- 212 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~----~~~~~~~-------- 212 (335)
||||++| +|.+++.. .+.+++..++.++.||+.||.|||+++ +. .....+.
T Consensus 126 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999985 99988875 567999999999999999999999988 10 0000011
Q ss_pred --------hcCCCC---HHHhhhhCCCCCC------------------CCCCCCCC------------CccccccccCCC
Q 019844 213 --------VLGTPT---REEIKCMNPNYTE------------------FKFPQIKP------------HPWHKVFQKRLP 251 (335)
Q Consensus 213 --------~~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~~~~~s 251 (335)
..|++. ++.+... .|.. ..+..... ..+....+..++
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred CcccccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 112221 1111100 0100 00000000 001112235688
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+++.+||.+||+.||++|||+.++|+||||....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=226.07 Aligned_cols=198 Identities=21% Similarity=0.278 Sum_probs=144.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|++++.||+|+||.||+|+++.+++.||||++.+. ...+.+|..++..+ +||||++++++| ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 345699999999999999999999999999999999643 24467899999988 799999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HH---------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LV--------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~--------- 208 (335)
..++|+|||||+| +|.+++.. .+.+++..++.|+.||+.||.|||++|+ +. ..
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 6679999999986 99999986 5679999999999999999999999980 00 00
Q ss_pred --------hHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCCCC-------ccccccccCCChHH
Q 019844 209 --------EIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEA 254 (335)
Q Consensus 209 --------~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~ 254 (335)
.....+|++.+....... ..|.. ..+...... .....++..+++++
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 001122333211111000 00100 000000000 00112456789999
Q ss_pred HHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 255 VDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
.+||.+||+.||.+||+ +.++++||||+.+.+
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999999994 699999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-28 Score=223.50 Aligned_cols=118 Identities=23% Similarity=0.346 Sum_probs=102.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhC------CCCceeeeceeeeeCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l------~hpnIv~~~~~~~~~~~ 149 (335)
....+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.+ +|+||+++++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~----- 168 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF----- 168 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----
Confidence 34457999999999999999999999999999999997543 4566888888887 577999999999
Q ss_pred CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++|+||||++++|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 169 ~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ 220 (429)
T 3kvw_A 169 TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR 220 (429)
T ss_dssp EETTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5556699999999999999988643 345999999999999999999999988
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=219.38 Aligned_cols=114 Identities=18% Similarity=0.336 Sum_probs=102.1
Q ss_pred eeeeEEe---eeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~---~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..+|.+. +.||+|+||.||+|.++.+++.||||++.+.. ....+|+.+++.+. ||||+++++++ .+..++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEE
Confidence 3467775 78999999999999999999999999997543 56779999999996 99999999999 556679
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||+| +|.+++.. .+.+++..++.|+.||+.||.|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ 126 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG 126 (325)
T ss_dssp EEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999986 99999986 678999999999999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=230.84 Aligned_cols=197 Identities=22% Similarity=0.304 Sum_probs=143.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|.+++.||+|+||.||+|++..+|+.||||++.+. ...+.+|+.+|+.++||||+++++++ ..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----ST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 3455799999999999999999999999999999999643 23577999999999999999999999 45
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHh-------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVE------- 209 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~------- 209 (335)
...+|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||+++ ++. ..+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a 163 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccch
Confidence 5569999999985 99998875 567999999999999999999999998 000 000
Q ss_pred --------HhhhcCCCCHHHhhhhCC-CCCC-------------------CCCCCCCCC-cc------ccccccCCChHH
Q 019844 210 --------IIKVLGTPTREEIKCMNP-NYTE-------------------FKFPQIKPH-PW------HKVFQKRLPPEA 254 (335)
Q Consensus 210 --------~~~~~g~~~~~~~~~~~~-~~~~-------------------~~~~~~~~~-~~------~~~~~~~~s~~~ 254 (335)
....+|++.+........ .|.. ..+...... .+ ....+..+++++
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 243 (476)
T 2y94_A 164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243 (476)
T ss_dssp EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHH
T ss_pred hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHH
Confidence 011123332111110000 0000 000000000 00 012345689999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.+||.+||+.||.+|||+.++++||||+..
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-27 Score=212.37 Aligned_cols=123 Identities=26% Similarity=0.422 Sum_probs=103.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-CCCcEEEEEEeccc------chhHHHHHHHHHhC---CCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~ 148 (335)
....+|++.+.||+|+||.||+|.+. .+++.||+|++... ...+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34467999999999999999999995 67899999998632 23566888888777 8999999999985433
Q ss_pred CCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
......+++||||++|+|.+++.... ...+++..++.++.||+.||.|||++|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g 140 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR 140 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 33567799999999999999988633 345999999999999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=218.45 Aligned_cols=196 Identities=19% Similarity=0.242 Sum_probs=144.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
...++|++++.||+|+||.||+|.++.+|+.||+|++... ...+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY---- 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE----
Confidence 4456799999999999999999999999999999999642 23477999999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChHH-----hH
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQLV-----EI 210 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~~-----~~ 210 (335)
.....+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++ +.... ..
T Consensus 85 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 -ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp -ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred -ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence 555669999999985 99999875 567999999999999999999999998 10000 01
Q ss_pred hhhcC----------------CCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCcc
Q 019844 211 IKVLG----------------TPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPW 242 (335)
Q Consensus 211 ~~~~g----------------~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~ 242 (335)
+..+| ++. ++.+... .+.. ..+... ....+
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EccCccceecCccccccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 11111 111 1111100 0000 000000 00011
Q ss_pred ccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 243 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
...++..+++.+.+||.+||+.||++|||+.++|+||||....
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 1222356889999999999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-27 Score=210.33 Aligned_cols=198 Identities=22% Similarity=0.301 Sum_probs=141.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...|.+.+.||+|+||.||+|.+..++..||+|++... ...+.+|+.+++.++||||+++++++.... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 34599999999999999999999999999999998642 245678999999999999999999985433 34567
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cCh-HH-------------hHhhh----
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--VDQ-LV-------------EIIKV---- 213 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~-~~-------------~~~~~---- 213 (335)
+|+||||++| +|.+++.. ...+++..++.|+.||+.||.|||+++ +-. .. ..+..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 8999999986 99999976 567999999999999999999999986 110 00 00001
Q ss_pred -----------cCCCCHHHhhhhCCCCCC------------------CCCCCC----------CCCccccccccCCChHH
Q 019844 214 -----------LGTPTREEIKCMNPNYTE------------------FKFPQI----------KPHPWHKVFQKRLPPEA 254 (335)
Q Consensus 214 -----------~g~~~~~~~~~~~~~~~~------------------~~~~~~----------~~~~~~~~~~~~~s~~~ 254 (335)
.|++.+.........+.. ..+... ........++...++++
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 122211000000000000 000000 00111123345678899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
.+||.+||+.||.+|||+.++|+||||++
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=224.46 Aligned_cols=123 Identities=21% Similarity=0.308 Sum_probs=101.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCC-----
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD----- 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~----- 149 (335)
..++|++++.||+|+||.||+|+++.+++.||||++... ...+.+|+.+|+.++|||||+++++|.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 456799999999999999999999999999999998632 2457899999999999999999999865432
Q ss_pred -----------------------------------------------CCccEEEEEeecchh-hHHHHHHHHhhhcCCCC
Q 019844 150 -----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP 181 (335)
Q Consensus 150 -----------------------------------------------~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~ 181 (335)
....++|+|||||+| +|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence 123458999999996 99999986332 23356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCC
Q 019844 182 LIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 182 ~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+..++.++.||+.||.|||+++
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ 184 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG 184 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHHHHHHhCC
Confidence 6778999999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=214.75 Aligned_cols=196 Identities=22% Similarity=0.349 Sum_probs=143.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..++|.+.+.||+|+||.||+|+++.+|+.||+|++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence 446799999999999999999999999999999999643 24577999999999999999999999 555668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC---------------h-HHhHhhhcCCCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD---------------Q-LVEIIKVLGTPT 218 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~---------------~-~~~~~~~~g~~~ 218 (335)
|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||++++- . ....+..+|...
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999986 99998876 56799999999999999999999999810 0 000111122111
Q ss_pred -----HHHhhhhCCCCCCCCCCCC---------------------------C-------------CCccccccccCCChH
Q 019844 219 -----REEIKCMNPNYTEFKFPQI---------------------------K-------------PHPWHKVFQKRLPPE 253 (335)
Q Consensus 219 -----~~~~~~~~~~~~~~~~~~~---------------------------~-------------~~~~~~~~~~~~s~~ 253 (335)
......+.+.|.+.+.... . ...+...++..++++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp CCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 0001112222222111000 0 001111233567899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+.+||.+||+.||++|||+.++|+||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=214.80 Aligned_cols=200 Identities=21% Similarity=0.267 Sum_probs=138.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ....++...++.++||||+++++++. ...
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 3457999999999999999999999999999999996432 22334555578889999999999994 444
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-Cc------------Ch--------H-----
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IV------------DQ--------L----- 207 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~------------~~--------~----- 207 (335)
.+|+||||++|+|.+++.........+++..++.++.||+.||.|||++ ++ +. +
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 5899999999999888887655567899999999999999999999997 70 00 0
Q ss_pred ----HhHhhhcCCCC---HHHhhh--hCCCCC------------------CCCCCCCCC----------CccccccccCC
Q 019844 208 ----VEIIKVLGTPT---REEIKC--MNPNYT------------------EFKFPQIKP----------HPWHKVFQKRL 250 (335)
Q Consensus 208 ----~~~~~~~g~~~---~~~~~~--~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~~ 250 (335)
.......|++. ++.+.. ....+. ...+..... .......+..+
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 00001123322 221100 000000 000000000 00001112467
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 8999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=214.95 Aligned_cols=197 Identities=20% Similarity=0.287 Sum_probs=144.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|++++.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~ 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----c
Confidence 45799999999999999999999999999999998642 24578999999999999999999999 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH-----HhHhh
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL-----VEIIK 212 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~-----~~~~~ 212 (335)
....+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++ ++.. ...+.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 55568999999985 99999976 567999999999999999999999988 0000 00111
Q ss_pred hc----------------CCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCcccc
Q 019844 213 VL----------------GTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPWHK 244 (335)
Q Consensus 213 ~~----------------g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~ 244 (335)
.+ |++. ++.+... .+.. ..+... ....+..
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 11 2211 1111100 0000 000000 0001111
Q ss_pred ccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 245 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
..+..+++.+.+||.+||+.||++|||+.++|+||||+.++...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 22356789999999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=216.16 Aligned_cols=116 Identities=20% Similarity=0.261 Sum_probs=101.9
Q ss_pred cceeeeEEe-eeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
...++|.+. +.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++++ +||||+++++++ ...
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 345679985 7899999999999999999999999999643 24577999999985 799999999999 455
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+|||||+| +|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 569999999995 99999986 567999999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=224.86 Aligned_cols=196 Identities=21% Similarity=0.296 Sum_probs=138.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHH-HHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQI-MQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~-l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..++|++++.||+|+||.||+|+++.+++.||||++.+.. ..+.+|..+ ++.++|||||+++++| ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 3457999999999999999999999999999999996532 334566666 5678999999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--HH--------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ--LV-------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~--~~-------- 208 (335)
..++|+|||||+| +|.+++.. .+.+++..++.|+.||+.||+|||++|+ +. ..
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence 6679999999996 99999886 5679999999999999999999999980 00 00
Q ss_pred --------hHhhhcCCCCH---HHhhhhCCCCCC------------------CCCCCCCCC-c------cccccccCCCh
Q 019844 209 --------EIIKVLGTPTR---EEIKCMNPNYTE------------------FKFPQIKPH-P------WHKVFQKRLPP 252 (335)
Q Consensus 209 --------~~~~~~g~~~~---~~~~~~~~~~~~------------------~~~~~~~~~-~------~~~~~~~~~s~ 252 (335)
.....+|++.+ +.+... .|.. ..+...... . ....++..+++
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 264 (373)
T 2r5t_A 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITN 264 (373)
T ss_dssp GGGBCCCCCCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCH
T ss_pred cccccCCCccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Confidence 01122344331 211100 0100 000000000 0 01124567899
Q ss_pred HHHHHHHHhccCCCCCCCCH----HHHhcCcccccCCC
Q 019844 253 EAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD 286 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~----~~~L~hp~f~~~~~ 286 (335)
++++||.+||+.||.+|+++ .++++||||+.+.+
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 99999999999999999986 69999999998765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=213.17 Aligned_cols=115 Identities=26% Similarity=0.300 Sum_probs=103.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..++|++.+.||+|+||.||+|.++.++..+|+|++.+. ...+.+|+.+++.++||||+++++++ .....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence 456799999999999999999999999999999998642 35678999999999999999999999 555668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN 126 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999986 99998876 567999999999999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=218.58 Aligned_cols=196 Identities=20% Similarity=0.259 Sum_probs=142.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCCCCceeeeceeeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFS 146 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 146 (335)
...++|++++.||+|+||.||+|+++.+++.||||++.+.. ..+.+|+.+++.++||||++++++|
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-- 98 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-- 98 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 34567999999999999999999999999999999996432 3466899999999999999999999
Q ss_pred CCCCCccEEEEEeecch-h-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh
Q 019844 147 TTDKEELYLNLVLEYVP-E-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII 211 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~ 211 (335)
....++++||||+. | +|.+++.. ...+++..++.|+.||+.||.|||++++ + .....+
T Consensus 99 ---~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 99 ---ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp ---ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred ---eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEE
Confidence 55667999999986 5 99998876 6679999999999999999999999980 0 000000
Q ss_pred ----------------hhcCCCC---HHHhhhhCCCCC------------------CCCCCCCCC-CccccccccCCChH
Q 019844 212 ----------------KVLGTPT---REEIKCMNPNYT------------------EFKFPQIKP-HPWHKVFQKRLPPE 253 (335)
Q Consensus 212 ----------------~~~g~~~---~~~~~~~~~~~~------------------~~~~~~~~~-~~~~~~~~~~~s~~ 253 (335)
..+|++. ++.+... +.+. ...+..... .......+..++++
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHH
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHH
Confidence 1112222 1111100 0000 000000000 00011223457999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 254 AVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 254 ~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=223.61 Aligned_cols=198 Identities=22% Similarity=0.304 Sum_probs=142.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|++++.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+|+.++||||+++++++ .....+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 45699999999999999999999999999999999643 34577999999999999999999999 5556699
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC---hHHhHhhhc------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD---QLVEIIKVL------ 214 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~---~~~~~~~~~------ 214 (335)
+|||||.| +|.+++.. ....+++..++.++.||+.||.|||+++ ++ .....+..+
T Consensus 125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999986 99888764 1346999999999999999999999998 10 000011111
Q ss_pred ----------CCCC---HHHhhh---------------------hCCCCCCCCC----CCCC--CCccccccccCCChHH
Q 019844 215 ----------GTPT---REEIKC---------------------MNPNYTEFKF----PQIK--PHPWHKVFQKRLPPEA 254 (335)
Q Consensus 215 ----------g~~~---~~~~~~---------------------~~~~~~~~~~----~~~~--~~~~~~~~~~~~s~~~ 254 (335)
|++. ++.+.. +.+.|..... ..+. ...+....+..+++++
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2221 111110 0111100000 0000 0001111224689999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
.+||.+||+.||.+|||+.++|+||||+....
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=218.35 Aligned_cols=120 Identities=29% Similarity=0.427 Sum_probs=101.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC---CC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---~~ 151 (335)
..+|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 45799999999999999999999999999999998532 2356799999999999999999999865321 12
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+|||||+|+|.+.+... ...+++..++.|+.||+.||.|||++|
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK 144 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568999999999888777642 356999999999999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=224.94 Aligned_cols=195 Identities=26% Similarity=0.384 Sum_probs=139.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCCCCceeeeceeeeeC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFST 147 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 147 (335)
..++|.+.+.||+|+||.||+|.++.+++.||||++.+.. ..+.+|+.+|+.++|||||++++++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--- 209 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--- 209 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE---
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 4568999999999999999999999999999999986431 2467999999999999999999997
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc---------------Ch-HHhH
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV---------------DQ-LVEI 210 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~---------------~~-~~~~ 210 (335)
... .+|+|||||+| +|.+++.. .+.+++..++.++.||+.||.|||++++ +. ....
T Consensus 210 --~~~-~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 210 --DAE-DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --ESS-EEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --ecC-ceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEE
Confidence 222 26799999986 99887764 5679999999999999999999999981 00 0001
Q ss_pred hhhcCCCC------HHHhhhhCCCCCCCCC--------------------------------CCCCC------------C
Q 019844 211 IKVLGTPT------REEIKCMNPNYTEFKF--------------------------------PQIKP------------H 240 (335)
Q Consensus 211 ~~~~g~~~------~~~~~~~~~~~~~~~~--------------------------------~~~~~------------~ 240 (335)
+..+|... .....++.+.|.+.+. ..... .
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 11111110 0000111122221111 00000 0
Q ss_pred ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 241 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.+....+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 363 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 01111224689999999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=212.70 Aligned_cols=197 Identities=23% Similarity=0.325 Sum_probs=140.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|.+++.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++ ..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----ST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ec
Confidence 3445799999999999999999999999999999998642 23567999999999999999999999 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChH-HhHhhhcCCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQL-VEIIKVLGTP 217 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~-~~~~~~~g~~ 217 (335)
...+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ +.. ...+..+|..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccc
Confidence 5568999999986 99999986 5679999999999999999999999881 000 0000001100
Q ss_pred C------HHHhhhhCCCCCCCCCCC------C----------------CCCccc---------------cccccCCChHH
Q 019844 218 T------REEIKCMNPNYTEFKFPQ------I----------------KPHPWH---------------KVFQKRLPPEA 254 (335)
Q Consensus 218 ~------~~~~~~~~~~~~~~~~~~------~----------------~~~~~~---------------~~~~~~~s~~~ 254 (335)
. ......+.+.|.+..... . ...+|. ..++..+++++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 238 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHH
Confidence 0 000001111111110000 0 000000 11345678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=225.32 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=144.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||.||+|+++.+|+.||||++.+. ...+.+|+.++..++||||++++++| .+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence 35699999999999999999999999999999999642 24467899999999999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HH----------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LV---------- 208 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~---------- 208 (335)
++|+|||||+| +|.+++... ...+++..++.|+.||+.||+|||+++ ++. ..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 79999999985 999999762 347999999999999999999999998 000 00
Q ss_pred -------hHhhhcCCCC---HHHhhhh-----CCCCCC------------------CCCCCCCCC-------cc--c---
Q 019844 209 -------EIIKVLGTPT---REEIKCM-----NPNYTE------------------FKFPQIKPH-------PW--H--- 243 (335)
Q Consensus 209 -------~~~~~~g~~~---~~~~~~~-----~~~~~~------------------~~~~~~~~~-------~~--~--- 243 (335)
.....+||+. ++.+... ...|.. ..+...... .+ .
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 0011234443 2222110 001110 001000000 00 0
Q ss_pred cccccCCChHHHHHHHHhccCCCCCC---CCHHHHhcCcccccCCCCCC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~~~L~hp~f~~~~~~~~ 289 (335)
..++..+|+++++||++||+ ||.+| ++++++++||||+.+.+...
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 01124689999999999999 99998 58999999999999877543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=214.49 Aligned_cols=198 Identities=22% Similarity=0.321 Sum_probs=143.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++ ...
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDR 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcC
Confidence 345799999999999999999999999999999998542 24577999999999999999999999 455
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhhc----
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKVL---- 214 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~~---- 214 (335)
..+|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||++++ + .....+..+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 668999999986 99999886 5679999999999999999999999980 0 000001111
Q ss_pred -----------CCCC---HHHhhhhCCCCC----------------CCCCCCCCCC-------ccccccccCCChHHHHH
Q 019844 215 -----------GTPT---REEIKCMNPNYT----------------EFKFPQIKPH-------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 215 -----------g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~s~~~~~l 257 (335)
|++. ++.+........ ...+...... .....++..+++++.+|
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 163 HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp ECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred cCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 1111 111110000000 0000000000 00112346689999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|||+.++|+||||+....
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=212.08 Aligned_cols=115 Identities=25% Similarity=0.276 Sum_probs=101.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|++++.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCE
Confidence 3467999999999999999999999999999999986432 4577999999999999999999999 45566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ 125 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG 125 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 8999999996 99888764 557999999999999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=212.23 Aligned_cols=199 Identities=23% Similarity=0.334 Sum_probs=142.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------------chhHHHHHHHHHhCC-CCceeeeceeee
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------------KRYKNRELQIMQMLD-HPNIVALKHCFF 145 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------------~~~~~~Ei~~l~~l~-hpnIv~~~~~~~ 145 (335)
..++|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 345699999999999999999999999999999998632 134568999999995 99999999999
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHh
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEII 211 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~ 211 (335)
....++|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++++ +. ....+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEE
Confidence 556679999999995 99999986 5679999999999999999999999980 00 00000
Q ss_pred hh----------------cCCCC---HHHhhhh----CCCCCC------------------CCCCCCC-----------C
Q 019844 212 KV----------------LGTPT---REEIKCM----NPNYTE------------------FKFPQIK-----------P 239 (335)
Q Consensus 212 ~~----------------~g~~~---~~~~~~~----~~~~~~------------------~~~~~~~-----------~ 239 (335)
.. .|++. ++.+... ...+.. ..+.... .
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 01 11111 2211100 000100 0000000 0
Q ss_pred CccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 240 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
..+....+..+++++.+||.+||+.||.+|||+.++|+||||++....
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 000111124678999999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=213.97 Aligned_cols=119 Identities=28% Similarity=0.411 Sum_probs=97.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCC------
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD------ 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~------ 149 (335)
...+|++++.||+|+||.||+|.+..+++.||||++.... +.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3456999999999999999999999999999999986432 456799999999999999999998743211
Q ss_pred ---CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 ---KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ---~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++|+|.+++. .+.+++..++.++.||+.||.|||+++
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ 140 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN 140 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 2346689999999999998885 467999999999999999999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=213.90 Aligned_cols=115 Identities=25% Similarity=0.365 Sum_probs=100.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|++++.||+|+||.||+|++..+++.||||++... .+.+.+|+.+++.+. ||||+++++++.. ....+++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~ 109 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 109 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence 3446799999999999999999999999999999999743 466889999999996 9999999999843 2245588
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.+ +|.+++. .+++..++.++.||+.||.|||+++
T Consensus 110 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ 150 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG 150 (330)
T ss_dssp EEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 8877764 3899999999999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=212.45 Aligned_cols=199 Identities=22% Similarity=0.352 Sum_probs=141.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...++|++++.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++. ....
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCe
Confidence 3445699999999999999999999999999999998642 255778999999999999999999994 4445
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--------------------ChHH--h--
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV--------------------DQLV--E-- 209 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------------~~~~--~-- 209 (335)
+|+||||++| +|.+++... ...+++..++.++.||+.||.|||++++ ..+. .
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 8999999996 998888753 4669999999999999999999999980 0000 0
Q ss_pred ------HhhhcCCCC---HHHhhh---hCCCCCC------------------CCCCCCC----------CCccccccccC
Q 019844 210 ------IIKVLGTPT---REEIKC---MNPNYTE------------------FKFPQIK----------PHPWHKVFQKR 249 (335)
Q Consensus 210 ------~~~~~g~~~---~~~~~~---~~~~~~~------------------~~~~~~~----------~~~~~~~~~~~ 249 (335)
.....|++. ++.+.. ....+.. ..+.... ........+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 001123322 222210 0001100 0000000 00001122356
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 789999999999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=213.03 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=140.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCCCCceeeeceeeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFS 146 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 146 (335)
...++|.+.+.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.++||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-
Confidence 34567999999999999999999999999999999986421 24679999999999999999999983
Q ss_pred CCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--H---H
Q 019844 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--L---V 208 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~---~ 208 (335)
... +|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++ ++. . .
T Consensus 86 ----~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 86 ----AED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ----SSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred ----CCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence 222 7899999986 99888865 567999999999999999999999998 000 0 0
Q ss_pred ---------------hHhhhcCCCC---HHHhhh-hCCCCCC------------------CCCCCCCC------------
Q 019844 209 ---------------EIIKVLGTPT---REEIKC-MNPNYTE------------------FKFPQIKP------------ 239 (335)
Q Consensus 209 ---------------~~~~~~g~~~---~~~~~~-~~~~~~~------------------~~~~~~~~------------ 239 (335)
......|++. ++.+.. ....|.. ..+.....
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 0011223322 222110 0111110 00100000
Q ss_pred CccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 240 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
..+....+..+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 001112235689999999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=230.83 Aligned_cols=199 Identities=25% Similarity=0.341 Sum_probs=145.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.+.+.||+|+||.||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++| .+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence 345699999999999999999999999999999999642 23467899999999999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-------------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ------------- 206 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~------------- 206 (335)
.++|+|||||+| +|.+++.... ...+++..++.|+.||+.||.|||+++ ++.
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence 679999999985 9999887522 345999999999999999999999998 000
Q ss_pred ----HHhHhhhcCCCCH---HHhh---------------------hhCCCCCCCCCCCCCCC-------ccccccccCCC
Q 019844 207 ----LVEIIKVLGTPTR---EEIK---------------------CMNPNYTEFKFPQIKPH-------PWHKVFQKRLP 251 (335)
Q Consensus 207 ----~~~~~~~~g~~~~---~~~~---------------------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~s 251 (335)
.......+|++.+ +.+. .+.+.|..... ..... .....++..++
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~-~~~~~~i~~~i~~~~~~~p~~~s 413 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-KIKREEVERLVKEVPEEYSERFS 413 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS-CCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc-chhHHHHHHHhhcccccCCccCC
Confidence 0000112344332 1111 01111111000 00000 01123456789
Q ss_pred hHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
+++++||.+||+.||.+|| ++.|+++||||+.+.+
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999999999999999999 7999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=224.52 Aligned_cols=200 Identities=21% Similarity=0.288 Sum_probs=145.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|+++++||+|+||+||+|+++.+++.||+|++.+. ...+.+|+.++..++||||++++++| .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 35799999999999999999999999999999999642 23477999999999999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HHhH---------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LVEI--------- 210 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~~~--------- 210 (335)
++|+|||||+| +|.+++... .+.+++..++.|+.||+.||.|||+++ ++. ....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 79999999985 999998752 367999999999999999999999998 000 0000
Q ss_pred ---------hhhcCCCC---HHHhhhh---CCCCCC------------------CCCCCCC---------CCccccccc-
Q 019844 211 ---------IKVLGTPT---REEIKCM---NPNYTE------------------FKFPQIK---------PHPWHKVFQ- 247 (335)
Q Consensus 211 ---------~~~~g~~~---~~~~~~~---~~~~~~------------------~~~~~~~---------~~~~~~~~~- 247 (335)
...+||+. ++.+... ...|.. ..+.... .......+|
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 01234433 2222110 011110 0010000 000001122
Q ss_pred --cCCChHHHHHHHHhccCCCCC--CCCHHHHhcCcccccCCCCC
Q 019844 248 --KRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 248 --~~~s~~~~~li~~~L~~dP~~--R~t~~~~L~hp~f~~~~~~~ 288 (335)
..+++++++||++||+.+|++ |++++|+++||||+.+.+..
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 348999999999999999988 99999999999999987643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=214.11 Aligned_cols=204 Identities=17% Similarity=0.191 Sum_probs=139.0
Q ss_pred cceeeeEEee-eeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 79 KQKVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 79 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
...++|.+.+ +||+|+||.||+|.++.+++.||||++........+....++.++||||+++++++.... ....++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence 4556799955 699999999999999999999999999765444444445567789999999999985422 23566899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC----hHHhHhhhc------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD----QLVEIIKVL------ 214 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~----~~~~~~~~~------ 214 (335)
|||||+| +|.+++.... ...+++..++.++.||+.||.|||+++ +. .....+..+
T Consensus 104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999996 9999998632 346999999999999999999999998 10 000011111
Q ss_pred ---------CCCCH---HHh---------------------hhhCCCCCCCCCCC--------C--CCCccccccccCCC
Q 019844 215 ---------GTPTR---EEI---------------------KCMNPNYTEFKFPQ--------I--KPHPWHKVFQKRLP 251 (335)
Q Consensus 215 ---------g~~~~---~~~---------------------~~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~s 251 (335)
|++.+ +.+ ..+.+.|....... + ....+....+..++
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred cccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 12111 000 00111111000000 0 00011111224689
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
+++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 9999999999999999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=231.55 Aligned_cols=202 Identities=21% Similarity=0.255 Sum_probs=147.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|.+.++||+|+||.||+|+++.+|+.||||++.+. ...+.+|+.+|+.++||||++++++| ...
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeC
Confidence 346799999999999999999999999999999999642 24467899999999999999999999 556
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HH---------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LV--------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~--------- 208 (335)
.++|+|||||+| +|.+++.........+++..++.|+.||+.||.|||+++ ++. ..
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 669999999996 999998764433457999999999999999999999998 000 00
Q ss_pred -------hHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCCC--C---------ccccccccCCC
Q 019844 209 -------EIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIKP--H---------PWHKVFQKRLP 251 (335)
Q Consensus 209 -------~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~~--~---------~~~~~~~~~~s 251 (335)
.....+||+.+....... ..|.. ..+..... . .....++..++
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 001124544421111100 00100 01110000 0 00123456789
Q ss_pred hHHHHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||.+||+ +.++++||||+.+.+
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 99999999999999999996 589999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=216.16 Aligned_cols=195 Identities=24% Similarity=0.293 Sum_probs=139.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.|...+.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+++.++||||+++++++. ....+|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEEE
Confidence 488889999999999999999999999999998642 245779999999999999999999994 44558999
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhh------------
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIK------------ 212 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~------------ 212 (335)
|||++| +|.+++. ...+++..++.++.||+.||.|||++++ + .....+.
T Consensus 121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 999986 9998876 3569999999999999999999999980 0 0000011
Q ss_pred -----hcCCCC---HHHhhh---------------------hCCCCCCCCCCC----CCCC-ccccccccCCChHHHHHH
Q 019844 213 -----VLGTPT---REEIKC---------------------MNPNYTEFKFPQ----IKPH-PWHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 213 -----~~g~~~---~~~~~~---------------------~~~~~~~~~~~~----~~~~-~~~~~~~~~~s~~~~~li 258 (335)
..|++. ++.+.. +.+.|....... +... ......+..+++++.+||
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence 122221 111110 000000000000 0000 000011235789999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 259 CRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 259 ~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
.+||+.||++|||+.++|+||||.+...|
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 99999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=220.29 Aligned_cols=195 Identities=22% Similarity=0.289 Sum_probs=134.4
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
|...+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+|+.++||||+++++++ .....+||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEE
Confidence 44478999999999999999999999999999753 35678999999999999999999999 5556699999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c--Ch-HHhHhhhc---------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V--DQ-LVEIIKVL--------- 214 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~--~~-~~~~~~~~--------- 214 (335)
|||+| +|.+++... ...+++..++.++.||+.||.|||+++ + +. ....+..+
T Consensus 166 E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp ECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99986 998888652 346999999999999999999999998 1 00 00011111
Q ss_pred -------CCCC---HHHhhh---------------------hCCCCCCCCC----CCCC--CCccccccccCCChHHHHH
Q 019844 215 -------GTPT---REEIKC---------------------MNPNYTEFKF----PQIK--PHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 215 -------g~~~---~~~~~~---------------------~~~~~~~~~~----~~~~--~~~~~~~~~~~~s~~~~~l 257 (335)
|++. ++.+.. +.+.|..... ..+. ...+....+..+++++.+|
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 2222 111100 0000000000 0000 0001111225689999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
|.+||+.||.+|||+.++|+||||++...
T Consensus 323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 99999999999999999999999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=213.80 Aligned_cols=203 Identities=21% Similarity=0.316 Sum_probs=142.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.++|++++.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 45799999999999999999999999999999999642 2457799999999999999999999853 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhhc-----
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKVL----- 214 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~~----- 214 (335)
..+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++++ +. ....+..+
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 4588999999988888877643 4679999999999999999999999980 00 00000011
Q ss_pred --------------CCCC---HHHhhhhCCCCC------------------CCCCCCCCCC-------ccccccccCCCh
Q 019844 215 --------------GTPT---REEIKCMNPNYT------------------EFKFPQIKPH-------PWHKVFQKRLPP 252 (335)
Q Consensus 215 --------------g~~~---~~~~~~~~~~~~------------------~~~~~~~~~~-------~~~~~~~~~~s~ 252 (335)
|++. ++.+......+. ...+...... .....++..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH
Confidence 1111 111110000000 0000000000 000123457899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
++.+||.+||+.||.+|||+.++++||||+....+.
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 999999999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=218.68 Aligned_cols=202 Identities=18% Similarity=0.169 Sum_probs=138.7
Q ss_pred ceeeeEEe-eeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHH-hCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~-~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++|.+. ++||+|+||+||+|.++.+++.||||++.. .....+|+.++. .++||||++++++|.... .+..++||
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 34567776 799999999999999999999999999964 456778999874 458999999999984321 23567899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC----hHHhHhhh-------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD----QLVEIIKV------- 213 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~----~~~~~~~~------- 213 (335)
|||||+| +|.+++.... ...+++..++.|+.||+.||.|||+++ ++ .....+..
T Consensus 137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999986 9999997522 346999999999999999999999988 11 00011111
Q ss_pred ---------cCCCCHHHhh------------------------hhCCCCCCCCCCCCC----------CCccccccccCC
Q 019844 214 ---------LGTPTREEIK------------------------CMNPNYTEFKFPQIK----------PHPWHKVFQKRL 250 (335)
Q Consensus 214 ---------~g~~~~~~~~------------------------~~~~~~~~~~~~~~~----------~~~~~~~~~~~~ 250 (335)
+|++.+.... .+.+.|......... ...+....+..+
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 2222211000 000111000000000 000011112468
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
++++.+||++||+.||++|||+.++|+||||.+..
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=215.72 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=141.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..+|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 346999999999999999999999999999999986421 3567999999999999999999999 4445
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh--------
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK-------- 212 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~-------- 212 (335)
.+|+|||||.|+|.+++... ...+++..++.++.||+.||.|||++++ +. ....+.
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred eEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 68999999999888887642 4679999999999999999999999981 00 000011
Q ss_pred -----hcCCCC---HHHhhhh-CCCCCC------------------CCCCCCC---------CCccccccccCCChHHHH
Q 019844 213 -----VLGTPT---REEIKCM-NPNYTE------------------FKFPQIK---------PHPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 213 -----~~g~~~---~~~~~~~-~~~~~~------------------~~~~~~~---------~~~~~~~~~~~~s~~~~~ 256 (335)
..|++. ++.+... ...|.. ..+.... ........+..+++.+.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp SSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred CCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 122222 2222100 001100 0000000 000011123467899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
||.+||+.||++|||+.++|+||||....
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=215.51 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=141.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
....+|++.+.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~----- 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY----- 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----
Confidence 3456899999999999999999999999999999998642 24577899999999999999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh------------------------------------cCCCCHHHHHHHHHHH
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQI 192 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi 192 (335)
....++|+|||||+| +|.+++...... ...+++..++.|+.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 556679999999985 999887421000 1124678899999999
Q ss_pred HHHHHHHHhCC------------c--ChH-HhHhhhc---------------------CCCC---HHHhhhhCCCCCC--
Q 019844 193 CRALAYIHNCI------------V--DQL-VEIIKVL---------------------GTPT---REEIKCMNPNYTE-- 231 (335)
Q Consensus 193 ~~aL~yLH~~~------------~--~~~-~~~~~~~---------------------g~~~---~~~~~~~~~~~~~-- 231 (335)
+.||.|||+++ + +.. ...+..+ |++. ++.+......|..
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999998 1 000 0011111 2221 1211110011110
Q ss_pred ----------------CCCCCCC-----------CCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 232 ----------------FKFPQIK-----------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 232 ----------------~~~~~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
..+.... ...+.......+++++.+||.+||+.||.+|||+.++|+||||+++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 0000000 0000111123478999999999999999999999999999999987
Q ss_pred CC
Q 019844 285 RD 286 (335)
Q Consensus 285 ~~ 286 (335)
.+
T Consensus 338 ~~ 339 (345)
T 3hko_A 338 SD 339 (345)
T ss_dssp SS
T ss_pred hH
Confidence 54
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-27 Score=211.66 Aligned_cols=197 Identities=21% Similarity=0.238 Sum_probs=141.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCC--CceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~~~ 152 (335)
..+|++++.||+|+||.||+|.+ .+++.||||++.... ..+.+|+.+|+.++| |||+++++++ ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 45699999999999999999998 568999999986421 456789999999976 9999999999 555
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC------------h-HH-----------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD------------Q-LV----------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~------------~-~~----------- 208 (335)
.++|+|||++.|+|.+++.. .+.+++..++.|+.||+.||.|||++++- . ..
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQM 157 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeeccccccc
Confidence 67999999877899999986 67899999999999999999999999800 0 00
Q ss_pred -------hHhhhcCCCC---HHHhhhhC---------CCCC------------------CCCCCCCCC----------Cc
Q 019844 209 -------EIIKVLGTPT---REEIKCMN---------PNYT------------------EFKFPQIKP----------HP 241 (335)
Q Consensus 209 -------~~~~~~g~~~---~~~~~~~~---------~~~~------------------~~~~~~~~~----------~~ 241 (335)
.....+|++. ++.+.... ..|. ...+..... ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 0012234433 22221100 0000 000110000 01
Q ss_pred cccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 242 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
....++...++++.+||.+||+.||.+|||+.++|+||||+....|
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 1123445667899999999999999999999999999999865444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=209.65 Aligned_cols=197 Identities=23% Similarity=0.329 Sum_probs=144.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc--------chhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
.++|++++.||+|+||.||+|++. .+++.||||++.+. ...+.+|+.+++.+ +||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence 457999999999999999999984 58999999998642 24567899999999 799999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c-----------
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V----------- 204 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~----------- 204 (335)
.....+|+|||||+| +|.+++.. ...+++..++.++.||+.||.|||+++ +
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred -eeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeC
Confidence 455568999999996 99999986 567999999999999999999999988 0
Q ss_pred --------ChHHhHhhhcCCCCH---HHhhhhCCCCC--------------------CCCCCCCCCC---------cccc
Q 019844 205 --------DQLVEIIKVLGTPTR---EEIKCMNPNYT--------------------EFKFPQIKPH---------PWHK 244 (335)
Q Consensus 205 --------~~~~~~~~~~g~~~~---~~~~~~~~~~~--------------------~~~~~~~~~~---------~~~~ 244 (335)
.........+|++.+ +.+......+. +|........ ....
T Consensus 204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283 (355)
T ss_dssp SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC
Confidence 000111123444432 22211011111 0100000000 0012
Q ss_pred ccccCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 245 VFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.++..+++.+.+||.+||..||.+|| ++.++++||||+.+.+
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 24567889999999999999999999 9999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=218.39 Aligned_cols=115 Identities=19% Similarity=0.353 Sum_probs=102.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++ .....
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCE
Confidence 345799999999999999999999999999999998643 24577999999999999999999999 44556
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
+|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||+. +
T Consensus 106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 152 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK 152 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999986 99999986 56799999999999999999999985 5
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=212.10 Aligned_cols=117 Identities=21% Similarity=0.301 Sum_probs=102.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCC-----CCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~-----hpnIv~~~~~~~~~~~~~ 151 (335)
..++|.++++||+|+||.||+|++..+++.||||++... .....+|+.+++.+. |||||++++++ ..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~-----~~ 107 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF-----MY 107 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE-----EE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee-----eE
Confidence 345699999999999999999999999999999999643 245678999999996 99999999999 44
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+||||+.++|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 108 ~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (360)
T 3llt_A 108 YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS 157 (360)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 55699999999779999998633 346999999999999999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=215.59 Aligned_cols=202 Identities=19% Similarity=0.241 Sum_probs=144.1
Q ss_pred cceeeeEEe-eeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~ 150 (335)
...++|.+. +.||+|+||.||+|.++.+++.||+|++.+. ...+.+|+.+++.+ +||||+++++++ .
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~ 99 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----E 99 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 455678888 8999999999999999999999999998642 24577999999999 569999999999 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-----HHhH--
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-----LVEI-- 210 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-----~~~~-- 210 (335)
....+|+|||||.| +|.+++.... ...+++..++.++.||+.||.|||+++ ++. ..++
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 56669999999996 9988875321 367999999999999999999999998 000 0000
Q ss_pred -------------hhhcCCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCccccc
Q 019844 211 -------------IKVLGTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPWHKV 245 (335)
Q Consensus 211 -------------~~~~g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~ 245 (335)
....|++. ++.+... .+.. ..+... ....+...
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CccccccCCccccccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 11123322 1111100 0000 000000 00011112
Q ss_pred cccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 246 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
.+..+++.+.+||.+||+.||.+|||+.++|+||||++..+...
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 22468899999999999999999999999999999998866433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=208.89 Aligned_cols=199 Identities=21% Similarity=0.281 Sum_probs=142.9
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
....+|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.++||||+++++++ ...
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCC
Confidence 3456899999999999999999999999999999998542 24577999999999999999999999 455
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH----HhHhhhcC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL----VEIIKVLG 215 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~----~~~~~~~g 215 (335)
..+|+||||+.| +|.+++.. ...+++..++.++.||+.||.|||+++ ++.. ...+..+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred CeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 568999999986 99888876 467999999999999999999999998 1000 00011111
Q ss_pred -------------------CCCHHHhh--------------------hhCCCCCCCCCCC----C--CCCccccccccCC
Q 019844 216 -------------------TPTREEIK--------------------CMNPNYTEFKFPQ----I--KPHPWHKVFQKRL 250 (335)
Q Consensus 216 -------------------~~~~~~~~--------------------~~~~~~~~~~~~~----~--~~~~~~~~~~~~~ 250 (335)
..+++.+. .+.+.|....... + ....+....+..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred cceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence 00111110 0001110000000 0 0000111112467
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
++++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 250 ~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 899999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=215.34 Aligned_cols=194 Identities=23% Similarity=0.367 Sum_probs=141.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhC-CCCceeeeceeeeeC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFST 147 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 147 (335)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ..+.+|+.+++.+ +||||+++++++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 169 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--- 169 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE---
Confidence 357999999999999999999999999999999986432 3467899999999 899999999999
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HHhH---
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LVEI--- 210 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~~~--- 210 (335)
.....+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+.| ++. ....
T Consensus 170 --~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 --ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp --EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred --eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 555669999999997 99999876 567999999999999999999999998 000 0000
Q ss_pred -------------hhhcCCCC---HHHhhhh----CCCCCC------------------CCCCCCC-----------CCc
Q 019844 211 -------------IKVLGTPT---REEIKCM----NPNYTE------------------FKFPQIK-----------PHP 241 (335)
Q Consensus 211 -------------~~~~g~~~---~~~~~~~----~~~~~~------------------~~~~~~~-----------~~~ 241 (335)
...+|++. ++.+... ...|.. ..+.... ...
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 01122222 2222111 001110 0000000 000
Q ss_pred cccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 242 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
+....+..+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 111122467889999999999999999999999999999973
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=205.94 Aligned_cols=201 Identities=21% Similarity=0.282 Sum_probs=145.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++|++.+.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 45799999999999999999999999999999999642 2457789999999999999999998853 23456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----cCh----------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----VDQ---------------------- 206 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~---------------------- 206 (335)
+|+||||++| +|.+++.........+++..++.++.||+.||.|||+++ +-.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 8999999986 999999876555566999999999999999999999865 100
Q ss_pred HH--------hHhhhcCCCC---HHHhhhhCCCCC------------------CCCCCCCCCC--------ccccccccC
Q 019844 207 LV--------EIIKVLGTPT---REEIKCMNPNYT------------------EFKFPQIKPH--------PWHKVFQKR 249 (335)
Q Consensus 207 ~~--------~~~~~~g~~~---~~~~~~~~~~~~------------------~~~~~~~~~~--------~~~~~~~~~ 249 (335)
.. ......|++. ++.+... .+. ...+...... .....++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred hheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 00 0001122222 1211100 000 0001000000 000123456
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+++++.+||.+||+.||.+|||+.++|+|+|+.+-..
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 8999999999999999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=209.70 Aligned_cols=203 Identities=19% Similarity=0.310 Sum_probs=143.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhC-CCCceeeeceeeeeCCC-CCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~-~~~~~ 154 (335)
..++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+ +||||+++++++..... .....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 345699999999999999999999999999999998643 35678999999999 89999999999965332 11456
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHh---------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEII--------- 211 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~--------- 211 (335)
+|+||||++| +|.+++.... ...+++..++.++.||+.||.|||++++ + .....+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 8999999996 9999998643 4579999999999999999999999980 0 000000
Q ss_pred --------hhcCCCC---HHHhhhh---CCCCCC------------------CCCCCCC---------CCccccccccCC
Q 019844 212 --------KVLGTPT---REEIKCM---NPNYTE------------------FKFPQIK---------PHPWHKVFQKRL 250 (335)
Q Consensus 212 --------~~~g~~~---~~~~~~~---~~~~~~------------------~~~~~~~---------~~~~~~~~~~~~ 250 (335)
...|++. ++.+... ...+.. ..+.... ........+..+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcccc
Confidence 1122221 1111100 000000 0000000 000111123467
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 8999999999999999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=214.42 Aligned_cols=198 Identities=20% Similarity=0.213 Sum_probs=140.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCC--CCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~~~~ 151 (335)
...+|.+++.||+|+||.||+|.+.. ++.||||++.... ..+.+|+.+|+.++ |||||++++++ ..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~ 127 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT 127 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ec
Confidence 34569999999999999999999864 8999999986432 45679999999996 59999999998 44
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChHHh----------
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQLVE---------- 209 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~~~---------- 209 (335)
..++|||||++.++|.+++.. ...+++..++.|+.||+.||.|||++++ +....
T Consensus 128 ~~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 128 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQ 203 (390)
T ss_dssp SSEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCC
T ss_pred CCEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCcccc
Confidence 556999999776799999986 5679999999999999999999999980 00000
Q ss_pred ---------HhhhcCCCC---HHHhhhhC---------CCCCC------------------CCCCCCCC----------C
Q 019844 210 ---------IIKVLGTPT---REEIKCMN---------PNYTE------------------FKFPQIKP----------H 240 (335)
Q Consensus 210 ---------~~~~~g~~~---~~~~~~~~---------~~~~~------------------~~~~~~~~----------~ 240 (335)
....+|++. ++.+.... ..|.. ..+..... .
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 011233333 22221100 00100 00110000 0
Q ss_pred ccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCC
Q 019844 241 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287 (335)
Q Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~ 287 (335)
.....++...++++.+||.+||+.||.+|||+.++|+||||+....|
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 11112345567899999999999999999999999999999876544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=234.81 Aligned_cols=198 Identities=21% Similarity=0.279 Sum_probs=146.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|.++++||+|+||.||+|+++.+++.||||++.+. ...+.+|..++..+ +||||++++++| .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 345799999999999999999999999999999999643 24467899999988 799999999999 66
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hHH---------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QLV--------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~~--------- 208 (335)
..++||||||++| +|..++.. .+.+++..++.|+.||+.||+|||+++ ++ ...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 6779999999996 99999986 567999999999999999999999998 00 000
Q ss_pred --------hHhhhcCCCCHHHhhhhC-CCCCC------------------CCCCCCCCC-------ccccccccCCChHH
Q 019844 209 --------EIIKVLGTPTREEIKCMN-PNYTE------------------FKFPQIKPH-------PWHKVFQKRLPPEA 254 (335)
Q Consensus 209 --------~~~~~~g~~~~~~~~~~~-~~~~~------------------~~~~~~~~~-------~~~~~~~~~~s~~~ 254 (335)
.....+||+.+...+... ..|.. ..+...... .....++..+++++
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHH
T ss_pred eccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence 011223443321111100 00100 001000000 00123556789999
Q ss_pred HHHHHHhccCCCCCCCCH-----HHHhcCcccccCCC
Q 019844 255 VDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD 286 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~-----~~~L~hp~f~~~~~ 286 (335)
.+||++||+.||.+|+++ .+|++||||+.+.+
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 999999999999999997 99999999998765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=210.76 Aligned_cols=198 Identities=26% Similarity=0.337 Sum_probs=137.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++. ....+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEEE
Confidence 345699999999999999999999999999999999643 356789999999999999999999994 4456899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------C-hHHhHhhh----------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------D-QLVEIIKV---------- 213 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~-~~~~~~~~---------- 213 (335)
||||++| +|.+++... ...+++..++.++.||+.||.|||++++ + .....+..
T Consensus 102 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999996 999998742 5679999999999999999999999980 0 00000011
Q ss_pred -------cCCCC---HHHhhhhCCCCC----------------CCCCCCCC----------CCccccccccCCChHHHHH
Q 019844 214 -------LGTPT---REEIKCMNPNYT----------------EFKFPQIK----------PHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 -------~g~~~---~~~~~~~~~~~~----------------~~~~~~~~----------~~~~~~~~~~~~s~~~~~l 257 (335)
.|++. ++.+........ ...+.... ........+..+++++.+|
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 11111 111100000000 00000000 0000011234578999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
|.+||..||.+|||+.++|+||||+...
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=209.15 Aligned_cols=202 Identities=23% Similarity=0.302 Sum_probs=125.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++. ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence 345799999999999999999999999999999988532 245678999999999999999999994 3445
Q ss_pred EEEEeecchh-hHHHHHHHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCc--------------------ChHH-
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIV--------------------DQLV- 208 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------------~~~~- 208 (335)
+|+||||++| +|.+++...... ...+++..++.++.||+.||.|||++++ ..+.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 8999999986 999998764321 3459999999999999999999999880 0000
Q ss_pred -h-------------HhhhcCCCC---HHHhhh----------------------hCCCCCCCC------------CCCC
Q 019844 209 -E-------------IIKVLGTPT---REEIKC----------------------MNPNYTEFK------------FPQI 237 (335)
Q Consensus 209 -~-------------~~~~~g~~~---~~~~~~----------------------~~~~~~~~~------------~~~~ 237 (335)
. .....|++. ++.+.. +.+.|.... .+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 0 001123332 222111 111111100 0000
Q ss_pred CCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 238 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 238 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
............+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 0000011122467899999999999999999999999999999997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-27 Score=213.82 Aligned_cols=120 Identities=20% Similarity=0.230 Sum_probs=101.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCC--------CCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~--------hpnIv~~~~~~~~~~~ 149 (335)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.+. |+||++++++|....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 457999999999999999999999999999999997542 45678999999985 788999999985322
Q ss_pred CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
....++|+||||++|+|.+.+.... ...+++..++.|+.||+.||.|||++ |
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g 167 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR 167 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 2556799999999887777776532 35799999999999999999999998 7
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=207.01 Aligned_cols=112 Identities=22% Similarity=0.231 Sum_probs=93.1
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHH--HHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKN--RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~--~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+|.+.++||+|+||+||+|++ +|+.||||++.... .... .|+..+..++|||||++++++.... .....+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 599999999999999999997 58999999997543 2233 4556667889999999999996533 2234589999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
|||+| +|.+++.. ..+++..+..|+.|++.||+|||++
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~ 119 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 99995 99999974 4699999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=212.95 Aligned_cols=201 Identities=19% Similarity=0.151 Sum_probs=143.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 44567999999999999999999999999999999996432 34678999999999999999999985433 23
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC-------------hHHhHhh-----
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD-------------QLVEIIK----- 212 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-------------~~~~~~~----- 212 (335)
..++|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||++++- .....+.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 3456899999985 99999986 56799999999999999999999999800 0000011
Q ss_pred ---------------hcCCCC---HHHhhhhCCCCCC------------------CCCCCCC-----------CCccccc
Q 019844 213 ---------------VLGTPT---REEIKCMNPNYTE------------------FKFPQIK-----------PHPWHKV 245 (335)
Q Consensus 213 ---------------~~g~~~---~~~~~~~~~~~~~------------------~~~~~~~-----------~~~~~~~ 245 (335)
.+|++. ++.+... .+.. ..+.... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp ------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence 122222 1111100 0000 0000000 0000011
Q ss_pred cccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 246 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
.+..+++++.+||.+||+.||.+||++.++|.|+|++....
T Consensus 242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 22468999999999999999999999999999999987544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=204.72 Aligned_cols=121 Identities=22% Similarity=0.267 Sum_probs=103.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCC-------
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD------- 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~------- 149 (335)
..++|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4567999999999999999999999999999999996532 456789999999999999999999864321
Q ss_pred -CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 -KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 -~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ 136 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG 136 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC
Confidence 235678999999986 999999852 345788999999999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=209.68 Aligned_cols=194 Identities=20% Similarity=0.248 Sum_probs=140.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|.+++.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeE
Confidence 34599999999999999999999999999999998643 25578999999999999999999999 445568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhhhc-------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIKVL------- 214 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~~~------- 214 (335)
|+||||++| +|.+++. .+.+++..++.++.||+.||.|||++++ +. ....+..+
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 999999996 9998886 4579999999999999999999999980 00 00000111
Q ss_pred ----------CCCC---HHHhhhhCCCCC----------------CCCCCCCCCC--------ccccccccCCChHHHHH
Q 019844 215 ----------GTPT---REEIKCMNPNYT----------------EFKFPQIKPH--------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 215 ----------g~~~---~~~~~~~~~~~~----------------~~~~~~~~~~--------~~~~~~~~~~s~~~~~l 257 (335)
|++. ++.+........ ...+...... .....++..+++.+.+|
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 1111 111110000000 0000000000 00112345789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|.+||+.||.+|||+.++|+||||...
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 999999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=217.92 Aligned_cols=206 Identities=15% Similarity=0.125 Sum_probs=134.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHH---HHHhCCCCceeeec-------e
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQ---IMQMLDHPNIVALK-------H 142 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~---~l~~l~hpnIv~~~-------~ 142 (335)
..++|.+.+.||+|+||.||+|+++.+|+.||||++... .+.+.+|+. +++.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346799999999999999999999999999999998632 245779994 55555899999999 4
Q ss_pred eeeeCC---------CCCcc---EEEEEeecchhhHHHHHHHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC----
Q 019844 143 CFFSTT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALAYIHNCI---- 203 (335)
Q Consensus 143 ~~~~~~---------~~~~~---~~~iv~e~~~g~L~~~l~~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---- 203 (335)
++.... +.... ..||||||++|+|.+++....... ..+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 442221 01111 378999999889999998743110 11234788889999999999999998
Q ss_pred --------cC--hHHhH-------------hhhcC--CCCHHHhhhhC---------CCCCC------------------
Q 019844 204 --------VD--QLVEI-------------IKVLG--TPTREEIKCMN---------PNYTE------------------ 231 (335)
Q Consensus 204 --------~~--~~~~~-------------~~~~g--~~~~~~~~~~~---------~~~~~------------------ 231 (335)
++ ...++ ...+| ..+++.+.... ..|..
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 00 00000 01112 11233222210 00100
Q ss_pred CCCCCC-CCCcccc--ccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 232 FKFPQI-KPHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 232 ~~~~~~-~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
..+... ....+.. ..+..+++++.+||.+||+.||++|||+.++|+||||+++.
T Consensus 311 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp CCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 000000 0001111 11257899999999999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=208.10 Aligned_cols=121 Identities=28% Similarity=0.418 Sum_probs=103.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCC-----------CCceeeeceeee
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFF 145 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~-----------hpnIv~~~~~~~ 145 (335)
...+|++++.||+|+||.||+|++..+++.||||++..+. ..+.+|+.+++.+. ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3457999999999999999999999999999999997542 45678999999886 899999999985
Q ss_pred eCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
... .+..++++||||+.++|.+++.... ...+++..++.++.||+.||.|||++ +
T Consensus 97 ~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ 152 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG 152 (373)
T ss_dssp EEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 432 2345789999999779999998643 45699999999999999999999998 7
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=204.52 Aligned_cols=204 Identities=19% Similarity=0.237 Sum_probs=145.7
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCC---------
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT--------- 148 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~--------- 148 (335)
.....+|++.+.||+|+||.||+|.+..+++.||+|++......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 34566899999999999999999999999999999999877778899999999999999999999884311
Q ss_pred --CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch-HHhHhh
Q 019844 149 --DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-LVEIIK 212 (335)
Q Consensus 149 --~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-~~~~~~ 212 (335)
......+|+||||++| +|.+++.... ...+++..++.++.||+.||.|||++++ +. ....+.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 0234568999999996 9999998643 4679999999999999999999999980 00 000011
Q ss_pred hcCCCCH------HHhhhhCCCCCCCCC-----CCCCCCcc---------------------------ccccccCCChHH
Q 019844 213 VLGTPTR------EEIKCMNPNYTEFKF-----PQIKPHPW---------------------------HKVFQKRLPPEA 254 (335)
Q Consensus 213 ~~g~~~~------~~~~~~~~~~~~~~~-----~~~~~~~~---------------------------~~~~~~~~s~~~ 254 (335)
.+|.... .....+.+.|.+.+. .....+.| ...++..+++++
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE 244 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSCHHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCCHHH
Confidence 1111000 000001111111000 00000000 012335678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
.+||.+||+.||.+|||+.++++|.+.-.
T Consensus 245 ~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 245 KTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999988654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-26 Score=206.53 Aligned_cols=203 Identities=15% Similarity=0.079 Sum_probs=125.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhC--CCCceeeece-------ee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML--DHPNIVALKH-------CF 144 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l--~hpnIv~~~~-------~~ 144 (335)
..+|.+++.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.| +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445999999999999999999999999999999997532 3456775544444 6999888663 33
Q ss_pred eeCCC------------CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHH------HHHHHHHHHHHHHHHhCC---
Q 019844 145 FSTTD------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCI--- 203 (335)
Q Consensus 145 ~~~~~------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~--- 203 (335)
..... .....+|||||||+|+|.+++.... ..+.+... ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 22111 0115589999999999999998743 23445555 577799999999999998
Q ss_pred ---------cCh--HHhHh-------------hhcCCCC---HHHhh-----------------------hhCCCCCCCC
Q 019844 204 ---------VDQ--LVEII-------------KVLGTPT---REEIK-----------------------CMNPNYTEFK 233 (335)
Q Consensus 204 ---------~~~--~~~~~-------------~~~g~~~---~~~~~-----------------------~~~~~~~~~~ 233 (335)
++. ..++. ...|++. ++.+. .+.+.|....
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 000 00000 1112211 22211 1111111100
Q ss_pred -----------CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 234 -----------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 234 -----------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
........+....+..+++++.+||.+||+.||++|||+.++|+||||+++.+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 00000111112223578999999999999999999999999999999987643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=206.13 Aligned_cols=196 Identities=20% Similarity=0.269 Sum_probs=142.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----------hhHHHHHHHHHhCC--CCceeeeceeeeeCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTT 148 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~ 148 (335)
..+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.+. ||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~---- 117 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 117 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE----
Confidence 446999999999999999999999999999999996431 45678999999996 59999999999
Q ss_pred CCCccEEEEEeecch--hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--hHHhHhh
Q 019844 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD--QLVEIIK 212 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~--~~~~~~~ 212 (335)
.....+++|||++. ++|.+++.. .+.+++..++.++.||+.||.|||+++ ++ .....+.
T Consensus 118 -~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 -ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred -ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 45556899999997 599999886 567999999999999999999999998 11 1111111
Q ss_pred hcC---------------CCC---HHHhhhhCCCCC------------------CCCCCCCCC-CccccccccCCChHHH
Q 019844 213 VLG---------------TPT---REEIKCMNPNYT------------------EFKFPQIKP-HPWHKVFQKRLPPEAV 255 (335)
Q Consensus 213 ~~g---------------~~~---~~~~~~~~~~~~------------------~~~~~~~~~-~~~~~~~~~~~s~~~~ 255 (335)
.+| ++. ++.+... ..+. ...+..... ......++..+++++.
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHH
T ss_pred eCccccccccccccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHH
Confidence 122 111 1111100 0000 000000000 0001123467899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+||.+||+.||++|||+.++++||||++...
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 9999999999999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=210.87 Aligned_cols=116 Identities=16% Similarity=0.224 Sum_probs=99.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---------------------hhHHHHHHHHHhCCCCce
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNI 137 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------------~~~~~Ei~~l~~l~hpnI 137 (335)
...++|++++.||+|+||.||+|.+ +++.||||++.... ..+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3445799999999999999999999 89999999986321 567899999999999999
Q ss_pred eeeceeeeeCCCCCccEEEEEeecchh-hHHHH------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRI------ARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 138 v~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
+++++++ .....+|+||||++| +|.++ +... ....+++..++.++.||+.||.|||+ +|
T Consensus 106 ~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~ 172 (348)
T 2pml_X 106 LTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN 172 (348)
T ss_dssp CCCSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC
T ss_pred ceEEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence 9999999 445569999999997 99887 4321 14679999999999999999999999 77
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=205.42 Aligned_cols=198 Identities=19% Similarity=0.242 Sum_probs=134.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhC----CCCceeeeceee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQML----DHPNIVALKHCF 144 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l----~hpnIv~~~~~~ 144 (335)
...++|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4456799999999999999999999999999999999643 23456899999999 899999999999
Q ss_pred eeCCCCCccEEEEEeec-chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC--hHH
Q 019844 145 FSTTDKEELYLNLVLEY-VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD--QLV 208 (335)
Q Consensus 145 ~~~~~~~~~~~~iv~e~-~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~--~~~ 208 (335)
.....+++|||+ +.| +|.+++.. .+.+++..++.++.||+.||.|||+++ ++ ...
T Consensus 108 -----~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 108 -----ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred -----ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 445558899999 564 99999986 567999999999999999999999988 11 100
Q ss_pred hHhhhcC---------------CCC---HHHhhhhCCCCC------------------CCCCCCCCC-CccccccccCCC
Q 019844 209 EIIKVLG---------------TPT---REEIKCMNPNYT------------------EFKFPQIKP-HPWHKVFQKRLP 251 (335)
Q Consensus 209 ~~~~~~g---------------~~~---~~~~~~~~~~~~------------------~~~~~~~~~-~~~~~~~~~~~s 251 (335)
..+..+| ++. ++.+.... .+. ...+..... ......++..++
T Consensus 179 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257 (312)
T ss_dssp EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSC
T ss_pred EEEEEcchhhhcccCcccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCC
Confidence 1111112 111 11110000 000 000000000 000112346789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
+++.+||.+||+.||++|||+.++|+||||+....
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 99999999999999999999999999999987644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=201.74 Aligned_cols=116 Identities=23% Similarity=0.269 Sum_probs=103.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...++|++++.||+|+||.||+|++..+++.||+|++... .+.+.+|+.+++.++||||+++++++ ..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence 3456799999999999999999999999999999998432 14567999999999999999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ 131 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR 131 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6679999999986 99999986 567999999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=203.78 Aligned_cols=118 Identities=17% Similarity=0.241 Sum_probs=98.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHH-HHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++|++++.||+|+||.||+|.++.+++.||||++.... ..+.+|+. +++.++||||+++++++ .....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCc
Confidence 356999999999999999999999999999999996432 23445655 67778999999999999 44456
Q ss_pred EEEEeecchhhHHHHHHHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 155 LNLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
+|+||||++|+|.+++..... ....+++..++.++.|++.||.|||++ +
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 899999999998888875332 256799999999999999999999998 6
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=200.76 Aligned_cols=197 Identities=22% Similarity=0.313 Sum_probs=137.0
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
|.....||+|+||.||+|.+..+++.||||.+... ...+.+|+.+++.++||||+++++++ .....+++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEEE
Confidence 33455999999999999999999999999998643 24577999999999999999999999 4555689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHhHhhh-----------
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVEIIKV----------- 213 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~~~~~----------- 213 (335)
||++| +|.+++.... ....+++..++.++.||+.||.|||+++ ++. ....+..
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99985 9999997632 1235679999999999999999999998 100 0000011
Q ss_pred ------cCCCC---HHHhhhhCCCCCC------------------CCCCCCCC----------CccccccccCCChHHHH
Q 019844 214 ------LGTPT---REEIKCMNPNYTE------------------FKFPQIKP----------HPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 214 ------~g~~~---~~~~~~~~~~~~~------------------~~~~~~~~----------~~~~~~~~~~~s~~~~~ 256 (335)
.|++. ++.+......+.. ..+..... ......++..+++++.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 11111 1211110000100 00000000 00112344678999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
||.+||+.||++|||+.++|+||||+....
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 999999999999999999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-25 Score=196.46 Aligned_cols=185 Identities=12% Similarity=0.001 Sum_probs=132.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ...
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EEC
Confidence 3356999999999999999999999999999999996432 4577999999999999999999999 455
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-ChHHh------------HhhhcCCCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-DQLVE------------IIKVLGTPT 218 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~~~~------------~~~~~g~~~ 218 (335)
..+|+||||++| +|.+++.. + ....++..|+.||+.||.|||++|+ +...+ .+...++..
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred CcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 669999999986 99999852 2 4666789999999999999999981 10000 000111111
Q ss_pred ---------------HHHhhhhCCCCCCCCCC-------CCCCC--ccccccccCCChHHHHHHHHhccCCCCCCCCHHH
Q 019844 219 ---------------REEIKCMNPNYTEFKFP-------QIKPH--PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 274 (335)
Q Consensus 219 ---------------~~~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 274 (335)
++.+ .+...|...... ..... .....++..+++++.+||.+||+.||++| |+.+
T Consensus 178 ~~~~~~Di~slG~il~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~e 255 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALL-VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SAST 255 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHH-HSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHH
T ss_pred CCCchhHHHHHHHHHHHHH-HCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHH
Confidence 1111 111222211100 00000 11112346789999999999999999999 9999
Q ss_pred Hhc
Q 019844 275 ACV 277 (335)
Q Consensus 275 ~L~ 277 (335)
+++
T Consensus 256 l~~ 258 (286)
T 3uqc_A 256 LLN 258 (286)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=201.72 Aligned_cols=201 Identities=20% Similarity=0.211 Sum_probs=140.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCC--CCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD--HPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~~~ 150 (335)
....+|.+++.||+|+||.||+|.+. +++.||||++... ...+.+|+.+++.++ ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~ 98 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----I 98 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----E
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----e
Confidence 34567999999999999999999985 5899999998532 245678999999996 59999999999 4
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------ChHHhHh-------
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQLVEII------- 211 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~~~~~~------- 211 (335)
...++|+|||++.++|.+++.. ...+++..++.++.||+.||.|||++++ +.....+
T Consensus 99 ~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 TDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIAN 174 (313)
T ss_dssp CSSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSC
T ss_pred cCCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccc
Confidence 5556999999777899999986 6679999999999999999999999980 0000000
Q ss_pred ------------hhcCCCC---HHHhhhhC---------CCCCC------------------CCCCCCCC----------
Q 019844 212 ------------KVLGTPT---REEIKCMN---------PNYTE------------------FKFPQIKP---------- 239 (335)
Q Consensus 212 ------------~~~g~~~---~~~~~~~~---------~~~~~------------------~~~~~~~~---------- 239 (335)
...|++. ++.+.... ..+.. ..+.....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 1122222 12111100 00000 00000000
Q ss_pred CccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCC
Q 019844 240 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 289 (335)
Q Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~ 289 (335)
......++...++++.+||.+||+.||.+|||+.++|+||||+....|..
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence 00111234556889999999999999999999999999999997655443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-25 Score=203.08 Aligned_cols=115 Identities=29% Similarity=0.430 Sum_probs=98.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCC-CC-----ceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-HP-----NIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~-hp-----nIv~~~~~~~~~~~~ 150 (335)
..++|++.+.||+|+||.||+|.++.+++.||||++.... ..+.+|+.+++.++ |+ +|+++++++ .
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~-----~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF-----M 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE-----E
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee-----c
Confidence 3457999999999999999999999999999999997543 44567899988884 55 499999999 4
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
...++|+||||++|+|.+++.... ...+++..++.++.||+.||.|||+
T Consensus 127 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~ 175 (382)
T 2vx3_A 127 FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLAT 175 (382)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred cCCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 456699999999999999998633 3569999999999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=203.29 Aligned_cols=120 Identities=18% Similarity=0.272 Sum_probs=103.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 83 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH 83 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCce
Confidence 456799999999999999999999999999999999642 2456799999999999999999999843 23345
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+||||++| +|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ 132 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG 132 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999985 99999986432 234999999999999999999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=196.98 Aligned_cols=115 Identities=26% Similarity=0.504 Sum_probs=102.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|.+++.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++ .....++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCeeE
Confidence 45799999999999999999999999999999988542 34577999999999999999999999 4455689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ 128 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN 128 (310)
T ss_dssp EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 999999863 456999999999999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=200.84 Aligned_cols=116 Identities=19% Similarity=0.274 Sum_probs=89.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ..+..+..+++.++||||+++++++ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCC
Confidence 3457999999999999999999999999999999996432 2233445567888999999999999 4455
Q ss_pred EEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 154 ~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
.+|+||||+++.+..+.... ...+++..++.++.||+.||.|||++ +
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 145 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG 145 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred cEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 68999999976666665532 46799999999999999999999985 6
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=212.33 Aligned_cols=114 Identities=20% Similarity=0.303 Sum_probs=95.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
..+|.+.+.||+|+||+|+. ....+++.||||++... .....+|+.+|+.+ +|||||++++++ .+..++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEE
Confidence 34699999999999999764 33468999999999653 34577999999999 799999999998 566679999
Q ss_pred eecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+|+|.+++... ...+.+..++.++.||+.||.|||+++
T Consensus 97 ~E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 138 (432)
T 3p23_A 97 IELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN 138 (432)
T ss_dssp EECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc
Confidence 999999999998752 334666678899999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=199.66 Aligned_cols=117 Identities=21% Similarity=0.357 Sum_probs=99.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEE-cCCCcEEEEEEecccc---hhHHHHHHHHHhCCCC------ceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hp------nIv~~~~~~~~~~~ 149 (335)
..++|++.+.||+|+||.||+|.+ +.+++.||||++.... ..+.+|+.+++.++|+ +|+++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----- 86 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----- 86 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence 345799999999999999999998 5688999999997532 4577899999998665 499999999
Q ss_pred CCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++|+||||++++|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 87 ~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ 138 (339)
T 1z57_A 87 EHHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK 138 (339)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 5556799999999779999988632 346899999999999999999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=193.67 Aligned_cols=115 Identities=21% Similarity=0.323 Sum_probs=100.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .+.+.+|+.+++.++||||+++++++ .....+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3457999999999999999999986 5778999999753 35678999999999999999999999 4555589
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC 126 (269)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999986 999998652 456999999999999999999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=195.71 Aligned_cols=118 Identities=20% Similarity=0.350 Sum_probs=104.3
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
....+|++.+.||+|+||.||+|.++.++..||+|++..+. ..+.+|+.+++.++||||+++++++ .....+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 45567999999999999999999999999999999997543 4577999999999999999999999 555558
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ 131 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN 131 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC
Confidence 999999995 9999998633 456999999999999999999999988
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=199.10 Aligned_cols=116 Identities=26% Similarity=0.419 Sum_probs=98.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...+|++.+.||+|+||.||+|++ ++..||||++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 345799999999999999999987 58899999986432 3567899999999999999999999 5555
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++| +|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN 157 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 58899999986 99999975221 224999999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=206.04 Aligned_cols=120 Identities=17% Similarity=0.179 Sum_probs=99.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEE-----EcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
....+|++++.||+|+||.||+|+ +..+++.||||++... ...+.+|+.+++.++|||||++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~---- 143 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS---- 143 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence 344679999999999999999999 4457789999998642 23567899999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
......|+|||||+| +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 144 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 201 (367)
T 3l9p_A 144 -LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201 (367)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 444557899999986 99999987431 1245999999999999999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=204.40 Aligned_cols=117 Identities=21% Similarity=0.319 Sum_probs=102.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
...++|.+.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+|+.++|||||++++++ ....
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCC
Confidence 3456799999999999999999999999999999998643 24577999999999999999999999 4445
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+|||||+| +|.+++... ...+++..+..++.||+.||+|||+++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ 233 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC 233 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 58899999985 999999753 345999999999999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=199.39 Aligned_cols=117 Identities=22% Similarity=0.328 Sum_probs=101.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
....+|.+.+.||+|+||.||+|.++.+++ .||||++... .+.+.+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 345679999999999999999999986655 4999999643 24577899999999999999999999 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+||||++| +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ 171 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG 171 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56668999999986 999998642 357999999999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-25 Score=195.13 Aligned_cols=122 Identities=20% Similarity=0.277 Sum_probs=104.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|++.+.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.++||||+++++++.... .....+|
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 45799999999999999999999999999999998532 345779999999999999999999985322 2455688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.+ +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 154 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 999999876555678999999999999999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=201.42 Aligned_cols=120 Identities=23% Similarity=0.346 Sum_probs=100.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-------CCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF 145 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 145 (335)
...++|.+++.||+|+||.||+|++. .++..||||++.... ..+.+|+.+|+.+ +||||+++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence 34567999999999999999999975 345679999996432 4577999999999 899999999999
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 157 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 223 (370)
T 2psq_A 157 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223 (370)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445558899999996 99999986321 1235899999999999999999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-25 Score=196.86 Aligned_cols=125 Identities=18% Similarity=0.260 Sum_probs=93.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
...++|.+++.||+|+||.||+|.++.++. .||||++... ...+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 344579999999999999999999987765 8999998643 2457799999999999999999999964332
Q ss_pred C-CccEEEEEeecchh-hHHHHHHHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 K-EELYLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~-~~~~~~iv~e~~~g-~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. .....++||||+.| +|.+++..... ....+++..++.|+.||+.||.|||+++
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 157 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence 1 11224899999996 99999976431 1225999999999999999999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-25 Score=194.52 Aligned_cols=119 Identities=29% Similarity=0.483 Sum_probs=103.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+|++.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++. ..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----ED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence 345699999999999999999999999999999998641 245678999999999999999999994 44
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++||||++| +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 568999999996 999999876655677999999999999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=199.29 Aligned_cols=116 Identities=21% Similarity=0.362 Sum_probs=98.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC-cEEEEEEeccc---chhHHHHHHHHHhCCCCc------eeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQD---KRYKNRELQIMQMLDHPN------IVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpn------Iv~~~~~~~~~~~~ 150 (335)
.++|++.+.||+|+||.||+|.+..++ +.||+|++... ...+.+|+.+++.++|++ |+.+++++ .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence 457999999999999999999998777 68999999753 345678999999997665 89999988 5
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...++|+||||++++|.+.+.... ...+++..++.++.||+.||.|||+++
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ 143 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ 143 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 556799999999888888777532 356999999999999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=197.51 Aligned_cols=118 Identities=31% Similarity=0.501 Sum_probs=101.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEE----EcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|++++.||+|+||.||+|+ +..+++.||||++.... +.+.+|+.+++.++||||+++++++.. .+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 44579999999999999999999 56789999999996533 457799999999999999999999843 22
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 134 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR 134 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3447899999986 999999863 235999999999999999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-25 Score=193.81 Aligned_cols=114 Identities=20% Similarity=0.213 Sum_probs=101.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeCC
Confidence 456999999999999999999999999999999986431 4567899999999999999999999 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++| +|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ 154 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG 154 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 68999999996 99999986 567999999999999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=209.19 Aligned_cols=118 Identities=20% Similarity=0.345 Sum_probs=103.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
....+|.+.+.||+|+||.||+|.++.++..||||++... ...+.+|+.+|+.++|||||++++++ .....+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcE
Confidence 3456799999999999999999999999999999999753 35678999999999999999999999 444558
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||||+| +|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ 338 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN 338 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899999995 9999998633 356899999999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=201.17 Aligned_cols=120 Identities=20% Similarity=0.281 Sum_probs=99.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEE-----EcCCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
..++|.+++.||+|+||.||+|+ +..+++.||||++.... +.+.+|+.+++.+ +|||||++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence 34679999999999999999999 55677899999996532 4578999999999 79999999999843
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh---------------------------------------------------
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI--------------------------------------------------- 176 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~--------------------------------------------------- 176 (335)
....+++|||||+| +|.+++......
T Consensus 98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 23347899999996 999999863210
Q ss_pred -----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 177 -----------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 177 -----------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++..++.|+.||+.||.|||+++
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ 213 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 213 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 112899999999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=196.26 Aligned_cols=116 Identities=17% Similarity=0.216 Sum_probs=100.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCC-------cEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
..++|.+.+.||+|+||.||+|.++.++ ..||+|++.... ..+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC---- 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE----
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE----
Confidence 3457999999999999999999998877 469999986432 4577999999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
......|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 82 -~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ 133 (289)
T 4fvq_A 82 -VCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT 133 (289)
T ss_dssp -CCTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -EeCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 444557899999995 999999863 234999999999999999999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=192.55 Aligned_cols=116 Identities=22% Similarity=0.281 Sum_probs=98.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|++++.||+|+||.||+|.+. ++..||+|++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 44567999999999999999999885 6778999999743 35678999999999999999999999 555568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 140 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ 140 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999985 999998753 356999999999999999999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=191.71 Aligned_cols=115 Identities=22% Similarity=0.325 Sum_probs=100.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++.+.||+|+||.||+|.++ ++..||+|++... ...+.+|+.+++.++||||+++++++ .....+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 3457999999999999999999885 6778999999653 35678999999999999999999999 5555689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 124 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ 124 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999986 999999763 345999999999999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=195.14 Aligned_cols=120 Identities=18% Similarity=0.335 Sum_probs=100.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
....+|.+.+.||+|+||.||+|.+. .+++.||||++.... +.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 34567999999999999999999983 456899999996432 4567899999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445558899999995 99999987432 1234899999999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-24 Score=192.48 Aligned_cols=122 Identities=22% Similarity=0.315 Sum_probs=104.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCC-CCceeeeceeeeeCCC---CCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD---KEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~---~~~ 152 (335)
..+|++.++||+|+||.||+|++..+++.||||++... ...+.+|+.+++.+. ||||+++++++..... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34799999999999999999999999999999998543 245678999999995 9999999999854322 455
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++||||+.|+|.+++..... .+.+++..++.|+.||+.||.|||+++
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred ceEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 66899999999999998876432 456999999999999999999999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=200.17 Aligned_cols=117 Identities=23% Similarity=0.330 Sum_probs=100.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
....+|++.+.||+|+||.||+|.+. ++.||||+++.. .+.+.+|+.+|+.++|||||++++++.. ....+|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence 34567999999999999999999985 789999999753 3567899999999999999999999853 223488
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||||+| +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ 309 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN 309 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999986 9999998632 334799999999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=197.35 Aligned_cols=119 Identities=25% Similarity=0.321 Sum_probs=101.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
..++|++++.||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC----- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 3456999999999999999999997 455899999997532 4577999999999999999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++.+++.|+.||+.||.|||+++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445558899999996 999999863211 157999999999999999999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=195.64 Aligned_cols=120 Identities=16% Similarity=0.174 Sum_probs=96.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEE-----EcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
....+|++++.||+|+||.||+|+ +..+++.||||++... ...+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 102 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS---- 102 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 344579999999999999999999 5567889999998532 24567899999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 103 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 160 (327)
T 2yfx_A 103 -LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160 (327)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 444557899999975 999999874211 145899999999999999999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=191.19 Aligned_cols=117 Identities=13% Similarity=0.214 Sum_probs=98.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|.+.+.||+|+||.||+|++. ++.||||++... .+.+.+|+.+++.++||||+++++++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 3456999999999999999999985 889999998643 24577999999999999999999998432 225
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++||||++| +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE 131 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS
T ss_pred CeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 58899999996 9999997522 235899999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=204.06 Aligned_cols=118 Identities=21% Similarity=0.248 Sum_probs=92.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ..+.+|+.+|+.+ +|||||++++++ ....++||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 33458888999999999998754 4689999999986543 4567999999876 899999999998 55667999
Q ss_pred EeecchhhHHHHHHHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQ---RMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||+|+|.+++........ ..++..++.++.||+.||+|||+++
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 135 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC
Confidence 999999999999975321111 1133456789999999999999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=188.83 Aligned_cols=114 Identities=25% Similarity=0.356 Sum_probs=98.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----------hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
..++|++.+.||+|+||.||+|++..+++.||+|++.... +.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---- 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence 3457999999999999999999999999999999985321 4577999999999999999999998
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.... ++||||++| +|.+.+... ...+++..++.++.||+.||.|||+++
T Consensus 93 -~~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~ 142 (287)
T 4f0f_A 93 -HNPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQN 142 (287)
T ss_dssp -TTTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred -cCCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 4443 489999995 998887642 457999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=194.81 Aligned_cols=119 Identities=21% Similarity=0.287 Sum_probs=98.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
..++|.+++.||+|+||.||+|.+. .++..||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 3457999999999999999999973 45678999998642 34578999999999 899999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 444558899999986 999999753210 134899999999999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=192.35 Aligned_cols=119 Identities=20% Similarity=0.270 Sum_probs=100.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEE-----cCCCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
..++|.+.+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 345799999999999999999985 457789999999643 24577999999999 999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+++||||++| +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 165 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 444558899999986 99999986321 1125899999999999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=194.41 Aligned_cols=119 Identities=25% Similarity=0.426 Sum_probs=101.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEE--EEEEecc-----cchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v--AvK~i~~-----~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~ 151 (335)
..++|++.+.||+|+||.||+|+++.++..+ |+|.+.. ....+.+|+.+++.+ +||||+++++++ ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 3457999999999999999999999888865 9998864 235578999999999 899999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+||||++| +|.+++.... .....+++..++.++.||+.||.|||+++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 162 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5669999999986 9999997532 11246999999999999999999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-25 Score=194.47 Aligned_cols=120 Identities=18% Similarity=0.228 Sum_probs=101.4
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 148 (335)
...++|++.+.||+|+||.||+|.++ .+++.||||.+.... ..+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence 44567999999999999999999986 467889999996432 3467899999999999999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 158 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445558899999986 999999864321 145799999999999999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=196.86 Aligned_cols=120 Identities=20% Similarity=0.308 Sum_probs=100.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCC-------CcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF 145 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 145 (335)
...++|.+++.||+|+||.||+|.+..+ +..||||++.... ..+.+|+.+++.+ +|||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 4456799999999999999999997543 3579999996432 4577999999999 999999999999
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++..++.|+.||+.||.|||+++
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 211 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445558899999986 999999873210 135999999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=219.22 Aligned_cols=122 Identities=25% Similarity=0.328 Sum_probs=99.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~ 154 (335)
.++|++.+.||+|+||.||+|.++.+|+.||||++... ...+.+|+.+++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 35799999999999999999999999999999998643 2457789999999999999999998743111 12455
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|+|||||+| +|.+++.... ....+++..++.|+.||+.||.|||++|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g 141 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR 141 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 7899999985 9999987532 1236999999999999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-24 Score=186.38 Aligned_cols=114 Identities=21% Similarity=0.313 Sum_probs=100.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeEE
Confidence 356999999999999999999985 6788999999753 35678999999999999999999999 44455889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 124 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC 124 (267)
T ss_dssp EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999986 999998762 356899999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=187.17 Aligned_cols=117 Identities=23% Similarity=0.330 Sum_probs=98.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|++.+.||+|+||.||+|.+. |+.||||++... .+.+.+|+.+++.++||||+++++++.. ....+|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~ 91 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 91 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence 34467999999999999999999874 889999999753 3567899999999999999999998742 233578
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN 137 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999996 9999998643 234899999999999999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-24 Score=191.86 Aligned_cols=119 Identities=24% Similarity=0.293 Sum_probs=101.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCc-----EEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 148 (335)
..++|.+.+.||+|+||.||+|.+..+++ .||+|.+... ...+.+|+.+++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 34579999999999999999999977664 7999998643 24577999999999 899999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 444558899999986 999999864321 346899999999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=189.84 Aligned_cols=124 Identities=19% Similarity=0.261 Sum_probs=97.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcC---CCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...+|.+++.||+|+||.||+|.+.. ++..||+|++... ...+.+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34569999999999999999998865 5568999998643 14477899999999999999999999654433
Q ss_pred CccEEEEEeecchh-hHHHHHHHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++||||+.+ +|.+++.... .....+++..++.++.||+.||.|||+++
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 33457899999996 9999986432 12456999999999999999999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=196.62 Aligned_cols=117 Identities=21% Similarity=0.373 Sum_probs=100.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.... ..+.+|+.+++.++||||+++++++ .....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTPTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCSSC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-----ecCCc
Confidence 345699999999999999999986 478999999986432 3578999999999999999999999 44455
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
.++|||||+| +|.+++.........+++..++.|+.||+.||.|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 150 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 7899999996 99999986544445699999999999999999999999
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=186.63 Aligned_cols=110 Identities=32% Similarity=0.534 Sum_probs=94.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|++.+.||+|+||.||+|.+. ++.||||++... .+.+.+|+.+++.++||||+++++++ ....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKEP 79 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC-
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCC
Confidence 46999999999999999999984 889999998632 24567899999999999999999999 5555
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+||||++| +|.+++. .+.+++..++.++.||+.||.|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ 125 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEA 125 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999986 9988875 467999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=193.39 Aligned_cols=119 Identities=26% Similarity=0.422 Sum_probs=102.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEE----EcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...++|++++.||+|+||.||+|+ +..+++.||||++.... +.+.+|+.+++.++||||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 345679999999999999999999 56789999999996532 447899999999999999999998853 3
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+...+|+||||++| +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ 147 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR 147 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45568899999975 999999863 345999999999999999999999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=191.34 Aligned_cols=117 Identities=25% Similarity=0.370 Sum_probs=99.4
Q ss_pred eeeeEEeeeeeccCceEEEEEE----EcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|++++.||+|+||.||+|+ +..+++.||+|++... ...+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3459999999999999999999 5678999999999643 25578999999999999999999998532 2
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 146 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ 146 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 2458899999986 999999653 456999999999999999999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=192.81 Aligned_cols=120 Identities=23% Similarity=0.349 Sum_probs=98.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEc-------CCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeee
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF 145 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 145 (335)
...++|++++.||+|+||.||+|.+. .++..||||++.... ..+.+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 34467999999999999999999986 457789999996432 4567999999999 899999999999
Q ss_pred eCCCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|+||||++| +|.+++..... ....+++..++.++.||+.||.|||+++
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 177 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445568899999986 99999985321 1234899999999999999999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=196.30 Aligned_cols=118 Identities=19% Similarity=0.293 Sum_probs=100.0
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..++|.+.+.||+|+||.||+|.+ .+++.||||++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 345699999999999999999997 47899999998643 24577999999999999999999999 455568
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.........+++..++.++.||+.||.|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 159 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC
Confidence 899999986 998888643222345999999999999999999999988
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-24 Score=184.26 Aligned_cols=116 Identities=26% Similarity=0.311 Sum_probs=98.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCC---CcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
....+|++.+.||+|+||.||+|.+..+ +..||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 4456799999999999999999998654 457999998642 245778999999999999999999972
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+ ..+|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR 136 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 2 236799999996 999999752 346999999999999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=196.86 Aligned_cols=116 Identities=24% Similarity=0.361 Sum_probs=99.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEc---CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|.+.+.||+|+||.||+|+++ .++..||||++... .+.+.+|+.+++.++||||+++++++ ..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3456999999999999999999987 46778999998643 24577999999999999999999999 44
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+|+|||||+| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG 167 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5558899999985 999999752 346999999999999999999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-24 Score=185.46 Aligned_cols=113 Identities=21% Similarity=0.272 Sum_probs=96.9
Q ss_pred eeeeEEee-eeeccCceEEEEEEE--cCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEH-VVGTGSFGVVFQAKC--RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~-~lG~G~fg~V~~~~~--~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|.+.+ .||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.++||||+++++++ . .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~----~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E----A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C----C
Confidence 35699998 999999999999954 567889999999643 24577999999999999999999998 2 1
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|+||||++| +|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ 137 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 137 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 227799999995 99999986 567999999999999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=190.46 Aligned_cols=119 Identities=20% Similarity=0.293 Sum_probs=98.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEE-----cCCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|++++.||+|+||.||+|.+ ..+++.||||++.... ..+.+|+.+++.+ +||||+++++++..
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 102 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 102 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec---
Confidence 45799999999999999999985 3567899999996532 3567999999999 79999999999842
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+|+|||||+| +|.+++...... ...+++..++.++.||+.||.|||+++
T Consensus 103 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 103 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp -TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 23347899999996 999999863211 122899999999999999999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-23 Score=184.27 Aligned_cols=117 Identities=20% Similarity=0.268 Sum_probs=96.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCC---cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.+... ...+.+|+.+++.++||||+++++++. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RS 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cC
Confidence 3456999999999999999999975433 36899998642 245679999999999999999999864 33
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~ 148 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK 148 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457899999997 999998742 456899999999999999999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=199.06 Aligned_cols=117 Identities=21% Similarity=0.296 Sum_probs=99.9
Q ss_pred ccceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 78 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
....++|.+.+.||+|+||.||+|.+. .+..||||+++.. .+.+.+|+.+|+.++|||||++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 345568999999999999999999985 5778999999753 356789999999999999999999983 223
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||||.+ +|.+++.... ...+++..+..++.||+.||.|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 7899999985 9999997533 346899999999999999999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-24 Score=197.08 Aligned_cols=116 Identities=23% Similarity=0.269 Sum_probs=99.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|++.+.||+|+||.||+|.+.. +..||||++... ...+.+|+.+|+.++||||+++++++. . ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cce
Confidence 445679999999999999999999964 467999999753 356789999999999999999999983 2 337
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||||+| +|.+++.... ...+++..+..++.||+.||+|||+++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ 300 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN 300 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899999985 9999997532 356999999999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=196.00 Aligned_cols=120 Identities=18% Similarity=0.272 Sum_probs=102.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
...+|.+.+.||+|+||.||+|+++.+++.||||++... ...+.+|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~ 83 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH 83 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCe
Confidence 346799999999999999999999999999999999642 2456799999999999999999999853 23345
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|+|||||+| +|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ 132 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG 132 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999985 99999875332 234999999999999999999999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=188.60 Aligned_cols=116 Identities=20% Similarity=0.313 Sum_probs=98.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCC----cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...+|.+.+.||+|+||.||+|.++.++ ..||||++... ...+.+|+.+++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 3446999999999999999999987553 35999998643 23467899999999999999999999 5
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN 167 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 55568999999996 999998752 357999999999999999999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=187.22 Aligned_cols=116 Identities=20% Similarity=0.231 Sum_probs=98.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|+++++||+|+||.||+|++. ++.||||++.... ....+|+.+++.++|||||++++++.... .....+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceE
Confidence 34467999999999999999999985 8999999996533 33456888999999999999999996533 224557
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
|+|||||+| +|.+++.. ..+++..++.++.||+.||.|||+.
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 899999986 99999974 4599999999999999999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=188.11 Aligned_cols=115 Identities=21% Similarity=0.381 Sum_probs=93.2
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEE----EEEEecc-----cchhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----AvK~i~~-----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...+|++.+.||+|+||.||+|++..+++.+ |+|.+.. ..+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES----
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----
Confidence 3457999999999999999999998887754 7777642 22467899999999999999999999842
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.. .++||||+.+ +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 89 -~~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ 137 (327)
T 3poz_A 89 -ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp -SS-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CC-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 22 6689999985 999988763 356999999999999999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-26 Score=205.18 Aligned_cols=116 Identities=23% Similarity=0.176 Sum_probs=89.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------hhHHHHHHHHHhCC---------CCceee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNIVA 139 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~Ei~~l~~l~---------hpnIv~ 139 (335)
.++|++++.||+|+||+||+|++ +|+.||||++.... +.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999998 68999999997532 55789999999886 555555
Q ss_pred ecee-----------------eeeCC--------CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHH
Q 019844 140 LKHC-----------------FFSTT--------DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQIC 193 (335)
Q Consensus 140 ~~~~-----------------~~~~~--------~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 193 (335)
++++ |.... -....++|||||||.| ++.+.+. .+.+++..++.|+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 5544 42200 0125669999999974 4444442 35689999999999999
Q ss_pred HHHHHHH-hCC
Q 019844 194 RALAYIH-NCI 203 (335)
Q Consensus 194 ~aL~yLH-~~~ 203 (335)
.||.||| +++
T Consensus 172 ~aL~~lH~~~~ 182 (336)
T 2vuw_A 172 ASLAVAEASLR 182 (336)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHhCC
Confidence 9999999 777
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=190.40 Aligned_cols=115 Identities=23% Similarity=0.293 Sum_probs=96.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcE----EEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...+|++++.||+|+||.||+|.+..+++. ||+|.+... ...+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~ 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-----P 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence 345699999999999999999999888876 677766422 24567899999999999999999988 3
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+ ..+++||||+.| +|.+++... .+.+++..++.|+.||+.||.|||+++
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 135 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG 135 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT
T ss_pred C-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 2 237899999995 999888752 356999999999999999999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=182.98 Aligned_cols=117 Identities=23% Similarity=0.375 Sum_probs=97.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
....|.+.++||+|+||.||+|.+..++. .||+|.+.... ..+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 94 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---- 94 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----
Confidence 34468899999999999999999765554 79999986422 4567999999999999999999999432
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||+++
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 2234799999985 99998875 2456899999999999999999999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=199.66 Aligned_cols=116 Identities=23% Similarity=0.269 Sum_probs=99.6
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|++.+.||+|+||.||+|.+.. +..||||++... .+.+.+|+.+|+.++|||||++++++. . ..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccc
Confidence 445679999999999999999999964 467999999753 356789999999999999999999983 2 337
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||||.| +|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ 383 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN 383 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899999986 9999997533 356999999999999999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=182.76 Aligned_cols=116 Identities=21% Similarity=0.235 Sum_probs=102.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+ +|+||+++++++ ....++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeE
Confidence 345699999999999999999999999999999998643 35688999999999 799999999998 5566689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 83 lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 126 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS 126 (298)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999966999999863 346999999999999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=182.57 Aligned_cols=116 Identities=28% Similarity=0.431 Sum_probs=97.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcC---CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
...++|.+.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence 344579999999999999999999754 3456999998753 345778999999999999999999982
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.. ..|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 133 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN 133 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 22 25799999996 999999763 356999999999999999999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=184.56 Aligned_cols=114 Identities=28% Similarity=0.332 Sum_probs=95.6
Q ss_pred eeeeEEee-eeeccCceEEEEEEEc--CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.++|.+.+ .||+|+||.||+|.++ .++..||||++... ...+.+|+.+++.++||||+++++++. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----AE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----CC
Confidence 34577776 9999999999999864 46788999999753 245779999999999999999999982 11
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++||||++| +|.+++.. ....+++..++.++.||+.||.|||+++
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 130 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 130 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 27899999996 99998864 1456999999999999999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=182.21 Aligned_cols=114 Identities=20% Similarity=0.259 Sum_probs=96.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHh--CCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~--l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|++++.||+|+||.||+|.+ +++.||||++.... ....+|.+++.. ++||||+++++++.... .....+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 3455799999999999999999988 68999999996543 445677787777 79999999999975432 345668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 200 (335)
|+||||++| +|.+++. ...+++..++.++.||+.||.|||
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHH
Confidence 899999996 9999985 457999999999999999999999
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=182.95 Aligned_cols=116 Identities=20% Similarity=0.257 Sum_probs=98.5
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|++++.||+|+||.||+|.+. ++..||+|.+... ...+.+|+.+++.++||||+++++++. .. .+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-Cc
Confidence 34467999999999999999999984 6778999999643 356789999999999999999999883 22 26
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||++| +|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 799999985 9999987532 236999999999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=185.12 Aligned_cols=114 Identities=21% Similarity=0.380 Sum_probs=96.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEE----EEEEecc-----cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----AvK~i~~-----~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
..+|++++.||+|+||.||+|.+..+++.+ |+|.+.. ....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 356999999999999999999998888765 6665532 23557899999999999999999999843
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.. .++||+|+.+ +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 137 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 22 6688999985 999988763 456999999999999999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=190.03 Aligned_cols=116 Identities=19% Similarity=0.254 Sum_probs=96.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC---cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence 346999999999999999999986433 46899988642 2457799999999999999999998742 23
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...|+||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 347899999996 999998742 356899999999999999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=188.32 Aligned_cols=116 Identities=15% Similarity=0.115 Sum_probs=97.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCC--------CcEEEEEEecccchhHHHHHHHHHhCCCCceeee------------
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL------------ 140 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~--------~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~------------ 140 (335)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+++.++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 35799999999999999999999874 889999999764 568899999999999999984
Q ss_pred ---ceeeeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 ---KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ---~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++. ....++|+||||+.|+|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 120 ~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ 179 (352)
T 2jii_A 120 PTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE 179 (352)
T ss_dssp CCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchhhccc----cCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 44442 1245689999999669999998632 367999999999999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=186.73 Aligned_cols=116 Identities=20% Similarity=0.192 Sum_probs=102.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...+|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.+ +||||+++++++ ....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCccE
Confidence 445699999999999999999999999999999998643 35688999999999 999999999999 4556689
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.|+|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999966999999863 357999999999999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=188.10 Aligned_cols=114 Identities=31% Similarity=0.467 Sum_probs=96.5
Q ss_pred eee-EEeeeeeccCceEEEEEEE----cCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSY-IAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y-~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+| ++++.||+|+||.||+|.. ..+++.||||++.... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AG 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CC
Confidence 345 9999999999999988764 4578899999997542 447799999999999999999999954 22
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++||||+++ +|.+++.. ..+++..++.++.||+.||.|||+++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~ 154 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH 154 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4568999999986 99998863 45999999999999999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=188.92 Aligned_cols=119 Identities=14% Similarity=0.180 Sum_probs=96.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCC-----CcEEEEEEecccchhHH---------------HHHHHHHhCCCCceeee
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVAL 140 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~~~~~---------------~Ei~~l~~l~hpnIv~~ 140 (335)
..+|++++.||+|+||.||+|.++.+ ++.||||++........ +|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34799999999999999999999764 57899999876543333 34455666789999999
Q ss_pred ceeeeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 141 ~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++++.... ....++|||||||.|+|.+++... .+.+++..++.|+.||+.||.|||+++
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99986532 235678999999966999999762 367999999999999999999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=186.56 Aligned_cols=118 Identities=31% Similarity=0.504 Sum_probs=99.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEE----EcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
...+|++++.||+|+||.||+|+ +..+++.||||++.... ..+.+|+.+++.++||||+++++++... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence 34569999999999999999999 46689999999996532 4577999999999999999999998432 2
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
...+++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ 165 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR 165 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3357899999986 999999862 346999999999999999999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=198.19 Aligned_cols=113 Identities=27% Similarity=0.308 Sum_probs=94.9
Q ss_pred eeeEEee-eeeccCceEEEEEEEc--CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
+++.+.+ .||+|+||.||+|.++ .++..||||+++.. ...+.+|+.+|+.++|||||++++++. . .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----~-~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A-E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----S-S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-----c-C
Confidence 3456665 8999999999999876 35667999999642 355789999999999999999999983 2 2
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|||||||+| +|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 38899999996 999988642 456999999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=177.92 Aligned_cols=118 Identities=22% Similarity=0.240 Sum_probs=97.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc--cchhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|++.+.||+|+||.||+|++..+++.||||++.. ....+.+|+.+++.++|++++..+..+. ....+.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCceE
Confidence 345679999999999999999999999999999998753 3356889999999999888777766664 3445688
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.|+|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp EEEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999977999998753 456999999999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-22 Score=177.73 Aligned_cols=118 Identities=22% Similarity=0.240 Sum_probs=100.7
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
...++|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.++|++++..+..+. ....+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 3445799999999999999999999999999999998643 356889999999999888777666654 3445688
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.++|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999977999999752 456999999999999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=182.59 Aligned_cols=111 Identities=29% Similarity=0.400 Sum_probs=94.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.++|++.+.||+|+||.||+|.+. ++.||||++... .+.+.+|+.+++.++||||+++++++ .+. +|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC-----LNP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBC-----TTT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cCC--cEEE
Confidence 346999999999999999999984 789999999653 35578999999999999999999988 332 6799
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 201 (335)
|||++| +|.+++.... ....+++..++.++.||+.||.|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHh
Confidence 999986 9999987522 12247899999999999999999999
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.9e-23 Score=197.15 Aligned_cols=110 Identities=22% Similarity=0.288 Sum_probs=93.6
Q ss_pred eEE-eeeeeccCceEEEEEEE--cCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 84 YIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 84 y~~-~~~lG~G~fg~V~~~~~--~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
+.+ .+.||+|+||.||+|.+ +.+++.||||+++.. ...+.+|+.+|+.++|||||++++++. .. .
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-S
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-C
Confidence 444 35899999999999955 456789999999643 245789999999999999999999882 22 2
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||||.| +|.+++.. ...+++..++.|+.||+.||.|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~ 489 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 489 (635)
T ss_dssp EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 7799999996 99999976 667999999999999999999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=187.76 Aligned_cols=118 Identities=17% Similarity=0.199 Sum_probs=94.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC---CCcEEEEEEecccc---------------hhHHHHHHHHHhCCCCceeeece
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKH 142 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~---------------~~~~~Ei~~l~~l~hpnIv~~~~ 142 (335)
.++|.+++.||+|+||.||+|.+.. ++..+|||++.... ..+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 78899999986532 22457788888999999999999
Q ss_pred eeeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 143 ~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++.... .+..++|+|||||.++|.+++.. .+.+++..++.|+.||+.||.|||+++
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 986532 23667999999996599998875 447999999999999999999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-22 Score=178.83 Aligned_cols=116 Identities=20% Similarity=0.267 Sum_probs=94.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHH--HHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~--l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++++.||+|+||.||+|++ +++.||||++.... .....|.++ +..++||||+++++.+..........+|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 345699999999999999999977 68999999996533 334445554 4458999999999876544445566789
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+|||||+| +|.+++.. ..+++..++.|+.||+.||.|||++
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhh
Confidence 99999985 99999974 4468999999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=180.23 Aligned_cols=114 Identities=25% Similarity=0.340 Sum_probs=89.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC-CCc--EEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~--~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
..+|++.+.||+|+||.||+|.+.. +++ .||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4579999999999999999998643 333 6899988642 2456799999999999999999999842
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.. +++||||+.+ +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 93 -~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 93 -PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp -SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 22 6799999995 999988763 356999999999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-23 Score=178.61 Aligned_cols=113 Identities=18% Similarity=0.238 Sum_probs=92.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
....+|++.+.||+|+||.||+|.+. ..||+|++... ...+.+|+.+++.++||||++++++. . .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-S
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-C
Confidence 34456999999999999999999874 35999998632 24577999999999999999999965 2 2
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++|||||+| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ 140 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS 140 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 236799999996 998888542 456999999999999999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=180.36 Aligned_cols=115 Identities=22% Similarity=0.273 Sum_probs=95.7
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhC--CCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l--~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|++++.||+|+||.||+|++. ++.||||++.... ....+|.+++..+ +||||+++++++.... .....+|
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 111 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLY 111 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceE
Confidence 3457999999999999999999985 8999999986443 3445666666655 8999999999986532 2235689
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+|||||+| +|.+++.. ..+++..++.++.||+.||.|||++
T Consensus 112 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~ 153 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTE 153 (337)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSC
T ss_pred EEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 99999986 99999964 4699999999999999999999988
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=200.90 Aligned_cols=118 Identities=24% Similarity=0.351 Sum_probs=98.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcC-CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++.+.||+|+||.||+|.++. +++.||||++.... ..+.+|+.+++.++|||||++++++.........
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34679999999999999999999976 78999999986422 3467899999999999999999999665443444
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+||||||++| +|.+++. ..+++..++.|+.||+.||.|||++|
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g 202 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG 202 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 57899999996 8887654 36999999999999999999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=177.87 Aligned_cols=112 Identities=21% Similarity=0.289 Sum_probs=95.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
|..++.||+|+||.||+|.+ +++.||||++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCce
Confidence 55679999999999999986 5889999998532 24577999999999999999999999 444558
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+||||++| +|.+++.... ....+++..++.++.||+.||.|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 153 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH 153 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999985 9999987533 2456999999999999999999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-22 Score=177.70 Aligned_cols=113 Identities=24% Similarity=0.262 Sum_probs=96.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHh--CCCCceeeeceeeeeCCCCCccEEE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~--l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..++|.+.+.||+|+||.||+|.+ +++.||||++... ...+.+|++++.. ++||||+++++++.... .....+|
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeE
Confidence 345799999999999999999998 4899999999654 3456789999988 68999999999985432 1223688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 200 (335)
+||||+++ +|.+++.. ..+++..++.++.||+.||.|||
T Consensus 117 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH 156 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLH 156 (342)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH
Confidence 99999996 99999974 46999999999999999999999
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-22 Score=192.89 Aligned_cols=116 Identities=26% Similarity=0.303 Sum_probs=98.0
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCC---CcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
....+|++++.||+|+||.||+|.++.+ +..||+|.+.... ..+.+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 3456799999999999999999998654 4579999886432 45779999999999999999999882
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+ ..+|+|||||+| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c-CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 2 227799999995 999998752 346999999999999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.6e-22 Score=184.50 Aligned_cols=117 Identities=20% Similarity=0.244 Sum_probs=98.2
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCC-ceeeeceeeeeCCCCCccEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hp-nIv~~~~~~~~~~~~~~~~~ 155 (335)
...++|+++++||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.|+|+ +|..+..++ ....+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~-----~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG-----VEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE-----EETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE-----eeCCEE
Confidence 3456799999999999999999999999999999988633 35688999999999874 455554444 345568
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||||+.++|.+++... ...+++..++.|+.||+.||.|||+++
T Consensus 79 ~lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g 123 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS 123 (483)
T ss_dssp EEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 899999977999999753 456999999999999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=183.33 Aligned_cols=204 Identities=18% Similarity=0.163 Sum_probs=130.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCC-Cceeeec-----------
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVALK----------- 141 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~h-pnIv~~~----------- 141 (335)
...|.+.+.||+|+||.||+|.+..+|+.||||++... .+.+.+|+.+++.+.| +|+..++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34599999999999999999999999999999998621 3457799999999977 3221111
Q ss_pred ----------eeeeeCCCCCccEEEEEeecchhhHHHHHHHHh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----
Q 019844 142 ----------HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS---RIHQRMPLIYVKLYTYQICRALAYIHNCI----- 203 (335)
Q Consensus 142 ----------~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----- 203 (335)
.++..........++++|+++.++|.+++.... .....+++..+..|+.||+.||+|||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111110011123478999999999999886432 12345788889999999999999999998
Q ss_pred -------cCh--HHhH-------------hhhcC--CCCHHHhhhhC------C--CCC------------------CCC
Q 019844 204 -------VDQ--LVEI-------------IKVLG--TPTREEIKCMN------P--NYT------------------EFK 233 (335)
Q Consensus 204 -------~~~--~~~~-------------~~~~g--~~~~~~~~~~~------~--~~~------------------~~~ 233 (335)
++. ..++ ...+| ...++.+.... . .|. ...
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 000 0000 01122 11233331110 0 000 000
Q ss_pred CCCC-CCCcccccc--ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 234 FPQI-KPHPWHKVF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 234 ~~~~-~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+... ....+...+ ...+++++.+||.+||+.||++|||+.++|+||||+++
T Consensus 317 f~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 317 NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp CCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 0000 001111112 24689999999999999999999999999999999775
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=178.02 Aligned_cols=113 Identities=17% Similarity=0.259 Sum_probs=96.3
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
..++|++.+.||+|+||.||+|.+.. .+|+|++... .+.+.+|+.+++.++||||+++++++. ...
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 34569999999999999999999853 4999998632 245678999999999999999999994 444
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+++||||++| +|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG 150 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 58999999985 999988641 346999999999999999999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-21 Score=173.75 Aligned_cols=119 Identities=17% Similarity=0.172 Sum_probs=99.4
Q ss_pred ceeeeEEeeeeeccCceEEEEE-----EEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC---CCceeeeceeeeeCCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDK 150 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~-----~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~ 150 (335)
...+|.+.+.||+|+||.||+| .+..+++.||||++... ...+.+|+.+++.++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~----- 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL----- 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-----
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee-----
Confidence 3457999999999999999999 46778999999999754 356778999999997 899999999994
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....|||||||+| +|.+++..... ....+++..++.|+.||+.||+|||+++
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ 192 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 44458899999995 99999986543 2457999999999999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=137.70 Aligned_cols=104 Identities=14% Similarity=-0.011 Sum_probs=81.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeccc--------------chhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCc
Q 019844 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------------~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++.|++|.+..++..-.|+.||||++.+. .+.+.+|+++|+++ .|+||+++++++ ++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence 3467788888888887778999999999643 13477999999999 799999999999 667
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|||||||+| +|.++|.. .+.+++. .|+.||+.||+|||++|
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G 359 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG 359 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC
Confidence 779999999998 99999986 5677764 48999999999999999
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-14 Score=123.15 Aligned_cols=99 Identities=15% Similarity=0.083 Sum_probs=78.9
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------------------chhHHHHHHHHHhCCCCceeeec
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------------------KRYKNRELQIMQMLDHPNIVALK 141 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------------------~~~~~~Ei~~l~~l~hpnIv~~~ 141 (335)
|.+++.||+|+||.||+|.+ .+|+.||||+++.. ...+.+|+.+|+.++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55669999999999999999 88999999999632 124679999999999 5 7777
Q ss_pred eeeeeCCCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 142 ~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+++. . ...|+|||||+| +|.+ + ....+..++.||+.||.|||++|
T Consensus 168 ~~~~-----~-~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~g 213 (282)
T 1zar_A 168 KVYA-----W-EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHRG 213 (282)
T ss_dssp CEEE-----E-ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHTT
T ss_pred eEEe-----c-cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHCC
Confidence 7652 1 225799999986 8866 2 12335679999999999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=8.6e-14 Score=131.81 Aligned_cols=100 Identities=17% Similarity=0.213 Sum_probs=72.0
Q ss_pred EEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 85 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
...+.||+|+||.||+|. ..++.+|+|++... .+.+.+|+.+|+.++||||+++..++.. .+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD---LDN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE---TTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe---CCc
Confidence 456799999999999994 45788999986421 1336799999999999999955444432 222
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.|||||||+| +|.+++.. +..|+.||+.||.|||+++
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g 451 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND 451 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc
Confidence 5799999985 99888753 5689999999999999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=115.33 Aligned_cols=105 Identities=15% Similarity=0.170 Sum_probs=79.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcE--EEEEEecccc----------------------------hhHHHHHHHHHhC
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML 132 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~~~----------------------------~~~~~Ei~~l~~l 132 (335)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++... ..+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999999778999 9999874321 1467899999999
Q ss_pred CCCce--eeeceeeeeCCCCCccEEEEEeecch--h----hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q 019844 133 DHPNI--VALKHCFFSTTDKEELYLNLVLEYVP--E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCI 203 (335)
Q Consensus 133 ~hpnI--v~~~~~~~~~~~~~~~~~~iv~e~~~--g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ 203 (335)
.|++| ..++++. ..+|||||++ | +|.++... +++..+..++.||+.||.||| +.|
T Consensus 128 ~~~~i~~p~~~~~~---------~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTYM---------KNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHTTCCCCCEEEEE---------TTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HhCCCCCCeEEEcC---------CCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 88764 2333221 1569999995 3 56554321 335568899999999999999 887
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.22 E-value=7.5e-12 Score=112.35 Aligned_cols=108 Identities=10% Similarity=0.058 Sum_probs=68.5
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------------------hhHHHHHHHHHhCCCCceeeeceeee
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHPNIVALKHCFF 145 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------~~~~~Ei~~l~~l~hpnIv~~~~~~~ 145 (335)
|.++..||.|+||.||+|.+ .+|+.||||+++... .....++.+.....|+|++++++...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 479999999875211 00112222222223444443333221
Q ss_pred eCCC--CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 146 STTD--KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 146 ~~~~--~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.... .... .+|||||++| .|.++ .....+..++.||+.||.|||.+|
T Consensus 176 ~vp~p~~~~~-~~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~g 225 (397)
T 4gyi_A 176 PVPEPIAQSR-HTIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKHG 225 (397)
T ss_dssp SCCCEEEEET-TEEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeeeeccC-ceEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHCC
Confidence 1000 0001 2599999998 76432 223346778999999999999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=7.2e-07 Score=76.09 Aligned_cols=106 Identities=12% Similarity=0.022 Sum_probs=82.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc----cchhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..|.+...+|.|+++.||++... +..+++|+... ....+.+|+.+++.+. +..+.++++++ ......|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCceE
Confidence 34888999999999999999853 68899999863 3346889999999994 67788888887 3445688
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| +|.+.+ .+......++.++..+|..||+..
T Consensus 87 lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~ 125 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSID 125 (263)
T ss_dssp EEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSC
T ss_pred EEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCC
Confidence 99999998 876542 112234578899999999999843
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=2.7e-05 Score=65.87 Aligned_cols=102 Identities=16% Similarity=0.071 Sum_probs=71.7
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCCCCc--eeeeceeeeeCCCCCccEEEEEee
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE 160 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~iv~e 160 (335)
|.+....+.|..+.||++.. .+|..+++|+.... ...+.+|+.+++.+.+.+ +.+++.+. ......++|||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~~v~e 95 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLG 95 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEE
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCEEEEE
Confidence 55544445667799999965 56778999987543 245779999999995444 45677776 33344789999
Q ss_pred cchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 161 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|++| +|. .. ... ...++.++...|..||...
T Consensus 96 ~i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 96 EVPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp CCSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSC
T ss_pred ecCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCC
Confidence 9998 662 11 112 2367889999999999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.85 E-value=2.3e-05 Score=69.93 Aligned_cols=108 Identities=12% Similarity=0.077 Sum_probs=77.2
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEec--c-----cchhHHHHHHHHHhCC--CCceeeeceeeeeCCCCCccEEE
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--Q-----DKRYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~--~-----~~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
..+.|+.|.++.||++... +..+++|+.. . ....+.+|+.+++.|. +..+.+++.++... ......|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 3677899999999999864 4678889776 2 2346789999999996 45577887776322 1113467
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| .+.+. ....++..+...++.+++.+|..||...
T Consensus 118 ~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~ 159 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVD 159 (359)
T ss_dssp EEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred EEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 99999998 55321 1234778888999999999999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0013 Score=57.06 Aligned_cols=104 Identities=10% Similarity=0.070 Sum_probs=71.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCC-CCc--eeeeceeeeeCCCCCccEEEEEeec
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPN--IVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~-hpn--Iv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
.+.++.|....||++. ..+++|..... ...+.+|+.+|+.+. +.. +.+++.... ........|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceEEEcc
Confidence 4558999999999863 46888976543 356789999998883 333 233333221 11111234689999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++| .|..... ..++..+...++.|++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~ 134 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSIN 134 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 998 7654322 24788889999999999999999765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0053 Score=53.29 Aligned_cols=103 Identities=12% Similarity=-0.010 Sum_probs=73.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCC---ceeeeceeeeeCCCCCccEEEEEeec
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hp---nIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
.+.++.|....||+. +..+++|+-... ...+.+|..+|+.|.+. .|.+++.+.. ......++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 456788998899988 567888875432 24577999999999642 2344444432 122345699999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV 204 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~ 204 (335)
++| .|.... -..++..+...++.++...|..||+...
T Consensus 95 i~G~~l~~~~------~~~l~~~~~~~~~~~lg~~La~LH~~~~ 132 (306)
T 3tdw_A 95 VQGQILGEDG------MAVLPDDAKDRLALQLAEFMNELSAFPV 132 (306)
T ss_dssp CCSEECHHHH------HTTSCHHHHHHHHHHHHHHHHHHHHSCH
T ss_pred cCCeECchhh------hhhCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 998 775532 2346888888999999999999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.004 Score=52.75 Aligned_cols=101 Identities=12% Similarity=0.072 Sum_probs=71.1
Q ss_pred eeccCce-EEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEEEeecchh-h
Q 019844 90 VGTGSFG-VVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-T 165 (335)
Q Consensus 90 lG~G~fg-~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~ 165 (335)
+..|..| .||+......+..+.+|+-+.. ...+.+|...|+.|. +--|.+++.+. .+....|+|||+++| +
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCcc
Confidence 4445544 6999888777888999987543 345778999998884 33355666666 333457899999998 7
Q ss_pred HHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 166 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+.+.... .......+..++...|.-||...
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSC
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCC
Confidence 7766543 12234567889999999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0096 Score=53.60 Aligned_cols=98 Identities=14% Similarity=0.069 Sum_probs=60.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----------chhHHHHHHHHHhCCC--Cc-eeeeceeeeeCCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PN-IVALKHCFFSTTDKEE 152 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----------~~~~~~Ei~~l~~l~h--pn-Iv~~~~~~~~~~~~~~ 152 (335)
.+.||.|.++.||++....+++.++||..... .....+|..+|+.+.. +. +.+++.+. ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-----~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-----CCc
Confidence 56799999999999987656788999976421 2345789999988732 33 33554432 222
Q ss_pred cEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019844 153 LYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (335)
Q Consensus 153 ~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 200 (335)
.++|||+++| .+...+.. . .... ..+.++...|.-+|
T Consensus 110 --~~lvmE~l~g~~~~~~~l~~----~-~~~~----~~~~~l~~~La~lH 148 (397)
T 2olc_A 110 --AVTVMEDLSHLKIARKGLIE----G-ENYP----HLSQHIGEFLGKTL 148 (397)
T ss_dssp --TEEEECCCTTSEEHHHHHHT----T-CCCT----THHHHHHHHHHHHH
T ss_pred --cEEEEEeCCCcchHHHHHhc----C-CcCH----HHHHHHHHHHHHHh
Confidence 3599999987 44333321 1 1121 23567777777788
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.028 Score=49.64 Aligned_cols=118 Identities=10% Similarity=0.054 Sum_probs=75.2
Q ss_pred eEEeeee-eccCceEEEEEEEc--C----CCcEEEEEEecccc-------hhHHHHHHHHHhCC-C--Cceeeeceeeee
Q 019844 84 YIAEHVV-GTGSFGVVFQAKCR--E----TGEIVAIKKVLQDK-------RYKNRELQIMQMLD-H--PNIVALKHCFFS 146 (335)
Q Consensus 84 y~~~~~l-G~G~fg~V~~~~~~--~----~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~-h--pnIv~~~~~~~~ 146 (335)
....+.| +.|..+.+|++... . ++..+++|...... ..+.+|+.+++.|. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88989999988753 0 25678999765432 45779999999884 3 345666666521
Q ss_pred CCCCCccEEEEEeecchh-hHHHHHHHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 147 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. ......|+||||++| .+.+.+..... ....++..+...++.++...|.-||+..
T Consensus 102 ~--~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~ 159 (357)
T 3ats_A 102 G--DVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIP 159 (357)
T ss_dssp S--TTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred C--CccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 1 111234689999998 55322100000 0013566667788999999999999865
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.071 Score=46.26 Aligned_cols=94 Identities=12% Similarity=0.029 Sum_probs=68.1
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC---CCceeeeceeeeeCCCCCccEEEEEeec
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
-.+.|+.|.+..+|+... ++..+++|+-... ...+.+|...|+.|. ...|.+++.+. ......++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEEEEEe
Confidence 357789999999999985 4678889987543 345778999998883 35567777765 223457899999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV 204 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~ 204 (335)
++| .+ +. ..+.++..+|.-||....
T Consensus 113 l~G~~~--------------~~----~~~~~lG~~LA~LH~~~~ 138 (312)
T 3jr1_A 113 LNKSKN--------------KQ----SSFTIFAEKIAQLHQIQG 138 (312)
T ss_dssp CCCCCC--------------CT----THHHHHHHHHHHHHHCCC
T ss_pred ccCCCC--------------Cc----hhHHHHHHHHHHHHcCCC
Confidence 997 32 11 235688889999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.62 Score=39.50 Aligned_cols=93 Identities=15% Similarity=0.078 Sum_probs=62.8
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----hhHHHHHHHHHhCCCC---ceeeeceeeeeCCCCCccEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~Ei~~l~~l~hp---nIv~~~~~~~~~~~~~~~~~~ 156 (335)
..-.+.+|.|..+.||++.. .+|+.|.+|+-+... ..+.+|...|+.|... -+.+++.+- . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ce
Confidence 56678899999999999987 578999999865322 3467899999988422 233444332 1 24
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||+.+. ..+... ..++...|.-||...
T Consensus 87 lv~e~l~~~-------------~~~~~~----~~~lg~~La~lH~~~ 116 (288)
T 3f7w_A 87 LAMEWVDER-------------PPTPEA----AERFGHQLAAMHLAG 116 (288)
T ss_dssp EEEECCCCC-------------CCCHHH----HHHHHHHHHHHHHTC
T ss_pred EEEEeeccc-------------CCChHH----HHHHHHHHHhhhhcc
Confidence 899998841 122222 345667788889765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.48 Score=43.37 Aligned_cols=99 Identities=14% Similarity=0.193 Sum_probs=65.0
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhH---HHHHHHHHhCCCCce-eeeceeeeeCCCCCccEEEEEeec
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLNLVLEY 161 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~---~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~iv~e~ 161 (335)
-.+.|+.|-...+|++.....+..+++|+.......+ .+|..+++.|...++ .++++++ .+. +||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~G----~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TNG----RIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TTE----EEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CCe----EEEEe
Confidence 3567888888999999875445789999775433222 589999999965444 4666665 321 59999
Q ss_pred chh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcC
Q 019844 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIVD 205 (335)
Q Consensus 162 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~ 205 (335)
++| .|. ...+.. ..++.+|+..|.-||.....
T Consensus 183 I~G~~l~---------~~~l~~---~~~~~~ia~~La~LH~~~~~ 215 (458)
T 2qg7_A 183 MDGYALS---------REDIKN---PKFQKLIAKNLKLLHDIKLN 215 (458)
T ss_dssp CCSEECC---------TTTTTS---HHHHHHHHHHHHHHHTCCCC
T ss_pred eCCccCC---------hhhcCC---HHHHHHHHHHHHHHhcCCcc
Confidence 998 542 111211 24578889999999987644
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=92.18 E-value=0.57 Score=42.50 Aligned_cols=96 Identities=16% Similarity=0.252 Sum_probs=65.2
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEecc-cc-hhHHHHHHHHHhCCCCce-eeeceeeeeCCCCCccEEE
Q 019844 87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~-~~-~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~ 156 (335)
.+.|+.|-...||++.... .++.+++|+... .. ..+.+|..+++.|...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 5678888889999998642 257899998744 33 556689999988843333 5666655 32 2
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| .|.. ..+. -..++.+|+..|.-||...
T Consensus 149 ~v~e~l~G~~l~~---------~~l~---~~~~~~~ia~~La~LH~~~ 184 (429)
T 1nw1_A 149 RLEEYIPSRPLSC---------HEIS---LAHMSTKIAKRVAKVHQLE 184 (429)
T ss_dssp EEECCCCEEECCT---------TGGG---SHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEeCCcccCh---------hhcC---CHHHHHHHHHHHHHHhCCc
Confidence 89999998 5421 0011 1235788999999999865
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.4 Score=41.52 Aligned_cols=98 Identities=13% Similarity=0.164 Sum_probs=54.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCC--CceeeeceeeeeCC--CCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--PNIVALKHCFFSTT--DKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~--~~~~~~~~iv~e~~ 162 (335)
.+.|+.|..+.||++... +..+++|+.......+..|+.+++.|.. -.|.+++... ... .......++||+|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~-~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNK-KGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCT-TSCSCEEETTEEEEEEECC
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecC-CCCEEEEECCEEEEEEEee
Confidence 455677788899999863 3459999987655555567777776631 1233333210 000 01233478999999
Q ss_pred hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 163 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+| .+. ..+. ..+.++...|.-||..
T Consensus 114 ~G~~~~-----------~~~~----~~~~~~g~~La~lH~~ 139 (346)
T 2q83_A 114 EGRPFE-----------LTVK----QDLEFIMKGLADFHTA 139 (346)
T ss_dssp CCBCCC-----------TTSH----HHHHHHHHHHHHHHHH
T ss_pred cCccCC-----------CCCH----HHHHHHHHHHHHHHHh
Confidence 98 431 0111 1246777777778853
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=91.61 E-value=0.97 Score=39.13 Aligned_cols=100 Identities=9% Similarity=0.019 Sum_probs=57.6
Q ss_pred eeeeccCceE-EEEEEEcCCCcEEEEEEecccc-hhHHHHHHHHHhCCC--CceeeeceeeeeCCCCCccEEEEEeecch
Q 019844 88 HVVGTGSFGV-VFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEYVP 163 (335)
Q Consensus 88 ~~lG~G~fg~-V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~iv~e~~~ 163 (335)
+.|+.|+... +|+... .++..+++|...... ..+..|+.+++.|.. -.+.+++.+. .... +++||+++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d-----~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE-----HARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE-----TTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec-----CCCC--EEEEeeCC
Confidence 4455554444 556653 236677788665443 567788988888742 2244555442 2223 47999998
Q ss_pred h-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 164 E-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 164 g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
| .+.+.+.. ....+ ...+.++...|.-||...
T Consensus 96 ~~~l~~~l~~-----~~~~~---~~~~~~~~~~La~lH~~~ 128 (333)
T 3csv_A 96 DALFTEVINN-----DPAQE---MPLYRAAVDLLIHLHDAQ 128 (333)
T ss_dssp SCBHHHHHHH-----CGGGH---HHHHHHHHHHHHHHHTSC
T ss_pred CcchHHHhcC-----CCccH---HHHHHHHHHHHHHHhcCC
Confidence 7 77776653 11211 456788999999999765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.18 E-value=0.82 Score=37.18 Aligned_cols=32 Identities=25% Similarity=0.309 Sum_probs=28.5
Q ss_pred hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 019844 165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199 (335)
Q Consensus 165 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yL 199 (335)
+|.++|..+ +.+++|.++|.++.|.+.+|.-+
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~ 65 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAA 65 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhh
Confidence 799999874 67899999999999999998776
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.31 E-value=0.023 Score=52.31 Aligned_cols=56 Identities=13% Similarity=0.033 Sum_probs=17.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEE------EEeccc------chhHHHHHHHHHhCCCCceeeeceeee
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAI------KKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFF 145 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAv------K~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 145 (335)
.+.|| ||.||++........||+ |..... ...+.+|..+++.++|||+++.+.+-.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45666 999999998765567888 655321 134567888999999999999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=88.54 E-value=1.4 Score=37.51 Aligned_cols=93 Identities=12% Similarity=0.026 Sum_probs=57.4
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecccch---hHHHHHHHHHhCCCCce-eeeceeeeeCCCCCccEEEEEeecc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLNLVLEYV 162 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~iv~e~~ 162 (335)
.+.|+.|....+|++ ..+++|+...... ...+|+.+++.+...++ .+++.+. .+.. ++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence 677889999999999 4588887754321 23578888877742222 3444433 2222 3899999
Q ss_pred -hh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 163 -PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 163 -~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+| +|...... . ...++.+++..|.-||...
T Consensus 90 ~~g~~l~~~~~~----~-------~~~~~~~~~~~La~lH~~~ 121 (301)
T 3dxq_A 90 AGAQTMSPEKFK----T-------RPGSPARAGEAFRKLHGSG 121 (301)
T ss_dssp TTCEECCHHHHH----H-------STTHHHHHHHHHHHHHTSC
T ss_pred CCCccCCHhhHh----h-------hHHHHHHHHHHHHHHhCCC
Confidence 76 44221100 0 0135778889999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=88.36 E-value=2.7 Score=37.72 Aligned_cols=99 Identities=14% Similarity=0.169 Sum_probs=59.3
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEec-------cc-c---hhHHHHHHHHHhC---CCCceeeeceeeeeCCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QD-K---RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~-------~~-~---~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+.||.|..+.||++.. +++.++||... .. . .....|.+++..+ ....+.+++.+. ..
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~-----~~- 110 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD-----RT- 110 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE-----TT-
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CC-
Confidence 56789999999999964 56789999421 11 1 2233454444433 234455666554 21
Q ss_pred cEEEEEeecc-hh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYV-PE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~-~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|||++ +| .+...+.. ....+ ..+.++...|.-||...
T Consensus 111 -~~~lv~e~l~~g~~~l~~~l~~----~~~~~-----~~~~~lg~~La~lH~~~ 154 (420)
T 2pyw_A 111 -MALIGMRYLEPPHIILRKGLIA----GIEYP-----FLADHMSDYMAKTLFFT 154 (420)
T ss_dssp -TTEEEECCCCTTCEEHHHHHHH----TCCCT-----THHHHHHHHHHHHHHTT
T ss_pred -ccEEEEeecCCcchhHHHHHhc----CCCCH-----HHHHHHHHHHHHHHHhc
Confidence 246999999 86 45444432 11111 24677888888889665
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.64 E-value=0.98 Score=40.20 Aligned_cols=96 Identities=16% Similarity=0.149 Sum_probs=58.2
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEecc---cchhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEE
Q 019844 87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~---~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.+.|..|-...+|++.... .++.|++|+... ......+|..+++.|. +.-..++++++ .+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g--- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG--- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc---
Confidence 3456667777889988642 357899987633 2234568999998884 32235566655 332
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+||||++| .|.. ..+.. ..+..+|+..|.-||...
T Consensus 127 -~v~e~i~G~~l~~---------~~l~~---p~~~~~ia~~La~LH~~~ 162 (379)
T 3feg_A 127 -RLEQYIPSRPLKT---------QELRE---PVLSAAIATKMAQFHGME 162 (379)
T ss_dssp -EEEECCSEEECCG---------GGGGC---HHHHHHHHHHHHHHHTCC
T ss_pred -cEEEEecCccCCh---------hHhCC---HHHHHHHHHHHHHHhCCC
Confidence 89999998 5421 11111 245678999999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=85.46 E-value=4.5 Score=34.49 Aligned_cols=99 Identities=11% Similarity=-0.017 Sum_probs=57.8
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEecc--cchhHHHHHHHHHhCCCCc--eeeeceeeeeCCC--CCccEEEEEe
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVL 159 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~Ei~~l~~l~hpn--Iv~~~~~~~~~~~--~~~~~~~iv~ 159 (335)
-.+.|+.|....+|++... .| .+++|.... ....+..|+.++..|...+ +.+++... .... ......+++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEE
Confidence 4567888888999999863 33 688998865 3456778999888874222 23333211 0000 0123467999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
+|++| .+. . .+ ...+.++...|.-||..
T Consensus 103 ~~l~G~~~~----------~-~~----~~~~~~~g~~La~lH~~ 131 (322)
T 2ppq_A 103 SFLEGMWLR----------K-PE----AKHCREVGKALAAMHLA 131 (322)
T ss_dssp ECCCCBCCS----------S-CC----HHHHHHHHHHHHHHHHH
T ss_pred EeCCCcCCC----------C-CC----HHHHHHHHHHHHHHHHH
Confidence 99998 331 1 12 23456778888888864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=84.31 E-value=2.3 Score=37.32 Aligned_cols=95 Identities=12% Similarity=0.099 Sum_probs=56.3
Q ss_pred eeeeeccCceEEEEEEEcC--------CCcEEEEEEecccchh---HHHHHHHHHhCCCCc-eeeeceeeeeCCCCCccE
Q 019844 87 EHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKRY---KNRELQIMQMLDHPN-IVALKHCFFSTTDKEELY 154 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~--------~~~~vAvK~i~~~~~~---~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~~~~~~ 154 (335)
.+.|+.|....+|++.... .+..+++|+....... ...|..+++.|...+ +.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~--- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG--- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence 4567888888999998643 1367888877543322 357888888884333 34565544 21
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
++||||++| .+... .+.. ...+.+++..|.-||..
T Consensus 110 -~~v~e~i~G~~l~~~---------~~~~---~~~~~~~a~~La~lH~~ 145 (369)
T 3c5i_A 110 -GRIEEWLYGDPLRID---------DLKN---PTILIGIANVLGKFHTL 145 (369)
T ss_dssp -EEEEECCCSEECCGG---------GGGC---HHHHHHHHHHHHHHHTH
T ss_pred -cEEEEEecCCcCChh---------hcCC---hHHHHHHHHHHHHHHcC
Confidence 489999998 43110 0110 23467888888888863
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=80.50 E-value=6 Score=35.64 Aligned_cols=96 Identities=10% Similarity=0.132 Sum_probs=59.8
Q ss_pred eeeeeccCceEEEEEEEcCC-------CcEEEEEEecccchh---HHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEE
Q 019844 87 EHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRY---KNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~-------~~~vAvK~i~~~~~~---~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.+.|..|-...+|++..... ++.|++++....... ..+|..+++.|. +.-..++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~---- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE---- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence 55677788889999987421 578999876543222 358999988884 32234555544 21
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||||++| .|.. ..+.. ..++.+|+..|.-||+..
T Consensus 146 ~~I~efI~G~~l~~---------~~l~~---~~~~~~ia~~La~LH~~~ 182 (424)
T 3mes_A 146 GRIEEFIDGEPLTT---------KQLQL---THICVEVAKNMGSLHIIN 182 (424)
T ss_dssp EEEEECCCSEECCT---------GGGGS---HHHHHHHHHHHHHHHTHH
T ss_pred CEEEEEeCCccCCh---------hhcCC---HHHHHHHHHHHHHHhcCc
Confidence 479999998 4310 01111 235678888888888643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=80.05 E-value=2.8 Score=36.46 Aligned_cols=96 Identities=18% Similarity=0.208 Sum_probs=58.4
Q ss_pred eccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCC---CceeeeceeeeeCC--CCCccEEEEEeecchh-
Q 019844 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH---PNIVALKHCFFSTT--DKEELYLNLVLEYVPE- 164 (335)
Q Consensus 91 G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~h---pnIv~~~~~~~~~~--~~~~~~~~iv~e~~~g- 164 (335)
|.|....||++.. ..| .+++|+..... ..+|+.+++.|.. |+|.+.+... ... .......++||+|++|
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~-~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTL-EAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCT-TSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecC-CCCEEEEECCEEEEEEeccCCC
Confidence 3344678999985 345 89999776533 3578888877732 3244444321 000 0123557899999998
Q ss_pred hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019844 165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV 204 (335)
Q Consensus 165 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~ 204 (335)
.+. ...++... +.++...|.-||....
T Consensus 107 ~~~---------~~~~~~~~----~~~lg~~La~LH~~~~ 133 (339)
T 3i1a_A 107 NGF---------TQNLTGKQ----WKQLGKVLRQIHETSV 133 (339)
T ss_dssp BTT---------TSCCCHHH----HHHHHHHHHHHHTCCC
T ss_pred cCc---------ccCCCHHH----HHHHHHHHHHHhCcCC
Confidence 441 12344433 4678888999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 335 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-05 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-23 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-06 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-23 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-06 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-05 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-22 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-22 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-06 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-21 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-21 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-04 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-13 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-10 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-20 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-20 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-04 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-14 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-10 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-13 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-05 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-05 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-16 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-11 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-16 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-16 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-15 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-13 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-15 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-14 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-14 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-13 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-13 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-12 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-12 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-12 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 0.002 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-12 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-12 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-08 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 84/122 (68%), Positives = 91/122 (74%), Gaps = 1/122 (0%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 263
VDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288
Query: 264 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 323
Y+P R T LEAC H FFDELRDPN +LPNGR P LFNF ELS PP LIP H
Sbjct: 289 YTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLA-TILIPPH 347
Query: 324 AR 325
AR
Sbjct: 348 AR 349
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-38
Identities = 82/130 (63%), Positives = 106/130 (81%), Gaps = 1/130 (0%)
Query: 73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
G+ + Q+VSY V+G GSFGVV+QAK ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
DH NIV L++ F+S+ K+E+YLNLVL+YVPETV R+AR+YSR Q +P+IYVKLY YQ
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHN 201
+ R+LAYIH+
Sbjct: 131 LFRSLAYIHS 140
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 6e-28
Identities = 48/273 (17%), Positives = 84/273 (30%), Gaps = 72/273 (26%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ + C+ + + LV+EY + + + + + T+ + L
Sbjct: 77 TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 197 AYIH------------NCIVD--------------QLVEIIKVLGTP---TREEIKCMNP 227
AY+H N ++ + +GTP E I M+
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDE 188
Query: 228 NYTEFK----------------------------FPQIKPHPWHKVFQKRLPPEAVDLVC 259
+ K I + + + V
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 260 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 292
Q P R T+ H F R P +
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 1e-24
Identities = 46/260 (17%), Positives = 90/260 (34%), Gaps = 69/260 (26%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+ +G GSF V++ ET VA ++ K K+ E ++++ L HPNIV
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + +T K + + LV E + + + Y + + M + ++ + QI + L ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 201 --------------NCIVDQLVEIIK-----------------VLGTP------------ 217
N + +K V+GTP
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY 189
Query: 218 -----------TREEIKCMNPNYTEFKFP-----QIKPHPWHKVFQKRLPPEAVDLVCRF 261
E+ Y+E + ++ F K PE +++
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249
Query: 262 FQYSPNLRCTALEACVHPFF 281
+ + + R + + H FF
Sbjct: 250 IRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 2e-24
Identities = 46/247 (18%), Positives = 80/247 (32%), Gaps = 23/247 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ + P+IV +
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + + L +V+E + E +RI R Q I A+ Y+H
Sbjct: 73 VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 201 NCIV---DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 257
+ + D E + +K + + + + PE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPE---- 183
Query: 258 VCRFFQYSP-----NLRCTALEACV--HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 310
V +Y +L PF+ + R + F PE S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 311 IPPETIN 317
+ E
Sbjct: 244 VSEEVKM 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (103), Expect = 1e-05
Identities = 15/86 (17%), Positives = 26/86 (30%), Gaps = 1/86 (1%)
Query: 215 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 274
G P + + ++ + + + E L+ + P R T E
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268
Query: 275 ACVHPFF-DELRDPNTRLPNGRPLPP 299
HP+ + P T L R L
Sbjct: 269 FMNHPWIMQSTKVPQTPLHTSRVLKE 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 95.5 bits (237), Expect = 6e-23
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 11/122 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
Y +GTG+FGVV + R TG A K V+ DK +E+Q M +L HP +V
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F D E+ ++ E++ + + H +M Y Q+C+ L ++
Sbjct: 88 LHDAF---EDDNEMV--MIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 200 HN 201
H
Sbjct: 141 HE 142
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 45.8 bits (108), Expect = 3e-06
Identities = 11/53 (20%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 248 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNGRPLP 298
+ + D + + PN R T +A HP+ P ++++P+ R
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 6e-23
Identities = 23/123 (18%), Positives = 49/123 (39%), Gaps = 13/123 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G+ GVVF+ + +G ++A K + + + RELQ++ + P IV
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F E+ + +E++ + R+P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEIS--ICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 199 IHN 201
+
Sbjct: 120 LRE 122
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (110), Expect = 2e-06
Identities = 15/91 (16%), Positives = 24/91 (26%), Gaps = 14/91 (15%)
Query: 205 DQLVEIIKVLGTPTREEIKCMNPNYTEFKF--------------PQIKPHPWHKVFQKRL 250
+L+ +V G + P + I P K+
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
Query: 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281
E D V + +P R + VH F
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 94.7 bits (235), Expect = 1e-22
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 15/120 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
+G+G+FGVV + + TG + K + DK E+ IM L HP ++ L F
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
DK E+ L+LE++ E +RIA +M V Y Q C L ++H
Sbjct: 96 ---EDKYEMV--LILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 42.0 bits (98), Expect = 6e-05
Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 1/91 (1%)
Query: 239 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPL 297
+ + + PEA D + Q P R T +A HP+ + + +R+P+ R
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 303
Query: 298 PPLFNFKPPELSGIPPETINRLIPEHARKQN 328
K P+ I + +
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (231), Expect = 1e-22
Identities = 28/124 (22%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y + +GTGS+G + + + G+I+ K++ +K+ E+ +++ L HPNI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V T+ L +V+EY + + ++ Q + +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 197 AYIH 200
H
Sbjct: 123 KECH 126
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 1e-22
Identities = 50/266 (18%), Positives = 87/266 (32%), Gaps = 75/266 (28%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 140
Y+ +G G FG+V + + + K V D+ +E+ I+ + H NI+ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F EEL ++ E++ + RI + +++R + Y +Q+C AL +
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 199 IH------------NCIVDQL----VEII-----KVLGTPTREEIKCMNPNYTEFKFPQI 237
+H N I ++II + L + P Y + Q
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 238 KP---------------------HPW---------HKVFQKRLPP----------EAVDL 257
+P+ + EA+D
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 258 VCRFFQYSPNLRCTALEACVHPFFDE 283
V R R TA EA HP+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (230), Expect = 2e-22
Identities = 50/259 (19%), Positives = 86/259 (33%), Gaps = 69/259 (26%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G G FG V+ A+ +++ I+A+K + + + K RE++I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ L F D +Y L+LEY P + + Y ++ AL
Sbjct: 68 ILRLYGYF---HDATRVY--LILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119
Query: 197 AYIH------------NCIVDQLVEI------IKVLGTPTREEIKCMNPNYT-------- 230
+Y H N ++ E+ V +R C +Y
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 231 ---------------------EFKFPQIKPHPWHK-------VFQKRLPPEAVDLVCRFF 262
+ F +K F + A DL+ R
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 263 QYSPNLRCTALEACVHPFF 281
+++P+ R E HP+
Sbjct: 240 KHNPSQRPMLREVLEHPWI 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.0 bits (228), Expect = 3e-22
Identities = 28/126 (22%), Positives = 47/126 (37%), Gaps = 13/126 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K V + +E+ I +ML+H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L LEY + MP + + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 199 IHNCIV 204
+H +
Sbjct: 119 LHGIGI 124
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 5e-06
Identities = 10/69 (14%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 215 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 274
G ++ Y+++K + +PW K+ + L+ + +P+ R T +
Sbjct: 202 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 256
Query: 275 ACVHPFFDE 283
++++
Sbjct: 257 IKKDRWYNK 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.4 bits (229), Expect = 5e-22
Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 13/126 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
Y V+GTG+F V A+ + T ++VAIK + + E+ ++ + HPNIV
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL + LY L+++ V + +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLY--LIMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 199 IHNCIV 204
+H+ +
Sbjct: 123 LHDLGI 128
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 1e-21
Identities = 38/266 (14%), Positives = 81/266 (30%), Gaps = 69/266 (25%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
Y ++G+G FG V+ VAIK V +D+ E+ +++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 134 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
++ L F L+LE + ++ + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118
Query: 192 ICRALAYIH------------NCIVDQLVEIIKVL-----------------GTPTREEI 222
+ A+ + H N ++D +K++ GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPP 178
Query: 223 KCMNPNYTEFKFPQIKP------------HPW---------HKVFQKRLPPEAVDLVCRF 261
+ + + + + P+ F++R+ E L+
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 238
Query: 262 FQYSPNLRCTALEACVHPFFDELRDP 287
P+ R T E HP+ ++ P
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 7e-21
Identities = 27/122 (22%), Positives = 55/122 (45%), Gaps = 11/122 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
+ +G G+FG V++A+ +ET + A K + ++ E+ I+ DHPNIV
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F + L+ +++E+ + + + + +++ Q AL Y+
Sbjct: 74 LLDAF---YYENNLW--ILIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 200 HN 201
H+
Sbjct: 127 HD 128
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 4e-04
Identities = 9/45 (20%), Positives = 15/45 (33%)
Query: 237 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281
K P R D + + + + + R T + HPF
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 88.3 bits (218), Expect = 9e-21
Identities = 28/125 (22%), Positives = 41/125 (32%), Gaps = 11/125 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
Y ++G G V A+ VA+K + D RE Q L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IVA+ + +V+EYV R+ M C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 197 AYIHN 201
+ H
Sbjct: 125 NFSHQ 129
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-20
Identities = 30/126 (23%), Positives = 60/126 (47%), Gaps = 12/126 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y VG+G++G V A TG VAIKK+ + + + REL++++ + H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L F ++ LV+ ++ + ++ + H+++ ++ YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134
Query: 197 AYIHNC 202
YIH
Sbjct: 135 RYIHAA 140
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 3e-13
Identities = 37/195 (18%), Positives = 70/195 (35%), Gaps = 15/195 (7%)
Query: 116 LQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV--LEYVPETVNRIARNY 173
+ +R+L+ + + + F + V Y V Y
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 174 SR---IHQRMPLIYVKLYTYQICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYT 230
++ I ++ I + + +DQL EI+KV GTP E ++ + +
Sbjct: 197 TQTVDIWSVGCIMA-----EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 231 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 287
+ P+++ + + P AV+L+ + R TA EA HP+F+ L D
Sbjct: 252 KNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 288 NTRLPNGRPLPPLFN 302
P + F+
Sbjct: 311 E-DEPQVQKYDDSFD 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 1e-20
Identities = 37/128 (28%), Positives = 49/128 (38%), Gaps = 15/128 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 136
+ ++G GSF V A+ T AIK + + K RE +M LDHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V L F D E+LY L Y N Y R + YT +I AL
Sbjct: 70 FVKLYFTF---QDDEKLY--FGLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 197 AYIHNCIV 204
Y+H +
Sbjct: 122 EYLHGKGI 129
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (90), Expect = 6e-04
Identities = 17/70 (24%), Positives = 25/70 (35%), Gaps = 17/70 (24%)
Query: 246 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDELRDPNTRLPNGRPLPP 299
F ++ P+A DLV + R E HPFF+ + N
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN----------- 277
Query: 300 LFNFKPPELS 309
L PP+L+
Sbjct: 278 LHQQTPPKLT 287
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.6 bits (219), Expect = 1e-20
Identities = 59/321 (18%), Positives = 105/321 (32%), Gaps = 87/321 (27%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
+ +GTGSFG V + R G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ + F ++ + ++++Y+ + R QR P K Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 197 AYIH------------NCIVDQ-----LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 239
Y+H N ++D+ + + P C P+Y + KP
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 240 ---------------------HPWHK---------------VFQKRLPPEAVDLVCRFFQ 263
P++ F + DL+ R
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237
Query: 264 YSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGI------- 311
+ R + HP+F E+ +L + P ++PP G
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWFKEV--VWEKLLSRNIETP---YEPPIQQGQGDTSQFD 292
Query: 312 --PPETINRLIPEHARKQNLF 330
P E IN + +LF
Sbjct: 293 KYPEEDINYGVQGEDPYADLF 313
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.0 bits (217), Expect = 2e-20
Identities = 52/251 (20%), Positives = 100/251 (39%), Gaps = 16/251 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 141
Y +G G + VF+A E V +K + K+ K RE++I++ L PNI+ L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
D LV E+V T ++ +++Q + ++ Y Y+I +AL Y H
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 201 NCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 260
I+ + V+ V+ +++ ++ EF P + + + P VD
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 261 FFQ---YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIP-PETI 316
+ +S ++ PFF + + + + L + + I
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 317 NRLIPEHARKQ 327
N ++ H+RK+
Sbjct: 268 NDILGRHSRKR 278
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 58.7 bits (141), Expect = 2e-10
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP--------PEAV 255
DQLV I KVLGT + + +F I K +++ + PEA+
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 256 DLVCRFFQYSPNLRCTALEACVHPFFDELR 285
D + + +Y R TA EA HP+F +
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.3 bits (218), Expect = 2e-20
Identities = 45/296 (15%), Positives = 86/296 (29%), Gaps = 86/296 (29%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
+ ++G G FG V+ + +TG++ A+K + + + + L ++ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
P IV + + F ++L +L+ + + H ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLS--FILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117
Query: 194 RALAYIH------------NCIVDQLVEI------IKVLGTPTREEIKCMNPNYT----- 230
L ++H N ++D+ + + + + Y
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 177
Query: 231 -------------------------EFKFPQIKPHPWHKVFQK----------RLPPEAV 255
F Q K H++ + PE
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 256 DLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306
L+ Q N R A E PFF L + + PP PP
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL--DWQMVFLQKYPPP---LIPP 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 28/134 (20%), Positives = 53/134 (39%), Gaps = 18/134 (13%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
+G R Y +G+GSFG ++ GE VAIK ++ E +I
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
+M+ + + D Y +V+E + ++ + ++ ++ L V L
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108
Query: 189 TYQICRALAYIHNC 202
Q+ + YIH+
Sbjct: 109 ADQMISRIEYIHSK 122
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (213), Expect = 5e-20
Identities = 30/130 (23%), Positives = 55/130 (42%), Gaps = 15/130 (11%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAI+++ K E+ +M+
Sbjct: 16 GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
+PNIV + +EL+ +V+EY+ M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELW--VVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 192 ICRALAYIHN 201
+AL ++H+
Sbjct: 125 CLQALEFLHS 134
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 4e-04
Identities = 9/56 (16%), Positives = 16/56 (28%)
Query: 237 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 292
++L D + R R +A E H F + ++ P
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 7e-20
Identities = 42/209 (20%), Positives = 74/209 (35%), Gaps = 26/209 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
+G G F V++A+ + T +IVAIKK+ R + RE++++Q L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F K + LV +++ + + ++K Y + L Y+
Sbjct: 65 LLDAF---GHKSNIS--LVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 200 HNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 259
H + L +K + + + + V + PE L+
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE---LLF 173
Query: 260 RFFQYSP-----NLRCTALE-ACVHPFFD 282
Y + C E PF
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLP 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 9e-14
Identities = 28/103 (27%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 192 ICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 251
+ R + +DQL I + LGTPT E+ M F P H +F
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF-SAAG 253
Query: 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLP 292
+ +DL+ F ++P R TA +A +F P +LP
Sbjct: 254 DDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 2e-19
Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 10/123 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 138
Y +G G++G+V A VAIKK+ + + Y RE++I+ H NI+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + T ++ + LV + + ++ + Q + ++ + YQI R L Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124
Query: 199 IHN 201
IH+
Sbjct: 125 IHS 127
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 2e-17
Identities = 31/140 (22%), Positives = 61/140 (43%), Gaps = 9/140 (6%)
Query: 190 YQICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVF 246
+ + +DQL I+ +LG+P++E++ C+ P PW+++F
Sbjct: 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264
Query: 247 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306
+A+DL+ + ++P+ R +A HP+ ++ DP+ P+
Sbjct: 265 -PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD-----EPIAEAPFKFDM 318
Query: 307 ELSGIPPETINRLIPEHARK 326
EL +P E + LI E +
Sbjct: 319 ELDDLPKEKLKELIFEETAR 338
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 3e-19
Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 9/117 (7%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
+G G FG V G VA+K + D + E +M L H N+V L
Sbjct: 13 QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
L +V EY+ + + + SR + + ++ +C A+ Y+
Sbjct: 71 EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 1e-18
Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 10/125 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y VG+G++G V A +TG VA+KK+ + + REL++++ + H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ L F EE ++ ++ N Q++ +V+ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 198 YIHNC 202
YIH+
Sbjct: 136 YIHSA 140
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 7e-15
Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 10/136 (7%)
Query: 190 YQICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKPHPWHKVF 246
+ + +DQL I++++GTP E +K ++ Q+ + VF
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270
Query: 247 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306
P AVDL+ + + R TA +A H +F + DP+ P+ ++
Sbjct: 271 -IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD-----EPVADPYDQ-SF 323
Query: 307 ELSGIPPETINRLIPE 322
E + + L +
Sbjct: 324 ESRDLLIDEWKSLTYD 339
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 2e-18
Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 12/128 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G+FG VF+A+ R+TG+ VA+KKVL + + RE++I+Q+L H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 138 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
V L + ++ + + LV ++ + +A S + + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 195 ALAYIHNC 202
L YIH
Sbjct: 129 GLYYIHRN 136
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 9e-10
Identities = 21/100 (21%), Positives = 36/100 (36%), Gaps = 3/100 (3%)
Query: 192 ICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP---WHKVFQK 248
R+ N QL I ++ G+ T E ++ K +K ++
Sbjct: 216 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 275
Query: 249 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288
P A+DL+ + P R + +A H FF P+
Sbjct: 276 VRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.7 bits (201), Expect = 3e-18
Identities = 26/131 (19%), Positives = 55/131 (41%), Gaps = 18/131 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
Y +G+G F VV + + + TG A K + + + + RE+ I++ +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN++ L + +K ++ L+LE V ++ + + + QI
Sbjct: 72 HPNVITLHEVY---ENKTDVI--LILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 194 RALAYIHNCIV 204
+ Y+H+ +
Sbjct: 124 NGVYYLHSLQI 134
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 1/62 (1%)
Query: 239 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 298
+ + + A D + R P R T ++ HP+ +D L + P
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDTQQALSSAWSHP 290
Query: 299 PL 300
Sbjct: 291 QF 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 4e-18
Identities = 52/297 (17%), Positives = 92/297 (30%), Gaps = 84/297 (28%)
Query: 81 KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
KV+ + ++G G+FG V + + TG A+K + ++ E +++Q
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
HP + ALK+ F + L + + + + Y
Sbjct: 61 NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 191 QICRALAYIH------------NCIVDQLVEI--------IKVLGTPTREEIKCMNPNYT 230
+I AL Y+H N ++D+ I + + + C P Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 231 EFKFPQIKPH---------------------PWHKV---------------FQKRLPPEA 254
+ + + P++ F + L PEA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 255 VDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306
L+ + P R A E H FF + + + LPP FKP
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--WQDVVQKKLLPP---FKPQ 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 2e-17
Identities = 37/127 (29%), Positives = 69/127 (54%), Gaps = 13/127 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
+ +G G++GVV++A+ + TGE+VA+KK+ D + RE+ +++ L+HPNI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + +LY LV E++ + + + + +PL +K Y +Q+ + LA
Sbjct: 64 VKLLDVI---HTENKLY--LVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116
Query: 198 YIHNCIV 204
+ H+ V
Sbjct: 117 FCHSHRV 123
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 4e-13
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 5/105 (4%)
Query: 192 ICRALAYIHNCIVDQLVEIIKVLGTPTREEIK-CMNPNYTEFKFPQIKPHPWHKVFQKRL 250
+ R + + +DQL I + LGTP + + FP+ + KV L
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV-PPL 255
Query: 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 295
+ L+ + Y PN R +A A HPFF ++ P +P+ R
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP---VPHLR 297
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 2e-17
Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 13/126 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G+G+ G+V A VAIKK+ + + + REL +M+ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 138 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
++L + F EE + LV+E + A I + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 197 AYIHNC 202
++H+
Sbjct: 133 KHLHSA 138
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.5 bits (161), Expect = 6e-13
Identities = 32/147 (21%), Positives = 55/147 (37%), Gaps = 17/147 (11%)
Query: 187 LYTYQICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCM----------NPNYTEFKFPQ 236
+ + + + +DQ ++I+ LGTP E +K + P Y FP+
Sbjct: 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266
Query: 237 IKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 293
+ P P K +A DL+ + P R + +A HP+ + DP
Sbjct: 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA- 325
Query: 294 GRPLPPLFNFKPPELSGIPPETINRLI 320
P P +++ + E E LI
Sbjct: 326 --PPPQIYDKQLDERE-HTIEEWKELI 349
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 2e-17
Identities = 27/127 (21%), Positives = 54/127 (42%), Gaps = 16/127 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 135
+I ++G GSFG VF A+ ++T + AIK + +D + +++ + +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ + F KE L+ +EY+ + + + L Y +I
Sbjct: 64 FLTHMFCTF---QTKENLFFV--MEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 196 LAYIHNC 202
L ++H+
Sbjct: 116 LQFLHSK 122
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (99), Expect = 4e-05
Identities = 22/96 (22%), Positives = 32/96 (33%), Gaps = 13/96 (13%)
Query: 246 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRDPNTRLPNGRPLPP----- 299
+ + L EA DL+ + F P R HP F E+ L PP
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN--WEELERKEIDPPFRPKV 279
Query: 300 -----LFNFKPPELSGIPPETINRLIPEHARKQNLF 330
NF L+ P + ++ QN+F
Sbjct: 280 KSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 78.6 bits (193), Expect = 2e-17
Identities = 20/133 (15%), Positives = 47/133 (35%), Gaps = 22/133 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 130
Y + ++G G VV + + T + A+K + + + +E+ I++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 131 ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
+ HPNI+ LK + + + LV + + +Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116
Query: 190 YQICRALAYIHNC 202
+ + +H
Sbjct: 117 RALLEVICALHKL 129
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 41.2 bits (96), Expect = 9e-05
Identities = 15/36 (41%), Positives = 16/36 (44%)
Query: 248 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283
DLV RF P R TA EA HPFF +
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 3e-17
Identities = 23/122 (18%), Positives = 45/122 (36%), Gaps = 11/122 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+E +Y ++ EY+ + + + ++ + + QI +A+I
Sbjct: 74 YAVV----TQEPIY--IITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 201 NC 202
Sbjct: 127 ER 128
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 78.7 bits (193), Expect = 4e-17
Identities = 48/278 (17%), Positives = 81/278 (29%), Gaps = 76/278 (27%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
+GTGSFG V K +E+G A+K + + K K E +I+Q ++ P +V L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
F ++ + + + + R R + + Y QI Y+H
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 201 -----------NCIVDQLVEI--------------------------------------- 210
N ++DQ I
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 211 -IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSP-- 266
LG E P + + + KV F + DL+ Q
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279
Query: 267 ---NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF 301
NL+ + H +F + R + F
Sbjct: 280 RFGNLKNGVNDIKNHKWF---ATTDWIAIYQRKVEAPF 314
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 5e-17
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 12/129 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 133
Y +G G++G VF+A+ + G VA+K+V + RE+ +++ L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN+V L + E L LV E+V + + +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 194 RALAYIHNC 202
R L ++H+
Sbjct: 127 RGLDFLHSH 135
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 5e-11
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 2/94 (2%)
Query: 192 ICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 251
R + + VDQL +I+ V+G P E+ + F P K +
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPRQAFHSKSAQPIEKFV-TDID 266
Query: 252 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285
DL+ + ++P R +A A HP+F +L
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 41/263 (15%), Positives = 86/263 (32%), Gaps = 70/263 (26%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
T + Y+ E++ Q + + + QI A+ Y+
Sbjct: 79 LGVC---TREPPFYII--TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132
Query: 201 ------------NCIVDQ--------------LVEIIKVLGTPTREEIKCMNPNYTEFK- 233
NC+V + + + IK P +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 234 ------------------------FPQIKPHPWHKVFQKRL--------PPEAVDLVCRF 261
+P I +++ +K P + +L+
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 262 FQYSPNLRCTALEACVHPFFDEL 284
+Q++P+ R + E +H F+ +
Sbjct: 253 WQWNPSDRPSFAE--IHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.9 bits (186), Expect = 2e-16
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 15/124 (12%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
IA+ +G G+FG V Q R + VAIK + Q + RE QIM LD+P I
Sbjct: 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV+E + + + +P+ V +Q+ +
Sbjct: 72 VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 198 YIHN 201
Y+
Sbjct: 124 YLEE 127
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-16
Identities = 36/127 (28%), Positives = 60/127 (47%), Gaps = 14/127 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV E+ + + + + + VK + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 198 YIHNCIV 204
+ H+ V
Sbjct: 116 FCHSRNV 122
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.7 bits (164), Expect = 2e-13
Identities = 25/90 (27%), Positives = 38/90 (42%)
Query: 198 YIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 257
+ N + DQL I ++LGTPT E+ M +P +L DL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 258 VCRFFQYSPNLRCTALEACVHPFFDELRDP 287
+ + +P R +A EA HP+F + P
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.9 bits (186), Expect = 3e-16
Identities = 26/130 (20%), Positives = 48/130 (36%), Gaps = 15/130 (11%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 134
E V+G G FG V + G+ VAIK + + +R E IM DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
PN++ L+ T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 195 ALAYIHNCIV 204
+ Y+ +
Sbjct: 140 GMKYLADMNY 149
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 75.2 bits (184), Expect = 4e-16
Identities = 25/134 (18%), Positives = 48/134 (35%), Gaps = 18/134 (13%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
+G Y +G GSFGV+F+ + VAIK + E +
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
++L + + F E L+ LV++ + ++ + R + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106
Query: 189 TYQICRALAYIHNC 202
Q+ + IH
Sbjct: 107 AKQMLARVQSIHEK 120
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 74.5 bits (182), Expect = 7e-16
Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 15/124 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G++GVV++A+ GE A+KK+ +K + RE+ I++ L H NI
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV E++ + + + + K + Q+ +A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 198 YIHN 201
Y H+
Sbjct: 115 YCHD 118
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 59.5 bits (143), Expect = 7e-11
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 262
DQL+ I ++LGTP + + + F +P PW K L +DL+ +
Sbjct: 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL-KGLDESGIDLLSKML 265
Query: 263 QYSPNLRCTALEACVHPFFDE 283
+ PN R TA +A H +F E
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 7e-16
Identities = 24/145 (16%), Positives = 46/145 (31%), Gaps = 31/145 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 132
+G G+FG V +A + VA+K + EL+++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 177
+H NIV L T ++ EY
Sbjct: 85 NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 178 QRMPLIYVKLYTYQICRALAYIHNC 202
+ L + ++YQ+ + +A++ +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK 164
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 7e-16
Identities = 26/124 (20%), Positives = 47/124 (37%), Gaps = 11/124 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+GTG FGVV K R VAIK + + ++ E ++M L H +V L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
T + ++ ++ EY+ + + R + +C A+ Y+
Sbjct: 65 YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 201 NCIV 204
+
Sbjct: 118 SKQF 121
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-15
Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 10/128 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 139
+ + + +G G FG V+ + + GE VA+K + ++ E+ ML H NI+
Sbjct: 4 TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ + L LV +Y + +Y + + + LA++
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 200 HNCIVDQL 207
H IV
Sbjct: 117 HMEIVGTQ 124
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 3e-15
Identities = 23/126 (18%), Positives = 49/126 (38%), Gaps = 17/126 (13%)
Query: 85 IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
+ + +G+G+FG V + + + + VA+K + + E +MQ LD+P
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV + + E LV+E Y + ++ + + +Q+ +
Sbjct: 70 IVRMIGIC----EAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 197 AYIHNC 202
Y+
Sbjct: 121 KYLEES 126
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.5 bits (179), Expect = 3e-15
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 15/131 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
YI +G G F V+ AK VA+K V DK Y E++++Q ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 141 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
F+ +++ +V E + E + + + Y H+ +PLIYVK +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132
Query: 191 QICRALAYIHN 201
Q+ L Y+H
Sbjct: 133 QLLLGLDYMHR 143
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 7e-13
Identities = 27/118 (22%), Positives = 42/118 (35%), Gaps = 20/118 (16%)
Query: 204 VDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRL 250
D + +II++LG ++ T F ++K P V F K
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
Query: 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 301
E D + Q P R A HP+ +E+R P+ L +G +P F
Sbjct: 301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 8e-15
Identities = 23/119 (19%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
+G+G FG+V + VAIK + + + E ++M L HP +V L
Sbjct: 12 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV 204
++ + LV E++ ++ + +C +AY+ V
Sbjct: 70 --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 1e-14
Identities = 26/124 (20%), Positives = 44/124 (35%), Gaps = 18/124 (14%)
Query: 89 VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 138
+G GSFGVV + + VA+K + D + RE+ M LDH N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L + +V E P + + L + Y Q+ + Y
Sbjct: 75 RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 199 IHNC 202
+ +
Sbjct: 127 LESK 130
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (172), Expect = 1e-14
Identities = 22/129 (17%), Positives = 46/129 (35%), Gaps = 18/129 (13%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
+G+GSFG V++ K VA+K + E+ +++ H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ L +V ++ + + + I + +I + Q + +
Sbjct: 66 ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 197 AYIH-NCIV 204
Y+H I+
Sbjct: 118 DYLHAKSII 126
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 3e-14
Identities = 29/127 (22%), Positives = 43/127 (33%), Gaps = 16/127 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 135
+G G FG V Q VAIK +E M+ DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+IV L E + +++E + + L + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 196 LAYIHNC 202
LAY+ +
Sbjct: 121 LAYLESK 127
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 4e-14
Identities = 25/125 (20%), Positives = 53/125 (42%), Gaps = 17/125 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L ++T + L+ + +P + + Y+ + QI + + Y+
Sbjct: 76 LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 200 HNCIV 204
+ +
Sbjct: 128 EDRRL 132
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 1e-13
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 36/150 (24%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 132
V+G+G+FG V A + VA+K + + EL++M L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 172
H NIV L T +Y L+ EY E N+
Sbjct: 99 SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 173 YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ + + YQ+ + + ++
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 1e-13
Identities = 29/125 (23%), Positives = 46/125 (36%), Gaps = 11/125 (8%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 139
S E +G G FG V+ T VAIK + +E Q+M+ L H +V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L +E +Y +V EY+ + + + L + QI +AY+
Sbjct: 77 LYAVV----SEEPIY--IVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 200 HNCIV 204
Sbjct: 130 ERMNY 134
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 1e-12
Identities = 21/142 (14%), Positives = 48/142 (33%), Gaps = 28/142 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 132
+G G+FG V +A T VA+K + + + + ++ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 179
H N+V L L +++E+ E V
Sbjct: 75 HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 180 MPLIYVKLYTYQICRALAYIHN 201
+ L ++ Y++Q+ + + ++ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS 152
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 2e-12
Identities = 45/268 (16%), Positives = 87/268 (32%), Gaps = 53/268 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 131
+ +G G+FG V A+ + VA+K + D K+ E+++M+M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 177
+ H NI+ + + T LY +++EY P +
Sbjct: 75 IGKHKNII---NLLGACTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 237
+++ + YQ+ R + Y+ + ++ N TE +I
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKC-------------IHRDLAARNVLVTEDNVMKI 176
Query: 238 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 297
+ +D + ++ A EA + D G L
Sbjct: 177 ADFGLARDIHH------IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD---VWSFGVLL 227
Query: 298 PPLFNFKPPELSGIPPETINRLIPEHAR 325
+F G+P E + +L+ E R
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGHR 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 2e-12
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 16/129 (12%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 133
+ V+G G FG V++ + + VAIK + K E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
H NI+ L+ + + ++ EY+ + ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 194 RALAYIHNC 202
+ Y+ N
Sbjct: 121 AGMKYLANM 129
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (156), Expect = 3e-12
Identities = 21/126 (16%), Positives = 43/126 (34%), Gaps = 14/126 (11%)
Query: 87 EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + + E IM+ HPN++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+L + E +VL Y+ R + + + Q+ + + +
Sbjct: 92 SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145
Query: 199 IHNCIV 204
+ +
Sbjct: 146 LASKKF 151
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 3e-12
Identities = 28/137 (20%), Positives = 58/137 (42%), Gaps = 21/137 (15%)
Query: 79 KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 124
+KV + V+GTG++G VF + +TG++ A+K + + +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
E Q+++ + + H F + +L+L L E +++ +R
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130
Query: 185 VKLYTYQICRALAYIHN 201
V++Y +I AL ++H
Sbjct: 131 VQIYVGEIVLALEHLHK 147
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 16/74 (21%), Positives = 25/74 (33%), Gaps = 10/74 (13%)
Query: 238 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPNTRLP 292
+ + + + A DL+ R P R A E H FF ++ + L
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD--LA 304
Query: 293 NGRPLPPLFNFKPP 306
+ P FKP
Sbjct: 305 AKKVPAP---FKPV 315
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 5e-12
Identities = 29/136 (21%), Positives = 51/136 (37%), Gaps = 26/136 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
+ V+G G+FG V +A+ ++ G AIK++ D R EL+++ L HPNI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 185
L YL L +EY P + + + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 186 KLYTYQICRALAYIHN 201
+ + R + Y+
Sbjct: 130 LHFAADVARGMDYLSQ 145
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 7e-12
Identities = 38/284 (13%), Positives = 82/284 (28%), Gaps = 88/284 (30%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 133
+G GSFG+V++ + E VAIK V ++++ E +M+ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 186
++V L +++E + R A + + L +
Sbjct: 82 CHHVVRLLGVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 187 LYTYQICRALAYIH------------NCIVD--------------------QLVEIIKVL 214
+I +AY++ NC+V + K L
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 215 GTPTREEIKCMNPNYTEFKFPQI------------KPHPWHKVFQKRL------------ 250
+ + P+ + +++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 251 ----PPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDEL 284
P +L+ +QY+P +R + ++ + P F E+
Sbjct: 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 62.6 bits (151), Expect = 1e-11
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 36/145 (24%)
Query: 89 VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+G G+FG VFQA+ E +VA+K + ++ RE +M D+PNIV
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 177
+ + L+ EY+ ++ AR S
Sbjct: 80 ---KLLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 178 QRMPLIYVKLYTYQICRALAYIHNC 202
+ Q+ +AY+
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER 159
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.2 bits (119), Expect = 5e-08
Identities = 12/131 (9%), Positives = 31/131 (23%), Gaps = 28/131 (21%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 134
++G G VF E +K + + +
Sbjct: 7 LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 135 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+ L+ E +++E ++ R+ + I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNA--VLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 194 RALAYIHNCIV 204
+A ++ +
Sbjct: 114 EEVAKFYHRGI 124
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 335 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.98 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.68 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=297.86 Aligned_cols=242 Identities=67% Similarity=1.095 Sum_probs=188.1
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccEEEEEe
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLVL 159 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~iv~ 159 (335)
..+|+.+++||+|+||+||+|+++.+|+.||||++.++.....+|+.+|++++|||||+++++|..... .+..++||||
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 447999999999999999999999999999999998877778899999999999999999999976432 4567899999
Q ss_pred ecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 019844 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------------ 203 (335)
Q Consensus 160 e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------ 203 (335)
|||++++...+.........+++.+++.|+.||+.||+|||++|
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99998777766655555678999999999999999999999998
Q ss_pred --------------------------------------------------cChHHhHhhhcCCCCHHHhhhhCCCCCCCC
Q 019844 204 --------------------------------------------------VDQLVEIIKVLGTPTREEIKCMNPNYTEFK 233 (335)
Q Consensus 204 --------------------------------------------------~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 233 (335)
.+.+..+...+|++..+.+....+.+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 111122222333333333434444444445
Q ss_pred CCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcccCCCCCH
Q 019844 234 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP 313 (335)
Q Consensus 234 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (335)
++.....++.......+++++.+||.+||++||++|||+.|+|+||||+++..+...++.....+.+++|...++.. .+
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~ 337 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS-NP 337 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT-CG
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccC-Cc
Confidence 55555666666666789999999999999999999999999999999999999888888888888888888655553 33
Q ss_pred HHHhhcChHH
Q 019844 314 ETINRLIPEH 323 (335)
Q Consensus 314 ~~~~~~~~~~ 323 (335)
+....+++.+
T Consensus 338 ~~~~~~~p~~ 347 (350)
T d1q5ka_ 338 PLATILIPPH 347 (350)
T ss_dssp GGHHHHSCTT
T ss_pred cccccCCCcc
Confidence 3344444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=266.65 Aligned_cols=191 Identities=26% Similarity=0.343 Sum_probs=143.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++++.||+|+||+||+|+++.+++.||+|++.+. ...+.+|+.+|+.++|||||++++++ .+..+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 5699999999999999999999999999999998632 24567999999999999999999999 55667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hHHhHh---------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QLVEII--------- 211 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~~~~~--------- 211 (335)
+|||||||+| +|.+++.. .+.+++..++.|+.||+.||+|||++| ++ .....+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999995 99999986 567999999999999999999999998 00 000001
Q ss_pred ------hhcCCCC---HHHhhhhCCCCCCC----------------CCCCCCCC---------ccccccccCCChHHHHH
Q 019844 212 ------KVLGTPT---REEIKCMNPNYTEF----------------KFPQIKPH---------PWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 212 ------~~~g~~~---~~~~~~~~~~~~~~----------------~~~~~~~~---------~~~~~~~~~~s~~~~~l 257 (335)
..+||+. ||.+... .|... ..|..... .....+|..+|+++++|
T Consensus 157 ~~~~~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 234 (263)
T d2j4za1 157 PSSRRTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234 (263)
T ss_dssp CCCCCEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred CCCcccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 1123322 2221110 11100 00000000 00113456789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
|.+||+.||++|||+.|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=263.25 Aligned_cols=194 Identities=22% Similarity=0.294 Sum_probs=145.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+.|++++.||+|+||+||+|+++.+++.||||++.+. .+.+.+|+.+|+.++|||||++++++ .+...+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 4599999999999999999999999999999999642 35678999999999999999999999 45566999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------cC-h
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-----------------------------VD-Q 206 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------~~-~ 206 (335)
|||||+| +|.+++... .+.+++.+++.|+.||+.||.|||++| .. .
T Consensus 87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999996 999987652 457999999999999999999999998 00 0
Q ss_pred HHhHhhhcCCCCHHHhhhh------CCCCCC------------------CCCCCCCC----------CccccccccCCCh
Q 019844 207 LVEIIKVLGTPTREEIKCM------NPNYTE------------------FKFPQIKP----------HPWHKVFQKRLPP 252 (335)
Q Consensus 207 ~~~~~~~~g~~~~~~~~~~------~~~~~~------------------~~~~~~~~----------~~~~~~~~~~~s~ 252 (335)
.......+||+.+...... ...|.. ..+..... .+.....+..+|+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence 0111233455542222111 111110 01110000 0001122457899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
++++||.+||+.||++|||+.|+|+||||+.
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-37 Score=269.85 Aligned_cols=194 Identities=22% Similarity=0.303 Sum_probs=141.8
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|++++.||+|+||+||+|+++.+++.||||++.+. ...+.+|+.+|+.++|||||+++++| .+..+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 346699999999999999999999999999999999643 24567899999999999999999999 56667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
+|||||||+| +|.+++.. .+.+++.+++.|+.||+.||+|||+++
T Consensus 82 ~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999995 99999976 678999999999999999999999998
Q ss_pred --cChHHhHhhhcCCCCH---HHhhhhCCCCCC------------------CCCCCC-----------CCCccccccccC
Q 019844 204 --VDQLVEIIKVLGTPTR---EEIKCMNPNYTE------------------FKFPQI-----------KPHPWHKVFQKR 249 (335)
Q Consensus 204 --~~~~~~~~~~~g~~~~---~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~~ 249 (335)
.+........+||+.+ |.+... .|.. ..+... ....+....+..
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ---------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 0000011122344442 221110 1110 001000 001111223357
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 250 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+|+++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 89999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-37 Score=266.86 Aligned_cols=196 Identities=20% Similarity=0.269 Sum_probs=145.1
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCCCCceeeeceeeeeCCC
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 149 (335)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .+.+.+|+.+|+.++|||||+++++|
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~----- 82 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----- 82 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 446799999999999999999999999999999999642 24577999999999999999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH-----HhHh
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL-----VEII 211 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~-----~~~~ 211 (335)
.+..++|||||||+| +|.+++.. .+.+++..++.|+.||+.||+|||+++ ++.. ...+
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 566679999999995 99999986 567999999999999999999999998 0000 0011
Q ss_pred hh----------------cCCCC---HHHhhhhCCCCCC------------------CCCCCC-----------CCCccc
Q 019844 212 KV----------------LGTPT---REEIKCMNPNYTE------------------FKFPQI-----------KPHPWH 243 (335)
Q Consensus 212 ~~----------------~g~~~---~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~ 243 (335)
.. .|++. ++.+... .|.. ..+... ....+.
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 11 22222 1211110 0100 001000 001122
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
...+..+|+++++||++||+.||++|||++|+|+||||+....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 2334678999999999999999999999999999999987543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=264.36 Aligned_cols=194 Identities=21% Similarity=0.229 Sum_probs=143.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.+|+.++|||||++++++ .+...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence 45799999999999999999999999999999998642 24578999999999999999999999 555669
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-h---------------
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-Q--------------- 206 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~--------------- 206 (335)
|||||||+| +|.+++.. .+.+++.+++.|+.||+.||+|||++| ++ .
T Consensus 79 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999996 99988864 567999999999999999999999998 00 0
Q ss_pred ----HHhHhhhcCCCCHHHhhhh-CCCCC-------------------CCCCCCCCCC----------ccccccccCCCh
Q 019844 207 ----LVEIIKVLGTPTREEIKCM-NPNYT-------------------EFKFPQIKPH----------PWHKVFQKRLPP 252 (335)
Q Consensus 207 ----~~~~~~~~g~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~----------~~~~~~~~~~s~ 252 (335)
.......+||+.+...+.. ...|. .+.+...... ......+..+|+
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCH
Confidence 0001122455432111100 00000 0001000000 001112256899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
++.+||.+||+.||++|||++|+|+||||++
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 235 APLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 9999999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=262.70 Aligned_cols=115 Identities=31% Similarity=0.563 Sum_probs=101.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+.+|+.+|+.++|||||+++++| .+..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 4699999999999999999999999999999999532 34577999999999999999999999 555669
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|+|||||.|++.+++.... ...+++..++.|+.||+.||+|||++|
T Consensus 77 ~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999987766665432 567999999999999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=264.42 Aligned_cols=110 Identities=28% Similarity=0.501 Sum_probs=93.1
Q ss_pred EeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 86 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.+++||+|+||+||+|+++.+|+.||||+++.. .+.+.+|+.+|+.++|||||+++++| ....++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 478999999999999999999999999998632 13577999999999999999999999 5566699
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||||.|++...+.. ....+++..++.|++||+.||+|||++|
T Consensus 77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~ 120 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW 120 (299)
T ss_dssp EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc
Confidence 9999999744333322 2567999999999999999999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-37 Score=262.88 Aligned_cols=197 Identities=20% Similarity=0.284 Sum_probs=142.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.+|++++|||||++++++.. .....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 35799999999999999999999999999999998643 2346799999999999999999999853 23345
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------ 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------ 203 (335)
+|||||||+| +|.+++....+..+.+++..++.|+.||+.||+|||+++
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 8999999995 999999877666788999999999999999999999753
Q ss_pred ----cC-hHHhHhhhcCCCCHHHhhhh-CCCCCC------------------CCCCCC---------CCCccccccccCC
Q 019844 204 ----VD-QLVEIIKVLGTPTREEIKCM-NPNYTE------------------FKFPQI---------KPHPWHKVFQKRL 250 (335)
Q Consensus 204 ----~~-~~~~~~~~~g~~~~~~~~~~-~~~~~~------------------~~~~~~---------~~~~~~~~~~~~~ 250 (335)
.. ........+||+.+...+.. ...|.. ..+... ....+ ..++..+
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~ 238 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRY 238 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTS
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCccc
Confidence 00 00111123455542211111 011110 001000 00011 1244678
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 281 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f 281 (335)
|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=265.94 Aligned_cols=198 Identities=24% Similarity=0.314 Sum_probs=147.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|++++|||||+++++| .+..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence 35799999999999999999999999999999999642 24578999999999999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------------- 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------- 203 (335)
++|||||||+| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence 79999999996 99998886 678999999999999999999999998
Q ss_pred cC---hHHhHhhhcCCCCHHHhhhh-CCCCCC------------------CCCCCCCC-------CccccccccCCChHH
Q 019844 204 VD---QLVEIIKVLGTPTREEIKCM-NPNYTE------------------FKFPQIKP-------HPWHKVFQKRLPPEA 254 (335)
Q Consensus 204 ~~---~~~~~~~~~g~~~~~~~~~~-~~~~~~------------------~~~~~~~~-------~~~~~~~~~~~s~~~ 254 (335)
.. ........+||+.+...+.. ...|.. ..+..... ......+|..+++++
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 237 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHH
T ss_pred cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHH
Confidence 00 01111223455542211110 011110 01110000 001123557899999
Q ss_pred HHHHHHhccCCCCCCCCHHH------HhcCcccccCCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDP 287 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~------~L~hp~f~~~~~~ 287 (335)
++||++||+.||++|||++| +++||||+.+.+.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 99999999999999999987 5889999988654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-36 Score=268.05 Aligned_cols=235 Identities=22% Similarity=0.356 Sum_probs=154.5
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .+.+.+|+.+|+.++|||||+++++|..... ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 456899999999999999999999999999999999643 2456799999999999999999999965432 234
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HH----------
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LV---------- 208 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~---------- 208 (335)
.++|+|||||+++|..+++ .+++++..++.|+.||+.||+|||++| ++. ..
T Consensus 96 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 4578999999778888776 357999999999999999999999998 000 00
Q ss_pred ---hHhhhcCCCC---HHHhh----------------------hhCCCCCCC----------------------------
Q 019844 209 ---EIIKVLGTPT---REEIK----------------------CMNPNYTEF---------------------------- 232 (335)
Q Consensus 209 ---~~~~~~g~~~---~~~~~----------------------~~~~~~~~~---------------------------- 232 (335)
......|++. ++.+. .+.+.|...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 0001112221 11111 111111100
Q ss_pred ------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 233 ------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 233 ------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
..+......+...+ ..+++++.+||++||+.||++|||+.|+|+||||+.+..+..+... . .++.. .
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~-~----~~~~~-~ 323 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-Q----KYDDS-F 323 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-C----CCCCC--
T ss_pred hhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccC-C----CCCCc-h
Confidence 01111222233223 5689999999999999999999999999999999998766543221 1 12222 2
Q ss_pred cCCCCCHHHHhhcChHHHhh
Q 019844 307 ELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (335)
+.-+.+.+++++++.+|+..
T Consensus 324 ~~~~~~~~e~k~~~~~e~~~ 343 (346)
T d1cm8a_ 324 DDVDRTLDEWKRVTYKEVLS 343 (346)
T ss_dssp ----CCHHHHHHHHHHHHHT
T ss_pred hhhhcCHHHHHHHHHHHhhc
Confidence 23345778999998888764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-37 Score=267.27 Aligned_cols=190 Identities=21% Similarity=0.238 Sum_probs=142.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.+|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.+|+.++|||||+++++| ....++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 3599999999999999999999999999999998642 24578999999999999999999999 45556999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh------------------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ------------------ 206 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~------------------ 206 (335)
|||||+| +|.+++.. +.+++.+++.|+.||+.||+|||++| ++.
T Consensus 95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999996 99988763 56999999999999999999999999 000
Q ss_pred HHhHhhhcCCCC---HHHhhhhCCCCCC------------------CCCCCCC----------CCccccccccCCChHHH
Q 019844 207 LVEIIKVLGTPT---REEIKCMNPNYTE------------------FKFPQIK----------PHPWHKVFQKRLPPEAV 255 (335)
Q Consensus 207 ~~~~~~~~g~~~---~~~~~~~~~~~~~------------------~~~~~~~----------~~~~~~~~~~~~s~~~~ 255 (335)
.......+||+. ||.+... .|.. ..|.... ........+..+|++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 247 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred cccccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence 000112234433 2221110 1110 0010000 00011223467899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccc
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDE 283 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~ 283 (335)
+||.+||+.||++|||+.|+|+||||+.
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-36 Score=265.72 Aligned_cols=235 Identities=23% Similarity=0.388 Sum_probs=160.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
..+|++++.||+|+||+||+|+++.+|+.||||+|.+.. +.+.+|+.+|+.++|||||++++++.........++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 456999999999999999999999999999999996432 356789999999999999999999966544455567
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH-H--------------
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL-V-------------- 208 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~-~-------------- 208 (335)
|++|++++|+|.+++.. +++++..++.++.||+.||+|||++| ++.. .
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 78888777899999974 46999999999999999999999999 0000 0
Q ss_pred ------hHhhhcCCCCHHHhhh-------------------------hCCCCCCC-------------------------
Q 019844 209 ------EIIKVLGTPTREEIKC-------------------------MNPNYTEF------------------------- 232 (335)
Q Consensus 209 ------~~~~~~g~~~~~~~~~-------------------------~~~~~~~~------------------------- 232 (335)
.....+|++.+..... +.+.|..-
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 0001122222111100 01111000
Q ss_pred ---------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCC
Q 019844 233 ---------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 303 (335)
Q Consensus 233 ---------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~ 303 (335)
..+.....+|...+ +.+++++++||.+||+.||.+|||+.|+|+||||++...+...... ...+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~~ 316 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF 316 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC--
T ss_pred hhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccCC
Confidence 01111111222222 5678999999999999999999999999999999988776543221 234556
Q ss_pred CcccCCCCCHHHHhhcChHHHhh
Q 019844 304 KPPELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~ 326 (335)
+ .+..+++.+.+++++.+|..+
T Consensus 317 ~-~~~~~~~~~~l~~l~~~e~~~ 338 (345)
T d1pmea_ 317 D-MELDDLPKEKLKELIFEETAR 338 (345)
T ss_dssp -------CCHHHHHHHHHHHSGG
T ss_pred C-hhhhhCCHHHHHHHHHHHHHh
Confidence 5 678888999999988887655
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-36 Score=258.13 Aligned_cols=194 Identities=22% Similarity=0.333 Sum_probs=142.6
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
|++.++||+|+||+||+|+++.+++.||+|++... .+.+.+|+++|++++|||||+++++|.... ....++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 47788999999999999999999999999998642 245779999999999999999999986433 34567899
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cCh--------------HHh----------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---VDQ--------------LVE---------- 209 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---~~~--------------~~~---------- 209 (335)
|||||+| +|.+++.. ...+++..++.|+.||+.||+|||+++ ++. ..+
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999996 99999986 567999999999999999999999986 000 000
Q ss_pred ----HhhhcCCCCHHHhhhhCCCCCC------------------CCCCCC----------CCCccccccccCCChHHHHH
Q 019844 210 ----IIKVLGTPTREEIKCMNPNYTE------------------FKFPQI----------KPHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 210 ----~~~~~g~~~~~~~~~~~~~~~~------------------~~~~~~----------~~~~~~~~~~~~~s~~~~~l 257 (335)
....+||+.+...+.....|.. ..+... ........++..+++++++|
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred cCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 0112344442211111111110 011100 01111223445689999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccc
Q 019844 258 VCRFFQYSPNLRCTALEACVHPFFD 282 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~hp~f~ 282 (335)
|.+||+.||++|||++|+|+||||+
T Consensus 246 i~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=265.64 Aligned_cols=235 Identities=24% Similarity=0.321 Sum_probs=163.6
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc------hhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~ 152 (335)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.. +.+.+|+.+|+.++|||||+++++|..... .+.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3567999999999999999999999999999999996432 356799999999999999999999865432 233
Q ss_pred cEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-ChHHh------------Hhhhc-----
Q 019844 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV-DQLVE------------IIKVL----- 214 (335)
Q Consensus 153 ~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~~~~------------~~~~~----- 214 (335)
.++++++++++|+|.+++. .+++++..++.|+.||+.||+|||++|+ +...+ .+..+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 4455655555569999885 4579999999999999999999999980 00000 00000
Q ss_pred ---------CCC---CHHH-------------hh---------hhCCCCCCC----------------------------
Q 019844 215 ---------GTP---TREE-------------IK---------CMNPNYTEF---------------------------- 232 (335)
Q Consensus 215 ---------g~~---~~~~-------------~~---------~~~~~~~~~---------------------------- 232 (335)
|++ .++. |. .+.+.|...
T Consensus 171 ~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp CTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred cCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 000 0010 00 111111100
Q ss_pred ------CCCCCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCCCCCCCCCcc
Q 019844 233 ------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 306 (335)
Q Consensus 233 ------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.........+...+ ..++++++|||++||+.||++|||+.|+|+||||+++..|..+. +...+++. .
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~-----~~~~~~~~-~ 323 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYDQS-F 323 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC-----CCCCCCCG-G
T ss_pred hhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC-----CCCCCCCc-c
Confidence 01111111222222 46899999999999999999999999999999999987765543 23334444 5
Q ss_pred cCCCCCHHHHhhcChHHHhh
Q 019844 307 ELSGIPPETINRLIPEHARK 326 (335)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (335)
+..++..+.+++++.+|+.+
T Consensus 324 ~~~~~~~~~~k~~~~~e~~~ 343 (348)
T d2gfsa1 324 ESRDLLIDEWKSLTYDEVIS 343 (348)
T ss_dssp GGCCCCHHHHHHHHHHHHHT
T ss_pred cchhcCHHHHHHHHHHHhhc
Confidence 56788889999988887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-36 Score=265.79 Aligned_cols=196 Identities=23% Similarity=0.336 Sum_probs=146.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++| .+..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 4699999999999999999999999999999999642 24577999999999999999999999 66677
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh---------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--------------- 206 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--------------- 206 (335)
+|+|||||+| +|.+++.. .+.++|..++.|+.||+.||+|||++| ++.
T Consensus 80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999996 99999887 678999999999999999999999998 000
Q ss_pred ---HHhHhhhcCCCCHHHhhhh-CCCCCCC----------------CCCCCCCCc---------cccccccCCChHHHHH
Q 019844 207 ---LVEIIKVLGTPTREEIKCM-NPNYTEF----------------KFPQIKPHP---------WHKVFQKRLPPEAVDL 257 (335)
Q Consensus 207 ---~~~~~~~~g~~~~~~~~~~-~~~~~~~----------------~~~~~~~~~---------~~~~~~~~~s~~~~~l 257 (335)
.......+||+.+...... ...|... ..+...... -...+|..+|+++++|
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 0001122344332111110 0011100 000000000 0123567899999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 258 VCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 258 i~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
|++||++||.+|++ +.|+++||||+++.+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 99999999999994 999999999988653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.2e-36 Score=257.24 Aligned_cols=194 Identities=23% Similarity=0.349 Sum_probs=144.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------------hhHHHHHHHHHhCC-CCceeeeceeeeeC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST 147 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~ 147 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ..+.+|+.+|+.++ |||||+++++|
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 56999999999999999999999999999999996431 24678999999996 99999999999
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------------------- 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------- 203 (335)
.+..++|||||||+| +|.+++.. .+.+++.+++.|+.||+.||+|||++|
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEcc
Confidence 566679999999996 99999986 567999999999999999999999998
Q ss_pred ------cChHHhHhhhcCCCC---HHHhhhh----CCCCCC------------------CCCCCC-----------CCCc
Q 019844 204 ------VDQLVEIIKVLGTPT---REEIKCM----NPNYTE------------------FKFPQI-----------KPHP 241 (335)
Q Consensus 204 ------~~~~~~~~~~~g~~~---~~~~~~~----~~~~~~------------------~~~~~~-----------~~~~ 241 (335)
..........+||+. ++.+... .+.|.. ..+... ....
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 000000111223322 2222110 011110 001000 0001
Q ss_pred cccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 242 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+.......+|+++++||.+||+.||++|||++|+|+||||+++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1122235789999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=266.13 Aligned_cols=196 Identities=20% Similarity=0.266 Sum_probs=143.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++++.||+|+||+||+|.++.+++.||||++++.. ..+.+|+.+|+.++|||||+++++| .+..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 356999999999999999999999999999999997543 3467999999999999999999999 55667999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC---hHHhHhhhc-------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD---QLVEIIKVL------- 214 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~---~~~~~~~~~------- 214 (335)
|||||+| +|.+++... ...+++.+++.|+.||+.||+|||++| ++ .....+..+
T Consensus 79 vmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999996 999988641 346999999999999999999999998 00 000001111
Q ss_pred ---------CCCC---HHHh------------h---------hhCCCCCCCCC----CCC--CCCccccccccCCChHHH
Q 019844 215 ---------GTPT---REEI------------K---------CMNPNYTEFKF----PQI--KPHPWHKVFQKRLPPEAV 255 (335)
Q Consensus 215 ---------g~~~---~~~~------------~---------~~~~~~~~~~~----~~~--~~~~~~~~~~~~~s~~~~ 255 (335)
|++. ++.. . .+.+.|..... ..+ ....+....+..+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 2221 1100 0 01111110000 000 001112223357899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 256 DLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 256 ~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
+||.+||+.||++|||+.|+|+||||++.
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=267.17 Aligned_cols=194 Identities=24% Similarity=0.369 Sum_probs=142.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHH-hCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~-~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.++ ...+.+|+.++. .++|||||+++++| .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 4699999999999999999999999999999999642 134566777665 68999999999999 5666
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc------------Ch--------------
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV------------DQ-------------- 206 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~------------~~-------------- 206 (335)
++|||||||+| +|.+++.. ...+++.+++.|+.||+.||+|||++++ +.
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 79999999996 99999986 6679999999999999999999999980 00
Q ss_pred ----HHhHhhhcCCCC---HHHhhhhCCCCCC----------------CCCCCCCCC---------ccccccccCCChHH
Q 019844 207 ----LVEIIKVLGTPT---REEIKCMNPNYTE----------------FKFPQIKPH---------PWHKVFQKRLPPEA 254 (335)
Q Consensus 207 ----~~~~~~~~g~~~---~~~~~~~~~~~~~----------------~~~~~~~~~---------~~~~~~~~~~s~~~ 254 (335)
.......+||+. ++.+... .|.. ...|..... .-...+|..+|+++
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~ 230 (320)
T d1xjda_ 153 NMLGDAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230 (320)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 000011233333 1211110 1110 000000000 00123456789999
Q ss_pred HHHHHHhccCCCCCCCCHH-HHhcCcccccCCC
Q 019844 255 VDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD 286 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~-~~L~hp~f~~~~~ 286 (335)
++||++||+.||++|||+. ++++||||+++.+
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 9999999999999999995 8999999988643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=254.48 Aligned_cols=113 Identities=31% Similarity=0.473 Sum_probs=100.9
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|++++.||+|+||+||+|+++.+++.||||+++.. ...+.+|+.+|+.++|||||+++++| ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 4799999999999999999999999999999998643 24567999999999999999999999 556668
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++||+++.| +|..++.. .+.+++..++.++.|++.||+|||+++
T Consensus 77 ~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp EEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 999999997 77766654 678999999999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-35 Score=264.32 Aligned_cols=200 Identities=23% Similarity=0.320 Sum_probs=146.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .+.+.+|+.+|+.++|||||+++++| .+..++|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999999643 24577999999999999999999999 5566799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c--Ch-HHhHhh--------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V--DQ-LVEIIK-------- 212 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~--~~-~~~~~~-------- 212 (335)
||||||+| +|.+++.. ..+.+++..++.|+.||+.||+|||++| + +. ....+.
T Consensus 100 ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999996 99988853 1457999999999999999999999999 1 00 000011
Q ss_pred --------hcCCCC---HHHhhh---------------------hCCCCCCCCC----CCCC--CCccccccccCCChHH
Q 019844 213 --------VLGTPT---REEIKC---------------------MNPNYTEFKF----PQIK--PHPWHKVFQKRLPPEA 254 (335)
Q Consensus 213 --------~~g~~~---~~~~~~---------------------~~~~~~~~~~----~~~~--~~~~~~~~~~~~s~~~ 254 (335)
..||+. +|.+.. +.+.|..... ..+. ...+.......+|+++
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 123332 222111 0011100000 0000 0011122235689999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCCCCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 288 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~ 288 (335)
++||.+||+.||++|||+.|+|+||||+....+.
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 9999999999999999999999999999876553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=263.62 Aligned_cols=233 Identities=21% Similarity=0.286 Sum_probs=154.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC-CCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~-~~~~~ 154 (335)
++|+++++||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++|..... ....+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999999999999999999643 2357799999999999999999999964332 34578
Q ss_pred EEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--------------C---------------
Q 019844 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIV--------------D--------------- 205 (335)
Q Consensus 155 ~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--------------~--------------- 205 (335)
+|+|||||.|++.+.+ ...+++..++.++.||+.||+|||++|+ +
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 9999999998766554 3569999999999999999999999990 0
Q ss_pred hHHhHhhhcCCCC---HHHhh---------------------hhCCCCCCC-----------------------------
Q 019844 206 QLVEIIKVLGTPT---REEIK---------------------CMNPNYTEF----------------------------- 232 (335)
Q Consensus 206 ~~~~~~~~~g~~~---~~~~~---------------------~~~~~~~~~----------------------------- 232 (335)
........+||+. ++.+. .+.+.|...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 0000011123322 12111 111111000
Q ss_pred ----CCCCCCCCcccccc-----------ccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCCCCCCCCCCCCCC
Q 019844 233 ----KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 297 (335)
Q Consensus 233 ----~~~~~~~~~~~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~~~~~~~~~~~~~ 297 (335)
..+......+...+ +...++++.+||++||++||++||||+|+|+||||+...++..... +-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~---~~ 327 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA---PP 327 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC---CC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC---CC
Confidence 00000000011111 1234678999999999999999999999999999998765443221 11
Q ss_pred CCCCCCCcccCCCCCHHHHhhcChHHH
Q 019844 298 PPLFNFKPPELSGIPPETINRLIPEHA 324 (335)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (335)
|.+++.+ .+....+.+.|+++|..|+
T Consensus 328 ~~~~~~~-~~~~~~~~~~~~~~~~~~~ 353 (355)
T d2b1pa1 328 PQIYDKQ-LDEREHTIEEWKELIYKEV 353 (355)
T ss_dssp C--------CCCCCCHHHHHHHHHHHH
T ss_pred CCCCCcc-hhhhhcCHHHHHHHHHHHh
Confidence 2333433 4456778888988877665
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-36 Score=264.69 Aligned_cols=115 Identities=19% Similarity=0.353 Sum_probs=102.9
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..++|++++.||+|+||+||+|+++.+|+.||+|+++.. ...+.+|+.+|+.++|||||+++++| .+..+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 346799999999999999999999999999999999643 24577999999999999999999999 55566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ 203 (335)
+|||||||+| +|.+++.. .+.+++..++.++.||+.||.|||++ +
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~ 125 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK 125 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999996 99999986 56799999999999999999999974 6
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-35 Score=259.29 Aligned_cols=195 Identities=23% Similarity=0.272 Sum_probs=142.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
..|++++.||+|+||+||+|+++.+|+.||||++.+.. +.+.+|+.+|+.++|||||+++++| .+..+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCE
Confidence 45999999999999999999999999999999996432 3467899999999999999999999 45566
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hH-------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QL------------- 207 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~------------- 207 (335)
+|||||||.| +|..++.. ++.+++.+++.|+.||+.||.|||++| ++ ..
T Consensus 90 ~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999996 67655554 678999999999999999999999998 00 00
Q ss_pred HhHhhhcCCCCHHHhhhh---C-CCCCC----------------CCCCCCCCC-----------ccccccccCCChHHHH
Q 019844 208 VEIIKVLGTPTREEIKCM---N-PNYTE----------------FKFPQIKPH-----------PWHKVFQKRLPPEAVD 256 (335)
Q Consensus 208 ~~~~~~~g~~~~~~~~~~---~-~~~~~----------------~~~~~~~~~-----------~~~~~~~~~~s~~~~~ 256 (335)
......+||+.+...... . ..|.. ...|..... ......+..+|+++++
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 166 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp SSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred CCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 001122344432222111 0 11111 000000000 0111223468999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
||.+||+.||.+|||++|+|+||||....
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99999999999999999999999998643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-34 Score=251.94 Aligned_cols=113 Identities=27% Similarity=0.431 Sum_probs=97.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
++|+++++||+|+||+||+|+++ +|+.||||++... ...+.+|+.+|+.++|||||+++++| .....+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 57999999999999999999995 8899999999643 24678999999999999999999999 445558
Q ss_pred EEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|++|||+.|++...+.. ..+.+++..++.|+.||+.||+|||+++
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 120 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR 120 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc
Confidence 99999999844444432 2577999999999999999999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-35 Score=262.13 Aligned_cols=197 Identities=22% Similarity=0.295 Sum_probs=143.9
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.|+|||||+++++| .+..++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35699999999999999999999999999999999653 24567899999999999999999999 5666799
Q ss_pred EEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC---hHHhHhhhc------
Q 019844 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD---QLVEIIKVL------ 214 (335)
Q Consensus 157 iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~---~~~~~~~~~------ 214 (335)
||||||+| +|.+++.. ...++++.+++.|+.||+.||+|||++| ++ .....+..+
T Consensus 103 ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999996 99877653 2456999999999999999999999998 10 000011122
Q ss_pred ----------CCCC---HHHhh---------------------hhCCCCCCCCCC----CC--CCCccccccccCCChHH
Q 019844 215 ----------GTPT---REEIK---------------------CMNPNYTEFKFP----QI--KPHPWHKVFQKRLPPEA 254 (335)
Q Consensus 215 ----------g~~~---~~~~~---------------------~~~~~~~~~~~~----~~--~~~~~~~~~~~~~s~~~ 254 (335)
|++. ++.+. ++.+.|...... .+ ....+....+..+|+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2221 11111 011111100000 00 00111222335789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 255 VDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 255 ~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
++||.+||+.||.+|||+.|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-35 Score=256.21 Aligned_cols=194 Identities=23% Similarity=0.388 Sum_probs=147.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .+.+.+|+.+|+.++|||||++++++ .+..+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 4599999999999999999999999999999999642 24577999999999999999999999 56667
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--H------------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--L------------ 207 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~------------ 207 (335)
+|+|||||.| +|..++.. ...+++..++.|+.||+.||+|||++| ++. .
T Consensus 79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999996 88888876 678999999999999999999999999 000 0
Q ss_pred -HhHhhhcCCCC---HHHhhhhCCCCCCC----------------CCCCCCCCc---------cccccccCCChHHHHHH
Q 019844 208 -VEIIKVLGTPT---REEIKCMNPNYTEF----------------KFPQIKPHP---------WHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 208 -~~~~~~~g~~~---~~~~~~~~~~~~~~----------------~~~~~~~~~---------~~~~~~~~~s~~~~~li 258 (335)
......+||+. +|.+... .|... ..|...... -...++..+|++++++|
T Consensus 155 ~~~~~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 155 PDVTYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232 (316)
T ss_dssp SSCBCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred ccccccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 00112345554 2222111 11110 011000000 01234567899999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.+||+.||.+|+ |++++|+||||+++.+
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 999999999996 8999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-34 Score=248.68 Aligned_cols=202 Identities=24% Similarity=0.398 Sum_probs=143.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCC-CcEEEEEEeccc------chhHHHHHHHHHhC---CCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAvK~i~~~------~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~ 150 (335)
.++|++++.||+|+||+||+|+++.+ ++.||||+++.. .....+|+.+|+.| +|||||+++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35799999999999999999999766 677999998632 23466898888776 799999999999765545
Q ss_pred CccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 019844 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------------- 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------- 203 (335)
...++|++||||+|++..+..... ...+++..++.|+.||+.||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 667899999999985544444322 567999999999999999999999998
Q ss_pred --cChHHhHhhhcCCCCH---HHhhh---------------------hCCCCCCC-------------------CCC---
Q 019844 204 --VDQLVEIIKVLGTPTR---EEIKC---------------------MNPNYTEF-------------------KFP--- 235 (335)
Q Consensus 204 --~~~~~~~~~~~g~~~~---~~~~~---------------------~~~~~~~~-------------------~~~--- 235 (335)
...........||+.+ |.+.. +.+.|... .++
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 0111111223445442 22111 11111100 000
Q ss_pred --------CCCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccCC
Q 019844 236 --------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 285 (335)
Q Consensus 236 --------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~~ 285 (335)
.....+ ...++..+++++++||.+||++||++|||+.|+|+||||+++.
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 000001 1123357899999999999999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-34 Score=257.34 Aligned_cols=194 Identities=25% Similarity=0.345 Sum_probs=145.0
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .+.+.+|+.+|+.++|||||+++++| .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 4699999999999999999999999999999999642 24567999999999999999999999 56666
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HHh----------
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LVE---------- 209 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~~---------- 209 (335)
+|+||||+.| +|..++.. .+.+++..++.|+.||+.||.|||+++ ++. ..+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999996 99888876 567999999999999999999999998 000 000
Q ss_pred ---HhhhcCCCC---HHHhhhhCCCCCC----------------CCCCCCCCCc---------cccccccCCChHHHHHH
Q 019844 210 ---IIKVLGTPT---REEIKCMNPNYTE----------------FKFPQIKPHP---------WHKVFQKRLPPEAVDLV 258 (335)
Q Consensus 210 ---~~~~~g~~~---~~~~~~~~~~~~~----------------~~~~~~~~~~---------~~~~~~~~~s~~~~~li 258 (335)
.....||+. ++.+... .|.. ...|...... ....++..+++++.+||
T Consensus 192 ~~~~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 192 KGRTWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp SSCBCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred ccccccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 011223333 2221110 0100 0000000000 01234567899999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 259 CRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 259 ~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
++||+.||.+|+ |++++|+||||+...+
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 999999999995 8999999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=253.86 Aligned_cols=201 Identities=18% Similarity=0.179 Sum_probs=141.5
Q ss_pred ceeeeEEee-eeeccCceEEEEEEEcCCCcEEEEEEecccchhHHHHHHHHHh-CCCCceeeeceeeeeCCCCCccEEEE
Q 019844 80 QKVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 80 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~Ei~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
..++|.+.. .||+|+||+||+|+++.+++.||||++++ ...+.+|+.++.+ ++|||||+++++|.+.. ....++||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence 345798875 69999999999999999999999999965 4567899998765 48999999999984322 23567999
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh----HHhHh---------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ----LVEII--------- 211 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~----~~~~~--------- 211 (335)
|||||+| +|.+++.... ...+++.+++.|+.||+.||+|||++| ++. ....+
T Consensus 87 vmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999995 9999997521 346999999999999999999999998 000 00001
Q ss_pred -------hhcCCCCHHH---------------hh---------hhCCCCCCCC----C----CCCCCC--ccccccccCC
Q 019844 212 -------KVLGTPTREE---------------IK---------CMNPNYTEFK----F----PQIKPH--PWHKVFQKRL 250 (335)
Q Consensus 212 -------~~~g~~~~~~---------------~~---------~~~~~~~~~~----~----~~~~~~--~~~~~~~~~~ 250 (335)
..+|++.+.. |. .+.+.|.... . ..+... .+....+..+
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 1123332110 00 0111110000 0 000000 1111122468
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 284 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~L~hp~f~~~ 284 (335)
|+++++||++||+.||++|||+.|+|+||||.+.
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 9999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=248.39 Aligned_cols=195 Identities=19% Similarity=0.247 Sum_probs=143.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----------chhHHHHHHHHHhCC--CCceeeeceeeeeCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLD--HPNIVALKHCFFSTTD 149 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~~ 149 (335)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++ |||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 4699999999999999999999999999999999642 134679999999996 89999999999
Q ss_pred CCccEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------c--ChHHhHhhh
Q 019844 150 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------V--DQLVEIIKV 213 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~--~~~~~~~~~ 213 (335)
.+...+|+||||+.| ++.+++.. ...+++.+++.|+.||+.||+|||+++ + +.....+..
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence 556669999999973 88888876 567999999999999999999999998 1 110111111
Q ss_pred ---------------cCCCCH---HHhhhhCCCCC------------------CCCCCCCCC-CccccccccCCChHHHH
Q 019844 214 ---------------LGTPTR---EEIKCMNPNYT------------------EFKFPQIKP-HPWHKVFQKRLPPEAVD 256 (335)
Q Consensus 214 ---------------~g~~~~---~~~~~~~~~~~------------------~~~~~~~~~-~~~~~~~~~~~s~~~~~ 256 (335)
.||+.+ +.+.. ...+. ...+..... ......++..+|+++++
T Consensus 155 FG~a~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 155 FGSGALLKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233 (273)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHH
T ss_pred cccceecccccccccccCCCcCCHHHHcC-CCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHH
Confidence 233321 11110 00000 000000000 00012345679999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccCCC
Q 019844 257 LVCRFFQYSPNLRCTALEACVHPFFDELRD 286 (335)
Q Consensus 257 li~~~L~~dP~~R~t~~~~L~hp~f~~~~~ 286 (335)
||++||+.||++|||++|+|+||||++...
T Consensus 234 li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999999997643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-34 Score=254.92 Aligned_cols=196 Identities=22% Similarity=0.312 Sum_probs=143.3
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHH---HHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~---Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
++|+++++||+|+||.||+|+++.+|+.||||++.+.. ..+.+ |+.+++.++|||||+++++| ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence 46999999999999999999999999999999996421 22333 46777788999999999999 55
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh--HH--------
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ--LV-------- 208 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~--~~-------- 208 (335)
...+|||||||+| +|.+++.. ...+++..++.|+.||+.||.|||+++ ++. ..
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence 6669999999995 99999986 677999999999999999999999998 000 00
Q ss_pred ------hHhhhcCCCCHHHhhhh--CCCCCC------------------CCCCCCCCC----------ccccccccCCCh
Q 019844 209 ------EIIKVLGTPTREEIKCM--NPNYTE------------------FKFPQIKPH----------PWHKVFQKRLPP 252 (335)
Q Consensus 209 ------~~~~~~g~~~~~~~~~~--~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~s~ 252 (335)
.....+||+.+...... ...|.. ..+...... .....++..+|+
T Consensus 155 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 155 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp EECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred eecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 01122344442221111 111111 011110000 111234567999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCcccccCCC
Q 019844 253 EAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 286 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t-----~~~~L~hp~f~~~~~ 286 (335)
++++||.+||+.||++||| |+++|+||||+.+.+
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 9999999999999999999 799999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-34 Score=254.24 Aligned_cols=113 Identities=27% Similarity=0.376 Sum_probs=98.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.++|+++++||+|+||+||+|+++.+|+.||||++++. .+.+.+|+.+|+.+. ||||++++++|.. ....++|+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEE
Confidence 35799999999999999999999999999999999754 356789999999995 9999999999853 234558899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||.+ +|..+ .+.+++..++.++.||+.||+|||++|
T Consensus 111 ~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~g 149 (328)
T d3bqca1 111 FEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSMG 149 (328)
T ss_dssp EECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence 999996 77544 346999999999999999999999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.1e-32 Score=239.56 Aligned_cols=120 Identities=29% Similarity=0.438 Sum_probs=96.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCC---CC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~---~~ 151 (335)
.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+.+|+.++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46799999999999999999999999999999998532 2456799999999999999999999854321 23
Q ss_pred ccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..++|+|||||.+++...... ....+++..++.|+.||+.||.|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC
Confidence 456899999999755443332 2567999999999999999999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.8e-32 Score=237.05 Aligned_cols=119 Identities=25% Similarity=0.227 Sum_probs=104.4
Q ss_pred ceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-------hhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 80 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..++|++.+.||+|+||+||+|+++.+|+.||||+++++. ..+.+|+.+|+.++|||||++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 3467999999999999999999999999999999996432 34679999999999999999999996543 334
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+|||||||+| +|.+++.. .+.+++.+++.|+.||+.||+|||++|
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ 131 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG 131 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568899999996 99988876 667999999999999999999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.3e-32 Score=237.21 Aligned_cols=116 Identities=21% Similarity=0.350 Sum_probs=103.0
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++++.||+|+||+||+|+++.+++.||||+++.+ .+.+.+|+.+|+.++|||||++++++ .+...+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeEE
Confidence 45699999999999999999999999999999999653 35678999999999999999999999 44555889
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||++ +|.+++.... ...+++..++.|+.||+.||+|||+++
T Consensus 91 v~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~ 135 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN 135 (287)
T ss_dssp EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999995 9999987632 467999999999999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=236.75 Aligned_cols=197 Identities=23% Similarity=0.333 Sum_probs=143.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEE---cCCCcEEEEEEeccc--------chhHHHHHHHHHhCCC-CceeeeceeeeeCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTT 148 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~---~~~~~~vAvK~i~~~--------~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~ 148 (335)
.++|++++.||+|+||+||+|++ +.+|+.||||++.+. .+.+.+|+.+|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 36799999999999999999997 447899999998532 2457799999999966 8999999999
Q ss_pred CCCccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------
Q 019844 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------ 203 (335)
Q Consensus 149 ~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------ 203 (335)
.+..+++++||||.| +|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred -ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeec
Confidence 556669999999996 99999887 667899999999999999999999998
Q ss_pred -------cChHHhHhhhcCCCC---HHHhhhhCCCCC--------------------CCCCCCCCCC---------cccc
Q 019844 204 -------VDQLVEIIKVLGTPT---REEIKCMNPNYT--------------------EFKFPQIKPH---------PWHK 244 (335)
Q Consensus 204 -------~~~~~~~~~~~g~~~---~~~~~~~~~~~~--------------------~~~~~~~~~~---------~~~~ 244 (335)
...........|++. ++.+......|. +|........ ....
T Consensus 174 G~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred cchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence 000111112233333 111111100111 0110000000 0112
Q ss_pred ccccCCChHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCCC
Q 019844 245 VFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 286 (335)
Q Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~~~L~hp~f~~~~~ 286 (335)
.++..+|+++.+||.+||++||.+|| |++|+|+||||+++.+
T Consensus 254 ~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 34567899999999999999999999 5899999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=226.67 Aligned_cols=113 Identities=23% Similarity=0.288 Sum_probs=98.8
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
++|+++++||+|+||+||+|+++ +++.||||++++. ...+.+|+.+++.++|||||++++++ .+...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence 45999999999999999999984 7889999999753 35688999999999999999999999 444458999
Q ss_pred eecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||+ |+|..++... ...+++..++.|+.||+.||.|||+++
T Consensus 78 ~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~ 120 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ 120 (258)
T ss_dssp EECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence 99998 5888886642 456999999999999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.1e-31 Score=225.52 Aligned_cols=113 Identities=21% Similarity=0.340 Sum_probs=98.7
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
++|++++.||+|+||.||+|+++ +++.||||++++. .+.+.+|+.+++.++|||||++++++. ....+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence 35999999999999999999985 6778999999753 356789999999999999999999994 44458899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++ +|.+++... ...+++..+..|+.||+.||+|||+++
T Consensus 79 ~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~ 121 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC 121 (263)
T ss_dssp EECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc
Confidence 999995 999988752 456899999999999999999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-31 Score=227.88 Aligned_cols=194 Identities=23% Similarity=0.239 Sum_probs=134.7
Q ss_pred eeeeEEeee-eeccCceEEEEEEEcC--CCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~-lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.. .+.+.+|+.+|++++|||||++++++. .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-----~~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----AE 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cC
Confidence 356888885 9999999999998764 3457999999643 245789999999999999999999883 22
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hHHhHh-------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QLVEII------- 211 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~~~~~------- 211 (335)
.+|||||||+| +|.+++.. .+..+++..+..|+.||+.||+|||+++ ++ .....+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence 27899999995 99998754 2457999999999999999999999998 00 000000
Q ss_pred -------------hhcCCCC---HHHh----------------------hhhCCCCCCCCCCCCC---CCccccccccCC
Q 019844 212 -------------KVLGTPT---REEI----------------------KCMNPNYTEFKFPQIK---PHPWHKVFQKRL 250 (335)
Q Consensus 212 -------------~~~g~~~---~~~~----------------------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 250 (335)
...|++. |+.+ ..+.+.|.......+. .......+|..+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 237 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 0112221 2211 1112222211100000 001122355789
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHH---hcCccccc
Q 019844 251 PPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE 283 (335)
Q Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~~---L~hp~f~~ 283 (335)
|+++.+||.+||..||++|||+.++ |+|+|+.-
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999877 67888754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-31 Score=223.70 Aligned_cols=115 Identities=23% Similarity=0.340 Sum_probs=98.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv 158 (335)
.++|++++.||+|+||.||+|.++ |..||||+++++ .+.+.+|+.+|++++|||||++++++.. ....+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEEE
Confidence 346999999999999999999984 788999999754 3568899999999999999999998853 22347899
Q ss_pred eecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 159 ~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||||++ +|.+++.... ...+++..+..|+.||+.||.|||+++
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~ 123 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN 123 (262)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc
Confidence 999995 9999997643 345899999999999999999999988
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-31 Score=227.35 Aligned_cols=194 Identities=20% Similarity=0.201 Sum_probs=137.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++++.||+|+||.||+|+++ ++..||||++... .+.+.+|+.+|++++|||||++++++. +. .+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeEE
Confidence 457999999999999999999985 6788999999643 356789999999999999999999872 22 2679
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cC-hHHhHhhh----------
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VD-QLVEIIKV---------- 213 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~-~~~~~~~~---------- 213 (335)
|||||++ +|.+++.... ...+++..+..|+.||+.||.|||+++ ++ .....+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999995 9988776433 346999999999999999999999998 00 00000111
Q ss_pred --------cCCCC---HHHhhh----------------------hCCCCCCCCCCC---CCCCccccccccCCChHHHHH
Q 019844 214 --------LGTPT---REEIKC----------------------MNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 214 --------~g~~~---~~~~~~----------------------~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~l 257 (335)
.|++. ++.+.. +.|.+....... .-........+..+++++.+|
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 22221 221110 111111000000 000011223456789999999
Q ss_pred HHHhccCCCCCCCCHHHHhc--Cccccc
Q 019844 258 VCRFFQYSPNLRCTALEACV--HPFFDE 283 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~--hp~f~~ 283 (335)
|.+||+.||++|||+.++++ |+||..
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999998 888863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.9e-31 Score=226.29 Aligned_cols=106 Identities=23% Similarity=0.291 Sum_probs=90.8
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 88 ~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
++||+|+||+||+|.++ .+++.||||+++.. .+.+.+|+.+|++++|||||++++++. .+. +||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~~-~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SSS-EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cCC-EEEEE
Confidence 57999999999999864 45678999999642 245789999999999999999999883 222 67999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||+| +|.+++.. ...+++..+..|+.||+.||+|||+++
T Consensus 87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~ 127 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 127 (277)
T ss_dssp ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC
Confidence 99995 99999886 677999999999999999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.7e-30 Score=226.68 Aligned_cols=114 Identities=23% Similarity=0.384 Sum_probs=96.6
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc---EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~ 153 (335)
.+|++.++||+|+||+||+|+++.+++ .||||.+... .+.+.+|+.+|++++|||||++++++ ....
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence 469999999999999999999987765 5899988542 24578999999999999999999999 4444
Q ss_pred EEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+|+|||||+| +|.+++... .+.+++.++..|+.||+.||.|||+++
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN 148 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 58899999996 999887752 456999999999999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-30 Score=222.29 Aligned_cols=195 Identities=22% Similarity=0.261 Sum_probs=138.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc---chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.++|++++.||+|+||+||+|+++.+ +.||||++... .+.+.+|+.+|+.++|||||++++++. ++. +|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~~-~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EEP-IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS-CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cCC-eEE
Confidence 35799999999999999999999654 57999999643 356889999999999999999999882 222 679
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cCh-HHhHhhhcCCCC-----
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQ-LVEIIKVLGTPT----- 218 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~-~~~~~~~~g~~~----- 218 (335)
|||||++ +|..++.... ...+++.+++.|+.||+.||+|||+++ ++. ....+..+|...
T Consensus 89 v~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999995 8888876533 456999999999999999999999998 111 111112222211
Q ss_pred ----------------HHHhhh----------------------hCCCCCCCCCCC---CCCCccccccccCCChHHHHH
Q 019844 219 ----------------REEIKC----------------------MNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAVDL 257 (335)
Q Consensus 219 ----------------~~~~~~----------------------~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~l 257 (335)
++.+.. +.|.+....... .........++..+++++++|
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 111110 001000000000 000011223557889999999
Q ss_pred HHHhccCCCCCCCCHHHHhc--CcccccC
Q 019844 258 VCRFFQYSPNLRCTALEACV--HPFFDEL 284 (335)
Q Consensus 258 i~~~L~~dP~~R~t~~~~L~--hp~f~~~ 284 (335)
|.+||+.||++|||++++++ ++||+..
T Consensus 247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 247 MCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999999988 8888765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-30 Score=227.30 Aligned_cols=193 Identities=16% Similarity=0.155 Sum_probs=134.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCc-----EEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|+++++||+|+||+||+|+++.+++ .||+|.+... ...+.+|+.+|+++ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 3579999999999999999999876554 6999998532 24577999999998 899999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC------
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCI------ 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~------ 203 (335)
.....+|||||||+| +|.+++..... ....+++..++.|+.||+.||+|||+++
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 455558999999995 99999975321 1235899999999999999999999998
Q ss_pred --------------cCh--HHh----------HhhhcCCCC---HHHhh----------------------hhCCCCCCC
Q 019844 204 --------------VDQ--LVE----------IIKVLGTPT---REEIK----------------------CMNPNYTEF 232 (335)
Q Consensus 204 --------------~~~--~~~----------~~~~~g~~~---~~~~~----------------------~~~~~~~~~ 232 (335)
+.. +.. .....||+. |+.+. .+.+.|...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 000 000 001122322 22211 111111111
Q ss_pred CCCC----CCCCccccccccCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019844 233 KFPQ----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 278 (335)
Q Consensus 233 ~~~~----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~h 278 (335)
.... +....+....|..+|+++++||.+||+.||++|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0000 000112233556889999999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.8e-30 Score=219.88 Aligned_cols=189 Identities=21% Similarity=0.229 Sum_probs=131.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC---cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.++|++++.||+|+||.||+|++..++ ..||||.+... ...+.+|+.+|+.++|||||++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence 457999999999999999999987553 46899988532 245779999999999999999999982 2
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------cC------
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------VD------ 205 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------~~------ 205 (335)
..+|+|||||++ +|.+++... ...+++..++.++.||+.||.|||+++ +.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 237899999995 898877652 457999999999999999999999998 00
Q ss_pred -----hHHhHhhhcCCCC---HHHhh----------------------hhCCCCCCCCCCCCC---CCccccccccCCCh
Q 019844 206 -----QLVEIIKVLGTPT---REEIK----------------------CMNPNYTEFKFPQIK---PHPWHKVFQKRLPP 252 (335)
Q Consensus 206 -----~~~~~~~~~g~~~---~~~~~----------------------~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~ 252 (335)
.........|++. ++.+. .+.+.+......... .......++..+|+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 0000011122222 12111 111111111000000 00111235678999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 019844 253 EAVDLVCRFFQYSPNLRCTALEACVH 278 (335)
Q Consensus 253 ~~~~li~~~L~~dP~~R~t~~~~L~h 278 (335)
++.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.4e-30 Score=223.81 Aligned_cols=192 Identities=22% Similarity=0.307 Sum_probs=135.1
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcE--EEEEEecc-----cchhHHHHHHHHHhC-CCCceeeeceeeeeCCCCCcc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~-----~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 153 (335)
++|++.++||+|+||.||+|+++.+|.. ||||.+.. ..+.+.+|+.+|+++ +|||||++++++ ....
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecCC
Confidence 5799999999999999999999888875 67787743 234678999999999 799999999999 4455
Q ss_pred EEEEEeecchh-hHHHHHHHHh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------cChH-
Q 019844 154 YLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCI------------VDQL- 207 (335)
Q Consensus 154 ~~~iv~e~~~g-~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------~~~~- 207 (335)
.+|||||||+| +|.+++.... .....+++..+..++.||+.||.|||+++ ++..
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 69999999995 9999987421 12367999999999999999999999998 0000
Q ss_pred HhHh----------------hhcCCCC---HHHhh----------------------hhCCCCCCCCCCCC---CCCccc
Q 019844 208 VEII----------------KVLGTPT---REEIK----------------------CMNPNYTEFKFPQI---KPHPWH 243 (335)
Q Consensus 208 ~~~~----------------~~~g~~~---~~~~~----------------------~~~~~~~~~~~~~~---~~~~~~ 243 (335)
...+ ...|++. ++.+. ...+.+.......+ -.....
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 0000 1122222 22111 01111111000000 000112
Q ss_pred cccccCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019844 244 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 278 (335)
Q Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~L~h 278 (335)
...+..+++++++||.+||+.||++|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33456789999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.5e-29 Score=217.79 Aligned_cols=189 Identities=16% Similarity=0.204 Sum_probs=129.4
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCc----EEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
.+|+++++||+|+||+||+|.++.+|+ .||+|.+... .+.+.+|+.+|++++|||||++++++.. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 359999999999999999999988876 5888887532 3467899999999999999999999843 2
Q ss_pred cEEEEEeecch-hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------c--ChHHh
Q 019844 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------------------V--DQLVE 209 (335)
Q Consensus 153 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------~--~~~~~ 209 (335)
. .+++|||+. |+|.+.+... ...+++..++.|+.||+.||+|||+++ + -.+..
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred C-eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 2 557788887 5888877652 567999999999999999999999998 0 00000
Q ss_pred ----------HhhhcCCCC---HHHhhh----------------------hCCCCCCCCCCCCC---CCccccccccCCC
Q 019844 210 ----------IIKVLGTPT---REEIKC----------------------MNPNYTEFKFPQIK---PHPWHKVFQKRLP 251 (335)
Q Consensus 210 ----------~~~~~g~~~---~~~~~~----------------------~~~~~~~~~~~~~~---~~~~~~~~~~~~s 251 (335)
.....|++. ++.+.. +.+.|.......+. ........+..++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 011123332 222111 11111111000000 0001123456789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCc
Q 019844 252 PEAVDLVCRFFQYSPNLRCTALEACVHP 279 (335)
Q Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~~L~hp 279 (335)
+++.+||.+||+.||++|||+.++++|-
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999883
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8e-29 Score=217.38 Aligned_cols=118 Identities=20% Similarity=0.260 Sum_probs=99.2
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|+++++||+|+||.||+|+++ .+++.||||++++.. ..+.+|+.+++.+ +|||||++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 467999999999999999999863 466789999996432 3567899999999 799999999999
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.....+|||||||+| +|.+++..... ....+++..++.|+.||+.||+|||+++
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ 165 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 444558899999995 99999876321 1236999999999999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-28 Score=212.53 Aligned_cols=114 Identities=20% Similarity=0.317 Sum_probs=96.2
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCC----cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCc
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~ 152 (335)
..|.+.++||+|+||.||+|.++.++ ..||||++... ...+.+|+.+|+.++|||||++++++ ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence 35999999999999999999987655 47999998642 23577999999999999999999999 444
Q ss_pred cEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
..+++|||||.+ ++.+++... ...+++.++..|+.||+.||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~ 130 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN 130 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc
Confidence 458899999996 888777652 467999999999999999999999988
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-29 Score=214.82 Aligned_cols=111 Identities=18% Similarity=0.247 Sum_probs=94.3
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 154 (335)
.++|++++.||+|+||+||+|+.+ ..||||+++.. .+.+.+|+.+|++++|||||++++++. . ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-cE
Confidence 356999999999999999999863 46999998632 245779999999999999999999862 2 23
Q ss_pred EEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 155 ~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||||+| +|.+++... ...+++..+..|+.||+.||+|||+++
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~ 124 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS 124 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 7899999995 999998742 456999999999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.7e-29 Score=214.11 Aligned_cols=113 Identities=25% Similarity=0.319 Sum_probs=88.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCC-C--cEEEEEEeccc-------chhHHHHHHHHHhCCCCceeeeceeeeeCCCCC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~-~--~~vAvK~i~~~-------~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 151 (335)
.+|++.+.||+|+||.||+|++..+ + ..||||++.+. .+.+.+|+.+|+.++|||||++++++. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 4599999999999999999987533 3 36899988642 245789999999999999999999993 2
Q ss_pred ccEEEEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 152 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
. .+++|||||++ +|.+.+... .+.+++..+..++.||+.||.|||+++
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~ 131 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR 131 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 2 36799999995 888777653 456999999999999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=215.83 Aligned_cols=118 Identities=18% Similarity=0.225 Sum_probs=98.5
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEecccc-----hhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|.+++.||+|+||.||+|.++. ++..||||++.+.. ..+.+|+.++++++|||||++++++ .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence 4679999999999999999999853 35789999996432 3467999999999999999999999 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++|||||++ +|.+++...... ...+++..+..|+.||+.||.|||+++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ 153 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 153 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 44458899999995 999998754311 134789999999999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-28 Score=215.20 Aligned_cols=118 Identities=20% Similarity=0.329 Sum_probs=92.8
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCC-------cEEEEEEecccc-----hhHHHHHHHHHhC-CCCceeeeceeeeeC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST 147 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAvK~i~~~~-----~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 147 (335)
.++|++++.||+|+||.||+|++..++ ..||||++.++. ..+.+|+..+.++ +|||||++++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--- 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence 457999999999999999999986654 379999996532 4466788888888 899999999999
Q ss_pred CCCCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.+...+|+|||||++ +|.+++..... ....+++..++.|+.||+.||+|||+++
T Consensus 89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ 155 (299)
T d1fgka_ 89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155 (299)
T ss_dssp --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 445558899999995 99999975321 1346899999999999999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=5.1e-28 Score=216.91 Aligned_cols=117 Identities=29% Similarity=0.439 Sum_probs=91.5
Q ss_pred eeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc---hhHHHHHHHHHhCC-----------CCceeeeceeeeeC
Q 019844 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFST 147 (335)
Q Consensus 82 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~Ei~~l~~l~-----------hpnIv~~~~~~~~~ 147 (335)
.||+++++||+|+||+||+|+++.+|+.||||+++++. ....+|+.+++.++ |+|||++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999999999999999997653 45678999988875 47899999988432
Q ss_pred CCCCccEEEEEeecch--hhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 019844 148 TDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CI 203 (335)
Q Consensus 148 ~~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ 203 (335)
...+.+++|+++. ++........ ....+++..++.++.||+.||.|||+ .|
T Consensus 93 ---~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~ 146 (362)
T d1q8ya_ 93 ---GPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG 146 (362)
T ss_dssp ---ETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ---cccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC
Confidence 2233555555554 4444433332 25679999999999999999999997 66
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=5.1e-28 Score=211.27 Aligned_cols=118 Identities=25% Similarity=0.323 Sum_probs=98.7
Q ss_pred eeeeEEeeeeeccCceEEEEEEEc-----CCCcEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 150 (335)
.++|++++.||+|+||+||+|+++ .+++.||||++... .+.+.+|+.+|+.++||||+++++++ .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-----c
Confidence 456999999999999999999975 35678999999643 24578999999999999999999999 4
Q ss_pred CccEEEEEeecchh-hHHHHHHHHh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 151 EELYLNLVLEYVPE-TVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 151 ~~~~~~iv~e~~~g-~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++||||+++ +|.+++.... .....+++..+..|+.||+.||+|||+++
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 44458899999995 9999987421 11235899999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.2e-28 Score=211.15 Aligned_cols=119 Identities=20% Similarity=0.291 Sum_probs=94.4
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcC-----CCcEEEEEEeccc-----chhHHHHHHHHHhC-CCCceeeeceeeeeCCC
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 149 (335)
.++|+++++||+|+||.||+|++.. +++.||||+++.. .+.+.+|+.++.++ +|+|||.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 3579999999999999999999754 4568999998643 24466778877777 68999999998743
Q ss_pred CCccEEEEEeecchh-hHHHHHHHHhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 150 KEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 150 ~~~~~~~iv~e~~~g-~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
....+++|||||+| +|.+++..... ....+++.+++.|+.||+.||+|||+++
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 154 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 33448899999995 99999986432 1245899999999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-27 Score=208.77 Aligned_cols=113 Identities=19% Similarity=0.261 Sum_probs=92.8
Q ss_pred eEEeeeeeccCceEEEEEEEcCCC---cEEEEEEeccc-----chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEE
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 155 (335)
+...++||+|+||+||+|++..++ ..||||++++. .+.+.+|+.+|++++|||||++++++.. ....+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCce
Confidence 344688999999999999986543 36999998642 2457899999999999999999999753 23458
Q ss_pred EEEeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 156 ~iv~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++|||||++ +|.+++.. ....+++..+..++.|++.||.|||+.+
T Consensus 105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~ 150 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK 150 (311)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC
Confidence 899999996 99888774 2456788899999999999999999988
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1.6e-26 Score=201.67 Aligned_cols=118 Identities=22% Similarity=0.240 Sum_probs=97.8
Q ss_pred cceeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc--chhHHHHHHHHHhCCCCceeeeceeeeeCCCCCccEEE
Q 019844 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (335)
Q Consensus 79 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 156 (335)
+.+++|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|+++++.++|+|+|..+..+. ......+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~ 79 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 79 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEE
Confidence 3456799999999999999999999999999999988643 356789999999998776555444443 3445688
Q ss_pred EEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 157 iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
+|||||+|+|...+... .+.+++..+..++.||+.||+|||++|
T Consensus 80 ivme~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999998877766542 467999999999999999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=3.7e-25 Score=192.17 Aligned_cols=115 Identities=22% Similarity=0.254 Sum_probs=101.6
Q ss_pred eeeeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecc--cchhHHHHHHHHHhCCC-CceeeeceeeeeCCCCCccEEEE
Q 019844 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 81 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~~i 157 (335)
+++|++++.||+|+||+||+|+++.+|+.||||++.. +...+.+|+++++.|.| +||+.+++++ ....+.|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEE
Confidence 3469999999999999999999999999999999854 34567899999999965 8999999998 55666899
Q ss_pred EeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
|||||+|+|.+++... ...+++..+..++.|++.||+|||++|
T Consensus 79 vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g 121 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS 121 (293)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC
Confidence 9999998999988753 456999999999999999999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.9e-25 Score=190.87 Aligned_cols=112 Identities=23% Similarity=0.235 Sum_probs=92.6
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc-hhHHHHH--HHHHhCCCCceeeeceeeeeCCCCCccEEEEEe
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNREL--QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~Ei--~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~iv~ 159 (335)
+|.+.+.||+|+||.||+|++ +|+.||||+++.+. ....+|. ..++.++|||||++++++.... .....+|+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 599999999999999999987 58999999996543 3333444 4556789999999999997544 3345689999
Q ss_pred ecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019844 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202 (335)
Q Consensus 160 e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 202 (335)
|||.+ +|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~ 119 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 99985 99999975 4699999999999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.50 E-value=2.7e-14 Score=115.02 Aligned_cols=100 Identities=14% Similarity=0.050 Sum_probs=79.2
Q ss_pred eEEeeeeeccCceEEEEEEEcCCCcEEEEEEecccc----------------------hhHHHHHHHHHhCCCCceeeec
Q 019844 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK 141 (335)
Q Consensus 84 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------------------~~~~~Ei~~l~~l~hpnIv~~~ 141 (335)
+.++++||+|+||+||+|.+ .+|+.||||+++... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999998 478999999875210 1224688899999999999987
Q ss_pred eeeeeCCCCCccEEEEEeecchhhHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 142 ~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++. . .+++|||+++.. ...+++..+..++.||+.||.|||++|
T Consensus 81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~~g 123 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYHRG 123 (191)
T ss_dssp EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHHTT
T ss_pred Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhhCC
Confidence 764 2 259999999732 122566678899999999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.32 E-value=0.0084 Score=48.37 Aligned_cols=105 Identities=12% Similarity=0.037 Sum_probs=69.8
Q ss_pred eeEEeeeeeccCceEEEEEEEcCCCcEEEEEEeccc----chhHHHHHHHHHhCC-CCceeeeceeeeeCCCCCccEEEE
Q 019844 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (335)
Q Consensus 83 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~i 157 (335)
.|++.+..+-++.+.||+.. ..+..+.+|+.... ...+.+|...+..+. +--+.+++.+. ...+..|+
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 46666665555667899886 35677888987543 234678999888774 32345555555 33455789
Q ss_pred Eeecchh-hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 158 v~e~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
||++++| .+..... +......++.++...|.-||+..
T Consensus 88 v~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~ 125 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSID 125 (263)
T ss_dssp EEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSC
T ss_pred EEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccC
Confidence 9999998 6644321 22224456788888999999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.01 E-value=0.084 Score=45.24 Aligned_cols=105 Identities=13% Similarity=0.068 Sum_probs=62.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEecc-----------cchhHHHHHHHHHhC-CC--CceeeeceeeeeCCCCCc
Q 019844 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQML-DH--PNIVALKHCFFSTTDKEE 152 (335)
Q Consensus 87 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~Ei~~l~~l-~h--pnIv~~~~~~~~~~~~~~ 152 (335)
.+.||.|....||++.+..+++.++||.-.. ...+..+|...|+.+ .+ ..+.+++.+- ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----CCC
Confidence 5578999999999999877788999996432 123456799888877 33 3455555432 222
Q ss_pred cEEEEEeecchh--hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 153 LYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 153 ~~~~iv~e~~~g--~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
.++|||++++ .+...+.. +......+..+...++.-+.+.|...
T Consensus 106 --~~lvmE~L~~~~~~~~~l~~-----~~~~~~~a~~lg~~La~~h~~~~~~~ 151 (392)
T d2pula1 106 --AVTVMEDLSHLKIARKGLIE-----GENYPHLSQHIGEFLGKTLFYSSDYA 151 (392)
T ss_dssp --TEEEECCCTTSEEHHHHHHH-----TCCCTTHHHHHHHHHHHHHHHTSTTT
T ss_pred --CEEEEeccCCcccchhhhcc-----cchhHHHHHHHHHHHHHHHHHhcccc
Confidence 3489999986 44444433 22333444455555555455555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.68 E-value=0.17 Score=39.89 Aligned_cols=97 Identities=15% Similarity=0.084 Sum_probs=61.9
Q ss_pred eeeccC-ceEEEEEEEcCCCcEEEEEEeccc-chhHHHHHHHHHhCCC--CceeeeceeeeeCCCCCccEEEEEeecchh
Q 019844 89 VVGTGS-FGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEYVPE 164 (335)
Q Consensus 89 ~lG~G~-fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g 164 (335)
.+..|. -+.||+... ..+..+.+|.-... ...+.+|...|+.|.. -.+.+++.+. .+....++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence 344444 357898876 45667888976543 3457789999988843 2245566655 233447899999998
Q ss_pred -hHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019844 165 -TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (335)
Q Consensus 165 -~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 203 (335)
++.. ..... ..++.++...|.-||...
T Consensus 91 ~~~~~---------~~~~~---~~~~~~l~~~la~LH~~~ 118 (255)
T d1nd4a_ 91 QDLLS---------SHLAP---AEKVSIMADAMRRLHTLD 118 (255)
T ss_dssp EETTT---------SCCCH---HHHHHHHHHHHHHHTTSC
T ss_pred ccccc---------ccccH---HHHHHHHHHHHHHHccCC
Confidence 6521 12332 233567788888899765
|